data_2l0w_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2l0w _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 29.1 p . . . . . 0 N--CA 1.479 1.023 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -71.21 -45.31 63.64 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.848 0.859 . . . . 0.0 111.997 178.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 61.5 tp -63.0 -37.08 85.77 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.742 0.817 . . . . 0.0 110.947 176.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -59.17 -28.34 66.51 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 178.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.9 m -67.98 -29.24 68.22 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.839 0.856 . . . . 0.0 111.108 173.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 17.6 mm -74.16 -41.45 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-N 119.017 0.826 . . . . 0.0 109.23 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 3.1 mp -58.94 -46.72 91.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 122.971 0.508 . . . . 0.0 110.269 170.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 84.8 mtm180 -63.49 -35.1 79.33 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 119.125 0.875 . . . . 0.0 113.069 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -69.8 -39.1 76.77 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.172 0.989 . . . . 0.0 112.671 174.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -77.37 -33.82 55.13 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.507 1.123 . . . . 0.0 111.988 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 . . . . . 0 CA--C 1.546 0.815 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -175.216 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.47 0.564 0 CA-C-O 122.09 0.947 . . . . 0.0 111.665 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.7 mptt -93.14 133.21 36.55 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 120.911 -1.118 . . . . 0.0 110.693 -177.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -161.17 155.05 22.32 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.689 1.196 . . . . 0.0 113.279 178.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 18.4 pt -140.74 152.61 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 125.777 1.631 . . . . 0.0 110.766 177.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 14.0 mt -111.05 132.4 59.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 125.856 1.663 . . . . 0.0 108.818 179.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -131.47 143.26 50.29 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.673 1.189 . . . . 0.0 111.489 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -67.78 119.22 12.14 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.518 0.727 . . . . 0.0 111.862 176.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -79.67 -19.59 48.67 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -178.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -77.97 -36.62 48.82 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.522 1.129 . . . . 0.0 112.359 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 55.0 t -70.5 130.5 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 125.361 1.464 . . . . 0.0 109.486 171.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -60.18 -43.26 96.01 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.289 1.036 . . . . 0.0 113.516 -169.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 20.0 p30 -74.94 -10.04 59.11 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 113.842 1.052 . . . . 0.0 113.842 178.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 79.7 m 55.68 65.16 1.53 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.927 1.691 . . . . 0.0 112.662 -175.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.61 136.01 57.85 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.472 0.709 . . . . 0.0 112.015 178.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 41.4 t -61.9 121.04 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 169.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 42.9 pt -103.68 -17.08 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 125.063 1.345 . . . . 0.0 112.221 175.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -159.62 152.32 21.49 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.278 1.031 . . . . 0.0 112.014 175.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 8.1 p -146.49 155.07 42.26 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.51 1.124 . . . . 0.0 112.756 178.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -75.96 -154.18 0.05 OUTLIER 'General case' 0 CA--C 1.558 1.266 0 C-N-CA 123.407 0.683 . . . . 0.0 112.317 -176.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -108.73 -21.83 12.5 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 120.271 -1.518 . . . . 0.0 112.896 165.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -75.84 -37.75 38.26 Favored Glycine 0 C--N 1.343 0.959 0 O-C-N 121.513 -0.742 . . . . 0.0 112.479 -176.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -56.92 -41.47 78.23 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.224 1.009 . . . . 0.0 111.109 177.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 40.5 t -57.12 -53.04 62.65 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.978 1.711 . . . . 0.0 112.214 177.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -73.23 -29.1 62.55 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -179.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -64.31 -42.25 96.43 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.296 1.438 . . . . 0.0 111.832 177.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 9.1 t -100.06 -28.96 12.79 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.88 11.87 62.95 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 124.916 1.246 . . . . 0.0 114.047 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -87.58 -154.14 0.25 Allowed 'General case' 0 CA--C 1.552 1.036 0 CA-C-N 118.524 1.162 . . . . 0.0 111.419 170.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 64.4 m -149.65 158.47 44.2 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.676 1.19 . . . . 0.0 110.787 177.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -48.67 -48.86 39.56 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.976 0.911 . . . . 0.0 111.333 173.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.77 -26.54 35.1 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 177.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -92.39 -37.62 12.48 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.61 1.164 . . . . 0.0 112.004 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 93.2 t -86.33 -16.26 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 124.665 1.186 . . . . 0.0 112.205 -178.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 87.0 mmm -76.27 143.28 41.02 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 120.91 -1.119 . . . . 0.0 111.058 171.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 24.8 mp0 59.21 36.6 23.86 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.69 1.196 . . . . 0.0 111.15 -169.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 88.5 mmt-85 -123.72 154.41 66.95 Favored Pre-proline 0 N--CA 1.472 0.656 0 C-N-CA 125.075 1.35 . . . . 0.0 110.5 169.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -68.56 137.17 38.46 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 123.191 2.594 . . . . 0.0 109.67 172.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 21.2 p -65.83 -11.89 49.97 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 -175.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 42.5 p -58.18 -26.06 62.31 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 126.242 1.817 . . . . 0.0 112.967 173.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 74.9 m 57.8 38.63 27.32 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.741 1.216 . . . . 0.0 112.816 178.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -56.1 -28.66 58.61 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.143 1.377 . . . . 0.0 113.366 -175.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -57.95 -23.99 56.01 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.828 1.651 . . . . 0.0 113.18 176.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 40.1 mt -82.03 -8.67 59.68 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -176.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 43.2 m170 -71.75 125.32 26.83 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.857 0.863 . . . . 0.0 111.693 -178.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -107.83 -162.16 21.17 Favored Glycine 0 CA--C 1.54 1.618 0 C-N-CA 126.452 1.977 . . . . 0.0 112.505 174.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -70.31 -26.23 25.2 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 123.276 2.651 . . . . 0.0 113.14 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 37.2 mmt180 -80.88 -14.24 58.19 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 177.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 38.1 m -70.64 138.08 50.45 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.177 0.991 . . . . 0.0 112.281 -167.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -88.65 110.45 20.96 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.514 1.526 . . . . 0.0 109.781 -171.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 50.9 tpt85 -61.57 -30.18 70.5 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 121.369 -0.832 . . . . 0.0 112.933 -177.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 20.6 tpt180 -66.96 -38.42 86.06 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.093 1.357 . . . . 0.0 111.64 174.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -72.51 -41.54 65.8 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.835 0.854 . . . . 0.0 111.774 175.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -54.95 -35.14 63.93 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.173 0.589 . . . . 0.0 111.849 171.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.58 -49.71 51.54 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.403 1.081 . . . . 0.0 111.66 173.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 21.9 mm-40 -59.55 -36.63 76.55 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 118.256 -0.878 . . . . 0.0 111.891 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 89.8 mt -60.35 -44.98 97.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 CA-C-N 120.234 1.379 . . . . 0.0 111.613 171.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.89 -40.15 91.29 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 118.88 0.764 . . . . 0.0 112.423 177.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -70.07 -28.4 65.4 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.319 0.648 . . . . 0.0 112.333 175.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.58 -28.99 68.91 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 119.908 1.231 . . . . 0.0 112.47 175.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 43.4 mt -74.22 -13.11 60.74 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.624 1.569 . . . . 0.0 113.381 175.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 67.3 mt -88.47 -16.58 32.37 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.107 0.963 . . . . 0.0 112.203 173.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -88.88 153.62 23.94 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 125.133 1.349 . . . . 0.0 113.425 -179.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -93.11 -1.07 56.8 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.102 1.361 . . . . 0.0 113.858 176.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -124.34 159.82 29.47 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 126.173 1.789 . . . . 0.0 111.583 -171.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -63.37 141.28 58.82 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.876 1.271 . . . . 0.0 112.201 -178.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 23.6 tpt180 -150.86 127.72 11.0 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.281 1.033 . . . . 0.0 112.06 -171.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 40.8 mtmt -106.29 140.66 38.88 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.735 1.214 . . . . 0.0 111.91 171.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 66.6 t -137.13 139.18 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 126.074 1.75 . . . . 0.0 108.575 175.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -107.37 133.55 51.74 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.242 1.017 . . . . 0.0 111.303 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.2 tt -160.34 146.4 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 123.882 0.873 . . . . 0.0 112.547 -166.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -84.68 125.5 32.56 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.122 -0.986 . . . . 0.0 112.154 174.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 20.2 m-30 -115.59 154.05 30.13 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.71 2.004 . . . . 0.0 111.395 171.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -94.26 155.07 17.21 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 123.726 0.81 . . . . 0.0 113.016 166.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -104.17 151.29 23.5 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 127.578 2.351 . . . . 0.0 109.729 168.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -60.27 -24.85 65.25 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 -174.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 53.2 p-10 -71.53 -12.89 61.61 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.185 1.394 . . . . 0.0 114.476 174.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 103.76 0.78 45.93 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 126.575 2.036 . . . . 0.0 114.524 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 70.5 m -82.86 162.04 21.73 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 119.406 1.603 . . . . 0.0 112.228 175.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 94.2 m -127.35 164.6 21.45 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.477 1.111 . . . . 0.0 112.014 178.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -165.03 149.51 9.02 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.899 1.28 . . . . 0.0 111.787 177.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -74.3 118.94 17.84 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 123.707 0.803 . . . . 0.0 109.558 164.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 16.3 t -101.3 137.92 39.01 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 126.444 1.898 . . . . 0.0 109.609 173.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 20.4 tp -90.44 119.71 30.95 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 159.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 29.6 t -100.88 122.84 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 172.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -119.53 111.76 18.51 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.175 1.39 . . . . 0.0 109.761 178.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.2 p -87.81 127.12 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-O 121.227 0.537 . . . . 0.0 109.837 172.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 90.6 t -113.59 112.09 48.7 Favored Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 125.908 1.683 . . . . 0.0 106.886 177.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.43 131.95 14.35 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.984 2.456 . . . . 0.0 110.276 -178.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 76.6 t -104.91 116.6 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 123.935 0.894 . . . . 0.0 109.083 174.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 62.4 mttt -87.32 153.69 21.27 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.624 0.77 . . . . 0.0 112.4 172.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -91.93 -173.77 3.59 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.313 1.045 . . . . 0.0 111.58 175.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -61.36 -20.81 63.42 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 179.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -95.11 -0.12 53.75 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.878 1.271 . . . . 0.0 113.148 177.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 79.71 22.22 64.66 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 124.173 0.892 . . . . 0.0 114.719 176.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -107.69 148.49 29.33 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.136 1.374 . . . . 0.0 109.92 171.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.6 p -81.02 122.25 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 123.701 0.8 . . . . 0.0 110.652 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -121.86 -23.79 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -174.096 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 60.9 mtm -129.74 150.5 51.02 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.07 1.348 . . . . 0.0 112.172 169.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -110.63 135.39 51.32 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 125.522 1.529 . . . . 0.0 108.978 166.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 53.2 mt -101.01 122.05 52.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 163.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 9.2 mp -103.89 123.62 47.47 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 172.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -101.83 150.43 23.17 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.375 1.07 . . . . 0.0 110.858 174.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -123.37 135.85 54.36 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.031 1.333 . . . . 0.0 110.601 178.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -142.38 134.12 26.92 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.245 1.418 . . . . 0.0 109.061 179.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 57.8 t -79.82 115.85 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 176.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.3 p -95.23 -24.91 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 39.1 tpp -163.94 111.87 1.16 Allowed 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.873 1.269 . . . . 0.0 110.882 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -79.81 127.88 32.76 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 121.16 -0.963 . . . . 0.0 110.99 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 41.8 mttt . . . . . 0 C--O 1.258 1.506 0 C-N-CA 125.245 1.418 . . . . 0.0 112.527 -179.843 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 31.1 p . . . . . 0 N--CA 1.479 0.989 0 N-CA-C 111.701 0.26 . . . . 0.0 111.701 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -65.06 -42.98 93.72 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.614 0.766 . . . . 0.0 111.629 177.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 64.7 tp -71.05 -39.78 72.04 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.557 0.743 . . . . 0.0 111.032 172.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -59.79 -27.25 66.4 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 177.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 92.6 m -69.54 -23.69 63.62 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.746 1.218 . . . . 0.0 111.641 174.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 23.6 mm -76.48 -38.16 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 123.923 0.889 . . . . 0.0 109.806 176.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.1 mp -57.7 -33.58 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 O-C-N 121.702 -0.624 . . . . 0.0 110.91 173.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 48.5 mtp85 -69.59 -18.95 63.66 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 119.455 1.025 . . . . 0.0 113.332 177.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 78.1 mttt -87.68 -38.87 15.48 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 125.096 1.358 . . . . 0.0 111.053 173.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -73.88 -18.88 60.86 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.929 1.292 . . . . 0.0 113.337 174.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 . . . . . 0 CA--C 1.543 0.701 0 C-N-CA 125.237 1.415 . . . . 0.0 112.828 172.222 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.0 mmt-85 . . . . . 0 CA--C 1.542 0.65 0 CA-C-O 121.984 0.897 . . . . 0.0 111.928 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -120.99 139.02 53.86 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.107 1.363 . . . . 0.0 110.427 -173.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -165.07 152.77 11.3 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -177.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 13.2 pt -140.93 149.35 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 125.969 1.708 . . . . 0.0 110.47 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 19.0 mt -108.87 133.75 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.343 1.457 . . . . 0.0 108.8 179.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -131.81 142.87 49.85 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.758 1.223 . . . . 0.0 111.634 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -70.47 124.81 25.1 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.342 0.657 . . . . 0.0 111.698 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.8 -15.77 60.2 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 120.922 -1.111 . . . . 0.0 113.218 -178.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 3.1 mpp_? -98.94 4.81 47.43 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.999 1.72 . . . . 0.0 113.336 -171.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 70.9 t -110.26 138.4 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 126.681 1.993 . . . . 0.0 108.898 179.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -54.14 -34.63 60.84 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 116.048 1.87 . . . . 0.0 116.048 -167.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -105.86 0.31 25.85 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.168 1.387 . . . . 0.0 113.027 -178.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 91.2 m 50.43 66.86 1.03 Allowed 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.875 1.67 . . . . 0.0 111.954 -171.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.88 140.53 58.82 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.154 0.982 . . . . 0.0 111.967 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 63.7 t -63.86 119.88 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 171.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 38.3 pt -101.09 -20.64 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.689 1.195 . . . . 0.0 112.341 174.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -154.46 147.57 24.71 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.43 1.092 . . . . 0.0 111.127 177.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.451 ' HB2' ' CE1' ' A' ' 48' ' ' PHE . 22.4 p -152.14 154.78 36.54 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 121.024 -1.047 . . . . 0.0 113.424 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -78.77 -168.81 1.53 Allowed 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 123.457 0.703 . . . . 0.0 112.321 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -104.12 -18.6 14.46 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.566 1.546 . . . . 0.0 112.59 169.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.61 -42.46 71.97 Favored Glycine 0 N--CA 1.469 0.895 0 C-N-CA 124.146 0.879 . . . . 0.0 112.253 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.451 ' CE1' ' HB2' ' A' ' 44' ' ' CYS . 0.9 OUTLIER -67.05 -29.31 69.06 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.315 0.646 . . . . 0.0 111.788 -175.853 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 83.7 m -52.64 -51.81 58.42 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.181 1.392 . . . . 0.0 111.808 172.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -74.57 -20.46 59.93 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.842 0.857 . . . . 0.0 113.179 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.38 -58.38 7.27 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.031 1.332 . . . . 0.0 110.253 176.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 69.2 m -97.73 -15.43 20.34 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 -175.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.37 2.16 68.37 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 125.519 1.533 . . . . 0.0 114.046 173.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -85.56 -154.52 0.2 Allowed 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 124.798 1.239 . . . . 0.0 111.811 170.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 9.5 t -161.22 170.07 20.99 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 120.498 -1.376 . . . . 0.0 111.61 175.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -50.34 -47.91 55.68 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.824 1.25 . . . . 0.0 111.48 177.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.63 -25.96 54.63 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 178.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -92.33 -39.79 11.28 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.284 1.434 . . . . 0.0 111.848 177.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 71.3 t -80.7 -17.41 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 125.742 1.617 . . . . 0.0 112.243 -177.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 70.0 mtp -60.97 131.15 49.72 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 120.549 -1.344 . . . . 0.0 109.843 173.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 14.0 mt-30 70.34 13.11 7.58 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.713 1.605 . . . . 0.0 114.105 -178.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -89.97 153.56 47.2 Favored Pre-proline 0 N--CA 1.475 0.778 0 C-N-CA 124.356 1.062 . . . . 0.0 110.991 172.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.53 132.28 23.36 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.995 2.464 . . . . 0.0 110.23 170.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 27.3 p -68.42 -9.9 51.64 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 115.105 1.521 . . . . 0.0 115.105 -175.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 38.3 p -62.3 -27.45 69.04 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.93 1.292 . . . . 0.0 111.588 168.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 73.4 m 48.89 42.53 20.5 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.506 1.522 . . . . 0.0 112.6 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -56.72 -32.03 65.1 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.159 1.383 . . . . 0.0 112.59 -175.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -59.1 -16.17 17.93 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.965 1.306 . . . . 0.0 114.501 175.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 97.2 mt -76.45 -3.95 39.93 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 174.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -59.7 134.08 56.69 Favored 'General case' 0 CA--C 1.549 0.942 0 CA-C-N 120.382 1.446 . . . . 0.0 113.051 176.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -105.2 -175.4 24.35 Favored Glycine 0 CA--C 1.538 1.499 0 C-N-CA 125.435 1.493 . . . . 0.0 111.42 167.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -66.57 -16.61 51.31 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 122.92 2.413 . . . . 0.0 113.674 176.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -90.08 -9.27 49.07 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 175.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 53.3 m -68.88 132.49 46.83 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 119.651 1.114 . . . . 0.0 110.852 -175.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -90.03 130.33 36.23 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.112 0.965 . . . . 0.0 110.323 -179.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -63.42 -31.9 73.18 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.581 0.753 . . . . 0.0 112.261 -175.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 36.5 mmt180 -61.81 -50.57 71.79 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.69 0.796 . . . . 0.0 111.797 172.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.24 -37.74 88.18 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 120.331 -1.481 . . . . 0.0 112.964 -178.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -56.93 -34.23 67.78 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 170.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -76.19 -42.53 46.03 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 124.886 1.274 . . . . 0.0 112.878 174.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -61.49 -33.51 73.9 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 118.598 0.636 . . . . 0.0 110.925 -178.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 91.3 mt -62.07 -36.84 76.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 CA-C-N 119.679 1.127 . . . . 0.0 112.315 170.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.89 -37.47 67.29 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 119.343 0.974 . . . . 0.0 112.186 173.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -62.97 -33.13 74.73 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 121.418 -0.802 . . . . 0.0 111.473 172.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.52 -19.76 65.05 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 175.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 43.8 mt -88.43 -18.32 28.55 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.229 1.411 . . . . 0.0 112.799 172.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 83.1 mt -85.12 -21.64 29.19 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.006 0.922 . . . . 0.0 111.667 171.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -81.94 143.1 22.95 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 125.156 1.36 . . . . 0.0 112.308 176.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -91.21 -3.18 57.2 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.347 1.059 . . . . 0.0 113.841 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -117.02 161.87 18.7 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.658 1.983 . . . . 0.0 110.804 174.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -64.61 145.94 55.42 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 122.276 1.036 . . . . 0.0 113.045 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 44.9 mmt-85 -142.08 135.8 29.5 Favored 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 125.314 1.446 . . . . 0.0 110.442 173.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.4 ptpp? -113.76 134.83 54.53 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 167.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 78.2 t -129.05 135.16 62.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 126.144 1.777 . . . . 0.0 107.908 -173.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -99.56 128.84 45.68 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.986 0.914 . . . . 0.0 110.319 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.1 tt -151.14 148.8 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.359 1.063 . . . . 0.0 111.463 -168.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -80.15 124.06 28.45 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 120.774 -1.204 . . . . 0.0 111.304 173.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 6.8 m-30 -107.29 136.92 46.28 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.883 1.673 . . . . 0.0 110.384 172.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -101.44 128.47 47.63 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.68 1.592 . . . . 0.0 110.955 177.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 57.4 ttp180 -94.56 152.55 18.44 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.203 1.801 . . . . 0.0 111.396 -174.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -59.68 -22.7 62.32 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 -174.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -79.91 -13.07 59.64 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.702 1.201 . . . . 0.0 114.069 176.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 107.13 0.59 35.66 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 126.269 1.89 . . . . 0.0 114.699 -178.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 75.0 m -80.42 160.19 25.41 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 119.489 1.644 . . . . 0.0 112.876 176.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 15.9 t -136.12 152.45 50.85 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.884 1.273 . . . . 0.0 110.574 176.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -166.97 161.38 14.96 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.369 1.468 . . . . 0.0 111.303 -176.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -80.4 121.02 25.19 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.912 0.885 . . . . 0.0 111.129 172.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 49.6 t -102.45 135.69 43.62 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.61 1.964 . . . . 0.0 110.423 171.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.1 tt -89.24 116.05 27.19 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 125.627 1.571 . . . . 0.0 107.033 163.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 66.5 t -103.06 111.78 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 169.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -101.84 113.6 26.95 Favored 'General case' 0 C--O 1.224 -0.246 0 C-N-CA 126.085 1.754 . . . . 0.0 109.547 172.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 67.5 t -85.99 126.32 40.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 169.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 89.7 t -113.22 116.22 46.92 Favored Pre-proline 0 CA--C 1.537 0.469 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 170.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -73.84 133.86 19.07 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 123.43 2.753 . . . . 0.0 110.079 -179.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 87.8 t -102.39 116.92 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 N-CA-C 107.902 -1.148 . . . . 0.0 107.902 171.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 33.2 mttp -88.86 161.13 16.87 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.447 0.699 . . . . 0.0 112.196 171.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -98.75 -174.13 2.71 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.384 1.074 . . . . 0.0 111.969 172.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -60.27 -22.58 63.27 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.276 1.43 . . . . 0.0 114.689 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -90.8 -1.49 57.85 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.161 0.984 . . . . 0.0 113.138 177.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 74.86 26.61 66.55 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 124.1 0.857 . . . . 0.0 113.932 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -103.63 146.12 29.05 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.98 1.312 . . . . 0.0 108.79 169.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 11.4 p -78.2 131.02 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-O 121.425 0.631 . . . . 0.0 110.529 175.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 2.8 pt -126.6 -21.16 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 124.652 1.181 . . . . 0.0 113.926 -169.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 73.6 mtm -148.8 155.65 41.24 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 126.09 1.756 . . . . 0.0 110.132 176.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -118.71 131.9 56.15 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 125.085 1.354 . . . . 0.0 109.514 174.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 56.6 mt -97.07 115.32 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 106.244 -1.761 . . . . 0.0 106.244 166.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -91.76 121.39 33.35 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 171.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -113.18 124.79 53.37 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 119.462 -0.304 . . . . 0.0 111.121 178.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 12.2 m-30 -103.46 144.06 31.89 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.301 1.441 . . . . 0.0 111.813 -177.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -150.63 135.68 17.63 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.726 1.611 . . . . 0.0 109.281 172.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 60.2 t -75.61 115.47 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 CA-C-N 119.53 1.059 . . . . 0.0 108.447 171.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.4 p -93.0 -25.3 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 123.539 0.735 . . . . 0.0 112.646 -178.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 30.5 ttm -162.17 118.42 2.01 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.552 1.141 . . . . 0.0 110.567 -176.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -82.08 124.16 29.58 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.679 -0.638 . . . . 0.0 110.021 174.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.255 1.355 0 CA-C-O 115.464 -2.208 . . . . 0.0 116.177 -172.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 13.1 t . . . . . 0 N--CA 1.481 1.1 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -72.43 -46.28 55.78 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 118.813 0.733 . . . . 0.0 111.746 175.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 53.9 tp -64.67 -34.04 77.36 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.978 1.311 . . . . 0.0 111.229 171.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -56.4 -31.12 63.56 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.731 1.212 . . . . 0.0 112.638 176.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 33.3 m -70.48 -29.98 66.66 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.939 1.296 . . . . 0.0 111.227 174.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.2 mm -78.66 -40.13 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 124.325 1.05 . . . . 0.0 110.221 176.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.438 ' HA ' ' CE2' ' A' ' 22' ' ' PHE . 87.6 mt -59.79 -44.27 93.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.308 0.643 . . . . 0.0 111.122 176.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 51.8 ptt85 -67.51 -24.26 65.55 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -179.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -69.03 -42.82 75.83 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.809 0.843 . . . . 0.0 111.671 174.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.438 ' CE2' ' HA ' ' A' ' 19' ' ' ILE . 17.0 p90 -87.0 -31.29 20.65 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 113.75 1.018 . . . . 0.0 113.75 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.908 0 CA-C-N 120.386 1.448 . . . . 0.0 111.388 178.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 18.8 mmm180 . . . . . 0 N--CA 1.47 0.527 0 CA-C-O 122.065 0.936 . . . . 0.0 111.646 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.6 mptt -91.93 125.95 36.83 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.312 -0.868 . . . . 0.0 110.577 -175.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -159.14 161.99 36.36 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.1 pt -144.91 155.7 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 127.171 2.188 . . . . 0.0 109.905 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.8 mp -120.51 135.01 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 125.021 1.329 . . . . 0.0 109.334 179.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -132.58 153.22 51.22 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.007 1.323 . . . . 0.0 112.32 -176.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 29.0 p30 -76.47 118.92 19.64 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.409 1.084 . . . . 0.0 112.738 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.23 -17.22 61.37 Favored 'General case' 0 CA--C 1.547 0.829 0 O-C-N 120.724 -1.235 . . . . 0.0 113.517 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 65.7 mtm-85 -86.23 5.67 33.16 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.701 1.601 . . . . 0.0 114.813 -168.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 13.0 m -133.81 158.33 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 125.59 1.556 . . . . 0.0 111.116 -173.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -62.46 -40.73 97.58 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.088 0.955 . . . . 0.0 113.505 -173.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -85.9 -14.59 44.36 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 114.285 1.216 . . . . 0.0 114.285 -173.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 84.2 m 41.55 69.49 0.35 Allowed 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.777 1.631 . . . . 0.0 112.306 -165.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.31 143.18 47.05 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.064 0.945 . . . . 0.0 111.757 -176.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 23.8 t -65.98 122.45 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 175.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.5 pt -104.25 -14.84 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 125.629 1.572 . . . . 0.0 112.468 176.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -157.67 142.79 16.85 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.533 1.133 . . . . 0.0 111.376 176.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.502 ' HB3' ' CE1' ' A' ' 48' ' ' PHE . 2.7 m -130.67 153.3 49.11 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.125 0.97 . . . . 0.0 112.101 -178.157 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -78.46 -168.96 1.5 Allowed 'General case' 0 CA--C 1.554 1.132 0 CA-C-N 118.973 0.806 . . . . 0.0 111.496 165.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -104.01 -21.76 13.56 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.162 1.385 . . . . 0.0 112.975 169.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.31 -35.02 60.44 Favored Glycine 0 C--N 1.343 0.95 0 O-C-N 121.5 -0.75 . . . . 0.0 112.436 -177.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.502 ' CE1' ' HB3' ' A' ' 44' ' ' CYS . 0.4 OUTLIER -68.78 -30.86 69.53 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.491 0.716 . . . . 0.0 111.885 178.979 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 86.4 m -50.7 -55.32 17.08 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.217 1.407 . . . . 0.0 111.944 176.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -70.1 -18.81 63.26 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.168 0.987 . . . . 0.0 113.334 -178.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.2 tp -63.89 -46.29 85.53 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.853 1.261 . . . . 0.0 111.878 -178.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 73.9 m -110.53 -16.2 13.72 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 178.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.72 -0.06 57.84 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 125.59 1.567 . . . . 0.0 114.395 174.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -82.46 -157.59 0.22 Allowed 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 124.812 1.245 . . . . 0.0 112.217 171.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 10.0 t -162.52 170.45 18.63 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 120.522 -1.361 . . . . 0.0 111.485 176.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -47.6 -50.99 22.72 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.199 1.4 . . . . 0.0 111.454 176.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.99 -25.86 32.85 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -95.78 -38.83 10.15 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.309 1.444 . . . . 0.0 112.241 178.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 76.7 t -83.08 -19.01 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 125.756 1.622 . . . . 0.0 111.938 -176.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 77.1 mmm -66.19 132.38 48.3 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 120.566 -1.334 . . . . 0.0 109.481 173.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 73.59 7.97 5.04 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 126.129 1.771 . . . . 0.0 114.292 -175.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 -90.03 154.28 47.29 Favored Pre-proline 0 N--CA 1.478 0.934 0 C-N-CA 124.832 1.253 . . . . 0.0 110.427 169.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.46 134.31 26.22 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 123.091 2.527 . . . . 0.0 110.245 175.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 24.3 p -69.79 -4.98 22.4 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 114.888 1.44 . . . . 0.0 114.888 -176.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 56.0 p -62.05 -30.22 70.83 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.91 1.284 . . . . 0.0 111.398 165.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 77.9 m 50.62 38.73 19.69 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.003 1.721 . . . . 0.0 112.563 -174.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -57.41 -30.11 64.68 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.615 1.166 . . . . 0.0 112.441 -176.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -59.42 -15.14 15.18 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.743 1.217 . . . . 0.0 114.085 176.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 90.9 mt -77.51 -4.76 47.26 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.617 1.167 . . . . 0.0 113.955 172.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 11.4 p-80 -66.86 158.86 29.52 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 120.275 1.398 . . . . 0.0 114.511 179.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -155.17 -162.59 11.38 Favored Glycine 0 CA--C 1.537 1.456 0 C-N-CA 126.274 1.893 . . . . 0.0 111.875 168.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.85 -13.88 41.94 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 123.272 2.648 . . . . 0.0 115.143 -175.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -97.0 2.14 51.11 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 119.845 1.202 . . . . 0.0 113.742 173.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 20.3 m -87.61 127.43 35.27 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 119.593 1.088 . . . . 0.0 110.553 -177.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -86.73 126.41 34.56 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.719 0.807 . . . . 0.0 109.674 -178.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 11.7 mpt_? -65.38 -31.93 73.3 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.437 0.695 . . . . 0.0 111.584 -175.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 25.1 tpp180 -58.46 -42.89 88.44 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.542 1.137 . . . . 0.0 112.024 172.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -71.03 -43.88 66.97 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.259 -0.901 . . . . 0.0 112.32 177.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -56.99 -36.63 70.61 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 121.826 -0.546 . . . . 0.0 112.039 174.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.93 -48.66 57.61 Favored 'General case' 0 C--O 1.223 -0.299 0 C-N-CA 125.101 1.36 . . . . 0.0 111.953 173.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.8 mm100 -58.44 -37.54 75.62 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 118.369 -0.824 . . . . 0.0 111.495 -178.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 93.5 mt -61.08 -45.6 98.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 CA-C-N 120.128 1.331 . . . . 0.0 111.65 170.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.97 -34.21 74.95 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 119.006 0.821 . . . . 0.0 113.09 179.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 86.4 mm-40 -71.98 -32.18 66.99 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.164 0.986 . . . . 0.0 111.58 174.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -58.3 -32.19 68.22 Favored 'General case' 0 CA--C 1.547 0.857 0 O-C-N 121.213 -0.929 . . . . 0.0 112.214 177.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 58.7 mt -70.41 -16.6 62.97 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.952 1.701 . . . . 0.0 113.946 178.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.6 pp -104.29 -1.33 27.15 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 119.331 0.969 . . . . 0.0 113.33 170.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -84.68 -20.44 58.18 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 124.719 1.152 . . . . 0.0 114.702 -178.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 56.88 32.19 21.01 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 125.789 1.635 . . . . 0.0 113.385 179.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -144.82 163.77 33.07 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.825 1.65 . . . . 0.0 111.246 -171.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -68.67 128.68 37.49 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.897 -0.502 . . . . 0.0 110.674 174.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -142.35 133.93 26.68 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.788 1.235 . . . . 0.0 111.841 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 37.6 mtmt -111.06 130.15 55.69 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.285 1.434 . . . . 0.0 109.965 168.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.8 t -133.05 137.06 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 125.203 1.401 . . . . 0.0 108.441 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -106.32 130.88 54.08 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.137 0.975 . . . . 0.0 111.249 -175.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.4 tt -155.19 146.92 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 124.065 0.946 . . . . 0.0 112.314 -165.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -83.45 121.02 26.63 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 120.949 -1.094 . . . . 0.0 111.815 174.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 13.8 m-30 -109.27 146.85 33.6 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.569 1.947 . . . . 0.0 111.29 173.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -110.65 137.31 48.49 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.564 1.546 . . . . 0.0 112.03 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -92.09 154.98 18.38 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 126.472 1.909 . . . . 0.0 111.252 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -58.5 -25.8 62.75 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.559 1.144 . . . . 0.0 113.833 175.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -69.7 -10.83 59.83 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.322 1.449 . . . . 0.0 113.572 176.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 93.98 4.28 63.33 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 125.334 1.445 . . . . 0.0 113.93 -178.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 63.7 p -92.04 170.87 9.5 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.789 1.236 . . . . 0.0 112.024 175.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 22.1 p -147.36 168.25 22.3 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 121.11 -0.994 . . . . 0.0 112.722 176.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -164.64 155.53 14.86 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.961 1.304 . . . . 0.0 110.722 -173.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -77.15 123.55 26.57 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.277 0.56 . . . . 0.0 110.238 167.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 19.1 t -106.53 136.03 47.01 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.128 1.771 . . . . 0.0 110.306 172.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.0 tp -89.7 120.6 31.11 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 161.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 59.8 t -106.36 117.91 53.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 124.764 1.226 . . . . 0.0 108.521 175.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -111.23 113.02 25.21 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.659 1.184 . . . . 0.0 108.436 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.2 p -88.75 128.06 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 168.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 96.1 t -116.8 116.84 38.09 Favored Pre-proline 0 CA--C 1.538 0.507 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 175.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -76.13 138.27 20.2 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 123.038 2.492 . . . . 0.0 110.373 -176.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 84.0 t -111.35 123.15 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.836 0.854 . . . . 0.0 109.708 174.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 65.0 mttt -95.25 154.73 17.05 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.258 1.023 . . . . 0.0 113.42 173.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -93.66 -173.62 3.23 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.603 1.161 . . . . 0.0 111.872 177.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -58.31 -23.28 55.99 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.374 1.469 . . . . 0.0 114.42 177.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -93.02 -4.63 52.24 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.322 1.449 . . . . 0.0 113.173 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 80.46 22.29 62.74 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 124.226 0.917 . . . . 0.0 114.592 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -107.61 149.66 27.8 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.987 1.315 . . . . 0.0 109.981 173.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 64.0 t -77.26 125.51 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.24 -23.9 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -177.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 62.1 mtm -132.57 155.92 47.8 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.407 1.483 . . . . 0.0 112.479 171.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -119.16 134.09 55.4 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 125.87 1.668 . . . . 0.0 109.443 169.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 54.3 mt -97.39 120.02 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 165.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -103.61 127.51 51.03 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 173.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -119.98 128.05 53.21 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.402 1.081 . . . . 0.0 109.819 -176.268 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 16.9 m-30 -103.9 138.31 40.65 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.326 1.45 . . . . 0.0 111.016 -176.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -142.4 131.3 22.97 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.622 1.169 . . . . 0.0 109.879 174.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 94.1 t -76.92 111.85 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 176.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 5.0 p -95.86 -26.27 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 123.8 0.84 . . . . 0.0 112.963 -174.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 25.0 ptp -162.21 148.06 13.06 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.41 1.084 . . . . 0.0 112.789 163.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -90.37 130.01 36.51 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.953 0.901 . . . . 0.0 110.585 178.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 13.1 mmmm . . . . . 0 C--O 1.253 1.263 0 C-N-CA 125.297 1.439 . . . . 0.0 113.805 178.452 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 38.2 p . . . . . 0 N--CA 1.478 0.952 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -76.02 -52.6 9.85 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.062 0.945 . . . . 0.0 111.553 176.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 60.4 tp -58.63 -34.47 71.21 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.43 1.092 . . . . 0.0 111.259 178.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -56.71 -30.97 64.03 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 176.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 89.7 m -77.01 -32.75 57.37 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.255 1.022 . . . . 0.0 110.89 175.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 20.9 mm -71.64 -39.42 69.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 123.541 0.736 . . . . 0.0 110.5 176.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 71.8 mt -56.31 -44.13 78.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 124.13 0.972 . . . . 0.0 110.753 175.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 39.9 mtt180 -59.75 -36.87 77.51 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 119.212 0.915 . . . . 0.0 112.489 177.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -74.0 -37.29 64.47 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.532 1.133 . . . . 0.0 112.071 177.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -79.57 -22.18 44.12 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.998 1.319 . . . . 0.0 112.954 178.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 . . . . . 0 N--CA 1.472 0.667 0 CA-C-N 118.817 0.735 . . . . 0.0 112.003 170.927 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? . . . . . 0 N--CA 1.477 0.888 0 CA-C-O 121.458 0.647 . . . . 0.0 110.715 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.4 mptt -88.27 136.51 32.95 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.506 1.123 . . . . 0.0 111.252 -175.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -163.47 167.06 22.02 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.412 1.085 . . . . 0.0 113.544 178.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 25.7 pt -144.76 152.1 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 126.617 1.967 . . . . 0.0 109.865 172.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 10.7 mt -117.68 133.61 63.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 125.538 1.535 . . . . 0.0 109.008 -178.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -134.78 152.18 51.55 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.393 1.077 . . . . 0.0 112.353 178.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 14.3 m-20 -74.68 117.99 17.13 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.334 0.653 . . . . 0.0 111.527 178.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.32 -20.21 66.03 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.934 0.894 . . . . 0.0 112.274 170.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 78.7 mtp85 -66.79 -11.87 56.72 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.825 2.05 . . . . 0.0 115.352 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 20.6 m -124.79 142.03 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 125.357 1.463 . . . . 0.0 111.01 -179.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -61.4 -40.68 95.26 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.718 1.207 . . . . 0.0 112.904 -170.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 22.2 p30 -72.32 -14.59 61.78 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 177.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 4.8 t 50.98 61.67 3.12 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.716 1.606 . . . . 0.0 111.695 -173.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.64 134.86 56.18 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 120.936 -1.103 . . . . 0.0 112.278 -179.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 40.5 t -63.79 122.66 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 C-N-CA 123.07 0.548 . . . . 0.0 109.912 173.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.1 pt -101.46 -21.37 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 125.404 1.482 . . . . 0.0 112.424 175.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -152.36 144.09 23.58 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.293 1.037 . . . . 0.0 111.816 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.467 ' HB3' ' CE1' ' A' ' 48' ' ' PHE . 3.1 m -128.07 155.07 44.96 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.056 0.942 . . . . 0.0 112.592 -179.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -73.88 -174.22 1.77 Allowed 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 123.159 0.584 . . . . 0.0 111.475 167.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -107.52 -17.97 13.97 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.58 1.152 . . . . 0.0 112.801 166.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -73.92 -38.81 48.18 Favored Glycine 0 C--N 1.337 0.599 0 C-N-CA 125.821 1.676 . . . . 0.0 112.734 176.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.467 ' CE1' ' HB3' ' A' ' 44' ' ' CYS . 0.3 OUTLIER -62.62 -34.51 77.17 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.207 0.603 . . . . 0.0 111.244 179.606 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 76.6 m -48.19 -56.13 8.67 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.942 1.697 . . . . 0.0 111.941 170.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -70.93 -19.79 62.54 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -177.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.95 -49.48 72.4 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.641 1.177 . . . . 0.0 111.43 177.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 76.6 m -107.61 -21.63 12.82 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 -176.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.02 -0.4 57.46 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 125.426 1.488 . . . . 0.0 114.348 178.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -83.08 -171.52 3.61 Favored 'General case' 0 CA--C 1.55 0.964 0 CA-C-N 118.499 1.15 . . . . 0.0 112.698 170.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 74.2 m -140.95 162.59 35.12 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.409 1.084 . . . . 0.0 111.312 178.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -46.37 -49.55 17.7 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.282 1.033 . . . . 0.0 112.025 176.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.96 -24.78 59.47 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -89.21 -39.31 13.63 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.765 1.226 . . . . 0.0 111.67 177.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 19.8 t -88.63 -12.46 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 124.107 0.963 . . . . 0.0 112.513 -176.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 75.4 mtp -64.35 139.33 58.75 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 120.463 -1.398 . . . . 0.0 111.276 168.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 69.37 6.89 5.93 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 126.301 1.841 . . . . 0.0 113.896 -177.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 32.4 mmt180 -83.85 154.58 64.65 Favored Pre-proline 0 N--CA 1.472 0.643 0 C-N-CA 124.23 1.012 . . . . 0.0 110.59 172.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -68.94 131.04 21.5 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.866 2.377 . . . . 0.0 109.671 170.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 6.7 t -66.04 -14.41 61.64 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.165 1.386 . . . . 0.0 114.069 -172.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 33.9 p -59.39 -24.27 63.3 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.863 1.665 . . . . 0.0 112.908 169.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 76.9 m 57.51 42.81 23.82 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.186 1.394 . . . . 0.0 111.76 -178.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -71.97 18.79 0.08 Allowed 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 127.519 2.328 . . . . 0.0 113.39 -175.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -112.46 -12.3 13.52 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 126.889 2.076 . . . . 0.0 112.747 170.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 78.6 mt -81.18 -9.62 59.76 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 114.801 1.408 . . . . 0.0 114.801 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 12.0 p80 -69.02 160.33 31.16 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 179.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -151.96 -161.37 10.12 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 126.1 1.81 . . . . 0.0 111.357 168.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -65.74 -18.54 58.58 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 122.961 2.441 . . . . 0.0 114.287 -177.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.5 tpm_? -88.15 -6.95 57.58 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 119.273 0.942 . . . . 0.0 113.106 176.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.8 m -85.92 137.81 32.47 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.382 1.473 . . . . 0.0 109.77 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -102.5 135.41 44.19 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.21 1.004 . . . . 0.0 110.269 -178.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 19.3 tpp180 -58.6 -36.37 73.9 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.359 1.064 . . . . 0.0 112.383 -178.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 21.1 tpp85 -55.5 -45.91 77.01 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.15 1.38 . . . . 0.0 112.118 176.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.77 -46.4 68.84 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.753 0.821 . . . . 0.0 111.773 178.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.82 -34.44 65.38 Favored 'General case' 0 CA--C 1.545 0.784 0 O-C-N 121.488 -0.758 . . . . 0.0 112.359 175.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.41 -40.57 70.4 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 125.27 1.428 . . . . 0.0 113.033 173.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -61.17 -30.55 70.47 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 118.061 -0.971 . . . . 0.0 112.174 178.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 58.0 mt -63.76 -47.28 91.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 CA-C-N 120.039 1.29 . . . . 0.0 110.273 172.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.89 -34.43 77.38 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 121.582 -0.699 . . . . 0.0 112.483 176.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 73.7 mm-40 -69.64 -31.32 69.34 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 121.481 -0.762 . . . . 0.0 112.194 171.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.5 -28.12 66.73 Favored 'General case' 0 CA--C 1.545 0.778 0 O-C-N 120.98 -1.075 . . . . 0.0 111.666 176.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 74.4 mt -73.97 -14.25 61.0 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.94 1.296 . . . . 0.0 113.655 169.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 94.3 mt -94.89 -10.64 30.58 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.249 1.02 . . . . 0.0 112.653 172.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -87.65 143.8 18.62 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 125.077 1.322 . . . . 0.0 112.9 177.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.5 -3.5 58.34 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.751 1.22 . . . . 0.0 113.801 175.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -125.62 165.17 19.03 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.578 1.951 . . . . 0.0 110.974 -175.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -61.62 139.79 58.23 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.014 0.926 . . . . 0.0 112.039 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.17 123.75 8.47 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.318 1.047 . . . . 0.0 110.872 -173.078 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -89.18 153.0 21.29 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.399 1.079 . . . . 0.0 113.719 169.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 46.1 t -138.73 134.48 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 126.808 2.043 . . . . 0.0 107.628 167.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -102.98 121.2 42.05 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.609 0.763 . . . . 0.0 109.15 173.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.5 tt -147.25 145.46 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 123.925 0.89 . . . . 0.0 112.212 -169.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -84.29 119.51 25.14 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.332 -0.855 . . . . 0.0 111.75 175.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 15.9 m-30 -107.07 150.43 26.55 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.544 1.938 . . . . 0.0 110.908 172.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -109.89 136.7 48.77 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.983 1.313 . . . . 0.0 111.871 175.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -86.37 168.24 14.01 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.744 0.818 . . . . 0.0 112.593 173.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -58.23 -30.96 66.91 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 125.684 1.593 . . . . 0.0 113.511 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -76.37 -6.32 51.07 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.946 1.299 . . . . 0.0 113.439 178.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 93.63 1.34 66.07 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 125.63 1.586 . . . . 0.0 114.541 178.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.4 m -80.32 154.02 28.04 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 118.766 1.283 . . . . 0.0 111.743 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 39.1 t -117.42 150.6 38.61 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.822 1.249 . . . . 0.0 111.733 -178.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -159.56 146.14 16.43 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.968 1.307 . . . . 0.0 111.412 178.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -71.02 123.86 23.04 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.279 0.632 . . . . 0.0 110.974 165.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 47.0 t -106.78 133.71 51.03 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.627 1.971 . . . . 0.0 109.672 169.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.0 tt -85.41 113.61 21.83 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.515 1.526 . . . . 0.0 107.075 162.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 63.9 t -98.1 110.93 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 124.82 1.248 . . . . 0.0 107.646 170.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -102.33 120.07 39.87 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 120.435 1.47 . . . . 0.0 108.733 167.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 67.5 t -82.66 135.79 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 170.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 48.5 t -115.25 111.2 44.73 Favored Pre-proline 0 CA--C 1.535 0.403 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 169.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.45 133.25 14.28 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.011 2.474 . . . . 0.0 109.741 178.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 94.6 t -107.8 123.55 63.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 123.98 0.912 . . . . 0.0 109.783 179.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 67.2 mttt -91.6 154.08 19.29 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.242 0.831 . . . . 0.0 113.242 170.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -92.7 -174.56 3.68 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.285 1.034 . . . . 0.0 110.765 173.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -66.1 -18.93 65.66 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -85.34 -5.79 59.28 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.318 1.047 . . . . 0.0 112.455 174.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 78.68 23.05 65.41 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 124.581 1.086 . . . . 0.0 114.385 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -107.88 150.31 27.21 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.542 1.537 . . . . 0.0 109.937 172.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 90.4 t -78.61 124.93 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 123.684 0.794 . . . . 0.0 109.202 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.22 -24.74 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 -175.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 51.9 mtm -130.2 152.22 49.86 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.822 1.249 . . . . 0.0 112.473 171.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -113.34 135.81 53.45 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 125.164 1.386 . . . . 0.0 109.081 166.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 49.6 mt -103.07 119.56 51.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 166.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -95.84 117.97 31.59 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 173.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -111.08 129.42 55.93 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 117.773 0.261 . . . . 0.0 110.978 -179.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 17.6 m-30 -107.62 137.91 44.79 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.481 1.512 . . . . 0.0 111.7 -171.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -144.54 116.99 8.55 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.568 1.147 . . . . 0.0 109.779 172.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.1 p -66.68 115.63 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 O-C-N 121.363 -0.836 . . . . 0.0 109.883 175.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 9.2 p -99.83 -27.04 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.904 1.281 . . . . 0.0 113.394 -171.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 25.1 ptp -162.69 149.93 13.4 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.328 1.051 . . . . 0.0 113.104 167.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -89.18 136.46 33.01 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.722 0.809 . . . . 0.0 111.037 177.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt . . . . . 0 C--O 1.254 1.326 0 C-N-CA 125.317 1.447 . . . . 0.0 112.732 175.875 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 25.9 p . . . . . 0 N--CA 1.484 1.252 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -65.01 -41.65 95.13 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.848 0.859 . . . . 0.0 112.481 -177.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 61.5 tp -72.79 -40.01 66.24 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.563 1.145 . . . . 0.0 111.098 173.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -62.66 -25.11 67.97 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.178 0.991 . . . . 0.0 112.459 178.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 95.0 m -67.85 -21.86 65.16 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.597 1.559 . . . . 0.0 111.487 171.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 11.5 mm -86.6 -37.41 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 124.749 1.22 . . . . 0.0 110.791 174.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.452 ' HA ' ' CE2' ' A' ' 22' ' ' PHE . 1.9 mp -58.31 -49.89 80.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 123.1 0.56 . . . . 0.0 110.397 174.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 16.3 ptp180 -67.43 -16.77 64.41 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 114.22 1.193 . . . . 0.0 114.22 -175.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.5 mtpt -70.59 -36.24 73.46 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.937 0.895 . . . . 0.0 111.986 171.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.452 ' CE2' ' HA ' ' A' ' 19' ' ' ILE . 6.2 p90 -93.74 -23.85 18.05 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 178.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 . . . . . 0 N--CA 1.474 0.738 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 173.705 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 21.5 mmt85 . . . . . 0 N--CA 1.47 0.529 0 CA-C-O 122.386 1.089 . . . . 0.0 113.666 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -94.82 129.77 41.65 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.906 1.282 . . . . 0.0 110.93 -172.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -160.35 161.63 33.21 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.323 1.049 . . . . 0.0 113.712 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.6 pt -141.79 153.68 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 127.125 2.17 . . . . 0.0 110.441 176.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.6 mp -116.43 132.61 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 124.732 1.213 . . . . 0.0 109.205 176.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -123.15 142.92 50.37 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 126.078 1.751 . . . . 0.0 110.603 -174.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -71.32 124.05 23.68 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 121.82 -0.55 . . . . 0.0 111.105 171.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.01 -33.93 63.97 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 121.142 -0.974 . . . . 0.0 111.986 177.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 60.6 mtm180 -80.31 33.68 0.3 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 126.007 1.723 . . . . 0.0 113.115 -174.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 79.8 t -145.15 133.42 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 127.142 2.177 . . . . 0.0 108.492 -173.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -57.93 -41.09 82.03 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.685 1.194 . . . . 0.0 113.336 -171.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 75.7 m-80 -84.76 -11.0 56.69 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -178.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 69.8 m 45.9 62.04 2.4 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.246 1.419 . . . . 0.0 111.95 -165.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.52 143.37 57.26 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.089 0.955 . . . . 0.0 111.955 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 56.6 t -61.47 116.33 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 124.534 1.134 . . . . 0.0 108.734 173.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 37.3 pt -98.47 -20.85 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 123.147 0.579 . . . . 0.0 112.326 170.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -156.72 152.61 27.24 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.106 0.962 . . . . 0.0 111.697 175.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.508 ' HB2' ' CE1' ' A' ' 48' ' ' PHE . 24.9 p -153.16 153.94 33.76 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.015 -1.053 . . . . 0.0 113.287 -179.33 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -79.89 -168.84 1.75 Allowed 'General case' 0 CA--C 1.553 1.091 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -179.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -101.33 -22.93 14.47 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.171 1.388 . . . . 0.0 112.57 169.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.45 -37.0 58.84 Favored Glycine 0 C--N 1.343 0.944 0 O-C-N 121.532 -0.73 . . . . 0.0 112.825 -177.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.508 ' CE1' ' HB2' ' A' ' 44' ' ' CYS . 0.8 OUTLIER -67.03 -30.38 70.44 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 117.451 0.626 . . . . 0.0 111.779 179.206 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 80.0 m -56.05 -52.02 65.76 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.608 1.163 . . . . 0.0 111.78 175.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -71.44 -20.36 62.11 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.739 0.816 . . . . 0.0 112.952 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.5 tp -64.92 -56.02 15.79 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.511 1.124 . . . . 0.0 111.116 176.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 62.0 m -98.64 -13.73 20.2 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -175.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 91.79 2.61 69.33 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 125.624 1.583 . . . . 0.0 114.152 171.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -85.64 -153.64 0.18 Allowed 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 124.899 1.28 . . . . 0.0 112.133 171.243 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 82.7 p -153.8 167.8 28.46 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 120.389 -1.444 . . . . 0.0 111.63 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -50.85 -52.96 36.45 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 118.817 -0.611 . . . . 0.0 110.512 169.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.55 -32.55 58.55 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -178.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -85.84 -37.63 18.99 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.887 0.875 . . . . 0.0 112.953 177.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 68.1 t -77.73 -15.76 14.21 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 C-N-CA 124.882 1.273 . . . . 0.0 111.625 178.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 75.1 mtp -60.59 131.35 50.45 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 120.468 -1.395 . . . . 0.0 111.508 175.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 71.92 14.01 5.93 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 126.587 1.955 . . . . 0.0 113.656 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 38.5 mtt180 -94.81 158.89 34.44 Favored Pre-proline 0 N--CA 1.474 0.761 0 C-N-CA 124.634 1.174 . . . . 0.0 111.214 174.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -70.3 136.83 32.51 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 123.307 2.672 . . . . 0.0 110.56 170.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 56.6 m -67.03 -8.58 31.25 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.46 1.281 . . . . 0.0 114.46 177.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 76.4 p -61.15 -28.37 69.07 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.351 1.061 . . . . 0.0 111.89 172.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 75.6 m 50.36 35.95 11.96 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.014 1.326 . . . . 0.0 113.104 -176.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -56.14 -33.28 65.02 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.362 1.465 . . . . 0.0 112.501 -176.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -60.26 -14.55 18.55 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.388 1.475 . . . . 0.0 114.35 177.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 92.7 mt -76.65 -2.97 35.42 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 174.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 3.6 p80 -59.87 145.3 46.18 Favored 'General case' 0 CA--C 1.552 1.026 0 CA-C-N 119.5 1.046 . . . . 0.0 113.41 176.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -118.51 -164.88 13.12 Favored Glycine 0 CA--C 1.539 1.591 0 C-N-CA 126.03 1.776 . . . . 0.0 111.525 165.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.84 -20.65 29.47 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 123.277 2.651 . . . . 0.0 112.937 174.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 29.3 ttm180 -93.59 2.2 56.44 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.26 1.424 . . . . 0.0 113.006 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 28.1 m -83.85 136.76 33.99 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.376 1.47 . . . . 0.0 110.011 177.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -96.89 123.62 40.65 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.021 0.928 . . . . 0.0 109.518 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 14.0 tpt180 -60.4 -30.57 69.69 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.721 0.809 . . . . 0.0 112.76 -176.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 21.4 tpp85 -56.9 -41.32 77.88 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.854 1.261 . . . . 0.0 112.504 173.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -72.73 -43.09 63.4 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 121.348 -0.845 . . . . 0.0 111.962 177.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -57.75 -36.49 72.16 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 121.545 -0.722 . . . . 0.0 112.038 174.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.95 -47.94 64.42 Favored 'General case' 0 C--O 1.225 -0.237 0 C-N-CA 125.197 1.399 . . . . 0.0 111.997 173.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.5 mm100 -58.25 -37.0 74.06 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 118.616 -0.707 . . . . 0.0 111.681 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 95.6 mt -59.54 -42.1 86.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 CA-C-N 119.829 1.195 . . . . 0.0 111.83 171.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.72 -34.98 70.04 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.458 0.703 . . . . 0.0 112.891 176.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -68.22 -32.83 73.31 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.981 0.912 . . . . 0.0 111.687 174.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -59.79 -27.91 66.97 Favored 'General case' 0 CA--C 1.547 0.827 0 CA-C-N 119.201 0.91 . . . . 0.0 113.035 178.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 53.7 mt -72.55 -14.7 61.7 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.648 1.579 . . . . 0.0 113.134 177.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 70.0 mt -81.86 -20.41 38.97 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.055 0.942 . . . . 0.0 112.268 174.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -89.44 152.74 22.83 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.139 1.352 . . . . 0.0 113.311 -178.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -95.83 7.9 45.04 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.088 1.355 . . . . 0.0 113.509 176.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -126.62 162.31 26.01 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.091 1.756 . . . . 0.0 112.082 -176.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -64.23 141.68 58.69 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.636 1.175 . . . . 0.0 112.063 -179.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 9.9 tpt180 -152.13 138.21 18.24 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.012 1.325 . . . . 0.0 110.646 -173.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -129.24 148.16 51.15 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 168.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 58.3 t -138.79 135.71 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 126.282 1.833 . . . . 0.0 108.232 -171.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -104.69 130.08 52.79 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.931 0.892 . . . . 0.0 110.98 -176.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.2 tt -152.26 147.36 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 123.999 0.919 . . . . 0.0 112.19 -168.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -81.59 121.08 25.88 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 120.872 -1.143 . . . . 0.0 111.601 171.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 10.1 m-30 -109.19 132.15 54.39 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.656 1.982 . . . . 0.0 111.147 173.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -78.31 162.15 26.71 Favored 'General case' 0 CA--C 1.549 0.906 0 O-C-N 121.89 -0.506 . . . . 0.0 112.084 167.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 23.9 ttp180 -115.39 147.56 40.38 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.766 1.626 . . . . 0.0 110.41 173.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -55.77 -24.92 38.41 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 178.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -64.08 -17.82 63.78 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.578 1.551 . . . . 0.0 113.77 173.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 100.41 4.43 54.98 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 125.849 1.69 . . . . 0.0 113.858 -175.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 86.3 p -92.77 -178.94 5.0 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 118.626 1.213 . . . . 0.0 112.569 176.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 21.8 t -150.02 156.67 42.1 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.681 1.192 . . . . 0.0 111.625 -177.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -161.2 164.63 30.32 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.316 1.846 . . . . 0.0 110.657 178.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.68 126.18 35.9 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 123.667 0.787 . . . . 0.0 112.459 170.296 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 43.4 t -105.07 135.34 46.59 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.837 2.055 . . . . 0.0 110.844 174.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 38.8 tp -93.42 112.79 24.78 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.786 1.235 . . . . 0.0 107.74 160.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 61.1 t -95.39 119.67 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 173.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -113.65 119.44 37.45 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 125.35 1.46 . . . . 0.0 109.598 174.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 5.8 p -94.44 127.64 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 123.897 0.879 . . . . 0.0 109.506 173.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 96.9 t -115.91 111.03 43.38 Favored Pre-proline 0 CA--C 1.537 0.452 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 178.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -73.61 130.71 15.13 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.684 2.256 . . . . 0.0 110.109 -178.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 58.6 t -100.26 124.93 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 123.942 0.897 . . . . 0.0 109.331 176.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 21.4 mtpt -94.58 150.82 19.85 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.665 0.745 . . . . 0.0 112.389 174.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 54.0 p30 -78.96 -173.43 3.54 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.832 1.253 . . . . 0.0 111.694 174.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -67.64 -15.36 63.61 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 175.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -96.59 -18.31 19.84 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.646 1.178 . . . . 0.0 113.206 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 86.67 43.98 5.94 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 125.966 1.746 . . . . 0.0 113.577 -174.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -118.69 154.27 32.99 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.394 1.477 . . . . 0.0 110.175 161.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 57.3 t -80.27 126.44 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 C-N-CA 123.413 0.685 . . . . 0.0 109.29 178.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.8 -24.63 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 N-CA-C 114.217 1.191 . . . . 0.0 114.217 -178.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 64.0 mtm -133.79 157.44 45.89 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.151 1.381 . . . . 0.0 112.205 172.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -117.56 137.08 52.82 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 125.532 1.533 . . . . 0.0 109.298 169.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 47.4 mt -101.54 121.34 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 164.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 8.2 mp -104.99 133.19 50.2 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 172.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -126.03 132.97 51.87 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.481 1.113 . . . . 0.0 110.114 -174.061 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 15.1 m-30 -107.46 128.21 54.29 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.02 1.328 . . . . 0.0 110.754 -176.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -124.19 131.88 53.57 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.177 1.391 . . . . 0.0 107.396 169.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 71.4 t -78.49 112.09 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 CA-C-N 119.415 1.007 . . . . 0.0 108.293 173.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.4 p -89.13 -24.5 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.429 1.091 . . . . 0.0 112.631 -174.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 13.4 tpt -161.16 119.24 2.4 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.721 1.209 . . . . 0.0 110.609 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -85.18 115.08 22.76 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.489 0.716 . . . . 0.0 109.767 176.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt . . . . . 0 C--O 1.255 1.348 0 C-N-CA 125.025 1.33 . . . . 0.0 113.733 -175.702 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 40.0 p . . . . . 0 N--CA 1.478 0.974 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -69.94 -55.57 9.31 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.982 0.913 . . . . 0.0 111.11 173.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 62.7 tp -59.34 -35.24 73.48 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.255 1.022 . . . . 0.0 111.255 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -58.56 -31.84 68.37 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 176.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 90.9 m -77.14 -32.89 56.7 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.13 0.972 . . . . 0.0 110.48 175.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 24.8 mm -68.58 -41.86 83.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 123.062 0.545 . . . . 0.0 110.367 173.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 76.1 mt -57.4 -46.67 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 124.384 1.074 . . . . 0.0 110.506 174.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 78.8 mtt-85 -58.71 -31.72 68.52 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 179.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -71.02 -30.51 66.75 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.08 0.952 . . . . 0.0 112.756 177.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -88.83 -26.13 21.83 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.487 1.115 . . . . 0.0 113.371 173.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 . . . . . 0 N--CA 1.472 0.651 0 CA-C-O 122.155 0.978 . . . . 0.0 113.369 178.244 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.1 mpt_? . . . . . 0 N--CA 1.476 0.826 0 CA-C-O 121.221 0.534 . . . . 0.0 110.309 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -122.84 128.65 50.68 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 121.002 -1.061 . . . . 0.0 111.766 -174.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 26.9 p90 -163.93 163.52 23.55 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.084 1.353 . . . . 0.0 112.96 175.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 14.3 pt -141.06 154.84 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 126.062 1.745 . . . . 0.0 110.19 175.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 15.9 mt -110.14 129.07 65.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 124.814 1.246 . . . . 0.0 108.67 177.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -122.5 142.76 50.24 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 124.897 1.279 . . . . 0.0 111.236 178.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -65.55 126.51 28.56 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.163 0.585 . . . . 0.0 111.435 172.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -80.93 -25.02 37.75 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 28.7 mmm180 -80.12 -36.82 34.76 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.616 1.166 . . . . 0.0 112.938 -173.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 52.9 t -68.98 131.85 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 C-N-CA 125.439 1.495 . . . . 0.0 109.753 173.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -59.63 -44.81 93.34 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.518 1.127 . . . . 0.0 113.309 -170.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 20.2 p30 -74.53 -9.54 58.68 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 113.78 1.029 . . . . 0.0 113.78 177.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 72.1 m 54.79 64.34 1.84 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.89 1.676 . . . . 0.0 112.23 -176.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.88 135.56 57.73 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.66 0.784 . . . . 0.0 111.735 179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 42.3 t -64.33 118.17 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 168.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 36.0 pt -100.17 -19.77 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 124.718 1.207 . . . . 0.0 112.367 177.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -155.24 146.43 22.73 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.246 1.018 . . . . 0.0 111.547 177.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -130.15 149.64 51.77 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.367 1.067 . . . . 0.0 111.858 178.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -74.13 -164.16 0.23 Allowed 'General case' 0 CA--C 1.554 1.134 0 CA-C-N 118.249 0.477 . . . . 0.0 111.128 169.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -107.26 -21.46 12.94 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.935 1.294 . . . . 0.0 112.713 169.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.8 -40.26 58.35 Favored Glycine 0 C--N 1.342 0.915 0 O-C-N 121.678 -0.639 . . . . 0.0 112.585 -178.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -64.39 -31.41 72.61 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 123.966 0.906 . . . . 0.0 112.365 -178.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 36.1 t -60.63 -53.42 57.72 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.373 1.469 . . . . 0.0 110.939 176.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -70.61 -26.7 63.62 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.531 0.732 . . . . 0.0 112.765 178.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 27.4 tp -61.52 -38.35 87.05 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.324 1.05 . . . . 0.0 112.343 173.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 39.1 m -106.3 -35.93 7.01 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 114.686 1.365 . . . . 0.0 114.686 -171.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.83 10.21 55.46 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 125.68 1.61 . . . . 0.0 114.266 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -89.58 -147.89 0.18 Allowed 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 118.558 1.179 . . . . 0.0 111.728 170.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.9 m -161.59 161.07 29.61 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 126.042 1.737 . . . . 0.0 110.606 176.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -53.67 -43.72 69.09 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 121.561 -0.712 . . . . 0.0 111.582 178.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.11 -30.43 36.54 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 175.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -92.85 -36.81 12.63 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.001 1.32 . . . . 0.0 112.193 178.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 53.8 t -73.12 -21.15 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 125.829 1.651 . . . . 0.0 111.504 177.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 57.0 mmm -65.07 135.07 55.12 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 121.014 -1.054 . . . . 0.0 112.126 179.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.0 tp60 69.87 10.33 7.45 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 126.438 1.895 . . . . 0.0 113.577 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 36.4 mmt180 -83.49 151.24 61.78 Favored Pre-proline 0 N--CA 1.471 0.621 0 C-N-CA 124.261 1.024 . . . . 0.0 110.879 177.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.23 131.71 21.13 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.982 2.454 . . . . 0.0 108.758 167.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 22.3 p -67.54 -9.97 47.49 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -172.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 30.8 p -61.17 -26.35 67.65 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.194 1.398 . . . . 0.0 112.269 170.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 94.3 m 52.16 46.9 25.82 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.147 1.379 . . . . 0.0 112.777 175.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -59.23 -23.46 62.34 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.663 1.185 . . . . 0.0 112.867 -178.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -54.6 -25.65 27.79 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.733 1.613 . . . . 0.0 112.96 172.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 74.1 mt -78.36 -7.41 57.27 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 178.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 7.4 t60 -63.66 141.89 58.6 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.48 1.112 . . . . 0.0 112.258 175.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -148.39 -170.17 16.02 Favored Glycine 0 CA--C 1.537 1.434 0 C-N-CA 127.252 2.358 . . . . 0.0 111.857 176.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -64.11 -21.95 67.69 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 123.221 2.614 . . . . 0.0 113.848 -175.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.85 -6.9 50.79 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 176.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 26.7 m -74.96 142.18 43.96 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-N 119.959 1.254 . . . . 0.0 110.474 -174.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 69.0 mm-40 -100.74 124.96 47.1 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.17 0.988 . . . . 0.0 110.133 -170.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -61.47 -40.22 93.75 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.572 0.749 . . . . 0.0 112.797 -176.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 36.1 mmt180 -66.24 -36.04 81.98 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.454 0.701 . . . . 0.0 112.62 175.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.78 -43.73 68.13 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 119.176 0.898 . . . . 0.0 112.045 177.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -57.89 -32.17 67.46 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.17 0.588 . . . . 0.0 112.044 173.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -72.32 -49.76 31.99 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.637 1.175 . . . . 0.0 111.847 172.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 11.6 mm-40 -59.96 -34.37 73.18 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 118.914 0.779 . . . . 0.0 111.738 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 83.1 mt -61.89 -34.89 64.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 CA-C-N 120.034 1.288 . . . . 0.0 112.749 170.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.26 -41.34 63.76 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 119.648 1.113 . . . . 0.0 112.101 172.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -65.44 -28.75 69.46 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 121.29 -0.881 . . . . 0.0 112.095 175.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.66 -20.99 62.3 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 119.353 0.978 . . . . 0.0 113.116 172.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 32.1 mt -90.03 -11.67 40.82 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.79 1.636 . . . . 0.0 112.93 175.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 82.0 mt -93.1 -17.03 24.28 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.605 1.162 . . . . 0.0 111.891 171.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -87.04 144.32 19.3 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 125.165 1.364 . . . . 0.0 113.331 -176.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -87.2 -8.07 57.27 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.751 1.22 . . . . 0.0 113.738 174.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -119.78 161.14 21.27 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.593 1.957 . . . . 0.0 111.01 -177.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -61.76 141.86 57.63 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.458 1.103 . . . . 0.0 112.401 -175.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 71.3 mmt-85 -137.98 131.65 31.1 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.183 0.993 . . . . 0.0 112.529 174.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 38.8 mtmt -108.95 131.51 54.98 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.756 1.622 . . . . 0.0 110.075 169.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 57.3 t -134.26 134.7 54.97 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 125.032 1.333 . . . . 0.0 108.926 -178.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -100.91 131.9 46.57 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.096 0.959 . . . . 0.0 110.776 178.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 19.7 tt -155.46 145.5 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 124.141 0.976 . . . . 0.0 111.82 -169.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -86.38 118.21 25.67 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.101 -0.999 . . . . 0.0 110.682 173.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 11.4 m-30 -105.19 140.6 38.11 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.714 1.605 . . . . 0.0 111.677 175.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -94.01 149.71 20.99 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.312 1.445 . . . . 0.0 111.078 174.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -108.22 156.2 19.61 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 125.735 1.614 . . . . 0.0 112.422 -175.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -64.03 -23.59 67.39 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 113.302 0.852 . . . . 0.0 113.302 175.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -78.87 -6.24 55.59 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.854 1.262 . . . . 0.0 113.618 177.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 94.21 -2.07 68.06 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 125.453 1.501 . . . . 0.0 114.3 -177.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 50.7 m -83.06 176.08 9.51 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.737 1.215 . . . . 0.0 112.244 175.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 23.3 p -154.14 165.78 35.16 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 120.918 -1.114 . . . . 0.0 112.106 172.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -164.91 167.76 18.3 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.214 1.405 . . . . 0.0 113.287 176.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -82.09 122.21 27.56 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.73 0.812 . . . . 0.0 110.141 169.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 45.5 t -105.09 141.25 36.98 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.659 1.984 . . . . 0.0 109.977 173.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 11.3 tp -96.74 118.19 32.66 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.954 1.302 . . . . 0.0 107.716 162.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 65.4 t -100.83 115.63 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 124.835 1.254 . . . . 0.0 108.316 173.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -111.44 110.57 21.08 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 125.278 1.431 . . . . 0.0 107.305 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 34.7 t -97.15 122.01 48.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 73.2 t -106.53 114.67 61.77 Favored Pre-proline 0 CA--C 1.536 0.417 0 N-CA-C 107.653 -1.239 . . . . 0.0 107.653 -177.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -73.46 120.35 6.45 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 123.078 2.518 . . . . 0.0 109.575 179.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 98.3 t -95.15 118.4 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.299 0.639 . . . . 0.0 109.53 175.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 60.8 mttt -87.62 153.42 21.4 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.692 0.797 . . . . 0.0 112.468 171.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -91.4 -173.57 3.63 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.425 1.09 . . . . 0.0 111.584 175.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -60.66 -21.74 63.12 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.05 1.34 . . . . 0.0 114.37 178.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -91.0 -5.45 55.34 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.072 1.349 . . . . 0.0 113.003 178.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 80.94 22.09 61.99 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 124.327 0.965 . . . . 0.0 114.554 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -108.25 148.86 29.37 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.193 1.397 . . . . 0.0 109.99 172.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.7 p -80.23 126.77 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 123.837 0.855 . . . . 0.0 110.703 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -128.31 -23.82 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -173.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 62.6 mtm -132.01 155.51 47.89 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.467 1.507 . . . . 0.0 111.993 171.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -114.83 135.86 53.73 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 125.251 1.421 . . . . 0.0 109.27 167.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 50.9 mt -98.94 115.99 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 163.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 6.2 mp -96.26 117.8 31.52 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 174.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -110.04 131.72 54.8 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 119.366 -0.349 . . . . 0.0 111.252 -177.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 11.2 m-30 -106.84 139.61 40.98 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.954 1.302 . . . . 0.0 111.129 -177.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -144.42 135.34 25.07 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.189 1.396 . . . . 0.0 109.482 175.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 27.5 t -77.46 114.95 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 176.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.9 p -95.44 -24.94 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -176.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 42.8 tpp -164.7 125.33 2.04 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.075 1.35 . . . . 0.0 110.425 179.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -83.81 125.22 31.73 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.574 0.749 . . . . 0.0 110.341 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.32 0 CA-C-O 115.836 -2.031 . . . . 0.0 114.568 -177.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 38.0 p . . . . . 0 N--CA 1.48 1.029 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -71.04 -56.05 6.96 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 123.922 0.889 . . . . 0.0 111.136 174.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 65.7 tp -57.84 -34.14 69.39 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.607 1.163 . . . . 0.0 111.49 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -60.64 -25.41 66.29 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 176.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 84.9 m -82.93 -33.0 26.9 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.728 1.211 . . . . 0.0 110.852 172.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 26.7 mm -73.05 -38.22 55.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 123.734 0.814 . . . . 0.0 111.496 178.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 54.9 mt -53.81 -38.56 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 123.857 0.863 . . . . 0.0 111.193 176.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 56.2 mtt180 -61.8 -26.2 67.95 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.488 1.115 . . . . 0.0 112.892 178.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -74.84 -38.56 61.97 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.805 1.242 . . . . 0.0 111.339 174.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -81.18 -21.63 39.53 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.245 1.418 . . . . 0.0 113.714 177.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 . . . . . 0 N--CA 1.475 0.81 0 C-N-CA 123.806 0.842 . . . . 0.0 112.556 173.262 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.8 mpp_? . . . . . 0 N--CA 1.47 0.571 0 CA-C-O 122.225 1.012 . . . . 0.0 111.026 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.04 140.09 29.98 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.054 0.942 . . . . 0.0 111.058 -176.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -162.79 156.99 20.92 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.555 1.142 . . . . 0.0 113.279 178.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.4 pt -141.34 150.35 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 126.318 1.847 . . . . 0.0 110.439 176.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 16.9 mt -109.67 134.96 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 125.699 1.6 . . . . 0.0 108.444 177.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -130.82 148.25 52.57 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 125.022 1.329 . . . . 0.0 111.09 177.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 15.4 m-20 -67.06 127.89 34.28 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 170.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.74 -30.55 59.24 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 121.864 -0.522 . . . . 0.0 112.355 172.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 64.8 mtm180 -80.68 44.49 0.73 Allowed 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.878 1.671 . . . . 0.0 112.992 -172.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.8 p -162.05 138.62 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 126.448 1.899 . . . . 0.0 110.0 -179.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -58.17 -40.99 82.88 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.168 0.987 . . . . 0.0 112.971 -172.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 24.1 p30 -77.77 -19.47 55.05 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 96.5 m 51.51 57.82 6.16 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.502 1.121 . . . . 0.0 112.43 -172.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.23 141.23 57.67 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.526 1.13 . . . . 0.0 113.098 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 61.8 t -63.75 124.71 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 124.018 0.927 . . . . 0.0 109.847 173.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 45.3 pt -103.51 -20.23 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 125.034 1.334 . . . . 0.0 112.315 172.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 15.1 t80 -155.62 150.61 26.55 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.057 0.943 . . . . 0.0 112.141 177.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 11.2 p -146.75 154.73 41.74 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 120.953 -1.092 . . . . 0.0 113.002 178.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 31.8 t-20 -74.14 -158.52 0.07 Allowed 'General case' 0 CA--C 1.56 1.339 0 C-N-CA 123.225 0.61 . . . . 0.0 112.167 -178.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -111.75 -18.37 12.75 Favored 'General case' 0 N--CA 1.48 1.04 0 O-C-N 120.249 -1.532 . . . . 0.0 112.966 166.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -75.6 -33.21 52.79 Favored Glycine 0 N--CA 1.47 0.911 0 C-N-CA 124.391 0.996 . . . . 0.0 112.632 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -65.47 -36.26 83.35 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.122 0.969 . . . . 0.0 110.989 -178.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 8.1 t -52.21 -47.19 65.76 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.48 1.512 . . . . 0.0 111.859 170.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -76.74 -21.75 54.79 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -178.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 51.9 tp -66.32 -53.84 31.73 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.95 0.9 . . . . 0.0 111.356 174.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 79.9 m -102.48 -17.43 15.79 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -172.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 87.1 6.38 78.96 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.985 1.279 . . . . 0.0 114.167 176.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -86.29 -153.61 0.2 Allowed 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.969 1.308 . . . . 0.0 111.81 171.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 12.0 t -162.8 170.1 18.82 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 120.562 -1.336 . . . . 0.0 111.521 176.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 44.5 ttm180 -53.36 -45.83 69.33 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.417 1.087 . . . . 0.0 111.257 178.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.0 -26.66 49.59 Favored 'General case' 0 CA--C 1.551 0.993 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 176.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -93.99 -38.34 11.22 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.991 1.316 . . . . 0.0 112.268 179.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 51.2 t -86.2 -11.15 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 125.07 1.348 . . . . 0.0 112.297 -177.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 20.0 mmt -65.28 135.44 55.36 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 120.395 -1.441 . . . . 0.0 111.242 168.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.8 tm0? 70.98 8.16 6.43 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 126.298 1.839 . . . . 0.0 113.198 -177.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 37.7 mmt180 -88.88 152.17 48.28 Favored Pre-proline 0 N--CA 1.472 0.673 0 C-N-CA 124.484 1.113 . . . . 0.0 110.837 175.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -70.1 136.04 31.11 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 123.203 2.602 . . . . 0.0 109.404 171.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 30.8 p -68.07 -3.57 10.7 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 -179.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 52.6 p -61.53 -30.99 70.99 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.575 1.15 . . . . 0.0 111.665 166.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 81.8 m 50.62 38.27 18.51 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.633 1.573 . . . . 0.0 112.77 -177.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -58.2 -30.02 66.13 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.641 1.176 . . . . 0.0 112.418 -176.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -59.56 -14.51 13.48 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.04 1.336 . . . . 0.0 114.121 175.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 99.4 mt -75.38 -4.64 40.58 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.369 1.068 . . . . 0.0 113.721 171.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 13.5 p-80 -63.61 140.53 58.88 Favored 'General case' 0 CA--C 1.548 0.888 0 CA-C-N 120.194 1.361 . . . . 0.0 112.911 175.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -115.18 -164.87 14.54 Favored Glycine 0 CA--C 1.539 1.562 0 C-N-CA 125.988 1.756 . . . . 0.0 111.144 165.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -68.96 -21.72 36.88 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.952 2.435 . . . . 0.0 113.008 175.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 83.4 mtt85 -89.28 -9.56 50.16 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.483 1.113 . . . . 0.0 113.869 -178.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 56.7 m -68.91 136.73 53.05 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.756 1.222 . . . . 0.0 111.272 -173.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 21.5 mp0 -83.7 118.63 24.0 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.808 1.243 . . . . 0.0 109.475 -174.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -63.7 -37.72 88.4 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 121.639 -0.663 . . . . 0.0 112.408 -173.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -64.02 -38.05 89.64 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.414 0.686 . . . . 0.0 112.374 173.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.13 -44.25 69.29 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.308 0.958 . . . . 0.0 111.849 177.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.59 -35.47 65.84 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.145 0.578 . . . . 0.0 112.002 173.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.14 -44.99 64.46 Favored 'General case' 0 C--O 1.224 -0.243 0 C-N-CA 124.303 1.041 . . . . 0.0 112.636 172.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 15.6 mm-40 -59.91 -30.83 69.29 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 117.719 -1.134 . . . . 0.0 112.465 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 69.0 mt -59.43 -48.94 85.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 CA-C-N 120.622 1.555 . . . . 0.0 110.773 169.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.41 -37.24 74.43 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.838 0.855 . . . . 0.0 112.824 -178.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 77.5 mm-40 -70.92 -31.38 67.98 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.168 0.987 . . . . 0.0 111.518 175.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -59.58 -31.74 69.73 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 119.464 1.029 . . . . 0.0 112.636 177.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 56.7 mt -68.17 -15.63 63.66 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.386 1.475 . . . . 0.0 113.12 177.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 61.3 mt -83.39 -15.74 48.65 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.041 0.936 . . . . 0.0 112.446 174.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -93.32 153.18 21.25 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 125.377 1.465 . . . . 0.0 113.115 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -97.21 5.7 49.64 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.025 1.33 . . . . 0.0 113.742 177.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.61 159.72 25.86 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.82 1.648 . . . . 0.0 111.416 -179.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -61.21 141.19 57.68 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.753 1.621 . . . . 0.0 112.239 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.48 121.75 8.39 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.058 0.943 . . . . 0.0 111.514 -168.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 37.8 mtmt -106.3 137.34 44.43 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.852 1.261 . . . . 0.0 112.107 172.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 8.3 p -132.16 135.85 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 127.298 2.239 . . . . 0.0 110.136 171.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -101.99 133.74 46.31 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.399 1.48 . . . . 0.0 110.164 176.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 19.1 tt -159.99 144.71 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 124.202 1.001 . . . . 0.0 111.904 -163.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -82.21 121.64 26.89 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 120.911 -1.118 . . . . 0.0 111.872 173.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 11.2 m-30 -103.01 149.9 24.09 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.155 1.782 . . . . 0.0 111.412 172.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -106.28 136.12 46.56 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.299 1.84 . . . . 0.0 111.344 175.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 46.4 ttp180 -99.89 148.98 23.87 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 126.138 1.775 . . . . 0.0 111.3 -176.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -59.13 -22.14 60.4 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 177.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -73.58 -6.63 47.83 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.311 1.444 . . . . 0.0 113.732 174.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 95.95 -1.67 63.4 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 125.955 1.74 . . . . 0.0 113.86 -176.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -80.16 169.47 17.76 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.373 1.469 . . . . 0.0 112.823 -178.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 28.6 p -147.63 158.04 43.83 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.149 -0.969 . . . . 0.0 112.457 168.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -162.89 156.12 19.66 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.787 1.235 . . . . 0.0 111.531 -174.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -75.66 124.1 26.67 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 123.076 0.55 . . . . 0.0 110.162 168.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 12.8 t -111.61 146.51 37.27 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.708 2.003 . . . . 0.0 109.82 173.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 20.0 tp -96.33 124.95 40.51 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 125.514 1.526 . . . . 0.0 108.106 163.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 47.1 t -105.77 121.35 57.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 169.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -114.96 116.06 27.88 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.59 1.556 . . . . 0.0 109.101 173.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.1 p -89.77 125.84 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-O 121.066 0.46 . . . . 0.0 109.897 169.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 88.8 t -109.39 108.54 60.08 Favored Pre-proline 0 CA--C 1.536 0.414 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 174.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.85 126.46 10.71 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.666 2.244 . . . . 0.0 109.462 177.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 52.3 t -96.64 123.26 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 177.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 20.4 mtpt -94.03 149.88 20.84 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.554 0.692 . . . . 0.0 112.269 174.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 54.7 p30 -79.29 -173.64 3.76 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.65 1.18 . . . . 0.0 111.682 174.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -67.27 -15.55 63.76 Favored 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 114.614 1.338 . . . . 0.0 114.614 175.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -96.65 -18.1 19.93 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.812 1.245 . . . . 0.0 113.206 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 85.96 42.85 6.57 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 125.911 1.719 . . . . 0.0 113.563 -173.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -116.27 154.37 30.27 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.277 1.431 . . . . 0.0 110.145 160.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 49.5 t -80.67 125.8 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 178.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.02 -27.03 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -177.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 61.5 mtm -131.42 153.25 49.9 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.784 1.234 . . . . 0.0 112.359 170.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -111.44 137.04 49.76 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 125.303 1.441 . . . . 0.0 109.063 166.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 48.2 mt -104.4 119.09 52.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 163.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -101.23 124.7 47.34 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 173.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -116.14 124.53 50.56 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 124.331 1.053 . . . . 0.0 109.346 -176.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -102.88 143.84 31.96 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.16 1.384 . . . . 0.0 110.571 -178.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.39 128.9 11.4 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.616 0.766 . . . . 0.0 110.361 171.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.4 p -72.69 116.08 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 O-C-N 121.383 -0.823 . . . . 0.0 109.771 175.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.2 p -94.24 -27.6 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 124.767 1.227 . . . . 0.0 112.759 -175.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 25.4 ptp -162.3 147.02 12.39 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.411 1.085 . . . . 0.0 112.618 166.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -89.99 131.49 35.86 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.794 0.838 . . . . 0.0 110.311 178.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.253 1.258 0 N-CA-C 115.492 1.664 . . . . 0.0 115.492 -175.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 42.2 p . . . . . 0 N--CA 1.482 1.141 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -65.79 -50.01 66.23 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.671 0.788 . . . . 0.0 111.838 176.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 61.9 tp -64.9 -36.05 83.1 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.58 1.152 . . . . 0.0 111.299 176.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -59.96 -30.55 69.17 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.75 0.82 . . . . 0.0 112.638 177.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 44.4 m -71.6 -24.12 61.84 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.803 1.241 . . . . 0.0 111.48 173.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 11.1 mm -83.93 -43.97 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.216 1.007 . . . . 0.0 110.434 173.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 97.5 mt -54.31 -47.35 69.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.669 0.787 . . . . 0.0 110.531 177.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 32.9 ptt180 -69.7 -12.22 61.46 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -178.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -83.19 -34.43 25.95 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.441 1.096 . . . . 0.0 112.045 170.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -78.58 -33.77 47.4 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.257 1.023 . . . . 0.0 112.321 173.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 . . . . . 0 CA--C 1.541 0.623 0 C-N-CA 123.428 0.691 . . . . 0.0 111.94 173.04 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 12.0 mpt_? . . . . . 0 CA--C 1.543 0.707 0 CA-C-O 122.01 0.909 . . . . 0.0 110.363 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.0 mptt -86.2 132.65 33.96 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.102 1.361 . . . . 0.0 110.099 -178.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -163.14 164.24 25.38 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.258 1.023 . . . . 0.0 113.689 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 30.3 pt -144.37 154.53 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 126.736 2.014 . . . . 0.0 110.508 177.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 14.8 mt -120.0 130.71 73.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 125.907 1.683 . . . . 0.0 109.394 -178.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -130.49 145.26 51.82 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 124.485 1.114 . . . . 0.0 111.437 176.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -70.58 125.53 27.07 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 122.043 -0.41 . . . . 0.0 111.159 176.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.58 -29.82 66.35 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -177.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 56.3 mtm180 -80.03 36.66 0.35 Allowed 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.64 1.576 . . . . 0.0 112.86 -172.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 60.5 t -145.62 135.51 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 126.839 2.056 . . . . 0.0 108.87 -169.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -59.13 -45.08 91.87 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.14 0.976 . . . . 0.0 112.726 -174.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -82.79 -12.72 57.26 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 90.9 m 48.65 62.96 2.3 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.375 1.47 . . . . 0.0 111.283 -167.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.81 136.26 55.18 Favored 'General case' 0 CA--C 1.547 0.843 0 O-C-N 121.514 -0.741 . . . . 0.0 111.869 -177.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.2 t -64.23 126.43 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 122.996 0.518 . . . . 0.0 109.873 176.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.1 pt -104.35 -23.16 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.586 1.154 . . . . 0.0 112.49 174.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -147.41 140.65 25.25 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.534 0.733 . . . . 0.0 111.349 178.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.472 ' HB3' ' CE1' ' A' ' 48' ' ' PHE . 2.0 m -131.59 147.62 52.54 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.097 0.959 . . . . 0.0 111.558 -177.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -78.33 -173.24 3.19 Favored 'General case' 0 CA--C 1.554 1.118 0 CA-C-N 119.255 0.934 . . . . 0.0 111.752 172.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -98.71 -22.72 15.75 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.027 1.331 . . . . 0.0 112.353 171.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -73.37 -39.53 50.9 Favored Glycine 0 C--N 1.342 0.873 0 O-C-N 121.815 -0.553 . . . . 0.0 112.455 -177.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.472 ' CE1' ' HB3' ' A' ' 44' ' ' CYS . 0.4 OUTLIER -66.07 -32.32 73.72 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.256 0.623 . . . . 0.0 111.854 -179.345 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 91.2 m -51.29 -55.31 18.93 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.252 1.421 . . . . 0.0 111.587 174.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -71.75 -22.33 61.62 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.876 0.871 . . . . 0.0 113.032 -179.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.16 -52.68 62.87 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.11 1.364 . . . . 0.0 110.873 178.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 76.8 m -98.68 -21.2 16.55 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.51 2.23 58.84 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 125.035 1.302 . . . . 0.0 114.355 179.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -85.81 -152.43 0.16 Allowed 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 124.607 1.163 . . . . 0.0 112.102 171.072 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 80.8 p -157.11 168.87 26.17 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 120.478 -1.389 . . . . 0.0 111.928 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -52.07 -51.65 56.24 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 119.1 -0.476 . . . . 0.0 110.48 168.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.28 -32.45 56.29 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 119.39 0.996 . . . . 0.0 113.52 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -86.4 -39.42 16.4 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.009 0.924 . . . . 0.0 113.295 177.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 79.5 t -80.46 -12.75 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 124.674 1.189 . . . . 0.0 111.639 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 66.1 mmm -66.27 137.1 56.71 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 120.522 -1.361 . . . . 0.0 111.261 173.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 76.43 4.71 3.6 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 127.064 2.145 . . . . 0.0 113.531 -176.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 42.7 mtt180 -92.42 156.21 41.7 Favored Pre-proline 0 N--CA 1.476 0.851 0 C-N-CA 124.257 1.023 . . . . 0.0 112.412 -179.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -67.57 134.91 34.4 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.697 2.931 . . . . 0.0 110.585 170.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 5.1 t -66.97 -18.6 65.46 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -173.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 39.7 p -56.2 -30.05 61.76 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.304 1.442 . . . . 0.0 112.458 172.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 79.1 m 54.05 36.94 25.85 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.25 1.42 . . . . 0.0 112.357 -176.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -57.1 -30.64 64.53 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.85 1.26 . . . . 0.0 112.462 -176.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -58.8 -15.31 11.72 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.912 1.285 . . . . 0.0 114.193 175.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.2 mt -75.21 -6.2 48.46 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.579 1.152 . . . . 0.0 113.694 172.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -65.83 147.81 52.78 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 119.988 1.267 . . . . 0.0 112.492 173.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -125.97 -155.31 8.93 Favored Glycine 0 CA--C 1.537 1.447 0 C-N-CA 125.7 1.619 . . . . 0.0 111.071 165.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.25 -26.91 17.12 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 123.116 2.544 . . . . 0.0 113.712 179.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 53.7 ttm-85 -87.4 -15.35 38.04 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 119.327 0.967 . . . . 0.0 113.1 -177.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 19.8 m -65.07 134.66 54.3 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.311 1.444 . . . . 0.0 110.926 -176.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -87.31 125.61 34.34 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -176.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 18.5 tpp85 -60.36 -35.24 75.22 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.206 1.003 . . . . 0.0 112.447 -178.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 24.6 tpp180 -60.23 -46.44 89.76 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.368 1.067 . . . . 0.0 111.715 174.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -69.46 -42.6 74.68 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 121.043 -1.036 . . . . 0.0 111.981 176.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.13 -35.03 64.25 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 173.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -74.67 -44.84 48.25 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.331 1.452 . . . . 0.0 112.999 173.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -59.16 -34.69 72.39 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 118.868 0.758 . . . . 0.0 111.538 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 86.6 mt -62.19 -37.44 78.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 CA-C-N 119.969 1.259 . . . . 0.0 112.198 172.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.8 -39.88 69.58 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 119.1 0.863 . . . . 0.0 112.143 174.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -64.88 -32.43 74.13 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.598 0.759 . . . . 0.0 111.867 175.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.47 -23.15 65.68 Favored 'General case' 0 CA--C 1.548 0.88 0 O-C-N 121.367 -0.833 . . . . 0.0 112.903 176.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 27.9 mt -85.94 -14.29 45.15 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.112 1.365 . . . . 0.0 113.258 174.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 80.8 mt -88.92 -17.59 29.24 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.139 0.976 . . . . 0.0 111.822 171.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -83.85 152.0 28.17 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 125.3 1.428 . . . . 0.0 112.696 175.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -99.51 11.69 38.46 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.905 1.282 . . . . 0.0 113.857 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -137.71 163.67 30.73 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.963 1.705 . . . . 0.0 111.834 -175.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.97 137.87 57.98 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.282 1.033 . . . . 0.0 111.767 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.69 124.97 10.85 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.297 1.039 . . . . 0.0 111.239 -175.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 43.3 mtmt -100.85 140.78 34.66 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.206 1.402 . . . . 0.0 112.271 171.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 46.2 t -136.44 136.56 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 126.094 1.758 . . . . 0.0 108.526 175.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -102.86 128.78 49.5 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.983 0.913 . . . . 0.0 110.647 178.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.2 tt -151.81 149.28 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.21 1.004 . . . . 0.0 112.207 -168.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -84.29 116.74 23.15 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 120.899 -1.125 . . . . 0.0 111.496 173.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 9.7 m-30 -103.08 140.9 36.71 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.419 1.488 . . . . 0.0 111.055 174.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -105.1 133.12 50.41 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.454 1.502 . . . . 0.0 111.813 178.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 73.9 mtp85 -77.37 163.16 26.67 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.667 1.587 . . . . 0.0 112.267 175.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -65.21 -23.65 67.14 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.722 1.209 . . . . 0.0 113.336 173.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -77.72 -7.7 56.9 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.841 1.257 . . . . 0.0 113.598 174.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 94.11 -1.83 68.05 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 125.425 1.488 . . . . 0.0 114.574 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 48.7 m -80.09 167.77 19.99 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 118.335 1.067 . . . . 0.0 111.756 175.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 20.5 p -148.35 170.33 18.19 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 120.886 -1.134 . . . . 0.0 113.399 176.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -170.21 166.52 8.86 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 126.258 1.823 . . . . 0.0 111.255 -178.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -79.35 123.0 27.07 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.16 0.505 . . . . 0.0 111.103 170.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 6.0 m -106.84 136.46 46.63 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.051 1.74 . . . . 0.0 110.1 168.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 19.0 tp -86.47 123.18 31.4 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 125.033 1.333 . . . . 0.0 107.602 162.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 91.6 t -103.61 117.94 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 169.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -112.16 107.11 15.89 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 126.462 1.905 . . . . 0.0 108.54 177.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 69.7 t -80.67 125.65 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 172.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 45.0 t -109.06 110.62 60.72 Favored Pre-proline 0 C--N 1.328 -0.359 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 169.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.41 132.79 16.68 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.559 2.172 . . . . 0.0 109.546 176.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 73.1 t -99.91 120.75 49.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 172.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 68.9 mttt -92.94 154.99 17.85 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.651 0.78 . . . . 0.0 112.698 171.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -93.66 -173.64 3.23 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.105 0.962 . . . . 0.0 111.641 174.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -61.04 -22.01 64.16 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.015 1.326 . . . . 0.0 114.152 178.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -90.3 -5.4 56.32 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.783 1.233 . . . . 0.0 113.043 178.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 79.32 20.62 69.06 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 124.455 1.026 . . . . 0.0 114.388 -178.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -99.63 146.21 26.72 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.94 1.296 . . . . 0.0 109.621 173.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 61.5 t -76.79 125.34 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 177.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 3.0 pt -121.28 -21.79 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 C-N-CA 124.905 1.282 . . . . 0.0 113.981 -172.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 44.7 mtm -145.52 151.35 38.01 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.72 1.608 . . . . 0.0 110.478 177.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -114.33 129.61 56.65 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 124.595 1.158 . . . . 0.0 109.084 169.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 33.5 mt -99.09 117.45 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 165.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -94.91 117.4 30.07 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 174.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -104.32 127.09 51.91 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 123.259 0.349 . . . . 0.0 111.476 176.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 13.7 m-30 -102.93 134.65 46.0 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.372 1.469 . . . . 0.0 111.146 -179.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -141.83 112.33 7.1 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.71 1.204 . . . . 0.0 109.092 176.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.7 p -64.46 112.7 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 O-C-N 121.186 -0.946 . . . . 0.0 109.399 173.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.0 p -98.83 -26.61 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.511 1.524 . . . . 0.0 112.954 -167.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 24.3 ptp -161.14 154.26 21.3 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.879 1.272 . . . . 0.0 111.241 166.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -77.12 156.48 31.63 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 122.126 0.965 . . . . 0.0 111.713 175.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.419 ' HA ' ' HE3' ' A' ' 135' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.288 0 C-N-CA 125.743 1.617 . . . . 0.0 112.822 161.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 46.6 p . . . . . 0 N--CA 1.481 1.123 0 N-CA-C 114.398 1.259 . . . . 0.0 114.398 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -64.49 -50.73 66.3 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.517 0.727 . . . . 0.0 111.491 176.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 60.8 tp -65.59 -37.97 88.16 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.56 1.144 . . . . 0.0 111.312 175.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -61.34 -29.03 69.64 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.153 0.981 . . . . 0.0 112.409 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 29.3 m -71.25 -25.65 62.56 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.823 1.249 . . . . 0.0 111.455 173.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.8 mm -82.38 -43.14 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.932 0.893 . . . . 0.0 110.252 173.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 97.0 mt -56.22 -44.25 78.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 123.628 0.771 . . . . 0.0 110.804 177.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 49.9 ptt85 -70.73 -19.64 62.72 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -78.47 -36.88 44.64 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.036 0.934 . . . . 0.0 111.766 169.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -79.53 -37.32 36.83 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.731 1.212 . . . . 0.0 112.525 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 . . . . . 0 CA--C 1.545 0.784 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -171.648 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? . . . . . 0 CA--C 1.541 0.6 0 CA-C-O 122.141 0.972 . . . . 0.0 111.705 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.5 mptt -90.99 137.22 32.53 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.388 1.075 . . . . 0.0 111.133 -174.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -165.16 162.59 20.15 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.01 1.324 . . . . 0.0 113.329 175.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 14.7 pt -142.18 152.4 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 126.295 1.838 . . . . 0.0 110.662 174.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 11.8 mt -108.61 130.46 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 125.973 1.709 . . . . 0.0 108.977 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -129.0 142.27 50.97 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 124.98 1.312 . . . . 0.0 110.975 177.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -70.36 125.7 27.54 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.75 -0.593 . . . . 0.0 111.087 177.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.39 -31.86 64.13 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.545 0.738 . . . . 0.0 112.355 -178.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 27.7 mmm180 -80.46 37.29 0.39 Allowed 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.922 1.689 . . . . 0.0 112.682 -174.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 98.4 t -143.93 134.78 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 126.911 2.084 . . . . 0.0 108.719 -172.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -56.13 -35.11 66.74 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 115.324 1.602 . . . . 0.0 115.324 -170.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -105.77 -2.33 23.32 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.287 1.435 . . . . 0.0 113.091 -178.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 89.6 m 50.43 68.78 0.71 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 126.074 1.75 . . . . 0.0 112.303 -174.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.22 137.94 57.33 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.04 0.936 . . . . 0.0 112.111 -178.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 37.1 t -65.21 123.75 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 123.587 0.755 . . . . 0.0 109.354 174.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 44.8 pt -103.92 -19.59 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 125.125 1.37 . . . . 0.0 112.52 176.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -156.42 145.64 20.53 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.233 1.013 . . . . 0.0 111.658 178.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 4.7 m -125.7 158.53 34.59 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.359 1.064 . . . . 0.0 112.341 176.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -74.87 -152.37 0.03 OUTLIER 'General case' 0 CA--C 1.559 1.306 0 CA-C-N 118.524 0.602 . . . . 0.0 111.167 166.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -115.05 -21.55 9.97 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.325 1.45 . . . . 0.0 113.215 165.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -74.85 -35.21 51.14 Favored Glycine 0 N--CA 1.471 1.012 0 C-N-CA 124.12 0.867 . . . . 0.0 112.813 -178.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -58.03 -37.31 74.12 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 124.837 1.255 . . . . 0.0 111.861 177.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 38.4 t -58.91 -52.0 67.61 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.405 1.482 . . . . 0.0 111.499 174.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -70.68 -25.97 63.22 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -179.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 38.6 tp -62.87 -40.54 97.83 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.376 1.07 . . . . 0.0 111.973 172.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 50.2 m -106.73 -32.08 8.14 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 115.054 1.502 . . . . 0.0 115.054 -168.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.61 9.51 66.46 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 125.932 1.729 . . . . 0.0 114.437 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -86.17 -144.85 0.11 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 124.609 1.164 . . . . 0.0 111.591 170.17 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 13.3 t -163.6 167.06 21.75 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.986 1.314 . . . . 0.0 111.065 169.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -54.65 -44.24 73.07 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.582 0.753 . . . . 0.0 110.801 176.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.23 -28.03 50.33 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 176.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -91.18 -39.18 12.26 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.982 1.313 . . . . 0.0 111.83 177.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 99.5 t -80.27 -17.6 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 125.671 1.588 . . . . 0.0 112.295 -177.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 80.9 mtp -61.55 133.13 55.32 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 120.85 -1.156 . . . . 0.0 111.309 170.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 23.7 tp60 74.05 3.67 4.45 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 127.08 2.152 . . . . 0.0 113.731 -178.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 33.2 mmt180 -84.55 151.46 58.82 Favored Pre-proline 0 N--CA 1.473 0.686 0 O-C-N 121.016 -1.052 . . . . 0.0 110.934 178.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.83 132.98 24.34 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.526 2.151 . . . . 0.0 109.598 169.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 32.0 p -66.76 -7.55 22.02 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 -176.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 41.3 p -59.7 -27.1 66.15 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.353 1.461 . . . . 0.0 112.536 168.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 67.5 m 57.23 40.56 27.88 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.022 1.329 . . . . 0.0 112.707 178.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -56.51 -29.77 62.22 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.361 1.464 . . . . 0.0 113.006 -175.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 29.2 p90 -62.26 -16.8 55.99 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.806 1.242 . . . . 0.0 114.107 175.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 87.8 mt -79.08 -10.42 59.82 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 174.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 47.2 m170 -69.44 118.78 12.74 Favored 'General case' 0 CA--C 1.546 0.827 0 CA-C-N 119.597 1.09 . . . . 0.0 111.402 -177.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -100.98 -163.14 27.75 Favored Glycine 0 CA--C 1.539 1.556 0 C-N-CA 126.166 1.841 . . . . 0.0 112.129 173.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -70.58 -28.41 21.34 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 123.153 2.569 . . . . 0.0 113.149 -179.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 30.4 tpt180 -84.61 -17.35 38.98 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 50.6 m -60.43 132.55 54.25 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.95 1.3 . . . . 0.0 111.876 -170.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 22.9 mp0 -85.26 111.59 19.99 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.546 1.138 . . . . 0.0 110.404 -171.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 -58.24 -33.86 69.81 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.59 0.756 . . . . 0.0 112.463 177.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 21.5 tpp180 -62.03 -39.91 93.93 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.591 1.157 . . . . 0.0 112.244 175.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -77.01 -41.46 42.64 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.526 1.13 . . . . 0.0 112.31 176.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -53.15 -33.36 52.12 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 118.842 0.747 . . . . 0.0 112.797 175.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.01 -41.3 82.4 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 124.969 1.308 . . . . 0.0 112.712 172.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 80.3 mm-40 -64.38 -32.6 74.28 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 118.507 -0.758 . . . . 0.0 111.48 178.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 45.9 mt -59.33 -41.35 83.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 CA-C-N 119.56 1.073 . . . . 0.0 110.586 170.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.16 -35.08 68.93 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 176.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 71.6 mm-40 -64.66 -35.58 81.49 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.439 -0.788 . . . . 0.0 111.446 172.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.15 -21.35 63.69 Favored 'General case' 0 CA--C 1.549 0.922 0 O-C-N 121.383 -0.823 . . . . 0.0 113.189 178.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 57.6 mt -87.9 -11.14 48.55 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 125.925 1.69 . . . . 0.0 114.009 178.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.7 pp -103.94 -2.73 25.7 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 170.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -90.3 144.22 17.38 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 125.039 1.305 . . . . 0.0 112.564 175.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.9 -2.12 58.12 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.7 1.2 . . . . 0.0 113.931 176.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -124.09 159.27 30.34 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.035 1.734 . . . . 0.0 110.739 -174.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 46.4 mp0 -57.28 135.88 56.49 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.522 1.129 . . . . 0.0 111.708 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.58 121.23 11.83 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.229 1.011 . . . . 0.0 110.322 -173.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt -105.05 142.81 34.17 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.358 1.463 . . . . 0.0 111.7 178.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 61.8 t -138.29 131.74 41.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 125.858 1.663 . . . . 0.0 108.91 -177.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -103.88 129.76 51.41 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.682 0.793 . . . . 0.0 110.811 177.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.3 tt -159.78 142.75 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 123.553 0.741 . . . . 0.0 112.149 -166.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -86.38 121.73 29.35 Favored 'General case' 0 N--CA 1.465 0.303 0 O-C-N 121.405 -0.809 . . . . 0.0 110.83 174.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -109.63 154.89 22.16 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.63 1.172 . . . . 0.0 111.844 172.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -113.79 130.85 56.4 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.796 1.638 . . . . 0.0 110.52 175.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 14.8 mmt180 -106.42 166.17 10.73 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.438 1.495 . . . . 0.0 112.811 -168.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -61.14 -26.41 67.66 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.153 0.981 . . . . 0.0 113.59 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -69.77 -9.66 55.39 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.162 1.385 . . . . 0.0 113.813 178.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 87.67 0.85 83.66 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 124.999 1.285 . . . . 0.0 113.241 -171.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 18.4 m -85.95 154.15 21.68 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.159 1.383 . . . . 0.0 111.855 179.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 31.1 p -133.04 153.8 51.14 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.778 0.831 . . . . 0.0 111.513 166.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 19.3 p90 -167.82 157.6 10.18 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 125.053 1.341 . . . . 0.0 112.814 -177.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -75.81 119.49 19.88 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.514 1.126 . . . . 0.0 110.514 176.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 26.8 t -103.74 144.86 30.91 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 125.607 1.563 . . . . 0.0 110.462 172.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 8.7 tp -98.4 112.95 24.79 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 162.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 46.6 t -92.64 115.56 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 124.794 1.238 . . . . 0.0 107.812 171.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -112.98 109.53 19.0 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 124.758 1.223 . . . . 0.0 107.777 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 79.4 t -82.36 128.95 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 172.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 55.2 t -111.37 112.38 54.62 Favored Pre-proline 0 CA--C 1.536 0.41 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 171.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -74.36 129.24 12.75 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 123.246 2.631 . . . . 0.0 109.88 178.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 80.2 t -102.13 118.66 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 123.9 0.88 . . . . 0.0 108.887 176.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 60.7 mttt -87.84 152.71 21.89 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.583 0.753 . . . . 0.0 112.397 172.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -91.17 -173.76 3.74 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.25 1.02 . . . . 0.0 111.519 175.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -60.31 -21.8 62.44 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.999 1.319 . . . . 0.0 114.394 178.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -90.84 -5.51 55.49 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.14 1.376 . . . . 0.0 113.023 178.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 80.58 22.2 62.65 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 124.403 1.001 . . . . 0.0 114.522 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -107.92 148.6 29.41 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.18 1.392 . . . . 0.0 109.904 172.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.1 p -80.15 126.27 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 123.654 0.782 . . . . 0.0 110.704 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.7 -23.28 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -174.074 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 55.4 mtm -130.25 150.9 51.29 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.028 1.331 . . . . 0.0 112.038 169.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -110.51 134.46 52.35 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 125.41 1.484 . . . . 0.0 109.189 167.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 72.6 mt -98.1 116.98 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 163.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -89.56 118.52 29.25 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 105.685 -1.968 . . . . 0.0 105.685 169.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -103.91 143.45 32.83 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 119.219 -0.42 . . . . 0.0 110.763 173.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -119.6 135.37 54.83 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.594 1.158 . . . . 0.0 110.434 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -138.41 150.49 46.57 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 125.541 1.536 . . . . 0.0 108.29 173.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.2 t -94.23 112.72 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.7 p -91.88 -25.75 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -177.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 32.0 ttm -165.44 124.93 1.75 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.589 1.156 . . . . 0.0 110.813 -175.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -84.33 128.11 34.38 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.584 -0.697 . . . . 0.0 110.481 175.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.446 ' HA ' ' HE2' ' A' ' 135' ' ' LYS . 7.8 mmpt? . . . . . 0 C--O 1.252 1.231 0 CA-C-O 117.644 -1.17 . . . . 0.0 113.11 174.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 40.5 p . . . . . 0 N--CA 1.478 0.949 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -79.94 -47.29 15.25 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.979 0.912 . . . . 0.0 112.076 177.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 69.3 tp -61.02 -35.15 76.11 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.522 0.729 . . . . 0.0 110.968 177.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -55.18 -28.8 55.55 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 176.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 36.5 m -70.69 -27.61 64.14 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.623 1.169 . . . . 0.0 111.484 174.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 15.4 mm -79.44 -34.77 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 124.265 1.026 . . . . 0.0 109.801 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.9 mp -53.88 -40.22 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 123.265 0.626 . . . . 0.0 110.735 170.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 24.2 mmm-85 -63.46 -29.75 70.98 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 119.058 0.845 . . . . 0.0 112.627 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -73.91 -39.01 64.15 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.353 1.061 . . . . 0.0 111.438 174.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -76.71 -21.88 54.69 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.67 1.188 . . . . 0.0 113.189 178.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 . . . . . 0 N--CA 1.475 0.792 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 168.984 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 9.3 mmt180 . . . . . 0 N--CA 1.469 0.523 0 CA-C-O 122.332 1.063 . . . . 0.0 113.148 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -107.66 133.37 52.19 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.861 1.264 . . . . 0.0 110.671 177.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -161.48 158.72 27.0 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 124.333 1.053 . . . . 0.0 112.908 177.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.5 pt -140.46 149.19 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 125.58 1.552 . . . . 0.0 110.767 176.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.1 mp -109.45 127.63 66.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 C-N-CA 125.914 1.685 . . . . 0.0 108.86 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -126.23 140.22 52.72 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 124.827 1.251 . . . . 0.0 111.23 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -71.43 121.79 19.23 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 122.729 0.412 . . . . 0.0 110.818 177.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.94 -28.64 61.61 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.335 0.654 . . . . 0.0 112.461 -178.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 -77.9 37.83 0.25 Allowed 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 126.084 1.753 . . . . 0.0 112.675 -178.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 98.0 t -145.19 136.55 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 127.042 2.137 . . . . 0.0 108.572 -172.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -54.84 -34.42 62.84 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 115.554 1.687 . . . . 0.0 115.554 -170.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -107.49 -0.15 22.37 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.241 1.416 . . . . 0.0 113.136 -178.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 99.4 m 53.83 71.67 0.49 Allowed 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.988 1.715 . . . . 0.0 111.984 -171.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.85 131.07 44.53 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.017 0.927 . . . . 0.0 112.168 -176.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 41.3 t -64.47 123.29 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 123.86 0.864 . . . . 0.0 109.254 172.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 38.3 pt -104.95 -19.04 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 124.869 1.268 . . . . 0.0 112.362 178.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -158.91 141.28 14.01 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.67 1.188 . . . . 0.0 111.145 -178.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 4.0 m -122.63 166.41 14.9 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 121.224 -0.922 . . . . 0.0 112.397 172.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -74.74 -151.64 0.03 OUTLIER 'General case' 0 CA--C 1.557 1.237 0 C-N-CA 122.51 0.324 . . . . 0.0 111.613 169.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -113.56 -22.5 10.27 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 120.472 -1.392 . . . . 0.0 113.2 163.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -74.44 -33.88 55.41 Favored Glycine 0 N--CA 1.47 0.941 0 O-C-N 121.355 -0.841 . . . . 0.0 112.876 -177.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -57.35 -37.84 73.21 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.673 1.189 . . . . 0.0 111.624 176.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 10.2 t -60.85 -53.05 62.11 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.354 1.462 . . . . 0.0 111.61 175.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -71.01 -25.21 62.58 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -178.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 31.8 tp -62.02 -45.23 94.52 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.609 1.164 . . . . 0.0 111.648 170.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 64.2 m -104.65 -32.55 8.86 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 -166.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.05 4.54 63.03 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 126.017 1.77 . . . . 0.0 114.541 -179.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -83.79 -156.22 0.21 Allowed 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 124.814 1.246 . . . . 0.0 112.185 170.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 9.5 t -152.17 168.77 24.26 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 120.286 -1.509 . . . . 0.0 111.135 170.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.1 ttp180 -58.63 -45.5 89.1 Favored 'General case' 0 C--O 1.22 -0.472 0 O-C-N 121.535 -0.728 . . . . 0.0 111.812 -173.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.44 -25.72 37.97 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 175.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -88.56 -39.14 14.35 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.746 1.218 . . . . 0.0 111.645 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 84.4 t -85.67 -24.48 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 125.053 1.341 . . . . 0.0 112.376 -177.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 86.6 mtp -63.44 139.11 58.74 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 120.979 -1.076 . . . . 0.0 110.819 171.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 13.7 tm0? 75.65 -4.1 2.44 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 126.789 2.036 . . . . 0.0 113.784 -177.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 36.9 mmt180 -79.32 157.33 75.49 Favored Pre-proline 0 N--CA 1.473 0.687 0 C-N-CA 124.657 1.183 . . . . 0.0 111.088 173.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -67.22 136.23 39.76 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.398 2.065 . . . . 0.0 109.999 166.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 26.7 p -68.01 -2.2 7.22 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 -179.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 57.1 p -65.32 -29.42 70.16 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.578 1.551 . . . . 0.0 112.231 169.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 74.2 m 58.32 42.76 21.07 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.585 1.554 . . . . 0.0 112.517 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -57.73 -27.01 62.6 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.858 1.263 . . . . 0.0 113.209 -176.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -61.71 -16.21 47.14 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.546 1.138 . . . . 0.0 113.927 174.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 79.9 mt -83.73 -11.45 57.13 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.365 1.066 . . . . 0.0 113.78 172.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 40.0 m170 -73.11 115.45 12.45 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 119.823 1.192 . . . . 0.0 110.65 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -101.66 -162.63 27.03 Favored Glycine 0 CA--C 1.539 1.576 0 C-N-CA 126.157 1.836 . . . . 0.0 112.464 177.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -70.07 -25.79 26.8 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 123.133 2.555 . . . . 0.0 113.132 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.2 tpm_? -82.75 -17.51 44.01 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.883 0.873 . . . . 0.0 113.195 179.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 40.9 m -65.96 138.95 58.17 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.991 1.316 . . . . 0.0 112.384 -168.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 22.3 mp0 -84.48 117.99 24.02 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.338 1.455 . . . . 0.0 110.545 -172.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -60.25 -33.76 72.76 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -177.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 36.6 mmt180 -63.4 -53.27 55.0 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.397 0.679 . . . . 0.0 111.202 172.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.8 -36.89 84.78 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 120.491 -1.381 . . . . 0.0 113.09 -178.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -54.69 -35.49 63.66 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.848 0.859 . . . . 0.0 112.378 171.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -76.81 -45.7 27.67 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 124.555 1.142 . . . . 0.0 112.527 173.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -58.46 -36.94 74.47 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 118.809 0.732 . . . . 0.0 111.15 -176.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 89.3 mt -61.18 -40.17 84.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 CA-C-N 119.825 1.193 . . . . 0.0 111.845 173.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.43 -37.11 68.68 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.526 0.731 . . . . 0.0 112.65 176.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 54.8 mm-40 -67.82 -33.26 74.44 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.987 0.915 . . . . 0.0 111.469 174.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -57.98 -26.02 61.8 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 121.19 -0.944 . . . . 0.0 113.105 178.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 55.3 mt -78.58 -18.13 55.07 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.737 1.615 . . . . 0.0 113.545 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.1 pp -83.38 -20.69 33.75 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 119.473 1.033 . . . . 0.0 112.1 173.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -81.38 154.87 35.27 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 125.075 1.322 . . . . 0.0 112.85 176.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -95.5 1.31 53.9 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.882 1.273 . . . . 0.0 114.214 -178.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -126.91 161.12 29.04 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.179 1.792 . . . . 0.0 111.725 -169.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -62.49 141.67 58.3 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.072 1.349 . . . . 0.0 112.304 -177.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 -152.19 125.54 8.76 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.818 0.847 . . . . 0.0 112.86 -171.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 44.3 mtmt -101.24 139.02 37.49 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.204 1.402 . . . . 0.0 111.592 171.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 67.7 t -134.16 143.66 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 126.082 1.753 . . . . 0.0 108.166 170.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -114.48 136.18 53.29 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.461 1.104 . . . . 0.0 110.9 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.1 tt -161.57 146.45 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 123.561 0.744 . . . . 0.0 112.659 -163.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -84.49 122.35 28.86 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 121.02 -1.05 . . . . 0.0 111.047 172.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 14.7 m-30 -108.42 147.01 32.23 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.232 1.413 . . . . 0.0 112.091 173.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -109.18 132.45 54.11 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.138 1.775 . . . . 0.0 110.627 177.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -107.08 160.23 15.71 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.718 1.607 . . . . 0.0 112.116 -166.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -64.28 -22.93 67.12 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -177.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -76.23 -7.25 54.46 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 124.633 1.173 . . . . 0.0 113.387 175.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 94.97 0.11 64.03 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 125.725 1.631 . . . . 0.0 114.28 -178.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 59.2 m -88.63 162.16 16.49 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.575 1.15 . . . . 0.0 112.421 179.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 26.5 p -138.27 155.64 48.42 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 121.147 -0.971 . . . . 0.0 112.031 168.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -166.04 157.07 13.33 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.982 1.313 . . . . 0.0 112.796 -176.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -75.49 123.04 24.77 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.803 0.811 . . . . 0.0 110.754 177.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 9.0 t -109.93 138.55 46.15 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.312 1.845 . . . . 0.0 109.681 174.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -83.19 140.46 32.56 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 156.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 13.8 t -124.01 112.36 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 125.336 1.454 . . . . 0.0 108.625 169.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -103.36 121.87 43.66 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.978 1.311 . . . . 0.0 109.994 172.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.1 p -91.48 124.38 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 166.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 81.6 t -109.02 111.79 60.35 Favored Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 175.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.31 130.34 13.94 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.875 2.383 . . . . 0.0 109.95 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 63.7 t -101.72 124.25 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 124.096 0.959 . . . . 0.0 108.604 173.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 35.1 mttp -98.09 153.75 18.21 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 175.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -93.11 -174.58 3.6 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.166 0.986 . . . . 0.0 111.294 176.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -59.82 -21.73 61.28 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.039 1.335 . . . . 0.0 114.421 178.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -91.4 -6.04 53.48 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.115 1.366 . . . . 0.0 113.181 179.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 78.62 25.63 60.38 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 124.239 0.923 . . . . 0.0 114.142 -178.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -108.53 152.22 25.03 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.198 1.399 . . . . 0.0 109.899 172.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 10.6 t -80.56 125.77 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 123.306 0.642 . . . . 0.0 109.318 -179.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.8 -24.83 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -176.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 56.6 mtm -130.76 152.91 49.6 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.558 1.143 . . . . 0.0 112.374 167.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -113.26 134.3 54.67 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 125.721 1.608 . . . . 0.0 109.172 168.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 46.1 mt -101.76 117.9 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 165.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -100.16 128.38 46.25 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 106.895 -1.521 . . . . 0.0 106.895 173.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -123.3 130.04 52.18 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.43 1.092 . . . . 0.0 110.313 -172.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -106.38 137.7 43.89 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.889 1.276 . . . . 0.0 111.08 -174.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -142.76 133.09 24.76 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.846 1.258 . . . . 0.0 109.463 177.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 59.4 t -80.27 115.29 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 5.2 p -97.94 -28.85 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -176.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 25.4 ptp -164.13 148.87 10.15 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.367 1.067 . . . . 0.0 113.337 167.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -90.91 130.3 36.86 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.036 0.934 . . . . 0.0 110.741 178.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.255 1.344 0 CA-C-O 115.806 -2.045 . . . . 0.0 115.587 -176.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 57.4 p . . . . . 0 N--CA 1.479 1.016 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -64.76 -53.96 38.88 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.989 0.915 . . . . 0.0 111.783 173.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 58.8 tp -60.7 -35.96 77.6 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.612 1.165 . . . . 0.0 111.175 176.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -62.31 -26.03 68.19 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 177.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 99.2 m -75.55 -28.13 58.9 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.554 1.141 . . . . 0.0 111.245 171.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 16.1 mm -77.68 -41.76 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 O-C-N 121.417 -0.802 . . . . 0.0 110.702 174.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 90.1 mt -56.19 -48.47 79.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 123.994 0.917 . . . . 0.0 110.564 177.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 16.2 ptp180 -67.08 -23.96 65.91 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -75.94 -33.46 59.82 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 119.523 1.056 . . . . 0.0 112.615 170.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -76.45 -32.01 58.17 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.533 1.133 . . . . 0.0 111.908 175.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 . . . . . 0 CA--C 1.543 0.688 0 CA-C-N 118.602 0.637 . . . . 0.0 111.322 172.382 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 6.0 mmt-85 . . . . . 0 N--CA 1.472 0.643 0 CA-C-O 122.607 1.194 . . . . 0.0 113.075 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.2 mptt -94.08 133.98 36.99 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.947 1.299 . . . . 0.0 110.412 178.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -163.27 161.88 24.97 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.482 1.113 . . . . 0.0 112.805 177.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.2 pt -139.74 158.61 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 126.06 1.744 . . . . 0.0 110.521 173.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 28.3 mt -118.54 132.97 66.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 125.601 1.56 . . . . 0.0 108.868 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -131.33 143.26 50.38 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.349 1.059 . . . . 0.0 111.585 176.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -72.15 123.76 23.58 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.246 0.618 . . . . 0.0 111.489 179.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -79.03 -21.16 47.31 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -178.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 63.7 mtp85 -75.97 28.28 0.11 Allowed 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 126.185 1.794 . . . . 0.0 113.367 -173.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.4 t -151.09 137.64 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 127.114 2.165 . . . . 0.0 108.426 -166.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -63.35 -39.93 95.88 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -175.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 24.9 p30 -81.68 -15.21 55.2 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 114.377 1.251 . . . . 0.0 114.377 179.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 86.2 m 51.56 56.57 7.68 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.439 1.496 . . . . 0.0 113.351 -176.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.87 138.47 55.69 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 12.7 t -60.41 125.07 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 170.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 42.4 pt -104.93 -18.59 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 124.871 1.268 . . . . 0.0 112.619 174.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -156.16 144.99 20.31 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.091 0.956 . . . . 0.0 111.855 177.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 8.1 m -123.94 154.66 39.43 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.294 1.038 . . . . 0.0 110.588 171.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -73.15 -149.16 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.288 0 CA-C-N 118.958 0.799 . . . . 0.0 111.885 172.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -115.66 -22.67 9.08 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 120.248 -1.533 . . . . 0.0 112.885 164.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -74.5 -33.84 55.32 Favored Glycine 0 C--N 1.343 0.962 0 C-N-CA 124.231 0.919 . . . . 0.0 112.791 -178.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -56.94 -38.17 72.54 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.319 1.048 . . . . 0.0 111.292 176.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 51.2 t -59.01 -51.56 69.55 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.108 1.363 . . . . 0.0 111.659 178.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -67.56 -20.28 65.38 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.925 0.89 . . . . 0.0 113.093 178.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.06 -35.56 81.53 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.622 1.169 . . . . 0.0 112.4 176.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 45.4 m -123.09 -24.1 4.79 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 115.578 1.696 . . . . 0.0 115.578 -176.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 87.9 15.46 61.19 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-N 119.77 1.168 . . . . 0.0 114.075 -177.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -85.59 -144.63 0.1 Allowed 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.699 1.199 . . . . 0.0 111.338 170.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 77.8 p -158.22 165.94 33.61 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 124.771 1.228 . . . . 0.0 111.765 174.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 44.8 ttm180 -54.83 -47.3 74.29 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 118.889 -0.577 . . . . 0.0 110.606 171.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.65 -32.58 52.04 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 119.611 1.096 . . . . 0.0 113.932 177.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -89.08 -34.53 16.73 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.942 0.897 . . . . 0.0 113.258 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 99.5 t -84.43 -14.39 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.278 1.031 . . . . 0.0 112.035 178.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 79.5 mmm -76.95 147.38 36.96 Favored 'General case' 0 N--CA 1.474 0.725 0 O-C-N 120.841 -1.162 . . . . 0.0 111.977 175.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 31.8 tp60 69.19 4.42 4.57 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 126.451 1.9 . . . . 0.0 113.433 -175.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 32.3 mmt180 -77.96 153.96 80.3 Favored Pre-proline 0 N--CA 1.47 0.561 0 C-N-CA 124.843 1.257 . . . . 0.0 109.875 174.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -73.55 11.62 1.02 Allowed 'Trans proline' 0 CA--C 1.546 1.118 0 C-N-CA 124.106 3.204 . . . . 0.0 115.205 176.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 7.8 t 77.84 -23.8 0.24 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 126.585 1.954 . . . . 0.0 114.453 163.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 37.7 p -58.05 -20.6 40.38 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 126.6 1.96 . . . . 0.0 113.376 172.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 90.6 m 60.53 28.45 18.13 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.388 1.475 . . . . 0.0 112.824 178.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -58.87 -27.72 65.45 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.635 1.174 . . . . 0.0 112.515 -177.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -59.81 -13.86 12.31 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 174.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 92.2 mt -84.02 -3.54 58.09 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.802 1.241 . . . . 0.0 113.891 172.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 9.4 p-80 -66.1 145.6 55.63 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 120.169 1.35 . . . . 0.0 113.415 178.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -128.83 -161.55 10.68 Favored Glycine 0 CA--C 1.538 1.506 0 C-N-CA 126.557 2.027 . . . . 0.0 111.225 166.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.26 -21.34 35.94 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.937 2.425 . . . . 0.0 113.194 177.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 21.6 tpt180 -89.86 -8.75 51.24 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.272 1.029 . . . . 0.0 113.491 -178.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 24.3 m -72.39 141.83 48.72 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.917 1.287 . . . . 0.0 110.579 -176.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 64.4 mm-40 -91.8 122.77 34.64 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.506 0.722 . . . . 0.0 110.04 -173.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 28.7 mmm180 -58.62 -39.36 80.26 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.803 0.841 . . . . 0.0 112.296 -178.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -64.86 -39.5 93.65 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.318 1.047 . . . . 0.0 112.081 176.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -69.2 -43.07 74.9 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.101 -1.0 . . . . 0.0 112.633 178.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -56.89 -34.92 68.36 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 122.95 0.5 . . . . 0.0 112.04 173.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -72.35 -46.75 54.05 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 124.82 1.248 . . . . 0.0 112.549 173.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -61.1 -34.86 75.61 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 118.563 -0.732 . . . . 0.0 111.565 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 87.4 mt -63.1 -38.87 83.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 CA-C-N 120.104 1.32 . . . . 0.0 111.749 171.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.92 -36.87 78.49 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 119.33 0.968 . . . . 0.0 112.296 173.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -65.84 -31.91 73.13 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 121.347 -0.846 . . . . 0.0 111.773 172.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.69 -20.59 65.83 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 119.203 0.911 . . . . 0.0 112.604 175.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 44.6 mt -88.32 -10.75 48.46 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.927 1.691 . . . . 0.0 113.374 172.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 84.5 mt -96.98 -14.64 21.55 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.529 1.132 . . . . 0.0 112.075 172.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -86.48 150.73 23.7 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 125.389 1.471 . . . . 0.0 113.162 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -100.28 8.94 43.4 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.136 1.374 . . . . 0.0 113.678 178.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -134.21 164.83 26.5 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.428 1.891 . . . . 0.0 111.476 -178.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -61.29 138.16 58.24 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.833 0.853 . . . . 0.0 111.854 -179.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 19.7 tpt180 -145.92 128.68 16.26 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.91 0.884 . . . . 0.0 112.058 -178.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 43.1 mtmt -107.34 139.86 41.16 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.76 1.624 . . . . 0.0 111.424 175.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 45.1 t -138.24 138.69 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 125.52 1.528 . . . . 0.0 109.251 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -102.92 127.76 50.0 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.221 1.008 . . . . 0.0 110.962 177.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 19.5 tt -150.71 146.32 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 124.208 1.003 . . . . 0.0 112.352 -171.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -89.9 119.05 29.94 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 121.055 -1.028 . . . . 0.0 111.578 176.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 20.0 m-30 -115.73 157.12 24.77 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.598 1.959 . . . . 0.0 111.314 175.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -114.05 151.9 31.8 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 178.237 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.54 158.79 28.45 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.493 1.517 . . . . 0.0 110.395 167.167 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -61.81 -23.78 66.44 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.235 1.014 . . . . 0.0 113.219 166.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -72.31 -9.02 57.95 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.739 1.616 . . . . 0.0 113.709 170.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 97.94 -6.4 62.17 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 126.127 1.822 . . . . 0.0 114.778 179.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 22.1 m -82.12 130.23 35.03 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 118.952 1.376 . . . . 0.0 112.627 -172.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 25.3 p -104.87 153.65 21.09 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.761 1.224 . . . . 0.0 112.46 -177.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -165.61 163.79 19.24 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 126.088 1.755 . . . . 0.0 112.672 169.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -77.87 124.88 28.54 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.37 1.068 . . . . 0.0 111.119 175.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 42.1 t -104.25 137.31 42.35 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.82 2.048 . . . . 0.0 110.128 170.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 6.8 tp -90.28 118.0 29.45 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 161.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 94.9 t -100.87 114.67 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 125.457 1.503 . . . . 0.0 107.903 173.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -115.45 108.72 16.85 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 125.606 1.562 . . . . 0.0 107.129 -175.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 17.1 t -93.52 127.37 45.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 -179.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 69.6 t -111.15 112.1 55.41 Favored Pre-proline 0 CA--C 1.535 0.374 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.88 131.6 15.92 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.64 2.227 . . . . 0.0 109.61 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 60.6 t -92.8 105.42 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 169.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 61.5 mttt -82.16 151.7 26.81 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.268 0.556 . . . . 0.0 111.202 166.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -92.96 -173.42 3.28 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.8 0.84 . . . . 0.0 111.831 174.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -60.14 -21.79 62.04 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.128 1.371 . . . . 0.0 114.693 178.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -93.73 -0.72 55.83 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.695 1.198 . . . . 0.0 113.155 177.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 77.87 20.55 73.27 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 124.301 0.953 . . . . 0.0 114.556 178.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -99.22 142.22 30.98 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.462 1.105 . . . . 0.0 109.12 171.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.7 p -76.55 118.97 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-O 122.089 0.947 . . . . 0.0 109.903 174.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.4 pt -106.91 -19.51 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 125.64 1.576 . . . . 0.0 113.29 -174.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 3.6 mtp -157.36 156.33 32.12 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 126.561 1.944 . . . . 0.0 110.512 -174.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -122.56 133.51 54.56 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 125.086 1.355 . . . . 0.0 109.563 175.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 56.8 mt -102.59 114.81 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 166.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 7.4 mp -98.57 119.77 37.85 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 177.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -110.82 135.81 50.82 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 123.354 0.409 . . . . 0.0 111.47 -178.144 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -111.86 138.37 48.55 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.12 1.368 . . . . 0.0 111.433 -175.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -144.03 136.34 26.68 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.42 1.488 . . . . 0.0 109.908 175.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 42.5 t -76.15 114.58 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 176.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.0 p -98.61 -25.61 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -173.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 44.4 tpp -165.2 128.21 2.23 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.154 0.981 . . . . 0.0 111.725 179.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -84.39 127.9 34.27 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.631 0.772 . . . . 0.0 111.386 -179.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.469 ' HA ' ' HE2' ' A' ' 135' ' ' LYS . 11.1 mmpt? . . . . . 0 C--O 1.254 1.299 0 C-N-CA 124.789 1.236 . . . . 0.0 113.103 174.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 39.7 p . . . . . 0 N--CA 1.479 0.985 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -62.14 -49.9 74.01 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.058 0.943 . . . . 0.0 111.954 175.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 58.2 tp -69.64 -39.93 76.83 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.343 1.457 . . . . 0.0 111.593 174.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -60.15 -28.41 67.87 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 176.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 95.1 m -69.03 -29.82 68.05 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.294 1.038 . . . . 0.0 110.739 173.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.8 mm -78.13 -41.92 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 123.683 0.793 . . . . 0.0 110.047 174.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 96.5 mt -56.9 -46.53 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 123.437 0.695 . . . . 0.0 110.661 176.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -70.66 -21.39 62.61 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.2 mtpt -78.57 -34.85 46.62 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.53 1.132 . . . . 0.0 112.606 170.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -78.02 -30.48 49.99 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.901 0.88 . . . . 0.0 111.82 175.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 . . . . . 0 CA--C 1.546 0.802 0 C-N-CA 123.903 0.881 . . . . 0.0 111.772 165.744 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.541 0.597 0 CA-C-O 122.738 1.256 . . . . 0.0 113.213 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.3 mptt -109.4 145.91 35.34 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.948 2.099 . . . . 0.0 110.376 -173.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -167.04 163.41 15.84 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.493 1.117 . . . . 0.0 113.333 178.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 20.2 pt -139.71 155.71 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 126.212 1.805 . . . . 0.0 110.327 172.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 17.2 mt -114.63 133.25 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 126.046 1.738 . . . . 0.0 108.688 -177.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -135.29 144.0 46.55 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.454 1.101 . . . . 0.0 112.171 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 57.8 t-20 -76.09 112.59 12.7 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.266 1.027 . . . . 0.0 112.151 -176.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -71.15 -19.69 62.39 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.293 1.037 . . . . 0.0 113.434 -177.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -75.32 -19.59 59.55 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.559 1.144 . . . . 0.0 113.256 179.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 95.4 t -89.42 136.36 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 125.769 1.627 . . . . 0.0 109.171 177.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -55.86 -41.2 74.01 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.789 1.236 . . . . 0.0 113.023 -175.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -79.42 -11.47 59.91 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.394 1.078 . . . . 0.0 113.717 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 88.4 m 52.8 57.85 5.94 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.355 1.462 . . . . 0.0 112.08 -170.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.39 137.07 57.7 Favored 'General case' 0 CA--C 1.548 0.87 0 O-C-N 121.405 -0.809 . . . . 0.0 112.616 -176.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.9 t -60.8 123.81 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 172.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.2 pt -105.03 -17.95 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 125.153 1.381 . . . . 0.0 112.547 175.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -157.2 145.75 19.61 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.065 0.946 . . . . 0.0 112.204 178.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 4.4 m -124.51 156.41 37.35 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.562 1.145 . . . . 0.0 111.504 172.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -73.79 -150.71 0.03 OUTLIER 'General case' 0 CA--C 1.56 1.349 0 CA-C-N 118.86 0.754 . . . . 0.0 111.397 171.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -116.23 -21.45 9.35 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 120.365 -1.459 . . . . 0.0 112.98 163.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -73.73 -34.01 57.11 Favored Glycine 0 N--CA 1.471 1.033 0 C-N-CA 124.126 0.869 . . . . 0.0 112.691 -178.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -58.69 -38.02 77.35 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.52 1.128 . . . . 0.0 111.652 177.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 33.5 t -55.58 -51.73 66.15 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.626 1.57 . . . . 0.0 111.758 178.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -69.27 -18.17 63.83 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 178.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.6 tp -66.99 -44.06 81.33 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.447 1.099 . . . . 0.0 112.317 178.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 80.3 m -112.68 -21.46 11.23 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 114.513 1.301 . . . . 0.0 114.513 -176.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 87.16 14.08 64.95 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 124.417 1.008 . . . . 0.0 114.2 -178.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -87.81 -154.65 0.27 Allowed 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 124.889 1.276 . . . . 0.0 111.857 172.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 70.1 m -150.61 159.47 44.48 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.951 1.3 . . . . 0.0 110.39 178.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 -50.59 -47.0 58.23 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 121.571 -0.706 . . . . 0.0 111.5 175.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.36 -27.53 36.87 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 177.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -91.71 -33.99 14.82 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.991 1.316 . . . . 0.0 112.368 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 57.4 t -88.21 -16.11 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 124.829 1.252 . . . . 0.0 111.947 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 84.0 mmm -73.62 148.06 43.2 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 120.96 -1.088 . . . . 0.0 111.344 171.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 9.7 tm0? 70.98 4.1 4.93 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 126.076 1.75 . . . . 0.0 113.068 -176.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 32.7 mmt180 -82.04 154.84 70.12 Favored Pre-proline 0 N--CA 1.472 0.63 0 C-N-CA 125.021 1.328 . . . . 0.0 110.375 175.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -75.16 11.8 1.4 Allowed 'Trans proline' 0 CA--C 1.548 1.215 0 C-N-CA 124.268 3.312 . . . . 0.0 115.72 176.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 8.3 t 73.89 -17.02 0.47 Allowed 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 126.348 1.859 . . . . 0.0 114.666 166.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 41.1 p -62.05 -23.48 66.5 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 126.095 1.758 . . . . 0.0 113.146 170.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 98.3 m 57.78 28.7 16.32 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.093 1.357 . . . . 0.0 113.004 -176.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -56.78 -31.91 65.11 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.595 1.158 . . . . 0.0 112.22 178.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -60.87 -12.54 11.37 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.995 1.318 . . . . 0.0 114.314 177.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.2 mt -83.74 -2.4 56.19 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 114.101 1.149 . . . . 0.0 114.101 174.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 18.3 p-80 -59.79 143.05 52.08 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 119.781 1.173 . . . . 0.0 113.617 179.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -123.94 -161.64 11.19 Favored Glycine 0 CA--C 1.539 1.551 0 C-N-CA 126.363 1.935 . . . . 0.0 111.517 169.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.22 -20.4 32.72 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 123.069 2.513 . . . . 0.0 113.184 177.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 -88.13 -12.04 45.21 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.245 1.018 . . . . 0.0 113.592 -179.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 18.6 m -72.38 138.83 47.48 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.994 1.317 . . . . 0.0 110.584 -175.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -102.87 131.11 50.01 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.295 1.038 . . . . 0.0 110.544 -177.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 19.9 tpp85 -60.76 -36.34 78.69 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.809 0.844 . . . . 0.0 112.538 -175.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 85.3 mmt-85 -60.67 -41.99 96.17 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.039 0.935 . . . . 0.0 112.448 175.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.64 -45.5 75.18 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 119.144 0.884 . . . . 0.0 112.112 177.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -57.18 -33.6 67.63 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.106 0.562 . . . . 0.0 112.318 173.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -73.28 -46.24 50.97 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 124.696 1.198 . . . . 0.0 112.293 175.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 12.9 mm-40 -61.42 -33.86 74.42 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 119.091 0.859 . . . . 0.0 111.715 -177.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 76.1 mt -63.96 -35.63 74.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 CA-C-N 120.307 1.412 . . . . 0.0 111.958 171.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.75 -35.56 67.5 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 119.112 0.869 . . . . 0.0 112.498 173.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 51.8 mm-40 -67.89 -33.67 75.16 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.564 0.745 . . . . 0.0 111.581 173.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -58.7 -22.05 56.34 Favored 'General case' 0 CA--C 1.547 0.847 0 O-C-N 121.063 -1.023 . . . . 0.0 113.392 178.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 57.7 mt -82.03 -14.55 55.74 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.751 1.621 . . . . 0.0 113.839 177.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.1 pp -85.65 -18.52 32.99 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 119.606 1.094 . . . . 0.0 112.643 173.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -79.82 167.26 51.27 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 124.919 1.247 . . . . 0.0 113.718 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -110.87 -7.57 14.58 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.011 1.725 . . . . 0.0 112.746 175.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -112.25 164.97 12.6 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 127.704 2.401 . . . . 0.0 111.642 179.262 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 44.1 mp0 -62.58 143.59 57.08 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.903 1.281 . . . . 0.0 112.141 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 16.0 mmt85 -140.64 130.05 23.88 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.891 1.276 . . . . 0.0 111.267 173.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 39.7 mtmt -104.81 136.04 45.06 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.297 1.439 . . . . 0.0 110.847 168.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 66.7 t -135.95 136.79 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 125.345 1.458 . . . . 0.0 108.742 176.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -101.01 131.82 46.71 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.987 0.915 . . . . 0.0 110.882 178.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.1 tt -154.11 150.05 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 124.612 1.165 . . . . 0.0 111.751 -170.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -89.22 125.85 35.25 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.243 -0.911 . . . . 0.0 111.825 174.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 20.0 m-30 -113.99 146.0 40.75 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.737 2.015 . . . . 0.0 111.115 173.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -86.52 156.36 20.12 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 169.257 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 58.3 ttm-85 -101.22 149.11 24.34 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 126.152 1.781 . . . . 0.0 109.332 166.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -54.37 -28.15 41.22 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 114.441 1.274 . . . . 0.0 114.441 177.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -73.68 -6.98 50.18 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.926 1.69 . . . . 0.0 114.088 176.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 99.17 -1.28 57.49 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 125.763 1.649 . . . . 0.0 114.229 -177.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -73.57 168.98 18.2 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 118.407 1.104 . . . . 0.0 112.215 177.041 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 34.9 t -143.02 151.66 41.06 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.341 1.056 . . . . 0.0 111.36 176.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -157.36 151.85 25.16 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.673 1.189 . . . . 0.0 111.587 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -76.57 123.18 25.69 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.411 0.624 . . . . 0.0 110.466 165.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 21.4 t -104.79 137.68 42.21 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.988 1.715 . . . . 0.0 110.377 170.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.3 tp -92.24 116.37 28.89 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 162.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 22.3 t -100.06 115.39 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 124.829 1.252 . . . . 0.0 108.468 176.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -110.79 110.61 21.31 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.721 1.208 . . . . 0.0 108.273 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 71.3 t -78.39 128.75 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 169.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 56.0 t -112.98 113.01 49.8 Favored Pre-proline 0 CA--C 1.538 0.496 0 N-CA-C 107.591 -1.262 . . . . 0.0 107.591 168.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.32 127.82 10.76 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 123.273 2.648 . . . . 0.0 109.741 178.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 79.3 t -102.02 119.7 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 123.912 0.885 . . . . 0.0 109.45 176.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 61.1 mttt -88.52 153.57 21.04 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.693 0.797 . . . . 0.0 112.635 172.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -92.35 -173.58 3.45 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.475 1.11 . . . . 0.0 111.663 175.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -60.11 -22.12 62.4 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.11 1.364 . . . . 0.0 114.465 178.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -90.66 -5.47 55.77 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.119 1.368 . . . . 0.0 112.991 178.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 80.43 22.35 62.71 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 124.396 0.998 . . . . 0.0 114.456 -179.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -108.16 148.24 30.17 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.193 1.397 . . . . 0.0 109.916 172.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.8 p -78.79 126.19 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 123.703 0.801 . . . . 0.0 110.525 178.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.47 -22.82 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 -174.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 56.0 mtm -130.18 149.91 51.67 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.848 1.259 . . . . 0.0 111.977 169.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -107.52 136.04 47.96 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 124.766 1.226 . . . . 0.0 109.126 164.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 75.9 mt -99.26 118.45 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 162.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -93.68 116.76 29.27 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 170.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -101.53 144.53 30.18 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 119.122 -0.466 . . . . 0.0 110.894 176.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -122.46 133.01 54.61 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.63 1.172 . . . . 0.0 111.151 -176.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -137.7 131.09 30.87 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 125.271 1.428 . . . . 0.0 109.2 176.138 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 71.3 t -76.86 110.95 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 175.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.2 p -93.9 -24.23 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 123.628 0.771 . . . . 0.0 112.744 -174.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 37.9 tpp -163.53 111.69 1.21 Allowed 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.769 1.228 . . . . 0.0 110.572 178.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -82.28 118.91 23.49 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.388 0.675 . . . . 0.0 109.919 176.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt . . . . . 0 C--O 1.254 1.306 0 C-N-CA 125.201 1.4 . . . . 0.0 113.475 -175.456 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 32.2 p . . . . . 0 N--CA 1.477 0.925 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -86.36 -56.98 3.18 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.88 0.872 . . . . 0.0 111.762 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 48.1 tp -57.87 -35.06 70.45 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.226 1.01 . . . . 0.0 111.065 178.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -44.77 -37.41 3.77 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 170.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 99.8 m -77.69 -31.64 52.54 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.39 1.076 . . . . 0.0 110.775 179.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 12.2 mm -75.38 -36.22 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 124.675 1.19 . . . . 0.0 110.661 177.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 94.0 mt -54.83 -41.46 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 123.547 0.739 . . . . 0.0 110.529 174.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 7.0 mmt85 -59.31 -32.91 70.48 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 118.864 0.756 . . . . 0.0 112.869 178.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -77.16 -36.75 54.95 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.888 1.275 . . . . 0.0 111.631 177.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -74.85 -25.9 59.31 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.65 1.18 . . . . 0.0 112.688 175.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 . . . . . 0 N--CA 1.475 0.809 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 173.178 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 22.8 mmm180 . . . . . 0 N--CA 1.469 0.496 0 CA-C-O 122.128 0.966 . . . . 0.0 111.239 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.6 mptt -92.85 123.24 35.97 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.128 -0.982 . . . . 0.0 110.935 -170.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -159.72 163.88 34.36 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.183 0.993 . . . . 0.0 113.096 177.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 32.6 pt -140.97 156.22 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 126.5 1.92 . . . . 0.0 110.006 173.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 10.7 mt -118.27 132.75 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 125.416 1.486 . . . . 0.0 109.006 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -130.87 148.54 52.65 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.44 1.096 . . . . 0.0 111.775 177.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 52.7 t-20 -71.22 125.3 26.57 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.863 0.865 . . . . 0.0 111.045 178.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.06 -26.78 59.65 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 121.463 -0.773 . . . . 0.0 112.824 175.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 77.4 mtp180 -76.41 23.59 0.15 Allowed 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 126.137 1.775 . . . . 0.0 114.462 -170.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.4 m -149.93 148.5 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 126.748 2.019 . . . . 0.0 110.563 -171.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -63.72 -41.01 98.15 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.414 1.086 . . . . 0.0 113.26 -169.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -83.55 -12.67 55.86 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -175.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 90.4 m 49.21 64.3 1.79 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.353 1.461 . . . . 0.0 111.489 -167.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.14 136.18 54.7 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.59 0.756 . . . . 0.0 112.027 -177.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.441 ' CG1' ' HG ' ' A' ' 44' ' ' CYS . 17.5 t -63.52 123.69 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 C-N-CA 122.869 0.467 . . . . 0.0 109.842 175.227 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.0 pt -103.67 -21.68 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 125.291 1.436 . . . . 0.0 112.551 175.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -151.07 144.55 24.91 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.187 0.995 . . . . 0.0 111.217 178.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.441 ' HG ' ' CG1' ' A' ' 41' ' ' VAL . 0.3 OUTLIER -135.46 140.65 45.02 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.411 1.084 . . . . 0.0 111.136 -177.685 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -78.96 -175.35 4.48 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 119.97 1.259 . . . . 0.0 112.403 176.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -90.95 -27.2 18.86 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 120.455 -1.403 . . . . 0.0 111.955 172.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -70.93 -41.64 61.49 Favored Glycine 0 C--N 1.343 0.95 0 O-C-N 121.869 -0.52 . . . . 0.0 112.248 -174.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.422 ' CE1' ' HB3' ' A' ' 44' ' ' CYS . 0.4 OUTLIER -69.39 -28.56 66.27 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.185 0.594 . . . . 0.0 112.332 -179.307 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 93.2 m -53.89 -51.76 62.65 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.18 0.992 . . . . 0.0 111.32 177.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -70.99 -19.72 62.5 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.111 0.964 . . . . 0.0 113.582 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 15.2 tp -62.81 -46.43 87.98 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.989 1.316 . . . . 0.0 111.788 -179.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 44.1 t -95.68 -33.52 12.29 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.167 0.987 . . . . 0.0 113.035 171.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.38 7.57 51.52 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 124.753 1.168 . . . . 0.0 114.091 -173.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -84.89 -158.3 0.35 Allowed 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 118.775 1.287 . . . . 0.0 112.36 168.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 10.5 t -155.83 170.24 22.55 Favored 'General case' 0 C--O 1.24 0.581 0 O-C-N 120.772 -1.205 . . . . 0.0 111.643 176.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 -47.46 -47.76 27.04 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.091 1.356 . . . . 0.0 111.44 176.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.05 -26.82 64.92 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -89.5 -36.07 15.6 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.192 0.997 . . . . 0.0 112.487 174.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 80.8 t -84.46 -17.12 10.32 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 C-N-CA 124.962 1.305 . . . . 0.0 111.914 -176.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 44.6 mtm -67.59 140.58 56.92 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 120.524 -1.36 . . . . 0.0 110.453 173.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 12.4 mt-30 67.77 9.64 7.24 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.566 1.546 . . . . 0.0 114.061 -178.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -83.86 155.11 64.82 Favored Pre-proline 0 N--CA 1.472 0.654 0 C-N-CA 124.611 1.165 . . . . 0.0 110.428 170.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.27 133.99 25.87 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.614 2.209 . . . . 0.0 109.029 166.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 3.9 t -65.6 -15.26 62.56 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -171.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 40.8 p -57.67 -28.26 63.61 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.586 1.554 . . . . 0.0 112.581 169.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 86.2 m 56.65 41.6 28.16 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.303 1.441 . . . . 0.0 112.099 -178.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -57.84 -27.45 63.21 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.687 1.195 . . . . 0.0 113.232 -175.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -62.47 -15.6 50.71 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 174.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 80.4 mt -79.47 -13.68 59.41 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 173.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 31.0 m170 -73.25 118.93 16.79 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 119.211 0.914 . . . . 0.0 110.911 -179.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -99.65 -164.32 29.26 Favored Glycine 0 CA--C 1.539 1.534 0 C-N-CA 125.841 1.686 . . . . 0.0 112.574 177.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -70.07 -25.15 27.46 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 123.096 2.531 . . . . 0.0 113.019 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 40.2 ttt180 -84.39 -14.84 48.32 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.898 0.879 . . . . 0.0 112.974 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 31.7 m -69.28 143.99 53.71 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.083 1.353 . . . . 0.0 112.074 -171.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 19.9 mp0 -91.19 118.08 30.16 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.308 1.443 . . . . 0.0 110.257 -168.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 57.6 mmm-85 -58.92 -36.46 74.76 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 121.414 -0.804 . . . . 0.0 113.011 -178.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 25.1 tpp180 -61.58 -45.27 94.82 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.212 1.005 . . . . 0.0 111.528 175.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -72.08 -40.46 68.25 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.104 -0.998 . . . . 0.0 112.724 179.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.42 -34.9 64.83 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.504 0.721 . . . . 0.0 112.017 173.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -73.38 -48.2 35.96 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 124.572 1.149 . . . . 0.0 112.291 172.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -58.62 -35.29 72.25 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 118.536 -0.745 . . . . 0.0 111.998 -178.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 80.7 mt -63.49 -35.63 73.23 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 CA-C-N 120.191 1.36 . . . . 0.0 112.293 172.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.13 -36.63 66.72 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 118.888 0.767 . . . . 0.0 112.339 173.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 48.3 mm-40 -68.91 -32.93 72.91 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.491 0.717 . . . . 0.0 111.74 175.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -58.61 -21.08 52.49 Favored 'General case' 0 CA--C 1.548 0.88 0 O-C-N 121.168 -0.957 . . . . 0.0 113.358 177.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 57.6 mt -83.74 -15.3 49.1 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.669 1.588 . . . . 0.0 113.89 177.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -85.69 -20.87 28.73 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 119.611 1.096 . . . . 0.0 112.183 173.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -82.36 149.75 27.89 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 125.042 1.306 . . . . 0.0 113.444 -178.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.66 -2.22 57.85 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.013 1.325 . . . . 0.0 114.008 178.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -126.27 162.53 25.25 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 126.177 1.791 . . . . 0.0 111.386 -173.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -59.75 136.03 57.87 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.559 1.144 . . . . 0.0 111.931 -178.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.2 129.99 22.96 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.674 1.19 . . . . 0.0 110.311 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 30.9 mtmt -109.26 140.57 42.74 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.565 1.546 . . . . 0.0 111.715 176.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 41.4 t -139.51 136.35 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 126.173 1.789 . . . . 0.0 108.849 178.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -104.31 135.41 45.82 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.262 1.025 . . . . 0.0 110.594 176.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.0 tt -161.11 150.57 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 123.623 0.769 . . . . 0.0 112.554 -165.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -86.72 123.36 31.8 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 121.402 -0.811 . . . . 0.0 112.165 173.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 12.0 m-30 -114.04 140.21 48.64 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 127.157 2.183 . . . . 0.0 111.6 175.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -77.7 162.61 26.86 Favored 'General case' 0 CA--C 1.55 0.942 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 172.193 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 13.2 ptt180 -122.64 155.66 35.92 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.758 1.223 . . . . 0.0 112.723 166.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -52.87 -28.21 22.02 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 126.354 1.861 . . . . 0.0 114.453 -176.068 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -68.06 -12.87 61.62 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.178 1.391 . . . . 0.0 113.683 177.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 94.79 22.95 22.22 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 125.007 1.289 . . . . 0.0 113.569 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 7.9 t -120.36 -173.1 2.5 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.595 1.158 . . . . 0.0 111.576 177.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 16.8 t -144.91 154.33 42.49 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.007 1.323 . . . . 0.0 112.514 -169.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -150.55 148.71 29.0 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.765 1.626 . . . . 0.0 110.97 177.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -74.72 134.26 41.92 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.712 0.768 . . . . 0.0 109.827 166.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 35.1 t -129.55 145.62 51.45 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.827 2.051 . . . . 0.0 110.235 -177.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 14.8 tp -93.9 127.31 39.6 Favored 'General case' 0 N--CA 1.463 0.175 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 161.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 68.7 t -101.87 127.23 55.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 161.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -122.3 121.77 37.51 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 119.289 0.95 . . . . 0.0 109.568 165.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 57.0 t -84.74 133.0 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 175.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 49.8 t -113.67 110.71 49.43 Favored Pre-proline 0 N--CA 1.467 0.411 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 170.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.85 129.99 12.06 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.903 2.402 . . . . 0.0 109.645 178.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 74.3 t -103.46 125.04 58.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.074 0.949 . . . . 0.0 109.587 178.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 66.7 mttt -94.11 153.98 17.84 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 172.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -93.49 -173.89 3.33 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.55 1.14 . . . . 0.0 111.506 176.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -60.27 -22.05 62.65 Favored 'General case' 0 CA--C 1.548 0.865 0 C-N-CA 125.038 1.335 . . . . 0.0 114.406 178.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -90.81 -5.52 55.51 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.144 1.377 . . . . 0.0 112.981 178.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 79.9 22.44 63.75 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 124.476 1.036 . . . . 0.0 114.458 -179.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -107.26 150.06 27.08 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.065 1.346 . . . . 0.0 110.001 173.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 86.8 t -78.25 125.95 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 123.551 0.74 . . . . 0.0 109.353 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.53 -23.27 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 -176.272 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 56.1 mtm -131.49 151.6 51.43 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.621 1.168 . . . . 0.0 112.155 170.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -110.63 135.25 51.55 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 124.985 1.314 . . . . 0.0 109.108 166.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 64.4 mt -102.19 119.15 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 165.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -95.31 118.09 31.45 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 172.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -107.58 131.92 53.84 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 123.338 0.399 . . . . 0.0 110.475 177.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 13.3 m-30 -108.76 147.94 31.26 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 125.724 1.609 . . . . 0.0 111.585 -177.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -148.63 141.9 25.12 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 125.3 1.44 . . . . 0.0 109.168 176.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 45.3 t -76.6 122.54 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 175.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.7 t -89.94 -39.74 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 125.025 1.33 . . . . 0.0 111.089 175.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 24.7 ttm -171.53 126.43 0.63 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.39 1.076 . . . . 0.0 110.957 -175.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -78.17 125.89 30.01 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 121.303 -0.873 . . . . 0.0 110.016 169.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt . . . . . 0 C--O 1.254 1.336 0 C-N-CA 125.038 1.335 . . . . 0.0 113.58 179.225 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 41.2 p . . . . . 0 N--CA 1.481 1.117 0 N-CA-C 114.136 1.162 . . . . 0.0 114.136 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -69.81 -50.62 41.2 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.033 0.933 . . . . 0.0 111.911 175.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 58.9 tp -61.84 -35.75 79.19 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.903 1.281 . . . . 0.0 111.154 176.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -56.69 -31.45 64.47 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.125 0.97 . . . . 0.0 112.671 177.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.2 m -72.13 -31.98 66.51 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.376 0.67 . . . . 0.0 111.175 174.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 16.1 mm -73.04 -41.8 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.889 0.876 . . . . 0.0 110.366 176.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 97.1 mt -54.47 -48.15 69.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.0 0.92 . . . . 0.0 110.019 174.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 81.6 mtt-85 -59.68 -27.18 66.19 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -78.18 -24.39 47.23 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.593 1.157 . . . . 0.0 113.112 177.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -90.31 -29.34 18.18 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.252 1.021 . . . . 0.0 112.75 170.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 . . . . . 0 CA--C 1.548 0.878 0 C-N-CA 124.688 1.195 . . . . 0.0 112.755 172.219 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? . . . . . 0 CA--C 1.543 0.696 0 CA-C-O 122.554 1.169 . . . . 0.0 111.3 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -104.46 142.09 35.21 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.285 1.434 . . . . 0.0 111.09 -163.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -166.03 162.24 17.81 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.366 1.066 . . . . 0.0 113.751 -178.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 31.4 pt -147.13 156.11 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 127.406 2.282 . . . . 0.0 110.081 -178.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.9 mp -122.03 131.61 72.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 125.126 1.371 . . . . 0.0 109.505 176.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -125.21 147.79 48.92 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 124.959 1.304 . . . . 0.0 111.499 176.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -77.88 130.0 36.07 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.105 0.478 . . . . 0.0 111.454 175.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.37 -21.01 62.92 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.632 1.173 . . . . 0.0 113.902 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 82.3 mtm180 -89.63 -4.56 57.75 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 114.622 1.342 . . . . 0.0 114.622 -167.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 32.4 m -108.99 150.49 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 125.114 1.366 . . . . 0.0 111.7 -173.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -50.21 -55.02 16.96 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 126.163 1.785 . . . . 0.0 114.03 -167.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -105.51 30.74 5.46 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.956 1.703 . . . . 0.0 111.689 -177.142 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 70.8 m 39.25 54.3 2.23 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 126.24 1.816 . . . . 0.0 113.299 170.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.8 141.04 56.63 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.773 0.829 . . . . 0.0 111.759 -168.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.5 t -65.18 121.51 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 174.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.1 pt -100.51 -15.61 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 125.171 1.389 . . . . 0.0 112.648 177.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -156.24 141.85 17.76 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.616 1.167 . . . . 0.0 111.198 176.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.491 ' HB3' ' CE1' ' A' ' 48' ' ' PHE . 3.3 m -129.66 156.56 44.04 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.971 0.909 . . . . 0.0 111.311 -178.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -78.71 -166.13 0.83 Allowed 'General case' 0 CA--C 1.558 1.272 0 CA-C-N 118.922 0.783 . . . . 0.0 111.274 164.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -111.54 -19.57 12.49 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 125.565 1.546 . . . . 0.0 112.77 168.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.19 -38.98 94.34 Favored Glycine 0 N--CA 1.472 1.047 0 C-N-CA 124.604 1.097 . . . . 0.0 111.942 176.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.491 ' CE1' ' HB3' ' A' ' 44' ' ' CYS . 0.6 OUTLIER -69.42 -30.87 68.91 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.73 0.812 . . . . 0.0 111.444 -176.454 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 83.4 m -49.63 -54.62 17.37 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.2 1.4 . . . . 0.0 111.905 174.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -72.74 -19.91 61.3 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -178.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 16.5 tp -65.01 -49.2 71.12 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.48 1.112 . . . . 0.0 111.461 179.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 79.0 m -107.8 -15.94 14.44 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 -177.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.39 -0.29 59.87 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 125.453 1.502 . . . . 0.0 114.428 172.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -84.39 -154.95 0.18 Allowed 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 124.757 1.223 . . . . 0.0 112.314 171.395 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.0 t -159.11 168.49 26.49 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 120.604 -1.31 . . . . 0.0 111.652 173.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 36.5 ttm180 -49.56 -49.49 46.12 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.247 1.419 . . . . 0.0 111.044 176.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.82 -27.87 53.47 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -87.98 -49.26 7.18 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.447 1.099 . . . . 0.0 110.651 175.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 69.2 t -72.16 -19.25 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 124.363 1.065 . . . . 0.0 112.13 -172.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 5.4 mmt -64.21 -2.13 1.96 Allowed 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 5.8 tm0? -132.87 14.95 4.32 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.667 1.187 . . . . 0.0 112.341 173.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 37.4 mmt180 -98.48 155.43 36.82 Favored Pre-proline 0 C--O 1.24 0.588 0 C-N-CA 125.459 1.504 . . . . 0.0 111.395 178.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.17 142.07 37.22 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.206 2.604 . . . . 0.0 110.192 172.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 3.2 t -66.15 -11.02 46.62 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 -177.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 40.0 p -68.79 -25.66 64.81 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.344 1.458 . . . . 0.0 112.223 171.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 83.6 m 51.41 42.89 29.65 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.464 1.506 . . . . 0.0 113.013 -177.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -56.42 -31.74 64.2 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.455 1.502 . . . . 0.0 112.978 -175.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -64.85 -15.57 62.02 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.493 1.117 . . . . 0.0 113.932 177.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 87.1 mt -80.69 -11.12 59.68 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.212 1.005 . . . . 0.0 113.019 172.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -76.8 119.48 20.62 Favored 'General case' 0 CA--C 1.546 0.789 0 O-C-N 121.063 -1.023 . . . . 0.0 110.492 -178.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -97.8 -167.26 32.05 Favored Glycine 0 CA--C 1.539 1.546 0 C-N-CA 125.684 1.612 . . . . 0.0 112.366 175.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -68.21 -25.59 36.81 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 123.045 2.497 . . . . 0.0 112.96 177.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -87.61 -5.34 58.78 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.076 0.951 . . . . 0.0 112.847 178.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 63.4 m -70.33 133.44 46.95 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 120.986 -1.071 . . . . 0.0 109.942 179.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 49.8 mm-40 -80.99 123.16 28.11 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -171.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -64.65 -32.8 74.63 Favored 'General case' 0 N--CA 1.476 0.839 0 O-C-N 121.721 -0.612 . . . . 0.0 112.529 -172.304 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 23.5 tpp180 -61.57 -48.33 81.44 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.298 1.039 . . . . 0.0 111.429 170.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.36 -39.59 81.76 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 121.199 -0.938 . . . . 0.0 112.949 -177.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -54.82 -37.31 65.98 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.234 0.614 . . . . 0.0 112.541 171.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -72.6 -41.39 65.67 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.116 0.967 . . . . 0.0 112.821 173.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -56.25 -34.4 66.36 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 118.024 -0.989 . . . . 0.0 112.096 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 74.9 mt -61.79 -50.24 81.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 CA-C-N 120.197 1.362 . . . . 0.0 110.667 173.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.15 -37.0 83.03 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.825 0.85 . . . . 0.0 112.647 -178.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 79.4 mm-40 -72.71 -31.5 65.05 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.318 1.047 . . . . 0.0 111.776 175.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.54 -29.96 70.95 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 119.592 1.087 . . . . 0.0 112.512 179.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 64.6 mt -65.81 -16.58 63.94 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.914 1.286 . . . . 0.0 113.001 175.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 60.3 mt -80.62 -14.23 58.36 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 121.266 -0.896 . . . . 0.0 112.52 173.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -89.85 145.81 18.46 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 125.159 1.361 . . . . 0.0 113.23 -178.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.17 -2.8 58.11 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.974 1.31 . . . . 0.0 113.942 176.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -125.45 163.9 21.63 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.475 1.91 . . . . 0.0 110.984 -177.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -62.13 146.58 50.12 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.411 1.084 . . . . 0.0 112.907 -175.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.56 127.17 10.86 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.597 1.159 . . . . 0.0 110.514 -170.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.4 mttt -112.46 142.07 45.44 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.997 0.919 . . . . 0.0 112.463 172.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 7.6 p -134.13 133.39 55.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 126.255 1.822 . . . . 0.0 111.275 171.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -93.51 129.56 39.67 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.712 1.605 . . . . 0.0 110.023 172.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.7 tt -158.13 147.77 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.497 1.119 . . . . 0.0 111.339 -166.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -84.64 127.79 34.26 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 120.723 -1.236 . . . . 0.0 111.6 174.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 9.7 m-30 -107.69 140.14 41.19 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.686 1.594 . . . . 0.0 110.134 171.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -108.14 124.16 49.82 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.989 1.715 . . . . 0.0 110.651 175.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 2.5 ptp180 -92.23 159.9 15.41 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.821 1.249 . . . . 0.0 113.755 -177.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -58.81 -22.46 58.6 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 125.272 1.429 . . . . 0.0 114.322 179.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -70.61 -12.34 61.5 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.501 1.12 . . . . 0.0 113.349 176.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 95.35 27.15 11.03 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 124.53 1.062 . . . . 0.0 113.693 178.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 69.0 m -132.8 169.07 17.25 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.735 1.214 . . . . 0.0 111.414 -177.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 22.8 p -139.82 169.9 16.86 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 179.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -164.82 154.62 13.52 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 126.308 1.843 . . . . 0.0 110.348 -176.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -76.81 121.4 23.3 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.952 0.882 . . . . 0.0 110.124 168.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 49.5 t -104.7 140.44 38.06 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 127.755 2.422 . . . . 0.0 109.92 174.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 14.2 tp -93.0 119.0 31.8 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 160.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 44.2 t -103.45 117.19 48.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 124.476 1.11 . . . . 0.0 108.452 172.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -105.33 120.85 42.61 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.375 1.47 . . . . 0.0 108.314 174.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.2 p -93.64 131.09 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 119.483 1.038 . . . . 0.0 109.365 164.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 99.5 t -119.43 103.85 46.26 Favored Pre-proline 0 CA--C 1.537 0.46 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 176.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -75.78 139.76 22.66 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.906 2.404 . . . . 0.0 110.574 -175.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 96.3 t -112.37 125.33 69.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.353 1.061 . . . . 0.0 109.76 -178.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 67.2 mttt -93.55 154.54 17.82 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.036 0.934 . . . . 0.0 113.26 171.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -93.09 -174.21 3.49 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.497 1.119 . . . . 0.0 111.521 176.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -61.67 -20.69 63.71 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.013 1.325 . . . . 0.0 114.548 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -95.39 0.02 53.04 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.856 1.263 . . . . 0.0 113.162 177.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 79.31 22.55 64.9 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 124.155 0.883 . . . . 0.0 114.788 176.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -107.24 150.41 26.68 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.134 1.374 . . . . 0.0 109.987 172.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 59.1 t -79.1 124.97 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 123.565 0.746 . . . . 0.0 109.284 -179.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -127.01 -22.41 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 -176.101 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 53.8 mtm -133.46 154.51 50.74 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.905 1.282 . . . . 0.0 112.552 172.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -119.18 132.94 56.02 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 125.581 1.552 . . . . 0.0 109.556 170.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 41.6 mt -100.66 117.39 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 167.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -102.98 135.42 44.69 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 173.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -130.48 127.44 39.2 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.321 1.049 . . . . 0.0 110.129 -171.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -108.02 139.39 42.73 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.817 1.647 . . . . 0.0 111.647 -173.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -147.72 135.03 20.61 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.129 1.372 . . . . 0.0 109.728 175.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 49.9 t -73.39 117.71 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 CA-C-N 119.365 0.984 . . . . 0.0 108.611 174.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.9 p -95.51 -24.62 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 123.597 0.759 . . . . 0.0 112.666 178.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 14.5 tpt -165.8 134.98 3.26 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.358 1.463 . . . . 0.0 110.411 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -92.28 130.4 37.98 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.482 -0.761 . . . . 0.0 110.979 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt . . . . . 0 C--O 1.253 1.272 0 C-N-CA 125.332 1.453 . . . . 0.0 113.941 178.394 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.8 t . . . . . 0 N--CA 1.485 1.295 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -65.01 -50.81 64.83 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.197 0.599 . . . . 0.0 111.567 176.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 54.5 tp -64.33 -35.98 82.62 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.201 1.4 . . . . 0.0 111.022 172.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.5 -28.6 67.19 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.677 1.191 . . . . 0.0 112.688 178.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 94.4 m -74.29 -33.34 63.2 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.47 1.108 . . . . 0.0 110.869 173.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.2 mm -73.6 -36.22 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 124.351 1.06 . . . . 0.0 111.108 176.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 96.5 mt -57.04 -42.59 79.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 123.488 0.715 . . . . 0.0 110.818 176.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 89.3 mtt-85 -61.54 -22.05 64.81 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 176.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -76.07 -35.96 59.2 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 120.885 -1.134 . . . . 0.0 112.131 177.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -96.99 -11.85 24.04 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 114.559 1.318 . . . . 0.0 114.559 176.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 . . . . . 0 CA--C 1.546 0.817 0 CA-C-N 119.537 1.062 . . . . 0.0 111.91 162.59 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.3 mpt_? . . . . . 0 N--CA 1.472 0.672 0 CA-C-O 122.217 1.008 . . . . 0.0 111.243 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -87.29 139.92 30.07 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.235 1.014 . . . . 0.0 110.667 -177.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -164.43 163.24 22.3 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 124.588 1.155 . . . . 0.0 112.889 177.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 20.5 pt -139.57 155.35 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 125.852 1.661 . . . . 0.0 110.576 173.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 16.0 mt -113.2 129.55 68.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 125.687 1.595 . . . . 0.0 108.479 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -127.07 144.87 50.92 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 124.53 1.132 . . . . 0.0 111.249 176.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 42.8 t-20 -68.16 127.61 33.54 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.344 0.657 . . . . 0.0 111.146 178.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -83.04 -20.21 35.42 Favored 'General case' 0 CA--C 1.546 0.812 0 O-C-N 121.364 -0.835 . . . . 0.0 113.085 176.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 75.2 mtp180 -77.73 41.01 0.32 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 126.345 1.858 . . . . 0.0 112.759 -175.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.5 p -170.37 138.24 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 126.895 2.078 . . . . 0.0 109.985 -168.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -61.07 -44.67 97.03 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.043 0.937 . . . . 0.0 112.286 -176.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -72.55 -23.18 60.95 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -176.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 89.3 m 57.87 58.95 3.37 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.755 1.222 . . . . 0.0 112.411 -175.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.0 135.83 56.8 Favored 'General case' 0 CA--C 1.551 0.998 0 O-C-N 121.203 -0.936 . . . . 0.0 112.528 -177.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 11.5 t -62.52 123.65 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 C-N-CA 123.473 0.709 . . . . 0.0 109.502 174.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.6 pt -104.61 -19.93 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 125.181 1.392 . . . . 0.0 112.354 176.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 21.3 t80 -153.98 146.17 23.78 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.864 0.866 . . . . 0.0 111.866 177.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 6.9 m -125.35 155.42 40.32 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.185 0.994 . . . . 0.0 111.161 171.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -71.34 -152.35 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.285 0 CA-C-N 118.362 0.528 . . . . 0.0 111.487 170.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -117.11 -17.52 10.26 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 120.229 -1.544 . . . . 0.0 113.205 164.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -76.3 -33.55 48.54 Favored Glycine 0 N--CA 1.471 1.007 0 O-C-N 121.324 -0.86 . . . . 0.0 112.852 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -58.13 -38.44 76.53 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.6 1.16 . . . . 0.0 111.599 177.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 9.9 t -53.0 -51.16 62.54 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.362 1.465 . . . . 0.0 111.825 173.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -74.02 -22.86 59.41 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -178.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 49.5 tp -65.16 -50.0 67.67 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.292 1.037 . . . . 0.0 111.815 176.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 80.6 m -105.86 -20.47 13.43 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 -174.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.77 6.01 70.56 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 124.585 1.088 . . . . 0.0 114.032 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -88.61 -175.72 5.03 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.578 1.151 . . . . 0.0 112.295 171.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 66.5 m -135.41 161.25 35.97 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.104 0.962 . . . . 0.0 111.104 -179.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 46.7 ttm180 -53.37 -42.49 66.95 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 121.497 -0.752 . . . . 0.0 111.842 178.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.04 -28.1 49.61 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 175.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -92.96 -35.2 13.42 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.818 1.247 . . . . 0.0 112.324 178.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 99.3 t -83.64 -12.52 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 124.509 1.123 . . . . 0.0 112.181 178.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 21.3 mmt -68.57 141.86 55.35 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 120.798 -1.189 . . . . 0.0 112.278 172.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 68.74 7.3 6.04 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 126.011 1.724 . . . . 0.0 113.609 -178.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -78.13 152.77 79.56 Favored Pre-proline 0 N--CA 1.472 0.667 0 CA-C-O 117.921 -1.038 . . . . 0.0 109.904 175.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -74.37 13.02 0.95 Allowed 'Trans proline' 0 CA--C 1.549 1.229 0 C-N-CA 124.319 3.346 . . . . 0.0 115.356 176.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 7.5 t 75.14 -27.6 0.19 Allowed 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 126.86 2.064 . . . . 0.0 113.922 167.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 38.8 p -58.92 -19.3 41.2 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 127.162 2.185 . . . . 0.0 113.92 173.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . 0.277 28.5 p 42.81 40.29 2.04 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 127.308 2.243 . . . . 0.0 114.31 178.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -57.59 -32.91 67.65 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.026 0.931 . . . . 0.0 111.765 -177.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -57.04 -15.75 5.79 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.155 1.382 . . . . 0.0 114.253 177.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 89.9 mt -75.18 -2.29 27.17 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 171.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 31.4 p-80 -60.55 133.22 55.89 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 119.826 1.194 . . . . 0.0 112.946 174.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -107.39 -161.95 21.55 Favored Glycine 0 CA--C 1.54 1.651 0 C-N-CA 126.229 1.871 . . . . 0.0 111.468 168.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.05 -26.02 18.75 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 123.083 2.522 . . . . 0.0 113.153 178.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 29.8 ttm180 -94.38 -8.09 39.74 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.547 1.139 . . . . 0.0 113.715 -176.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 25.8 m -64.6 139.41 58.76 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.254 1.421 . . . . 0.0 110.555 179.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -102.43 123.03 45.46 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.174 0.989 . . . . 0.0 109.735 179.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 42.5 mmt180 -61.58 -26.91 68.27 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 24.6 tpp180 -56.21 -46.0 79.65 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.472 1.109 . . . . 0.0 111.797 171.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.36 -45.57 65.82 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.449 1.1 . . . . 0.0 111.954 175.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.52 -33.34 63.68 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 121.62 -0.675 . . . . 0.0 112.709 177.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.59 -41.85 71.78 Favored 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 125.1 1.36 . . . . 0.0 112.502 173.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 24.5 mm-40 -60.81 -33.48 73.08 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 118.328 -0.844 . . . . 0.0 111.347 179.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 46.1 mt -59.36 -43.66 90.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 CA-C-N 120.042 1.292 . . . . 0.0 111.026 171.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.2 -35.8 74.16 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.327 0.651 . . . . 0.0 112.71 177.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 78.4 mm-40 -69.27 -32.52 71.76 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 121.604 -0.685 . . . . 0.0 111.861 174.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.71 -23.21 67.04 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.936 0.894 . . . . 0.0 112.771 178.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 61.1 mt -77.26 -15.04 59.63 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.677 1.591 . . . . 0.0 113.45 174.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 64.2 mt -89.97 -14.67 33.56 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.124 0.969 . . . . 0.0 112.426 179.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -92.64 148.48 19.11 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 125.164 1.364 . . . . 0.0 113.15 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.84 -1.57 58.02 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.721 1.208 . . . . 0.0 113.83 175.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -115.33 161.32 18.66 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.711 2.004 . . . . 0.0 111.208 176.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.79 154.34 39.37 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 178.15 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 29.9 tpt180 -155.07 129.14 8.82 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.635 1.174 . . . . 0.0 111.148 -175.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 39.5 mtmt -102.68 137.63 40.65 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.598 1.559 . . . . 0.0 111.622 174.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 64.4 t -132.97 134.94 57.7 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 C-N-CA 126.414 1.885 . . . . 0.0 108.025 177.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -106.0 130.61 53.9 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.765 0.826 . . . . 0.0 110.381 177.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.0 tt -156.98 147.2 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 124.022 0.929 . . . . 0.0 112.217 -166.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -85.73 126.66 34.15 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.027 -1.046 . . . . 0.0 111.858 174.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 18.3 m-30 -111.92 147.8 35.07 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.528 1.931 . . . . 0.0 111.116 172.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -101.25 150.14 23.29 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.8 0.84 . . . . 0.0 112.538 166.415 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 40.9 mtm180 -89.59 159.03 17.38 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.956 1.302 . . . . 0.0 112.283 169.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 5.9 mptp? -59.19 -27.16 65.44 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.02 0.928 . . . . 0.0 112.639 166.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -69.93 -11.46 60.89 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 126.255 1.822 . . . . 0.0 114.067 173.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 90.39 -0.67 78.22 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 125.472 1.51 . . . . 0.0 114.471 -176.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -76.74 154.63 33.9 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.533 1.133 . . . . 0.0 111.451 176.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 95.5 m -126.99 156.96 40.78 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 119.382 0.992 . . . . 0.0 112.176 174.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -161.42 154.68 21.25 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.851 1.26 . . . . 0.0 111.998 177.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -77.72 122.78 25.83 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.627 0.771 . . . . 0.0 110.392 165.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 8.2 t -107.55 140.95 39.75 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 126.083 1.753 . . . . 0.0 110.224 173.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.3 tt -92.16 121.59 33.84 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 125.158 1.383 . . . . 0.0 107.491 162.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 48.0 t -101.0 111.37 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 125.068 1.347 . . . . 0.0 108.484 169.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -107.75 107.78 18.71 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.612 1.565 . . . . 0.0 108.997 174.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 50.4 t -78.43 126.91 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 170.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 75.6 t -114.36 116.3 44.19 Favored Pre-proline 0 CA--C 1.538 0.51 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 170.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.69 127.0 9.9 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 123.238 2.625 . . . . 0.0 109.736 179.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 63.0 t -97.18 118.64 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 123.736 0.815 . . . . 0.0 109.279 174.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 60.4 mttt -88.48 153.51 21.1 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.675 0.79 . . . . 0.0 112.587 171.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -93.02 -173.52 3.3 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.518 1.127 . . . . 0.0 111.747 175.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -60.7 -21.36 62.8 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 125.206 1.402 . . . . 0.0 114.705 178.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -93.93 -0.82 55.43 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.854 1.262 . . . . 0.0 113.22 177.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 79.11 22.05 66.46 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 124.222 0.915 . . . . 0.0 114.537 177.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -107.29 147.89 29.69 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 125.119 1.368 . . . . 0.0 109.923 172.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.6 p -77.82 126.38 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 123.405 0.682 . . . . 0.0 110.273 178.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.58 -22.45 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 -175.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 57.7 mtm -131.99 150.96 52.01 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.779 1.231 . . . . 0.0 112.068 168.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -107.92 133.7 51.89 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 125.06 1.344 . . . . 0.0 109.215 165.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 69.2 mt -97.15 119.0 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 163.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 8.6 mp -96.47 119.09 34.32 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 169.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -102.81 124.88 49.16 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 123.547 0.529 . . . . 0.0 110.984 177.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -100.9 126.88 47.55 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.232 1.413 . . . . 0.0 109.998 179.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -141.53 103.94 4.48 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.38 1.072 . . . . 0.0 108.246 -172.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.2 p -61.51 116.9 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 O-C-N 120.981 -1.074 . . . . 0.0 110.473 178.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.9 p -96.76 -27.54 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.817 1.247 . . . . 0.0 113.102 -174.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 24.7 ptp -161.41 147.17 14.02 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.24 1.016 . . . . 0.0 112.64 166.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -88.93 134.31 34.0 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.705 0.802 . . . . 0.0 110.845 177.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt . . . . . 0 C--O 1.253 1.246 0 C-N-CA 125.36 1.464 . . . . 0.0 112.473 177.114 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.8 t . . . . . 0 N--CA 1.48 1.031 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -75.28 -45.09 42.07 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.252 -0.905 . . . . 0.0 112.018 172.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 52.9 tp -63.18 -35.94 81.96 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.764 1.226 . . . . 0.0 111.16 171.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -52.1 -33.31 39.01 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.548 1.539 . . . . 0.0 112.583 175.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 21.4 m -72.65 -21.56 61.07 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.546 1.538 . . . . 0.0 112.02 176.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.6 mm -82.22 -39.56 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 124.168 0.987 . . . . 0.0 109.953 177.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.9 mp -55.21 -38.95 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 123.422 0.689 . . . . 0.0 111.367 177.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 50.0 ptt85 -73.45 -16.86 61.3 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -178.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -85.69 -36.77 20.04 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.121 1.368 . . . . 0.0 111.297 171.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -70.74 -28.83 65.0 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.485 1.114 . . . . 0.0 112.029 174.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 . . . . . 0 CA--C 1.541 0.626 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 167.405 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.54 0.565 0 CA-C-O 122.557 1.17 . . . . 0.0 111.477 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.7 mptt -97.74 139.09 34.14 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.512 1.525 . . . . 0.0 110.351 -179.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -162.15 160.93 27.8 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 124.072 0.949 . . . . 0.0 113.127 173.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 12.8 pt -139.72 153.22 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 125.996 1.718 . . . . 0.0 109.937 175.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.2 mp -116.5 133.31 63.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 C-N-CA 125.337 1.455 . . . . 0.0 109.146 -179.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -132.54 142.81 49.35 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 124.825 1.25 . . . . 0.0 111.815 -176.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -65.56 121.69 15.51 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.518 1.127 . . . . 0.0 111.944 177.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -78.82 -19.87 51.03 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 178.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 26.0 mmm180 -73.31 -40.65 64.34 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.468 1.107 . . . . 0.0 112.527 -175.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 32.6 m -73.55 147.78 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 124.013 0.925 . . . . 0.0 111.892 175.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -62.22 -42.02 98.92 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.574 1.149 . . . . 0.0 113.225 -172.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -77.32 -11.32 59.82 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 113.785 1.032 . . . . 0.0 113.785 -176.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 81.6 m 51.03 60.31 3.97 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.451 1.5 . . . . 0.0 111.776 -170.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.06 137.51 55.07 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.749 0.82 . . . . 0.0 112.023 -176.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 41.4 t -63.71 123.79 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 123.723 0.809 . . . . 0.0 109.263 174.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.6 pt -103.83 -19.74 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.727 1.211 . . . . 0.0 112.298 175.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -154.08 143.72 21.66 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.34 1.056 . . . . 0.0 111.506 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 4.2 m -125.62 157.63 36.73 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.816 1.246 . . . . 0.0 111.594 174.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -73.79 -149.95 0.02 OUTLIER 'General case' 0 CA--C 1.56 1.364 0 CA-C-N 118.622 0.646 . . . . 0.0 111.399 169.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -116.72 -18.69 10.2 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 120.425 -1.422 . . . . 0.0 113.266 163.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -76.0 -34.98 45.83 Favored Glycine 0 N--CA 1.471 0.99 0 O-C-N 121.276 -0.89 . . . . 0.0 112.684 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -55.29 -39.12 69.5 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.857 1.263 . . . . 0.0 111.605 177.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 2.8 t -54.6 -56.76 15.65 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.69 1.596 . . . . 0.0 112.09 176.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -71.31 -20.54 62.18 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -179.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.8 -53.51 56.96 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.64 1.176 . . . . 0.0 110.947 175.129 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 75.9 m -104.94 -31.97 8.99 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 -174.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 109.72 0.12 30.55 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 127.207 2.337 . . . . 0.0 115.945 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -79.58 -160.75 0.28 Allowed 'General case' 0 CA--C 1.554 1.102 0 CA-C-N 118.786 1.293 . . . . 0.0 112.466 177.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 69.8 m -145.01 160.91 40.62 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.055 1.342 . . . . 0.0 110.582 174.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -53.03 -44.11 67.09 Favored 'General case' 0 N--CA 1.478 0.956 0 O-C-N 121.355 -0.841 . . . . 0.0 111.668 177.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.69 -25.95 42.45 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 176.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -91.69 -39.46 11.82 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.024 1.33 . . . . 0.0 112.176 177.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 87.4 t -80.81 -15.84 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 124.502 1.121 . . . . 0.0 112.277 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 68.2 mmm -65.72 137.87 57.58 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 120.843 -1.16 . . . . 0.0 111.34 172.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 29.7 tp60 72.92 6.14 5.29 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 126.508 1.923 . . . . 0.0 113.633 -177.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 34.6 mmt180 -86.88 153.1 54.61 Favored Pre-proline 0 N--CA 1.473 0.699 0 C-N-CA 124.548 1.139 . . . . 0.0 110.84 176.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -71.52 136.01 27.56 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.109 2.539 . . . . 0.0 110.092 171.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 19.0 p -68.69 -7.67 35.53 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -176.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 41.2 p -62.3 -23.97 67.04 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.065 1.346 . . . . 0.0 112.124 168.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 84.0 m 57.69 36.5 26.69 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.617 1.567 . . . . 0.0 113.009 178.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -56.16 -29.44 60.81 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.766 1.226 . . . . 0.0 112.24 177.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -60.62 -13.68 15.84 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.852 1.261 . . . . 0.0 114.357 175.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.3 mt -90.35 -0.65 57.73 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.112 1.365 . . . . 0.0 113.853 174.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -70.96 161.52 30.95 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 -178.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -160.85 -164.62 16.08 Favored Glycine 0 CA--C 1.538 1.52 0 C-N-CA 126.857 2.17 . . . . 0.0 111.052 166.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -63.54 -20.47 69.6 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 123.083 2.522 . . . . 0.0 114.523 -176.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 27.1 mmt85 -88.66 -8.54 54.43 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 119.298 0.954 . . . . 0.0 113.306 175.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 28.7 m -73.7 132.4 42.65 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 119.464 1.029 . . . . 0.0 109.502 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 -87.07 122.16 30.52 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.366 0.666 . . . . 0.0 109.761 -169.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 31.9 mmm180 -58.86 -39.17 80.53 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.771 0.828 . . . . 0.0 112.608 -175.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 17.6 ttm180 -67.99 -35.79 78.93 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.649 0.779 . . . . 0.0 112.31 176.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -71.6 -43.07 66.87 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.061 -1.024 . . . . 0.0 112.217 179.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -56.15 -33.38 65.16 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.161 0.584 . . . . 0.0 111.83 171.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -72.37 -47.65 47.78 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 124.703 1.201 . . . . 0.0 112.259 172.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 13.6 mm-40 -62.28 -34.25 76.2 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 118.404 -0.808 . . . . 0.0 111.775 -179.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 90.7 mt -62.61 -40.06 86.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 CA-C-N 120.198 1.363 . . . . 0.0 111.557 171.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.86 -37.08 81.39 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 119.296 0.953 . . . . 0.0 112.361 174.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 -67.65 -32.18 72.69 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 121.591 -0.693 . . . . 0.0 112.04 173.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.43 -21.97 66.61 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 119.239 0.927 . . . . 0.0 112.761 176.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 41.1 mt -83.38 -14.87 51.82 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.282 1.433 . . . . 0.0 113.134 172.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 74.8 mt -89.9 -16.89 29.07 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.003 0.921 . . . . 0.0 112.01 171.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -83.31 145.52 23.16 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 125.159 1.361 . . . . 0.0 112.5 176.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.81 -4.63 56.49 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -179.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -125.57 160.92 28.37 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.452 1.901 . . . . 0.0 110.652 -178.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -65.11 147.17 53.95 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -176.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.48 123.84 5.91 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.627 1.171 . . . . 0.0 111.147 -164.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 44.1 mtmt -97.65 141.84 30.19 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.2 1.4 . . . . 0.0 112.735 176.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 56.8 t -139.2 138.63 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 126.356 1.863 . . . . 0.0 108.738 174.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -102.15 129.93 48.65 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.163 0.985 . . . . 0.0 110.713 177.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.8 tt -153.22 148.2 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 124.614 1.166 . . . . 0.0 111.847 -168.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -87.78 119.06 27.74 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 120.969 -1.082 . . . . 0.0 111.472 176.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 13.7 m-30 -106.46 140.25 39.66 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.991 1.716 . . . . 0.0 110.9 174.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -92.69 142.3 27.52 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.022 0.929 . . . . 0.0 112.805 176.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 43.0 ttm-85 -80.2 156.57 26.86 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.629 1.972 . . . . 0.0 110.404 174.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 25.6 mmmt -58.02 -26.53 62.55 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 176.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -78.58 -5.98 54.3 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.635 1.574 . . . . 0.0 113.984 177.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 92.14 1.46 69.71 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 125.039 1.304 . . . . 0.0 114.455 -176.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 8.6 t -77.45 178.44 7.19 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 118.319 1.059 . . . . 0.0 111.763 171.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 39.4 t -151.42 154.77 37.27 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.78 1.232 . . . . 0.0 112.376 -170.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -158.81 154.4 26.08 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.232 1.813 . . . . 0.0 110.882 179.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -81.22 124.78 29.58 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 121.815 0.817 . . . . 0.0 110.403 170.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 36.6 t -111.59 140.8 45.91 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.638 1.975 . . . . 0.0 110.801 177.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 18.8 tp -93.15 115.72 28.35 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.996 1.318 . . . . 0.0 108.163 165.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 81.4 t -99.37 118.22 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 171.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -109.69 109.42 20.14 Favored 'General case' 0 C--O 1.225 -0.198 0 C-N-CA 125.689 1.596 . . . . 0.0 108.411 172.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 71.5 t -78.66 130.43 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 169.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 78.1 t -117.22 111.33 40.4 Favored Pre-proline 0 N--CA 1.466 0.361 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 167.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.83 133.79 18.99 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.751 2.301 . . . . 0.0 109.884 179.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 41.1 t -91.74 119.62 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 173.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 66.0 mttt -92.96 151.9 19.65 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.649 0.738 . . . . 0.0 112.365 167.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -92.2 -173.87 3.57 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.959 0.904 . . . . 0.0 111.7 175.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -60.81 -21.3 62.99 Favored 'General case' 0 CA--C 1.548 0.865 0 C-N-CA 125.083 1.353 . . . . 0.0 114.553 178.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -93.99 -0.42 55.54 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.396 1.078 . . . . 0.0 113.105 177.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 77.48 19.87 75.56 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 124.173 0.892 . . . . 0.0 114.465 179.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -98.73 146.81 25.51 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.796 1.238 . . . . 0.0 109.393 172.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 84.1 t -77.2 127.97 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 177.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 3.3 pt -123.39 -23.15 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 -171.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 72.2 mtm -150.58 157.42 42.97 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.855 1.662 . . . . 0.0 110.487 178.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -115.24 132.22 56.68 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 124.683 1.193 . . . . 0.0 109.98 173.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 46.7 mt -97.18 114.84 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 105.647 -1.983 . . . . 0.0 105.647 164.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -92.98 117.91 30.58 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 171.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -107.53 129.76 54.94 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 119.478 -0.296 . . . . 0.0 111.02 178.216 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -109.39 143.18 39.31 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.111 1.364 . . . . 0.0 111.928 -176.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -145.36 145.34 31.15 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 126.007 1.723 . . . . 0.0 108.553 172.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 60.7 t -84.49 117.02 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 174.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.0 p -93.17 -25.97 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -179.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 44.6 tpp -165.28 123.68 1.65 Allowed 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.799 1.24 . . . . 0.0 110.75 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -84.36 123.51 30.27 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 121.562 -0.711 . . . . 0.0 109.819 174.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.255 1.357 0 CA-C-O 115.744 -2.074 . . . . 0.0 115.463 -170.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 43.2 p . . . . . 0 N--CA 1.48 1.048 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -67.87 -47.72 68.11 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.94 0.896 . . . . 0.0 112.116 175.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 39.4 tp -63.15 -36.53 83.92 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.88 1.272 . . . . 0.0 111.072 175.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -59.93 -29.61 68.5 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.667 0.787 . . . . 0.0 112.815 179.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 73.8 m -72.74 -21.43 61.03 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.227 1.411 . . . . 0.0 111.935 173.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.7 mm -87.42 -42.71 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.087 1.355 . . . . 0.0 110.819 173.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 93.5 mt -53.68 -45.25 60.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 124.036 0.934 . . . . 0.0 110.598 178.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -66.09 -24.6 66.73 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 -179.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -79.06 -33.41 44.64 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.602 1.161 . . . . 0.0 111.949 175.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -73.56 -34.17 65.02 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.144 0.978 . . . . 0.0 111.496 170.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.544 0.747 0 N-CA-C 114.395 1.257 . . . . 0.0 114.395 178.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? . . . . . 0 N--CA 1.474 0.757 0 CA-C-O 122.518 1.151 . . . . 0.0 111.883 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.5 mptt -89.96 134.83 34.0 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.351 1.46 . . . . 0.0 110.393 -177.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -159.4 161.7 35.65 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 124.289 1.036 . . . . 0.0 113.17 178.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 20.7 pt -140.02 161.46 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 126.671 1.988 . . . . 0.0 109.733 173.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.9 mp -126.26 133.88 67.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 C-N-CA 124.813 1.245 . . . . 0.0 109.545 177.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -130.85 144.71 51.65 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.673 1.189 . . . . 0.0 111.477 178.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -72.78 125.06 26.63 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 122.844 0.458 . . . . 0.0 111.436 178.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.22 -32.6 70.55 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.341 1.056 . . . . 0.0 112.412 -177.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 25.0 mmm180 -80.11 36.52 0.35 Allowed 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 126.082 1.753 . . . . 0.0 112.796 -173.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 70.3 t -144.07 133.38 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 126.719 2.008 . . . . 0.0 108.977 -171.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -56.61 -35.92 68.83 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 -172.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -103.05 -3.86 25.38 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.544 1.538 . . . . 0.0 113.05 -178.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 5.9 t 52.14 71.37 0.47 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 126.372 1.869 . . . . 0.0 111.664 -174.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.74 133.82 50.94 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 121.254 -0.904 . . . . 0.0 111.658 -176.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 15.6 t -62.62 120.66 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 CA-C-N 118.705 0.684 . . . . 0.0 109.159 171.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 42.9 pt -102.08 -21.68 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 124.766 1.227 . . . . 0.0 112.26 176.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -152.18 144.42 23.95 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.363 1.065 . . . . 0.0 111.575 178.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.433 ' HB3' ' CE1' ' A' ' 48' ' ' PHE . 0.6 OUTLIER -135.04 149.14 50.08 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.491 1.116 . . . . 0.0 111.53 -178.942 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -76.57 -168.96 1.1 Allowed 'General case' 0 CA--C 1.555 1.164 0 CA-C-N 119.226 0.921 . . . . 0.0 111.367 169.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -103.84 -21.63 13.63 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.248 1.419 . . . . 0.0 112.553 169.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.23 -36.18 60.09 Favored Glycine 0 C--N 1.343 0.917 0 O-C-N 121.578 -0.701 . . . . 0.0 112.551 -178.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.433 ' CE1' ' HB3' ' A' ' 44' ' ' CYS . 0.6 OUTLIER -67.68 -30.45 69.98 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 122.98 0.512 . . . . 0.0 111.869 179.53 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 77.6 m -53.53 -52.29 60.14 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.712 1.205 . . . . 0.0 111.757 174.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -71.38 -19.06 62.32 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.966 0.906 . . . . 0.0 113.211 -179.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.3 tp -64.21 -52.83 56.96 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.809 1.244 . . . . 0.0 111.313 179.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 71.0 m -101.87 -19.09 15.43 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 95.12 2.11 62.5 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 125.813 1.673 . . . . 0.0 114.344 177.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -83.95 -175.27 5.72 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.778 1.231 . . . . 0.0 113.224 170.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.439 ' H ' ' CG ' ' A' ' 58' ' ' GLU . 69.1 m -137.34 160.13 39.95 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 121.317 -0.865 . . . . 0.0 111.663 -179.076 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 36.1 ttm180 -46.28 -42.25 14.26 Favored 'General case' 0 N--CA 1.48 1.035 0 O-C-N 121.421 -0.799 . . . . 0.0 112.029 171.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.73 -32.84 63.72 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.899 1.28 . . . . 0.0 113.652 178.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.439 ' CG ' ' H ' ' A' ' 55' ' ' SER . 14.2 pt-20 -99.6 -23.65 14.99 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 177.05 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 85.3 t -85.26 -20.49 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 C-N-CA 124.83 1.252 . . . . 0.0 112.659 176.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 53.3 mmm -63.2 138.12 58.44 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 120.403 -1.436 . . . . 0.0 110.843 175.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 67.97 10.06 7.56 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.429 1.492 . . . . 0.0 114.094 179.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 -85.33 156.43 59.68 Favored Pre-proline 0 N--CA 1.472 0.668 0 C-N-CA 124.716 1.206 . . . . 0.0 111.059 174.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -67.27 127.17 16.17 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.495 2.13 . . . . 0.0 109.415 167.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . 0.426 ' HG ' HD23 ' A' ' 127' ' ' LEU . 9.1 t -69.69 -8.88 51.62 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -172.321 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 37.5 p -59.83 -28.1 67.19 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.893 1.277 . . . . 0.0 112.163 169.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 80.9 m 52.35 36.24 19.32 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.208 1.403 . . . . 0.0 112.726 -177.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -57.67 -30.1 65.18 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.624 1.17 . . . . 0.0 112.327 -177.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -59.03 -14.26 9.05 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.186 1.395 . . . . 0.0 114.211 175.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 89.5 mt -78.73 -4.14 47.72 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 173.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 15.9 p-80 -60.71 150.57 31.83 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-N 120.123 1.328 . . . . 0.0 114.268 178.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -142.84 -162.76 9.42 Favored Glycine 0 CA--C 1.54 1.605 0 C-N-CA 126.64 2.067 . . . . 0.0 112.42 173.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -71.04 -8.83 24.45 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 123.623 2.882 . . . . 0.0 114.122 -178.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 84.8 mmt-85 -107.27 8.04 29.64 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.045 1.338 . . . . 0.0 113.531 175.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 22.2 m -89.95 133.24 34.9 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.89 1.276 . . . . 0.0 109.803 178.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -102.45 137.52 40.58 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.295 1.038 . . . . 0.0 109.871 -179.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 27.8 mmt85 -58.84 -37.88 77.45 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.987 0.915 . . . . 0.0 112.199 -177.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 31.6 tpt180 -59.73 -43.99 93.94 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.486 1.115 . . . . 0.0 112.258 176.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.49 -45.9 74.5 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 121.42 -0.8 . . . . 0.0 112.147 178.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -57.28 -35.66 70.06 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 121.645 -0.659 . . . . 0.0 112.522 174.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -72.15 -44.85 62.47 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 125.186 1.394 . . . . 0.0 112.377 175.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.3 mm100 -60.85 -34.98 75.42 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.946 0.899 . . . . 0.0 111.227 -179.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 93.0 mt -60.63 -41.57 88.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 CA-C-N 119.702 1.137 . . . . 0.0 111.841 169.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.78 -32.22 70.59 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 119.562 1.074 . . . . 0.0 112.805 174.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 73.9 mm-40 -64.19 -37.35 87.14 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 121.475 -0.765 . . . . 0.0 111.232 171.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.96 -23.13 65.1 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 113.229 0.826 . . . . 0.0 113.229 177.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 70.3 mt -87.53 -14.09 41.24 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.433 1.493 . . . . 0.0 114.059 178.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.1 pp -100.84 -8.14 22.89 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 168.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -86.26 146.09 20.85 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 125.18 1.371 . . . . 0.0 112.344 175.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -93.42 1.32 56.9 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.57 1.148 . . . . 0.0 113.601 176.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.14 159.92 23.08 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.071 1.748 . . . . 0.0 111.604 -178.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -62.23 135.24 57.39 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.281 1.432 . . . . 0.0 111.937 178.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -138.82 127.9 23.95 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.506 1.122 . . . . 0.0 112.44 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 37.1 mtmt -101.18 132.26 46.75 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.496 1.518 . . . . 0.0 110.465 167.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 46.8 t -133.38 134.5 57.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 125.597 1.559 . . . . 0.0 108.231 177.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -103.85 132.03 50.49 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.761 0.824 . . . . 0.0 110.666 179.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.3 tt -154.79 150.15 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 124.288 1.035 . . . . 0.0 111.729 -168.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -86.98 127.43 35.09 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 120.998 -1.064 . . . . 0.0 111.747 172.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 17.6 m-30 -114.05 138.92 49.74 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.612 1.965 . . . . 0.0 110.719 171.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -85.5 156.31 20.84 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.382 0.673 . . . . 0.0 112.13 167.156 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -115.02 157.61 23.23 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.061 1.344 . . . . 0.0 113.246 172.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -48.84 -33.59 10.87 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 127.141 2.176 . . . . 0.0 114.637 -178.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -70.57 -10.48 59.39 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.259 1.423 . . . . 0.0 113.895 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 97.09 13.05 47.28 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 125.29 1.424 . . . . 0.0 114.264 178.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 22.9 m -107.51 -177.49 3.36 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.696 1.198 . . . . 0.0 111.242 177.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 25.1 p -148.33 171.14 16.48 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 120.878 -1.138 . . . . 0.0 113.291 176.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 18.2 p90 -160.76 159.98 30.75 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.764 1.626 . . . . 0.0 111.468 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -80.44 123.2 27.85 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 123.528 0.731 . . . . 0.0 110.328 167.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 19.0 t -106.93 134.63 49.79 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.212 1.805 . . . . 0.0 110.356 172.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.0 tt -88.13 118.48 27.74 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 161.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 59.7 t -99.78 110.55 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 124.881 1.272 . . . . 0.0 108.217 169.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -102.89 111.47 23.81 Favored 'General case' 0 C--O 1.227 -0.081 0 C-N-CA 125.426 1.49 . . . . 0.0 108.055 172.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 28.0 t -95.17 124.1 47.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 74.7 t -110.34 115.38 54.38 Favored Pre-proline 0 CA--C 1.537 0.466 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 -178.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -73.96 124.18 8.95 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.947 2.431 . . . . 0.0 109.904 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 88.3 t -98.48 117.12 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 123.328 0.651 . . . . 0.0 109.724 173.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 61.5 mttt -87.39 154.33 20.75 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.883 0.873 . . . . 0.0 112.581 172.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -92.57 -173.53 3.39 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.386 1.075 . . . . 0.0 111.629 175.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -60.18 -22.25 62.69 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.039 1.336 . . . . 0.0 114.416 178.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -90.68 -5.39 55.86 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.058 1.343 . . . . 0.0 113.026 178.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 80.5 22.56 62.12 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 124.425 1.012 . . . . 0.0 114.48 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -108.33 148.38 30.14 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.281 1.432 . . . . 0.0 109.88 172.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.0 p -79.51 125.67 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 123.56 0.744 . . . . 0.0 110.615 179.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.23 -22.86 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 -174.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 56.8 mtm -132.19 154.83 49.17 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.288 1.435 . . . . 0.0 111.857 170.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -117.14 133.52 55.9 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 124.957 1.303 . . . . 0.0 109.27 168.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 55.4 mt -96.59 118.98 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 105.647 -1.982 . . . . 0.0 105.647 166.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.426 HD23 ' HG ' ' A' ' 64' ' ' CYS . 6.9 mp -103.88 117.32 34.06 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 177.66 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -107.71 126.62 52.83 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 123.417 0.448 . . . . 0.0 110.842 -176.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 16.5 m-30 -102.67 134.07 46.65 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.094 1.358 . . . . 0.0 110.49 -177.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -138.08 127.61 24.92 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 124.885 1.274 . . . . 0.0 109.369 176.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 71.5 t -74.43 110.75 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 175.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.3 p -93.99 -23.58 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 123.711 0.804 . . . . 0.0 112.705 -173.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 14.3 tpt -164.4 129.4 2.74 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.113 1.365 . . . . 0.0 110.461 179.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -89.22 124.33 34.27 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.551 0.74 . . . . 0.0 110.339 178.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 6.7 mmpt? . . . . . 0 C--O 1.253 1.273 0 CA-C-O 117.67 -1.157 . . . . 0.0 112.911 178.648 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 39.0 p . . . . . 0 N--CA 1.476 0.872 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -80.0 -48.01 14.02 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.658 0.783 . . . . 0.0 111.642 177.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 61.8 tp -61.67 -33.39 73.9 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.457 1.103 . . . . 0.0 111.314 177.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -55.22 -32.61 62.41 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.405 1.082 . . . . 0.0 113.271 174.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 27.8 m -76.56 -24.73 53.58 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.437 1.495 . . . . 0.0 111.369 176.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 17.0 mm -81.91 -42.32 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 124.059 0.944 . . . . 0.0 110.522 175.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 81.9 mt -54.34 -48.29 68.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 123.862 0.865 . . . . 0.0 110.61 177.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 36.7 ptt180 -65.85 -19.8 66.01 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 -178.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 24.6 mtpp -77.28 -33.1 55.9 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.52 1.055 . . . . 0.0 112.447 172.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -92.97 -12.07 31.68 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.145 1.378 . . . . 0.0 114.293 178.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 . . . . . 0 CA--C 1.552 1.056 0 CA-C-O 122.353 1.073 . . . . 0.0 112.943 165.481 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? . . . . . 0 N--CA 1.471 0.6 0 CA-C-O 122.107 0.956 . . . . 0.0 111.645 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.3 mptt -98.88 138.61 35.76 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.32 1.448 . . . . 0.0 111.071 -171.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -162.93 161.93 25.96 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.229 1.012 . . . . 0.0 113.57 179.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 18.0 pt -140.88 157.52 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 126.529 1.931 . . . . 0.0 110.37 174.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 13.5 mt -119.27 134.51 62.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 125.897 1.679 . . . . 0.0 109.062 -178.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -135.86 151.27 49.86 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.205 1.402 . . . . 0.0 112.148 -178.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 34.7 p30 -80.3 111.55 16.78 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.133 0.973 . . . . 0.0 113.335 -174.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.8 -25.0 66.25 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 120.594 -1.316 . . . . 0.0 113.815 -173.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 52.3 mtm180 -84.2 -3.17 57.99 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 -173.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.4 t -109.49 137.16 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 125.434 1.494 . . . . 0.0 108.789 178.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -55.63 -41.58 73.73 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.447 1.099 . . . . 0.0 113.292 -172.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.3 p30 -78.03 -14.82 59.37 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 178.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 96.3 m 49.59 61.92 2.91 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.372 1.469 . . . . 0.0 112.492 -174.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.68 136.13 57.97 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.693 0.797 . . . . 0.0 112.448 179.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 43.7 t -60.8 119.4 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 169.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 45.4 pt -100.8 -17.55 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 125.534 1.533 . . . . 0.0 112.315 176.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -157.93 146.83 19.35 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.336 1.055 . . . . 0.0 112.099 178.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.484 ' HB3' ' CE1' ' A' ' 48' ' ' PHE . 1.9 m -131.24 153.8 49.13 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.462 1.105 . . . . 0.0 111.947 177.114 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -76.84 -166.9 0.75 Allowed 'General case' 0 CA--C 1.556 1.201 0 CA-C-N 118.939 0.79 . . . . 0.0 111.673 169.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -105.61 -19.16 13.86 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.496 1.518 . . . . 0.0 112.759 169.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -75.35 -35.99 46.18 Favored Glycine 0 C--N 1.343 0.968 0 O-C-N 121.488 -0.758 . . . . 0.0 112.549 -179.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.484 ' CE1' ' HB3' ' A' ' 44' ' ' CYS . 0.6 OUTLIER -65.4 -34.38 78.16 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.586 0.754 . . . . 0.0 111.59 179.72 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 57.2 m -51.42 -52.24 47.83 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.192 1.397 . . . . 0.0 111.799 172.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -71.85 -20.14 61.86 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -179.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.52 -54.06 42.13 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.51 1.124 . . . . 0.0 110.618 177.015 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 41.9 t -92.83 -32.64 14.56 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.53 1.84 55.47 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.447 1.499 . . . . 0.0 114.185 -175.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -81.69 -165.99 1.1 Allowed 'General case' 0 CA--C 1.555 1.151 0 CA-C-N 118.706 1.253 . . . . 0.0 113.055 171.097 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 32.8 m -142.39 160.02 41.09 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.894 1.278 . . . . 0.0 111.424 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -47.99 -49.16 31.71 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.018 0.927 . . . . 0.0 111.967 178.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.34 -25.9 37.58 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 179.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -89.62 -35.52 15.81 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.856 1.262 . . . . 0.0 112.124 178.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 18.9 t -93.67 -11.03 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.372 1.069 . . . . 0.0 112.659 -176.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 75.4 mmm -68.46 142.72 55.25 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 120.586 -1.321 . . . . 0.0 111.302 170.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 71.14 5.17 5.37 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 126.268 1.827 . . . . 0.0 113.77 -177.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -76.63 155.26 83.5 Favored Pre-proline 0 N--CA 1.475 0.817 0 C-N-CA 124.483 1.113 . . . . 0.0 110.317 173.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -74.58 12.23 1.16 Allowed 'Trans proline' 0 CA--C 1.549 1.234 0 C-N-CA 124.016 3.144 . . . . 0.0 116.273 179.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 5.8 t 75.24 -23.46 0.24 Allowed 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 126.6 1.96 . . . . 0.0 114.154 169.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 39.3 p -64.05 -21.73 66.64 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 127.561 2.344 . . . . 0.0 113.442 173.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 89.0 m 59.55 36.53 22.85 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.85 1.26 . . . . 0.0 113.168 -178.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -52.14 -36.39 51.27 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.797 1.639 . . . . 0.0 112.434 177.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -66.9 -11.39 55.96 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.715 1.206 . . . . 0.0 114.041 179.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 33.7 mt -93.75 -3.15 52.69 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.976 1.31 . . . . 0.0 113.649 171.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -77.95 118.82 20.62 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 121.092 -1.005 . . . . 0.0 110.318 -178.384 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -107.97 -162.95 21.19 Favored Glycine 0 CA--C 1.538 1.529 0 C-N-CA 126.189 1.852 . . . . 0.0 112.605 178.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -69.12 -22.43 35.04 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 123.339 2.693 . . . . 0.0 113.162 179.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 85.5 mtt85 -84.89 -12.2 53.97 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.16 0.984 . . . . 0.0 113.297 177.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 18.4 m -76.93 151.73 35.61 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.645 1.178 . . . . 0.0 111.244 -173.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.8 109.25 18.99 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.027 1.331 . . . . 0.0 109.144 -170.115 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 36.5 mmt180 -64.46 -24.24 67.55 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 121.449 -0.782 . . . . 0.0 112.996 179.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 20.5 tpp180 -58.71 -40.16 82.9 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.344 1.058 . . . . 0.0 112.327 168.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -77.8 -42.05 35.18 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.493 1.517 . . . . 0.0 112.161 175.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -54.18 -37.1 64.12 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 121.559 -0.713 . . . . 0.0 112.167 174.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.95 -47.81 76.32 Favored 'General case' 0 C--O 1.227 -0.113 0 C-N-CA 125.213 1.405 . . . . 0.0 111.291 175.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 22.3 mm-40 -61.51 -38.27 86.76 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 118.136 -0.935 . . . . 0.0 111.039 178.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 96.8 mt -63.16 -45.63 98.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 CA-C-N 120.439 1.472 . . . . 0.0 111.629 172.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.31 -39.48 92.51 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 118.898 0.772 . . . . 0.0 112.779 178.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -76.2 -25.75 55.46 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 124.049 0.94 . . . . 0.0 112.233 176.631 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -58.74 -29.92 67.09 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 120.172 1.351 . . . . 0.0 112.368 175.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 51.6 mt -67.51 -13.34 61.96 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.998 1.719 . . . . 0.0 113.442 175.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 66.9 mt -87.87 -13.62 41.57 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.307 1.043 . . . . 0.0 112.443 174.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -90.8 146.53 18.48 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 125.102 1.334 . . . . 0.0 113.542 -175.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -86.8 -7.74 57.97 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.899 1.279 . . . . 0.0 113.737 173.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -118.32 162.4 18.35 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.491 1.916 . . . . 0.0 111.428 -175.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -64.6 143.14 58.13 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.613 1.165 . . . . 0.0 112.912 -175.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 27.6 mmt180 -139.52 132.42 29.31 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.101 1.36 . . . . 0.0 111.546 176.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 38.3 mtmt -110.72 131.22 55.23 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.413 1.485 . . . . 0.0 109.854 167.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 64.3 t -132.44 137.08 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 125.126 1.371 . . . . 0.0 108.51 177.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -102.2 131.12 48.93 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.139 0.975 . . . . 0.0 110.762 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.3 tt -156.57 147.58 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.005 0.922 . . . . 0.0 112.033 -169.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -88.97 124.39 34.2 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 120.921 -1.112 . . . . 0.0 111.843 178.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 15.2 m-30 -113.02 134.3 54.58 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.702 1.601 . . . . 0.0 111.678 177.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -73.2 146.08 45.8 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.135 1.374 . . . . 0.0 112.308 169.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 32.4 ptt-85 -117.96 150.69 38.82 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.781 1.632 . . . . 0.0 112.609 173.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -61.83 -13.81 27.6 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.974 1.71 . . . . 0.0 114.373 -179.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -67.33 -12.9 61.35 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.548 1.139 . . . . 0.0 112.797 169.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 100.21 30.1 6.46 Favored Glycine 0 C--N 1.341 0.859 0 C-N-CA 124.914 1.245 . . . . 0.0 113.328 174.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 16.5 t -153.4 -168.33 2.97 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 118.303 1.051 . . . . 0.0 111.991 -174.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 27.0 t -146.64 161.13 41.2 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.203 1.401 . . . . 0.0 111.924 -166.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -165.16 163.35 20.36 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.202 1.801 . . . . 0.0 112.301 173.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -79.53 124.74 28.77 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 123.484 0.714 . . . . 0.0 110.783 176.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 34.0 t -107.2 136.85 46.33 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.254 1.822 . . . . 0.0 109.528 170.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 14.2 tp -88.08 123.28 32.6 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 161.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 60.5 t -108.75 116.91 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 125.336 1.454 . . . . 0.0 108.763 177.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -113.13 112.88 24.57 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.348 1.059 . . . . 0.0 108.991 -178.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.3 p -88.74 120.36 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 121.276 0.56 . . . . 0.0 109.706 172.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 90.5 t -104.25 111.76 65.26 Favored Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 125.341 1.456 . . . . 0.0 107.432 175.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.5 122.76 7.65 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 123.093 2.528 . . . . 0.0 109.418 177.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 60.2 t -94.59 117.8 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 174.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 20.3 mtpt -88.68 149.17 23.64 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.469 0.652 . . . . 0.0 111.175 172.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 51.2 p30 -77.77 -173.39 3.02 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.065 1.346 . . . . 0.0 111.997 175.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -66.24 -15.74 63.43 Favored 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 114.749 1.388 . . . . 0.0 114.749 175.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -97.25 -17.14 20.0 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.567 1.147 . . . . 0.0 113.271 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 86.36 40.48 7.36 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 125.846 1.689 . . . . 0.0 113.636 -174.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -115.06 151.31 34.48 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.267 1.427 . . . . 0.0 109.879 159.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.6 p -83.5 126.58 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 CA-C-N 119.055 0.843 . . . . 0.0 110.532 179.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.69 -27.04 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 -173.43 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 61.2 mtm -129.86 150.72 51.03 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.875 1.27 . . . . 0.0 112.117 171.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -110.75 133.22 53.52 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 125.458 1.503 . . . . 0.0 109.104 167.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 32.9 mt -102.8 119.94 51.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 165.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -100.35 119.62 38.71 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 175.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -107.31 127.8 53.88 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.437 1.095 . . . . 0.0 109.505 -177.438 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 16.1 m-30 -104.37 133.65 48.91 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.084 1.354 . . . . 0.0 110.571 -178.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -142.34 118.68 10.85 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 123.899 0.88 . . . . 0.0 109.758 173.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.0 p -68.27 115.01 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 O-C-N 121.437 -0.79 . . . . 0.0 109.525 176.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.3 p -99.57 -26.61 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 125.283 1.433 . . . . 0.0 113.315 -169.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 24.9 ptp -161.43 148.01 14.43 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.173 0.989 . . . . 0.0 112.898 168.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -90.46 130.04 36.57 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.019 0.927 . . . . 0.0 110.732 -179.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 7.0 mmpt? . . . . . 0 C--O 1.254 1.29 0 C-N-CA 124.355 1.062 . . . . 0.0 112.723 175.046 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 37.1 p . . . . . 0 N--CA 1.479 1.014 0 N-CA-C 111.719 0.266 . . . . 0.0 111.719 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -71.54 -46.77 58.62 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.498 0.719 . . . . 0.0 111.221 176.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 64.5 tp -63.15 -36.09 82.46 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.081 0.953 . . . . 0.0 111.138 176.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -59.85 -29.26 68.16 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 174.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 66.3 m -77.04 -19.88 56.6 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.014 1.325 . . . . 0.0 111.505 175.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 22.5 mm -84.33 -43.64 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 125.258 1.423 . . . . 0.0 111.351 170.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 71.6 mt -58.38 -35.54 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 O-C-N 121.424 -0.798 . . . . 0.0 111.022 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -72.47 -7.95 52.53 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 179.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 17.6 mtmt -84.32 -42.08 16.14 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.215 1.406 . . . . 0.0 110.731 171.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -79.72 -40.18 29.49 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.045 1.338 . . . . 0.0 113.054 179.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 . . . . . 0 N--CA 1.475 0.816 0 CA-C-N 118.972 0.806 . . . . 0.0 112.231 -179.846 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? . . . . . 0 N--CA 1.468 0.457 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.78 134.61 34.89 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 120.753 -1.217 . . . . 0.0 111.394 178.573 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -157.89 153.64 26.63 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.311 1.044 . . . . 0.0 112.928 178.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 15.2 pt -140.62 150.14 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 125.871 1.668 . . . . 0.0 109.758 175.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.7 mp -114.27 132.29 63.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 125.364 1.466 . . . . 0.0 108.983 -178.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -132.72 147.42 52.32 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 124.9 1.28 . . . . 0.0 111.849 -176.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 24.2 p30 -73.71 119.25 17.67 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.566 0.746 . . . . 0.0 112.217 -178.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.81 -29.13 61.99 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 120.705 -1.247 . . . . 0.0 112.191 -178.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 29.6 mmm180 -74.61 27.48 0.08 Allowed 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 126.486 1.914 . . . . 0.0 114.039 -176.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 84.9 t -147.33 136.61 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 126.942 2.097 . . . . 0.0 108.805 -171.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -56.93 -43.17 81.18 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.596 1.159 . . . . 0.0 113.019 -173.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -80.2 -14.97 58.02 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -177.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 96.5 m 49.85 68.34 0.76 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.614 1.566 . . . . 0.0 111.487 -168.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.26 136.23 44.56 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.562 0.745 . . . . 0.0 111.516 -174.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 39.8 t -63.74 122.48 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 174.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.6 pt -102.99 -19.66 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 124.987 1.315 . . . . 0.0 112.312 175.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -155.3 144.73 21.13 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.886 0.874 . . . . 0.0 112.54 178.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.413 ' HB3' ' CE1' ' A' ' 48' ' ' PHE . 1.8 m -130.63 152.95 49.44 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.767 1.227 . . . . 0.0 112.656 -179.551 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -75.22 -166.8 0.54 Allowed 'General case' 0 CA--C 1.557 1.216 0 C-N-CA 122.905 0.482 . . . . 0.0 112.074 170.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -102.9 -23.07 13.76 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.296 1.438 . . . . 0.0 112.705 168.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.85 -34.0 59.58 Favored Glycine 0 N--CA 1.47 0.917 0 C-N-CA 124.892 1.234 . . . . 0.0 112.754 -177.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.413 ' CE1' ' HB3' ' A' ' 44' ' ' CYS . 0.6 OUTLIER -71.4 -32.87 68.93 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 123.904 0.882 . . . . 0.0 111.268 -176.98 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 6.2 t -53.74 -49.26 68.54 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.637 1.175 . . . . 0.0 111.658 171.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -75.56 -21.19 58.1 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -179.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 47.6 tp -63.6 -48.59 76.73 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 121.488 -0.757 . . . . 0.0 111.198 172.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 17.8 t -103.76 -30.63 10.28 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 -172.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.25 6.79 58.67 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 124.307 0.955 . . . . 0.0 114.568 -176.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -88.42 -155.54 0.33 Allowed 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 118.698 1.249 . . . . 0.0 111.655 169.523 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 12.2 t -162.06 169.12 21.54 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 120.564 -1.335 . . . . 0.0 111.006 175.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -53.51 -44.74 69.32 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.12 0.968 . . . . 0.0 111.394 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.85 -28.49 56.66 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 119.811 1.187 . . . . 0.0 114.025 177.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -92.01 -38.12 12.42 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.854 1.262 . . . . 0.0 112.018 177.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 79.1 t -79.38 -19.07 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 126.057 1.743 . . . . 0.0 111.508 -177.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.39 131.56 50.67 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 120.895 -1.128 . . . . 0.0 110.788 172.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 8.0 tm0? 75.49 5.76 4.05 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 126.229 1.812 . . . . 0.0 113.561 179.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 34.7 mmt180 -85.71 153.01 57.83 Favored Pre-proline 0 N--CA 1.473 0.696 0 C-N-CA 124.536 1.134 . . . . 0.0 111.352 176.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -69.98 134.92 28.66 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 123.133 2.555 . . . . 0.0 109.978 171.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 20.6 p -67.52 -11.57 58.31 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 114.848 1.425 . . . . 0.0 114.848 -174.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 46.9 p -58.44 -30.53 66.98 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.379 1.472 . . . . 0.0 112.114 172.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 91.7 m 51.82 35.21 14.89 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.041 1.336 . . . . 0.0 112.604 -173.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -58.4 -29.72 66.27 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.427 1.091 . . . . 0.0 112.331 -179.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -60.91 -10.36 5.57 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.371 1.468 . . . . 0.0 114.307 175.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 58.0 mt -84.8 2.01 44.18 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.937 1.295 . . . . 0.0 113.952 173.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 13.8 p-80 -66.29 154.5 39.79 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 114.724 1.379 . . . . 0.0 114.724 177.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -151.9 -163.94 11.88 Favored Glycine 0 CA--C 1.54 1.609 0 C-N-CA 127.359 2.409 . . . . 0.0 111.231 167.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.95 -23.08 62.12 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 123.01 2.473 . . . . 0.0 114.916 -173.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 40.1 mmt180 -89.75 -4.28 57.75 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 119.509 1.049 . . . . 0.0 113.644 174.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 31.5 m -73.3 134.18 44.11 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 119.534 1.061 . . . . 0.0 109.532 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 81.2 mm-40 -91.03 117.53 29.66 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -174.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 7.9 tmm_? -59.6 -37.07 77.57 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 121.535 -0.728 . . . . 0.0 112.013 -176.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 25.7 tpt180 -61.22 -40.22 93.2 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.184 0.994 . . . . 0.0 112.087 173.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -71.68 -41.45 68.66 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 120.755 -1.216 . . . . 0.0 112.706 177.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -56.16 -35.03 66.71 Favored 'General case' 0 CA--C 1.546 0.815 0 O-C-N 121.644 -0.66 . . . . 0.0 111.846 172.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.1 -47.76 56.27 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.8 1.24 . . . . 0.0 112.571 172.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -57.71 -37.27 73.23 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 118.764 0.711 . . . . 0.0 111.402 178.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 85.5 mt -62.46 -38.83 82.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 CA-C-N 120.098 1.317 . . . . 0.0 112.068 173.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.71 -38.07 76.8 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 119.326 0.966 . . . . 0.0 112.169 174.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 94.4 mm-40 -66.86 -31.8 72.65 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.55 0.74 . . . . 0.0 111.916 174.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.48 -23.52 66.97 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.997 0.919 . . . . 0.0 112.718 177.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 41.6 mt -82.81 -15.06 53.11 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.255 1.422 . . . . 0.0 113.257 173.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 73.7 mt -90.19 -16.2 29.94 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.236 1.015 . . . . 0.0 112.002 173.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -85.33 148.35 22.96 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 125.238 1.399 . . . . 0.0 112.754 176.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -96.69 4.34 51.91 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 114.279 1.215 . . . . 0.0 114.279 -179.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.32 160.9 30.75 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.349 1.86 . . . . 0.0 110.324 177.214 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -64.53 145.89 55.44 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -178.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 12.5 tpt180 -148.22 129.57 14.77 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.114 1.366 . . . . 0.0 110.94 -172.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 39.7 mtmt -104.55 138.42 40.94 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.514 1.525 . . . . 0.0 111.274 178.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 45.0 t -139.23 134.67 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 125.163 1.385 . . . . 0.0 109.292 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -101.43 128.41 47.64 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.835 0.854 . . . . 0.0 111.082 178.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.5 tt -153.95 147.2 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 124.924 1.29 . . . . 0.0 111.694 -167.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -84.84 123.88 30.96 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 120.716 -1.24 . . . . 0.0 111.462 173.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 10.2 m-30 -105.64 145.32 31.18 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.807 1.643 . . . . 0.0 110.695 172.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -110.61 131.24 55.22 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.232 1.413 . . . . 0.0 111.716 175.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 59.4 mtt180 -71.21 165.5 23.49 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.922 1.689 . . . . 0.0 112.54 174.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -66.47 -23.02 66.2 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.088 0.955 . . . . 0.0 112.753 170.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -73.36 -11.71 60.58 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.626 1.571 . . . . 0.0 113.814 172.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 90.27 -3.95 82.44 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 125.267 1.413 . . . . 0.0 114.352 -175.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 30.4 m -77.25 164.51 25.52 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 118.213 1.007 . . . . 0.0 111.644 175.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 30.6 p -145.91 166.07 27.09 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 120.9 -1.125 . . . . 0.0 114.007 -178.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -165.44 160.49 18.0 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.154 1.781 . . . . 0.0 110.918 -178.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -79.72 121.69 25.64 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.746 0.818 . . . . 0.0 110.453 169.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 44.5 t -105.64 138.48 41.77 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 127.463 2.305 . . . . 0.0 109.687 174.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 15.4 tp -96.65 112.88 24.45 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 164.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 95.7 t -94.51 114.36 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 124.994 1.318 . . . . 0.0 108.564 174.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -106.23 107.59 18.67 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.991 1.316 . . . . 0.0 107.835 175.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 61.3 t -77.78 130.1 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 166.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 88.6 t -119.55 112.49 35.53 Favored Pre-proline 0 CA--C 1.537 0.462 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 167.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -74.59 134.59 18.75 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.738 2.292 . . . . 0.0 109.91 -179.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 45.5 t -92.81 119.4 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 171.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 66.1 mttt -93.01 151.95 19.59 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 121.648 0.737 . . . . 0.0 112.294 168.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -91.61 -173.78 3.66 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.887 0.875 . . . . 0.0 111.66 174.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -60.26 -22.11 62.68 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.986 1.315 . . . . 0.0 114.347 178.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -90.44 -5.6 55.9 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.747 1.219 . . . . 0.0 113.055 178.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 79.15 20.14 70.59 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 124.371 0.986 . . . . 0.0 114.262 -178.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -98.99 146.49 25.97 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.788 1.235 . . . . 0.0 109.46 172.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 96.5 t -76.09 128.49 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 176.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 3.3 pt -122.91 -24.87 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 113.863 1.061 . . . . 0.0 113.863 -172.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 71.4 mtm -147.82 155.09 41.29 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.492 1.517 . . . . 0.0 110.473 177.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -112.26 132.65 54.82 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.453 1.101 . . . . 0.0 109.774 171.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 56.6 mt -97.57 115.93 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 163.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -95.19 125.78 40.07 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 171.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -114.42 123.6 49.86 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 118.65 -0.691 . . . . 0.0 111.713 179.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 17.9 m-30 -108.9 97.6 7.21 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.409 1.484 . . . . 0.0 113.435 -170.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -109.26 112.9 25.31 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 120.231 -1.543 . . . . 0.0 109.743 -177.159 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.3 p -62.86 108.09 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 O-C-N 121.236 -0.915 . . . . 0.0 110.105 173.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.3 p -85.59 -23.77 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 125.199 1.4 . . . . 0.0 112.749 -176.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 32.5 ttm -163.43 124.89 2.41 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.71 1.204 . . . . 0.0 110.686 -175.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -81.12 127.02 32.18 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.216 0.606 . . . . 0.0 109.943 172.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 6.4 mmpt? . . . . . 0 C--O 1.253 1.284 0 C-N-CA 124.701 1.201 . . . . 0.0 112.81 177.232 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 62.3 p . . . . . 0 N--CA 1.48 1.072 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -68.97 -52.01 33.58 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.839 0.856 . . . . 0.0 111.715 173.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 57.3 tp -61.61 -35.61 78.35 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.83 1.252 . . . . 0.0 111.155 176.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -57.84 -31.16 66.37 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.829 0.851 . . . . 0.0 113.049 176.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 94.7 m -72.91 -29.64 63.29 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.199 1.0 . . . . 0.0 110.929 174.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 12.3 mm -77.07 -41.88 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 O-C-N 121.606 -0.684 . . . . 0.0 110.163 175.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 92.0 mt -55.36 -49.63 71.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 124.07 0.948 . . . . 0.0 110.435 175.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 11.4 ptm180 -71.85 -19.23 62.0 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -176.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -75.49 -39.92 57.91 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.046 0.939 . . . . 0.0 112.443 168.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -82.29 -27.66 32.2 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.516 1.126 . . . . 0.0 113.199 -179.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 . . . . . 0 CA--C 1.538 0.514 0 C-N-CA 123.933 0.893 . . . . 0.0 111.855 174.114 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? . . . . . 0 N--CA 1.477 0.902 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.52 149.13 30.07 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.537 1.135 . . . . 0.0 112.328 -173.544 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -165.46 165.52 19.09 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.764 1.226 . . . . 0.0 114.232 -178.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 15.2 pt -144.0 153.1 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 126.978 2.111 . . . . 0.0 109.708 171.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.9 mp -119.57 128.1 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 124.858 1.263 . . . . 0.0 108.795 176.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -120.63 144.56 48.08 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 124.87 1.268 . . . . 0.0 111.413 175.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -68.72 129.51 40.14 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.298 0.639 . . . . 0.0 110.818 172.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -78.44 -26.13 46.13 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 175.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 29.8 mmm180 -76.87 29.06 0.13 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 126.312 1.845 . . . . 0.0 113.894 -174.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.0 m -148.45 148.83 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 126.811 2.044 . . . . 0.0 110.099 -176.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -63.57 -38.13 89.95 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.202 1.001 . . . . 0.0 113.61 -168.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 -89.33 -9.25 51.17 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -174.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 97.6 m 50.65 57.71 6.32 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.603 1.161 . . . . 0.0 111.301 -167.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.26 136.92 52.62 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.028 0.931 . . . . 0.0 112.039 -176.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 46.3 t -63.48 123.03 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.809 0.844 . . . . 0.0 109.723 175.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 38.8 pt -103.18 -19.39 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 125.369 1.468 . . . . 0.0 112.361 175.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -151.91 139.91 20.11 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.537 1.135 . . . . 0.0 110.915 178.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 8.2 m -120.9 157.78 29.11 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.713 0.805 . . . . 0.0 111.818 177.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -69.93 -173.15 0.6 Allowed 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 122.707 0.403 . . . . 0.0 111.324 160.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -116.98 -13.34 10.62 Favored 'General case' 0 N--CA 1.481 1.076 0 O-C-N 120.715 -1.241 . . . . 0.0 112.643 167.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -68.31 -41.07 86.86 Favored Glycine 0 N--CA 1.469 0.837 0 C-N-CA 127.492 2.472 . . . . 0.0 112.951 168.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -65.09 -32.27 73.89 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 123.873 0.869 . . . . 0.0 111.709 -175.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 35.3 t -56.3 -50.61 70.92 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.455 1.902 . . . . 0.0 111.374 170.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -74.39 -25.35 59.43 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 178.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 38.2 tp -62.56 -47.59 83.18 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.955 0.902 . . . . 0.0 111.249 170.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 69.0 m -99.76 -32.9 10.8 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 -168.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 93.39 6.77 62.5 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 125.865 1.697 . . . . 0.0 114.089 -178.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -86.69 -144.93 0.12 Allowed 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.642 1.177 . . . . 0.0 111.397 170.377 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 78.2 p -158.36 165.25 35.19 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.901 1.281 . . . . 0.0 112.302 170.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 45.9 ttm105 -52.39 -46.78 66.4 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.242 0.617 . . . . 0.0 111.278 169.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.04 -30.79 60.32 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 119.467 1.031 . . . . 0.0 113.772 177.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -90.05 -38.53 13.52 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.811 0.844 . . . . 0.0 112.927 178.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 41.0 t -82.21 -11.7 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 124.059 0.943 . . . . 0.0 112.302 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 66.1 mmm -67.07 135.08 53.1 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 120.614 -1.304 . . . . 0.0 110.687 171.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 8.8 tm0? 75.2 4.97 4.22 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 126.614 1.966 . . . . 0.0 113.38 -176.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -88.65 155.14 50.84 Favored Pre-proline 0 N--CA 1.476 0.827 0 C-N-CA 124.657 1.183 . . . . 0.0 111.285 175.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -68.42 139.83 46.39 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 123.271 2.647 . . . . 0.0 110.609 170.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 32.1 p -68.41 -2.96 9.67 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 -178.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 40.6 p -63.47 -31.5 72.68 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.154 1.382 . . . . 0.0 112.236 172.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 81.4 m 51.07 34.86 11.65 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.755 1.222 . . . . 0.0 112.862 -173.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -57.98 -31.17 66.65 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.834 1.253 . . . . 0.0 112.58 -175.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -58.11 -15.6 10.1 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.484 1.514 . . . . 0.0 114.311 176.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 87.9 mt -74.51 -7.65 53.73 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 173.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 17.6 p-80 -60.99 140.19 57.87 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 120.197 1.362 . . . . 0.0 113.259 178.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -124.73 -163.57 11.69 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 126.546 2.022 . . . . 0.0 111.786 171.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -69.91 -21.15 33.17 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 123.15 2.567 . . . . 0.0 113.333 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.15 3.0 55.89 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.501 1.12 . . . . 0.0 113.355 178.754 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 17.3 m -85.76 137.17 32.98 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.092 1.357 . . . . 0.0 109.946 178.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -102.82 131.58 49.6 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.234 1.014 . . . . 0.0 109.997 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 22.4 tpp85 -58.1 -35.17 71.05 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.019 0.927 . . . . 0.0 112.618 -177.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -57.09 -42.02 79.94 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.645 1.178 . . . . 0.0 112.463 177.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -73.12 -43.9 61.02 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.437 -0.789 . . . . 0.0 112.202 177.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.07 -36.15 72.4 Favored 'General case' 0 CA--C 1.545 0.758 0 O-C-N 121.405 -0.809 . . . . 0.0 111.99 174.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.36 -48.02 65.91 Favored 'General case' 0 C--O 1.224 -0.24 0 C-N-CA 125.543 1.537 . . . . 0.0 111.927 173.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -57.43 -39.52 76.4 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 118.286 -0.864 . . . . 0.0 111.215 178.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 97.4 mt -59.92 -45.87 94.61 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 CA-C-N 120.256 1.389 . . . . 0.0 112.003 172.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.9 -36.85 80.92 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 118.827 0.74 . . . . 0.0 112.862 179.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 96.4 mm-40 -69.7 -32.81 71.62 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.707 1.203 . . . . 0.0 111.593 175.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -59.74 -29.99 68.53 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 119.09 0.859 . . . . 0.0 112.786 179.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 56.1 mt -70.86 -15.93 62.67 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.342 1.457 . . . . 0.0 113.215 177.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 60.5 mt -86.25 -13.04 47.97 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.105 0.962 . . . . 0.0 112.351 174.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -91.6 151.79 21.12 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 125.41 1.481 . . . . 0.0 113.078 178.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -93.39 0.07 56.72 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.91 1.284 . . . . 0.0 113.906 177.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -123.16 160.25 26.89 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.946 1.698 . . . . 0.0 111.208 -173.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -60.06 144.79 48.67 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.106 0.963 . . . . 0.0 112.567 -178.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 13.6 tpt180 -150.36 130.71 13.74 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.199 0.999 . . . . 0.0 111.597 -178.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 38.6 mtmt -110.44 132.27 54.32 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.226 1.41 . . . . 0.0 110.412 173.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 42.6 t -130.24 133.23 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 124.989 1.316 . . . . 0.0 108.466 177.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -102.41 134.92 44.94 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.099 0.96 . . . . 0.0 110.482 -179.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.0 tt -159.32 146.22 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.551 0.741 . . . . 0.0 112.08 -166.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -88.38 122.81 32.3 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 121.516 -0.74 . . . . 0.0 110.466 172.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -110.45 148.34 32.25 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.676 1.191 . . . . 0.0 112.092 173.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -107.63 134.38 50.71 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.995 1.718 . . . . 0.0 110.616 177.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -108.6 156.72 19.21 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.822 1.649 . . . . 0.0 111.394 -166.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -64.59 -20.89 66.52 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 -176.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -76.14 -7.26 54.38 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.525 1.13 . . . . 0.0 113.561 175.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 97.06 0.57 59.96 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 125.581 1.562 . . . . 0.0 114.362 -179.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 25.5 m -90.37 164.04 14.47 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.759 1.223 . . . . 0.0 112.383 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 28.3 p -140.23 158.72 43.59 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 121.103 -0.998 . . . . 0.0 111.734 167.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -167.86 160.1 12.08 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.081 1.352 . . . . 0.0 113.019 -178.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -77.81 121.57 24.26 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 124.186 0.994 . . . . 0.0 110.827 176.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 10.6 t -106.24 141.26 37.88 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.056 1.742 . . . . 0.0 109.566 172.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -86.9 133.42 33.61 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 156.343 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.4 t -117.57 117.18 54.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 124.527 1.131 . . . . 0.0 108.446 171.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -113.52 114.01 25.92 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.288 1.035 . . . . 0.0 108.74 -176.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.4 p -86.0 126.94 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 169.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 97.6 t -114.59 106.43 52.31 Favored Pre-proline 0 CA--C 1.537 0.447 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 173.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -74.77 132.56 15.88 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.027 2.485 . . . . 0.0 109.819 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 99.1 t -97.14 110.62 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 172.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 63.4 mttt -82.89 152.81 25.4 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.356 0.598 . . . . 0.0 111.556 167.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -92.68 -173.88 3.48 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.922 0.889 . . . . 0.0 111.829 172.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -60.3 -22.06 62.71 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.158 1.383 . . . . 0.0 114.379 178.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -89.7 -5.61 56.87 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.873 1.269 . . . . 0.0 112.993 177.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 78.65 21.53 68.89 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 124.588 1.089 . . . . 0.0 114.27 -178.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -100.3 143.33 30.62 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.678 1.191 . . . . 0.0 109.216 171.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.7 p -76.69 125.22 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-O 121.806 0.812 . . . . 0.0 110.175 174.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 3.9 pt -116.49 -22.66 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 125.378 1.471 . . . . 0.0 113.543 -171.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 55.4 mtm -145.93 150.2 35.63 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.595 1.558 . . . . 0.0 110.799 175.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -114.43 124.54 52.19 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 125.197 1.399 . . . . 0.0 109.504 172.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 47.3 mt -98.39 114.68 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 169.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -102.17 125.22 48.81 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 175.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -117.74 130.21 56.18 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.142 0.977 . . . . 0.0 110.389 -173.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -106.65 135.42 48.2 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.017 1.327 . . . . 0.0 110.554 -177.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -145.17 136.28 24.86 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.757 1.223 . . . . 0.0 109.27 175.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 43.5 t -74.32 117.63 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 177.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.3 p -96.17 -27.53 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -179.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 47.2 tpp -167.45 141.67 3.68 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.064 1.346 . . . . 0.0 110.723 -178.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -88.91 140.12 29.76 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 121.229 -0.919 . . . . 0.0 111.117 177.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.265 0 CA-C-O 117.468 -1.254 . . . . 0.0 112.951 169.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 N--CA 1.499 1.981 0 CA-C-O 118.461 -0.781 . . . . 0.0 110.565 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -77.23 -24.05 9.76 Favored 'Trans proline' 0 C--N 1.358 1.036 0 C-N-CA 123.933 3.089 . . . . 0.0 114.236 -177.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.5 p -157.78 151.89 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 125.091 1.356 . . . . 0.0 110.443 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 52.6 ptt85 -153.23 154.78 35.36 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.192 1.397 . . . . 0.0 112.195 -176.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 77.0 mtp85 -116.88 135.56 53.64 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.234 1.414 . . . . 0.0 111.13 178.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.31 -109.82 3.03 Favored Glycine 0 N--CA 1.472 1.064 0 C-N-CA 125.955 1.741 . . . . 0.0 111.15 176.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 10.4 t-80 77.56 11.12 2.2 Favored 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 126.47 1.908 . . . . 0.0 113.792 169.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 78.3 t -79.95 113.3 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 O-C-N 120.85 -1.157 . . . . 0.0 109.431 178.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -77.93 148.31 75.27 Favored Pre-proline 0 CA--C 1.551 0.995 0 C-N-CA 124.269 1.027 . . . . 0.0 111.638 174.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -68.77 126.17 13.63 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.149 2.566 . . . . 0.0 110.848 -178.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 23.0 mp0 -85.74 172.0 11.16 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.946 1.298 . . . . 0.0 111.205 176.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -66.8 151.11 48.12 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 121.308 -0.87 . . . . 0.0 110.54 161.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 29.1 p -117.01 -50.22 2.59 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.699 1.2 . . . . 0.0 112.965 -172.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -71.21 -45.31 63.64 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.848 0.859 . . . . 0.0 111.997 178.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 61.5 tp -63.0 -37.08 85.77 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.742 0.817 . . . . 0.0 110.947 176.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -59.17 -28.34 66.51 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 178.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.9 m -67.98 -29.24 68.22 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.839 0.856 . . . . 0.0 111.108 173.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 17.6 mm -74.16 -41.45 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-N 119.017 0.826 . . . . 0.0 109.23 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 3.1 mp -58.94 -46.72 91.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 122.971 0.508 . . . . 0.0 110.269 170.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 84.8 mtm180 -63.49 -35.1 79.33 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 119.125 0.875 . . . . 0.0 113.069 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -69.8 -39.1 76.77 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.172 0.989 . . . . 0.0 112.671 174.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -77.37 -33.82 55.13 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.507 1.123 . . . . 0.0 111.988 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -88.31 169.31 11.95 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -175.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -78.47 50.61 3.53 Favored Glycine 0 N--CA 1.473 1.149 0 C-N-CA 125.737 1.636 . . . . 0.0 112.86 178.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -67.93 -9.55 46.09 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 126.974 2.11 . . . . 0.0 113.834 -172.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 8.5 m -67.47 -6.8 21.11 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.679 1.591 . . . . 0.0 114.927 -168.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -111.5 167.68 10.13 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.695 1.198 . . . . 0.0 111.665 177.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.7 mptt -93.14 133.21 36.55 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 120.911 -1.118 . . . . 0.0 110.693 -177.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -161.17 155.05 22.32 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.689 1.196 . . . . 0.0 113.279 178.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 18.4 pt -140.74 152.61 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 125.777 1.631 . . . . 0.0 110.766 177.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 14.0 mt -111.05 132.4 59.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 125.856 1.663 . . . . 0.0 108.818 179.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -131.47 143.26 50.29 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.673 1.189 . . . . 0.0 111.489 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -67.78 119.22 12.14 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.518 0.727 . . . . 0.0 111.862 176.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -79.67 -19.59 48.67 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -178.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -77.97 -36.62 48.82 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.522 1.129 . . . . 0.0 112.359 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 55.0 t -70.5 130.5 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 125.361 1.464 . . . . 0.0 109.486 171.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -60.18 -43.26 96.01 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.289 1.036 . . . . 0.0 113.516 -169.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 20.0 p30 -74.94 -10.04 59.11 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 113.842 1.052 . . . . 0.0 113.842 178.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 79.7 m 55.68 65.16 1.53 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.927 1.691 . . . . 0.0 112.662 -175.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.61 136.01 57.85 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.472 0.709 . . . . 0.0 112.015 178.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 41.4 t -61.9 121.04 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 169.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 42.9 pt -103.68 -17.08 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 125.063 1.345 . . . . 0.0 112.221 175.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -159.62 152.32 21.49 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.278 1.031 . . . . 0.0 112.014 175.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 8.1 p -146.49 155.07 42.26 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.51 1.124 . . . . 0.0 112.756 178.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -75.96 -154.18 0.05 OUTLIER 'General case' 0 CA--C 1.558 1.266 0 C-N-CA 123.407 0.683 . . . . 0.0 112.317 -176.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -108.73 -21.83 12.5 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 120.271 -1.518 . . . . 0.0 112.896 165.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -75.84 -37.75 38.26 Favored Glycine 0 C--N 1.343 0.959 0 O-C-N 121.513 -0.742 . . . . 0.0 112.479 -176.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -56.92 -41.47 78.23 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.224 1.009 . . . . 0.0 111.109 177.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 40.5 t -57.12 -53.04 62.65 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.978 1.711 . . . . 0.0 112.214 177.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -73.23 -29.1 62.55 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -179.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -64.31 -42.25 96.43 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.296 1.438 . . . . 0.0 111.832 177.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 9.1 t -100.06 -28.96 12.79 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.88 11.87 62.95 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 124.916 1.246 . . . . 0.0 114.047 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -87.58 -154.14 0.25 Allowed 'General case' 0 CA--C 1.552 1.036 0 CA-C-N 118.524 1.162 . . . . 0.0 111.419 170.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 64.4 m -149.65 158.47 44.2 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.676 1.19 . . . . 0.0 110.787 177.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -48.67 -48.86 39.56 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.976 0.911 . . . . 0.0 111.333 173.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.77 -26.54 35.1 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 177.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -92.39 -37.62 12.48 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.61 1.164 . . . . 0.0 112.004 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 93.2 t -86.33 -16.26 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 124.665 1.186 . . . . 0.0 112.205 -178.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 87.0 mmm -76.27 143.28 41.02 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 120.91 -1.119 . . . . 0.0 111.058 171.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 24.8 mp0 59.21 36.6 23.86 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.69 1.196 . . . . 0.0 111.15 -169.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 88.5 mmt-85 -123.72 154.41 66.95 Favored Pre-proline 0 N--CA 1.472 0.656 0 C-N-CA 125.075 1.35 . . . . 0.0 110.5 169.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -68.56 137.17 38.46 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 123.191 2.594 . . . . 0.0 109.67 172.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 21.2 p -65.83 -11.89 49.97 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 -175.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 42.5 p -58.18 -26.06 62.31 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 126.242 1.817 . . . . 0.0 112.967 173.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 74.9 m 57.8 38.63 27.32 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.741 1.216 . . . . 0.0 112.816 178.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -56.1 -28.66 58.61 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.143 1.377 . . . . 0.0 113.366 -175.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -57.95 -23.99 56.01 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.828 1.651 . . . . 0.0 113.18 176.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 40.1 mt -82.03 -8.67 59.68 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -176.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 43.2 m170 -71.75 125.32 26.83 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.857 0.863 . . . . 0.0 111.693 -178.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -107.83 -162.16 21.17 Favored Glycine 0 CA--C 1.54 1.618 0 C-N-CA 126.452 1.977 . . . . 0.0 112.505 174.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -70.31 -26.23 25.2 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 123.276 2.651 . . . . 0.0 113.14 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 37.2 mmt180 -80.88 -14.24 58.19 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 177.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 38.1 m -70.64 138.08 50.45 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.177 0.991 . . . . 0.0 112.281 -167.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -88.65 110.45 20.96 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.514 1.526 . . . . 0.0 109.781 -171.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 50.9 tpt85 -61.57 -30.18 70.5 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 121.369 -0.832 . . . . 0.0 112.933 -177.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 20.6 tpt180 -66.96 -38.42 86.06 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.093 1.357 . . . . 0.0 111.64 174.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -72.51 -41.54 65.8 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.835 0.854 . . . . 0.0 111.774 175.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -54.95 -35.14 63.93 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.173 0.589 . . . . 0.0 111.849 171.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.58 -49.71 51.54 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.403 1.081 . . . . 0.0 111.66 173.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 21.9 mm-40 -59.55 -36.63 76.55 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 118.256 -0.878 . . . . 0.0 111.891 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 89.8 mt -60.35 -44.98 97.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 CA-C-N 120.234 1.379 . . . . 0.0 111.613 171.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.89 -40.15 91.29 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 118.88 0.764 . . . . 0.0 112.423 177.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -70.07 -28.4 65.4 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.319 0.648 . . . . 0.0 112.333 175.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.58 -28.99 68.91 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 119.908 1.231 . . . . 0.0 112.47 175.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 43.4 mt -74.22 -13.11 60.74 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.624 1.569 . . . . 0.0 113.381 175.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 67.3 mt -88.47 -16.58 32.37 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.107 0.963 . . . . 0.0 112.203 173.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -88.88 153.62 23.94 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 125.133 1.349 . . . . 0.0 113.425 -179.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -93.11 -1.07 56.8 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.102 1.361 . . . . 0.0 113.858 176.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -124.34 159.82 29.47 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 126.173 1.789 . . . . 0.0 111.583 -171.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -63.37 141.28 58.82 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.876 1.271 . . . . 0.0 112.201 -178.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 23.6 tpt180 -150.86 127.72 11.0 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.281 1.033 . . . . 0.0 112.06 -171.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 40.8 mtmt -106.29 140.66 38.88 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.735 1.214 . . . . 0.0 111.91 171.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 66.6 t -137.13 139.18 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 126.074 1.75 . . . . 0.0 108.575 175.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -107.37 133.55 51.74 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.242 1.017 . . . . 0.0 111.303 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.2 tt -160.34 146.4 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 123.882 0.873 . . . . 0.0 112.547 -166.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -84.68 125.5 32.56 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.122 -0.986 . . . . 0.0 112.154 174.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 20.2 m-30 -115.59 154.05 30.13 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.71 2.004 . . . . 0.0 111.395 171.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -94.26 155.07 17.21 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 123.726 0.81 . . . . 0.0 113.016 166.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -104.17 151.29 23.5 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 127.578 2.351 . . . . 0.0 109.729 168.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -60.27 -24.85 65.25 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 -174.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 53.2 p-10 -71.53 -12.89 61.61 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.185 1.394 . . . . 0.0 114.476 174.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 103.76 0.78 45.93 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 126.575 2.036 . . . . 0.0 114.524 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 70.5 m -82.86 162.04 21.73 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 119.406 1.603 . . . . 0.0 112.228 175.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 94.2 m -127.35 164.6 21.45 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.477 1.111 . . . . 0.0 112.014 178.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -165.03 149.51 9.02 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.899 1.28 . . . . 0.0 111.787 177.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -74.3 118.94 17.84 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 123.707 0.803 . . . . 0.0 109.558 164.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 16.3 t -101.3 137.92 39.01 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 126.444 1.898 . . . . 0.0 109.609 173.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 20.4 tp -90.44 119.71 30.95 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 159.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 29.6 t -100.88 122.84 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 172.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -119.53 111.76 18.51 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.175 1.39 . . . . 0.0 109.761 178.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.2 p -87.81 127.12 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-O 121.227 0.537 . . . . 0.0 109.837 172.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 90.6 t -113.59 112.09 48.7 Favored Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 125.908 1.683 . . . . 0.0 106.886 177.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.43 131.95 14.35 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.984 2.456 . . . . 0.0 110.276 -178.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 76.6 t -104.91 116.6 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 123.935 0.894 . . . . 0.0 109.083 174.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 62.4 mttt -87.32 153.69 21.27 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.624 0.77 . . . . 0.0 112.4 172.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -91.93 -173.77 3.59 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.313 1.045 . . . . 0.0 111.58 175.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -61.36 -20.81 63.42 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 179.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -95.11 -0.12 53.75 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.878 1.271 . . . . 0.0 113.148 177.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 79.71 22.22 64.66 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 124.173 0.892 . . . . 0.0 114.719 176.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -107.69 148.49 29.33 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.136 1.374 . . . . 0.0 109.92 171.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.6 p -81.02 122.25 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 123.701 0.8 . . . . 0.0 110.652 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -121.86 -23.79 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -174.096 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 60.9 mtm -129.74 150.5 51.02 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.07 1.348 . . . . 0.0 112.172 169.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -110.63 135.39 51.32 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 125.522 1.529 . . . . 0.0 108.978 166.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 53.2 mt -101.01 122.05 52.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 163.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 9.2 mp -103.89 123.62 47.47 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 172.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -101.83 150.43 23.17 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.375 1.07 . . . . 0.0 110.858 174.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -123.37 135.85 54.36 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.031 1.333 . . . . 0.0 110.601 178.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -142.38 134.12 26.92 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.245 1.418 . . . . 0.0 109.061 179.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 57.8 t -79.82 115.85 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 176.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.3 p -95.23 -24.91 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 39.1 tpp -163.94 111.87 1.16 Allowed 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.873 1.269 . . . . 0.0 110.882 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -79.81 127.88 32.76 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 121.16 -0.963 . . . . 0.0 110.99 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 41.8 mttt . . . . . 0 C--O 1.258 1.506 0 C-N-CA 125.245 1.418 . . . . 0.0 112.527 -179.843 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 mmt . . . . . 0 N--CA 1.496 1.833 0 CA-C-O 118.397 -0.811 . . . . 0.0 110.604 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -75.79 131.12 13.08 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 123.095 2.53 . . . . 0.0 111.02 178.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.8 p -168.01 149.07 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 125.48 1.512 . . . . 0.0 110.841 -178.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 6.0 mmp_? -90.5 135.74 33.5 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.575 1.15 . . . . 0.0 111.253 173.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -100.86 152.77 20.13 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.435 1.494 . . . . 0.0 112.21 -175.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -90.14 -153.45 28.54 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 125.618 1.58 . . . . 0.0 112.691 175.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 40.1 m80 -65.69 138.44 57.97 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.585 0.754 . . . . 0.0 111.557 175.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.2 p -70.25 -34.4 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -171.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 64.98 159.41 0.12 Allowed Pre-proline 0 CA--C 1.556 1.186 0 C-N-CA 127.209 2.204 . . . . 0.0 113.392 -176.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -74.06 125.51 9.88 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.567 2.178 . . . . 0.0 110.513 172.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 10.5 mp0 -87.9 -63.66 1.27 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 122.01 0.91 . . . . 0.0 109.793 169.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.1 p-10 -85.9 147.68 26.15 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 126.245 1.818 . . . . 0.0 110.732 -174.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 31.1 p -131.1 -49.48 1.01 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 126.419 1.888 . . . . 0.0 111.701 -176.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -65.06 -42.98 93.72 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.614 0.766 . . . . 0.0 111.629 177.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 64.7 tp -71.05 -39.78 72.04 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.557 0.743 . . . . 0.0 111.032 172.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -59.79 -27.25 66.4 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 177.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 92.6 m -69.54 -23.69 63.62 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.746 1.218 . . . . 0.0 111.641 174.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 23.6 mm -76.48 -38.16 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 123.923 0.889 . . . . 0.0 109.806 176.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.1 mp -57.7 -33.58 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 O-C-N 121.702 -0.624 . . . . 0.0 110.91 173.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 48.5 mtp85 -69.59 -18.95 63.66 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 119.455 1.025 . . . . 0.0 113.332 177.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 78.1 mttt -87.68 -38.87 15.48 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 125.096 1.358 . . . . 0.0 111.053 173.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -73.88 -18.88 60.86 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.929 1.292 . . . . 0.0 113.337 174.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -52.34 147.72 7.57 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.237 1.415 . . . . 0.0 112.828 172.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -90.75 52.69 3.32 Favored Glycine 0 C--N 1.34 0.761 0 C-N-CA 125.586 1.565 . . . . 0.0 110.379 -179.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 60.82 41.74 14.21 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.9 1.68 . . . . 0.0 111.579 178.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 8.1 m -76.31 7.45 4.3 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.864 1.266 . . . . 0.0 114.296 -170.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.0 mmt-85 -76.52 -167.81 0.87 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.747 1.219 . . . . 0.0 111.928 175.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -120.99 139.02 53.86 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.107 1.363 . . . . 0.0 110.427 -173.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -165.07 152.77 11.3 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -177.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 13.2 pt -140.93 149.35 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 125.969 1.708 . . . . 0.0 110.47 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 19.0 mt -108.87 133.75 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.343 1.457 . . . . 0.0 108.8 179.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -131.81 142.87 49.85 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.758 1.223 . . . . 0.0 111.634 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -70.47 124.81 25.1 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.342 0.657 . . . . 0.0 111.698 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.8 -15.77 60.2 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 120.922 -1.111 . . . . 0.0 113.218 -178.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 3.1 mpp_? -98.94 4.81 47.43 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.999 1.72 . . . . 0.0 113.336 -171.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 70.9 t -110.26 138.4 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 126.681 1.993 . . . . 0.0 108.898 179.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -54.14 -34.63 60.84 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 116.048 1.87 . . . . 0.0 116.048 -167.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -105.86 0.31 25.85 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.168 1.387 . . . . 0.0 113.027 -178.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 91.2 m 50.43 66.86 1.03 Allowed 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.875 1.67 . . . . 0.0 111.954 -171.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.88 140.53 58.82 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.154 0.982 . . . . 0.0 111.967 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 63.7 t -63.86 119.88 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 171.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 38.3 pt -101.09 -20.64 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.689 1.195 . . . . 0.0 112.341 174.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -154.46 147.57 24.71 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.43 1.092 . . . . 0.0 111.127 177.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.451 ' HB2' ' CE1' ' A' ' 48' ' ' PHE . 22.4 p -152.14 154.78 36.54 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 121.024 -1.047 . . . . 0.0 113.424 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -78.77 -168.81 1.53 Allowed 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 123.457 0.703 . . . . 0.0 112.321 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -104.12 -18.6 14.46 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.566 1.546 . . . . 0.0 112.59 169.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.61 -42.46 71.97 Favored Glycine 0 N--CA 1.469 0.895 0 C-N-CA 124.146 0.879 . . . . 0.0 112.253 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.451 ' CE1' ' HB2' ' A' ' 44' ' ' CYS . 0.9 OUTLIER -67.05 -29.31 69.06 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.315 0.646 . . . . 0.0 111.788 -175.853 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 83.7 m -52.64 -51.81 58.42 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.181 1.392 . . . . 0.0 111.808 172.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -74.57 -20.46 59.93 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.842 0.857 . . . . 0.0 113.179 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.38 -58.38 7.27 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.031 1.332 . . . . 0.0 110.253 176.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 69.2 m -97.73 -15.43 20.34 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 -175.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.37 2.16 68.37 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 125.519 1.533 . . . . 0.0 114.046 173.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -85.56 -154.52 0.2 Allowed 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 124.798 1.239 . . . . 0.0 111.811 170.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 9.5 t -161.22 170.07 20.99 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 120.498 -1.376 . . . . 0.0 111.61 175.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -50.34 -47.91 55.68 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.824 1.25 . . . . 0.0 111.48 177.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.63 -25.96 54.63 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 178.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -92.33 -39.79 11.28 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.284 1.434 . . . . 0.0 111.848 177.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 71.3 t -80.7 -17.41 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 125.742 1.617 . . . . 0.0 112.243 -177.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 70.0 mtp -60.97 131.15 49.72 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 120.549 -1.344 . . . . 0.0 109.843 173.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 14.0 mt-30 70.34 13.11 7.58 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.713 1.605 . . . . 0.0 114.105 -178.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -89.97 153.56 47.2 Favored Pre-proline 0 N--CA 1.475 0.778 0 C-N-CA 124.356 1.062 . . . . 0.0 110.991 172.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.53 132.28 23.36 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.995 2.464 . . . . 0.0 110.23 170.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 27.3 p -68.42 -9.9 51.64 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 115.105 1.521 . . . . 0.0 115.105 -175.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 38.3 p -62.3 -27.45 69.04 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.93 1.292 . . . . 0.0 111.588 168.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 73.4 m 48.89 42.53 20.5 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.506 1.522 . . . . 0.0 112.6 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -56.72 -32.03 65.1 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.159 1.383 . . . . 0.0 112.59 -175.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -59.1 -16.17 17.93 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.965 1.306 . . . . 0.0 114.501 175.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 97.2 mt -76.45 -3.95 39.93 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 174.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -59.7 134.08 56.69 Favored 'General case' 0 CA--C 1.549 0.942 0 CA-C-N 120.382 1.446 . . . . 0.0 113.051 176.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -105.2 -175.4 24.35 Favored Glycine 0 CA--C 1.538 1.499 0 C-N-CA 125.435 1.493 . . . . 0.0 111.42 167.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -66.57 -16.61 51.31 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 122.92 2.413 . . . . 0.0 113.674 176.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -90.08 -9.27 49.07 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 175.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 53.3 m -68.88 132.49 46.83 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 119.651 1.114 . . . . 0.0 110.852 -175.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -90.03 130.33 36.23 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.112 0.965 . . . . 0.0 110.323 -179.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -63.42 -31.9 73.18 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.581 0.753 . . . . 0.0 112.261 -175.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 36.5 mmt180 -61.81 -50.57 71.79 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.69 0.796 . . . . 0.0 111.797 172.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.24 -37.74 88.18 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 120.331 -1.481 . . . . 0.0 112.964 -178.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -56.93 -34.23 67.78 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 170.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -76.19 -42.53 46.03 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 124.886 1.274 . . . . 0.0 112.878 174.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -61.49 -33.51 73.9 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 118.598 0.636 . . . . 0.0 110.925 -178.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 91.3 mt -62.07 -36.84 76.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 CA-C-N 119.679 1.127 . . . . 0.0 112.315 170.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.89 -37.47 67.29 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 119.343 0.974 . . . . 0.0 112.186 173.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -62.97 -33.13 74.73 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 121.418 -0.802 . . . . 0.0 111.473 172.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.52 -19.76 65.05 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 175.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 43.8 mt -88.43 -18.32 28.55 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.229 1.411 . . . . 0.0 112.799 172.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 83.1 mt -85.12 -21.64 29.19 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.006 0.922 . . . . 0.0 111.667 171.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -81.94 143.1 22.95 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 125.156 1.36 . . . . 0.0 112.308 176.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -91.21 -3.18 57.2 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.347 1.059 . . . . 0.0 113.841 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -117.02 161.87 18.7 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.658 1.983 . . . . 0.0 110.804 174.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -64.61 145.94 55.42 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 122.276 1.036 . . . . 0.0 113.045 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 44.9 mmt-85 -142.08 135.8 29.5 Favored 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 125.314 1.446 . . . . 0.0 110.442 173.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.4 ptpp? -113.76 134.83 54.53 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 167.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 78.2 t -129.05 135.16 62.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 126.144 1.777 . . . . 0.0 107.908 -173.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -99.56 128.84 45.68 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.986 0.914 . . . . 0.0 110.319 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.1 tt -151.14 148.8 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.359 1.063 . . . . 0.0 111.463 -168.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -80.15 124.06 28.45 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 120.774 -1.204 . . . . 0.0 111.304 173.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 6.8 m-30 -107.29 136.92 46.28 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.883 1.673 . . . . 0.0 110.384 172.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -101.44 128.47 47.63 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.68 1.592 . . . . 0.0 110.955 177.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 57.4 ttp180 -94.56 152.55 18.44 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.203 1.801 . . . . 0.0 111.396 -174.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -59.68 -22.7 62.32 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 -174.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -79.91 -13.07 59.64 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.702 1.201 . . . . 0.0 114.069 176.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 107.13 0.59 35.66 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 126.269 1.89 . . . . 0.0 114.699 -178.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 75.0 m -80.42 160.19 25.41 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 119.489 1.644 . . . . 0.0 112.876 176.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 15.9 t -136.12 152.45 50.85 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.884 1.273 . . . . 0.0 110.574 176.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -166.97 161.38 14.96 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.369 1.468 . . . . 0.0 111.303 -176.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -80.4 121.02 25.19 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.912 0.885 . . . . 0.0 111.129 172.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 49.6 t -102.45 135.69 43.62 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.61 1.964 . . . . 0.0 110.423 171.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.1 tt -89.24 116.05 27.19 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 125.627 1.571 . . . . 0.0 107.033 163.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 66.5 t -103.06 111.78 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 169.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -101.84 113.6 26.95 Favored 'General case' 0 C--O 1.224 -0.246 0 C-N-CA 126.085 1.754 . . . . 0.0 109.547 172.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 67.5 t -85.99 126.32 40.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 169.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 89.7 t -113.22 116.22 46.92 Favored Pre-proline 0 CA--C 1.537 0.469 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 170.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -73.84 133.86 19.07 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 123.43 2.753 . . . . 0.0 110.079 -179.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 87.8 t -102.39 116.92 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 N-CA-C 107.902 -1.148 . . . . 0.0 107.902 171.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 33.2 mttp -88.86 161.13 16.87 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.447 0.699 . . . . 0.0 112.196 171.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -98.75 -174.13 2.71 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.384 1.074 . . . . 0.0 111.969 172.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -60.27 -22.58 63.27 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.276 1.43 . . . . 0.0 114.689 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -90.8 -1.49 57.85 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.161 0.984 . . . . 0.0 113.138 177.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 74.86 26.61 66.55 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 124.1 0.857 . . . . 0.0 113.932 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -103.63 146.12 29.05 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.98 1.312 . . . . 0.0 108.79 169.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 11.4 p -78.2 131.02 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-O 121.425 0.631 . . . . 0.0 110.529 175.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 2.8 pt -126.6 -21.16 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 124.652 1.181 . . . . 0.0 113.926 -169.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 73.6 mtm -148.8 155.65 41.24 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 126.09 1.756 . . . . 0.0 110.132 176.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -118.71 131.9 56.15 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 125.085 1.354 . . . . 0.0 109.514 174.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 56.6 mt -97.07 115.32 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 106.244 -1.761 . . . . 0.0 106.244 166.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -91.76 121.39 33.35 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 171.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -113.18 124.79 53.37 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 119.462 -0.304 . . . . 0.0 111.121 178.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 12.2 m-30 -103.46 144.06 31.89 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.301 1.441 . . . . 0.0 111.813 -177.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -150.63 135.68 17.63 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.726 1.611 . . . . 0.0 109.281 172.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 60.2 t -75.61 115.47 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 CA-C-N 119.53 1.059 . . . . 0.0 108.447 171.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.4 p -93.0 -25.3 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 123.539 0.735 . . . . 0.0 112.646 -178.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 30.5 ttm -162.17 118.42 2.01 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.552 1.141 . . . . 0.0 110.567 -176.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -82.08 124.16 29.58 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.679 -0.638 . . . . 0.0 110.021 174.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.255 1.355 0 CA-C-O 115.464 -2.208 . . . . 0.0 116.177 -172.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.6 mtt . . . . . 0 N--CA 1.494 1.763 0 CA-C-O 118.594 -0.717 . . . . 0.0 110.757 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -77.91 164.51 27.49 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 123.815 3.01 . . . . 0.0 112.159 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.6 p -161.66 135.77 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 125.295 1.438 . . . . 0.0 110.518 174.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -141.97 158.55 43.64 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.597 1.559 . . . . 0.0 111.87 -177.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.33 169.31 15.97 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 127.079 2.152 . . . . 0.0 111.756 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 152.97 -27.08 0.81 Allowed Glycine 0 N--CA 1.477 1.376 0 C-N-CA 124.591 1.091 . . . . 0.0 115.33 174.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 37.9 m80 -76.02 150.35 37.4 Favored 'General case' 0 CA--C 1.551 1.005 0 CA-C-N 118.387 1.093 . . . . 0.0 111.857 174.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.7 p -69.36 -32.9 55.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -177.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 68.63 160.51 0.15 Allowed Pre-proline 0 CA--C 1.556 1.189 0 C-N-CA 127.473 2.309 . . . . 0.0 113.452 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -64.36 123.63 12.09 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 122.413 2.076 . . . . 0.0 108.885 165.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -110.46 170.07 8.33 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.49 1.116 . . . . 0.0 112.326 -171.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -78.27 40.38 0.35 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.698 1.599 . . . . 0.0 113.93 -175.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 13.1 t -52.65 -29.76 28.04 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 127.812 2.445 . . . . 0.0 114.539 -168.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -72.43 -46.28 55.78 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 118.813 0.733 . . . . 0.0 111.746 175.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 53.9 tp -64.67 -34.04 77.36 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.978 1.311 . . . . 0.0 111.229 171.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -56.4 -31.12 63.56 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.731 1.212 . . . . 0.0 112.638 176.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 33.3 m -70.48 -29.98 66.66 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.939 1.296 . . . . 0.0 111.227 174.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.2 mm -78.66 -40.13 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 124.325 1.05 . . . . 0.0 110.221 176.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.438 ' HA ' ' CE2' ' A' ' 22' ' ' PHE . 87.6 mt -59.79 -44.27 93.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.308 0.643 . . . . 0.0 111.122 176.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 51.8 ptt85 -67.51 -24.26 65.55 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -179.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -69.03 -42.82 75.83 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.809 0.843 . . . . 0.0 111.671 174.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.438 ' CE2' ' HA ' ' A' ' 19' ' ' ILE . 17.0 p90 -87.0 -31.29 20.65 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 113.75 1.018 . . . . 0.0 113.75 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.29 -39.54 68.24 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 120.386 1.448 . . . . 0.0 111.388 178.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -70.02 -7.2 59.02 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 125.799 1.666 . . . . 0.0 114.528 176.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -80.7 -3.42 50.64 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 124.683 1.193 . . . . 0.0 111.948 169.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.2 t 84.59 25.18 0.09 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 126.735 2.014 . . . . 0.0 112.518 164.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 18.8 mmm180 -76.92 165.59 24.47 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.206 1.002 . . . . 0.0 111.646 -175.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.6 mptt -91.93 125.95 36.83 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.312 -0.868 . . . . 0.0 110.577 -175.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -159.14 161.99 36.36 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.1 pt -144.91 155.7 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 127.171 2.188 . . . . 0.0 109.905 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.8 mp -120.51 135.01 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 125.021 1.329 . . . . 0.0 109.334 179.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -132.58 153.22 51.22 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.007 1.323 . . . . 0.0 112.32 -176.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 29.0 p30 -76.47 118.92 19.64 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.409 1.084 . . . . 0.0 112.738 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.23 -17.22 61.37 Favored 'General case' 0 CA--C 1.547 0.829 0 O-C-N 120.724 -1.235 . . . . 0.0 113.517 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 65.7 mtm-85 -86.23 5.67 33.16 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.701 1.601 . . . . 0.0 114.813 -168.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 13.0 m -133.81 158.33 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 125.59 1.556 . . . . 0.0 111.116 -173.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -62.46 -40.73 97.58 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.088 0.955 . . . . 0.0 113.505 -173.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -85.9 -14.59 44.36 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 114.285 1.216 . . . . 0.0 114.285 -173.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 84.2 m 41.55 69.49 0.35 Allowed 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.777 1.631 . . . . 0.0 112.306 -165.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.31 143.18 47.05 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.064 0.945 . . . . 0.0 111.757 -176.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 23.8 t -65.98 122.45 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 175.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.5 pt -104.25 -14.84 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 125.629 1.572 . . . . 0.0 112.468 176.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -157.67 142.79 16.85 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.533 1.133 . . . . 0.0 111.376 176.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.502 ' HB3' ' CE1' ' A' ' 48' ' ' PHE . 2.7 m -130.67 153.3 49.11 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.125 0.97 . . . . 0.0 112.101 -178.157 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -78.46 -168.96 1.5 Allowed 'General case' 0 CA--C 1.554 1.132 0 CA-C-N 118.973 0.806 . . . . 0.0 111.496 165.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -104.01 -21.76 13.56 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.162 1.385 . . . . 0.0 112.975 169.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.31 -35.02 60.44 Favored Glycine 0 C--N 1.343 0.95 0 O-C-N 121.5 -0.75 . . . . 0.0 112.436 -177.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.502 ' CE1' ' HB3' ' A' ' 44' ' ' CYS . 0.4 OUTLIER -68.78 -30.86 69.53 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.491 0.716 . . . . 0.0 111.885 178.979 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 86.4 m -50.7 -55.32 17.08 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.217 1.407 . . . . 0.0 111.944 176.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -70.1 -18.81 63.26 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.168 0.987 . . . . 0.0 113.334 -178.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.2 tp -63.89 -46.29 85.53 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.853 1.261 . . . . 0.0 111.878 -178.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 73.9 m -110.53 -16.2 13.72 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 178.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.72 -0.06 57.84 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 125.59 1.567 . . . . 0.0 114.395 174.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -82.46 -157.59 0.22 Allowed 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 124.812 1.245 . . . . 0.0 112.217 171.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 10.0 t -162.52 170.45 18.63 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 120.522 -1.361 . . . . 0.0 111.485 176.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -47.6 -50.99 22.72 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.199 1.4 . . . . 0.0 111.454 176.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.99 -25.86 32.85 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -95.78 -38.83 10.15 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.309 1.444 . . . . 0.0 112.241 178.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 76.7 t -83.08 -19.01 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 125.756 1.622 . . . . 0.0 111.938 -176.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 77.1 mmm -66.19 132.38 48.3 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 120.566 -1.334 . . . . 0.0 109.481 173.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 73.59 7.97 5.04 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 126.129 1.771 . . . . 0.0 114.292 -175.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 -90.03 154.28 47.29 Favored Pre-proline 0 N--CA 1.478 0.934 0 C-N-CA 124.832 1.253 . . . . 0.0 110.427 169.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.46 134.31 26.22 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 123.091 2.527 . . . . 0.0 110.245 175.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 24.3 p -69.79 -4.98 22.4 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 114.888 1.44 . . . . 0.0 114.888 -176.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 56.0 p -62.05 -30.22 70.83 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.91 1.284 . . . . 0.0 111.398 165.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 77.9 m 50.62 38.73 19.69 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.003 1.721 . . . . 0.0 112.563 -174.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -57.41 -30.11 64.68 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.615 1.166 . . . . 0.0 112.441 -176.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -59.42 -15.14 15.18 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.743 1.217 . . . . 0.0 114.085 176.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 90.9 mt -77.51 -4.76 47.26 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.617 1.167 . . . . 0.0 113.955 172.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 11.4 p-80 -66.86 158.86 29.52 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 120.275 1.398 . . . . 0.0 114.511 179.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -155.17 -162.59 11.38 Favored Glycine 0 CA--C 1.537 1.456 0 C-N-CA 126.274 1.893 . . . . 0.0 111.875 168.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.85 -13.88 41.94 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 123.272 2.648 . . . . 0.0 115.143 -175.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -97.0 2.14 51.11 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 119.845 1.202 . . . . 0.0 113.742 173.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 20.3 m -87.61 127.43 35.27 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 119.593 1.088 . . . . 0.0 110.553 -177.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -86.73 126.41 34.56 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.719 0.807 . . . . 0.0 109.674 -178.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 11.7 mpt_? -65.38 -31.93 73.3 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.437 0.695 . . . . 0.0 111.584 -175.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 25.1 tpp180 -58.46 -42.89 88.44 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.542 1.137 . . . . 0.0 112.024 172.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -71.03 -43.88 66.97 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.259 -0.901 . . . . 0.0 112.32 177.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -56.99 -36.63 70.61 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 121.826 -0.546 . . . . 0.0 112.039 174.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.93 -48.66 57.61 Favored 'General case' 0 C--O 1.223 -0.299 0 C-N-CA 125.101 1.36 . . . . 0.0 111.953 173.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.8 mm100 -58.44 -37.54 75.62 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 118.369 -0.824 . . . . 0.0 111.495 -178.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 93.5 mt -61.08 -45.6 98.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 CA-C-N 120.128 1.331 . . . . 0.0 111.65 170.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.97 -34.21 74.95 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 119.006 0.821 . . . . 0.0 113.09 179.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 86.4 mm-40 -71.98 -32.18 66.99 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.164 0.986 . . . . 0.0 111.58 174.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -58.3 -32.19 68.22 Favored 'General case' 0 CA--C 1.547 0.857 0 O-C-N 121.213 -0.929 . . . . 0.0 112.214 177.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 58.7 mt -70.41 -16.6 62.97 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.952 1.701 . . . . 0.0 113.946 178.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.6 pp -104.29 -1.33 27.15 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 119.331 0.969 . . . . 0.0 113.33 170.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -84.68 -20.44 58.18 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 124.719 1.152 . . . . 0.0 114.702 -178.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 56.88 32.19 21.01 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 125.789 1.635 . . . . 0.0 113.385 179.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -144.82 163.77 33.07 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.825 1.65 . . . . 0.0 111.246 -171.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -68.67 128.68 37.49 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.897 -0.502 . . . . 0.0 110.674 174.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -142.35 133.93 26.68 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.788 1.235 . . . . 0.0 111.841 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 37.6 mtmt -111.06 130.15 55.69 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.285 1.434 . . . . 0.0 109.965 168.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.8 t -133.05 137.06 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 125.203 1.401 . . . . 0.0 108.441 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -106.32 130.88 54.08 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.137 0.975 . . . . 0.0 111.249 -175.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.4 tt -155.19 146.92 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 124.065 0.946 . . . . 0.0 112.314 -165.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -83.45 121.02 26.63 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 120.949 -1.094 . . . . 0.0 111.815 174.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 13.8 m-30 -109.27 146.85 33.6 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.569 1.947 . . . . 0.0 111.29 173.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -110.65 137.31 48.49 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.564 1.546 . . . . 0.0 112.03 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -92.09 154.98 18.38 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 126.472 1.909 . . . . 0.0 111.252 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -58.5 -25.8 62.75 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.559 1.144 . . . . 0.0 113.833 175.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -69.7 -10.83 59.83 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.322 1.449 . . . . 0.0 113.572 176.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 93.98 4.28 63.33 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 125.334 1.445 . . . . 0.0 113.93 -178.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 63.7 p -92.04 170.87 9.5 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.789 1.236 . . . . 0.0 112.024 175.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 22.1 p -147.36 168.25 22.3 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 121.11 -0.994 . . . . 0.0 112.722 176.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -164.64 155.53 14.86 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.961 1.304 . . . . 0.0 110.722 -173.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -77.15 123.55 26.57 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.277 0.56 . . . . 0.0 110.238 167.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 19.1 t -106.53 136.03 47.01 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.128 1.771 . . . . 0.0 110.306 172.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.0 tp -89.7 120.6 31.11 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 161.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 59.8 t -106.36 117.91 53.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 124.764 1.226 . . . . 0.0 108.521 175.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -111.23 113.02 25.21 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.659 1.184 . . . . 0.0 108.436 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.2 p -88.75 128.06 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 168.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 96.1 t -116.8 116.84 38.09 Favored Pre-proline 0 CA--C 1.538 0.507 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 175.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -76.13 138.27 20.2 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 123.038 2.492 . . . . 0.0 110.373 -176.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 84.0 t -111.35 123.15 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.836 0.854 . . . . 0.0 109.708 174.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 65.0 mttt -95.25 154.73 17.05 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.258 1.023 . . . . 0.0 113.42 173.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -93.66 -173.62 3.23 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.603 1.161 . . . . 0.0 111.872 177.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -58.31 -23.28 55.99 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.374 1.469 . . . . 0.0 114.42 177.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -93.02 -4.63 52.24 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.322 1.449 . . . . 0.0 113.173 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 80.46 22.29 62.74 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 124.226 0.917 . . . . 0.0 114.592 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -107.61 149.66 27.8 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.987 1.315 . . . . 0.0 109.981 173.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 64.0 t -77.26 125.51 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.24 -23.9 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -177.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 62.1 mtm -132.57 155.92 47.8 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.407 1.483 . . . . 0.0 112.479 171.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -119.16 134.09 55.4 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 125.87 1.668 . . . . 0.0 109.443 169.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 54.3 mt -97.39 120.02 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 165.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -103.61 127.51 51.03 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 173.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -119.98 128.05 53.21 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.402 1.081 . . . . 0.0 109.819 -176.268 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 16.9 m-30 -103.9 138.31 40.65 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.326 1.45 . . . . 0.0 111.016 -176.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -142.4 131.3 22.97 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.622 1.169 . . . . 0.0 109.879 174.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 94.1 t -76.92 111.85 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 176.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 5.0 p -95.86 -26.27 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 123.8 0.84 . . . . 0.0 112.963 -174.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 25.0 ptp -162.21 148.06 13.06 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.41 1.084 . . . . 0.0 112.789 163.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -90.37 130.01 36.51 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.953 0.901 . . . . 0.0 110.585 178.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 13.1 mmmm . . . . . 0 C--O 1.253 1.263 0 C-N-CA 125.297 1.439 . . . . 0.0 113.805 178.452 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.0 mmt . . . . . 0 N--CA 1.496 1.868 0 CA-C-O 118.642 -0.694 . . . . 0.0 111.238 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -68.29 134.75 32.16 Favored 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 123.59 2.86 . . . . 0.0 111.376 178.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 57.9 t -99.52 115.19 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 124.53 1.132 . . . . 0.0 110.566 -173.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 6.7 mpt_? -85.8 174.88 9.01 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.825 1.25 . . . . 0.0 111.803 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 13.6 ptp180 -55.39 147.89 16.29 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.856 1.263 . . . . 0.0 112.142 173.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -92.02 108.57 3.64 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 123.955 0.788 . . . . 0.0 112.175 -176.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -166.83 167.13 15.22 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 126.476 1.911 . . . . 0.0 110.86 175.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 59.8 t -137.07 134.9 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 124.606 1.163 . . . . 0.0 109.591 172.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -157.67 154.22 24.55 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 127.095 2.158 . . . . 0.0 108.881 174.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -65.03 110.39 1.5 Allowed 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.892 2.395 . . . . 0.0 110.23 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -69.81 165.12 22.16 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.652 1.181 . . . . 0.0 111.498 176.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -69.31 147.36 51.24 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 121.244 -0.91 . . . . 0.0 111.019 171.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 38.2 p -117.45 -40.57 3.04 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 125.509 1.523 . . . . 0.0 112.389 -174.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -76.02 -52.6 9.85 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.062 0.945 . . . . 0.0 111.553 176.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 60.4 tp -58.63 -34.47 71.21 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.43 1.092 . . . . 0.0 111.259 178.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -56.71 -30.97 64.03 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 176.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 89.7 m -77.01 -32.75 57.37 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.255 1.022 . . . . 0.0 110.89 175.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 20.9 mm -71.64 -39.42 69.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 123.541 0.736 . . . . 0.0 110.5 176.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 71.8 mt -56.31 -44.13 78.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 124.13 0.972 . . . . 0.0 110.753 175.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 39.9 mtt180 -59.75 -36.87 77.51 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 119.212 0.915 . . . . 0.0 112.489 177.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -74.0 -37.29 64.47 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.532 1.133 . . . . 0.0 112.071 177.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -79.57 -22.18 44.12 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.998 1.319 . . . . 0.0 112.954 178.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -62.01 -31.71 72.12 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 118.817 0.735 . . . . 0.0 112.003 170.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.52 44.65 40.11 Favored Glycine 0 C--N 1.341 0.838 0 N-CA-C 114.848 0.699 . . . . 0.0 114.848 156.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -58.36 -25.31 61.85 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 114.568 1.321 . . . . 0.0 114.568 -176.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.9 t -91.64 -5.71 53.4 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 177.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -91.01 171.36 9.32 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.8 1.24 . . . . 0.0 110.715 175.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.4 mptt -88.27 136.51 32.95 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.506 1.123 . . . . 0.0 111.252 -175.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -163.47 167.06 22.02 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.412 1.085 . . . . 0.0 113.544 178.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 25.7 pt -144.76 152.1 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 126.617 1.967 . . . . 0.0 109.865 172.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 10.7 mt -117.68 133.61 63.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 125.538 1.535 . . . . 0.0 109.008 -178.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -134.78 152.18 51.55 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.393 1.077 . . . . 0.0 112.353 178.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 14.3 m-20 -74.68 117.99 17.13 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.334 0.653 . . . . 0.0 111.527 178.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.32 -20.21 66.03 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.934 0.894 . . . . 0.0 112.274 170.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 78.7 mtp85 -66.79 -11.87 56.72 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.825 2.05 . . . . 0.0 115.352 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 20.6 m -124.79 142.03 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 125.357 1.463 . . . . 0.0 111.01 -179.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -61.4 -40.68 95.26 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.718 1.207 . . . . 0.0 112.904 -170.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 22.2 p30 -72.32 -14.59 61.78 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 177.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 4.8 t 50.98 61.67 3.12 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.716 1.606 . . . . 0.0 111.695 -173.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.64 134.86 56.18 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 120.936 -1.103 . . . . 0.0 112.278 -179.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 40.5 t -63.79 122.66 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 C-N-CA 123.07 0.548 . . . . 0.0 109.912 173.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.1 pt -101.46 -21.37 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 125.404 1.482 . . . . 0.0 112.424 175.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -152.36 144.09 23.58 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.293 1.037 . . . . 0.0 111.816 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.467 ' HB3' ' CE1' ' A' ' 48' ' ' PHE . 3.1 m -128.07 155.07 44.96 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.056 0.942 . . . . 0.0 112.592 -179.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -73.88 -174.22 1.77 Allowed 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 123.159 0.584 . . . . 0.0 111.475 167.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -107.52 -17.97 13.97 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.58 1.152 . . . . 0.0 112.801 166.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -73.92 -38.81 48.18 Favored Glycine 0 C--N 1.337 0.599 0 C-N-CA 125.821 1.676 . . . . 0.0 112.734 176.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.467 ' CE1' ' HB3' ' A' ' 44' ' ' CYS . 0.3 OUTLIER -62.62 -34.51 77.17 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.207 0.603 . . . . 0.0 111.244 179.606 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 76.6 m -48.19 -56.13 8.67 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.942 1.697 . . . . 0.0 111.941 170.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -70.93 -19.79 62.54 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -177.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.95 -49.48 72.4 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.641 1.177 . . . . 0.0 111.43 177.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 76.6 m -107.61 -21.63 12.82 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 -176.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.02 -0.4 57.46 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 125.426 1.488 . . . . 0.0 114.348 178.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -83.08 -171.52 3.61 Favored 'General case' 0 CA--C 1.55 0.964 0 CA-C-N 118.499 1.15 . . . . 0.0 112.698 170.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 74.2 m -140.95 162.59 35.12 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.409 1.084 . . . . 0.0 111.312 178.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -46.37 -49.55 17.7 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.282 1.033 . . . . 0.0 112.025 176.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.96 -24.78 59.47 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -89.21 -39.31 13.63 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.765 1.226 . . . . 0.0 111.67 177.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 19.8 t -88.63 -12.46 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 124.107 0.963 . . . . 0.0 112.513 -176.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 75.4 mtp -64.35 139.33 58.75 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 120.463 -1.398 . . . . 0.0 111.276 168.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 69.37 6.89 5.93 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 126.301 1.841 . . . . 0.0 113.896 -177.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 32.4 mmt180 -83.85 154.58 64.65 Favored Pre-proline 0 N--CA 1.472 0.643 0 C-N-CA 124.23 1.012 . . . . 0.0 110.59 172.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -68.94 131.04 21.5 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.866 2.377 . . . . 0.0 109.671 170.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 6.7 t -66.04 -14.41 61.64 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.165 1.386 . . . . 0.0 114.069 -172.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 33.9 p -59.39 -24.27 63.3 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.863 1.665 . . . . 0.0 112.908 169.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 76.9 m 57.51 42.81 23.82 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.186 1.394 . . . . 0.0 111.76 -178.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -71.97 18.79 0.08 Allowed 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 127.519 2.328 . . . . 0.0 113.39 -175.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -112.46 -12.3 13.52 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 126.889 2.076 . . . . 0.0 112.747 170.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 78.6 mt -81.18 -9.62 59.76 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 114.801 1.408 . . . . 0.0 114.801 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 12.0 p80 -69.02 160.33 31.16 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 179.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -151.96 -161.37 10.12 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 126.1 1.81 . . . . 0.0 111.357 168.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -65.74 -18.54 58.58 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 122.961 2.441 . . . . 0.0 114.287 -177.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.5 tpm_? -88.15 -6.95 57.58 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 119.273 0.942 . . . . 0.0 113.106 176.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.8 m -85.92 137.81 32.47 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.382 1.473 . . . . 0.0 109.77 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -102.5 135.41 44.19 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.21 1.004 . . . . 0.0 110.269 -178.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 19.3 tpp180 -58.6 -36.37 73.9 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.359 1.064 . . . . 0.0 112.383 -178.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 21.1 tpp85 -55.5 -45.91 77.01 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.15 1.38 . . . . 0.0 112.118 176.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.77 -46.4 68.84 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.753 0.821 . . . . 0.0 111.773 178.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.82 -34.44 65.38 Favored 'General case' 0 CA--C 1.545 0.784 0 O-C-N 121.488 -0.758 . . . . 0.0 112.359 175.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.41 -40.57 70.4 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 125.27 1.428 . . . . 0.0 113.033 173.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -61.17 -30.55 70.47 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 118.061 -0.971 . . . . 0.0 112.174 178.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 58.0 mt -63.76 -47.28 91.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 CA-C-N 120.039 1.29 . . . . 0.0 110.273 172.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.89 -34.43 77.38 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 121.582 -0.699 . . . . 0.0 112.483 176.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 73.7 mm-40 -69.64 -31.32 69.34 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 121.481 -0.762 . . . . 0.0 112.194 171.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.5 -28.12 66.73 Favored 'General case' 0 CA--C 1.545 0.778 0 O-C-N 120.98 -1.075 . . . . 0.0 111.666 176.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 74.4 mt -73.97 -14.25 61.0 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.94 1.296 . . . . 0.0 113.655 169.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 94.3 mt -94.89 -10.64 30.58 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.249 1.02 . . . . 0.0 112.653 172.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -87.65 143.8 18.62 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 125.077 1.322 . . . . 0.0 112.9 177.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.5 -3.5 58.34 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.751 1.22 . . . . 0.0 113.801 175.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -125.62 165.17 19.03 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.578 1.951 . . . . 0.0 110.974 -175.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -61.62 139.79 58.23 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.014 0.926 . . . . 0.0 112.039 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.17 123.75 8.47 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.318 1.047 . . . . 0.0 110.872 -173.078 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -89.18 153.0 21.29 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.399 1.079 . . . . 0.0 113.719 169.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 46.1 t -138.73 134.48 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 126.808 2.043 . . . . 0.0 107.628 167.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -102.98 121.2 42.05 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.609 0.763 . . . . 0.0 109.15 173.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.5 tt -147.25 145.46 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 123.925 0.89 . . . . 0.0 112.212 -169.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -84.29 119.51 25.14 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.332 -0.855 . . . . 0.0 111.75 175.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 15.9 m-30 -107.07 150.43 26.55 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.544 1.938 . . . . 0.0 110.908 172.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -109.89 136.7 48.77 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.983 1.313 . . . . 0.0 111.871 175.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -86.37 168.24 14.01 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.744 0.818 . . . . 0.0 112.593 173.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -58.23 -30.96 66.91 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 125.684 1.593 . . . . 0.0 113.511 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -76.37 -6.32 51.07 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.946 1.299 . . . . 0.0 113.439 178.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 93.63 1.34 66.07 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 125.63 1.586 . . . . 0.0 114.541 178.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.4 m -80.32 154.02 28.04 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 118.766 1.283 . . . . 0.0 111.743 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 39.1 t -117.42 150.6 38.61 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.822 1.249 . . . . 0.0 111.733 -178.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -159.56 146.14 16.43 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.968 1.307 . . . . 0.0 111.412 178.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -71.02 123.86 23.04 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.279 0.632 . . . . 0.0 110.974 165.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 47.0 t -106.78 133.71 51.03 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.627 1.971 . . . . 0.0 109.672 169.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.0 tt -85.41 113.61 21.83 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.515 1.526 . . . . 0.0 107.075 162.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 63.9 t -98.1 110.93 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 124.82 1.248 . . . . 0.0 107.646 170.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -102.33 120.07 39.87 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 120.435 1.47 . . . . 0.0 108.733 167.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 67.5 t -82.66 135.79 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 170.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 48.5 t -115.25 111.2 44.73 Favored Pre-proline 0 CA--C 1.535 0.403 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 169.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.45 133.25 14.28 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.011 2.474 . . . . 0.0 109.741 178.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 94.6 t -107.8 123.55 63.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 123.98 0.912 . . . . 0.0 109.783 179.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 67.2 mttt -91.6 154.08 19.29 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.242 0.831 . . . . 0.0 113.242 170.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -92.7 -174.56 3.68 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.285 1.034 . . . . 0.0 110.765 173.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -66.1 -18.93 65.66 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -85.34 -5.79 59.28 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.318 1.047 . . . . 0.0 112.455 174.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 78.68 23.05 65.41 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 124.581 1.086 . . . . 0.0 114.385 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -107.88 150.31 27.21 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.542 1.537 . . . . 0.0 109.937 172.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 90.4 t -78.61 124.93 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 123.684 0.794 . . . . 0.0 109.202 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.22 -24.74 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 -175.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 51.9 mtm -130.2 152.22 49.86 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.822 1.249 . . . . 0.0 112.473 171.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -113.34 135.81 53.45 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 125.164 1.386 . . . . 0.0 109.081 166.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 49.6 mt -103.07 119.56 51.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 166.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -95.84 117.97 31.59 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 173.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -111.08 129.42 55.93 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 117.773 0.261 . . . . 0.0 110.978 -179.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 17.6 m-30 -107.62 137.91 44.79 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.481 1.512 . . . . 0.0 111.7 -171.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -144.54 116.99 8.55 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.568 1.147 . . . . 0.0 109.779 172.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.1 p -66.68 115.63 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 O-C-N 121.363 -0.836 . . . . 0.0 109.883 175.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 9.2 p -99.83 -27.04 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.904 1.281 . . . . 0.0 113.394 -171.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 25.1 ptp -162.69 149.93 13.4 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.328 1.051 . . . . 0.0 113.104 167.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -89.18 136.46 33.01 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.722 0.809 . . . . 0.0 111.037 177.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt . . . . . 0 C--O 1.254 1.326 0 C-N-CA 125.317 1.447 . . . . 0.0 112.732 175.875 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.1 ttm . . . . . 0 N--CA 1.494 1.743 0 CA-C-O 118.341 -0.837 . . . . 0.0 110.731 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -75.56 143.34 27.24 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 123.224 2.616 . . . . 0.0 110.688 175.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 17.4 m -149.43 152.99 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 125.018 1.327 . . . . 0.0 111.303 -178.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 18.5 ptp180 -68.3 160.96 28.36 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.039 0.936 . . . . 0.0 112.702 173.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 19.0 ptp180 -157.76 160.71 38.13 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.669 1.588 . . . . 0.0 112.413 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -173.31 -144.19 4.56 Favored Glycine 0 N--CA 1.471 1.02 0 C-N-CA 125.539 1.543 . . . . 0.0 112.573 -177.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -64.89 124.43 21.99 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 123.518 0.727 . . . . 0.0 111.227 176.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.5 p -75.89 -19.9 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 N-CA-C 113.761 1.022 . . . . 0.0 113.761 -173.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 71.55 162.63 0.15 Allowed Pre-proline 0 CA--C 1.555 1.164 0 C-N-CA 127.485 2.314 . . . . 0.0 112.716 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -70.88 139.16 35.76 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.518 2.146 . . . . 0.0 110.494 170.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -168.07 179.33 4.65 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.649 1.58 . . . . 0.0 111.865 -175.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -75.58 63.34 1.53 Allowed 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 126.661 1.984 . . . . 0.0 114.701 -172.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 25.9 p -42.18 -45.4 4.06 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 128.025 2.53 . . . . 0.0 114.372 -178.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -65.01 -41.65 95.13 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.848 0.859 . . . . 0.0 112.481 -177.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 61.5 tp -72.79 -40.01 66.24 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.563 1.145 . . . . 0.0 111.098 173.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -62.66 -25.11 67.97 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.178 0.991 . . . . 0.0 112.459 178.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 95.0 m -67.85 -21.86 65.16 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.597 1.559 . . . . 0.0 111.487 171.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 11.5 mm -86.6 -37.41 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 124.749 1.22 . . . . 0.0 110.791 174.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.452 ' HA ' ' CE2' ' A' ' 22' ' ' PHE . 1.9 mp -58.31 -49.89 80.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 123.1 0.56 . . . . 0.0 110.397 174.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 16.3 ptp180 -67.43 -16.77 64.41 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 114.22 1.193 . . . . 0.0 114.22 -175.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.5 mtpt -70.59 -36.24 73.46 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.937 0.895 . . . . 0.0 111.986 171.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.452 ' CE2' ' HA ' ' A' ' 19' ' ' ILE . 6.2 p90 -93.74 -23.85 18.05 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 178.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -77.94 160.79 27.99 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 173.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -108.52 5.79 33.39 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 126.089 1.804 . . . . 0.0 115.537 178.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -91.77 -23.84 19.61 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 119.259 1.529 . . . . 0.0 114.334 -175.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.8 m -86.6 11.53 12.58 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 114.074 1.139 . . . . 0.0 114.074 -170.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 21.5 mmt85 -79.72 165.77 22.47 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.06 1.344 . . . . 0.0 113.666 -167.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -94.82 129.77 41.65 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.906 1.282 . . . . 0.0 110.93 -172.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -160.35 161.63 33.21 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.323 1.049 . . . . 0.0 113.712 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.6 pt -141.79 153.68 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 127.125 2.17 . . . . 0.0 110.441 176.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.6 mp -116.43 132.61 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 124.732 1.213 . . . . 0.0 109.205 176.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -123.15 142.92 50.37 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 126.078 1.751 . . . . 0.0 110.603 -174.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -71.32 124.05 23.68 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 121.82 -0.55 . . . . 0.0 111.105 171.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.01 -33.93 63.97 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 121.142 -0.974 . . . . 0.0 111.986 177.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 60.6 mtm180 -80.31 33.68 0.3 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 126.007 1.723 . . . . 0.0 113.115 -174.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 79.8 t -145.15 133.42 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 127.142 2.177 . . . . 0.0 108.492 -173.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -57.93 -41.09 82.03 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.685 1.194 . . . . 0.0 113.336 -171.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 75.7 m-80 -84.76 -11.0 56.69 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -178.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 69.8 m 45.9 62.04 2.4 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.246 1.419 . . . . 0.0 111.95 -165.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.52 143.37 57.26 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.089 0.955 . . . . 0.0 111.955 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 56.6 t -61.47 116.33 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 124.534 1.134 . . . . 0.0 108.734 173.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 37.3 pt -98.47 -20.85 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 123.147 0.579 . . . . 0.0 112.326 170.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -156.72 152.61 27.24 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.106 0.962 . . . . 0.0 111.697 175.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.508 ' HB2' ' CE1' ' A' ' 48' ' ' PHE . 24.9 p -153.16 153.94 33.76 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.015 -1.053 . . . . 0.0 113.287 -179.33 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -79.89 -168.84 1.75 Allowed 'General case' 0 CA--C 1.553 1.091 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -179.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -101.33 -22.93 14.47 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.171 1.388 . . . . 0.0 112.57 169.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.45 -37.0 58.84 Favored Glycine 0 C--N 1.343 0.944 0 O-C-N 121.532 -0.73 . . . . 0.0 112.825 -177.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.508 ' CE1' ' HB2' ' A' ' 44' ' ' CYS . 0.8 OUTLIER -67.03 -30.38 70.44 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 117.451 0.626 . . . . 0.0 111.779 179.206 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 80.0 m -56.05 -52.02 65.76 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.608 1.163 . . . . 0.0 111.78 175.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -71.44 -20.36 62.11 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.739 0.816 . . . . 0.0 112.952 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.5 tp -64.92 -56.02 15.79 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.511 1.124 . . . . 0.0 111.116 176.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 62.0 m -98.64 -13.73 20.2 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -175.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 91.79 2.61 69.33 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 125.624 1.583 . . . . 0.0 114.152 171.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -85.64 -153.64 0.18 Allowed 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 124.899 1.28 . . . . 0.0 112.133 171.243 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 82.7 p -153.8 167.8 28.46 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 120.389 -1.444 . . . . 0.0 111.63 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -50.85 -52.96 36.45 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 118.817 -0.611 . . . . 0.0 110.512 169.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.55 -32.55 58.55 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -178.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -85.84 -37.63 18.99 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.887 0.875 . . . . 0.0 112.953 177.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 68.1 t -77.73 -15.76 14.21 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 C-N-CA 124.882 1.273 . . . . 0.0 111.625 178.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 75.1 mtp -60.59 131.35 50.45 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 120.468 -1.395 . . . . 0.0 111.508 175.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 71.92 14.01 5.93 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 126.587 1.955 . . . . 0.0 113.656 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 38.5 mtt180 -94.81 158.89 34.44 Favored Pre-proline 0 N--CA 1.474 0.761 0 C-N-CA 124.634 1.174 . . . . 0.0 111.214 174.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -70.3 136.83 32.51 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 123.307 2.672 . . . . 0.0 110.56 170.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 56.6 m -67.03 -8.58 31.25 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.46 1.281 . . . . 0.0 114.46 177.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 76.4 p -61.15 -28.37 69.07 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.351 1.061 . . . . 0.0 111.89 172.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 75.6 m 50.36 35.95 11.96 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.014 1.326 . . . . 0.0 113.104 -176.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -56.14 -33.28 65.02 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.362 1.465 . . . . 0.0 112.501 -176.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -60.26 -14.55 18.55 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.388 1.475 . . . . 0.0 114.35 177.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 92.7 mt -76.65 -2.97 35.42 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 174.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 3.6 p80 -59.87 145.3 46.18 Favored 'General case' 0 CA--C 1.552 1.026 0 CA-C-N 119.5 1.046 . . . . 0.0 113.41 176.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -118.51 -164.88 13.12 Favored Glycine 0 CA--C 1.539 1.591 0 C-N-CA 126.03 1.776 . . . . 0.0 111.525 165.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.84 -20.65 29.47 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 123.277 2.651 . . . . 0.0 112.937 174.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 29.3 ttm180 -93.59 2.2 56.44 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.26 1.424 . . . . 0.0 113.006 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 28.1 m -83.85 136.76 33.99 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.376 1.47 . . . . 0.0 110.011 177.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -96.89 123.62 40.65 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.021 0.928 . . . . 0.0 109.518 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 14.0 tpt180 -60.4 -30.57 69.69 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.721 0.809 . . . . 0.0 112.76 -176.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 21.4 tpp85 -56.9 -41.32 77.88 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.854 1.261 . . . . 0.0 112.504 173.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -72.73 -43.09 63.4 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 121.348 -0.845 . . . . 0.0 111.962 177.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -57.75 -36.49 72.16 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 121.545 -0.722 . . . . 0.0 112.038 174.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.95 -47.94 64.42 Favored 'General case' 0 C--O 1.225 -0.237 0 C-N-CA 125.197 1.399 . . . . 0.0 111.997 173.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.5 mm100 -58.25 -37.0 74.06 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 118.616 -0.707 . . . . 0.0 111.681 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 95.6 mt -59.54 -42.1 86.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 CA-C-N 119.829 1.195 . . . . 0.0 111.83 171.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.72 -34.98 70.04 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.458 0.703 . . . . 0.0 112.891 176.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -68.22 -32.83 73.31 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.981 0.912 . . . . 0.0 111.687 174.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -59.79 -27.91 66.97 Favored 'General case' 0 CA--C 1.547 0.827 0 CA-C-N 119.201 0.91 . . . . 0.0 113.035 178.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 53.7 mt -72.55 -14.7 61.7 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.648 1.579 . . . . 0.0 113.134 177.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 70.0 mt -81.86 -20.41 38.97 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.055 0.942 . . . . 0.0 112.268 174.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -89.44 152.74 22.83 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.139 1.352 . . . . 0.0 113.311 -178.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -95.83 7.9 45.04 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.088 1.355 . . . . 0.0 113.509 176.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -126.62 162.31 26.01 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.091 1.756 . . . . 0.0 112.082 -176.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -64.23 141.68 58.69 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.636 1.175 . . . . 0.0 112.063 -179.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 9.9 tpt180 -152.13 138.21 18.24 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.012 1.325 . . . . 0.0 110.646 -173.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -129.24 148.16 51.15 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 168.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 58.3 t -138.79 135.71 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 126.282 1.833 . . . . 0.0 108.232 -171.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -104.69 130.08 52.79 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.931 0.892 . . . . 0.0 110.98 -176.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.2 tt -152.26 147.36 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 123.999 0.919 . . . . 0.0 112.19 -168.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -81.59 121.08 25.88 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 120.872 -1.143 . . . . 0.0 111.601 171.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 10.1 m-30 -109.19 132.15 54.39 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.656 1.982 . . . . 0.0 111.147 173.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -78.31 162.15 26.71 Favored 'General case' 0 CA--C 1.549 0.906 0 O-C-N 121.89 -0.506 . . . . 0.0 112.084 167.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 23.9 ttp180 -115.39 147.56 40.38 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.766 1.626 . . . . 0.0 110.41 173.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -55.77 -24.92 38.41 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 178.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -64.08 -17.82 63.78 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.578 1.551 . . . . 0.0 113.77 173.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 100.41 4.43 54.98 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 125.849 1.69 . . . . 0.0 113.858 -175.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 86.3 p -92.77 -178.94 5.0 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 118.626 1.213 . . . . 0.0 112.569 176.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 21.8 t -150.02 156.67 42.1 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.681 1.192 . . . . 0.0 111.625 -177.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -161.2 164.63 30.32 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.316 1.846 . . . . 0.0 110.657 178.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.68 126.18 35.9 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 123.667 0.787 . . . . 0.0 112.459 170.296 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 43.4 t -105.07 135.34 46.59 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.837 2.055 . . . . 0.0 110.844 174.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 38.8 tp -93.42 112.79 24.78 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.786 1.235 . . . . 0.0 107.74 160.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 61.1 t -95.39 119.67 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 173.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -113.65 119.44 37.45 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 125.35 1.46 . . . . 0.0 109.598 174.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 5.8 p -94.44 127.64 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 123.897 0.879 . . . . 0.0 109.506 173.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 96.9 t -115.91 111.03 43.38 Favored Pre-proline 0 CA--C 1.537 0.452 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 178.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -73.61 130.71 15.13 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.684 2.256 . . . . 0.0 110.109 -178.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 58.6 t -100.26 124.93 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 123.942 0.897 . . . . 0.0 109.331 176.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 21.4 mtpt -94.58 150.82 19.85 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.665 0.745 . . . . 0.0 112.389 174.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 54.0 p30 -78.96 -173.43 3.54 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.832 1.253 . . . . 0.0 111.694 174.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -67.64 -15.36 63.61 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 175.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -96.59 -18.31 19.84 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.646 1.178 . . . . 0.0 113.206 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 86.67 43.98 5.94 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 125.966 1.746 . . . . 0.0 113.577 -174.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -118.69 154.27 32.99 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.394 1.477 . . . . 0.0 110.175 161.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 57.3 t -80.27 126.44 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 C-N-CA 123.413 0.685 . . . . 0.0 109.29 178.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.8 -24.63 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 N-CA-C 114.217 1.191 . . . . 0.0 114.217 -178.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 64.0 mtm -133.79 157.44 45.89 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.151 1.381 . . . . 0.0 112.205 172.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -117.56 137.08 52.82 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 125.532 1.533 . . . . 0.0 109.298 169.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 47.4 mt -101.54 121.34 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 164.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 8.2 mp -104.99 133.19 50.2 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 172.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -126.03 132.97 51.87 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.481 1.113 . . . . 0.0 110.114 -174.061 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 15.1 m-30 -107.46 128.21 54.29 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.02 1.328 . . . . 0.0 110.754 -176.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -124.19 131.88 53.57 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.177 1.391 . . . . 0.0 107.396 169.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 71.4 t -78.49 112.09 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 CA-C-N 119.415 1.007 . . . . 0.0 108.293 173.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.4 p -89.13 -24.5 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.429 1.091 . . . . 0.0 112.631 -174.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 13.4 tpt -161.16 119.24 2.4 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.721 1.209 . . . . 0.0 110.609 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -85.18 115.08 22.76 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.489 0.716 . . . . 0.0 109.767 176.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt . . . . . 0 C--O 1.255 1.348 0 C-N-CA 125.025 1.33 . . . . 0.0 113.733 -175.702 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 91.5 mmm . . . . . 0 N--CA 1.495 1.791 0 CA-C-O 118.607 -0.711 . . . . 0.0 110.829 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -80.18 167.69 19.43 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 123.815 3.01 . . . . 0.0 111.88 177.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.5 p -161.07 132.13 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 125.095 1.358 . . . . 0.0 110.619 173.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 31.0 tpt85 -92.09 102.87 15.41 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.165 0.986 . . . . 0.0 110.091 175.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -83.0 169.99 15.37 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.073 1.349 . . . . 0.0 111.117 174.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 128.58 123.48 2.58 Favored Glycine 0 N--CA 1.472 1.073 0 C-N-CA 125.69 1.614 . . . . 0.0 113.028 175.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 48.2 m80 -149.26 172.93 14.07 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 127.214 2.205 . . . . 0.0 109.97 178.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.5 p -151.44 141.59 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 124.09 0.956 . . . . 0.0 111.531 177.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.24 154.15 92.15 Favored Pre-proline 0 CA--C 1.552 1.034 0 C-N-CA 124.666 1.187 . . . . 0.0 112.453 178.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -65.74 128.42 19.92 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 123.298 2.665 . . . . 0.0 110.601 176.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 23.0 mp0 -80.77 169.95 16.92 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.115 1.366 . . . . 0.0 110.953 176.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -71.61 148.22 46.8 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.187 -0.946 . . . . 0.0 110.865 169.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 40.0 p -122.63 -40.54 2.44 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 125.48 1.512 . . . . 0.0 112.122 -174.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -69.94 -55.57 9.31 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.982 0.913 . . . . 0.0 111.11 173.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 62.7 tp -59.34 -35.24 73.48 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.255 1.022 . . . . 0.0 111.255 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -58.56 -31.84 68.37 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 176.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 90.9 m -77.14 -32.89 56.7 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.13 0.972 . . . . 0.0 110.48 175.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 24.8 mm -68.58 -41.86 83.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 123.062 0.545 . . . . 0.0 110.367 173.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 76.1 mt -57.4 -46.67 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 124.384 1.074 . . . . 0.0 110.506 174.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 78.8 mtt-85 -58.71 -31.72 68.52 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 179.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -71.02 -30.51 66.75 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.08 0.952 . . . . 0.0 112.756 177.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -88.83 -26.13 21.83 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.487 1.115 . . . . 0.0 113.371 173.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -67.0 153.89 42.54 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 122.155 0.978 . . . . 0.0 113.369 178.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -79.81 61.21 4.32 Favored Glycine 0 C--N 1.34 0.764 0 C-N-CA 126.074 1.797 . . . . 0.0 110.695 173.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -62.11 -21.36 64.93 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.165 1.386 . . . . 0.0 112.624 -178.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 7.8 t -83.45 -20.11 34.67 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 175.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.1 mpt_? -90.55 179.61 5.8 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.892 1.277 . . . . 0.0 110.309 170.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -122.84 128.65 50.68 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 121.002 -1.061 . . . . 0.0 111.766 -174.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 26.9 p90 -163.93 163.52 23.55 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.084 1.353 . . . . 0.0 112.96 175.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 14.3 pt -141.06 154.84 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 126.062 1.745 . . . . 0.0 110.19 175.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 15.9 mt -110.14 129.07 65.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 124.814 1.246 . . . . 0.0 108.67 177.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -122.5 142.76 50.24 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 124.897 1.279 . . . . 0.0 111.236 178.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -65.55 126.51 28.56 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.163 0.585 . . . . 0.0 111.435 172.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -80.93 -25.02 37.75 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 28.7 mmm180 -80.12 -36.82 34.76 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.616 1.166 . . . . 0.0 112.938 -173.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 52.9 t -68.98 131.85 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 C-N-CA 125.439 1.495 . . . . 0.0 109.753 173.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -59.63 -44.81 93.34 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.518 1.127 . . . . 0.0 113.309 -170.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 20.2 p30 -74.53 -9.54 58.68 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 113.78 1.029 . . . . 0.0 113.78 177.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 72.1 m 54.79 64.34 1.84 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.89 1.676 . . . . 0.0 112.23 -176.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.88 135.56 57.73 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.66 0.784 . . . . 0.0 111.735 179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 42.3 t -64.33 118.17 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 168.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 36.0 pt -100.17 -19.77 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 124.718 1.207 . . . . 0.0 112.367 177.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -155.24 146.43 22.73 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.246 1.018 . . . . 0.0 111.547 177.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -130.15 149.64 51.77 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.367 1.067 . . . . 0.0 111.858 178.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -74.13 -164.16 0.23 Allowed 'General case' 0 CA--C 1.554 1.134 0 CA-C-N 118.249 0.477 . . . . 0.0 111.128 169.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -107.26 -21.46 12.94 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.935 1.294 . . . . 0.0 112.713 169.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.8 -40.26 58.35 Favored Glycine 0 C--N 1.342 0.915 0 O-C-N 121.678 -0.639 . . . . 0.0 112.585 -178.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -64.39 -31.41 72.61 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 123.966 0.906 . . . . 0.0 112.365 -178.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 36.1 t -60.63 -53.42 57.72 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.373 1.469 . . . . 0.0 110.939 176.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -70.61 -26.7 63.62 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.531 0.732 . . . . 0.0 112.765 178.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 27.4 tp -61.52 -38.35 87.05 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.324 1.05 . . . . 0.0 112.343 173.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 39.1 m -106.3 -35.93 7.01 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 114.686 1.365 . . . . 0.0 114.686 -171.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.83 10.21 55.46 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 125.68 1.61 . . . . 0.0 114.266 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -89.58 -147.89 0.18 Allowed 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 118.558 1.179 . . . . 0.0 111.728 170.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.9 m -161.59 161.07 29.61 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 126.042 1.737 . . . . 0.0 110.606 176.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -53.67 -43.72 69.09 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 121.561 -0.712 . . . . 0.0 111.582 178.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.11 -30.43 36.54 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 175.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -92.85 -36.81 12.63 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.001 1.32 . . . . 0.0 112.193 178.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 53.8 t -73.12 -21.15 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 125.829 1.651 . . . . 0.0 111.504 177.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 57.0 mmm -65.07 135.07 55.12 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 121.014 -1.054 . . . . 0.0 112.126 179.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.0 tp60 69.87 10.33 7.45 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 126.438 1.895 . . . . 0.0 113.577 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 36.4 mmt180 -83.49 151.24 61.78 Favored Pre-proline 0 N--CA 1.471 0.621 0 C-N-CA 124.261 1.024 . . . . 0.0 110.879 177.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.23 131.71 21.13 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.982 2.454 . . . . 0.0 108.758 167.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 22.3 p -67.54 -9.97 47.49 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -172.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 30.8 p -61.17 -26.35 67.65 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.194 1.398 . . . . 0.0 112.269 170.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 94.3 m 52.16 46.9 25.82 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.147 1.379 . . . . 0.0 112.777 175.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -59.23 -23.46 62.34 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.663 1.185 . . . . 0.0 112.867 -178.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -54.6 -25.65 27.79 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.733 1.613 . . . . 0.0 112.96 172.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 74.1 mt -78.36 -7.41 57.27 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 178.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 7.4 t60 -63.66 141.89 58.6 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.48 1.112 . . . . 0.0 112.258 175.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -148.39 -170.17 16.02 Favored Glycine 0 CA--C 1.537 1.434 0 C-N-CA 127.252 2.358 . . . . 0.0 111.857 176.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -64.11 -21.95 67.69 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 123.221 2.614 . . . . 0.0 113.848 -175.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.85 -6.9 50.79 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 176.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 26.7 m -74.96 142.18 43.96 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-N 119.959 1.254 . . . . 0.0 110.474 -174.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 69.0 mm-40 -100.74 124.96 47.1 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.17 0.988 . . . . 0.0 110.133 -170.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -61.47 -40.22 93.75 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.572 0.749 . . . . 0.0 112.797 -176.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 36.1 mmt180 -66.24 -36.04 81.98 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.454 0.701 . . . . 0.0 112.62 175.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.78 -43.73 68.13 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 119.176 0.898 . . . . 0.0 112.045 177.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -57.89 -32.17 67.46 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.17 0.588 . . . . 0.0 112.044 173.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -72.32 -49.76 31.99 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.637 1.175 . . . . 0.0 111.847 172.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 11.6 mm-40 -59.96 -34.37 73.18 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 118.914 0.779 . . . . 0.0 111.738 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 83.1 mt -61.89 -34.89 64.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 CA-C-N 120.034 1.288 . . . . 0.0 112.749 170.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.26 -41.34 63.76 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 119.648 1.113 . . . . 0.0 112.101 172.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -65.44 -28.75 69.46 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 121.29 -0.881 . . . . 0.0 112.095 175.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.66 -20.99 62.3 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 119.353 0.978 . . . . 0.0 113.116 172.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 32.1 mt -90.03 -11.67 40.82 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.79 1.636 . . . . 0.0 112.93 175.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 82.0 mt -93.1 -17.03 24.28 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.605 1.162 . . . . 0.0 111.891 171.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -87.04 144.32 19.3 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 125.165 1.364 . . . . 0.0 113.331 -176.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -87.2 -8.07 57.27 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.751 1.22 . . . . 0.0 113.738 174.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -119.78 161.14 21.27 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.593 1.957 . . . . 0.0 111.01 -177.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -61.76 141.86 57.63 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.458 1.103 . . . . 0.0 112.401 -175.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 71.3 mmt-85 -137.98 131.65 31.1 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.183 0.993 . . . . 0.0 112.529 174.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 38.8 mtmt -108.95 131.51 54.98 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.756 1.622 . . . . 0.0 110.075 169.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 57.3 t -134.26 134.7 54.97 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 125.032 1.333 . . . . 0.0 108.926 -178.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -100.91 131.9 46.57 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.096 0.959 . . . . 0.0 110.776 178.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 19.7 tt -155.46 145.5 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 124.141 0.976 . . . . 0.0 111.82 -169.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -86.38 118.21 25.67 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.101 -0.999 . . . . 0.0 110.682 173.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 11.4 m-30 -105.19 140.6 38.11 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.714 1.605 . . . . 0.0 111.677 175.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -94.01 149.71 20.99 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.312 1.445 . . . . 0.0 111.078 174.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -108.22 156.2 19.61 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 125.735 1.614 . . . . 0.0 112.422 -175.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -64.03 -23.59 67.39 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 113.302 0.852 . . . . 0.0 113.302 175.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -78.87 -6.24 55.59 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.854 1.262 . . . . 0.0 113.618 177.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 94.21 -2.07 68.06 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 125.453 1.501 . . . . 0.0 114.3 -177.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 50.7 m -83.06 176.08 9.51 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.737 1.215 . . . . 0.0 112.244 175.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 23.3 p -154.14 165.78 35.16 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 120.918 -1.114 . . . . 0.0 112.106 172.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -164.91 167.76 18.3 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.214 1.405 . . . . 0.0 113.287 176.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -82.09 122.21 27.56 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.73 0.812 . . . . 0.0 110.141 169.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 45.5 t -105.09 141.25 36.98 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.659 1.984 . . . . 0.0 109.977 173.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 11.3 tp -96.74 118.19 32.66 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.954 1.302 . . . . 0.0 107.716 162.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 65.4 t -100.83 115.63 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 124.835 1.254 . . . . 0.0 108.316 173.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -111.44 110.57 21.08 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 125.278 1.431 . . . . 0.0 107.305 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 34.7 t -97.15 122.01 48.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 73.2 t -106.53 114.67 61.77 Favored Pre-proline 0 CA--C 1.536 0.417 0 N-CA-C 107.653 -1.239 . . . . 0.0 107.653 -177.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -73.46 120.35 6.45 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 123.078 2.518 . . . . 0.0 109.575 179.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 98.3 t -95.15 118.4 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.299 0.639 . . . . 0.0 109.53 175.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 60.8 mttt -87.62 153.42 21.4 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.692 0.797 . . . . 0.0 112.468 171.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -91.4 -173.57 3.63 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.425 1.09 . . . . 0.0 111.584 175.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -60.66 -21.74 63.12 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.05 1.34 . . . . 0.0 114.37 178.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -91.0 -5.45 55.34 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.072 1.349 . . . . 0.0 113.003 178.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 80.94 22.09 61.99 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 124.327 0.965 . . . . 0.0 114.554 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -108.25 148.86 29.37 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.193 1.397 . . . . 0.0 109.99 172.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.7 p -80.23 126.77 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 123.837 0.855 . . . . 0.0 110.703 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -128.31 -23.82 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -173.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 62.6 mtm -132.01 155.51 47.89 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.467 1.507 . . . . 0.0 111.993 171.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -114.83 135.86 53.73 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 125.251 1.421 . . . . 0.0 109.27 167.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 50.9 mt -98.94 115.99 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 163.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 6.2 mp -96.26 117.8 31.52 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 174.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -110.04 131.72 54.8 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 119.366 -0.349 . . . . 0.0 111.252 -177.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 11.2 m-30 -106.84 139.61 40.98 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.954 1.302 . . . . 0.0 111.129 -177.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -144.42 135.34 25.07 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.189 1.396 . . . . 0.0 109.482 175.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 27.5 t -77.46 114.95 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 176.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.9 p -95.44 -24.94 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -176.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 42.8 tpp -164.7 125.33 2.04 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.075 1.35 . . . . 0.0 110.425 179.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -83.81 125.22 31.73 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.574 0.749 . . . . 0.0 110.341 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.32 0 CA-C-O 115.836 -2.031 . . . . 0.0 114.568 -177.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.3 mpp? . . . . . 0 N--CA 1.495 1.789 0 CA-C-O 118.719 -0.658 . . . . 0.0 110.772 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -74.57 157.45 44.58 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 123.67 2.914 . . . . 0.0 111.578 177.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 95.3 t -86.89 110.9 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 174.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 31.8 mmm180 -76.26 139.36 41.08 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.382 1.073 . . . . 0.0 111.159 177.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 9.5 ptp180 -165.13 157.33 15.53 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.873 1.669 . . . . 0.0 112.38 -178.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -107.03 -173.27 22.62 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 125.686 1.612 . . . . 0.0 112.34 168.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 51.7 m80 -83.45 159.16 21.82 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 123.769 0.828 . . . . 0.0 111.547 170.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.3 p -64.8 141.33 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 O-C-N 121.513 -0.742 . . . . 0.0 111.974 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -126.2 154.3 74.41 Favored Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 126.075 1.75 . . . . 0.0 110.994 177.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -65.0 126.1 15.9 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 123.141 2.56 . . . . 0.0 110.891 -179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 20.9 mp0 -82.64 170.31 15.28 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.299 1.439 . . . . 0.0 110.938 178.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -72.12 147.88 46.25 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 121.137 -0.977 . . . . 0.0 110.661 169.061 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 38.0 p -120.87 -41.24 2.57 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 125.4 1.48 . . . . 0.0 112.141 -174.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -71.04 -56.05 6.96 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 123.922 0.889 . . . . 0.0 111.136 174.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 65.7 tp -57.84 -34.14 69.39 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.607 1.163 . . . . 0.0 111.49 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -60.64 -25.41 66.29 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 176.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 84.9 m -82.93 -33.0 26.9 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.728 1.211 . . . . 0.0 110.852 172.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 26.7 mm -73.05 -38.22 55.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 123.734 0.814 . . . . 0.0 111.496 178.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 54.9 mt -53.81 -38.56 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 123.857 0.863 . . . . 0.0 111.193 176.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 56.2 mtt180 -61.8 -26.2 67.95 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.488 1.115 . . . . 0.0 112.892 178.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -74.84 -38.56 61.97 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.805 1.242 . . . . 0.0 111.339 174.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -81.18 -21.63 39.53 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.245 1.418 . . . . 0.0 113.714 177.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -62.3 -29.48 70.46 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.806 0.842 . . . . 0.0 112.556 173.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 111.97 92.75 2.09 Favored Glycine 0 C--N 1.341 0.843 0 C-N-CA 125.474 1.511 . . . . 0.0 111.288 171.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 61.43 37.69 16.52 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.335 1.454 . . . . 0.0 112.354 166.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 17.4 t -71.78 -25.2 61.92 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -173.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.8 mpp_? -74.63 156.64 36.51 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 122.225 1.012 . . . . 0.0 111.026 174.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.04 140.09 29.98 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.054 0.942 . . . . 0.0 111.058 -176.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -162.79 156.99 20.92 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.555 1.142 . . . . 0.0 113.279 178.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.4 pt -141.34 150.35 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 126.318 1.847 . . . . 0.0 110.439 176.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 16.9 mt -109.67 134.96 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 125.699 1.6 . . . . 0.0 108.444 177.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -130.82 148.25 52.57 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 125.022 1.329 . . . . 0.0 111.09 177.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 15.4 m-20 -67.06 127.89 34.28 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 170.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.74 -30.55 59.24 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 121.864 -0.522 . . . . 0.0 112.355 172.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 64.8 mtm180 -80.68 44.49 0.73 Allowed 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.878 1.671 . . . . 0.0 112.992 -172.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.8 p -162.05 138.62 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 126.448 1.899 . . . . 0.0 110.0 -179.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -58.17 -40.99 82.88 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.168 0.987 . . . . 0.0 112.971 -172.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 24.1 p30 -77.77 -19.47 55.05 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 96.5 m 51.51 57.82 6.16 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.502 1.121 . . . . 0.0 112.43 -172.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.23 141.23 57.67 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.526 1.13 . . . . 0.0 113.098 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 61.8 t -63.75 124.71 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 124.018 0.927 . . . . 0.0 109.847 173.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 45.3 pt -103.51 -20.23 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 125.034 1.334 . . . . 0.0 112.315 172.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 15.1 t80 -155.62 150.61 26.55 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.057 0.943 . . . . 0.0 112.141 177.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 11.2 p -146.75 154.73 41.74 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 120.953 -1.092 . . . . 0.0 113.002 178.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 31.8 t-20 -74.14 -158.52 0.07 Allowed 'General case' 0 CA--C 1.56 1.339 0 C-N-CA 123.225 0.61 . . . . 0.0 112.167 -178.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -111.75 -18.37 12.75 Favored 'General case' 0 N--CA 1.48 1.04 0 O-C-N 120.249 -1.532 . . . . 0.0 112.966 166.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -75.6 -33.21 52.79 Favored Glycine 0 N--CA 1.47 0.911 0 C-N-CA 124.391 0.996 . . . . 0.0 112.632 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -65.47 -36.26 83.35 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.122 0.969 . . . . 0.0 110.989 -178.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 8.1 t -52.21 -47.19 65.76 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.48 1.512 . . . . 0.0 111.859 170.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -76.74 -21.75 54.79 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -178.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 51.9 tp -66.32 -53.84 31.73 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.95 0.9 . . . . 0.0 111.356 174.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 79.9 m -102.48 -17.43 15.79 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -172.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 87.1 6.38 78.96 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.985 1.279 . . . . 0.0 114.167 176.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -86.29 -153.61 0.2 Allowed 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.969 1.308 . . . . 0.0 111.81 171.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 12.0 t -162.8 170.1 18.82 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 120.562 -1.336 . . . . 0.0 111.521 176.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 44.5 ttm180 -53.36 -45.83 69.33 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.417 1.087 . . . . 0.0 111.257 178.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.0 -26.66 49.59 Favored 'General case' 0 CA--C 1.551 0.993 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 176.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -93.99 -38.34 11.22 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.991 1.316 . . . . 0.0 112.268 179.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 51.2 t -86.2 -11.15 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 125.07 1.348 . . . . 0.0 112.297 -177.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 20.0 mmt -65.28 135.44 55.36 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 120.395 -1.441 . . . . 0.0 111.242 168.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.8 tm0? 70.98 8.16 6.43 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 126.298 1.839 . . . . 0.0 113.198 -177.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 37.7 mmt180 -88.88 152.17 48.28 Favored Pre-proline 0 N--CA 1.472 0.673 0 C-N-CA 124.484 1.113 . . . . 0.0 110.837 175.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -70.1 136.04 31.11 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 123.203 2.602 . . . . 0.0 109.404 171.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 30.8 p -68.07 -3.57 10.7 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 -179.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 52.6 p -61.53 -30.99 70.99 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.575 1.15 . . . . 0.0 111.665 166.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 81.8 m 50.62 38.27 18.51 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.633 1.573 . . . . 0.0 112.77 -177.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -58.2 -30.02 66.13 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.641 1.176 . . . . 0.0 112.418 -176.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -59.56 -14.51 13.48 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.04 1.336 . . . . 0.0 114.121 175.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 99.4 mt -75.38 -4.64 40.58 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.369 1.068 . . . . 0.0 113.721 171.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 13.5 p-80 -63.61 140.53 58.88 Favored 'General case' 0 CA--C 1.548 0.888 0 CA-C-N 120.194 1.361 . . . . 0.0 112.911 175.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -115.18 -164.87 14.54 Favored Glycine 0 CA--C 1.539 1.562 0 C-N-CA 125.988 1.756 . . . . 0.0 111.144 165.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -68.96 -21.72 36.88 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.952 2.435 . . . . 0.0 113.008 175.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 83.4 mtt85 -89.28 -9.56 50.16 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.483 1.113 . . . . 0.0 113.869 -178.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 56.7 m -68.91 136.73 53.05 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.756 1.222 . . . . 0.0 111.272 -173.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 21.5 mp0 -83.7 118.63 24.0 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.808 1.243 . . . . 0.0 109.475 -174.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -63.7 -37.72 88.4 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 121.639 -0.663 . . . . 0.0 112.408 -173.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -64.02 -38.05 89.64 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.414 0.686 . . . . 0.0 112.374 173.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.13 -44.25 69.29 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.308 0.958 . . . . 0.0 111.849 177.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.59 -35.47 65.84 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.145 0.578 . . . . 0.0 112.002 173.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.14 -44.99 64.46 Favored 'General case' 0 C--O 1.224 -0.243 0 C-N-CA 124.303 1.041 . . . . 0.0 112.636 172.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 15.6 mm-40 -59.91 -30.83 69.29 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 117.719 -1.134 . . . . 0.0 112.465 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 69.0 mt -59.43 -48.94 85.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 CA-C-N 120.622 1.555 . . . . 0.0 110.773 169.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.41 -37.24 74.43 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.838 0.855 . . . . 0.0 112.824 -178.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 77.5 mm-40 -70.92 -31.38 67.98 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.168 0.987 . . . . 0.0 111.518 175.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -59.58 -31.74 69.73 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 119.464 1.029 . . . . 0.0 112.636 177.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 56.7 mt -68.17 -15.63 63.66 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.386 1.475 . . . . 0.0 113.12 177.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 61.3 mt -83.39 -15.74 48.65 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.041 0.936 . . . . 0.0 112.446 174.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -93.32 153.18 21.25 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 125.377 1.465 . . . . 0.0 113.115 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -97.21 5.7 49.64 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.025 1.33 . . . . 0.0 113.742 177.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.61 159.72 25.86 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.82 1.648 . . . . 0.0 111.416 -179.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -61.21 141.19 57.68 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.753 1.621 . . . . 0.0 112.239 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.48 121.75 8.39 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.058 0.943 . . . . 0.0 111.514 -168.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 37.8 mtmt -106.3 137.34 44.43 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.852 1.261 . . . . 0.0 112.107 172.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 8.3 p -132.16 135.85 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 127.298 2.239 . . . . 0.0 110.136 171.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -101.99 133.74 46.31 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.399 1.48 . . . . 0.0 110.164 176.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 19.1 tt -159.99 144.71 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 124.202 1.001 . . . . 0.0 111.904 -163.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -82.21 121.64 26.89 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 120.911 -1.118 . . . . 0.0 111.872 173.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 11.2 m-30 -103.01 149.9 24.09 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.155 1.782 . . . . 0.0 111.412 172.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -106.28 136.12 46.56 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.299 1.84 . . . . 0.0 111.344 175.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 46.4 ttp180 -99.89 148.98 23.87 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 126.138 1.775 . . . . 0.0 111.3 -176.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -59.13 -22.14 60.4 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 177.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -73.58 -6.63 47.83 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.311 1.444 . . . . 0.0 113.732 174.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 95.95 -1.67 63.4 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 125.955 1.74 . . . . 0.0 113.86 -176.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -80.16 169.47 17.76 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.373 1.469 . . . . 0.0 112.823 -178.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 28.6 p -147.63 158.04 43.83 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.149 -0.969 . . . . 0.0 112.457 168.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -162.89 156.12 19.66 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.787 1.235 . . . . 0.0 111.531 -174.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -75.66 124.1 26.67 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 123.076 0.55 . . . . 0.0 110.162 168.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 12.8 t -111.61 146.51 37.27 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.708 2.003 . . . . 0.0 109.82 173.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 20.0 tp -96.33 124.95 40.51 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 125.514 1.526 . . . . 0.0 108.106 163.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 47.1 t -105.77 121.35 57.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 169.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -114.96 116.06 27.88 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.59 1.556 . . . . 0.0 109.101 173.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.1 p -89.77 125.84 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-O 121.066 0.46 . . . . 0.0 109.897 169.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 88.8 t -109.39 108.54 60.08 Favored Pre-proline 0 CA--C 1.536 0.414 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 174.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.85 126.46 10.71 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.666 2.244 . . . . 0.0 109.462 177.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 52.3 t -96.64 123.26 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 177.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 20.4 mtpt -94.03 149.88 20.84 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.554 0.692 . . . . 0.0 112.269 174.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 54.7 p30 -79.29 -173.64 3.76 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.65 1.18 . . . . 0.0 111.682 174.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -67.27 -15.55 63.76 Favored 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 114.614 1.338 . . . . 0.0 114.614 175.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -96.65 -18.1 19.93 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.812 1.245 . . . . 0.0 113.206 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 85.96 42.85 6.57 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 125.911 1.719 . . . . 0.0 113.563 -173.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -116.27 154.37 30.27 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.277 1.431 . . . . 0.0 110.145 160.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 49.5 t -80.67 125.8 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 178.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.02 -27.03 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -177.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 61.5 mtm -131.42 153.25 49.9 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.784 1.234 . . . . 0.0 112.359 170.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -111.44 137.04 49.76 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 125.303 1.441 . . . . 0.0 109.063 166.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 48.2 mt -104.4 119.09 52.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 163.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -101.23 124.7 47.34 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 173.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -116.14 124.53 50.56 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 124.331 1.053 . . . . 0.0 109.346 -176.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -102.88 143.84 31.96 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.16 1.384 . . . . 0.0 110.571 -178.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.39 128.9 11.4 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.616 0.766 . . . . 0.0 110.361 171.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.4 p -72.69 116.08 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 O-C-N 121.383 -0.823 . . . . 0.0 109.771 175.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.2 p -94.24 -27.6 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 124.767 1.227 . . . . 0.0 112.759 -175.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 25.4 ptp -162.3 147.02 12.39 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.411 1.085 . . . . 0.0 112.618 166.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -89.99 131.49 35.86 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.794 0.838 . . . . 0.0 110.311 178.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.253 1.258 0 N-CA-C 115.492 1.664 . . . . 0.0 115.492 -175.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 pmm? . . . . . 0 N--CA 1.497 1.879 0 CA-C-O 118.778 -0.63 . . . . 0.0 111.511 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -78.7 91.64 1.19 Allowed 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 123.324 2.683 . . . . 0.0 111.064 -177.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 35.3 m -141.13 152.64 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 124.931 1.292 . . . . 0.0 111.778 177.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 76.7 mtp85 -62.7 136.3 57.8 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.796 1.239 . . . . 0.0 111.857 177.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 33.6 ptt-85 -170.37 152.27 3.99 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 126.518 1.927 . . . . 0.0 111.903 -176.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.87 117.22 5.8 Favored Glycine 0 N--CA 1.472 1.096 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 168.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 22.9 t-80 -63.24 -45.56 91.02 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 117.978 0.889 . . . . 0.0 113.11 -170.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.3 p -167.23 141.59 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 125.007 1.323 . . . . 0.0 111.122 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -85.57 145.27 41.62 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 123.751 0.82 . . . . 0.0 110.46 167.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -67.26 158.31 57.59 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.771 2.314 . . . . 0.0 111.656 -179.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -151.22 158.74 44.3 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.717 1.207 . . . . 0.0 111.753 -173.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -80.82 59.7 3.8 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.994 1.718 . . . . 0.0 113.853 -171.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 42.2 p -49.82 -36.46 26.64 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 127.231 2.212 . . . . 0.0 113.969 -176.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -65.79 -50.01 66.23 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.671 0.788 . . . . 0.0 111.838 176.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 61.9 tp -64.9 -36.05 83.1 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.58 1.152 . . . . 0.0 111.299 176.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -59.96 -30.55 69.17 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.75 0.82 . . . . 0.0 112.638 177.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 44.4 m -71.6 -24.12 61.84 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.803 1.241 . . . . 0.0 111.48 173.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 11.1 mm -83.93 -43.97 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.216 1.007 . . . . 0.0 110.434 173.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 97.5 mt -54.31 -47.35 69.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.669 0.787 . . . . 0.0 110.531 177.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 32.9 ptt180 -69.7 -12.22 61.46 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -178.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -83.19 -34.43 25.95 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.441 1.096 . . . . 0.0 112.045 170.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -78.58 -33.77 47.4 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.257 1.023 . . . . 0.0 112.321 173.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -72.32 141.39 48.83 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.428 0.691 . . . . 0.0 111.94 173.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -99.54 -6.72 54.73 Favored Glycine 0 N--CA 1.476 1.317 0 C-N-CA 124.728 1.156 . . . . 0.0 114.114 172.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -89.77 63.28 6.06 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.174 1.39 . . . . 0.0 110.641 -172.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.6 t -77.02 40.98 0.27 Allowed 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 125.27 1.428 . . . . 0.0 112.858 178.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 12.0 mpt_? -91.62 -163.85 1.1 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 128.596 2.759 . . . . 0.0 110.363 177.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.0 mptt -86.2 132.65 33.96 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.102 1.361 . . . . 0.0 110.099 -178.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -163.14 164.24 25.38 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.258 1.023 . . . . 0.0 113.689 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 30.3 pt -144.37 154.53 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 126.736 2.014 . . . . 0.0 110.508 177.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 14.8 mt -120.0 130.71 73.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 125.907 1.683 . . . . 0.0 109.394 -178.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -130.49 145.26 51.82 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 124.485 1.114 . . . . 0.0 111.437 176.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -70.58 125.53 27.07 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 122.043 -0.41 . . . . 0.0 111.159 176.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.58 -29.82 66.35 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -177.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 56.3 mtm180 -80.03 36.66 0.35 Allowed 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.64 1.576 . . . . 0.0 112.86 -172.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 60.5 t -145.62 135.51 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 126.839 2.056 . . . . 0.0 108.87 -169.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -59.13 -45.08 91.87 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.14 0.976 . . . . 0.0 112.726 -174.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -82.79 -12.72 57.26 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 90.9 m 48.65 62.96 2.3 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.375 1.47 . . . . 0.0 111.283 -167.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.81 136.26 55.18 Favored 'General case' 0 CA--C 1.547 0.843 0 O-C-N 121.514 -0.741 . . . . 0.0 111.869 -177.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.2 t -64.23 126.43 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 122.996 0.518 . . . . 0.0 109.873 176.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.1 pt -104.35 -23.16 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.586 1.154 . . . . 0.0 112.49 174.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -147.41 140.65 25.25 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.534 0.733 . . . . 0.0 111.349 178.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.472 ' HB3' ' CE1' ' A' ' 48' ' ' PHE . 2.0 m -131.59 147.62 52.54 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.097 0.959 . . . . 0.0 111.558 -177.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -78.33 -173.24 3.19 Favored 'General case' 0 CA--C 1.554 1.118 0 CA-C-N 119.255 0.934 . . . . 0.0 111.752 172.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -98.71 -22.72 15.75 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.027 1.331 . . . . 0.0 112.353 171.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -73.37 -39.53 50.9 Favored Glycine 0 C--N 1.342 0.873 0 O-C-N 121.815 -0.553 . . . . 0.0 112.455 -177.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.472 ' CE1' ' HB3' ' A' ' 44' ' ' CYS . 0.4 OUTLIER -66.07 -32.32 73.72 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.256 0.623 . . . . 0.0 111.854 -179.345 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 91.2 m -51.29 -55.31 18.93 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.252 1.421 . . . . 0.0 111.587 174.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -71.75 -22.33 61.62 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.876 0.871 . . . . 0.0 113.032 -179.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.16 -52.68 62.87 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.11 1.364 . . . . 0.0 110.873 178.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 76.8 m -98.68 -21.2 16.55 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.51 2.23 58.84 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 125.035 1.302 . . . . 0.0 114.355 179.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -85.81 -152.43 0.16 Allowed 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 124.607 1.163 . . . . 0.0 112.102 171.072 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 80.8 p -157.11 168.87 26.17 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 120.478 -1.389 . . . . 0.0 111.928 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -52.07 -51.65 56.24 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 119.1 -0.476 . . . . 0.0 110.48 168.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.28 -32.45 56.29 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 119.39 0.996 . . . . 0.0 113.52 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -86.4 -39.42 16.4 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.009 0.924 . . . . 0.0 113.295 177.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 79.5 t -80.46 -12.75 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 124.674 1.189 . . . . 0.0 111.639 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 66.1 mmm -66.27 137.1 56.71 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 120.522 -1.361 . . . . 0.0 111.261 173.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 76.43 4.71 3.6 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 127.064 2.145 . . . . 0.0 113.531 -176.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 42.7 mtt180 -92.42 156.21 41.7 Favored Pre-proline 0 N--CA 1.476 0.851 0 C-N-CA 124.257 1.023 . . . . 0.0 112.412 -179.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -67.57 134.91 34.4 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.697 2.931 . . . . 0.0 110.585 170.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 5.1 t -66.97 -18.6 65.46 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -173.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 39.7 p -56.2 -30.05 61.76 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.304 1.442 . . . . 0.0 112.458 172.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 79.1 m 54.05 36.94 25.85 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.25 1.42 . . . . 0.0 112.357 -176.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -57.1 -30.64 64.53 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.85 1.26 . . . . 0.0 112.462 -176.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -58.8 -15.31 11.72 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.912 1.285 . . . . 0.0 114.193 175.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.2 mt -75.21 -6.2 48.46 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.579 1.152 . . . . 0.0 113.694 172.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -65.83 147.81 52.78 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 119.988 1.267 . . . . 0.0 112.492 173.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -125.97 -155.31 8.93 Favored Glycine 0 CA--C 1.537 1.447 0 C-N-CA 125.7 1.619 . . . . 0.0 111.071 165.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.25 -26.91 17.12 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 123.116 2.544 . . . . 0.0 113.712 179.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 53.7 ttm-85 -87.4 -15.35 38.04 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 119.327 0.967 . . . . 0.0 113.1 -177.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 19.8 m -65.07 134.66 54.3 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.311 1.444 . . . . 0.0 110.926 -176.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -87.31 125.61 34.34 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -176.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 18.5 tpp85 -60.36 -35.24 75.22 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.206 1.003 . . . . 0.0 112.447 -178.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 24.6 tpp180 -60.23 -46.44 89.76 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.368 1.067 . . . . 0.0 111.715 174.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -69.46 -42.6 74.68 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 121.043 -1.036 . . . . 0.0 111.981 176.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.13 -35.03 64.25 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 173.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -74.67 -44.84 48.25 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.331 1.452 . . . . 0.0 112.999 173.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -59.16 -34.69 72.39 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 118.868 0.758 . . . . 0.0 111.538 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 86.6 mt -62.19 -37.44 78.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 CA-C-N 119.969 1.259 . . . . 0.0 112.198 172.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.8 -39.88 69.58 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 119.1 0.863 . . . . 0.0 112.143 174.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -64.88 -32.43 74.13 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.598 0.759 . . . . 0.0 111.867 175.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.47 -23.15 65.68 Favored 'General case' 0 CA--C 1.548 0.88 0 O-C-N 121.367 -0.833 . . . . 0.0 112.903 176.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 27.9 mt -85.94 -14.29 45.15 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.112 1.365 . . . . 0.0 113.258 174.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 80.8 mt -88.92 -17.59 29.24 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.139 0.976 . . . . 0.0 111.822 171.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -83.85 152.0 28.17 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 125.3 1.428 . . . . 0.0 112.696 175.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -99.51 11.69 38.46 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.905 1.282 . . . . 0.0 113.857 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -137.71 163.67 30.73 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.963 1.705 . . . . 0.0 111.834 -175.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.97 137.87 57.98 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.282 1.033 . . . . 0.0 111.767 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.69 124.97 10.85 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.297 1.039 . . . . 0.0 111.239 -175.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 43.3 mtmt -100.85 140.78 34.66 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.206 1.402 . . . . 0.0 112.271 171.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 46.2 t -136.44 136.56 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 126.094 1.758 . . . . 0.0 108.526 175.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -102.86 128.78 49.5 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.983 0.913 . . . . 0.0 110.647 178.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.2 tt -151.81 149.28 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.21 1.004 . . . . 0.0 112.207 -168.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -84.29 116.74 23.15 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 120.899 -1.125 . . . . 0.0 111.496 173.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 9.7 m-30 -103.08 140.9 36.71 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.419 1.488 . . . . 0.0 111.055 174.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -105.1 133.12 50.41 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.454 1.502 . . . . 0.0 111.813 178.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 73.9 mtp85 -77.37 163.16 26.67 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.667 1.587 . . . . 0.0 112.267 175.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -65.21 -23.65 67.14 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.722 1.209 . . . . 0.0 113.336 173.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -77.72 -7.7 56.9 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.841 1.257 . . . . 0.0 113.598 174.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 94.11 -1.83 68.05 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 125.425 1.488 . . . . 0.0 114.574 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 48.7 m -80.09 167.77 19.99 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 118.335 1.067 . . . . 0.0 111.756 175.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 20.5 p -148.35 170.33 18.19 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 120.886 -1.134 . . . . 0.0 113.399 176.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -170.21 166.52 8.86 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 126.258 1.823 . . . . 0.0 111.255 -178.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -79.35 123.0 27.07 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.16 0.505 . . . . 0.0 111.103 170.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 6.0 m -106.84 136.46 46.63 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.051 1.74 . . . . 0.0 110.1 168.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 19.0 tp -86.47 123.18 31.4 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 125.033 1.333 . . . . 0.0 107.602 162.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 91.6 t -103.61 117.94 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 169.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -112.16 107.11 15.89 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 126.462 1.905 . . . . 0.0 108.54 177.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 69.7 t -80.67 125.65 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 172.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 45.0 t -109.06 110.62 60.72 Favored Pre-proline 0 C--N 1.328 -0.359 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 169.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.41 132.79 16.68 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.559 2.172 . . . . 0.0 109.546 176.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 73.1 t -99.91 120.75 49.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 172.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 68.9 mttt -92.94 154.99 17.85 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.651 0.78 . . . . 0.0 112.698 171.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -93.66 -173.64 3.23 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.105 0.962 . . . . 0.0 111.641 174.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -61.04 -22.01 64.16 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.015 1.326 . . . . 0.0 114.152 178.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -90.3 -5.4 56.32 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.783 1.233 . . . . 0.0 113.043 178.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 79.32 20.62 69.06 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 124.455 1.026 . . . . 0.0 114.388 -178.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -99.63 146.21 26.72 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.94 1.296 . . . . 0.0 109.621 173.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 61.5 t -76.79 125.34 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 177.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 3.0 pt -121.28 -21.79 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 C-N-CA 124.905 1.282 . . . . 0.0 113.981 -172.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 44.7 mtm -145.52 151.35 38.01 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.72 1.608 . . . . 0.0 110.478 177.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -114.33 129.61 56.65 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 124.595 1.158 . . . . 0.0 109.084 169.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 33.5 mt -99.09 117.45 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 165.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -94.91 117.4 30.07 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 174.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -104.32 127.09 51.91 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 123.259 0.349 . . . . 0.0 111.476 176.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 13.7 m-30 -102.93 134.65 46.0 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.372 1.469 . . . . 0.0 111.146 -179.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -141.83 112.33 7.1 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.71 1.204 . . . . 0.0 109.092 176.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.7 p -64.46 112.7 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 O-C-N 121.186 -0.946 . . . . 0.0 109.399 173.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.0 p -98.83 -26.61 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.511 1.524 . . . . 0.0 112.954 -167.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 24.3 ptp -161.14 154.26 21.3 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.879 1.272 . . . . 0.0 111.241 166.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -77.12 156.48 31.63 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 122.126 0.965 . . . . 0.0 111.713 175.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.419 ' HA ' ' HE3' ' A' ' 135' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.288 0 C-N-CA 125.743 1.617 . . . . 0.0 112.822 161.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.496 1.869 0 CA-C-O 118.874 -0.584 . . . . 0.0 110.992 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -73.67 173.57 13.69 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 123.829 3.019 . . . . 0.0 111.748 173.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 8.5 p -152.39 128.33 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 123.751 0.82 . . . . 0.0 111.252 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 7.3 ppt_? -85.96 -23.29 26.97 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 114.252 1.204 . . . . 0.0 114.252 -175.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 81.8 mtp180 -74.37 142.83 45.04 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.633 1.173 . . . . 0.0 111.595 -178.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -164.9 159.8 32.93 Favored Glycine 0 N--CA 1.47 0.96 0 C-N-CA 124.753 1.168 . . . . 0.0 113.5 178.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 65.4 t60 -160.03 147.99 16.81 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.627 1.571 . . . . 0.0 110.6 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.9 p -165.14 146.09 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 125.557 1.543 . . . . 0.0 110.157 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.25 147.37 98.63 Favored Pre-proline 0 CA--C 1.553 1.082 0 C-N-CA 123.405 0.682 . . . . 0.0 111.646 174.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -67.12 128.88 19.37 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.025 2.484 . . . . 0.0 110.58 -178.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 27.2 mp0 -81.45 155.75 25.7 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.286 1.034 . . . . 0.0 111.742 -176.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -79.77 47.75 0.88 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.292 1.437 . . . . 0.0 113.509 179.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 46.6 p -50.15 -35.76 27.36 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 127.882 2.473 . . . . 0.0 114.398 -171.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -64.49 -50.73 66.3 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.517 0.727 . . . . 0.0 111.491 176.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 60.8 tp -65.59 -37.97 88.16 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.56 1.144 . . . . 0.0 111.312 175.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -61.34 -29.03 69.64 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.153 0.981 . . . . 0.0 112.409 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 29.3 m -71.25 -25.65 62.56 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.823 1.249 . . . . 0.0 111.455 173.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.8 mm -82.38 -43.14 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.932 0.893 . . . . 0.0 110.252 173.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 97.0 mt -56.22 -44.25 78.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 123.628 0.771 . . . . 0.0 110.804 177.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 49.9 ptt85 -70.73 -19.64 62.72 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -78.47 -36.88 44.64 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.036 0.934 . . . . 0.0 111.766 169.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -79.53 -37.32 36.83 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.731 1.212 . . . . 0.0 112.525 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -87.11 158.23 19.22 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -171.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -94.72 13.74 66.62 Favored Glycine 0 N--CA 1.477 1.408 0 C-N-CA 125.554 1.549 . . . . 0.0 114.637 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 56.8 mm-40 -83.49 55.02 3.03 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.447 1.499 . . . . 0.0 111.441 -175.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.1 m -70.69 -3.69 19.82 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.041 1.336 . . . . 0.0 114.189 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -79.59 170.12 17.02 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.226 1.411 . . . . 0.0 111.705 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.5 mptt -90.99 137.22 32.53 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.388 1.075 . . . . 0.0 111.133 -174.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -165.16 162.59 20.15 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.01 1.324 . . . . 0.0 113.329 175.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 14.7 pt -142.18 152.4 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 126.295 1.838 . . . . 0.0 110.662 174.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 11.8 mt -108.61 130.46 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 125.973 1.709 . . . . 0.0 108.977 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -129.0 142.27 50.97 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 124.98 1.312 . . . . 0.0 110.975 177.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -70.36 125.7 27.54 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.75 -0.593 . . . . 0.0 111.087 177.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.39 -31.86 64.13 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.545 0.738 . . . . 0.0 112.355 -178.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 27.7 mmm180 -80.46 37.29 0.39 Allowed 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.922 1.689 . . . . 0.0 112.682 -174.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 98.4 t -143.93 134.78 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 126.911 2.084 . . . . 0.0 108.719 -172.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -56.13 -35.11 66.74 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 115.324 1.602 . . . . 0.0 115.324 -170.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -105.77 -2.33 23.32 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.287 1.435 . . . . 0.0 113.091 -178.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 89.6 m 50.43 68.78 0.71 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 126.074 1.75 . . . . 0.0 112.303 -174.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.22 137.94 57.33 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.04 0.936 . . . . 0.0 112.111 -178.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 37.1 t -65.21 123.75 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 123.587 0.755 . . . . 0.0 109.354 174.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 44.8 pt -103.92 -19.59 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 125.125 1.37 . . . . 0.0 112.52 176.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -156.42 145.64 20.53 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.233 1.013 . . . . 0.0 111.658 178.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 4.7 m -125.7 158.53 34.59 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.359 1.064 . . . . 0.0 112.341 176.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -74.87 -152.37 0.03 OUTLIER 'General case' 0 CA--C 1.559 1.306 0 CA-C-N 118.524 0.602 . . . . 0.0 111.167 166.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -115.05 -21.55 9.97 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.325 1.45 . . . . 0.0 113.215 165.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -74.85 -35.21 51.14 Favored Glycine 0 N--CA 1.471 1.012 0 C-N-CA 124.12 0.867 . . . . 0.0 112.813 -178.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -58.03 -37.31 74.12 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 124.837 1.255 . . . . 0.0 111.861 177.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 38.4 t -58.91 -52.0 67.61 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.405 1.482 . . . . 0.0 111.499 174.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -70.68 -25.97 63.22 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -179.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 38.6 tp -62.87 -40.54 97.83 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.376 1.07 . . . . 0.0 111.973 172.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 50.2 m -106.73 -32.08 8.14 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 115.054 1.502 . . . . 0.0 115.054 -168.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.61 9.51 66.46 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 125.932 1.729 . . . . 0.0 114.437 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -86.17 -144.85 0.11 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 124.609 1.164 . . . . 0.0 111.591 170.17 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 13.3 t -163.6 167.06 21.75 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.986 1.314 . . . . 0.0 111.065 169.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -54.65 -44.24 73.07 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.582 0.753 . . . . 0.0 110.801 176.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.23 -28.03 50.33 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 176.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -91.18 -39.18 12.26 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.982 1.313 . . . . 0.0 111.83 177.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 99.5 t -80.27 -17.6 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 125.671 1.588 . . . . 0.0 112.295 -177.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 80.9 mtp -61.55 133.13 55.32 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 120.85 -1.156 . . . . 0.0 111.309 170.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 23.7 tp60 74.05 3.67 4.45 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 127.08 2.152 . . . . 0.0 113.731 -178.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 33.2 mmt180 -84.55 151.46 58.82 Favored Pre-proline 0 N--CA 1.473 0.686 0 O-C-N 121.016 -1.052 . . . . 0.0 110.934 178.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.83 132.98 24.34 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.526 2.151 . . . . 0.0 109.598 169.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 32.0 p -66.76 -7.55 22.02 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 -176.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 41.3 p -59.7 -27.1 66.15 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.353 1.461 . . . . 0.0 112.536 168.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 67.5 m 57.23 40.56 27.88 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.022 1.329 . . . . 0.0 112.707 178.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -56.51 -29.77 62.22 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.361 1.464 . . . . 0.0 113.006 -175.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 29.2 p90 -62.26 -16.8 55.99 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.806 1.242 . . . . 0.0 114.107 175.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 87.8 mt -79.08 -10.42 59.82 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 174.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 47.2 m170 -69.44 118.78 12.74 Favored 'General case' 0 CA--C 1.546 0.827 0 CA-C-N 119.597 1.09 . . . . 0.0 111.402 -177.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -100.98 -163.14 27.75 Favored Glycine 0 CA--C 1.539 1.556 0 C-N-CA 126.166 1.841 . . . . 0.0 112.129 173.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -70.58 -28.41 21.34 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 123.153 2.569 . . . . 0.0 113.149 -179.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 30.4 tpt180 -84.61 -17.35 38.98 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 50.6 m -60.43 132.55 54.25 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.95 1.3 . . . . 0.0 111.876 -170.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 22.9 mp0 -85.26 111.59 19.99 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.546 1.138 . . . . 0.0 110.404 -171.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 -58.24 -33.86 69.81 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.59 0.756 . . . . 0.0 112.463 177.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 21.5 tpp180 -62.03 -39.91 93.93 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.591 1.157 . . . . 0.0 112.244 175.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -77.01 -41.46 42.64 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.526 1.13 . . . . 0.0 112.31 176.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -53.15 -33.36 52.12 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 118.842 0.747 . . . . 0.0 112.797 175.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.01 -41.3 82.4 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 124.969 1.308 . . . . 0.0 112.712 172.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 80.3 mm-40 -64.38 -32.6 74.28 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 118.507 -0.758 . . . . 0.0 111.48 178.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 45.9 mt -59.33 -41.35 83.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 CA-C-N 119.56 1.073 . . . . 0.0 110.586 170.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.16 -35.08 68.93 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 176.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 71.6 mm-40 -64.66 -35.58 81.49 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.439 -0.788 . . . . 0.0 111.446 172.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.15 -21.35 63.69 Favored 'General case' 0 CA--C 1.549 0.922 0 O-C-N 121.383 -0.823 . . . . 0.0 113.189 178.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 57.6 mt -87.9 -11.14 48.55 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 125.925 1.69 . . . . 0.0 114.009 178.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.7 pp -103.94 -2.73 25.7 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 170.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -90.3 144.22 17.38 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 125.039 1.305 . . . . 0.0 112.564 175.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.9 -2.12 58.12 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.7 1.2 . . . . 0.0 113.931 176.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -124.09 159.27 30.34 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.035 1.734 . . . . 0.0 110.739 -174.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 46.4 mp0 -57.28 135.88 56.49 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.522 1.129 . . . . 0.0 111.708 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.58 121.23 11.83 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.229 1.011 . . . . 0.0 110.322 -173.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt -105.05 142.81 34.17 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.358 1.463 . . . . 0.0 111.7 178.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 61.8 t -138.29 131.74 41.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 125.858 1.663 . . . . 0.0 108.91 -177.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -103.88 129.76 51.41 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.682 0.793 . . . . 0.0 110.811 177.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.3 tt -159.78 142.75 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 123.553 0.741 . . . . 0.0 112.149 -166.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -86.38 121.73 29.35 Favored 'General case' 0 N--CA 1.465 0.303 0 O-C-N 121.405 -0.809 . . . . 0.0 110.83 174.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -109.63 154.89 22.16 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.63 1.172 . . . . 0.0 111.844 172.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -113.79 130.85 56.4 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.796 1.638 . . . . 0.0 110.52 175.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 14.8 mmt180 -106.42 166.17 10.73 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.438 1.495 . . . . 0.0 112.811 -168.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -61.14 -26.41 67.66 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.153 0.981 . . . . 0.0 113.59 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -69.77 -9.66 55.39 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.162 1.385 . . . . 0.0 113.813 178.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 87.67 0.85 83.66 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 124.999 1.285 . . . . 0.0 113.241 -171.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 18.4 m -85.95 154.15 21.68 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.159 1.383 . . . . 0.0 111.855 179.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 31.1 p -133.04 153.8 51.14 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.778 0.831 . . . . 0.0 111.513 166.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 19.3 p90 -167.82 157.6 10.18 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 125.053 1.341 . . . . 0.0 112.814 -177.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -75.81 119.49 19.88 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.514 1.126 . . . . 0.0 110.514 176.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 26.8 t -103.74 144.86 30.91 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 125.607 1.563 . . . . 0.0 110.462 172.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 8.7 tp -98.4 112.95 24.79 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 162.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 46.6 t -92.64 115.56 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 124.794 1.238 . . . . 0.0 107.812 171.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -112.98 109.53 19.0 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 124.758 1.223 . . . . 0.0 107.777 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 79.4 t -82.36 128.95 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 172.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 55.2 t -111.37 112.38 54.62 Favored Pre-proline 0 CA--C 1.536 0.41 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 171.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -74.36 129.24 12.75 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 123.246 2.631 . . . . 0.0 109.88 178.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 80.2 t -102.13 118.66 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 123.9 0.88 . . . . 0.0 108.887 176.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 60.7 mttt -87.84 152.71 21.89 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.583 0.753 . . . . 0.0 112.397 172.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -91.17 -173.76 3.74 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.25 1.02 . . . . 0.0 111.519 175.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -60.31 -21.8 62.44 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.999 1.319 . . . . 0.0 114.394 178.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -90.84 -5.51 55.49 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.14 1.376 . . . . 0.0 113.023 178.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 80.58 22.2 62.65 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 124.403 1.001 . . . . 0.0 114.522 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -107.92 148.6 29.41 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.18 1.392 . . . . 0.0 109.904 172.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.1 p -80.15 126.27 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 123.654 0.782 . . . . 0.0 110.704 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.7 -23.28 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -174.074 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 55.4 mtm -130.25 150.9 51.29 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.028 1.331 . . . . 0.0 112.038 169.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -110.51 134.46 52.35 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 125.41 1.484 . . . . 0.0 109.189 167.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 72.6 mt -98.1 116.98 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 163.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -89.56 118.52 29.25 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 105.685 -1.968 . . . . 0.0 105.685 169.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -103.91 143.45 32.83 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 119.219 -0.42 . . . . 0.0 110.763 173.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -119.6 135.37 54.83 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.594 1.158 . . . . 0.0 110.434 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -138.41 150.49 46.57 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 125.541 1.536 . . . . 0.0 108.29 173.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.2 t -94.23 112.72 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.7 p -91.88 -25.75 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -177.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 32.0 ttm -165.44 124.93 1.75 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.589 1.156 . . . . 0.0 110.813 -175.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -84.33 128.11 34.38 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.584 -0.697 . . . . 0.0 110.481 175.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.446 ' HA ' ' HE2' ' A' ' 135' ' ' LYS . 7.8 mmpt? . . . . . 0 C--O 1.252 1.231 0 CA-C-O 117.644 -1.17 . . . . 0.0 113.11 174.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 N--CA 1.495 1.82 0 CA-C-O 118.748 -0.644 . . . . 0.0 110.823 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -72.76 159.48 48.38 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 123.717 2.945 . . . . 0.0 111.867 177.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 40.2 t -138.18 134.95 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 124.923 1.289 . . . . 0.0 109.462 179.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.73 36.33 1.54 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.502 1.521 . . . . 0.0 113.419 -175.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 -118.51 155.0 31.6 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 126.354 1.862 . . . . 0.0 111.115 178.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -87.96 98.02 2.36 Favored Glycine 0 N--CA 1.473 1.104 0 C-N-CA 124.731 1.158 . . . . 0.0 112.464 -176.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 32.6 p80 -167.07 167.43 14.51 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 126.52 1.928 . . . . 0.0 110.839 175.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 86.9 t -73.67 142.23 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 123.39 0.676 . . . . 0.0 109.785 171.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -154.66 159.88 31.45 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 126.405 1.882 . . . . 0.0 109.947 178.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -67.91 106.21 1.28 Allowed 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.779 2.319 . . . . 0.0 109.787 174.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -80.13 166.91 21.01 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.689 1.196 . . . . 0.0 111.608 178.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -68.85 147.22 52.04 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 121.611 -0.68 . . . . 0.0 111.309 172.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 40.5 p -116.24 -38.89 3.49 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.772 1.629 . . . . 0.0 112.818 -174.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -79.94 -47.29 15.25 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.979 0.912 . . . . 0.0 112.076 177.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 69.3 tp -61.02 -35.15 76.11 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.522 0.729 . . . . 0.0 110.968 177.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -55.18 -28.8 55.55 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 176.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 36.5 m -70.69 -27.61 64.14 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.623 1.169 . . . . 0.0 111.484 174.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 15.4 mm -79.44 -34.77 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 124.265 1.026 . . . . 0.0 109.801 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.9 mp -53.88 -40.22 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 123.265 0.626 . . . . 0.0 110.735 170.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 24.2 mmm-85 -63.46 -29.75 70.98 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 119.058 0.845 . . . . 0.0 112.627 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -73.91 -39.01 64.15 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.353 1.061 . . . . 0.0 111.438 174.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -76.71 -21.88 54.69 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.67 1.188 . . . . 0.0 113.189 178.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -62.18 -15.41 46.15 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 168.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -76.07 43.42 1.72 Allowed Glycine 0 CA--C 1.532 1.113 0 C-N-CA 126.531 2.015 . . . . 0.0 112.969 174.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.4 tp-100 78.89 13.98 1.22 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 127.484 2.313 . . . . 0.0 113.196 171.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 8.6 m -80.99 -5.72 57.91 Favored 'General case' 0 N--CA 1.476 0.868 0 O-C-N 120.384 -1.447 . . . . 0.0 113.758 -173.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 9.3 mmt180 -81.2 171.44 14.87 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.519 1.128 . . . . 0.0 113.148 -175.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -107.66 133.37 52.19 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.861 1.264 . . . . 0.0 110.671 177.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -161.48 158.72 27.0 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 124.333 1.053 . . . . 0.0 112.908 177.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.5 pt -140.46 149.19 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 125.58 1.552 . . . . 0.0 110.767 176.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.1 mp -109.45 127.63 66.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 C-N-CA 125.914 1.685 . . . . 0.0 108.86 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -126.23 140.22 52.72 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 124.827 1.251 . . . . 0.0 111.23 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -71.43 121.79 19.23 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 122.729 0.412 . . . . 0.0 110.818 177.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.94 -28.64 61.61 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.335 0.654 . . . . 0.0 112.461 -178.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 -77.9 37.83 0.25 Allowed 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 126.084 1.753 . . . . 0.0 112.675 -178.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 98.0 t -145.19 136.55 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 127.042 2.137 . . . . 0.0 108.572 -172.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -54.84 -34.42 62.84 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 115.554 1.687 . . . . 0.0 115.554 -170.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -107.49 -0.15 22.37 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.241 1.416 . . . . 0.0 113.136 -178.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 99.4 m 53.83 71.67 0.49 Allowed 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.988 1.715 . . . . 0.0 111.984 -171.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.85 131.07 44.53 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.017 0.927 . . . . 0.0 112.168 -176.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 41.3 t -64.47 123.29 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 123.86 0.864 . . . . 0.0 109.254 172.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 38.3 pt -104.95 -19.04 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 124.869 1.268 . . . . 0.0 112.362 178.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -158.91 141.28 14.01 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.67 1.188 . . . . 0.0 111.145 -178.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 4.0 m -122.63 166.41 14.9 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 121.224 -0.922 . . . . 0.0 112.397 172.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -74.74 -151.64 0.03 OUTLIER 'General case' 0 CA--C 1.557 1.237 0 C-N-CA 122.51 0.324 . . . . 0.0 111.613 169.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -113.56 -22.5 10.27 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 120.472 -1.392 . . . . 0.0 113.2 163.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -74.44 -33.88 55.41 Favored Glycine 0 N--CA 1.47 0.941 0 O-C-N 121.355 -0.841 . . . . 0.0 112.876 -177.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -57.35 -37.84 73.21 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.673 1.189 . . . . 0.0 111.624 176.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 10.2 t -60.85 -53.05 62.11 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.354 1.462 . . . . 0.0 111.61 175.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -71.01 -25.21 62.58 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -178.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 31.8 tp -62.02 -45.23 94.52 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.609 1.164 . . . . 0.0 111.648 170.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 64.2 m -104.65 -32.55 8.86 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 -166.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.05 4.54 63.03 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 126.017 1.77 . . . . 0.0 114.541 -179.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -83.79 -156.22 0.21 Allowed 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 124.814 1.246 . . . . 0.0 112.185 170.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 9.5 t -152.17 168.77 24.26 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 120.286 -1.509 . . . . 0.0 111.135 170.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.1 ttp180 -58.63 -45.5 89.1 Favored 'General case' 0 C--O 1.22 -0.472 0 O-C-N 121.535 -0.728 . . . . 0.0 111.812 -173.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.44 -25.72 37.97 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 175.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -88.56 -39.14 14.35 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.746 1.218 . . . . 0.0 111.645 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 84.4 t -85.67 -24.48 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 125.053 1.341 . . . . 0.0 112.376 -177.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 86.6 mtp -63.44 139.11 58.74 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 120.979 -1.076 . . . . 0.0 110.819 171.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 13.7 tm0? 75.65 -4.1 2.44 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 126.789 2.036 . . . . 0.0 113.784 -177.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 36.9 mmt180 -79.32 157.33 75.49 Favored Pre-proline 0 N--CA 1.473 0.687 0 C-N-CA 124.657 1.183 . . . . 0.0 111.088 173.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -67.22 136.23 39.76 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.398 2.065 . . . . 0.0 109.999 166.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 26.7 p -68.01 -2.2 7.22 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 -179.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 57.1 p -65.32 -29.42 70.16 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.578 1.551 . . . . 0.0 112.231 169.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 74.2 m 58.32 42.76 21.07 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.585 1.554 . . . . 0.0 112.517 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -57.73 -27.01 62.6 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.858 1.263 . . . . 0.0 113.209 -176.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -61.71 -16.21 47.14 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.546 1.138 . . . . 0.0 113.927 174.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 79.9 mt -83.73 -11.45 57.13 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.365 1.066 . . . . 0.0 113.78 172.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 40.0 m170 -73.11 115.45 12.45 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 119.823 1.192 . . . . 0.0 110.65 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -101.66 -162.63 27.03 Favored Glycine 0 CA--C 1.539 1.576 0 C-N-CA 126.157 1.836 . . . . 0.0 112.464 177.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -70.07 -25.79 26.8 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 123.133 2.555 . . . . 0.0 113.132 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.2 tpm_? -82.75 -17.51 44.01 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.883 0.873 . . . . 0.0 113.195 179.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 40.9 m -65.96 138.95 58.17 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.991 1.316 . . . . 0.0 112.384 -168.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 22.3 mp0 -84.48 117.99 24.02 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.338 1.455 . . . . 0.0 110.545 -172.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -60.25 -33.76 72.76 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -177.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 36.6 mmt180 -63.4 -53.27 55.0 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.397 0.679 . . . . 0.0 111.202 172.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.8 -36.89 84.78 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 120.491 -1.381 . . . . 0.0 113.09 -178.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -54.69 -35.49 63.66 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.848 0.859 . . . . 0.0 112.378 171.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -76.81 -45.7 27.67 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 124.555 1.142 . . . . 0.0 112.527 173.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -58.46 -36.94 74.47 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 118.809 0.732 . . . . 0.0 111.15 -176.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 89.3 mt -61.18 -40.17 84.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 CA-C-N 119.825 1.193 . . . . 0.0 111.845 173.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.43 -37.11 68.68 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.526 0.731 . . . . 0.0 112.65 176.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 54.8 mm-40 -67.82 -33.26 74.44 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.987 0.915 . . . . 0.0 111.469 174.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -57.98 -26.02 61.8 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 121.19 -0.944 . . . . 0.0 113.105 178.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 55.3 mt -78.58 -18.13 55.07 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.737 1.615 . . . . 0.0 113.545 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.1 pp -83.38 -20.69 33.75 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 119.473 1.033 . . . . 0.0 112.1 173.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -81.38 154.87 35.27 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 125.075 1.322 . . . . 0.0 112.85 176.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -95.5 1.31 53.9 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.882 1.273 . . . . 0.0 114.214 -178.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -126.91 161.12 29.04 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.179 1.792 . . . . 0.0 111.725 -169.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -62.49 141.67 58.3 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.072 1.349 . . . . 0.0 112.304 -177.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 -152.19 125.54 8.76 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.818 0.847 . . . . 0.0 112.86 -171.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 44.3 mtmt -101.24 139.02 37.49 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.204 1.402 . . . . 0.0 111.592 171.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 67.7 t -134.16 143.66 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 126.082 1.753 . . . . 0.0 108.166 170.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -114.48 136.18 53.29 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.461 1.104 . . . . 0.0 110.9 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.1 tt -161.57 146.45 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 123.561 0.744 . . . . 0.0 112.659 -163.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -84.49 122.35 28.86 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 121.02 -1.05 . . . . 0.0 111.047 172.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 14.7 m-30 -108.42 147.01 32.23 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.232 1.413 . . . . 0.0 112.091 173.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -109.18 132.45 54.11 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.138 1.775 . . . . 0.0 110.627 177.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -107.08 160.23 15.71 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.718 1.607 . . . . 0.0 112.116 -166.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -64.28 -22.93 67.12 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -177.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -76.23 -7.25 54.46 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 124.633 1.173 . . . . 0.0 113.387 175.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 94.97 0.11 64.03 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 125.725 1.631 . . . . 0.0 114.28 -178.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 59.2 m -88.63 162.16 16.49 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.575 1.15 . . . . 0.0 112.421 179.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 26.5 p -138.27 155.64 48.42 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 121.147 -0.971 . . . . 0.0 112.031 168.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -166.04 157.07 13.33 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.982 1.313 . . . . 0.0 112.796 -176.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -75.49 123.04 24.77 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.803 0.811 . . . . 0.0 110.754 177.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 9.0 t -109.93 138.55 46.15 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.312 1.845 . . . . 0.0 109.681 174.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -83.19 140.46 32.56 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 156.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 13.8 t -124.01 112.36 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 125.336 1.454 . . . . 0.0 108.625 169.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -103.36 121.87 43.66 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.978 1.311 . . . . 0.0 109.994 172.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.1 p -91.48 124.38 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 166.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 81.6 t -109.02 111.79 60.35 Favored Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 175.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.31 130.34 13.94 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.875 2.383 . . . . 0.0 109.95 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 63.7 t -101.72 124.25 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 124.096 0.959 . . . . 0.0 108.604 173.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 35.1 mttp -98.09 153.75 18.21 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 175.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -93.11 -174.58 3.6 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.166 0.986 . . . . 0.0 111.294 176.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -59.82 -21.73 61.28 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.039 1.335 . . . . 0.0 114.421 178.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -91.4 -6.04 53.48 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.115 1.366 . . . . 0.0 113.181 179.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 78.62 25.63 60.38 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 124.239 0.923 . . . . 0.0 114.142 -178.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -108.53 152.22 25.03 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.198 1.399 . . . . 0.0 109.899 172.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 10.6 t -80.56 125.77 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 123.306 0.642 . . . . 0.0 109.318 -179.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.8 -24.83 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -176.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 56.6 mtm -130.76 152.91 49.6 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.558 1.143 . . . . 0.0 112.374 167.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -113.26 134.3 54.67 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 125.721 1.608 . . . . 0.0 109.172 168.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 46.1 mt -101.76 117.9 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 165.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -100.16 128.38 46.25 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 106.895 -1.521 . . . . 0.0 106.895 173.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -123.3 130.04 52.18 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.43 1.092 . . . . 0.0 110.313 -172.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -106.38 137.7 43.89 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.889 1.276 . . . . 0.0 111.08 -174.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -142.76 133.09 24.76 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.846 1.258 . . . . 0.0 109.463 177.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 59.4 t -80.27 115.29 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 5.2 p -97.94 -28.85 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -176.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 25.4 ptp -164.13 148.87 10.15 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.367 1.067 . . . . 0.0 113.337 167.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -90.91 130.3 36.86 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.036 0.934 . . . . 0.0 110.741 178.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.255 1.344 0 CA-C-O 115.806 -2.045 . . . . 0.0 115.587 -176.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.2 mtt . . . . . 0 N--CA 1.496 1.856 0 CA-C-O 116.428 -1.749 . . . . 0.0 112.23 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -70.19 151.91 66.82 Favored 'Trans proline' 0 C--N 1.357 1.017 0 C-N-CA 122.432 2.088 . . . . 0.0 111.568 177.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 57.2 t -93.07 127.59 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 123.942 0.897 . . . . 0.0 109.774 -178.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 31.2 mmm180 -89.65 54.38 2.86 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.347 1.459 . . . . 0.0 111.7 -179.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 75.7 ttt-85 -64.21 140.56 58.88 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.459 1.503 . . . . 0.0 111.85 -177.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 145.47 163.72 10.34 Favored Glycine 0 N--CA 1.474 1.173 0 C-N-CA 125.509 1.528 . . . . 0.0 113.647 179.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 60.3 m80 -141.54 170.67 15.28 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 125.917 1.687 . . . . 0.0 111.147 -178.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.5 p -59.6 139.74 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 123.778 0.831 . . . . 0.0 112.23 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.62 153.13 95.53 Favored Pre-proline 0 CA--C 1.552 1.035 0 C-N-CA 124.063 0.945 . . . . 0.0 112.005 174.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -66.69 151.64 82.23 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.91 2.407 . . . . 0.0 111.245 176.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 72.8 mm-40 -66.45 160.27 25.29 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.839 0.856 . . . . 0.0 112.503 177.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -82.72 46.52 1.09 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.27 1.428 . . . . 0.0 113.351 -173.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 57.4 p -51.13 -33.68 27.62 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 127.419 2.287 . . . . 0.0 113.572 -174.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -64.76 -53.96 38.88 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.989 0.915 . . . . 0.0 111.783 173.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 58.8 tp -60.7 -35.96 77.6 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.612 1.165 . . . . 0.0 111.175 176.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -62.31 -26.03 68.19 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 177.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 99.2 m -75.55 -28.13 58.9 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.554 1.141 . . . . 0.0 111.245 171.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 16.1 mm -77.68 -41.76 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 O-C-N 121.417 -0.802 . . . . 0.0 110.702 174.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 90.1 mt -56.19 -48.47 79.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 123.994 0.917 . . . . 0.0 110.564 177.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 16.2 ptp180 -67.08 -23.96 65.91 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -75.94 -33.46 59.82 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 119.523 1.056 . . . . 0.0 112.615 170.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -76.45 -32.01 58.17 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.533 1.133 . . . . 0.0 111.908 175.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -63.45 129.94 42.32 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 118.602 0.637 . . . . 0.0 111.322 172.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.73 8.59 84.55 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 124.457 1.027 . . . . 0.0 115.222 177.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 25.8 tp60 -83.82 52.95 2.41 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.564 1.545 . . . . 0.0 111.952 -171.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 67.8 m -89.04 0.75 56.42 Favored 'General case' 0 N--CA 1.48 1.038 0 O-C-N 120.938 -1.101 . . . . 0.0 113.434 -179.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 6.0 mmt-85 -79.8 177.62 8.77 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.015 1.326 . . . . 0.0 113.075 -176.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.2 mptt -94.08 133.98 36.99 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.947 1.299 . . . . 0.0 110.412 178.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -163.27 161.88 24.97 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.482 1.113 . . . . 0.0 112.805 177.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.2 pt -139.74 158.61 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 126.06 1.744 . . . . 0.0 110.521 173.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 28.3 mt -118.54 132.97 66.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 125.601 1.56 . . . . 0.0 108.868 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -131.33 143.26 50.38 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.349 1.059 . . . . 0.0 111.585 176.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -72.15 123.76 23.58 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.246 0.618 . . . . 0.0 111.489 179.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -79.03 -21.16 47.31 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -178.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 63.7 mtp85 -75.97 28.28 0.11 Allowed 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 126.185 1.794 . . . . 0.0 113.367 -173.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.4 t -151.09 137.64 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 127.114 2.165 . . . . 0.0 108.426 -166.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -63.35 -39.93 95.88 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -175.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 24.9 p30 -81.68 -15.21 55.2 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 114.377 1.251 . . . . 0.0 114.377 179.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 86.2 m 51.56 56.57 7.68 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.439 1.496 . . . . 0.0 113.351 -176.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.87 138.47 55.69 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 12.7 t -60.41 125.07 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 170.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 42.4 pt -104.93 -18.59 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 124.871 1.268 . . . . 0.0 112.619 174.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -156.16 144.99 20.31 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.091 0.956 . . . . 0.0 111.855 177.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 8.1 m -123.94 154.66 39.43 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.294 1.038 . . . . 0.0 110.588 171.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -73.15 -149.16 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.288 0 CA-C-N 118.958 0.799 . . . . 0.0 111.885 172.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -115.66 -22.67 9.08 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 120.248 -1.533 . . . . 0.0 112.885 164.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -74.5 -33.84 55.32 Favored Glycine 0 C--N 1.343 0.962 0 C-N-CA 124.231 0.919 . . . . 0.0 112.791 -178.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -56.94 -38.17 72.54 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.319 1.048 . . . . 0.0 111.292 176.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 51.2 t -59.01 -51.56 69.55 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.108 1.363 . . . . 0.0 111.659 178.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -67.56 -20.28 65.38 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.925 0.89 . . . . 0.0 113.093 178.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.06 -35.56 81.53 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.622 1.169 . . . . 0.0 112.4 176.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 45.4 m -123.09 -24.1 4.79 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 115.578 1.696 . . . . 0.0 115.578 -176.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 87.9 15.46 61.19 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-N 119.77 1.168 . . . . 0.0 114.075 -177.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -85.59 -144.63 0.1 Allowed 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.699 1.199 . . . . 0.0 111.338 170.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 77.8 p -158.22 165.94 33.61 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 124.771 1.228 . . . . 0.0 111.765 174.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 44.8 ttm180 -54.83 -47.3 74.29 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 118.889 -0.577 . . . . 0.0 110.606 171.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.65 -32.58 52.04 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 119.611 1.096 . . . . 0.0 113.932 177.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -89.08 -34.53 16.73 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.942 0.897 . . . . 0.0 113.258 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 99.5 t -84.43 -14.39 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.278 1.031 . . . . 0.0 112.035 178.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 79.5 mmm -76.95 147.38 36.96 Favored 'General case' 0 N--CA 1.474 0.725 0 O-C-N 120.841 -1.162 . . . . 0.0 111.977 175.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 31.8 tp60 69.19 4.42 4.57 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 126.451 1.9 . . . . 0.0 113.433 -175.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 32.3 mmt180 -77.96 153.96 80.3 Favored Pre-proline 0 N--CA 1.47 0.561 0 C-N-CA 124.843 1.257 . . . . 0.0 109.875 174.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -73.55 11.62 1.02 Allowed 'Trans proline' 0 CA--C 1.546 1.118 0 C-N-CA 124.106 3.204 . . . . 0.0 115.205 176.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 7.8 t 77.84 -23.8 0.24 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 126.585 1.954 . . . . 0.0 114.453 163.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 37.7 p -58.05 -20.6 40.38 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 126.6 1.96 . . . . 0.0 113.376 172.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 90.6 m 60.53 28.45 18.13 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.388 1.475 . . . . 0.0 112.824 178.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -58.87 -27.72 65.45 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.635 1.174 . . . . 0.0 112.515 -177.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -59.81 -13.86 12.31 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 174.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 92.2 mt -84.02 -3.54 58.09 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.802 1.241 . . . . 0.0 113.891 172.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 9.4 p-80 -66.1 145.6 55.63 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 120.169 1.35 . . . . 0.0 113.415 178.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -128.83 -161.55 10.68 Favored Glycine 0 CA--C 1.538 1.506 0 C-N-CA 126.557 2.027 . . . . 0.0 111.225 166.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.26 -21.34 35.94 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.937 2.425 . . . . 0.0 113.194 177.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 21.6 tpt180 -89.86 -8.75 51.24 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.272 1.029 . . . . 0.0 113.491 -178.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 24.3 m -72.39 141.83 48.72 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.917 1.287 . . . . 0.0 110.579 -176.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 64.4 mm-40 -91.8 122.77 34.64 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.506 0.722 . . . . 0.0 110.04 -173.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 28.7 mmm180 -58.62 -39.36 80.26 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.803 0.841 . . . . 0.0 112.296 -178.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -64.86 -39.5 93.65 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.318 1.047 . . . . 0.0 112.081 176.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -69.2 -43.07 74.9 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.101 -1.0 . . . . 0.0 112.633 178.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -56.89 -34.92 68.36 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 122.95 0.5 . . . . 0.0 112.04 173.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -72.35 -46.75 54.05 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 124.82 1.248 . . . . 0.0 112.549 173.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -61.1 -34.86 75.61 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 118.563 -0.732 . . . . 0.0 111.565 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 87.4 mt -63.1 -38.87 83.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 CA-C-N 120.104 1.32 . . . . 0.0 111.749 171.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.92 -36.87 78.49 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 119.33 0.968 . . . . 0.0 112.296 173.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -65.84 -31.91 73.13 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 121.347 -0.846 . . . . 0.0 111.773 172.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.69 -20.59 65.83 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 119.203 0.911 . . . . 0.0 112.604 175.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 44.6 mt -88.32 -10.75 48.46 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.927 1.691 . . . . 0.0 113.374 172.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 84.5 mt -96.98 -14.64 21.55 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.529 1.132 . . . . 0.0 112.075 172.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -86.48 150.73 23.7 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 125.389 1.471 . . . . 0.0 113.162 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -100.28 8.94 43.4 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.136 1.374 . . . . 0.0 113.678 178.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -134.21 164.83 26.5 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.428 1.891 . . . . 0.0 111.476 -178.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -61.29 138.16 58.24 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.833 0.853 . . . . 0.0 111.854 -179.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 19.7 tpt180 -145.92 128.68 16.26 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.91 0.884 . . . . 0.0 112.058 -178.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 43.1 mtmt -107.34 139.86 41.16 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.76 1.624 . . . . 0.0 111.424 175.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 45.1 t -138.24 138.69 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 125.52 1.528 . . . . 0.0 109.251 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -102.92 127.76 50.0 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.221 1.008 . . . . 0.0 110.962 177.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 19.5 tt -150.71 146.32 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 124.208 1.003 . . . . 0.0 112.352 -171.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -89.9 119.05 29.94 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 121.055 -1.028 . . . . 0.0 111.578 176.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 20.0 m-30 -115.73 157.12 24.77 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.598 1.959 . . . . 0.0 111.314 175.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -114.05 151.9 31.8 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 178.237 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.54 158.79 28.45 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.493 1.517 . . . . 0.0 110.395 167.167 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -61.81 -23.78 66.44 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.235 1.014 . . . . 0.0 113.219 166.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -72.31 -9.02 57.95 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.739 1.616 . . . . 0.0 113.709 170.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 97.94 -6.4 62.17 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 126.127 1.822 . . . . 0.0 114.778 179.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 22.1 m -82.12 130.23 35.03 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 118.952 1.376 . . . . 0.0 112.627 -172.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 25.3 p -104.87 153.65 21.09 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.761 1.224 . . . . 0.0 112.46 -177.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -165.61 163.79 19.24 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 126.088 1.755 . . . . 0.0 112.672 169.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -77.87 124.88 28.54 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.37 1.068 . . . . 0.0 111.119 175.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 42.1 t -104.25 137.31 42.35 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.82 2.048 . . . . 0.0 110.128 170.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 6.8 tp -90.28 118.0 29.45 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 161.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 94.9 t -100.87 114.67 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 125.457 1.503 . . . . 0.0 107.903 173.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -115.45 108.72 16.85 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 125.606 1.562 . . . . 0.0 107.129 -175.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 17.1 t -93.52 127.37 45.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 -179.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 69.6 t -111.15 112.1 55.41 Favored Pre-proline 0 CA--C 1.535 0.374 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.88 131.6 15.92 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.64 2.227 . . . . 0.0 109.61 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 60.6 t -92.8 105.42 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 169.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 61.5 mttt -82.16 151.7 26.81 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.268 0.556 . . . . 0.0 111.202 166.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -92.96 -173.42 3.28 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.8 0.84 . . . . 0.0 111.831 174.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -60.14 -21.79 62.04 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.128 1.371 . . . . 0.0 114.693 178.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -93.73 -0.72 55.83 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.695 1.198 . . . . 0.0 113.155 177.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 77.87 20.55 73.27 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 124.301 0.953 . . . . 0.0 114.556 178.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -99.22 142.22 30.98 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.462 1.105 . . . . 0.0 109.12 171.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.7 p -76.55 118.97 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-O 122.089 0.947 . . . . 0.0 109.903 174.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.4 pt -106.91 -19.51 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 125.64 1.576 . . . . 0.0 113.29 -174.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 3.6 mtp -157.36 156.33 32.12 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 126.561 1.944 . . . . 0.0 110.512 -174.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -122.56 133.51 54.56 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 125.086 1.355 . . . . 0.0 109.563 175.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 56.8 mt -102.59 114.81 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 166.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 7.4 mp -98.57 119.77 37.85 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 177.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -110.82 135.81 50.82 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 123.354 0.409 . . . . 0.0 111.47 -178.144 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -111.86 138.37 48.55 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.12 1.368 . . . . 0.0 111.433 -175.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -144.03 136.34 26.68 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.42 1.488 . . . . 0.0 109.908 175.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 42.5 t -76.15 114.58 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 176.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.0 p -98.61 -25.61 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -173.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 44.4 tpp -165.2 128.21 2.23 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.154 0.981 . . . . 0.0 111.725 179.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -84.39 127.9 34.27 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.631 0.772 . . . . 0.0 111.386 -179.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.469 ' HA ' ' HE2' ' A' ' 135' ' ' LYS . 11.1 mmpt? . . . . . 0 C--O 1.254 1.299 0 C-N-CA 124.789 1.236 . . . . 0.0 113.103 174.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.1 ttm . . . . . 0 N--CA 1.496 1.857 0 CA-C-O 118.356 -0.83 . . . . 0.0 110.704 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -83.25 -26.08 2.4 Favored 'Trans proline' 0 C--N 1.357 1.011 0 C-N-CA 123.334 2.689 . . . . 0.0 114.535 -175.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.4 t 68.14 54.37 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 125.449 1.5 . . . . 0.0 110.53 177.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -126.22 49.45 1.99 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 126.198 1.799 . . . . 0.0 110.478 -177.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 38.9 mmt180 -67.02 161.94 23.23 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.784 1.633 . . . . 0.0 112.872 -174.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 106.11 145.05 12.59 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 125.895 1.712 . . . . 0.0 112.737 178.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -80.53 58.04 3.07 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 125.231 1.412 . . . . 0.0 111.761 -176.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 36.9 t 79.9 118.2 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 129.106 2.962 . . . . 0.0 109.577 -171.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.23 153.2 94.34 Favored Pre-proline 0 CA--C 1.55 0.968 0 C-N-CA 124.09 0.956 . . . . 0.0 112.266 -178.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -72.8 -8.62 22.66 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 123.369 2.713 . . . . 0.0 114.13 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 68.15 0.89 2.6 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 127.001 2.12 . . . . 0.0 114.674 171.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 36.82 53.53 1.1 Allowed 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 131.398 3.879 . . . . 0.0 113.271 176.228 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 39.7 p -46.19 -38.09 7.89 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 127.758 2.423 . . . . 0.0 114.086 -169.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -62.14 -49.9 74.01 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.058 0.943 . . . . 0.0 111.954 175.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 58.2 tp -69.64 -39.93 76.83 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.343 1.457 . . . . 0.0 111.593 174.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -60.15 -28.41 67.87 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 176.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 95.1 m -69.03 -29.82 68.05 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.294 1.038 . . . . 0.0 110.739 173.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.8 mm -78.13 -41.92 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 123.683 0.793 . . . . 0.0 110.047 174.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 96.5 mt -56.9 -46.53 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 123.437 0.695 . . . . 0.0 110.661 176.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -70.66 -21.39 62.61 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.2 mtpt -78.57 -34.85 46.62 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.53 1.132 . . . . 0.0 112.606 170.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -78.02 -30.48 49.99 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.901 0.88 . . . . 0.0 111.82 175.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 -70.34 168.82 15.16 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.903 0.881 . . . . 0.0 111.772 165.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -81.74 7.5 62.11 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 124.614 1.102 . . . . 0.0 115.299 -177.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -68.16 -38.33 81.99 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 118.845 1.323 . . . . 0.0 113.04 -169.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 83.8 p -92.01 -2.67 56.59 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 -179.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -83.43 171.11 13.79 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 122.738 1.256 . . . . 0.0 113.213 -171.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.3 mptt -109.4 145.91 35.34 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.948 2.099 . . . . 0.0 110.376 -173.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -167.04 163.41 15.84 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.493 1.117 . . . . 0.0 113.333 178.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 20.2 pt -139.71 155.71 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 126.212 1.805 . . . . 0.0 110.327 172.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 17.2 mt -114.63 133.25 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 126.046 1.738 . . . . 0.0 108.688 -177.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -135.29 144.0 46.55 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.454 1.101 . . . . 0.0 112.171 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 57.8 t-20 -76.09 112.59 12.7 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.266 1.027 . . . . 0.0 112.151 -176.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -71.15 -19.69 62.39 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.293 1.037 . . . . 0.0 113.434 -177.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -75.32 -19.59 59.55 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.559 1.144 . . . . 0.0 113.256 179.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 95.4 t -89.42 136.36 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 125.769 1.627 . . . . 0.0 109.171 177.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -55.86 -41.2 74.01 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.789 1.236 . . . . 0.0 113.023 -175.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -79.42 -11.47 59.91 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.394 1.078 . . . . 0.0 113.717 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 88.4 m 52.8 57.85 5.94 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.355 1.462 . . . . 0.0 112.08 -170.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.39 137.07 57.7 Favored 'General case' 0 CA--C 1.548 0.87 0 O-C-N 121.405 -0.809 . . . . 0.0 112.616 -176.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.9 t -60.8 123.81 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 172.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.2 pt -105.03 -17.95 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 125.153 1.381 . . . . 0.0 112.547 175.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -157.2 145.75 19.61 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.065 0.946 . . . . 0.0 112.204 178.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 4.4 m -124.51 156.41 37.35 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.562 1.145 . . . . 0.0 111.504 172.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -73.79 -150.71 0.03 OUTLIER 'General case' 0 CA--C 1.56 1.349 0 CA-C-N 118.86 0.754 . . . . 0.0 111.397 171.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -116.23 -21.45 9.35 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 120.365 -1.459 . . . . 0.0 112.98 163.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -73.73 -34.01 57.11 Favored Glycine 0 N--CA 1.471 1.033 0 C-N-CA 124.126 0.869 . . . . 0.0 112.691 -178.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -58.69 -38.02 77.35 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.52 1.128 . . . . 0.0 111.652 177.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 33.5 t -55.58 -51.73 66.15 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.626 1.57 . . . . 0.0 111.758 178.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -69.27 -18.17 63.83 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 178.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.6 tp -66.99 -44.06 81.33 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.447 1.099 . . . . 0.0 112.317 178.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 80.3 m -112.68 -21.46 11.23 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 114.513 1.301 . . . . 0.0 114.513 -176.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 87.16 14.08 64.95 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 124.417 1.008 . . . . 0.0 114.2 -178.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -87.81 -154.65 0.27 Allowed 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 124.889 1.276 . . . . 0.0 111.857 172.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 70.1 m -150.61 159.47 44.48 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.951 1.3 . . . . 0.0 110.39 178.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 -50.59 -47.0 58.23 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 121.571 -0.706 . . . . 0.0 111.5 175.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.36 -27.53 36.87 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 177.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -91.71 -33.99 14.82 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.991 1.316 . . . . 0.0 112.368 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 57.4 t -88.21 -16.11 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 124.829 1.252 . . . . 0.0 111.947 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 84.0 mmm -73.62 148.06 43.2 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 120.96 -1.088 . . . . 0.0 111.344 171.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 9.7 tm0? 70.98 4.1 4.93 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 126.076 1.75 . . . . 0.0 113.068 -176.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 32.7 mmt180 -82.04 154.84 70.12 Favored Pre-proline 0 N--CA 1.472 0.63 0 C-N-CA 125.021 1.328 . . . . 0.0 110.375 175.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -75.16 11.8 1.4 Allowed 'Trans proline' 0 CA--C 1.548 1.215 0 C-N-CA 124.268 3.312 . . . . 0.0 115.72 176.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 8.3 t 73.89 -17.02 0.47 Allowed 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 126.348 1.859 . . . . 0.0 114.666 166.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 41.1 p -62.05 -23.48 66.5 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 126.095 1.758 . . . . 0.0 113.146 170.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 98.3 m 57.78 28.7 16.32 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.093 1.357 . . . . 0.0 113.004 -176.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -56.78 -31.91 65.11 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.595 1.158 . . . . 0.0 112.22 178.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -60.87 -12.54 11.37 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.995 1.318 . . . . 0.0 114.314 177.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.2 mt -83.74 -2.4 56.19 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 114.101 1.149 . . . . 0.0 114.101 174.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 18.3 p-80 -59.79 143.05 52.08 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 119.781 1.173 . . . . 0.0 113.617 179.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -123.94 -161.64 11.19 Favored Glycine 0 CA--C 1.539 1.551 0 C-N-CA 126.363 1.935 . . . . 0.0 111.517 169.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.22 -20.4 32.72 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 123.069 2.513 . . . . 0.0 113.184 177.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 -88.13 -12.04 45.21 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.245 1.018 . . . . 0.0 113.592 -179.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 18.6 m -72.38 138.83 47.48 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.994 1.317 . . . . 0.0 110.584 -175.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -102.87 131.11 50.01 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.295 1.038 . . . . 0.0 110.544 -177.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 19.9 tpp85 -60.76 -36.34 78.69 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.809 0.844 . . . . 0.0 112.538 -175.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 85.3 mmt-85 -60.67 -41.99 96.17 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.039 0.935 . . . . 0.0 112.448 175.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.64 -45.5 75.18 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 119.144 0.884 . . . . 0.0 112.112 177.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -57.18 -33.6 67.63 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.106 0.562 . . . . 0.0 112.318 173.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -73.28 -46.24 50.97 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 124.696 1.198 . . . . 0.0 112.293 175.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 12.9 mm-40 -61.42 -33.86 74.42 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 119.091 0.859 . . . . 0.0 111.715 -177.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 76.1 mt -63.96 -35.63 74.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 CA-C-N 120.307 1.412 . . . . 0.0 111.958 171.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.75 -35.56 67.5 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 119.112 0.869 . . . . 0.0 112.498 173.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 51.8 mm-40 -67.89 -33.67 75.16 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.564 0.745 . . . . 0.0 111.581 173.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -58.7 -22.05 56.34 Favored 'General case' 0 CA--C 1.547 0.847 0 O-C-N 121.063 -1.023 . . . . 0.0 113.392 178.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 57.7 mt -82.03 -14.55 55.74 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.751 1.621 . . . . 0.0 113.839 177.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.1 pp -85.65 -18.52 32.99 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 119.606 1.094 . . . . 0.0 112.643 173.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -79.82 167.26 51.27 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 124.919 1.247 . . . . 0.0 113.718 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -110.87 -7.57 14.58 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.011 1.725 . . . . 0.0 112.746 175.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -112.25 164.97 12.6 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 127.704 2.401 . . . . 0.0 111.642 179.262 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 44.1 mp0 -62.58 143.59 57.08 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.903 1.281 . . . . 0.0 112.141 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 16.0 mmt85 -140.64 130.05 23.88 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.891 1.276 . . . . 0.0 111.267 173.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 39.7 mtmt -104.81 136.04 45.06 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.297 1.439 . . . . 0.0 110.847 168.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 66.7 t -135.95 136.79 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 125.345 1.458 . . . . 0.0 108.742 176.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -101.01 131.82 46.71 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.987 0.915 . . . . 0.0 110.882 178.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.1 tt -154.11 150.05 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 124.612 1.165 . . . . 0.0 111.751 -170.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -89.22 125.85 35.25 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.243 -0.911 . . . . 0.0 111.825 174.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 20.0 m-30 -113.99 146.0 40.75 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.737 2.015 . . . . 0.0 111.115 173.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -86.52 156.36 20.12 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 169.257 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 58.3 ttm-85 -101.22 149.11 24.34 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 126.152 1.781 . . . . 0.0 109.332 166.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -54.37 -28.15 41.22 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 114.441 1.274 . . . . 0.0 114.441 177.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -73.68 -6.98 50.18 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.926 1.69 . . . . 0.0 114.088 176.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 99.17 -1.28 57.49 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 125.763 1.649 . . . . 0.0 114.229 -177.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -73.57 168.98 18.2 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 118.407 1.104 . . . . 0.0 112.215 177.041 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 34.9 t -143.02 151.66 41.06 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.341 1.056 . . . . 0.0 111.36 176.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -157.36 151.85 25.16 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.673 1.189 . . . . 0.0 111.587 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -76.57 123.18 25.69 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.411 0.624 . . . . 0.0 110.466 165.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 21.4 t -104.79 137.68 42.21 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.988 1.715 . . . . 0.0 110.377 170.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.3 tp -92.24 116.37 28.89 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 162.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 22.3 t -100.06 115.39 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 124.829 1.252 . . . . 0.0 108.468 176.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -110.79 110.61 21.31 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.721 1.208 . . . . 0.0 108.273 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 71.3 t -78.39 128.75 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 169.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 56.0 t -112.98 113.01 49.8 Favored Pre-proline 0 CA--C 1.538 0.496 0 N-CA-C 107.591 -1.262 . . . . 0.0 107.591 168.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.32 127.82 10.76 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 123.273 2.648 . . . . 0.0 109.741 178.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 79.3 t -102.02 119.7 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 123.912 0.885 . . . . 0.0 109.45 176.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 61.1 mttt -88.52 153.57 21.04 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.693 0.797 . . . . 0.0 112.635 172.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -92.35 -173.58 3.45 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.475 1.11 . . . . 0.0 111.663 175.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -60.11 -22.12 62.4 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.11 1.364 . . . . 0.0 114.465 178.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -90.66 -5.47 55.77 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.119 1.368 . . . . 0.0 112.991 178.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 80.43 22.35 62.71 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 124.396 0.998 . . . . 0.0 114.456 -179.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -108.16 148.24 30.17 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.193 1.397 . . . . 0.0 109.916 172.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.8 p -78.79 126.19 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 123.703 0.801 . . . . 0.0 110.525 178.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.47 -22.82 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 -174.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 56.0 mtm -130.18 149.91 51.67 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.848 1.259 . . . . 0.0 111.977 169.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -107.52 136.04 47.96 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 124.766 1.226 . . . . 0.0 109.126 164.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 75.9 mt -99.26 118.45 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 162.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -93.68 116.76 29.27 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 170.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -101.53 144.53 30.18 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 119.122 -0.466 . . . . 0.0 110.894 176.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -122.46 133.01 54.61 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.63 1.172 . . . . 0.0 111.151 -176.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -137.7 131.09 30.87 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 125.271 1.428 . . . . 0.0 109.2 176.138 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 71.3 t -76.86 110.95 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 175.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.2 p -93.9 -24.23 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 123.628 0.771 . . . . 0.0 112.744 -174.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 37.9 tpp -163.53 111.69 1.21 Allowed 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.769 1.228 . . . . 0.0 110.572 178.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -82.28 118.91 23.49 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.388 0.675 . . . . 0.0 109.919 176.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt . . . . . 0 C--O 1.254 1.306 0 C-N-CA 125.201 1.4 . . . . 0.0 113.475 -175.456 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 93.1 mtp . . . . . 0 N--CA 1.497 1.893 0 CA-C-O 116.441 -1.742 . . . . 0.0 112.254 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -71.31 157.58 56.54 Favored 'Trans proline' 0 C--N 1.359 1.095 0 C-N-CA 122.521 2.148 . . . . 0.0 111.933 178.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 90.2 t -86.9 125.19 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.031 0.932 . . . . 0.0 110.146 -179.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 35.4 mmt180 -80.21 138.4 36.83 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.615 1.166 . . . . 0.0 111.086 173.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -106.23 160.66 15.18 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.173 1.389 . . . . 0.0 111.275 177.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -85.37 102.18 2.6 Favored Glycine 0 N--CA 1.471 1.002 0 C-N-CA 124.571 1.081 . . . . 0.0 111.647 177.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -166.55 169.75 13.42 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.634 1.973 . . . . 0.0 111.169 177.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.6 p -155.02 133.68 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 124.461 1.104 . . . . 0.0 111.094 176.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -91.63 152.72 43.64 Favored Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 124.952 1.301 . . . . 0.0 111.866 177.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -66.02 118.21 5.31 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 123.267 2.645 . . . . 0.0 110.312 176.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -134.95 -65.97 0.6 Allowed 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.277 1.431 . . . . 0.0 109.74 -175.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -63.94 130.51 44.39 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.101 0.96 . . . . 0.0 110.954 173.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 32.2 p -117.54 -50.77 2.52 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.433 1.493 . . . . 0.0 112.216 172.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -86.36 -56.98 3.18 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.88 0.872 . . . . 0.0 111.762 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 48.1 tp -57.87 -35.06 70.45 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.226 1.01 . . . . 0.0 111.065 178.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -44.77 -37.41 3.77 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 170.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 99.8 m -77.69 -31.64 52.54 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.39 1.076 . . . . 0.0 110.775 179.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 12.2 mm -75.38 -36.22 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 124.675 1.19 . . . . 0.0 110.661 177.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 94.0 mt -54.83 -41.46 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 123.547 0.739 . . . . 0.0 110.529 174.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 7.0 mmt85 -59.31 -32.91 70.48 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 118.864 0.756 . . . . 0.0 112.869 178.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -77.16 -36.75 54.95 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.888 1.275 . . . . 0.0 111.631 177.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -74.85 -25.9 59.31 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.65 1.18 . . . . 0.0 112.688 175.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -60.58 -19.86 58.83 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 173.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -74.8 -10.3 83.39 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 124.632 1.111 . . . . 0.0 114.506 173.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -95.89 45.78 1.08 Allowed 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.772 1.629 . . . . 0.0 110.55 178.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.1 t -85.6 44.87 1.14 Allowed 'General case' 0 N--CA 1.476 0.854 0 O-C-N 120.567 -1.333 . . . . 0.0 112.273 -171.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 22.8 mmm180 -69.27 163.52 24.84 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.519 1.127 . . . . 0.0 111.239 176.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.6 mptt -92.85 123.24 35.97 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.128 -0.982 . . . . 0.0 110.935 -170.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -159.72 163.88 34.36 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.183 0.993 . . . . 0.0 113.096 177.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 32.6 pt -140.97 156.22 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 126.5 1.92 . . . . 0.0 110.006 173.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 10.7 mt -118.27 132.75 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 125.416 1.486 . . . . 0.0 109.006 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -130.87 148.54 52.65 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.44 1.096 . . . . 0.0 111.775 177.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 52.7 t-20 -71.22 125.3 26.57 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.863 0.865 . . . . 0.0 111.045 178.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.06 -26.78 59.65 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 121.463 -0.773 . . . . 0.0 112.824 175.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 77.4 mtp180 -76.41 23.59 0.15 Allowed 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 126.137 1.775 . . . . 0.0 114.462 -170.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.4 m -149.93 148.5 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 126.748 2.019 . . . . 0.0 110.563 -171.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -63.72 -41.01 98.15 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.414 1.086 . . . . 0.0 113.26 -169.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -83.55 -12.67 55.86 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -175.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 90.4 m 49.21 64.3 1.79 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.353 1.461 . . . . 0.0 111.489 -167.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.14 136.18 54.7 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.59 0.756 . . . . 0.0 112.027 -177.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.441 ' CG1' ' HG ' ' A' ' 44' ' ' CYS . 17.5 t -63.52 123.69 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 C-N-CA 122.869 0.467 . . . . 0.0 109.842 175.227 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.0 pt -103.67 -21.68 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 125.291 1.436 . . . . 0.0 112.551 175.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -151.07 144.55 24.91 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.187 0.995 . . . . 0.0 111.217 178.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.441 ' HG ' ' CG1' ' A' ' 41' ' ' VAL . 0.3 OUTLIER -135.46 140.65 45.02 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.411 1.084 . . . . 0.0 111.136 -177.685 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -78.96 -175.35 4.48 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 119.97 1.259 . . . . 0.0 112.403 176.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -90.95 -27.2 18.86 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 120.455 -1.403 . . . . 0.0 111.955 172.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -70.93 -41.64 61.49 Favored Glycine 0 C--N 1.343 0.95 0 O-C-N 121.869 -0.52 . . . . 0.0 112.248 -174.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.422 ' CE1' ' HB3' ' A' ' 44' ' ' CYS . 0.4 OUTLIER -69.39 -28.56 66.27 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.185 0.594 . . . . 0.0 112.332 -179.307 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 93.2 m -53.89 -51.76 62.65 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.18 0.992 . . . . 0.0 111.32 177.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -70.99 -19.72 62.5 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.111 0.964 . . . . 0.0 113.582 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 15.2 tp -62.81 -46.43 87.98 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.989 1.316 . . . . 0.0 111.788 -179.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 44.1 t -95.68 -33.52 12.29 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.167 0.987 . . . . 0.0 113.035 171.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.38 7.57 51.52 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 124.753 1.168 . . . . 0.0 114.091 -173.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -84.89 -158.3 0.35 Allowed 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 118.775 1.287 . . . . 0.0 112.36 168.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 10.5 t -155.83 170.24 22.55 Favored 'General case' 0 C--O 1.24 0.581 0 O-C-N 120.772 -1.205 . . . . 0.0 111.643 176.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 -47.46 -47.76 27.04 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.091 1.356 . . . . 0.0 111.44 176.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.05 -26.82 64.92 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -89.5 -36.07 15.6 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.192 0.997 . . . . 0.0 112.487 174.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 80.8 t -84.46 -17.12 10.32 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 C-N-CA 124.962 1.305 . . . . 0.0 111.914 -176.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 44.6 mtm -67.59 140.58 56.92 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 120.524 -1.36 . . . . 0.0 110.453 173.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 12.4 mt-30 67.77 9.64 7.24 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.566 1.546 . . . . 0.0 114.061 -178.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -83.86 155.11 64.82 Favored Pre-proline 0 N--CA 1.472 0.654 0 C-N-CA 124.611 1.165 . . . . 0.0 110.428 170.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.27 133.99 25.87 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.614 2.209 . . . . 0.0 109.029 166.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 3.9 t -65.6 -15.26 62.56 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -171.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 40.8 p -57.67 -28.26 63.61 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.586 1.554 . . . . 0.0 112.581 169.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 86.2 m 56.65 41.6 28.16 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.303 1.441 . . . . 0.0 112.099 -178.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -57.84 -27.45 63.21 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.687 1.195 . . . . 0.0 113.232 -175.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -62.47 -15.6 50.71 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 174.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 80.4 mt -79.47 -13.68 59.41 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 173.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 31.0 m170 -73.25 118.93 16.79 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 119.211 0.914 . . . . 0.0 110.911 -179.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -99.65 -164.32 29.26 Favored Glycine 0 CA--C 1.539 1.534 0 C-N-CA 125.841 1.686 . . . . 0.0 112.574 177.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -70.07 -25.15 27.46 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 123.096 2.531 . . . . 0.0 113.019 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 40.2 ttt180 -84.39 -14.84 48.32 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.898 0.879 . . . . 0.0 112.974 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 31.7 m -69.28 143.99 53.71 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.083 1.353 . . . . 0.0 112.074 -171.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 19.9 mp0 -91.19 118.08 30.16 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.308 1.443 . . . . 0.0 110.257 -168.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 57.6 mmm-85 -58.92 -36.46 74.76 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 121.414 -0.804 . . . . 0.0 113.011 -178.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 25.1 tpp180 -61.58 -45.27 94.82 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.212 1.005 . . . . 0.0 111.528 175.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -72.08 -40.46 68.25 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.104 -0.998 . . . . 0.0 112.724 179.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.42 -34.9 64.83 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.504 0.721 . . . . 0.0 112.017 173.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -73.38 -48.2 35.96 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 124.572 1.149 . . . . 0.0 112.291 172.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -58.62 -35.29 72.25 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 118.536 -0.745 . . . . 0.0 111.998 -178.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 80.7 mt -63.49 -35.63 73.23 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 CA-C-N 120.191 1.36 . . . . 0.0 112.293 172.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.13 -36.63 66.72 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 118.888 0.767 . . . . 0.0 112.339 173.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 48.3 mm-40 -68.91 -32.93 72.91 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.491 0.717 . . . . 0.0 111.74 175.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -58.61 -21.08 52.49 Favored 'General case' 0 CA--C 1.548 0.88 0 O-C-N 121.168 -0.957 . . . . 0.0 113.358 177.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 57.6 mt -83.74 -15.3 49.1 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.669 1.588 . . . . 0.0 113.89 177.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -85.69 -20.87 28.73 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 119.611 1.096 . . . . 0.0 112.183 173.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -82.36 149.75 27.89 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 125.042 1.306 . . . . 0.0 113.444 -178.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.66 -2.22 57.85 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.013 1.325 . . . . 0.0 114.008 178.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -126.27 162.53 25.25 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 126.177 1.791 . . . . 0.0 111.386 -173.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -59.75 136.03 57.87 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.559 1.144 . . . . 0.0 111.931 -178.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.2 129.99 22.96 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.674 1.19 . . . . 0.0 110.311 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 30.9 mtmt -109.26 140.57 42.74 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.565 1.546 . . . . 0.0 111.715 176.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 41.4 t -139.51 136.35 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 126.173 1.789 . . . . 0.0 108.849 178.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -104.31 135.41 45.82 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.262 1.025 . . . . 0.0 110.594 176.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.0 tt -161.11 150.57 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 123.623 0.769 . . . . 0.0 112.554 -165.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -86.72 123.36 31.8 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 121.402 -0.811 . . . . 0.0 112.165 173.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 12.0 m-30 -114.04 140.21 48.64 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 127.157 2.183 . . . . 0.0 111.6 175.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -77.7 162.61 26.86 Favored 'General case' 0 CA--C 1.55 0.942 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 172.193 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 13.2 ptt180 -122.64 155.66 35.92 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.758 1.223 . . . . 0.0 112.723 166.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -52.87 -28.21 22.02 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 126.354 1.861 . . . . 0.0 114.453 -176.068 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -68.06 -12.87 61.62 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.178 1.391 . . . . 0.0 113.683 177.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 94.79 22.95 22.22 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 125.007 1.289 . . . . 0.0 113.569 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 7.9 t -120.36 -173.1 2.5 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.595 1.158 . . . . 0.0 111.576 177.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 16.8 t -144.91 154.33 42.49 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.007 1.323 . . . . 0.0 112.514 -169.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -150.55 148.71 29.0 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.765 1.626 . . . . 0.0 110.97 177.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -74.72 134.26 41.92 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.712 0.768 . . . . 0.0 109.827 166.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 35.1 t -129.55 145.62 51.45 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.827 2.051 . . . . 0.0 110.235 -177.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 14.8 tp -93.9 127.31 39.6 Favored 'General case' 0 N--CA 1.463 0.175 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 161.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 68.7 t -101.87 127.23 55.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 161.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -122.3 121.77 37.51 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 119.289 0.95 . . . . 0.0 109.568 165.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 57.0 t -84.74 133.0 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 175.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 49.8 t -113.67 110.71 49.43 Favored Pre-proline 0 N--CA 1.467 0.411 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 170.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.85 129.99 12.06 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.903 2.402 . . . . 0.0 109.645 178.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 74.3 t -103.46 125.04 58.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.074 0.949 . . . . 0.0 109.587 178.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 66.7 mttt -94.11 153.98 17.84 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 172.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -93.49 -173.89 3.33 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.55 1.14 . . . . 0.0 111.506 176.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -60.27 -22.05 62.65 Favored 'General case' 0 CA--C 1.548 0.865 0 C-N-CA 125.038 1.335 . . . . 0.0 114.406 178.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -90.81 -5.52 55.51 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.144 1.377 . . . . 0.0 112.981 178.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 79.9 22.44 63.75 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 124.476 1.036 . . . . 0.0 114.458 -179.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -107.26 150.06 27.08 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.065 1.346 . . . . 0.0 110.001 173.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 86.8 t -78.25 125.95 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 123.551 0.74 . . . . 0.0 109.353 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.53 -23.27 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 -176.272 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 56.1 mtm -131.49 151.6 51.43 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.621 1.168 . . . . 0.0 112.155 170.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -110.63 135.25 51.55 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 124.985 1.314 . . . . 0.0 109.108 166.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 64.4 mt -102.19 119.15 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 165.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -95.31 118.09 31.45 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 172.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -107.58 131.92 53.84 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 123.338 0.399 . . . . 0.0 110.475 177.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 13.3 m-30 -108.76 147.94 31.26 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 125.724 1.609 . . . . 0.0 111.585 -177.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -148.63 141.9 25.12 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 125.3 1.44 . . . . 0.0 109.168 176.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 45.3 t -76.6 122.54 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 175.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.7 t -89.94 -39.74 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 125.025 1.33 . . . . 0.0 111.089 175.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 24.7 ttm -171.53 126.43 0.63 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.39 1.076 . . . . 0.0 110.957 -175.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -78.17 125.89 30.01 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 121.303 -0.873 . . . . 0.0 110.016 169.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt . . . . . 0 C--O 1.254 1.336 0 C-N-CA 125.038 1.335 . . . . 0.0 113.58 179.225 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.1 ttp . . . . . 0 N--CA 1.494 1.728 0 CA-C-O 118.429 -0.796 . . . . 0.0 110.709 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -76.63 155.03 35.38 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 123.53 2.82 . . . . 0.0 111.343 175.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.6 p -165.06 143.67 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.905 1.282 . . . . 0.0 110.971 -179.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 37.9 mmt180 -112.98 127.28 56.18 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.164 1.386 . . . . 0.0 110.396 174.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 84.4 mtp180 -84.92 165.78 17.37 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.127 1.371 . . . . 0.0 112.28 -178.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 102.41 -9.65 56.0 Favored Glycine 0 N--CA 1.477 1.424 0 C-N-CA 125.763 1.649 . . . . 0.0 115.085 176.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 59.4 m80 -142.69 156.93 45.1 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.793 1.637 . . . . 0.0 110.846 175.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.8 p -163.75 149.36 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 125.267 1.427 . . . . 0.0 110.696 -178.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.83 151.72 84.37 Favored Pre-proline 0 CA--C 1.552 1.05 0 C-N-CA 124.088 0.955 . . . . 0.0 112.248 174.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -67.38 114.78 3.38 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 123.134 2.556 . . . . 0.0 110.586 -179.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -76.67 -34.67 58.22 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.648 0.779 . . . . 0.0 112.933 -177.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -117.4 64.98 0.73 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 127.351 2.26 . . . . 0.0 110.151 -177.47 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 41.2 p -49.5 -32.24 11.81 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 127.327 2.251 . . . . 0.0 114.136 -177.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -69.81 -50.62 41.2 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.033 0.933 . . . . 0.0 111.911 175.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 58.9 tp -61.84 -35.75 79.19 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.903 1.281 . . . . 0.0 111.154 176.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -56.69 -31.45 64.47 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.125 0.97 . . . . 0.0 112.671 177.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.2 m -72.13 -31.98 66.51 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.376 0.67 . . . . 0.0 111.175 174.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 16.1 mm -73.04 -41.8 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.889 0.876 . . . . 0.0 110.366 176.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 97.1 mt -54.47 -48.15 69.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.0 0.92 . . . . 0.0 110.019 174.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 81.6 mtt-85 -59.68 -27.18 66.19 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -78.18 -24.39 47.23 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.593 1.157 . . . . 0.0 113.112 177.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -90.31 -29.34 18.18 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.252 1.021 . . . . 0.0 112.75 170.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -70.32 177.04 3.54 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.688 1.195 . . . . 0.0 112.755 172.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.96 14.09 82.53 Favored Glycine 0 N--CA 1.471 1.026 0 C-N-CA 124.367 0.984 . . . . 0.0 113.399 176.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 63.19 17.52 10.26 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 127.437 2.295 . . . . 0.0 112.261 -173.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 48.8 m -81.59 41.46 0.63 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 126.56 1.944 . . . . 0.0 112.559 -176.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -67.41 166.63 14.18 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 122.554 1.169 . . . . 0.0 111.3 174.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -104.46 142.09 35.21 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.285 1.434 . . . . 0.0 111.09 -163.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -166.03 162.24 17.81 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.366 1.066 . . . . 0.0 113.751 -178.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 31.4 pt -147.13 156.11 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 127.406 2.282 . . . . 0.0 110.081 -178.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.9 mp -122.03 131.61 72.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 125.126 1.371 . . . . 0.0 109.505 176.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -125.21 147.79 48.92 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 124.959 1.304 . . . . 0.0 111.499 176.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -77.88 130.0 36.07 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.105 0.478 . . . . 0.0 111.454 175.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.37 -21.01 62.92 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.632 1.173 . . . . 0.0 113.902 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 82.3 mtm180 -89.63 -4.56 57.75 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 114.622 1.342 . . . . 0.0 114.622 -167.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 32.4 m -108.99 150.49 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 125.114 1.366 . . . . 0.0 111.7 -173.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -50.21 -55.02 16.96 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 126.163 1.785 . . . . 0.0 114.03 -167.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -105.51 30.74 5.46 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.956 1.703 . . . . 0.0 111.689 -177.142 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 70.8 m 39.25 54.3 2.23 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 126.24 1.816 . . . . 0.0 113.299 170.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.8 141.04 56.63 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.773 0.829 . . . . 0.0 111.759 -168.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.5 t -65.18 121.51 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 174.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.1 pt -100.51 -15.61 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 125.171 1.389 . . . . 0.0 112.648 177.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -156.24 141.85 17.76 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.616 1.167 . . . . 0.0 111.198 176.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.491 ' HB3' ' CE1' ' A' ' 48' ' ' PHE . 3.3 m -129.66 156.56 44.04 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.971 0.909 . . . . 0.0 111.311 -178.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -78.71 -166.13 0.83 Allowed 'General case' 0 CA--C 1.558 1.272 0 CA-C-N 118.922 0.783 . . . . 0.0 111.274 164.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -111.54 -19.57 12.49 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 125.565 1.546 . . . . 0.0 112.77 168.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.19 -38.98 94.34 Favored Glycine 0 N--CA 1.472 1.047 0 C-N-CA 124.604 1.097 . . . . 0.0 111.942 176.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.491 ' CE1' ' HB3' ' A' ' 44' ' ' CYS . 0.6 OUTLIER -69.42 -30.87 68.91 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.73 0.812 . . . . 0.0 111.444 -176.454 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 83.4 m -49.63 -54.62 17.37 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.2 1.4 . . . . 0.0 111.905 174.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -72.74 -19.91 61.3 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -178.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 16.5 tp -65.01 -49.2 71.12 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.48 1.112 . . . . 0.0 111.461 179.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 79.0 m -107.8 -15.94 14.44 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 -177.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.39 -0.29 59.87 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 125.453 1.502 . . . . 0.0 114.428 172.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -84.39 -154.95 0.18 Allowed 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 124.757 1.223 . . . . 0.0 112.314 171.395 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.0 t -159.11 168.49 26.49 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 120.604 -1.31 . . . . 0.0 111.652 173.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 36.5 ttm180 -49.56 -49.49 46.12 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.247 1.419 . . . . 0.0 111.044 176.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.82 -27.87 53.47 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -87.98 -49.26 7.18 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.447 1.099 . . . . 0.0 110.651 175.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 69.2 t -72.16 -19.25 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 124.363 1.065 . . . . 0.0 112.13 -172.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 5.4 mmt -64.21 -2.13 1.96 Allowed 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 5.8 tm0? -132.87 14.95 4.32 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.667 1.187 . . . . 0.0 112.341 173.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 37.4 mmt180 -98.48 155.43 36.82 Favored Pre-proline 0 C--O 1.24 0.588 0 C-N-CA 125.459 1.504 . . . . 0.0 111.395 178.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.17 142.07 37.22 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.206 2.604 . . . . 0.0 110.192 172.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 3.2 t -66.15 -11.02 46.62 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 -177.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 40.0 p -68.79 -25.66 64.81 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.344 1.458 . . . . 0.0 112.223 171.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 83.6 m 51.41 42.89 29.65 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.464 1.506 . . . . 0.0 113.013 -177.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -56.42 -31.74 64.2 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.455 1.502 . . . . 0.0 112.978 -175.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -64.85 -15.57 62.02 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.493 1.117 . . . . 0.0 113.932 177.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 87.1 mt -80.69 -11.12 59.68 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.212 1.005 . . . . 0.0 113.019 172.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -76.8 119.48 20.62 Favored 'General case' 0 CA--C 1.546 0.789 0 O-C-N 121.063 -1.023 . . . . 0.0 110.492 -178.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -97.8 -167.26 32.05 Favored Glycine 0 CA--C 1.539 1.546 0 C-N-CA 125.684 1.612 . . . . 0.0 112.366 175.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -68.21 -25.59 36.81 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 123.045 2.497 . . . . 0.0 112.96 177.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -87.61 -5.34 58.78 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.076 0.951 . . . . 0.0 112.847 178.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 63.4 m -70.33 133.44 46.95 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 120.986 -1.071 . . . . 0.0 109.942 179.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 49.8 mm-40 -80.99 123.16 28.11 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -171.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -64.65 -32.8 74.63 Favored 'General case' 0 N--CA 1.476 0.839 0 O-C-N 121.721 -0.612 . . . . 0.0 112.529 -172.304 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 23.5 tpp180 -61.57 -48.33 81.44 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.298 1.039 . . . . 0.0 111.429 170.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.36 -39.59 81.76 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 121.199 -0.938 . . . . 0.0 112.949 -177.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -54.82 -37.31 65.98 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.234 0.614 . . . . 0.0 112.541 171.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -72.6 -41.39 65.67 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.116 0.967 . . . . 0.0 112.821 173.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -56.25 -34.4 66.36 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 118.024 -0.989 . . . . 0.0 112.096 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 74.9 mt -61.79 -50.24 81.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 CA-C-N 120.197 1.362 . . . . 0.0 110.667 173.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.15 -37.0 83.03 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.825 0.85 . . . . 0.0 112.647 -178.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 79.4 mm-40 -72.71 -31.5 65.05 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.318 1.047 . . . . 0.0 111.776 175.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.54 -29.96 70.95 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 119.592 1.087 . . . . 0.0 112.512 179.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 64.6 mt -65.81 -16.58 63.94 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.914 1.286 . . . . 0.0 113.001 175.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 60.3 mt -80.62 -14.23 58.36 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 121.266 -0.896 . . . . 0.0 112.52 173.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -89.85 145.81 18.46 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 125.159 1.361 . . . . 0.0 113.23 -178.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.17 -2.8 58.11 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.974 1.31 . . . . 0.0 113.942 176.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -125.45 163.9 21.63 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.475 1.91 . . . . 0.0 110.984 -177.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -62.13 146.58 50.12 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.411 1.084 . . . . 0.0 112.907 -175.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.56 127.17 10.86 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.597 1.159 . . . . 0.0 110.514 -170.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.4 mttt -112.46 142.07 45.44 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.997 0.919 . . . . 0.0 112.463 172.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 7.6 p -134.13 133.39 55.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 126.255 1.822 . . . . 0.0 111.275 171.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -93.51 129.56 39.67 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.712 1.605 . . . . 0.0 110.023 172.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.7 tt -158.13 147.77 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.497 1.119 . . . . 0.0 111.339 -166.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -84.64 127.79 34.26 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 120.723 -1.236 . . . . 0.0 111.6 174.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 9.7 m-30 -107.69 140.14 41.19 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.686 1.594 . . . . 0.0 110.134 171.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -108.14 124.16 49.82 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.989 1.715 . . . . 0.0 110.651 175.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 2.5 ptp180 -92.23 159.9 15.41 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.821 1.249 . . . . 0.0 113.755 -177.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -58.81 -22.46 58.6 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 125.272 1.429 . . . . 0.0 114.322 179.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -70.61 -12.34 61.5 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.501 1.12 . . . . 0.0 113.349 176.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 95.35 27.15 11.03 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 124.53 1.062 . . . . 0.0 113.693 178.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 69.0 m -132.8 169.07 17.25 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.735 1.214 . . . . 0.0 111.414 -177.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 22.8 p -139.82 169.9 16.86 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 179.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -164.82 154.62 13.52 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 126.308 1.843 . . . . 0.0 110.348 -176.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -76.81 121.4 23.3 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.952 0.882 . . . . 0.0 110.124 168.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 49.5 t -104.7 140.44 38.06 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 127.755 2.422 . . . . 0.0 109.92 174.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 14.2 tp -93.0 119.0 31.8 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 160.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 44.2 t -103.45 117.19 48.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 124.476 1.11 . . . . 0.0 108.452 172.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -105.33 120.85 42.61 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.375 1.47 . . . . 0.0 108.314 174.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.2 p -93.64 131.09 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 119.483 1.038 . . . . 0.0 109.365 164.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 99.5 t -119.43 103.85 46.26 Favored Pre-proline 0 CA--C 1.537 0.46 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 176.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -75.78 139.76 22.66 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.906 2.404 . . . . 0.0 110.574 -175.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 96.3 t -112.37 125.33 69.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.353 1.061 . . . . 0.0 109.76 -178.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 67.2 mttt -93.55 154.54 17.82 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.036 0.934 . . . . 0.0 113.26 171.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -93.09 -174.21 3.49 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.497 1.119 . . . . 0.0 111.521 176.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -61.67 -20.69 63.71 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.013 1.325 . . . . 0.0 114.548 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -95.39 0.02 53.04 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.856 1.263 . . . . 0.0 113.162 177.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 79.31 22.55 64.9 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 124.155 0.883 . . . . 0.0 114.788 176.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -107.24 150.41 26.68 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.134 1.374 . . . . 0.0 109.987 172.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 59.1 t -79.1 124.97 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 123.565 0.746 . . . . 0.0 109.284 -179.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -127.01 -22.41 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 -176.101 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 53.8 mtm -133.46 154.51 50.74 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.905 1.282 . . . . 0.0 112.552 172.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -119.18 132.94 56.02 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 125.581 1.552 . . . . 0.0 109.556 170.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 41.6 mt -100.66 117.39 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 167.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -102.98 135.42 44.69 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 173.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -130.48 127.44 39.2 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.321 1.049 . . . . 0.0 110.129 -171.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -108.02 139.39 42.73 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.817 1.647 . . . . 0.0 111.647 -173.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -147.72 135.03 20.61 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.129 1.372 . . . . 0.0 109.728 175.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 49.9 t -73.39 117.71 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 CA-C-N 119.365 0.984 . . . . 0.0 108.611 174.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.9 p -95.51 -24.62 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 123.597 0.759 . . . . 0.0 112.666 178.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 14.5 tpt -165.8 134.98 3.26 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.358 1.463 . . . . 0.0 110.411 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -92.28 130.4 37.98 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.482 -0.761 . . . . 0.0 110.979 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt . . . . . 0 C--O 1.253 1.272 0 C-N-CA 125.332 1.453 . . . . 0.0 113.941 178.394 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.4 ttm . . . . . 0 N--CA 1.494 1.751 0 CA-C-O 118.431 -0.795 . . . . 0.0 110.689 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -75.92 141.21 23.83 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 123.254 2.636 . . . . 0.0 110.85 175.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 19.4 m -139.34 38.88 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 124.832 1.253 . . . . 0.0 111.454 -177.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 12.3 ptp85 -65.77 -19.21 65.81 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 115.205 1.558 . . . . 0.0 115.205 -171.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 76.5 mtp85 -128.03 133.25 49.09 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.922 1.689 . . . . 0.0 110.378 174.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -89.93 -54.38 2.19 Favored Glycine 0 N--CA 1.475 1.262 0 C-N-CA 124.783 1.183 . . . . 0.0 112.726 -176.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 66.1 t60 69.22 -33.66 0.25 Allowed 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 128.319 2.647 . . . . 0.0 115.765 170.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.8 p -55.29 -42.97 69.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 126.098 1.759 . . . . 0.0 114.58 -173.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 164.57 157.98 0.07 OUTLIER Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 129.446 3.099 . . . . 0.0 108.392 -165.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -80.53 128.87 7.14 Favored 'Trans proline' 0 CA--C 1.538 0.725 0 C-N-CA 122.444 2.096 . . . . 0.0 111.632 178.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 14.3 mp0 -83.99 -31.89 25.26 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.98 0.912 . . . . 0.0 112.735 173.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -135.0 32.66 3.18 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.902 1.281 . . . . 0.0 113.755 -162.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.8 t -45.83 -35.52 4.51 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 128.186 2.594 . . . . 0.0 114.628 -172.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -65.01 -50.81 64.83 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.197 0.599 . . . . 0.0 111.567 176.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 54.5 tp -64.33 -35.98 82.62 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.201 1.4 . . . . 0.0 111.022 172.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.5 -28.6 67.19 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.677 1.191 . . . . 0.0 112.688 178.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 94.4 m -74.29 -33.34 63.2 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.47 1.108 . . . . 0.0 110.869 173.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.2 mm -73.6 -36.22 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 124.351 1.06 . . . . 0.0 111.108 176.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 96.5 mt -57.04 -42.59 79.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 123.488 0.715 . . . . 0.0 110.818 176.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 89.3 mtt-85 -61.54 -22.05 64.81 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 176.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -76.07 -35.96 59.2 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 120.885 -1.134 . . . . 0.0 112.131 177.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -96.99 -11.85 24.04 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 114.559 1.318 . . . . 0.0 114.559 176.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -64.1 162.33 14.48 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 119.537 1.062 . . . . 0.0 111.91 162.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -80.14 -7.11 88.82 Favored Glycine 0 N--CA 1.473 1.129 0 C-N-CA 124.8 1.191 . . . . 0.0 114.812 -174.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 64.07 30.02 14.02 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.826 1.651 . . . . 0.0 113.195 169.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.2 m -72.42 -9.88 59.08 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.498 1.119 . . . . 0.0 113.941 178.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.3 mpt_? -75.41 166.67 23.24 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.661 1.185 . . . . 0.0 111.243 176.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -87.29 139.92 30.07 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.235 1.014 . . . . 0.0 110.667 -177.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -164.43 163.24 22.3 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 124.588 1.155 . . . . 0.0 112.889 177.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 20.5 pt -139.57 155.35 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 125.852 1.661 . . . . 0.0 110.576 173.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 16.0 mt -113.2 129.55 68.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 125.687 1.595 . . . . 0.0 108.479 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -127.07 144.87 50.92 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 124.53 1.132 . . . . 0.0 111.249 176.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 42.8 t-20 -68.16 127.61 33.54 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.344 0.657 . . . . 0.0 111.146 178.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -83.04 -20.21 35.42 Favored 'General case' 0 CA--C 1.546 0.812 0 O-C-N 121.364 -0.835 . . . . 0.0 113.085 176.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 75.2 mtp180 -77.73 41.01 0.32 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 126.345 1.858 . . . . 0.0 112.759 -175.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.5 p -170.37 138.24 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 126.895 2.078 . . . . 0.0 109.985 -168.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -61.07 -44.67 97.03 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.043 0.937 . . . . 0.0 112.286 -176.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -72.55 -23.18 60.95 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -176.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 89.3 m 57.87 58.95 3.37 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.755 1.222 . . . . 0.0 112.411 -175.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.0 135.83 56.8 Favored 'General case' 0 CA--C 1.551 0.998 0 O-C-N 121.203 -0.936 . . . . 0.0 112.528 -177.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 11.5 t -62.52 123.65 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 C-N-CA 123.473 0.709 . . . . 0.0 109.502 174.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.6 pt -104.61 -19.93 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 125.181 1.392 . . . . 0.0 112.354 176.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 21.3 t80 -153.98 146.17 23.78 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.864 0.866 . . . . 0.0 111.866 177.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 6.9 m -125.35 155.42 40.32 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.185 0.994 . . . . 0.0 111.161 171.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -71.34 -152.35 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.285 0 CA-C-N 118.362 0.528 . . . . 0.0 111.487 170.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -117.11 -17.52 10.26 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 120.229 -1.544 . . . . 0.0 113.205 164.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -76.3 -33.55 48.54 Favored Glycine 0 N--CA 1.471 1.007 0 O-C-N 121.324 -0.86 . . . . 0.0 112.852 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -58.13 -38.44 76.53 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.6 1.16 . . . . 0.0 111.599 177.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 9.9 t -53.0 -51.16 62.54 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.362 1.465 . . . . 0.0 111.825 173.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -74.02 -22.86 59.41 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -178.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 49.5 tp -65.16 -50.0 67.67 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.292 1.037 . . . . 0.0 111.815 176.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 80.6 m -105.86 -20.47 13.43 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 -174.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.77 6.01 70.56 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 124.585 1.088 . . . . 0.0 114.032 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -88.61 -175.72 5.03 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.578 1.151 . . . . 0.0 112.295 171.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 66.5 m -135.41 161.25 35.97 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.104 0.962 . . . . 0.0 111.104 -179.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 46.7 ttm180 -53.37 -42.49 66.95 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 121.497 -0.752 . . . . 0.0 111.842 178.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.04 -28.1 49.61 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 175.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -92.96 -35.2 13.42 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.818 1.247 . . . . 0.0 112.324 178.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 99.3 t -83.64 -12.52 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 124.509 1.123 . . . . 0.0 112.181 178.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 21.3 mmt -68.57 141.86 55.35 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 120.798 -1.189 . . . . 0.0 112.278 172.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 68.74 7.3 6.04 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 126.011 1.724 . . . . 0.0 113.609 -178.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -78.13 152.77 79.56 Favored Pre-proline 0 N--CA 1.472 0.667 0 CA-C-O 117.921 -1.038 . . . . 0.0 109.904 175.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -74.37 13.02 0.95 Allowed 'Trans proline' 0 CA--C 1.549 1.229 0 C-N-CA 124.319 3.346 . . . . 0.0 115.356 176.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 7.5 t 75.14 -27.6 0.19 Allowed 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 126.86 2.064 . . . . 0.0 113.922 167.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 38.8 p -58.92 -19.3 41.2 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 127.162 2.185 . . . . 0.0 113.92 173.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . 0.277 28.5 p 42.81 40.29 2.04 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 127.308 2.243 . . . . 0.0 114.31 178.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -57.59 -32.91 67.65 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.026 0.931 . . . . 0.0 111.765 -177.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -57.04 -15.75 5.79 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.155 1.382 . . . . 0.0 114.253 177.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 89.9 mt -75.18 -2.29 27.17 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 171.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 31.4 p-80 -60.55 133.22 55.89 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 119.826 1.194 . . . . 0.0 112.946 174.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -107.39 -161.95 21.55 Favored Glycine 0 CA--C 1.54 1.651 0 C-N-CA 126.229 1.871 . . . . 0.0 111.468 168.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.05 -26.02 18.75 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 123.083 2.522 . . . . 0.0 113.153 178.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 29.8 ttm180 -94.38 -8.09 39.74 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.547 1.139 . . . . 0.0 113.715 -176.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 25.8 m -64.6 139.41 58.76 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.254 1.421 . . . . 0.0 110.555 179.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -102.43 123.03 45.46 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.174 0.989 . . . . 0.0 109.735 179.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 42.5 mmt180 -61.58 -26.91 68.27 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 24.6 tpp180 -56.21 -46.0 79.65 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.472 1.109 . . . . 0.0 111.797 171.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.36 -45.57 65.82 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.449 1.1 . . . . 0.0 111.954 175.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.52 -33.34 63.68 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 121.62 -0.675 . . . . 0.0 112.709 177.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.59 -41.85 71.78 Favored 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 125.1 1.36 . . . . 0.0 112.502 173.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 24.5 mm-40 -60.81 -33.48 73.08 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 118.328 -0.844 . . . . 0.0 111.347 179.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 46.1 mt -59.36 -43.66 90.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 CA-C-N 120.042 1.292 . . . . 0.0 111.026 171.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.2 -35.8 74.16 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.327 0.651 . . . . 0.0 112.71 177.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 78.4 mm-40 -69.27 -32.52 71.76 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 121.604 -0.685 . . . . 0.0 111.861 174.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.71 -23.21 67.04 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.936 0.894 . . . . 0.0 112.771 178.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 61.1 mt -77.26 -15.04 59.63 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.677 1.591 . . . . 0.0 113.45 174.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 64.2 mt -89.97 -14.67 33.56 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.124 0.969 . . . . 0.0 112.426 179.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -92.64 148.48 19.11 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 125.164 1.364 . . . . 0.0 113.15 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.84 -1.57 58.02 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.721 1.208 . . . . 0.0 113.83 175.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -115.33 161.32 18.66 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.711 2.004 . . . . 0.0 111.208 176.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.79 154.34 39.37 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 178.15 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 29.9 tpt180 -155.07 129.14 8.82 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.635 1.174 . . . . 0.0 111.148 -175.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 39.5 mtmt -102.68 137.63 40.65 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.598 1.559 . . . . 0.0 111.622 174.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 64.4 t -132.97 134.94 57.7 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 C-N-CA 126.414 1.885 . . . . 0.0 108.025 177.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -106.0 130.61 53.9 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.765 0.826 . . . . 0.0 110.381 177.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.0 tt -156.98 147.2 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 124.022 0.929 . . . . 0.0 112.217 -166.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -85.73 126.66 34.15 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.027 -1.046 . . . . 0.0 111.858 174.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 18.3 m-30 -111.92 147.8 35.07 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.528 1.931 . . . . 0.0 111.116 172.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -101.25 150.14 23.29 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.8 0.84 . . . . 0.0 112.538 166.415 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 40.9 mtm180 -89.59 159.03 17.38 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.956 1.302 . . . . 0.0 112.283 169.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 5.9 mptp? -59.19 -27.16 65.44 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.02 0.928 . . . . 0.0 112.639 166.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -69.93 -11.46 60.89 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 126.255 1.822 . . . . 0.0 114.067 173.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 90.39 -0.67 78.22 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 125.472 1.51 . . . . 0.0 114.471 -176.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -76.74 154.63 33.9 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.533 1.133 . . . . 0.0 111.451 176.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 95.5 m -126.99 156.96 40.78 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 119.382 0.992 . . . . 0.0 112.176 174.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -161.42 154.68 21.25 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.851 1.26 . . . . 0.0 111.998 177.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -77.72 122.78 25.83 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.627 0.771 . . . . 0.0 110.392 165.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 8.2 t -107.55 140.95 39.75 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 126.083 1.753 . . . . 0.0 110.224 173.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.3 tt -92.16 121.59 33.84 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 125.158 1.383 . . . . 0.0 107.491 162.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 48.0 t -101.0 111.37 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 125.068 1.347 . . . . 0.0 108.484 169.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -107.75 107.78 18.71 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.612 1.565 . . . . 0.0 108.997 174.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 50.4 t -78.43 126.91 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 170.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 75.6 t -114.36 116.3 44.19 Favored Pre-proline 0 CA--C 1.538 0.51 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 170.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.69 127.0 9.9 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 123.238 2.625 . . . . 0.0 109.736 179.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 63.0 t -97.18 118.64 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 123.736 0.815 . . . . 0.0 109.279 174.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 60.4 mttt -88.48 153.51 21.1 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.675 0.79 . . . . 0.0 112.587 171.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -93.02 -173.52 3.3 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.518 1.127 . . . . 0.0 111.747 175.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -60.7 -21.36 62.8 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 125.206 1.402 . . . . 0.0 114.705 178.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -93.93 -0.82 55.43 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.854 1.262 . . . . 0.0 113.22 177.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 79.11 22.05 66.46 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 124.222 0.915 . . . . 0.0 114.537 177.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -107.29 147.89 29.69 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 125.119 1.368 . . . . 0.0 109.923 172.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.6 p -77.82 126.38 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 123.405 0.682 . . . . 0.0 110.273 178.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.58 -22.45 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 -175.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 57.7 mtm -131.99 150.96 52.01 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.779 1.231 . . . . 0.0 112.068 168.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -107.92 133.7 51.89 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 125.06 1.344 . . . . 0.0 109.215 165.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 69.2 mt -97.15 119.0 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 163.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 8.6 mp -96.47 119.09 34.32 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 169.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -102.81 124.88 49.16 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 123.547 0.529 . . . . 0.0 110.984 177.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -100.9 126.88 47.55 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.232 1.413 . . . . 0.0 109.998 179.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -141.53 103.94 4.48 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.38 1.072 . . . . 0.0 108.246 -172.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.2 p -61.51 116.9 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 O-C-N 120.981 -1.074 . . . . 0.0 110.473 178.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.9 p -96.76 -27.54 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.817 1.247 . . . . 0.0 113.102 -174.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 24.7 ptp -161.41 147.17 14.02 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.24 1.016 . . . . 0.0 112.64 166.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -88.93 134.31 34.0 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.705 0.802 . . . . 0.0 110.845 177.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt . . . . . 0 C--O 1.253 1.246 0 C-N-CA 125.36 1.464 . . . . 0.0 112.473 177.114 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.8 mmt . . . . . 0 N--CA 1.495 1.78 0 CA-C-O 118.837 -0.602 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -75.35 162.15 36.67 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 123.713 2.942 . . . . 0.0 111.796 176.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 19.7 m -142.1 152.53 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 125.407 1.483 . . . . 0.0 110.707 175.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -161.67 143.69 11.6 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.464 1.106 . . . . 0.0 111.603 -176.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 7.2 ppt_? -159.76 157.57 29.61 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.97 1.708 . . . . 0.0 112.018 175.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -122.38 -144.94 6.88 Favored Glycine 0 N--CA 1.474 1.196 0 C-N-CA 125.987 1.756 . . . . 0.0 112.24 174.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 11.7 p-80 -83.95 151.29 25.14 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 124.049 0.94 . . . . 0.0 111.081 165.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.8 p -76.72 -37.5 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 O-C-N 121.279 -0.888 . . . . 0.0 113.384 -173.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 62.98 152.67 0.11 Allowed Pre-proline 0 CA--C 1.557 1.232 0 C-N-CA 127.234 2.213 . . . . 0.0 112.932 -169.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -68.88 120.4 7.31 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 122.556 2.171 . . . . 0.0 111.281 -177.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 80.5 mm-40 -109.39 -31.96 7.34 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.219 1.008 . . . . 0.0 112.681 179.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -140.92 41.99 1.82 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.795 1.638 . . . . 0.0 112.277 -168.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.8 t -55.95 -23.29 31.18 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 126.634 1.974 . . . . 0.0 114.815 -170.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -75.28 -45.09 42.07 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.252 -0.905 . . . . 0.0 112.018 172.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 52.9 tp -63.18 -35.94 81.96 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.764 1.226 . . . . 0.0 111.16 171.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -52.1 -33.31 39.01 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.548 1.539 . . . . 0.0 112.583 175.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 21.4 m -72.65 -21.56 61.07 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.546 1.538 . . . . 0.0 112.02 176.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.6 mm -82.22 -39.56 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 124.168 0.987 . . . . 0.0 109.953 177.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.9 mp -55.21 -38.95 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 123.422 0.689 . . . . 0.0 111.367 177.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 50.0 ptt85 -73.45 -16.86 61.3 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -178.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -85.69 -36.77 20.04 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.121 1.368 . . . . 0.0 111.297 171.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -70.74 -28.83 65.0 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.485 1.114 . . . . 0.0 112.029 174.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -76.43 168.34 20.24 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 167.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 122.6 -21.86 7.49 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 127.128 2.299 . . . . 0.0 112.554 -176.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 26.3 mp0 -92.5 -19.98 21.43 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.513 1.125 . . . . 0.0 112.256 173.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.9 m 79.66 16.19 0.86 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 126.984 2.113 . . . . 0.0 113.395 168.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.1 173.26 10.34 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 122.557 1.17 . . . . 0.0 111.477 172.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.7 mptt -97.74 139.09 34.14 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.512 1.525 . . . . 0.0 110.351 -179.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -162.15 160.93 27.8 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 124.072 0.949 . . . . 0.0 113.127 173.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 12.8 pt -139.72 153.22 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 125.996 1.718 . . . . 0.0 109.937 175.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.2 mp -116.5 133.31 63.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 C-N-CA 125.337 1.455 . . . . 0.0 109.146 -179.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -132.54 142.81 49.35 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 124.825 1.25 . . . . 0.0 111.815 -176.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -65.56 121.69 15.51 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.518 1.127 . . . . 0.0 111.944 177.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -78.82 -19.87 51.03 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 178.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 26.0 mmm180 -73.31 -40.65 64.34 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.468 1.107 . . . . 0.0 112.527 -175.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 32.6 m -73.55 147.78 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 124.013 0.925 . . . . 0.0 111.892 175.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -62.22 -42.02 98.92 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.574 1.149 . . . . 0.0 113.225 -172.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -77.32 -11.32 59.82 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 113.785 1.032 . . . . 0.0 113.785 -176.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 81.6 m 51.03 60.31 3.97 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.451 1.5 . . . . 0.0 111.776 -170.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.06 137.51 55.07 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.749 0.82 . . . . 0.0 112.023 -176.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 41.4 t -63.71 123.79 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 123.723 0.809 . . . . 0.0 109.263 174.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.6 pt -103.83 -19.74 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.727 1.211 . . . . 0.0 112.298 175.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -154.08 143.72 21.66 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.34 1.056 . . . . 0.0 111.506 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 4.2 m -125.62 157.63 36.73 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.816 1.246 . . . . 0.0 111.594 174.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -73.79 -149.95 0.02 OUTLIER 'General case' 0 CA--C 1.56 1.364 0 CA-C-N 118.622 0.646 . . . . 0.0 111.399 169.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -116.72 -18.69 10.2 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 120.425 -1.422 . . . . 0.0 113.266 163.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -76.0 -34.98 45.83 Favored Glycine 0 N--CA 1.471 0.99 0 O-C-N 121.276 -0.89 . . . . 0.0 112.684 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -55.29 -39.12 69.5 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.857 1.263 . . . . 0.0 111.605 177.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 2.8 t -54.6 -56.76 15.65 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.69 1.596 . . . . 0.0 112.09 176.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -71.31 -20.54 62.18 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -179.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.8 -53.51 56.96 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.64 1.176 . . . . 0.0 110.947 175.129 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 75.9 m -104.94 -31.97 8.99 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 -174.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 109.72 0.12 30.55 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 127.207 2.337 . . . . 0.0 115.945 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -79.58 -160.75 0.28 Allowed 'General case' 0 CA--C 1.554 1.102 0 CA-C-N 118.786 1.293 . . . . 0.0 112.466 177.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 69.8 m -145.01 160.91 40.62 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.055 1.342 . . . . 0.0 110.582 174.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -53.03 -44.11 67.09 Favored 'General case' 0 N--CA 1.478 0.956 0 O-C-N 121.355 -0.841 . . . . 0.0 111.668 177.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.69 -25.95 42.45 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 176.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -91.69 -39.46 11.82 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.024 1.33 . . . . 0.0 112.176 177.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 87.4 t -80.81 -15.84 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 124.502 1.121 . . . . 0.0 112.277 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 68.2 mmm -65.72 137.87 57.58 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 120.843 -1.16 . . . . 0.0 111.34 172.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 29.7 tp60 72.92 6.14 5.29 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 126.508 1.923 . . . . 0.0 113.633 -177.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 34.6 mmt180 -86.88 153.1 54.61 Favored Pre-proline 0 N--CA 1.473 0.699 0 C-N-CA 124.548 1.139 . . . . 0.0 110.84 176.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -71.52 136.01 27.56 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.109 2.539 . . . . 0.0 110.092 171.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 19.0 p -68.69 -7.67 35.53 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -176.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 41.2 p -62.3 -23.97 67.04 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.065 1.346 . . . . 0.0 112.124 168.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 84.0 m 57.69 36.5 26.69 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.617 1.567 . . . . 0.0 113.009 178.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -56.16 -29.44 60.81 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.766 1.226 . . . . 0.0 112.24 177.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -60.62 -13.68 15.84 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.852 1.261 . . . . 0.0 114.357 175.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.3 mt -90.35 -0.65 57.73 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.112 1.365 . . . . 0.0 113.853 174.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -70.96 161.52 30.95 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 -178.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -160.85 -164.62 16.08 Favored Glycine 0 CA--C 1.538 1.52 0 C-N-CA 126.857 2.17 . . . . 0.0 111.052 166.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -63.54 -20.47 69.6 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 123.083 2.522 . . . . 0.0 114.523 -176.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 27.1 mmt85 -88.66 -8.54 54.43 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 119.298 0.954 . . . . 0.0 113.306 175.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 28.7 m -73.7 132.4 42.65 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 119.464 1.029 . . . . 0.0 109.502 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 -87.07 122.16 30.52 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.366 0.666 . . . . 0.0 109.761 -169.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 31.9 mmm180 -58.86 -39.17 80.53 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.771 0.828 . . . . 0.0 112.608 -175.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 17.6 ttm180 -67.99 -35.79 78.93 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.649 0.779 . . . . 0.0 112.31 176.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -71.6 -43.07 66.87 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.061 -1.024 . . . . 0.0 112.217 179.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -56.15 -33.38 65.16 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.161 0.584 . . . . 0.0 111.83 171.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -72.37 -47.65 47.78 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 124.703 1.201 . . . . 0.0 112.259 172.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 13.6 mm-40 -62.28 -34.25 76.2 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 118.404 -0.808 . . . . 0.0 111.775 -179.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 90.7 mt -62.61 -40.06 86.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 CA-C-N 120.198 1.363 . . . . 0.0 111.557 171.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.86 -37.08 81.39 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 119.296 0.953 . . . . 0.0 112.361 174.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 -67.65 -32.18 72.69 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 121.591 -0.693 . . . . 0.0 112.04 173.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.43 -21.97 66.61 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 119.239 0.927 . . . . 0.0 112.761 176.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 41.1 mt -83.38 -14.87 51.82 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.282 1.433 . . . . 0.0 113.134 172.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 74.8 mt -89.9 -16.89 29.07 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.003 0.921 . . . . 0.0 112.01 171.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -83.31 145.52 23.16 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 125.159 1.361 . . . . 0.0 112.5 176.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.81 -4.63 56.49 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -179.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -125.57 160.92 28.37 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.452 1.901 . . . . 0.0 110.652 -178.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -65.11 147.17 53.95 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -176.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.48 123.84 5.91 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.627 1.171 . . . . 0.0 111.147 -164.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 44.1 mtmt -97.65 141.84 30.19 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.2 1.4 . . . . 0.0 112.735 176.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 56.8 t -139.2 138.63 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 126.356 1.863 . . . . 0.0 108.738 174.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -102.15 129.93 48.65 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.163 0.985 . . . . 0.0 110.713 177.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.8 tt -153.22 148.2 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 124.614 1.166 . . . . 0.0 111.847 -168.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -87.78 119.06 27.74 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 120.969 -1.082 . . . . 0.0 111.472 176.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 13.7 m-30 -106.46 140.25 39.66 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.991 1.716 . . . . 0.0 110.9 174.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -92.69 142.3 27.52 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.022 0.929 . . . . 0.0 112.805 176.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 43.0 ttm-85 -80.2 156.57 26.86 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.629 1.972 . . . . 0.0 110.404 174.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 25.6 mmmt -58.02 -26.53 62.55 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 176.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -78.58 -5.98 54.3 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.635 1.574 . . . . 0.0 113.984 177.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 92.14 1.46 69.71 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 125.039 1.304 . . . . 0.0 114.455 -176.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 8.6 t -77.45 178.44 7.19 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 118.319 1.059 . . . . 0.0 111.763 171.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 39.4 t -151.42 154.77 37.27 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.78 1.232 . . . . 0.0 112.376 -170.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -158.81 154.4 26.08 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.232 1.813 . . . . 0.0 110.882 179.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -81.22 124.78 29.58 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 121.815 0.817 . . . . 0.0 110.403 170.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 36.6 t -111.59 140.8 45.91 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.638 1.975 . . . . 0.0 110.801 177.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 18.8 tp -93.15 115.72 28.35 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.996 1.318 . . . . 0.0 108.163 165.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 81.4 t -99.37 118.22 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 171.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -109.69 109.42 20.14 Favored 'General case' 0 C--O 1.225 -0.198 0 C-N-CA 125.689 1.596 . . . . 0.0 108.411 172.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 71.5 t -78.66 130.43 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 169.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 78.1 t -117.22 111.33 40.4 Favored Pre-proline 0 N--CA 1.466 0.361 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 167.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.83 133.79 18.99 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.751 2.301 . . . . 0.0 109.884 179.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 41.1 t -91.74 119.62 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 173.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 66.0 mttt -92.96 151.9 19.65 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.649 0.738 . . . . 0.0 112.365 167.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -92.2 -173.87 3.57 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.959 0.904 . . . . 0.0 111.7 175.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -60.81 -21.3 62.99 Favored 'General case' 0 CA--C 1.548 0.865 0 C-N-CA 125.083 1.353 . . . . 0.0 114.553 178.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -93.99 -0.42 55.54 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.396 1.078 . . . . 0.0 113.105 177.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 77.48 19.87 75.56 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 124.173 0.892 . . . . 0.0 114.465 179.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -98.73 146.81 25.51 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.796 1.238 . . . . 0.0 109.393 172.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 84.1 t -77.2 127.97 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 177.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 3.3 pt -123.39 -23.15 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 -171.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 72.2 mtm -150.58 157.42 42.97 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.855 1.662 . . . . 0.0 110.487 178.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -115.24 132.22 56.68 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 124.683 1.193 . . . . 0.0 109.98 173.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 46.7 mt -97.18 114.84 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 105.647 -1.983 . . . . 0.0 105.647 164.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -92.98 117.91 30.58 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 171.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -107.53 129.76 54.94 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 119.478 -0.296 . . . . 0.0 111.02 178.216 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -109.39 143.18 39.31 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.111 1.364 . . . . 0.0 111.928 -176.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -145.36 145.34 31.15 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 126.007 1.723 . . . . 0.0 108.553 172.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 60.7 t -84.49 117.02 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 174.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.0 p -93.17 -25.97 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -179.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 44.6 tpp -165.28 123.68 1.65 Allowed 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.799 1.24 . . . . 0.0 110.75 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -84.36 123.51 30.27 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 121.562 -0.711 . . . . 0.0 109.819 174.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.255 1.357 0 CA-C-O 115.744 -2.074 . . . . 0.0 115.463 -170.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.4 mtt . . . . . 0 N--CA 1.497 1.882 0 CA-C-O 118.771 -0.633 . . . . 0.0 110.944 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -72.39 160.97 45.62 Favored 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 123.723 2.949 . . . . 0.0 112.149 179.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 67.9 t -83.55 125.33 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 123.883 0.873 . . . . 0.0 109.712 178.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 43.4 ttt-85 -66.63 113.52 4.86 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.272 1.029 . . . . 0.0 111.088 179.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 9.8 ttm-85 48.72 28.99 2.03 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 127.458 2.303 . . . . 0.0 116.787 176.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.86 117.4 5.8 Favored Glycine 0 N--CA 1.472 1.076 0 C-N-CA 124.988 1.28 . . . . 0.0 111.196 178.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 7.6 p-80 -167.98 165.93 13.44 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.856 1.662 . . . . 0.0 111.708 -178.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 42.0 t -139.05 141.65 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 125.909 1.684 . . . . 0.0 108.637 174.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.59 150.69 55.44 Favored Pre-proline 0 CA--C 1.551 0.99 0 C-N-CA 124.263 1.025 . . . . 0.0 112.354 176.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -64.46 116.36 3.72 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.857 2.371 . . . . 0.0 110.636 -176.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 72.5 mm-40 -75.39 -35.38 61.08 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.468 0.707 . . . . 0.0 110.974 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -86.49 58.5 5.1 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.625 1.97 . . . . 0.0 111.749 177.638 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 43.2 p -50.92 -33.35 23.95 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 126.869 2.067 . . . . 0.0 113.749 -178.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -67.87 -47.72 68.11 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.94 0.896 . . . . 0.0 112.116 175.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 39.4 tp -63.15 -36.53 83.92 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.88 1.272 . . . . 0.0 111.072 175.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -59.93 -29.61 68.5 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.667 0.787 . . . . 0.0 112.815 179.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 73.8 m -72.74 -21.43 61.03 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.227 1.411 . . . . 0.0 111.935 173.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.7 mm -87.42 -42.71 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.087 1.355 . . . . 0.0 110.819 173.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 93.5 mt -53.68 -45.25 60.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 124.036 0.934 . . . . 0.0 110.598 178.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -66.09 -24.6 66.73 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 -179.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -79.06 -33.41 44.64 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.602 1.161 . . . . 0.0 111.949 175.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -73.56 -34.17 65.02 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.144 0.978 . . . . 0.0 111.496 170.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.45 178.39 5.3 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 114.395 1.257 . . . . 0.0 114.395 178.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 102.79 12.09 33.25 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 126.596 2.046 . . . . 0.0 112.039 -160.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -133.64 -24.3 1.77 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.636 1.174 . . . . 0.0 113.177 -171.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 75.29 16.57 2.69 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 126.114 1.766 . . . . 0.0 114.38 168.074 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? -73.0 166.42 23.11 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 120.771 -1.206 . . . . 0.0 111.883 174.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.5 mptt -89.96 134.83 34.0 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.351 1.46 . . . . 0.0 110.393 -177.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -159.4 161.7 35.65 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 124.289 1.036 . . . . 0.0 113.17 178.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 20.7 pt -140.02 161.46 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 126.671 1.988 . . . . 0.0 109.733 173.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.9 mp -126.26 133.88 67.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 C-N-CA 124.813 1.245 . . . . 0.0 109.545 177.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -130.85 144.71 51.65 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.673 1.189 . . . . 0.0 111.477 178.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -72.78 125.06 26.63 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 122.844 0.458 . . . . 0.0 111.436 178.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.22 -32.6 70.55 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.341 1.056 . . . . 0.0 112.412 -177.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 25.0 mmm180 -80.11 36.52 0.35 Allowed 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 126.082 1.753 . . . . 0.0 112.796 -173.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 70.3 t -144.07 133.38 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 126.719 2.008 . . . . 0.0 108.977 -171.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -56.61 -35.92 68.83 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 -172.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -103.05 -3.86 25.38 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.544 1.538 . . . . 0.0 113.05 -178.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 5.9 t 52.14 71.37 0.47 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 126.372 1.869 . . . . 0.0 111.664 -174.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.74 133.82 50.94 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 121.254 -0.904 . . . . 0.0 111.658 -176.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 15.6 t -62.62 120.66 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 CA-C-N 118.705 0.684 . . . . 0.0 109.159 171.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 42.9 pt -102.08 -21.68 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 124.766 1.227 . . . . 0.0 112.26 176.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -152.18 144.42 23.95 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.363 1.065 . . . . 0.0 111.575 178.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.433 ' HB3' ' CE1' ' A' ' 48' ' ' PHE . 0.6 OUTLIER -135.04 149.14 50.08 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.491 1.116 . . . . 0.0 111.53 -178.942 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -76.57 -168.96 1.1 Allowed 'General case' 0 CA--C 1.555 1.164 0 CA-C-N 119.226 0.921 . . . . 0.0 111.367 169.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -103.84 -21.63 13.63 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.248 1.419 . . . . 0.0 112.553 169.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.23 -36.18 60.09 Favored Glycine 0 C--N 1.343 0.917 0 O-C-N 121.578 -0.701 . . . . 0.0 112.551 -178.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.433 ' CE1' ' HB3' ' A' ' 44' ' ' CYS . 0.6 OUTLIER -67.68 -30.45 69.98 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 122.98 0.512 . . . . 0.0 111.869 179.53 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 77.6 m -53.53 -52.29 60.14 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.712 1.205 . . . . 0.0 111.757 174.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -71.38 -19.06 62.32 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.966 0.906 . . . . 0.0 113.211 -179.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.3 tp -64.21 -52.83 56.96 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.809 1.244 . . . . 0.0 111.313 179.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 71.0 m -101.87 -19.09 15.43 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 95.12 2.11 62.5 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 125.813 1.673 . . . . 0.0 114.344 177.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -83.95 -175.27 5.72 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.778 1.231 . . . . 0.0 113.224 170.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.439 ' H ' ' CG ' ' A' ' 58' ' ' GLU . 69.1 m -137.34 160.13 39.95 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 121.317 -0.865 . . . . 0.0 111.663 -179.076 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 36.1 ttm180 -46.28 -42.25 14.26 Favored 'General case' 0 N--CA 1.48 1.035 0 O-C-N 121.421 -0.799 . . . . 0.0 112.029 171.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.73 -32.84 63.72 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.899 1.28 . . . . 0.0 113.652 178.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.439 ' CG ' ' H ' ' A' ' 55' ' ' SER . 14.2 pt-20 -99.6 -23.65 14.99 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 177.05 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 85.3 t -85.26 -20.49 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 C-N-CA 124.83 1.252 . . . . 0.0 112.659 176.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 53.3 mmm -63.2 138.12 58.44 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 120.403 -1.436 . . . . 0.0 110.843 175.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 67.97 10.06 7.56 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.429 1.492 . . . . 0.0 114.094 179.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 -85.33 156.43 59.68 Favored Pre-proline 0 N--CA 1.472 0.668 0 C-N-CA 124.716 1.206 . . . . 0.0 111.059 174.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -67.27 127.17 16.17 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.495 2.13 . . . . 0.0 109.415 167.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . 0.426 ' HG ' HD23 ' A' ' 127' ' ' LEU . 9.1 t -69.69 -8.88 51.62 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -172.321 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 37.5 p -59.83 -28.1 67.19 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.893 1.277 . . . . 0.0 112.163 169.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 80.9 m 52.35 36.24 19.32 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.208 1.403 . . . . 0.0 112.726 -177.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -57.67 -30.1 65.18 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.624 1.17 . . . . 0.0 112.327 -177.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -59.03 -14.26 9.05 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.186 1.395 . . . . 0.0 114.211 175.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 89.5 mt -78.73 -4.14 47.72 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 173.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 15.9 p-80 -60.71 150.57 31.83 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-N 120.123 1.328 . . . . 0.0 114.268 178.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -142.84 -162.76 9.42 Favored Glycine 0 CA--C 1.54 1.605 0 C-N-CA 126.64 2.067 . . . . 0.0 112.42 173.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -71.04 -8.83 24.45 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 123.623 2.882 . . . . 0.0 114.122 -178.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 84.8 mmt-85 -107.27 8.04 29.64 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.045 1.338 . . . . 0.0 113.531 175.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 22.2 m -89.95 133.24 34.9 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.89 1.276 . . . . 0.0 109.803 178.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -102.45 137.52 40.58 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.295 1.038 . . . . 0.0 109.871 -179.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 27.8 mmt85 -58.84 -37.88 77.45 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.987 0.915 . . . . 0.0 112.199 -177.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 31.6 tpt180 -59.73 -43.99 93.94 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.486 1.115 . . . . 0.0 112.258 176.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.49 -45.9 74.5 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 121.42 -0.8 . . . . 0.0 112.147 178.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -57.28 -35.66 70.06 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 121.645 -0.659 . . . . 0.0 112.522 174.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -72.15 -44.85 62.47 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 125.186 1.394 . . . . 0.0 112.377 175.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.3 mm100 -60.85 -34.98 75.42 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.946 0.899 . . . . 0.0 111.227 -179.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 93.0 mt -60.63 -41.57 88.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 CA-C-N 119.702 1.137 . . . . 0.0 111.841 169.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.78 -32.22 70.59 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 119.562 1.074 . . . . 0.0 112.805 174.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 73.9 mm-40 -64.19 -37.35 87.14 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 121.475 -0.765 . . . . 0.0 111.232 171.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.96 -23.13 65.1 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 113.229 0.826 . . . . 0.0 113.229 177.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 70.3 mt -87.53 -14.09 41.24 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.433 1.493 . . . . 0.0 114.059 178.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.1 pp -100.84 -8.14 22.89 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 168.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -86.26 146.09 20.85 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 125.18 1.371 . . . . 0.0 112.344 175.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -93.42 1.32 56.9 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.57 1.148 . . . . 0.0 113.601 176.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.14 159.92 23.08 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.071 1.748 . . . . 0.0 111.604 -178.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -62.23 135.24 57.39 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.281 1.432 . . . . 0.0 111.937 178.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -138.82 127.9 23.95 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.506 1.122 . . . . 0.0 112.44 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 37.1 mtmt -101.18 132.26 46.75 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.496 1.518 . . . . 0.0 110.465 167.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 46.8 t -133.38 134.5 57.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 125.597 1.559 . . . . 0.0 108.231 177.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -103.85 132.03 50.49 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.761 0.824 . . . . 0.0 110.666 179.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.3 tt -154.79 150.15 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 124.288 1.035 . . . . 0.0 111.729 -168.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -86.98 127.43 35.09 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 120.998 -1.064 . . . . 0.0 111.747 172.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 17.6 m-30 -114.05 138.92 49.74 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.612 1.965 . . . . 0.0 110.719 171.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -85.5 156.31 20.84 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.382 0.673 . . . . 0.0 112.13 167.156 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -115.02 157.61 23.23 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.061 1.344 . . . . 0.0 113.246 172.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -48.84 -33.59 10.87 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 127.141 2.176 . . . . 0.0 114.637 -178.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -70.57 -10.48 59.39 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.259 1.423 . . . . 0.0 113.895 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 97.09 13.05 47.28 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 125.29 1.424 . . . . 0.0 114.264 178.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 22.9 m -107.51 -177.49 3.36 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.696 1.198 . . . . 0.0 111.242 177.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 25.1 p -148.33 171.14 16.48 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 120.878 -1.138 . . . . 0.0 113.291 176.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 18.2 p90 -160.76 159.98 30.75 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.764 1.626 . . . . 0.0 111.468 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -80.44 123.2 27.85 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 123.528 0.731 . . . . 0.0 110.328 167.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 19.0 t -106.93 134.63 49.79 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.212 1.805 . . . . 0.0 110.356 172.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.0 tt -88.13 118.48 27.74 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 161.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 59.7 t -99.78 110.55 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 124.881 1.272 . . . . 0.0 108.217 169.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -102.89 111.47 23.81 Favored 'General case' 0 C--O 1.227 -0.081 0 C-N-CA 125.426 1.49 . . . . 0.0 108.055 172.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 28.0 t -95.17 124.1 47.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 74.7 t -110.34 115.38 54.38 Favored Pre-proline 0 CA--C 1.537 0.466 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 -178.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -73.96 124.18 8.95 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.947 2.431 . . . . 0.0 109.904 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 88.3 t -98.48 117.12 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 123.328 0.651 . . . . 0.0 109.724 173.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 61.5 mttt -87.39 154.33 20.75 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.883 0.873 . . . . 0.0 112.581 172.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -92.57 -173.53 3.39 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.386 1.075 . . . . 0.0 111.629 175.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -60.18 -22.25 62.69 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.039 1.336 . . . . 0.0 114.416 178.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -90.68 -5.39 55.86 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.058 1.343 . . . . 0.0 113.026 178.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 80.5 22.56 62.12 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 124.425 1.012 . . . . 0.0 114.48 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -108.33 148.38 30.14 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.281 1.432 . . . . 0.0 109.88 172.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.0 p -79.51 125.67 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 123.56 0.744 . . . . 0.0 110.615 179.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.23 -22.86 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 -174.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 56.8 mtm -132.19 154.83 49.17 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.288 1.435 . . . . 0.0 111.857 170.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -117.14 133.52 55.9 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 124.957 1.303 . . . . 0.0 109.27 168.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 55.4 mt -96.59 118.98 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 105.647 -1.982 . . . . 0.0 105.647 166.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.426 HD23 ' HG ' ' A' ' 64' ' ' CYS . 6.9 mp -103.88 117.32 34.06 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 177.66 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -107.71 126.62 52.83 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 123.417 0.448 . . . . 0.0 110.842 -176.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 16.5 m-30 -102.67 134.07 46.65 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.094 1.358 . . . . 0.0 110.49 -177.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -138.08 127.61 24.92 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 124.885 1.274 . . . . 0.0 109.369 176.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 71.5 t -74.43 110.75 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 175.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.3 p -93.99 -23.58 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 123.711 0.804 . . . . 0.0 112.705 -173.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 14.3 tpt -164.4 129.4 2.74 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.113 1.365 . . . . 0.0 110.461 179.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -89.22 124.33 34.27 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.551 0.74 . . . . 0.0 110.339 178.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 6.7 mmpt? . . . . . 0 C--O 1.253 1.273 0 CA-C-O 117.67 -1.157 . . . . 0.0 112.911 178.648 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.5 ttm . . . . . 0 N--CA 1.495 1.8 0 CA-C-O 118.467 -0.777 . . . . 0.0 110.545 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -75.94 155.29 38.61 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 123.547 2.831 . . . . 0.0 111.889 179.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 58.3 t -141.07 134.69 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 125.252 1.421 . . . . 0.0 109.196 176.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 39.6 ptt180 -163.92 166.02 22.12 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.549 1.54 . . . . 0.0 112.575 -177.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 66.16 26.25 10.6 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 126.418 1.887 . . . . 0.0 113.823 169.073 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -140.45 167.9 25.36 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 125.729 1.633 . . . . 0.0 113.632 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 7.0 p-80 -80.39 172.22 14.05 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 124.916 1.287 . . . . 0.0 112.443 173.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.5 p -57.19 129.06 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 124.159 0.983 . . . . 0.0 112.658 -176.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -88.07 152.08 50.18 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 124.815 1.246 . . . . 0.0 111.971 178.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -63.75 134.55 44.33 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.948 2.432 . . . . 0.0 110.061 174.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -73.37 -66.49 0.68 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.905 0.86 . . . . 0.0 110.612 -177.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 52.1 p-10 -147.18 168.19 22.28 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 126.986 2.114 . . . . 0.0 111.026 -171.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 39.0 p -140.49 -51.76 0.48 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.927 1.691 . . . . 0.0 112.41 -170.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -80.0 -48.01 14.02 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.658 0.783 . . . . 0.0 111.642 177.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 61.8 tp -61.67 -33.39 73.9 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.457 1.103 . . . . 0.0 111.314 177.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -55.22 -32.61 62.41 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.405 1.082 . . . . 0.0 113.271 174.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 27.8 m -76.56 -24.73 53.58 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.437 1.495 . . . . 0.0 111.369 176.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 17.0 mm -81.91 -42.32 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 124.059 0.944 . . . . 0.0 110.522 175.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 81.9 mt -54.34 -48.29 68.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 123.862 0.865 . . . . 0.0 110.61 177.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 36.7 ptt180 -65.85 -19.8 66.01 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 -178.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 24.6 mtpp -77.28 -33.1 55.9 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.52 1.055 . . . . 0.0 112.447 172.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -92.97 -12.07 31.68 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.145 1.378 . . . . 0.0 114.293 178.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -59.47 165.08 3.02 Favored 'General case' 0 CA--C 1.552 1.056 0 CA-C-O 122.353 1.073 . . . . 0.0 112.943 165.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -96.67 42.72 2.16 Favored Glycine 0 N--CA 1.468 0.83 0 C-N-CA 125.878 1.704 . . . . 0.0 114.668 -164.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 25.7 mp0 -74.18 62.22 0.91 Allowed 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.151 1.38 . . . . 0.0 111.292 174.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.7 t 95.4 -2.18 0.07 Allowed 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 128.936 2.894 . . . . 0.0 113.828 165.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -82.45 165.53 20.13 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 122.107 0.956 . . . . 0.0 111.645 178.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.3 mptt -98.88 138.61 35.76 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.32 1.448 . . . . 0.0 111.071 -171.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -162.93 161.93 25.96 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.229 1.012 . . . . 0.0 113.57 179.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 18.0 pt -140.88 157.52 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 126.529 1.931 . . . . 0.0 110.37 174.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 13.5 mt -119.27 134.51 62.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 125.897 1.679 . . . . 0.0 109.062 -178.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -135.86 151.27 49.86 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.205 1.402 . . . . 0.0 112.148 -178.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 34.7 p30 -80.3 111.55 16.78 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.133 0.973 . . . . 0.0 113.335 -174.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.8 -25.0 66.25 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 120.594 -1.316 . . . . 0.0 113.815 -173.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 52.3 mtm180 -84.2 -3.17 57.99 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 -173.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.4 t -109.49 137.16 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 125.434 1.494 . . . . 0.0 108.789 178.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -55.63 -41.58 73.73 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.447 1.099 . . . . 0.0 113.292 -172.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.3 p30 -78.03 -14.82 59.37 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 178.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 96.3 m 49.59 61.92 2.91 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.372 1.469 . . . . 0.0 112.492 -174.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.68 136.13 57.97 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.693 0.797 . . . . 0.0 112.448 179.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 43.7 t -60.8 119.4 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 169.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 45.4 pt -100.8 -17.55 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 125.534 1.533 . . . . 0.0 112.315 176.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -157.93 146.83 19.35 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.336 1.055 . . . . 0.0 112.099 178.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.484 ' HB3' ' CE1' ' A' ' 48' ' ' PHE . 1.9 m -131.24 153.8 49.13 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.462 1.105 . . . . 0.0 111.947 177.114 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -76.84 -166.9 0.75 Allowed 'General case' 0 CA--C 1.556 1.201 0 CA-C-N 118.939 0.79 . . . . 0.0 111.673 169.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -105.61 -19.16 13.86 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.496 1.518 . . . . 0.0 112.759 169.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -75.35 -35.99 46.18 Favored Glycine 0 C--N 1.343 0.968 0 O-C-N 121.488 -0.758 . . . . 0.0 112.549 -179.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.484 ' CE1' ' HB3' ' A' ' 44' ' ' CYS . 0.6 OUTLIER -65.4 -34.38 78.16 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.586 0.754 . . . . 0.0 111.59 179.72 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 57.2 m -51.42 -52.24 47.83 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.192 1.397 . . . . 0.0 111.799 172.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -71.85 -20.14 61.86 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -179.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.52 -54.06 42.13 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.51 1.124 . . . . 0.0 110.618 177.015 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 41.9 t -92.83 -32.64 14.56 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.53 1.84 55.47 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.447 1.499 . . . . 0.0 114.185 -175.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -81.69 -165.99 1.1 Allowed 'General case' 0 CA--C 1.555 1.151 0 CA-C-N 118.706 1.253 . . . . 0.0 113.055 171.097 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 32.8 m -142.39 160.02 41.09 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.894 1.278 . . . . 0.0 111.424 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -47.99 -49.16 31.71 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.018 0.927 . . . . 0.0 111.967 178.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.34 -25.9 37.58 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 179.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -89.62 -35.52 15.81 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.856 1.262 . . . . 0.0 112.124 178.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 18.9 t -93.67 -11.03 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.372 1.069 . . . . 0.0 112.659 -176.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 75.4 mmm -68.46 142.72 55.25 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 120.586 -1.321 . . . . 0.0 111.302 170.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 71.14 5.17 5.37 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 126.268 1.827 . . . . 0.0 113.77 -177.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -76.63 155.26 83.5 Favored Pre-proline 0 N--CA 1.475 0.817 0 C-N-CA 124.483 1.113 . . . . 0.0 110.317 173.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -74.58 12.23 1.16 Allowed 'Trans proline' 0 CA--C 1.549 1.234 0 C-N-CA 124.016 3.144 . . . . 0.0 116.273 179.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 5.8 t 75.24 -23.46 0.24 Allowed 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 126.6 1.96 . . . . 0.0 114.154 169.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 39.3 p -64.05 -21.73 66.64 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 127.561 2.344 . . . . 0.0 113.442 173.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 89.0 m 59.55 36.53 22.85 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.85 1.26 . . . . 0.0 113.168 -178.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -52.14 -36.39 51.27 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.797 1.639 . . . . 0.0 112.434 177.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -66.9 -11.39 55.96 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.715 1.206 . . . . 0.0 114.041 179.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 33.7 mt -93.75 -3.15 52.69 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.976 1.31 . . . . 0.0 113.649 171.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -77.95 118.82 20.62 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 121.092 -1.005 . . . . 0.0 110.318 -178.384 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -107.97 -162.95 21.19 Favored Glycine 0 CA--C 1.538 1.529 0 C-N-CA 126.189 1.852 . . . . 0.0 112.605 178.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -69.12 -22.43 35.04 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 123.339 2.693 . . . . 0.0 113.162 179.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 85.5 mtt85 -84.89 -12.2 53.97 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.16 0.984 . . . . 0.0 113.297 177.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 18.4 m -76.93 151.73 35.61 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.645 1.178 . . . . 0.0 111.244 -173.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.8 109.25 18.99 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.027 1.331 . . . . 0.0 109.144 -170.115 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 36.5 mmt180 -64.46 -24.24 67.55 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 121.449 -0.782 . . . . 0.0 112.996 179.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 20.5 tpp180 -58.71 -40.16 82.9 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.344 1.058 . . . . 0.0 112.327 168.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -77.8 -42.05 35.18 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.493 1.517 . . . . 0.0 112.161 175.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -54.18 -37.1 64.12 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 121.559 -0.713 . . . . 0.0 112.167 174.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.95 -47.81 76.32 Favored 'General case' 0 C--O 1.227 -0.113 0 C-N-CA 125.213 1.405 . . . . 0.0 111.291 175.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 22.3 mm-40 -61.51 -38.27 86.76 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 118.136 -0.935 . . . . 0.0 111.039 178.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 96.8 mt -63.16 -45.63 98.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 CA-C-N 120.439 1.472 . . . . 0.0 111.629 172.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.31 -39.48 92.51 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 118.898 0.772 . . . . 0.0 112.779 178.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -76.2 -25.75 55.46 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 124.049 0.94 . . . . 0.0 112.233 176.631 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -58.74 -29.92 67.09 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 120.172 1.351 . . . . 0.0 112.368 175.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 51.6 mt -67.51 -13.34 61.96 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.998 1.719 . . . . 0.0 113.442 175.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 66.9 mt -87.87 -13.62 41.57 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.307 1.043 . . . . 0.0 112.443 174.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -90.8 146.53 18.48 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 125.102 1.334 . . . . 0.0 113.542 -175.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -86.8 -7.74 57.97 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.899 1.279 . . . . 0.0 113.737 173.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -118.32 162.4 18.35 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.491 1.916 . . . . 0.0 111.428 -175.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -64.6 143.14 58.13 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.613 1.165 . . . . 0.0 112.912 -175.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 27.6 mmt180 -139.52 132.42 29.31 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.101 1.36 . . . . 0.0 111.546 176.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 38.3 mtmt -110.72 131.22 55.23 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.413 1.485 . . . . 0.0 109.854 167.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 64.3 t -132.44 137.08 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 125.126 1.371 . . . . 0.0 108.51 177.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -102.2 131.12 48.93 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.139 0.975 . . . . 0.0 110.762 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.3 tt -156.57 147.58 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.005 0.922 . . . . 0.0 112.033 -169.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -88.97 124.39 34.2 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 120.921 -1.112 . . . . 0.0 111.843 178.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 15.2 m-30 -113.02 134.3 54.58 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.702 1.601 . . . . 0.0 111.678 177.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -73.2 146.08 45.8 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.135 1.374 . . . . 0.0 112.308 169.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 32.4 ptt-85 -117.96 150.69 38.82 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.781 1.632 . . . . 0.0 112.609 173.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -61.83 -13.81 27.6 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.974 1.71 . . . . 0.0 114.373 -179.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -67.33 -12.9 61.35 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.548 1.139 . . . . 0.0 112.797 169.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 100.21 30.1 6.46 Favored Glycine 0 C--N 1.341 0.859 0 C-N-CA 124.914 1.245 . . . . 0.0 113.328 174.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 16.5 t -153.4 -168.33 2.97 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 118.303 1.051 . . . . 0.0 111.991 -174.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 27.0 t -146.64 161.13 41.2 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.203 1.401 . . . . 0.0 111.924 -166.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -165.16 163.35 20.36 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.202 1.801 . . . . 0.0 112.301 173.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -79.53 124.74 28.77 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 123.484 0.714 . . . . 0.0 110.783 176.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 34.0 t -107.2 136.85 46.33 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.254 1.822 . . . . 0.0 109.528 170.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 14.2 tp -88.08 123.28 32.6 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 161.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 60.5 t -108.75 116.91 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 125.336 1.454 . . . . 0.0 108.763 177.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -113.13 112.88 24.57 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.348 1.059 . . . . 0.0 108.991 -178.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.3 p -88.74 120.36 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 121.276 0.56 . . . . 0.0 109.706 172.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 90.5 t -104.25 111.76 65.26 Favored Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 125.341 1.456 . . . . 0.0 107.432 175.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.5 122.76 7.65 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 123.093 2.528 . . . . 0.0 109.418 177.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 60.2 t -94.59 117.8 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 174.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 20.3 mtpt -88.68 149.17 23.64 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.469 0.652 . . . . 0.0 111.175 172.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 51.2 p30 -77.77 -173.39 3.02 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.065 1.346 . . . . 0.0 111.997 175.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -66.24 -15.74 63.43 Favored 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 114.749 1.388 . . . . 0.0 114.749 175.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -97.25 -17.14 20.0 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.567 1.147 . . . . 0.0 113.271 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 86.36 40.48 7.36 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 125.846 1.689 . . . . 0.0 113.636 -174.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -115.06 151.31 34.48 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.267 1.427 . . . . 0.0 109.879 159.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.6 p -83.5 126.58 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 CA-C-N 119.055 0.843 . . . . 0.0 110.532 179.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.69 -27.04 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 -173.43 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 61.2 mtm -129.86 150.72 51.03 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.875 1.27 . . . . 0.0 112.117 171.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -110.75 133.22 53.52 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 125.458 1.503 . . . . 0.0 109.104 167.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 32.9 mt -102.8 119.94 51.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 165.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -100.35 119.62 38.71 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 175.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -107.31 127.8 53.88 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.437 1.095 . . . . 0.0 109.505 -177.438 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 16.1 m-30 -104.37 133.65 48.91 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.084 1.354 . . . . 0.0 110.571 -178.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -142.34 118.68 10.85 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 123.899 0.88 . . . . 0.0 109.758 173.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.0 p -68.27 115.01 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 O-C-N 121.437 -0.79 . . . . 0.0 109.525 176.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.3 p -99.57 -26.61 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 125.283 1.433 . . . . 0.0 113.315 -169.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 24.9 ptp -161.43 148.01 14.43 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.173 0.989 . . . . 0.0 112.898 168.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -90.46 130.04 36.57 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.019 0.927 . . . . 0.0 110.732 -179.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 7.0 mmpt? . . . . . 0 C--O 1.254 1.29 0 C-N-CA 124.355 1.062 . . . . 0.0 112.723 175.046 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.3 mtp . . . . . 0 N--CA 1.496 1.866 0 CA-C-O 118.42 -0.8 . . . . 0.0 110.679 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -78.48 155.43 28.2 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 123.507 2.804 . . . . 0.0 111.512 176.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 62.9 t -91.8 86.57 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 170.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 20.9 tpp180 -64.32 -43.57 94.26 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.469 1.108 . . . . 0.0 112.948 -169.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -122.65 147.27 46.64 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.122 1.769 . . . . 0.0 109.692 170.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -81.11 164.47 46.15 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.477 1.037 . . . . 0.0 111.68 171.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 59.4 m-70 -81.55 161.01 23.73 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 124.283 1.033 . . . . 0.0 112.013 176.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -137.44 -67.87 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 C-N-CA 123.685 0.794 . . . . 0.0 111.523 -174.649 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 40.75 55.91 7.76 Favored Pre-proline 0 CA--C 1.562 1.409 0 N-CA-C 117.597 2.443 . . . . 0.0 117.597 -174.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -85.21 36.86 0.56 Allowed 'Trans proline' 0 CA--C 1.544 0.991 1 C-N-CA 126.731 4.954 . . . . 0.0 111.348 176.469 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 -83.97 -159.77 0.4 Allowed 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.716 0.807 . . . . 0.0 109.663 -178.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -73.88 140.98 46.06 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 120.113 -1.617 . . . . 0.0 109.919 167.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 37.1 p -120.98 -45.56 2.37 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.4 1.48 . . . . 0.0 111.719 -172.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -71.54 -46.77 58.62 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.498 0.719 . . . . 0.0 111.221 176.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 64.5 tp -63.15 -36.09 82.46 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.081 0.953 . . . . 0.0 111.138 176.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -59.85 -29.26 68.16 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 174.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 66.3 m -77.04 -19.88 56.6 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.014 1.325 . . . . 0.0 111.505 175.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 22.5 mm -84.33 -43.64 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 125.258 1.423 . . . . 0.0 111.351 170.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 71.6 mt -58.38 -35.54 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 O-C-N 121.424 -0.798 . . . . 0.0 111.022 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -72.47 -7.95 52.53 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 179.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 17.6 mtmt -84.32 -42.08 16.14 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.215 1.406 . . . . 0.0 110.731 171.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -79.72 -40.18 29.49 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.045 1.338 . . . . 0.0 113.054 179.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -81.5 -28.2 34.15 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 118.972 0.806 . . . . 0.0 112.231 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 99.98 97.88 2.21 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 126.436 1.969 . . . . 0.0 112.337 169.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -61.58 -13.76 24.47 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.228 1.411 . . . . 0.0 114.294 178.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.2 m -68.22 -23.74 64.84 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.191 0.996 . . . . 0.0 113.15 170.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -78.35 150.51 33.2 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.193 0.997 . . . . 0.0 109.872 170.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.78 134.61 34.89 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 120.753 -1.217 . . . . 0.0 111.394 178.573 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -157.89 153.64 26.63 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.311 1.044 . . . . 0.0 112.928 178.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 15.2 pt -140.62 150.14 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 125.871 1.668 . . . . 0.0 109.758 175.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.7 mp -114.27 132.29 63.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 125.364 1.466 . . . . 0.0 108.983 -178.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -132.72 147.42 52.32 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 124.9 1.28 . . . . 0.0 111.849 -176.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 24.2 p30 -73.71 119.25 17.67 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.566 0.746 . . . . 0.0 112.217 -178.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.81 -29.13 61.99 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 120.705 -1.247 . . . . 0.0 112.191 -178.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 29.6 mmm180 -74.61 27.48 0.08 Allowed 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 126.486 1.914 . . . . 0.0 114.039 -176.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 84.9 t -147.33 136.61 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 126.942 2.097 . . . . 0.0 108.805 -171.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -56.93 -43.17 81.18 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.596 1.159 . . . . 0.0 113.019 -173.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -80.2 -14.97 58.02 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -177.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 96.5 m 49.85 68.34 0.76 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.614 1.566 . . . . 0.0 111.487 -168.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.26 136.23 44.56 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.562 0.745 . . . . 0.0 111.516 -174.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 39.8 t -63.74 122.48 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 174.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.6 pt -102.99 -19.66 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 124.987 1.315 . . . . 0.0 112.312 175.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -155.3 144.73 21.13 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.886 0.874 . . . . 0.0 112.54 178.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.413 ' HB3' ' CE1' ' A' ' 48' ' ' PHE . 1.8 m -130.63 152.95 49.44 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.767 1.227 . . . . 0.0 112.656 -179.551 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -75.22 -166.8 0.54 Allowed 'General case' 0 CA--C 1.557 1.216 0 C-N-CA 122.905 0.482 . . . . 0.0 112.074 170.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -102.9 -23.07 13.76 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.296 1.438 . . . . 0.0 112.705 168.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.85 -34.0 59.58 Favored Glycine 0 N--CA 1.47 0.917 0 C-N-CA 124.892 1.234 . . . . 0.0 112.754 -177.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.413 ' CE1' ' HB3' ' A' ' 44' ' ' CYS . 0.6 OUTLIER -71.4 -32.87 68.93 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 123.904 0.882 . . . . 0.0 111.268 -176.98 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 6.2 t -53.74 -49.26 68.54 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.637 1.175 . . . . 0.0 111.658 171.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -75.56 -21.19 58.1 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -179.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 47.6 tp -63.6 -48.59 76.73 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 121.488 -0.757 . . . . 0.0 111.198 172.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 17.8 t -103.76 -30.63 10.28 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 -172.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.25 6.79 58.67 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 124.307 0.955 . . . . 0.0 114.568 -176.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -88.42 -155.54 0.33 Allowed 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 118.698 1.249 . . . . 0.0 111.655 169.523 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 12.2 t -162.06 169.12 21.54 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 120.564 -1.335 . . . . 0.0 111.006 175.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -53.51 -44.74 69.32 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.12 0.968 . . . . 0.0 111.394 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.85 -28.49 56.66 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 119.811 1.187 . . . . 0.0 114.025 177.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -92.01 -38.12 12.42 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.854 1.262 . . . . 0.0 112.018 177.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 79.1 t -79.38 -19.07 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 126.057 1.743 . . . . 0.0 111.508 -177.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.39 131.56 50.67 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 120.895 -1.128 . . . . 0.0 110.788 172.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 8.0 tm0? 75.49 5.76 4.05 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 126.229 1.812 . . . . 0.0 113.561 179.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 34.7 mmt180 -85.71 153.01 57.83 Favored Pre-proline 0 N--CA 1.473 0.696 0 C-N-CA 124.536 1.134 . . . . 0.0 111.352 176.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -69.98 134.92 28.66 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 123.133 2.555 . . . . 0.0 109.978 171.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 20.6 p -67.52 -11.57 58.31 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 114.848 1.425 . . . . 0.0 114.848 -174.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 46.9 p -58.44 -30.53 66.98 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.379 1.472 . . . . 0.0 112.114 172.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 91.7 m 51.82 35.21 14.89 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.041 1.336 . . . . 0.0 112.604 -173.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -58.4 -29.72 66.27 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.427 1.091 . . . . 0.0 112.331 -179.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -60.91 -10.36 5.57 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.371 1.468 . . . . 0.0 114.307 175.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 58.0 mt -84.8 2.01 44.18 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.937 1.295 . . . . 0.0 113.952 173.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 13.8 p-80 -66.29 154.5 39.79 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 114.724 1.379 . . . . 0.0 114.724 177.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -151.9 -163.94 11.88 Favored Glycine 0 CA--C 1.54 1.609 0 C-N-CA 127.359 2.409 . . . . 0.0 111.231 167.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.95 -23.08 62.12 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 123.01 2.473 . . . . 0.0 114.916 -173.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 40.1 mmt180 -89.75 -4.28 57.75 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 119.509 1.049 . . . . 0.0 113.644 174.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 31.5 m -73.3 134.18 44.11 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 119.534 1.061 . . . . 0.0 109.532 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 81.2 mm-40 -91.03 117.53 29.66 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -174.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 7.9 tmm_? -59.6 -37.07 77.57 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 121.535 -0.728 . . . . 0.0 112.013 -176.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 25.7 tpt180 -61.22 -40.22 93.2 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.184 0.994 . . . . 0.0 112.087 173.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -71.68 -41.45 68.66 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 120.755 -1.216 . . . . 0.0 112.706 177.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -56.16 -35.03 66.71 Favored 'General case' 0 CA--C 1.546 0.815 0 O-C-N 121.644 -0.66 . . . . 0.0 111.846 172.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.1 -47.76 56.27 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.8 1.24 . . . . 0.0 112.571 172.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -57.71 -37.27 73.23 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 118.764 0.711 . . . . 0.0 111.402 178.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 85.5 mt -62.46 -38.83 82.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 CA-C-N 120.098 1.317 . . . . 0.0 112.068 173.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.71 -38.07 76.8 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 119.326 0.966 . . . . 0.0 112.169 174.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 94.4 mm-40 -66.86 -31.8 72.65 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.55 0.74 . . . . 0.0 111.916 174.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.48 -23.52 66.97 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.997 0.919 . . . . 0.0 112.718 177.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 41.6 mt -82.81 -15.06 53.11 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.255 1.422 . . . . 0.0 113.257 173.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 73.7 mt -90.19 -16.2 29.94 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.236 1.015 . . . . 0.0 112.002 173.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -85.33 148.35 22.96 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 125.238 1.399 . . . . 0.0 112.754 176.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -96.69 4.34 51.91 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 114.279 1.215 . . . . 0.0 114.279 -179.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.32 160.9 30.75 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.349 1.86 . . . . 0.0 110.324 177.214 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -64.53 145.89 55.44 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -178.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 12.5 tpt180 -148.22 129.57 14.77 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.114 1.366 . . . . 0.0 110.94 -172.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 39.7 mtmt -104.55 138.42 40.94 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.514 1.525 . . . . 0.0 111.274 178.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 45.0 t -139.23 134.67 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 125.163 1.385 . . . . 0.0 109.292 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -101.43 128.41 47.64 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.835 0.854 . . . . 0.0 111.082 178.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.5 tt -153.95 147.2 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 124.924 1.29 . . . . 0.0 111.694 -167.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -84.84 123.88 30.96 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 120.716 -1.24 . . . . 0.0 111.462 173.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 10.2 m-30 -105.64 145.32 31.18 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.807 1.643 . . . . 0.0 110.695 172.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -110.61 131.24 55.22 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.232 1.413 . . . . 0.0 111.716 175.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 59.4 mtt180 -71.21 165.5 23.49 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.922 1.689 . . . . 0.0 112.54 174.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -66.47 -23.02 66.2 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.088 0.955 . . . . 0.0 112.753 170.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -73.36 -11.71 60.58 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.626 1.571 . . . . 0.0 113.814 172.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 90.27 -3.95 82.44 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 125.267 1.413 . . . . 0.0 114.352 -175.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 30.4 m -77.25 164.51 25.52 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 118.213 1.007 . . . . 0.0 111.644 175.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 30.6 p -145.91 166.07 27.09 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 120.9 -1.125 . . . . 0.0 114.007 -178.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -165.44 160.49 18.0 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.154 1.781 . . . . 0.0 110.918 -178.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -79.72 121.69 25.64 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.746 0.818 . . . . 0.0 110.453 169.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 44.5 t -105.64 138.48 41.77 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 127.463 2.305 . . . . 0.0 109.687 174.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 15.4 tp -96.65 112.88 24.45 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 164.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 95.7 t -94.51 114.36 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 124.994 1.318 . . . . 0.0 108.564 174.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -106.23 107.59 18.67 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.991 1.316 . . . . 0.0 107.835 175.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 61.3 t -77.78 130.1 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 166.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 88.6 t -119.55 112.49 35.53 Favored Pre-proline 0 CA--C 1.537 0.462 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 167.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -74.59 134.59 18.75 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.738 2.292 . . . . 0.0 109.91 -179.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 45.5 t -92.81 119.4 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 171.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 66.1 mttt -93.01 151.95 19.59 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 121.648 0.737 . . . . 0.0 112.294 168.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -91.61 -173.78 3.66 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.887 0.875 . . . . 0.0 111.66 174.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -60.26 -22.11 62.68 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.986 1.315 . . . . 0.0 114.347 178.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -90.44 -5.6 55.9 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.747 1.219 . . . . 0.0 113.055 178.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 79.15 20.14 70.59 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 124.371 0.986 . . . . 0.0 114.262 -178.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -98.99 146.49 25.97 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.788 1.235 . . . . 0.0 109.46 172.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 96.5 t -76.09 128.49 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 176.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 3.3 pt -122.91 -24.87 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 113.863 1.061 . . . . 0.0 113.863 -172.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 71.4 mtm -147.82 155.09 41.29 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.492 1.517 . . . . 0.0 110.473 177.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -112.26 132.65 54.82 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.453 1.101 . . . . 0.0 109.774 171.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 56.6 mt -97.57 115.93 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 163.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -95.19 125.78 40.07 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 171.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -114.42 123.6 49.86 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 118.65 -0.691 . . . . 0.0 111.713 179.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 17.9 m-30 -108.9 97.6 7.21 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.409 1.484 . . . . 0.0 113.435 -170.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -109.26 112.9 25.31 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 120.231 -1.543 . . . . 0.0 109.743 -177.159 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.3 p -62.86 108.09 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 O-C-N 121.236 -0.915 . . . . 0.0 110.105 173.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.3 p -85.59 -23.77 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 125.199 1.4 . . . . 0.0 112.749 -176.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 32.5 ttm -163.43 124.89 2.41 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.71 1.204 . . . . 0.0 110.686 -175.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -81.12 127.02 32.18 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.216 0.606 . . . . 0.0 109.943 172.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 6.4 mmpt? . . . . . 0 C--O 1.253 1.284 0 C-N-CA 124.701 1.201 . . . . 0.0 112.81 177.232 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.8 mtp . . . . . 0 N--CA 1.496 1.848 0 CA-C-O 116.543 -1.694 . . . . 0.0 112.424 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.61 138.65 32.6 Favored 'Trans proline' 0 C--N 1.359 1.114 0 C-N-CA 122.324 2.016 . . . . 0.0 111.994 -176.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 96.8 t -145.42 129.67 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 125.617 1.567 . . . . 0.0 108.584 175.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 74.6 mtp85 -103.01 125.63 49.85 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.449 1.099 . . . . 0.0 110.432 175.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 51.5 ptt85 -169.13 167.44 10.46 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 126.895 2.078 . . . . 0.0 111.725 -174.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 131.47 -108.87 0.83 Allowed Glycine 0 N--CA 1.473 1.137 0 C-N-CA 125.489 1.519 . . . . 0.0 111.158 -174.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 33.8 p80 -139.83 164.42 30.03 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.925 1.29 . . . . 0.0 111.945 177.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.0 p -69.99 147.06 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 123.83 0.852 . . . . 0.0 111.431 176.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.16 153.28 95.67 Favored Pre-proline 0 CA--C 1.554 1.11 0 C-N-CA 124.216 1.006 . . . . 0.0 112.059 172.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -67.54 152.33 78.55 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 123.15 2.567 . . . . 0.0 111.697 178.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 23.5 mp0 -71.06 160.28 33.18 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.837 1.255 . . . . 0.0 112.333 -177.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -83.01 47.39 1.22 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.374 1.47 . . . . 0.0 113.181 -175.583 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 62.3 p -52.74 -30.52 33.07 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 127.543 2.337 . . . . 0.0 114.117 -173.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -68.97 -52.01 33.58 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.839 0.856 . . . . 0.0 111.715 173.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 57.3 tp -61.61 -35.61 78.35 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.83 1.252 . . . . 0.0 111.155 176.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -57.84 -31.16 66.37 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.829 0.851 . . . . 0.0 113.049 176.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 94.7 m -72.91 -29.64 63.29 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.199 1.0 . . . . 0.0 110.929 174.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 12.3 mm -77.07 -41.88 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 O-C-N 121.606 -0.684 . . . . 0.0 110.163 175.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 92.0 mt -55.36 -49.63 71.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 124.07 0.948 . . . . 0.0 110.435 175.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 11.4 ptm180 -71.85 -19.23 62.0 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -176.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -75.49 -39.92 57.91 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.046 0.939 . . . . 0.0 112.443 168.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -82.29 -27.66 32.2 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.516 1.126 . . . . 0.0 113.199 -179.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -64.73 146.62 54.52 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.933 0.893 . . . . 0.0 111.855 174.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -80.37 52.15 4.29 Favored Glycine 0 N--CA 1.467 0.757 0 C-N-CA 125.433 1.492 . . . . 0.0 113.231 -174.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -76.96 -27.57 54.85 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.087 0.555 . . . . 0.0 112.13 170.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 47.0 m -106.4 -34.97 7.26 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -175.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -113.59 149.42 34.54 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.342 1.457 . . . . 0.0 110.216 178.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.52 149.13 30.07 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.537 1.135 . . . . 0.0 112.328 -173.544 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -165.46 165.52 19.09 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.764 1.226 . . . . 0.0 114.232 -178.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 15.2 pt -144.0 153.1 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 126.978 2.111 . . . . 0.0 109.708 171.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.9 mp -119.57 128.1 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 124.858 1.263 . . . . 0.0 108.795 176.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -120.63 144.56 48.08 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 124.87 1.268 . . . . 0.0 111.413 175.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -68.72 129.51 40.14 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.298 0.639 . . . . 0.0 110.818 172.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -78.44 -26.13 46.13 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 175.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 29.8 mmm180 -76.87 29.06 0.13 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 126.312 1.845 . . . . 0.0 113.894 -174.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.0 m -148.45 148.83 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 126.811 2.044 . . . . 0.0 110.099 -176.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -63.57 -38.13 89.95 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.202 1.001 . . . . 0.0 113.61 -168.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 -89.33 -9.25 51.17 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -174.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 97.6 m 50.65 57.71 6.32 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.603 1.161 . . . . 0.0 111.301 -167.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.26 136.92 52.62 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.028 0.931 . . . . 0.0 112.039 -176.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 46.3 t -63.48 123.03 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.809 0.844 . . . . 0.0 109.723 175.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 38.8 pt -103.18 -19.39 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 125.369 1.468 . . . . 0.0 112.361 175.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -151.91 139.91 20.11 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.537 1.135 . . . . 0.0 110.915 178.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 8.2 m -120.9 157.78 29.11 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.713 0.805 . . . . 0.0 111.818 177.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -69.93 -173.15 0.6 Allowed 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 122.707 0.403 . . . . 0.0 111.324 160.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -116.98 -13.34 10.62 Favored 'General case' 0 N--CA 1.481 1.076 0 O-C-N 120.715 -1.241 . . . . 0.0 112.643 167.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -68.31 -41.07 86.86 Favored Glycine 0 N--CA 1.469 0.837 0 C-N-CA 127.492 2.472 . . . . 0.0 112.951 168.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -65.09 -32.27 73.89 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 123.873 0.869 . . . . 0.0 111.709 -175.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 35.3 t -56.3 -50.61 70.92 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.455 1.902 . . . . 0.0 111.374 170.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -74.39 -25.35 59.43 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 178.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 38.2 tp -62.56 -47.59 83.18 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.955 0.902 . . . . 0.0 111.249 170.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 69.0 m -99.76 -32.9 10.8 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 -168.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 93.39 6.77 62.5 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 125.865 1.697 . . . . 0.0 114.089 -178.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -86.69 -144.93 0.12 Allowed 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.642 1.177 . . . . 0.0 111.397 170.377 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 78.2 p -158.36 165.25 35.19 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.901 1.281 . . . . 0.0 112.302 170.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 45.9 ttm105 -52.39 -46.78 66.4 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.242 0.617 . . . . 0.0 111.278 169.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.04 -30.79 60.32 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 119.467 1.031 . . . . 0.0 113.772 177.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -90.05 -38.53 13.52 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.811 0.844 . . . . 0.0 112.927 178.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 41.0 t -82.21 -11.7 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 124.059 0.943 . . . . 0.0 112.302 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 66.1 mmm -67.07 135.08 53.1 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 120.614 -1.304 . . . . 0.0 110.687 171.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 8.8 tm0? 75.2 4.97 4.22 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 126.614 1.966 . . . . 0.0 113.38 -176.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -88.65 155.14 50.84 Favored Pre-proline 0 N--CA 1.476 0.827 0 C-N-CA 124.657 1.183 . . . . 0.0 111.285 175.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -68.42 139.83 46.39 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 123.271 2.647 . . . . 0.0 110.609 170.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 32.1 p -68.41 -2.96 9.67 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 -178.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 40.6 p -63.47 -31.5 72.68 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.154 1.382 . . . . 0.0 112.236 172.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 81.4 m 51.07 34.86 11.65 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.755 1.222 . . . . 0.0 112.862 -173.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -57.98 -31.17 66.65 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.834 1.253 . . . . 0.0 112.58 -175.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -58.11 -15.6 10.1 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.484 1.514 . . . . 0.0 114.311 176.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 87.9 mt -74.51 -7.65 53.73 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 173.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 17.6 p-80 -60.99 140.19 57.87 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 120.197 1.362 . . . . 0.0 113.259 178.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -124.73 -163.57 11.69 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 126.546 2.022 . . . . 0.0 111.786 171.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -69.91 -21.15 33.17 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 123.15 2.567 . . . . 0.0 113.333 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.15 3.0 55.89 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.501 1.12 . . . . 0.0 113.355 178.754 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 17.3 m -85.76 137.17 32.98 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.092 1.357 . . . . 0.0 109.946 178.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -102.82 131.58 49.6 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.234 1.014 . . . . 0.0 109.997 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 22.4 tpp85 -58.1 -35.17 71.05 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.019 0.927 . . . . 0.0 112.618 -177.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -57.09 -42.02 79.94 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.645 1.178 . . . . 0.0 112.463 177.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -73.12 -43.9 61.02 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.437 -0.789 . . . . 0.0 112.202 177.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.07 -36.15 72.4 Favored 'General case' 0 CA--C 1.545 0.758 0 O-C-N 121.405 -0.809 . . . . 0.0 111.99 174.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.36 -48.02 65.91 Favored 'General case' 0 C--O 1.224 -0.24 0 C-N-CA 125.543 1.537 . . . . 0.0 111.927 173.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -57.43 -39.52 76.4 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 118.286 -0.864 . . . . 0.0 111.215 178.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 97.4 mt -59.92 -45.87 94.61 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 CA-C-N 120.256 1.389 . . . . 0.0 112.003 172.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.9 -36.85 80.92 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 118.827 0.74 . . . . 0.0 112.862 179.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 96.4 mm-40 -69.7 -32.81 71.62 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.707 1.203 . . . . 0.0 111.593 175.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -59.74 -29.99 68.53 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 119.09 0.859 . . . . 0.0 112.786 179.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 56.1 mt -70.86 -15.93 62.67 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.342 1.457 . . . . 0.0 113.215 177.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 60.5 mt -86.25 -13.04 47.97 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.105 0.962 . . . . 0.0 112.351 174.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -91.6 151.79 21.12 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 125.41 1.481 . . . . 0.0 113.078 178.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -93.39 0.07 56.72 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.91 1.284 . . . . 0.0 113.906 177.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -123.16 160.25 26.89 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.946 1.698 . . . . 0.0 111.208 -173.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -60.06 144.79 48.67 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.106 0.963 . . . . 0.0 112.567 -178.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 13.6 tpt180 -150.36 130.71 13.74 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.199 0.999 . . . . 0.0 111.597 -178.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 38.6 mtmt -110.44 132.27 54.32 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.226 1.41 . . . . 0.0 110.412 173.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 42.6 t -130.24 133.23 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 124.989 1.316 . . . . 0.0 108.466 177.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -102.41 134.92 44.94 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.099 0.96 . . . . 0.0 110.482 -179.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.0 tt -159.32 146.22 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.551 0.741 . . . . 0.0 112.08 -166.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -88.38 122.81 32.3 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 121.516 -0.74 . . . . 0.0 110.466 172.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -110.45 148.34 32.25 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.676 1.191 . . . . 0.0 112.092 173.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -107.63 134.38 50.71 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.995 1.718 . . . . 0.0 110.616 177.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -108.6 156.72 19.21 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.822 1.649 . . . . 0.0 111.394 -166.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -64.59 -20.89 66.52 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 -176.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -76.14 -7.26 54.38 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.525 1.13 . . . . 0.0 113.561 175.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 97.06 0.57 59.96 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 125.581 1.562 . . . . 0.0 114.362 -179.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 25.5 m -90.37 164.04 14.47 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.759 1.223 . . . . 0.0 112.383 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 28.3 p -140.23 158.72 43.59 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 121.103 -0.998 . . . . 0.0 111.734 167.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -167.86 160.1 12.08 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.081 1.352 . . . . 0.0 113.019 -178.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -77.81 121.57 24.26 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 124.186 0.994 . . . . 0.0 110.827 176.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 10.6 t -106.24 141.26 37.88 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.056 1.742 . . . . 0.0 109.566 172.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -86.9 133.42 33.61 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 156.343 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.4 t -117.57 117.18 54.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 124.527 1.131 . . . . 0.0 108.446 171.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -113.52 114.01 25.92 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.288 1.035 . . . . 0.0 108.74 -176.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.4 p -86.0 126.94 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 169.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 97.6 t -114.59 106.43 52.31 Favored Pre-proline 0 CA--C 1.537 0.447 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 173.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -74.77 132.56 15.88 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.027 2.485 . . . . 0.0 109.819 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 99.1 t -97.14 110.62 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 172.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 63.4 mttt -82.89 152.81 25.4 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.356 0.598 . . . . 0.0 111.556 167.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -92.68 -173.88 3.48 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.922 0.889 . . . . 0.0 111.829 172.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -60.3 -22.06 62.71 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.158 1.383 . . . . 0.0 114.379 178.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -89.7 -5.61 56.87 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.873 1.269 . . . . 0.0 112.993 177.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 78.65 21.53 68.89 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 124.588 1.089 . . . . 0.0 114.27 -178.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -100.3 143.33 30.62 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.678 1.191 . . . . 0.0 109.216 171.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.7 p -76.69 125.22 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-O 121.806 0.812 . . . . 0.0 110.175 174.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 3.9 pt -116.49 -22.66 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 125.378 1.471 . . . . 0.0 113.543 -171.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 55.4 mtm -145.93 150.2 35.63 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.595 1.558 . . . . 0.0 110.799 175.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -114.43 124.54 52.19 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 125.197 1.399 . . . . 0.0 109.504 172.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 47.3 mt -98.39 114.68 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 169.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -102.17 125.22 48.81 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 175.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -117.74 130.21 56.18 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.142 0.977 . . . . 0.0 110.389 -173.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -106.65 135.42 48.2 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.017 1.327 . . . . 0.0 110.554 -177.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -145.17 136.28 24.86 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.757 1.223 . . . . 0.0 109.27 175.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 43.5 t -74.32 117.63 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 177.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.3 p -96.17 -27.53 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -179.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 47.2 tpp -167.45 141.67 3.68 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.064 1.346 . . . . 0.0 110.723 -178.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -88.91 140.12 29.76 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 121.229 -0.919 . . . . 0.0 111.117 177.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.265 0 CA-C-O 117.468 -1.254 . . . . 0.0 112.951 169.599 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 29.1 p . . . . . 0 N--CA 1.479 1.023 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -71.21 -45.31 63.64 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.848 0.859 . . . . 0.0 111.997 178.244 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 61.5 tp -63.0 -37.08 85.77 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.742 0.817 . . . . 0.0 110.947 176.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -59.17 -28.34 66.51 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 178.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.9 m -67.98 -29.24 68.22 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.839 0.856 . . . . 0.0 111.108 173.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 17.6 mm -74.16 -41.45 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-N 119.017 0.826 . . . . 0.0 109.23 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 3.1 mp -58.94 -46.72 91.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 122.971 0.508 . . . . 0.0 110.269 170.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 84.8 mtm180 -63.49 -35.1 79.33 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 119.125 0.875 . . . . 0.0 113.069 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -69.8 -39.1 76.77 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.172 0.989 . . . . 0.0 112.671 174.034 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -77.37 -33.82 55.13 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.507 1.123 . . . . 0.0 111.988 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 . . . . . 0 CA--C 1.546 0.815 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -175.216 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.47 0.564 0 CA-C-O 122.09 0.947 . . . . 0.0 111.665 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.7 mptt -93.14 133.21 36.55 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 120.911 -1.118 . . . . 0.0 110.693 -177.255 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -161.17 155.05 22.32 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.689 1.196 . . . . 0.0 113.279 178.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 18.4 pt -140.74 152.61 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 125.777 1.631 . . . . 0.0 110.766 177.054 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 14.0 mt -111.05 132.4 59.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 125.856 1.663 . . . . 0.0 108.818 179.161 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -131.47 143.26 50.29 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.673 1.189 . . . . 0.0 111.489 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -67.78 119.22 12.14 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.518 0.727 . . . . 0.0 111.862 176.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -79.67 -19.59 48.67 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -178.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -77.97 -36.62 48.82 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.522 1.129 . . . . 0.0 112.359 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 55.0 t -70.5 130.5 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 125.361 1.464 . . . . 0.0 109.486 171.052 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -60.18 -43.26 96.01 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.289 1.036 . . . . 0.0 113.516 -169.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 20.0 p30 -74.94 -10.04 59.11 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 113.842 1.052 . . . . 0.0 113.842 178.22 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 79.7 m 55.68 65.16 1.53 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.927 1.691 . . . . 0.0 112.662 -175.385 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.61 136.01 57.85 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.472 0.709 . . . . 0.0 112.015 178.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 41.4 t -61.9 121.04 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 169.441 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 42.9 pt -103.68 -17.08 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 125.063 1.345 . . . . 0.0 112.221 175.31 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -159.62 152.32 21.49 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.278 1.031 . . . . 0.0 112.014 175.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 8.1 p -146.49 155.07 42.26 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.51 1.124 . . . . 0.0 112.756 178.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -75.96 -154.18 0.05 OUTLIER 'General case' 0 CA--C 1.558 1.266 0 C-N-CA 123.407 0.683 . . . . 0.0 112.317 -176.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -108.73 -21.83 12.5 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 120.271 -1.518 . . . . 0.0 112.896 165.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -75.84 -37.75 38.26 Favored Glycine 0 C--N 1.343 0.959 0 O-C-N 121.513 -0.742 . . . . 0.0 112.479 -176.383 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -56.92 -41.47 78.23 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.224 1.009 . . . . 0.0 111.109 177.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 40.5 t -57.12 -53.04 62.65 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.978 1.711 . . . . 0.0 112.214 177.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -73.23 -29.1 62.55 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -179.126 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -64.31 -42.25 96.43 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.296 1.438 . . . . 0.0 111.832 177.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 9.1 t -100.06 -28.96 12.79 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.88 11.87 62.95 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 124.916 1.246 . . . . 0.0 114.047 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -87.58 -154.14 0.25 Allowed 'General case' 0 CA--C 1.552 1.036 0 CA-C-N 118.524 1.162 . . . . 0.0 111.419 170.068 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 64.4 m -149.65 158.47 44.2 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.676 1.19 . . . . 0.0 110.787 177.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -48.67 -48.86 39.56 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.976 0.911 . . . . 0.0 111.333 173.11 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.77 -26.54 35.1 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 177.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -92.39 -37.62 12.48 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.61 1.164 . . . . 0.0 112.004 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 93.2 t -86.33 -16.26 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 124.665 1.186 . . . . 0.0 112.205 -178.15 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 87.0 mmm -76.27 143.28 41.02 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 120.91 -1.119 . . . . 0.0 111.058 171.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 24.8 mp0 59.21 36.6 23.86 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.69 1.196 . . . . 0.0 111.15 -169.205 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 88.5 mmt-85 -123.72 154.41 66.95 Favored Pre-proline 0 N--CA 1.472 0.656 0 C-N-CA 125.075 1.35 . . . . 0.0 110.5 169.217 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -68.56 137.17 38.46 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 123.191 2.594 . . . . 0.0 109.67 172.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 21.2 p -65.83 -11.89 49.97 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 -175.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 42.5 p -58.18 -26.06 62.31 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 126.242 1.817 . . . . 0.0 112.967 173.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 74.9 m 57.8 38.63 27.32 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.741 1.216 . . . . 0.0 112.816 178.155 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -56.1 -28.66 58.61 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.143 1.377 . . . . 0.0 113.366 -175.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -57.95 -23.99 56.01 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.828 1.651 . . . . 0.0 113.18 176.191 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 40.1 mt -82.03 -8.67 59.68 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -176.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -71.75 125.32 26.83 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.857 0.863 . . . . 0.0 111.693 -178.283 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -107.83 -162.16 21.17 Favored Glycine 0 CA--C 1.54 1.618 0 C-N-CA 126.452 1.977 . . . . 0.0 112.505 174.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -70.31 -26.23 25.2 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 123.276 2.651 . . . . 0.0 113.14 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 37.2 mmt180 -80.88 -14.24 58.19 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 177.539 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 38.1 m -70.64 138.08 50.45 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.177 0.991 . . . . 0.0 112.281 -167.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -88.65 110.45 20.96 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.514 1.526 . . . . 0.0 109.781 -171.194 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 50.9 tpt85 -61.57 -30.18 70.5 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 121.369 -0.832 . . . . 0.0 112.933 -177.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 20.6 tpt180 -66.96 -38.42 86.06 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.093 1.357 . . . . 0.0 111.64 174.436 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -72.51 -41.54 65.8 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.835 0.854 . . . . 0.0 111.774 175.318 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -54.95 -35.14 63.93 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.173 0.589 . . . . 0.0 111.849 171.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.58 -49.71 51.54 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.403 1.081 . . . . 0.0 111.66 173.013 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 21.9 mm-40 -59.55 -36.63 76.55 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 118.256 -0.878 . . . . 0.0 111.891 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 89.8 mt -60.35 -44.98 97.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 CA-C-N 120.234 1.379 . . . . 0.0 111.613 171.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.89 -40.15 91.29 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 118.88 0.764 . . . . 0.0 112.423 177.5 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -70.07 -28.4 65.4 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.319 0.648 . . . . 0.0 112.333 175.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.475 ' HB1' HG11 ' A' ' 112' ' ' VAL . . . -60.58 -28.99 68.91 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 119.908 1.231 . . . . 0.0 112.47 175.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 43.4 mt -74.22 -13.11 60.74 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.624 1.569 . . . . 0.0 113.381 175.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 67.3 mt -88.47 -16.58 32.37 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.107 0.963 . . . . 0.0 112.203 173.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -88.88 153.62 23.94 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 125.133 1.349 . . . . 0.0 113.425 -179.23 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -93.11 -1.07 56.8 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.102 1.361 . . . . 0.0 113.858 176.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -124.34 159.82 29.47 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 126.173 1.789 . . . . 0.0 111.583 -171.364 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -63.37 141.28 58.82 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.876 1.271 . . . . 0.0 112.201 -178.042 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 23.6 tpt180 -150.86 127.72 11.0 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.281 1.033 . . . . 0.0 112.06 -171.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 40.8 mtmt -106.29 140.66 38.88 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.735 1.214 . . . . 0.0 111.91 171.03 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 66.6 t -137.13 139.18 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 126.074 1.75 . . . . 0.0 108.575 175.336 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -107.37 133.55 51.74 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.242 1.017 . . . . 0.0 111.303 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.2 tt -160.34 146.4 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 123.882 0.873 . . . . 0.0 112.547 -166.282 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -84.68 125.5 32.56 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.122 -0.986 . . . . 0.0 112.154 174.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 20.2 m-30 -115.59 154.05 30.13 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.71 2.004 . . . . 0.0 111.395 171.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -94.26 155.07 17.21 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 123.726 0.81 . . . . 0.0 113.016 166.667 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -104.17 151.29 23.5 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 127.578 2.351 . . . . 0.0 109.729 168.276 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -60.27 -24.85 65.25 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 -174.118 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 53.2 p-10 -71.53 -12.89 61.61 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.185 1.394 . . . . 0.0 114.476 174.223 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 103.76 0.78 45.93 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 126.575 2.036 . . . . 0.0 114.524 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 70.5 m -82.86 162.04 21.73 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 119.406 1.603 . . . . 0.0 112.228 175.389 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 94.2 m -127.35 164.6 21.45 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.477 1.111 . . . . 0.0 112.014 178.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -165.03 149.51 9.02 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.899 1.28 . . . . 0.0 111.787 177.414 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -74.3 118.94 17.84 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 123.707 0.803 . . . . 0.0 109.558 164.175 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 16.3 t -101.3 137.92 39.01 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 126.444 1.898 . . . . 0.0 109.609 173.115 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 20.4 tp -90.44 119.71 30.95 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 159.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 29.6 t -100.88 122.84 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 172.287 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -119.53 111.76 18.51 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.175 1.39 . . . . 0.0 109.761 178.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.475 HG11 ' HB1' ' A' ' 85' ' ' ALA . 7.2 p -87.81 127.12 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-O 121.227 0.537 . . . . 0.0 109.837 172.566 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 90.6 t -113.59 112.09 48.7 Favored Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 125.908 1.683 . . . . 0.0 106.886 177.12 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.43 131.95 14.35 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.984 2.456 . . . . 0.0 110.276 -178.125 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 76.6 t -104.91 116.6 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 123.935 0.894 . . . . 0.0 109.083 174.023 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 62.4 mttt -87.32 153.69 21.27 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.624 0.77 . . . . 0.0 112.4 172.182 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -91.93 -173.77 3.59 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.313 1.045 . . . . 0.0 111.58 175.588 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -61.36 -20.81 63.42 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 179.251 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -95.11 -0.12 53.75 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.878 1.271 . . . . 0.0 113.148 177.244 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 79.71 22.22 64.66 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 124.173 0.892 . . . . 0.0 114.719 176.65 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -107.69 148.49 29.33 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.136 1.374 . . . . 0.0 109.92 171.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.6 p -81.02 122.25 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 123.701 0.8 . . . . 0.0 110.652 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -121.86 -23.79 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -174.096 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 60.9 mtm -129.74 150.5 51.02 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.07 1.348 . . . . 0.0 112.172 169.157 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -110.63 135.39 51.32 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 125.522 1.529 . . . . 0.0 108.978 166.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 53.2 mt -101.01 122.05 52.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 163.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 9.2 mp -103.89 123.62 47.47 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 172.045 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -101.83 150.43 23.17 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.375 1.07 . . . . 0.0 110.858 174.261 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -123.37 135.85 54.36 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.031 1.333 . . . . 0.0 110.601 178.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -142.38 134.12 26.92 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.245 1.418 . . . . 0.0 109.061 179.077 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 57.8 t -79.82 115.85 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 176.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.3 p -95.23 -24.91 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 39.1 tpp -163.94 111.87 1.16 Allowed 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.873 1.269 . . . . 0.0 110.882 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -79.81 127.88 32.76 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 121.16 -0.963 . . . . 0.0 110.99 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 41.8 mttt . . . . . 0 C--O 1.258 1.506 0 C-N-CA 125.245 1.418 . . . . 0.0 112.527 -179.843 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 31.1 p . . . . . 0 N--CA 1.479 0.989 0 N-CA-C 111.701 0.26 . . . . 0.0 111.701 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -65.06 -42.98 93.72 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.614 0.766 . . . . 0.0 111.629 177.079 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 64.7 tp -71.05 -39.78 72.04 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.557 0.743 . . . . 0.0 111.032 172.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -59.79 -27.25 66.4 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 177.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 92.6 m -69.54 -23.69 63.62 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.746 1.218 . . . . 0.0 111.641 174.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 23.6 mm -76.48 -38.16 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 123.923 0.889 . . . . 0.0 109.806 176.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.1 mp -57.7 -33.58 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 O-C-N 121.702 -0.624 . . . . 0.0 110.91 173.271 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 48.5 mtp85 -69.59 -18.95 63.66 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 119.455 1.025 . . . . 0.0 113.332 177.539 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 78.1 mttt -87.68 -38.87 15.48 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 125.096 1.358 . . . . 0.0 111.053 173.356 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -73.88 -18.88 60.86 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.929 1.292 . . . . 0.0 113.337 174.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 . . . . . 0 CA--C 1.543 0.701 0 C-N-CA 125.237 1.415 . . . . 0.0 112.828 172.222 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.0 mmt-85 . . . . . 0 CA--C 1.542 0.65 0 CA-C-O 121.984 0.897 . . . . 0.0 111.928 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -120.99 139.02 53.86 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.107 1.363 . . . . 0.0 110.427 -173.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -165.07 152.77 11.3 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -177.229 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 13.2 pt -140.93 149.35 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 125.969 1.708 . . . . 0.0 110.47 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 19.0 mt -108.87 133.75 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.343 1.457 . . . . 0.0 108.8 179.239 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -131.81 142.87 49.85 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.758 1.223 . . . . 0.0 111.634 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -70.47 124.81 25.1 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.342 0.657 . . . . 0.0 111.698 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.8 -15.77 60.2 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 120.922 -1.111 . . . . 0.0 113.218 -178.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 3.1 mpp_? -98.94 4.81 47.43 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.999 1.72 . . . . 0.0 113.336 -171.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 70.9 t -110.26 138.4 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 126.681 1.993 . . . . 0.0 108.898 179.053 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -54.14 -34.63 60.84 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 116.048 1.87 . . . . 0.0 116.048 -167.413 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -105.86 0.31 25.85 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.168 1.387 . . . . 0.0 113.027 -178.514 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 91.2 m 50.43 66.86 1.03 Allowed 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.875 1.67 . . . . 0.0 111.954 -171.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.88 140.53 58.82 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.154 0.982 . . . . 0.0 111.967 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 63.7 t -63.86 119.88 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 171.288 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 38.3 pt -101.09 -20.64 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.689 1.195 . . . . 0.0 112.341 174.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -154.46 147.57 24.71 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.43 1.092 . . . . 0.0 111.127 177.464 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.453 ' HB2' ' CE1' ' A' ' 48' ' ' PHE . 22.4 p -152.14 154.78 36.54 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 121.024 -1.047 . . . . 0.0 113.424 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -78.77 -168.81 1.53 Allowed 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 123.457 0.703 . . . . 0.0 112.321 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -104.12 -18.6 14.46 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.566 1.546 . . . . 0.0 112.59 169.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.61 -42.46 71.97 Favored Glycine 0 N--CA 1.469 0.895 0 C-N-CA 124.146 0.879 . . . . 0.0 112.253 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.453 ' CE1' ' HB2' ' A' ' 44' ' ' CYS . 0.9 OUTLIER -67.05 -29.31 69.06 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.315 0.646 . . . . 0.0 111.788 -175.853 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 83.7 m -52.64 -51.81 58.42 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.181 1.392 . . . . 0.0 111.808 172.502 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -74.57 -20.46 59.93 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.842 0.857 . . . . 0.0 113.179 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.38 -58.38 7.27 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.031 1.332 . . . . 0.0 110.253 176.164 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 69.2 m -97.73 -15.43 20.34 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 -175.617 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.37 2.16 68.37 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 125.519 1.533 . . . . 0.0 114.046 173.01 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -85.56 -154.52 0.2 Allowed 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 124.798 1.239 . . . . 0.0 111.811 170.674 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 9.5 t -161.22 170.07 20.99 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 120.498 -1.376 . . . . 0.0 111.61 175.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -50.34 -47.91 55.68 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.824 1.25 . . . . 0.0 111.48 177.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.63 -25.96 54.63 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 178.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -92.33 -39.79 11.28 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.284 1.434 . . . . 0.0 111.848 177.155 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 71.3 t -80.7 -17.41 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 125.742 1.617 . . . . 0.0 112.243 -177.089 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 70.0 mtp -60.97 131.15 49.72 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 120.549 -1.344 . . . . 0.0 109.843 173.471 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 14.0 mt-30 70.34 13.11 7.58 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.713 1.605 . . . . 0.0 114.105 -178.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -89.97 153.56 47.2 Favored Pre-proline 0 N--CA 1.475 0.778 0 C-N-CA 124.356 1.062 . . . . 0.0 110.991 172.232 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.53 132.28 23.36 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.995 2.464 . . . . 0.0 110.23 170.39 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 27.3 p -68.42 -9.9 51.64 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 115.105 1.521 . . . . 0.0 115.105 -175.614 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 38.3 p -62.3 -27.45 69.04 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.93 1.292 . . . . 0.0 111.588 168.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 73.4 m 48.89 42.53 20.5 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.506 1.522 . . . . 0.0 112.6 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -56.72 -32.03 65.1 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.159 1.383 . . . . 0.0 112.59 -175.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -59.1 -16.17 17.93 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.965 1.306 . . . . 0.0 114.501 175.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 97.2 mt -76.45 -3.95 39.93 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 174.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -59.7 134.08 56.69 Favored 'General case' 0 CA--C 1.549 0.942 0 CA-C-N 120.382 1.446 . . . . 0.0 113.051 176.431 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -105.2 -175.4 24.35 Favored Glycine 0 CA--C 1.538 1.499 0 C-N-CA 125.435 1.493 . . . . 0.0 111.42 167.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -66.57 -16.61 51.31 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 122.92 2.413 . . . . 0.0 113.674 176.143 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -90.08 -9.27 49.07 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 175.508 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 53.3 m -68.88 132.49 46.83 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 119.651 1.114 . . . . 0.0 110.852 -175.461 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -90.03 130.33 36.23 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.112 0.965 . . . . 0.0 110.323 -179.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -63.42 -31.9 73.18 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.581 0.753 . . . . 0.0 112.261 -175.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 36.5 mmt180 -61.81 -50.57 71.79 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.69 0.796 . . . . 0.0 111.797 172.365 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.24 -37.74 88.18 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 120.331 -1.481 . . . . 0.0 112.964 -178.322 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -56.93 -34.23 67.78 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 170.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -76.19 -42.53 46.03 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 124.886 1.274 . . . . 0.0 112.878 174.454 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -61.49 -33.51 73.9 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 118.598 0.636 . . . . 0.0 110.925 -178.107 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 91.3 mt -62.07 -36.84 76.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 CA-C-N 119.679 1.127 . . . . 0.0 112.315 170.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.89 -37.47 67.29 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 119.343 0.974 . . . . 0.0 112.186 173.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -62.97 -33.13 74.73 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 121.418 -0.802 . . . . 0.0 111.473 172.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.52 -19.76 65.05 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 175.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 43.8 mt -88.43 -18.32 28.55 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.229 1.411 . . . . 0.0 112.799 172.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 83.1 mt -85.12 -21.64 29.19 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.006 0.922 . . . . 0.0 111.667 171.211 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -81.94 143.1 22.95 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 125.156 1.36 . . . . 0.0 112.308 176.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -91.21 -3.18 57.2 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.347 1.059 . . . . 0.0 113.841 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -117.02 161.87 18.7 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.658 1.983 . . . . 0.0 110.804 174.067 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -64.61 145.94 55.42 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 122.276 1.036 . . . . 0.0 113.045 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 44.9 mmt-85 -142.08 135.8 29.5 Favored 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 125.314 1.446 . . . . 0.0 110.442 173.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.4 ptpp? -113.76 134.83 54.53 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 167.3 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 78.2 t -129.05 135.16 62.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 126.144 1.777 . . . . 0.0 107.908 -173.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -99.56 128.84 45.68 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.986 0.914 . . . . 0.0 110.319 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.1 tt -151.14 148.8 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.359 1.063 . . . . 0.0 111.463 -168.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -80.15 124.06 28.45 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 120.774 -1.204 . . . . 0.0 111.304 173.041 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 6.8 m-30 -107.29 136.92 46.28 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.883 1.673 . . . . 0.0 110.384 172.405 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -101.44 128.47 47.63 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.68 1.592 . . . . 0.0 110.955 177.079 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 57.4 ttp180 -94.56 152.55 18.44 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.203 1.801 . . . . 0.0 111.396 -174.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -59.68 -22.7 62.32 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 -174.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -79.91 -13.07 59.64 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.702 1.201 . . . . 0.0 114.069 176.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 107.13 0.59 35.66 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 126.269 1.89 . . . . 0.0 114.699 -178.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 75.0 m -80.42 160.19 25.41 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 119.489 1.644 . . . . 0.0 112.876 176.57 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 15.9 t -136.12 152.45 50.85 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.884 1.273 . . . . 0.0 110.574 176.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -166.97 161.38 14.96 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.369 1.468 . . . . 0.0 111.303 -176.051 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -80.4 121.02 25.19 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.912 0.885 . . . . 0.0 111.129 172.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 49.6 t -102.45 135.69 43.62 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.61 1.964 . . . . 0.0 110.423 171.216 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.1 tt -89.24 116.05 27.19 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 125.627 1.571 . . . . 0.0 107.033 163.205 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 66.5 t -103.06 111.78 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 169.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -101.84 113.6 26.95 Favored 'General case' 0 C--O 1.224 -0.246 0 C-N-CA 126.085 1.754 . . . . 0.0 109.547 172.43 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.416 HG22 HD13 ' A' ' 127' ' ' LEU . 67.5 t -85.99 126.32 40.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 169.579 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 89.7 t -113.22 116.22 46.92 Favored Pre-proline 0 CA--C 1.537 0.469 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 170.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -73.84 133.86 19.07 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 123.43 2.753 . . . . 0.0 110.079 -179.498 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 87.8 t -102.39 116.92 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 N-CA-C 107.902 -1.148 . . . . 0.0 107.902 171.228 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 33.2 mttp -88.86 161.13 16.87 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.447 0.699 . . . . 0.0 112.196 171.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -98.75 -174.13 2.71 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.384 1.074 . . . . 0.0 111.969 172.061 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -60.27 -22.58 63.27 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.276 1.43 . . . . 0.0 114.689 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -90.8 -1.49 57.85 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.161 0.984 . . . . 0.0 113.138 177.391 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 74.86 26.61 66.55 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 124.1 0.857 . . . . 0.0 113.932 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -103.63 146.12 29.05 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.98 1.312 . . . . 0.0 108.79 169.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 11.4 p -78.2 131.02 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-O 121.425 0.631 . . . . 0.0 110.529 175.558 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 2.8 pt -126.6 -21.16 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 124.652 1.181 . . . . 0.0 113.926 -169.136 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 73.6 mtm -148.8 155.65 41.24 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 126.09 1.756 . . . . 0.0 110.132 176.244 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -118.71 131.9 56.15 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 125.085 1.354 . . . . 0.0 109.514 174.298 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 56.6 mt -97.07 115.32 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 106.244 -1.761 . . . . 0.0 106.244 166.143 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.416 HD13 HG22 ' A' ' 112' ' ' VAL . 1.7 mm? -91.76 121.39 33.35 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 171.402 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -113.18 124.79 53.37 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 119.462 -0.304 . . . . 0.0 111.121 178.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 12.2 m-30 -103.46 144.06 31.89 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.301 1.441 . . . . 0.0 111.813 -177.417 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -150.63 135.68 17.63 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.726 1.611 . . . . 0.0 109.281 172.126 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 60.2 t -75.61 115.47 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 CA-C-N 119.53 1.059 . . . . 0.0 108.447 171.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.4 p -93.0 -25.3 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 123.539 0.735 . . . . 0.0 112.646 -178.55 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 30.5 ttm -162.17 118.42 2.01 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.552 1.141 . . . . 0.0 110.567 -176.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -82.08 124.16 29.58 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.679 -0.638 . . . . 0.0 110.021 174.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.255 1.355 0 CA-C-O 115.464 -2.208 . . . . 0.0 116.177 -172.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 13.1 t . . . . . 0 N--CA 1.481 1.1 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -72.43 -46.28 55.78 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 118.813 0.733 . . . . 0.0 111.746 175.241 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 53.9 tp -64.67 -34.04 77.36 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.978 1.311 . . . . 0.0 111.229 171.678 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -56.4 -31.12 63.56 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.731 1.212 . . . . 0.0 112.638 176.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 33.3 m -70.48 -29.98 66.66 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.939 1.296 . . . . 0.0 111.227 174.302 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.2 mm -78.66 -40.13 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 124.325 1.05 . . . . 0.0 110.221 176.299 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.45 ' HA ' ' CE2' ' A' ' 22' ' ' PHE . 87.6 mt -59.79 -44.27 93.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.308 0.643 . . . . 0.0 111.122 176.726 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 51.8 ptt85 -67.51 -24.26 65.55 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -179.098 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -69.03 -42.82 75.83 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.809 0.843 . . . . 0.0 111.671 174.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.45 ' CE2' ' HA ' ' A' ' 19' ' ' ILE . 17.0 p90 -87.0 -31.29 20.65 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 113.75 1.018 . . . . 0.0 113.75 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.908 0 CA-C-N 120.386 1.448 . . . . 0.0 111.388 178.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 18.8 mmm180 . . . . . 0 N--CA 1.47 0.527 0 CA-C-O 122.065 0.936 . . . . 0.0 111.646 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.6 mptt -91.93 125.95 36.83 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.312 -0.868 . . . . 0.0 110.577 -175.272 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -159.14 161.99 36.36 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.1 pt -144.91 155.7 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 127.171 2.188 . . . . 0.0 109.905 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.8 mp -120.51 135.01 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 125.021 1.329 . . . . 0.0 109.334 179.151 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -132.58 153.22 51.22 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.007 1.323 . . . . 0.0 112.32 -176.115 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 29.0 p30 -76.47 118.92 19.64 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.409 1.084 . . . . 0.0 112.738 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.23 -17.22 61.37 Favored 'General case' 0 CA--C 1.547 0.829 0 O-C-N 120.724 -1.235 . . . . 0.0 113.517 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 65.7 mtm-85 -86.23 5.67 33.16 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.701 1.601 . . . . 0.0 114.813 -168.716 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 13.0 m -133.81 158.33 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 125.59 1.556 . . . . 0.0 111.116 -173.283 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -62.46 -40.73 97.58 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.088 0.955 . . . . 0.0 113.505 -173.119 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -85.9 -14.59 44.36 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 114.285 1.216 . . . . 0.0 114.285 -173.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 84.2 m 41.55 69.49 0.35 Allowed 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.777 1.631 . . . . 0.0 112.306 -165.013 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.31 143.18 47.05 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.064 0.945 . . . . 0.0 111.757 -176.442 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 23.8 t -65.98 122.45 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 175.496 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.5 pt -104.25 -14.84 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 125.629 1.572 . . . . 0.0 112.468 176.18 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -157.67 142.79 16.85 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.533 1.133 . . . . 0.0 111.376 176.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.539 ' HB3' ' CE1' ' A' ' 48' ' ' PHE . 2.7 m -130.67 153.3 49.11 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.125 0.97 . . . . 0.0 112.101 -178.157 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -78.46 -168.96 1.5 Allowed 'General case' 0 CA--C 1.554 1.132 0 CA-C-N 118.973 0.806 . . . . 0.0 111.496 165.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -104.01 -21.76 13.56 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.162 1.385 . . . . 0.0 112.975 169.35 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.31 -35.02 60.44 Favored Glycine 0 C--N 1.343 0.95 0 O-C-N 121.5 -0.75 . . . . 0.0 112.436 -177.281 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.539 ' CE1' ' HB3' ' A' ' 44' ' ' CYS . 0.4 OUTLIER -68.78 -30.86 69.53 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.491 0.716 . . . . 0.0 111.885 178.979 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 86.4 m -50.7 -55.32 17.08 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.217 1.407 . . . . 0.0 111.944 176.54 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -70.1 -18.81 63.26 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.168 0.987 . . . . 0.0 113.334 -178.341 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.2 tp -63.89 -46.29 85.53 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.853 1.261 . . . . 0.0 111.878 -178.608 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 73.9 m -110.53 -16.2 13.72 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 178.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.72 -0.06 57.84 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 125.59 1.567 . . . . 0.0 114.395 174.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -82.46 -157.59 0.22 Allowed 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 124.812 1.245 . . . . 0.0 112.217 171.442 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 10.0 t -162.52 170.45 18.63 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 120.522 -1.361 . . . . 0.0 111.485 176.242 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -47.6 -50.99 22.72 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.199 1.4 . . . . 0.0 111.454 176.41 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.99 -25.86 32.85 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -95.78 -38.83 10.15 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.309 1.444 . . . . 0.0 112.241 178.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 76.7 t -83.08 -19.01 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 125.756 1.622 . . . . 0.0 111.938 -176.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 77.1 mmm -66.19 132.38 48.3 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 120.566 -1.334 . . . . 0.0 109.481 173.678 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 73.59 7.97 5.04 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 126.129 1.771 . . . . 0.0 114.292 -175.003 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 -90.03 154.28 47.29 Favored Pre-proline 0 N--CA 1.478 0.934 0 C-N-CA 124.832 1.253 . . . . 0.0 110.427 169.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.46 134.31 26.22 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 123.091 2.527 . . . . 0.0 110.245 175.18 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 24.3 p -69.79 -4.98 22.4 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 114.888 1.44 . . . . 0.0 114.888 -176.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 56.0 p -62.05 -30.22 70.83 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.91 1.284 . . . . 0.0 111.398 165.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 77.9 m 50.62 38.73 19.69 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.003 1.721 . . . . 0.0 112.563 -174.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -57.41 -30.11 64.68 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.615 1.166 . . . . 0.0 112.441 -176.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -59.42 -15.14 15.18 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.743 1.217 . . . . 0.0 114.085 176.029 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 90.9 mt -77.51 -4.76 47.26 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.617 1.167 . . . . 0.0 113.955 172.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 11.4 p-80 -66.86 158.86 29.52 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 120.275 1.398 . . . . 0.0 114.511 179.273 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -155.17 -162.59 11.38 Favored Glycine 0 CA--C 1.537 1.456 0 C-N-CA 126.274 1.893 . . . . 0.0 111.875 168.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.85 -13.88 41.94 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 123.272 2.648 . . . . 0.0 115.143 -175.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -97.0 2.14 51.11 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 119.845 1.202 . . . . 0.0 113.742 173.334 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 20.3 m -87.61 127.43 35.27 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 119.593 1.088 . . . . 0.0 110.553 -177.564 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -86.73 126.41 34.56 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.719 0.807 . . . . 0.0 109.674 -178.413 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 11.7 mpt_? -65.38 -31.93 73.3 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.437 0.695 . . . . 0.0 111.584 -175.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 25.1 tpp180 -58.46 -42.89 88.44 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.542 1.137 . . . . 0.0 112.024 172.142 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -71.03 -43.88 66.97 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.259 -0.901 . . . . 0.0 112.32 177.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -56.99 -36.63 70.61 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 121.826 -0.546 . . . . 0.0 112.039 174.364 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.93 -48.66 57.61 Favored 'General case' 0 C--O 1.223 -0.299 0 C-N-CA 125.101 1.36 . . . . 0.0 111.953 173.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.8 mm100 -58.44 -37.54 75.62 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 118.369 -0.824 . . . . 0.0 111.495 -178.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 93.5 mt -61.08 -45.6 98.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 CA-C-N 120.128 1.331 . . . . 0.0 111.65 170.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.97 -34.21 74.95 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 119.006 0.821 . . . . 0.0 113.09 179.404 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 86.4 mm-40 -71.98 -32.18 66.99 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.164 0.986 . . . . 0.0 111.58 174.185 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -58.3 -32.19 68.22 Favored 'General case' 0 CA--C 1.547 0.857 0 O-C-N 121.213 -0.929 . . . . 0.0 112.214 177.154 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 58.7 mt -70.41 -16.6 62.97 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.952 1.701 . . . . 0.0 113.946 178.224 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.6 pp -104.29 -1.33 27.15 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 119.331 0.969 . . . . 0.0 113.33 170.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -84.68 -20.44 58.18 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 124.719 1.152 . . . . 0.0 114.702 -178.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 56.88 32.19 21.01 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 125.789 1.635 . . . . 0.0 113.385 179.122 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -144.82 163.77 33.07 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.825 1.65 . . . . 0.0 111.246 -171.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -68.67 128.68 37.49 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.897 -0.502 . . . . 0.0 110.674 174.308 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -142.35 133.93 26.68 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.788 1.235 . . . . 0.0 111.841 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 37.6 mtmt -111.06 130.15 55.69 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.285 1.434 . . . . 0.0 109.965 168.226 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.8 t -133.05 137.06 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 125.203 1.401 . . . . 0.0 108.441 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -106.32 130.88 54.08 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.137 0.975 . . . . 0.0 111.249 -175.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.4 tt -155.19 146.92 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 124.065 0.946 . . . . 0.0 112.314 -165.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -83.45 121.02 26.63 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 120.949 -1.094 . . . . 0.0 111.815 174.441 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 13.8 m-30 -109.27 146.85 33.6 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.569 1.947 . . . . 0.0 111.29 173.356 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -110.65 137.31 48.49 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.564 1.546 . . . . 0.0 112.03 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -92.09 154.98 18.38 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 126.472 1.909 . . . . 0.0 111.252 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -58.5 -25.8 62.75 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.559 1.144 . . . . 0.0 113.833 175.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -69.7 -10.83 59.83 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.322 1.449 . . . . 0.0 113.572 176.133 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 93.98 4.28 63.33 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 125.334 1.445 . . . . 0.0 113.93 -178.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 63.7 p -92.04 170.87 9.5 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.789 1.236 . . . . 0.0 112.024 175.444 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 22.1 p -147.36 168.25 22.3 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 121.11 -0.994 . . . . 0.0 112.722 176.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -164.64 155.53 14.86 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.961 1.304 . . . . 0.0 110.722 -173.007 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -77.15 123.55 26.57 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.277 0.56 . . . . 0.0 110.238 167.184 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 19.1 t -106.53 136.03 47.01 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.128 1.771 . . . . 0.0 110.306 172.538 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.0 tp -89.7 120.6 31.11 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 161.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 59.8 t -106.36 117.91 53.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 124.764 1.226 . . . . 0.0 108.521 175.078 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -111.23 113.02 25.21 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.659 1.184 . . . . 0.0 108.436 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.2 p -88.75 128.06 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 168.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 96.1 t -116.8 116.84 38.09 Favored Pre-proline 0 CA--C 1.538 0.507 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 175.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -76.13 138.27 20.2 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 123.038 2.492 . . . . 0.0 110.373 -176.349 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 84.0 t -111.35 123.15 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.836 0.854 . . . . 0.0 109.708 174.568 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 65.0 mttt -95.25 154.73 17.05 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.258 1.023 . . . . 0.0 113.42 173.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -93.66 -173.62 3.23 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.603 1.161 . . . . 0.0 111.872 177.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -58.31 -23.28 55.99 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.374 1.469 . . . . 0.0 114.42 177.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -93.02 -4.63 52.24 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.322 1.449 . . . . 0.0 113.173 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 80.46 22.29 62.74 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 124.226 0.917 . . . . 0.0 114.592 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -107.61 149.66 27.8 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.987 1.315 . . . . 0.0 109.981 173.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 64.0 t -77.26 125.51 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.24 -23.9 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -177.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 62.1 mtm -132.57 155.92 47.8 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.407 1.483 . . . . 0.0 112.479 171.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -119.16 134.09 55.4 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 125.87 1.668 . . . . 0.0 109.443 169.511 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 54.3 mt -97.39 120.02 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 165.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -103.61 127.51 51.03 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 173.428 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -119.98 128.05 53.21 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.402 1.081 . . . . 0.0 109.819 -176.268 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 16.9 m-30 -103.9 138.31 40.65 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.326 1.45 . . . . 0.0 111.016 -176.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -142.4 131.3 22.97 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.622 1.169 . . . . 0.0 109.879 174.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 94.1 t -76.92 111.85 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 176.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 5.0 p -95.86 -26.27 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 123.8 0.84 . . . . 0.0 112.963 -174.054 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 25.0 ptp -162.21 148.06 13.06 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.41 1.084 . . . . 0.0 112.789 163.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -90.37 130.01 36.51 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.953 0.901 . . . . 0.0 110.585 178.233 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 13.1 mmmm . . . . . 0 C--O 1.253 1.263 0 C-N-CA 125.297 1.439 . . . . 0.0 113.805 178.452 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 38.2 p . . . . . 0 N--CA 1.478 0.952 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -76.02 -52.6 9.85 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.062 0.945 . . . . 0.0 111.553 176.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 60.4 tp -58.63 -34.47 71.21 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.43 1.092 . . . . 0.0 111.259 178.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -56.71 -30.97 64.03 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 176.18 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 89.7 m -77.01 -32.75 57.37 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.255 1.022 . . . . 0.0 110.89 175.205 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 20.9 mm -71.64 -39.42 69.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 123.541 0.736 . . . . 0.0 110.5 176.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 71.8 mt -56.31 -44.13 78.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 124.13 0.972 . . . . 0.0 110.753 175.579 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 39.9 mtt180 -59.75 -36.87 77.51 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 119.212 0.915 . . . . 0.0 112.489 177.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -74.0 -37.29 64.47 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.532 1.133 . . . . 0.0 112.071 177.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -79.57 -22.18 44.12 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.998 1.319 . . . . 0.0 112.954 178.369 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 . . . . . 0 N--CA 1.472 0.667 0 CA-C-N 118.817 0.735 . . . . 0.0 112.003 170.927 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? . . . . . 0 N--CA 1.477 0.888 0 CA-C-O 121.458 0.647 . . . . 0.0 110.715 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.4 mptt -88.27 136.51 32.95 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.506 1.123 . . . . 0.0 111.252 -175.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -163.47 167.06 22.02 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.412 1.085 . . . . 0.0 113.544 178.035 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 25.7 pt -144.76 152.1 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 126.617 1.967 . . . . 0.0 109.865 172.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 10.7 mt -117.68 133.61 63.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 125.538 1.535 . . . . 0.0 109.008 -178.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -134.78 152.18 51.55 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.393 1.077 . . . . 0.0 112.353 178.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 14.3 m-20 -74.68 117.99 17.13 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.334 0.653 . . . . 0.0 111.527 178.114 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.32 -20.21 66.03 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.934 0.894 . . . . 0.0 112.274 170.386 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 78.7 mtp85 -66.79 -11.87 56.72 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.825 2.05 . . . . 0.0 115.352 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 20.6 m -124.79 142.03 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 125.357 1.463 . . . . 0.0 111.01 -179.07 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -61.4 -40.68 95.26 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.718 1.207 . . . . 0.0 112.904 -170.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 22.2 p30 -72.32 -14.59 61.78 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 177.196 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 4.8 t 50.98 61.67 3.12 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.716 1.606 . . . . 0.0 111.695 -173.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.64 134.86 56.18 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 120.936 -1.103 . . . . 0.0 112.278 -179.335 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 40.5 t -63.79 122.66 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 C-N-CA 123.07 0.548 . . . . 0.0 109.912 173.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.1 pt -101.46 -21.37 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 125.404 1.482 . . . . 0.0 112.424 175.401 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -152.36 144.09 23.58 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.293 1.037 . . . . 0.0 111.816 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.507 ' HB3' ' CE1' ' A' ' 48' ' ' PHE . 3.1 m -128.07 155.07 44.96 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.056 0.942 . . . . 0.0 112.592 -179.38 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -73.88 -174.22 1.77 Allowed 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 123.159 0.584 . . . . 0.0 111.475 167.055 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -107.52 -17.97 13.97 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.58 1.152 . . . . 0.0 112.801 166.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -73.92 -38.81 48.18 Favored Glycine 0 C--N 1.337 0.599 0 C-N-CA 125.821 1.676 . . . . 0.0 112.734 176.13 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.507 ' CE1' ' HB3' ' A' ' 44' ' ' CYS . 0.3 OUTLIER -62.62 -34.51 77.17 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.207 0.603 . . . . 0.0 111.244 179.606 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 76.6 m -48.19 -56.13 8.67 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.942 1.697 . . . . 0.0 111.941 170.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -70.93 -19.79 62.54 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -177.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.95 -49.48 72.4 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.641 1.177 . . . . 0.0 111.43 177.646 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 76.6 m -107.61 -21.63 12.82 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 -176.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.02 -0.4 57.46 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 125.426 1.488 . . . . 0.0 114.348 178.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -83.08 -171.52 3.61 Favored 'General case' 0 CA--C 1.55 0.964 0 CA-C-N 118.499 1.15 . . . . 0.0 112.698 170.615 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 74.2 m -140.95 162.59 35.12 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.409 1.084 . . . . 0.0 111.312 178.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -46.37 -49.55 17.7 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.282 1.033 . . . . 0.0 112.025 176.192 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.96 -24.78 59.47 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -89.21 -39.31 13.63 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.765 1.226 . . . . 0.0 111.67 177.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 19.8 t -88.63 -12.46 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 124.107 0.963 . . . . 0.0 112.513 -176.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 75.4 mtp -64.35 139.33 58.75 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 120.463 -1.398 . . . . 0.0 111.276 168.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 69.37 6.89 5.93 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 126.301 1.841 . . . . 0.0 113.896 -177.053 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 32.4 mmt180 -83.85 154.58 64.65 Favored Pre-proline 0 N--CA 1.472 0.643 0 C-N-CA 124.23 1.012 . . . . 0.0 110.59 172.119 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -68.94 131.04 21.5 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.866 2.377 . . . . 0.0 109.671 170.219 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 6.7 t -66.04 -14.41 61.64 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.165 1.386 . . . . 0.0 114.069 -172.335 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 33.9 p -59.39 -24.27 63.3 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.863 1.665 . . . . 0.0 112.908 169.435 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 76.9 m 57.51 42.81 23.82 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.186 1.394 . . . . 0.0 111.76 -178.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -71.97 18.79 0.08 Allowed 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 127.519 2.328 . . . . 0.0 113.39 -175.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -112.46 -12.3 13.52 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 126.889 2.076 . . . . 0.0 112.747 170.334 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 78.6 mt -81.18 -9.62 59.76 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 114.801 1.408 . . . . 0.0 114.801 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 12.0 p80 -69.02 160.33 31.16 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 179.065 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -151.96 -161.37 10.12 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 126.1 1.81 . . . . 0.0 111.357 168.03 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -65.74 -18.54 58.58 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 122.961 2.441 . . . . 0.0 114.287 -177.07 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.5 tpm_? -88.15 -6.95 57.58 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 119.273 0.942 . . . . 0.0 113.106 176.504 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.8 m -85.92 137.81 32.47 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.382 1.473 . . . . 0.0 109.77 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -102.5 135.41 44.19 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.21 1.004 . . . . 0.0 110.269 -178.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 19.3 tpp180 -58.6 -36.37 73.9 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.359 1.064 . . . . 0.0 112.383 -178.077 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 21.1 tpp85 -55.5 -45.91 77.01 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.15 1.38 . . . . 0.0 112.118 176.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.77 -46.4 68.84 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.753 0.821 . . . . 0.0 111.773 178.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.82 -34.44 65.38 Favored 'General case' 0 CA--C 1.545 0.784 0 O-C-N 121.488 -0.758 . . . . 0.0 112.359 175.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.41 -40.57 70.4 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 125.27 1.428 . . . . 0.0 113.033 173.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -61.17 -30.55 70.47 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 118.061 -0.971 . . . . 0.0 112.174 178.25 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 58.0 mt -63.76 -47.28 91.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 CA-C-N 120.039 1.29 . . . . 0.0 110.273 172.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.89 -34.43 77.38 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 121.582 -0.699 . . . . 0.0 112.483 176.578 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 73.7 mm-40 -69.64 -31.32 69.34 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 121.481 -0.762 . . . . 0.0 112.194 171.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.5 -28.12 66.73 Favored 'General case' 0 CA--C 1.545 0.778 0 O-C-N 120.98 -1.075 . . . . 0.0 111.666 176.058 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 74.4 mt -73.97 -14.25 61.0 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.94 1.296 . . . . 0.0 113.655 169.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 94.3 mt -94.89 -10.64 30.58 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.249 1.02 . . . . 0.0 112.653 172.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -87.65 143.8 18.62 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 125.077 1.322 . . . . 0.0 112.9 177.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.5 -3.5 58.34 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.751 1.22 . . . . 0.0 113.801 175.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -125.62 165.17 19.03 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.578 1.951 . . . . 0.0 110.974 -175.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -61.62 139.79 58.23 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.014 0.926 . . . . 0.0 112.039 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.17 123.75 8.47 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.318 1.047 . . . . 0.0 110.872 -173.078 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -89.18 153.0 21.29 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.399 1.079 . . . . 0.0 113.719 169.108 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 46.1 t -138.73 134.48 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 126.808 2.043 . . . . 0.0 107.628 167.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -102.98 121.2 42.05 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.609 0.763 . . . . 0.0 109.15 173.474 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.5 tt -147.25 145.46 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 123.925 0.89 . . . . 0.0 112.212 -169.261 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -84.29 119.51 25.14 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.332 -0.855 . . . . 0.0 111.75 175.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 15.9 m-30 -107.07 150.43 26.55 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.544 1.938 . . . . 0.0 110.908 172.455 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -109.89 136.7 48.77 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.983 1.313 . . . . 0.0 111.871 175.17 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -86.37 168.24 14.01 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.744 0.818 . . . . 0.0 112.593 173.291 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -58.23 -30.96 66.91 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 125.684 1.593 . . . . 0.0 113.511 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -76.37 -6.32 51.07 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.946 1.299 . . . . 0.0 113.439 178.257 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 93.63 1.34 66.07 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 125.63 1.586 . . . . 0.0 114.541 178.443 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.4 m -80.32 154.02 28.04 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 118.766 1.283 . . . . 0.0 111.743 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 39.1 t -117.42 150.6 38.61 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.822 1.249 . . . . 0.0 111.733 -178.133 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -159.56 146.14 16.43 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.968 1.307 . . . . 0.0 111.412 178.524 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -71.02 123.86 23.04 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.279 0.632 . . . . 0.0 110.974 165.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 47.0 t -106.78 133.71 51.03 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.627 1.971 . . . . 0.0 109.672 169.48 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.0 tt -85.41 113.61 21.83 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.515 1.526 . . . . 0.0 107.075 162.179 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 63.9 t -98.1 110.93 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 124.82 1.248 . . . . 0.0 107.646 170.055 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -102.33 120.07 39.87 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 120.435 1.47 . . . . 0.0 108.733 167.032 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.407 HG22 HD13 ' A' ' 127' ' ' LEU . 67.5 t -82.66 135.79 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 170.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 48.5 t -115.25 111.2 44.73 Favored Pre-proline 0 CA--C 1.535 0.403 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 169.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.45 133.25 14.28 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.011 2.474 . . . . 0.0 109.741 178.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 94.6 t -107.8 123.55 63.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 123.98 0.912 . . . . 0.0 109.783 179.105 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 67.2 mttt -91.6 154.08 19.29 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.242 0.831 . . . . 0.0 113.242 170.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -92.7 -174.56 3.68 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.285 1.034 . . . . 0.0 110.765 173.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -66.1 -18.93 65.66 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -85.34 -5.79 59.28 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.318 1.047 . . . . 0.0 112.455 174.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 78.68 23.05 65.41 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 124.581 1.086 . . . . 0.0 114.385 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -107.88 150.31 27.21 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.542 1.537 . . . . 0.0 109.937 172.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 90.4 t -78.61 124.93 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 123.684 0.794 . . . . 0.0 109.202 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.22 -24.74 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 -175.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 51.9 mtm -130.2 152.22 49.86 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.822 1.249 . . . . 0.0 112.473 171.077 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -113.34 135.81 53.45 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 125.164 1.386 . . . . 0.0 109.081 166.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 49.6 mt -103.07 119.56 51.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 166.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.407 HD13 HG22 ' A' ' 112' ' ' VAL . 1.6 mm? -95.84 117.97 31.59 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 173.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -111.08 129.42 55.93 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 117.773 0.261 . . . . 0.0 110.978 -179.452 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 17.6 m-30 -107.62 137.91 44.79 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.481 1.512 . . . . 0.0 111.7 -171.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -144.54 116.99 8.55 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.568 1.147 . . . . 0.0 109.779 172.389 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.1 p -66.68 115.63 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 O-C-N 121.363 -0.836 . . . . 0.0 109.883 175.309 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 9.2 p -99.83 -27.04 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.904 1.281 . . . . 0.0 113.394 -171.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 25.1 ptp -162.69 149.93 13.4 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.328 1.051 . . . . 0.0 113.104 167.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -89.18 136.46 33.01 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.722 0.809 . . . . 0.0 111.037 177.36 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt . . . . . 0 C--O 1.254 1.326 0 C-N-CA 125.317 1.447 . . . . 0.0 112.732 175.875 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 25.9 p . . . . . 0 N--CA 1.484 1.252 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -65.01 -41.65 95.13 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.848 0.859 . . . . 0.0 112.481 -177.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 61.5 tp -72.79 -40.01 66.24 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.563 1.145 . . . . 0.0 111.098 173.368 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -62.66 -25.11 67.97 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.178 0.991 . . . . 0.0 112.459 178.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 95.0 m -67.85 -21.86 65.16 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.597 1.559 . . . . 0.0 111.487 171.38 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 11.5 mm -86.6 -37.41 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 124.749 1.22 . . . . 0.0 110.791 174.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.456 ' HA ' ' CE2' ' A' ' 22' ' ' PHE . 1.9 mp -58.31 -49.89 80.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 123.1 0.56 . . . . 0.0 110.397 174.673 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 16.3 ptp180 -67.43 -16.77 64.41 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 114.22 1.193 . . . . 0.0 114.22 -175.403 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.5 mtpt -70.59 -36.24 73.46 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.937 0.895 . . . . 0.0 111.986 171.385 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.456 ' CE2' ' HA ' ' A' ' 19' ' ' ILE . 6.2 p90 -93.74 -23.85 18.05 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 178.594 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 . . . . . 0 N--CA 1.474 0.738 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 173.705 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 21.5 mmt85 . . . . . 0 N--CA 1.47 0.529 0 CA-C-O 122.386 1.089 . . . . 0.0 113.666 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -94.82 129.77 41.65 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.906 1.282 . . . . 0.0 110.93 -172.278 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -160.35 161.63 33.21 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.323 1.049 . . . . 0.0 113.712 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.6 pt -141.79 153.68 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 127.125 2.17 . . . . 0.0 110.441 176.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.6 mp -116.43 132.61 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 124.732 1.213 . . . . 0.0 109.205 176.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.726 ' HB2' ' SG ' ' A' ' 64' ' ' CYS . . . -123.15 142.92 50.37 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 126.078 1.751 . . . . 0.0 110.603 -174.073 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -71.32 124.05 23.68 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 121.82 -0.55 . . . . 0.0 111.105 171.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.01 -33.93 63.97 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 121.142 -0.974 . . . . 0.0 111.986 177.461 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 60.6 mtm180 -80.31 33.68 0.3 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 126.007 1.723 . . . . 0.0 113.115 -174.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 79.8 t -145.15 133.42 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 127.142 2.177 . . . . 0.0 108.492 -173.221 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -57.93 -41.09 82.03 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.685 1.194 . . . . 0.0 113.336 -171.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 75.7 m-80 -84.76 -11.0 56.69 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -178.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 69.8 m 45.9 62.04 2.4 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.246 1.419 . . . . 0.0 111.95 -165.21 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.52 143.37 57.26 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.089 0.955 . . . . 0.0 111.955 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.656 HG22 ' SG ' ' A' ' 64' ' ' CYS . 56.6 t -61.47 116.33 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 124.534 1.134 . . . . 0.0 108.734 173.809 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 37.3 pt -98.47 -20.85 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 123.147 0.579 . . . . 0.0 112.326 170.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -156.72 152.61 27.24 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.106 0.962 . . . . 0.0 111.697 175.537 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.514 ' HB2' ' CE1' ' A' ' 48' ' ' PHE . 24.9 p -153.16 153.94 33.76 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.015 -1.053 . . . . 0.0 113.287 -179.33 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -79.89 -168.84 1.75 Allowed 'General case' 0 CA--C 1.553 1.091 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -179.28 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -101.33 -22.93 14.47 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.171 1.388 . . . . 0.0 112.57 169.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.45 -37.0 58.84 Favored Glycine 0 C--N 1.343 0.944 0 O-C-N 121.532 -0.73 . . . . 0.0 112.825 -177.068 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.514 ' CE1' ' HB2' ' A' ' 44' ' ' CYS . 0.8 OUTLIER -67.03 -30.38 70.44 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 117.451 0.626 . . . . 0.0 111.779 179.206 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 80.0 m -56.05 -52.02 65.76 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.608 1.163 . . . . 0.0 111.78 175.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -71.44 -20.36 62.11 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.739 0.816 . . . . 0.0 112.952 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.5 tp -64.92 -56.02 15.79 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.511 1.124 . . . . 0.0 111.116 176.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 62.0 m -98.64 -13.73 20.2 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -175.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 91.79 2.61 69.33 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 125.624 1.583 . . . . 0.0 114.152 171.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -85.64 -153.64 0.18 Allowed 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 124.899 1.28 . . . . 0.0 112.133 171.243 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 82.7 p -153.8 167.8 28.46 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 120.389 -1.444 . . . . 0.0 111.63 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -50.85 -52.96 36.45 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 118.817 -0.611 . . . . 0.0 110.512 169.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.55 -32.55 58.55 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -178.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -85.84 -37.63 18.99 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.887 0.875 . . . . 0.0 112.953 177.231 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 68.1 t -77.73 -15.76 14.21 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 C-N-CA 124.882 1.273 . . . . 0.0 111.625 178.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 75.1 mtp -60.59 131.35 50.45 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 120.468 -1.395 . . . . 0.0 111.508 175.38 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 71.92 14.01 5.93 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 126.587 1.955 . . . . 0.0 113.656 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 38.5 mtt180 -94.81 158.89 34.44 Favored Pre-proline 0 N--CA 1.474 0.761 0 C-N-CA 124.634 1.174 . . . . 0.0 111.214 174.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -70.3 136.83 32.51 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 123.307 2.672 . . . . 0.0 110.56 170.364 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.726 ' SG ' ' HB2' ' A' ' 32' ' ' ALA . 56.6 m -67.03 -8.58 31.25 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.46 1.281 . . . . 0.0 114.46 177.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 76.4 p -61.15 -28.37 69.07 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.351 1.061 . . . . 0.0 111.89 172.132 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 75.6 m 50.36 35.95 11.96 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.014 1.326 . . . . 0.0 113.104 -176.483 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -56.14 -33.28 65.02 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.362 1.465 . . . . 0.0 112.501 -176.262 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -60.26 -14.55 18.55 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.388 1.475 . . . . 0.0 114.35 177.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 92.7 mt -76.65 -2.97 35.42 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 174.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 3.6 p80 -59.87 145.3 46.18 Favored 'General case' 0 CA--C 1.552 1.026 0 CA-C-N 119.5 1.046 . . . . 0.0 113.41 176.365 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -118.51 -164.88 13.12 Favored Glycine 0 CA--C 1.539 1.591 0 C-N-CA 126.03 1.776 . . . . 0.0 111.525 165.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.84 -20.65 29.47 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 123.277 2.651 . . . . 0.0 112.937 174.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 29.3 ttm180 -93.59 2.2 56.44 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.26 1.424 . . . . 0.0 113.006 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 28.1 m -83.85 136.76 33.99 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.376 1.47 . . . . 0.0 110.011 177.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -96.89 123.62 40.65 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.021 0.928 . . . . 0.0 109.518 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 14.0 tpt180 -60.4 -30.57 69.69 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.721 0.809 . . . . 0.0 112.76 -176.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 21.4 tpp85 -56.9 -41.32 77.88 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.854 1.261 . . . . 0.0 112.504 173.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -72.73 -43.09 63.4 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 121.348 -0.845 . . . . 0.0 111.962 177.228 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -57.75 -36.49 72.16 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 121.545 -0.722 . . . . 0.0 112.038 174.274 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.95 -47.94 64.42 Favored 'General case' 0 C--O 1.225 -0.237 0 C-N-CA 125.197 1.399 . . . . 0.0 111.997 173.363 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.5 mm100 -58.25 -37.0 74.06 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 118.616 -0.707 . . . . 0.0 111.681 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 95.6 mt -59.54 -42.1 86.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 CA-C-N 119.829 1.195 . . . . 0.0 111.83 171.224 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.72 -34.98 70.04 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.458 0.703 . . . . 0.0 112.891 176.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -68.22 -32.83 73.31 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.981 0.912 . . . . 0.0 111.687 174.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.401 ' HB1' HG11 ' A' ' 112' ' ' VAL . . . -59.79 -27.91 66.97 Favored 'General case' 0 CA--C 1.547 0.827 0 CA-C-N 119.201 0.91 . . . . 0.0 113.035 178.691 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 53.7 mt -72.55 -14.7 61.7 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.648 1.579 . . . . 0.0 113.134 177.451 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 70.0 mt -81.86 -20.41 38.97 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.055 0.942 . . . . 0.0 112.268 174.433 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -89.44 152.74 22.83 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.139 1.352 . . . . 0.0 113.311 -178.301 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -95.83 7.9 45.04 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.088 1.355 . . . . 0.0 113.509 176.435 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -126.62 162.31 26.01 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.091 1.756 . . . . 0.0 112.082 -176.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -64.23 141.68 58.69 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.636 1.175 . . . . 0.0 112.063 -179.274 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 9.9 tpt180 -152.13 138.21 18.24 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.012 1.325 . . . . 0.0 110.646 -173.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -129.24 148.16 51.15 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 168.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 58.3 t -138.79 135.71 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 126.282 1.833 . . . . 0.0 108.232 -171.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -104.69 130.08 52.79 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.931 0.892 . . . . 0.0 110.98 -176.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.2 tt -152.26 147.36 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 123.999 0.919 . . . . 0.0 112.19 -168.131 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -81.59 121.08 25.88 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 120.872 -1.143 . . . . 0.0 111.601 171.19 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 10.1 m-30 -109.19 132.15 54.39 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.656 1.982 . . . . 0.0 111.147 173.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -78.31 162.15 26.71 Favored 'General case' 0 CA--C 1.549 0.906 0 O-C-N 121.89 -0.506 . . . . 0.0 112.084 167.605 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 23.9 ttp180 -115.39 147.56 40.38 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.766 1.626 . . . . 0.0 110.41 173.082 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -55.77 -24.92 38.41 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 178.349 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -64.08 -17.82 63.78 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.578 1.551 . . . . 0.0 113.77 173.029 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 100.41 4.43 54.98 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 125.849 1.69 . . . . 0.0 113.858 -175.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 86.3 p -92.77 -178.94 5.0 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 118.626 1.213 . . . . 0.0 112.569 176.291 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 21.8 t -150.02 156.67 42.1 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.681 1.192 . . . . 0.0 111.625 -177.369 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -161.2 164.63 30.32 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.316 1.846 . . . . 0.0 110.657 178.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.68 126.18 35.9 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 123.667 0.787 . . . . 0.0 112.459 170.296 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 43.4 t -105.07 135.34 46.59 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.837 2.055 . . . . 0.0 110.844 174.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 38.8 tp -93.42 112.79 24.78 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.786 1.235 . . . . 0.0 107.74 160.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 61.1 t -95.39 119.67 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 173.452 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -113.65 119.44 37.45 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 125.35 1.46 . . . . 0.0 109.598 174.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.401 HG11 ' HB1' ' A' ' 85' ' ' ALA . 5.8 p -94.44 127.64 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 123.897 0.879 . . . . 0.0 109.506 173.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 96.9 t -115.91 111.03 43.38 Favored Pre-proline 0 CA--C 1.537 0.452 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 178.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -73.61 130.71 15.13 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.684 2.256 . . . . 0.0 110.109 -178.347 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 58.6 t -100.26 124.93 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 123.942 0.897 . . . . 0.0 109.331 176.509 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 21.4 mtpt -94.58 150.82 19.85 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.665 0.745 . . . . 0.0 112.389 174.022 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 54.0 p30 -78.96 -173.43 3.54 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.832 1.253 . . . . 0.0 111.694 174.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -67.64 -15.36 63.61 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 175.163 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -96.59 -18.31 19.84 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.646 1.178 . . . . 0.0 113.206 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 86.67 43.98 5.94 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 125.966 1.746 . . . . 0.0 113.577 -174.163 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -118.69 154.27 32.99 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.394 1.477 . . . . 0.0 110.175 161.328 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 57.3 t -80.27 126.44 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 C-N-CA 123.413 0.685 . . . . 0.0 109.29 178.171 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.8 -24.63 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 N-CA-C 114.217 1.191 . . . . 0.0 114.217 -178.181 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 64.0 mtm -133.79 157.44 45.89 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.151 1.381 . . . . 0.0 112.205 172.585 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -117.56 137.08 52.82 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 125.532 1.533 . . . . 0.0 109.298 169.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 47.4 mt -101.54 121.34 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 164.079 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 8.2 mp -104.99 133.19 50.2 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 172.292 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -126.03 132.97 51.87 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.481 1.113 . . . . 0.0 110.114 -174.061 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 15.1 m-30 -107.46 128.21 54.29 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.02 1.328 . . . . 0.0 110.754 -176.261 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -124.19 131.88 53.57 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.177 1.391 . . . . 0.0 107.396 169.663 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 71.4 t -78.49 112.09 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 CA-C-N 119.415 1.007 . . . . 0.0 108.293 173.397 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.4 p -89.13 -24.5 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.429 1.091 . . . . 0.0 112.631 -174.337 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 13.4 tpt -161.16 119.24 2.4 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.721 1.209 . . . . 0.0 110.609 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -85.18 115.08 22.76 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.489 0.716 . . . . 0.0 109.767 176.237 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt . . . . . 0 C--O 1.255 1.348 0 C-N-CA 125.025 1.33 . . . . 0.0 113.733 -175.702 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 40.0 p . . . . . 0 N--CA 1.478 0.974 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -69.94 -55.57 9.31 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.982 0.913 . . . . 0.0 111.11 173.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 62.7 tp -59.34 -35.24 73.48 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.255 1.022 . . . . 0.0 111.255 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -58.56 -31.84 68.37 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 176.088 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 90.9 m -77.14 -32.89 56.7 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.13 0.972 . . . . 0.0 110.48 175.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 24.8 mm -68.58 -41.86 83.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 123.062 0.545 . . . . 0.0 110.367 173.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 76.1 mt -57.4 -46.67 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 124.384 1.074 . . . . 0.0 110.506 174.395 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 78.8 mtt-85 -58.71 -31.72 68.52 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 179.327 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -71.02 -30.51 66.75 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.08 0.952 . . . . 0.0 112.756 177.103 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -88.83 -26.13 21.83 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.487 1.115 . . . . 0.0 113.371 173.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 . . . . . 0 N--CA 1.472 0.651 0 CA-C-O 122.155 0.978 . . . . 0.0 113.369 178.244 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.1 mpt_? . . . . . 0 N--CA 1.476 0.826 0 CA-C-O 121.221 0.534 . . . . 0.0 110.309 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -122.84 128.65 50.68 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 121.002 -1.061 . . . . 0.0 111.766 -174.731 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 26.9 p90 -163.93 163.52 23.55 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.084 1.353 . . . . 0.0 112.96 175.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 14.3 pt -141.06 154.84 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 126.062 1.745 . . . . 0.0 110.19 175.128 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 15.9 mt -110.14 129.07 65.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 124.814 1.246 . . . . 0.0 108.67 177.364 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -122.5 142.76 50.24 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 124.897 1.279 . . . . 0.0 111.236 178.202 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -65.55 126.51 28.56 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.163 0.585 . . . . 0.0 111.435 172.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -80.93 -25.02 37.75 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 28.7 mmm180 -80.12 -36.82 34.76 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.616 1.166 . . . . 0.0 112.938 -173.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 52.9 t -68.98 131.85 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 C-N-CA 125.439 1.495 . . . . 0.0 109.753 173.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -59.63 -44.81 93.34 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.518 1.127 . . . . 0.0 113.309 -170.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 20.2 p30 -74.53 -9.54 58.68 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 113.78 1.029 . . . . 0.0 113.78 177.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 72.1 m 54.79 64.34 1.84 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.89 1.676 . . . . 0.0 112.23 -176.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.88 135.56 57.73 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.66 0.784 . . . . 0.0 111.735 179.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 42.3 t -64.33 118.17 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 168.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 36.0 pt -100.17 -19.77 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 124.718 1.207 . . . . 0.0 112.367 177.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -155.24 146.43 22.73 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.246 1.018 . . . . 0.0 111.547 177.289 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -130.15 149.64 51.77 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.367 1.067 . . . . 0.0 111.858 178.636 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -74.13 -164.16 0.23 Allowed 'General case' 0 CA--C 1.554 1.134 0 CA-C-N 118.249 0.477 . . . . 0.0 111.128 169.408 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -107.26 -21.46 12.94 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.935 1.294 . . . . 0.0 112.713 169.596 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.8 -40.26 58.35 Favored Glycine 0 C--N 1.342 0.915 0 O-C-N 121.678 -0.639 . . . . 0.0 112.585 -178.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -64.39 -31.41 72.61 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 123.966 0.906 . . . . 0.0 112.365 -178.357 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 36.1 t -60.63 -53.42 57.72 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.373 1.469 . . . . 0.0 110.939 176.018 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -70.61 -26.7 63.62 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.531 0.732 . . . . 0.0 112.765 178.031 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 27.4 tp -61.52 -38.35 87.05 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.324 1.05 . . . . 0.0 112.343 173.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 39.1 m -106.3 -35.93 7.01 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 114.686 1.365 . . . . 0.0 114.686 -171.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.83 10.21 55.46 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 125.68 1.61 . . . . 0.0 114.266 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -89.58 -147.89 0.18 Allowed 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 118.558 1.179 . . . . 0.0 111.728 170.545 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.9 m -161.59 161.07 29.61 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 126.042 1.737 . . . . 0.0 110.606 176.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -53.67 -43.72 69.09 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 121.561 -0.712 . . . . 0.0 111.582 178.222 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.11 -30.43 36.54 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 175.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -92.85 -36.81 12.63 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.001 1.32 . . . . 0.0 112.193 178.156 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 53.8 t -73.12 -21.15 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 125.829 1.651 . . . . 0.0 111.504 177.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 57.0 mmm -65.07 135.07 55.12 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 121.014 -1.054 . . . . 0.0 112.126 179.267 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.0 tp60 69.87 10.33 7.45 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 126.438 1.895 . . . . 0.0 113.577 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 36.4 mmt180 -83.49 151.24 61.78 Favored Pre-proline 0 N--CA 1.471 0.621 0 C-N-CA 124.261 1.024 . . . . 0.0 110.879 177.161 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.23 131.71 21.13 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.982 2.454 . . . . 0.0 108.758 167.298 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 22.3 p -67.54 -9.97 47.49 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -172.574 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 30.8 p -61.17 -26.35 67.65 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.194 1.398 . . . . 0.0 112.269 170.474 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 94.3 m 52.16 46.9 25.82 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.147 1.379 . . . . 0.0 112.777 175.14 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -59.23 -23.46 62.34 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.663 1.185 . . . . 0.0 112.867 -178.084 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -54.6 -25.65 27.79 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.733 1.613 . . . . 0.0 112.96 172.271 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 74.1 mt -78.36 -7.41 57.27 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 178.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 7.4 t60 -63.66 141.89 58.6 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.48 1.112 . . . . 0.0 112.258 175.284 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -148.39 -170.17 16.02 Favored Glycine 0 CA--C 1.537 1.434 0 C-N-CA 127.252 2.358 . . . . 0.0 111.857 176.236 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -64.11 -21.95 67.69 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 123.221 2.614 . . . . 0.0 113.848 -175.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.85 -6.9 50.79 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 176.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 26.7 m -74.96 142.18 43.96 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-N 119.959 1.254 . . . . 0.0 110.474 -174.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 69.0 mm-40 -100.74 124.96 47.1 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.17 0.988 . . . . 0.0 110.133 -170.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -61.47 -40.22 93.75 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.572 0.749 . . . . 0.0 112.797 -176.124 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 36.1 mmt180 -66.24 -36.04 81.98 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.454 0.701 . . . . 0.0 112.62 175.632 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.78 -43.73 68.13 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 119.176 0.898 . . . . 0.0 112.045 177.435 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -57.89 -32.17 67.46 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.17 0.588 . . . . 0.0 112.044 173.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -72.32 -49.76 31.99 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.637 1.175 . . . . 0.0 111.847 172.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 11.6 mm-40 -59.96 -34.37 73.18 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 118.914 0.779 . . . . 0.0 111.738 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 83.1 mt -61.89 -34.89 64.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 CA-C-N 120.034 1.288 . . . . 0.0 112.749 170.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.26 -41.34 63.76 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 119.648 1.113 . . . . 0.0 112.101 172.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -65.44 -28.75 69.46 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 121.29 -0.881 . . . . 0.0 112.095 175.283 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.66 -20.99 62.3 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 119.353 0.978 . . . . 0.0 113.116 172.084 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 32.1 mt -90.03 -11.67 40.82 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.79 1.636 . . . . 0.0 112.93 175.391 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 82.0 mt -93.1 -17.03 24.28 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.605 1.162 . . . . 0.0 111.891 171.652 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -87.04 144.32 19.3 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 125.165 1.364 . . . . 0.0 113.331 -176.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -87.2 -8.07 57.27 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.751 1.22 . . . . 0.0 113.738 174.417 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -119.78 161.14 21.27 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.593 1.957 . . . . 0.0 111.01 -177.294 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -61.76 141.86 57.63 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.458 1.103 . . . . 0.0 112.401 -175.239 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 71.3 mmt-85 -137.98 131.65 31.1 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.183 0.993 . . . . 0.0 112.529 174.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 38.8 mtmt -108.95 131.51 54.98 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.756 1.622 . . . . 0.0 110.075 169.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 57.3 t -134.26 134.7 54.97 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 125.032 1.333 . . . . 0.0 108.926 -178.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -100.91 131.9 46.57 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.096 0.959 . . . . 0.0 110.776 178.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 19.7 tt -155.46 145.5 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 124.141 0.976 . . . . 0.0 111.82 -169.193 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -86.38 118.21 25.67 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.101 -0.999 . . . . 0.0 110.682 173.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 11.4 m-30 -105.19 140.6 38.11 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.714 1.605 . . . . 0.0 111.677 175.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -94.01 149.71 20.99 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.312 1.445 . . . . 0.0 111.078 174.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -108.22 156.2 19.61 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 125.735 1.614 . . . . 0.0 112.422 -175.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -64.03 -23.59 67.39 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 113.302 0.852 . . . . 0.0 113.302 175.261 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -78.87 -6.24 55.59 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.854 1.262 . . . . 0.0 113.618 177.266 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 94.21 -2.07 68.06 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 125.453 1.501 . . . . 0.0 114.3 -177.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 50.7 m -83.06 176.08 9.51 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.737 1.215 . . . . 0.0 112.244 175.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 23.3 p -154.14 165.78 35.16 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 120.918 -1.114 . . . . 0.0 112.106 172.17 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -164.91 167.76 18.3 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.214 1.405 . . . . 0.0 113.287 176.52 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -82.09 122.21 27.56 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.73 0.812 . . . . 0.0 110.141 169.257 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 45.5 t -105.09 141.25 36.98 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.659 1.984 . . . . 0.0 109.977 173.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 11.3 tp -96.74 118.19 32.66 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.954 1.302 . . . . 0.0 107.716 162.092 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 65.4 t -100.83 115.63 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 124.835 1.254 . . . . 0.0 108.316 173.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -111.44 110.57 21.08 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 125.278 1.431 . . . . 0.0 107.305 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 34.7 t -97.15 122.01 48.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 73.2 t -106.53 114.67 61.77 Favored Pre-proline 0 CA--C 1.536 0.417 0 N-CA-C 107.653 -1.239 . . . . 0.0 107.653 -177.543 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -73.46 120.35 6.45 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 123.078 2.518 . . . . 0.0 109.575 179.082 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 98.3 t -95.15 118.4 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.299 0.639 . . . . 0.0 109.53 175.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 60.8 mttt -87.62 153.42 21.4 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.692 0.797 . . . . 0.0 112.468 171.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -91.4 -173.57 3.63 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.425 1.09 . . . . 0.0 111.584 175.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -60.66 -21.74 63.12 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.05 1.34 . . . . 0.0 114.37 178.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -91.0 -5.45 55.34 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.072 1.349 . . . . 0.0 113.003 178.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 80.94 22.09 61.99 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 124.327 0.965 . . . . 0.0 114.554 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -108.25 148.86 29.37 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.193 1.397 . . . . 0.0 109.99 172.153 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.7 p -80.23 126.77 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 123.837 0.855 . . . . 0.0 110.703 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -128.31 -23.82 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -173.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 62.6 mtm -132.01 155.51 47.89 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.467 1.507 . . . . 0.0 111.993 171.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -114.83 135.86 53.73 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 125.251 1.421 . . . . 0.0 109.27 167.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 50.9 mt -98.94 115.99 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 163.229 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 6.2 mp -96.26 117.8 31.52 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 174.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -110.04 131.72 54.8 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 119.366 -0.349 . . . . 0.0 111.252 -177.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 11.2 m-30 -106.84 139.61 40.98 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.954 1.302 . . . . 0.0 111.129 -177.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -144.42 135.34 25.07 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.189 1.396 . . . . 0.0 109.482 175.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 27.5 t -77.46 114.95 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 176.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.9 p -95.44 -24.94 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -176.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 42.8 tpp -164.7 125.33 2.04 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.075 1.35 . . . . 0.0 110.425 179.045 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -83.81 125.22 31.73 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.574 0.749 . . . . 0.0 110.341 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.32 0 CA-C-O 115.836 -2.031 . . . . 0.0 114.568 -177.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 38.0 p . . . . . 0 N--CA 1.48 1.029 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -71.04 -56.05 6.96 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 123.922 0.889 . . . . 0.0 111.136 174.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 65.7 tp -57.84 -34.14 69.39 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.607 1.163 . . . . 0.0 111.49 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -60.64 -25.41 66.29 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 176.275 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 84.9 m -82.93 -33.0 26.9 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.728 1.211 . . . . 0.0 110.852 172.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 26.7 mm -73.05 -38.22 55.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 123.734 0.814 . . . . 0.0 111.496 178.502 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 54.9 mt -53.81 -38.56 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 123.857 0.863 . . . . 0.0 111.193 176.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 56.2 mtt180 -61.8 -26.2 67.95 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.488 1.115 . . . . 0.0 112.892 178.509 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -74.84 -38.56 61.97 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.805 1.242 . . . . 0.0 111.339 174.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -81.18 -21.63 39.53 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.245 1.418 . . . . 0.0 113.714 177.356 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 . . . . . 0 N--CA 1.475 0.81 0 C-N-CA 123.806 0.842 . . . . 0.0 112.556 173.262 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.8 mpp_? . . . . . 0 N--CA 1.47 0.571 0 CA-C-O 122.225 1.012 . . . . 0.0 111.026 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.04 140.09 29.98 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.054 0.942 . . . . 0.0 111.058 -176.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -162.79 156.99 20.92 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.555 1.142 . . . . 0.0 113.279 178.141 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.4 pt -141.34 150.35 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 126.318 1.847 . . . . 0.0 110.439 176.535 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 16.9 mt -109.67 134.96 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 125.699 1.6 . . . . 0.0 108.444 177.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -130.82 148.25 52.57 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 125.022 1.329 . . . . 0.0 111.09 177.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 15.4 m-20 -67.06 127.89 34.28 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 170.339 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.74 -30.55 59.24 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 121.864 -0.522 . . . . 0.0 112.355 172.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 64.8 mtm180 -80.68 44.49 0.73 Allowed 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.878 1.671 . . . . 0.0 112.992 -172.095 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.8 p -162.05 138.62 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 126.448 1.899 . . . . 0.0 110.0 -179.303 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -58.17 -40.99 82.88 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.168 0.987 . . . . 0.0 112.971 -172.121 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 24.1 p30 -77.77 -19.47 55.05 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 96.5 m 51.51 57.82 6.16 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.502 1.121 . . . . 0.0 112.43 -172.461 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.23 141.23 57.67 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.526 1.13 . . . . 0.0 113.098 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 61.8 t -63.75 124.71 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 124.018 0.927 . . . . 0.0 109.847 173.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 45.3 pt -103.51 -20.23 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 125.034 1.334 . . . . 0.0 112.315 172.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 15.1 t80 -155.62 150.61 26.55 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.057 0.943 . . . . 0.0 112.141 177.282 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 11.2 p -146.75 154.73 41.74 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 120.953 -1.092 . . . . 0.0 113.002 178.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 31.8 t-20 -74.14 -158.52 0.07 Allowed 'General case' 0 CA--C 1.56 1.339 0 C-N-CA 123.225 0.61 . . . . 0.0 112.167 -178.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -111.75 -18.37 12.75 Favored 'General case' 0 N--CA 1.48 1.04 0 O-C-N 120.249 -1.532 . . . . 0.0 112.966 166.415 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -75.6 -33.21 52.79 Favored Glycine 0 N--CA 1.47 0.911 0 C-N-CA 124.391 0.996 . . . . 0.0 112.632 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -65.47 -36.26 83.35 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.122 0.969 . . . . 0.0 110.989 -178.477 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 8.1 t -52.21 -47.19 65.76 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.48 1.512 . . . . 0.0 111.859 170.112 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -76.74 -21.75 54.79 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -178.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 51.9 tp -66.32 -53.84 31.73 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.95 0.9 . . . . 0.0 111.356 174.563 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 79.9 m -102.48 -17.43 15.79 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -172.382 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 87.1 6.38 78.96 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.985 1.279 . . . . 0.0 114.167 176.236 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -86.29 -153.61 0.2 Allowed 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.969 1.308 . . . . 0.0 111.81 171.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 12.0 t -162.8 170.1 18.82 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 120.562 -1.336 . . . . 0.0 111.521 176.185 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 44.5 ttm180 -53.36 -45.83 69.33 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.417 1.087 . . . . 0.0 111.257 178.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.0 -26.66 49.59 Favored 'General case' 0 CA--C 1.551 0.993 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 176.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -93.99 -38.34 11.22 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.991 1.316 . . . . 0.0 112.268 179.088 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 51.2 t -86.2 -11.15 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 125.07 1.348 . . . . 0.0 112.297 -177.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 20.0 mmt -65.28 135.44 55.36 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 120.395 -1.441 . . . . 0.0 111.242 168.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.8 tm0? 70.98 8.16 6.43 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 126.298 1.839 . . . . 0.0 113.198 -177.535 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 37.7 mmt180 -88.88 152.17 48.28 Favored Pre-proline 0 N--CA 1.472 0.673 0 C-N-CA 124.484 1.113 . . . . 0.0 110.837 175.455 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -70.1 136.04 31.11 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 123.203 2.602 . . . . 0.0 109.404 171.047 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 30.8 p -68.07 -3.57 10.7 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 -179.406 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 52.6 p -61.53 -30.99 70.99 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.575 1.15 . . . . 0.0 111.665 166.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 81.8 m 50.62 38.27 18.51 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.633 1.573 . . . . 0.0 112.77 -177.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -58.2 -30.02 66.13 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.641 1.176 . . . . 0.0 112.418 -176.052 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -59.56 -14.51 13.48 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.04 1.336 . . . . 0.0 114.121 175.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 99.4 mt -75.38 -4.64 40.58 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.369 1.068 . . . . 0.0 113.721 171.252 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 13.5 p-80 -63.61 140.53 58.88 Favored 'General case' 0 CA--C 1.548 0.888 0 CA-C-N 120.194 1.361 . . . . 0.0 112.911 175.201 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -115.18 -164.87 14.54 Favored Glycine 0 CA--C 1.539 1.562 0 C-N-CA 125.988 1.756 . . . . 0.0 111.144 165.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -68.96 -21.72 36.88 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.952 2.435 . . . . 0.0 113.008 175.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 83.4 mtt85 -89.28 -9.56 50.16 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.483 1.113 . . . . 0.0 113.869 -178.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 56.7 m -68.91 136.73 53.05 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.756 1.222 . . . . 0.0 111.272 -173.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 21.5 mp0 -83.7 118.63 24.0 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.808 1.243 . . . . 0.0 109.475 -174.343 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -63.7 -37.72 88.4 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 121.639 -0.663 . . . . 0.0 112.408 -173.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -64.02 -38.05 89.64 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.414 0.686 . . . . 0.0 112.374 173.155 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.13 -44.25 69.29 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.308 0.958 . . . . 0.0 111.849 177.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.59 -35.47 65.84 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.145 0.578 . . . . 0.0 112.002 173.01 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.14 -44.99 64.46 Favored 'General case' 0 C--O 1.224 -0.243 0 C-N-CA 124.303 1.041 . . . . 0.0 112.636 172.308 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.41 ' HB2' HG21 ' A' ' 94' ' ' VAL . 15.6 mm-40 -59.91 -30.83 69.29 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 117.719 -1.134 . . . . 0.0 112.465 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 69.0 mt -59.43 -48.94 85.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 CA-C-N 120.622 1.555 . . . . 0.0 110.773 169.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.41 -37.24 74.43 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.838 0.855 . . . . 0.0 112.824 -178.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 77.5 mm-40 -70.92 -31.38 67.98 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.168 0.987 . . . . 0.0 111.518 175.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -59.58 -31.74 69.73 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 119.464 1.029 . . . . 0.0 112.636 177.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 56.7 mt -68.17 -15.63 63.66 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.386 1.475 . . . . 0.0 113.12 177.482 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 61.3 mt -83.39 -15.74 48.65 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.041 0.936 . . . . 0.0 112.446 174.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -93.32 153.18 21.25 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 125.377 1.465 . . . . 0.0 113.115 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -97.21 5.7 49.64 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.025 1.33 . . . . 0.0 113.742 177.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.61 159.72 25.86 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.82 1.648 . . . . 0.0 111.416 -179.106 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -61.21 141.19 57.68 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.753 1.621 . . . . 0.0 112.239 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.48 121.75 8.39 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.058 0.943 . . . . 0.0 111.514 -168.215 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 37.8 mtmt -106.3 137.34 44.43 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.852 1.261 . . . . 0.0 112.107 172.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.41 HG21 ' HB2' ' A' ' 81' ' ' GLN . 8.3 p -132.16 135.85 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 127.298 2.239 . . . . 0.0 110.136 171.353 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -101.99 133.74 46.31 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.399 1.48 . . . . 0.0 110.164 176.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 19.1 tt -159.99 144.71 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 124.202 1.001 . . . . 0.0 111.904 -163.313 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -82.21 121.64 26.89 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 120.911 -1.118 . . . . 0.0 111.872 173.415 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 11.2 m-30 -103.01 149.9 24.09 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.155 1.782 . . . . 0.0 111.412 172.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -106.28 136.12 46.56 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.299 1.84 . . . . 0.0 111.344 175.093 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 46.4 ttp180 -99.89 148.98 23.87 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 126.138 1.775 . . . . 0.0 111.3 -176.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -59.13 -22.14 60.4 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 177.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -73.58 -6.63 47.83 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.311 1.444 . . . . 0.0 113.732 174.101 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 95.95 -1.67 63.4 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 125.955 1.74 . . . . 0.0 113.86 -176.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -80.16 169.47 17.76 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.373 1.469 . . . . 0.0 112.823 -178.462 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 28.6 p -147.63 158.04 43.83 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.149 -0.969 . . . . 0.0 112.457 168.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -162.89 156.12 19.66 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.787 1.235 . . . . 0.0 111.531 -174.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -75.66 124.1 26.67 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 123.076 0.55 . . . . 0.0 110.162 168.164 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 12.8 t -111.61 146.51 37.27 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.708 2.003 . . . . 0.0 109.82 173.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 20.0 tp -96.33 124.95 40.51 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 125.514 1.526 . . . . 0.0 108.106 163.115 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 47.1 t -105.77 121.35 57.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 169.363 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -114.96 116.06 27.88 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.59 1.556 . . . . 0.0 109.101 173.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.1 p -89.77 125.84 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-O 121.066 0.46 . . . . 0.0 109.897 169.302 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 88.8 t -109.39 108.54 60.08 Favored Pre-proline 0 CA--C 1.536 0.414 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 174.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.85 126.46 10.71 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.666 2.244 . . . . 0.0 109.462 177.422 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 52.3 t -96.64 123.26 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 177.098 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 20.4 mtpt -94.03 149.88 20.84 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.554 0.692 . . . . 0.0 112.269 174.538 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 54.7 p30 -79.29 -173.64 3.76 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.65 1.18 . . . . 0.0 111.682 174.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -67.27 -15.55 63.76 Favored 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 114.614 1.338 . . . . 0.0 114.614 175.219 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -96.65 -18.1 19.93 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.812 1.245 . . . . 0.0 113.206 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 85.96 42.85 6.57 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 125.911 1.719 . . . . 0.0 113.563 -173.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -116.27 154.37 30.27 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.277 1.431 . . . . 0.0 110.145 160.535 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 49.5 t -80.67 125.8 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 178.022 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.02 -27.03 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -177.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 61.5 mtm -131.42 153.25 49.9 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.784 1.234 . . . . 0.0 112.359 170.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -111.44 137.04 49.76 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 125.303 1.441 . . . . 0.0 109.063 166.41 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 48.2 mt -104.4 119.09 52.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 163.277 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -101.23 124.7 47.34 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 173.261 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -116.14 124.53 50.56 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 124.331 1.053 . . . . 0.0 109.346 -176.39 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -102.88 143.84 31.96 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.16 1.384 . . . . 0.0 110.571 -178.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.39 128.9 11.4 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.616 0.766 . . . . 0.0 110.361 171.556 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.4 p -72.69 116.08 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 O-C-N 121.383 -0.823 . . . . 0.0 109.771 175.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.2 p -94.24 -27.6 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 124.767 1.227 . . . . 0.0 112.759 -175.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 25.4 ptp -162.3 147.02 12.39 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.411 1.085 . . . . 0.0 112.618 166.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -89.99 131.49 35.86 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.794 0.838 . . . . 0.0 110.311 178.145 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.253 1.258 0 N-CA-C 115.492 1.664 . . . . 0.0 115.492 -175.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 42.2 p . . . . . 0 N--CA 1.482 1.141 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -65.79 -50.01 66.23 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.671 0.788 . . . . 0.0 111.838 176.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 61.9 tp -64.9 -36.05 83.1 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.58 1.152 . . . . 0.0 111.299 176.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -59.96 -30.55 69.17 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.75 0.82 . . . . 0.0 112.638 177.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 44.4 m -71.6 -24.12 61.84 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.803 1.241 . . . . 0.0 111.48 173.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 11.1 mm -83.93 -43.97 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.216 1.007 . . . . 0.0 110.434 173.347 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 97.5 mt -54.31 -47.35 69.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.669 0.787 . . . . 0.0 110.531 177.229 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 32.9 ptt180 -69.7 -12.22 61.46 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -178.185 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -83.19 -34.43 25.95 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.441 1.096 . . . . 0.0 112.045 170.548 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -78.58 -33.77 47.4 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.257 1.023 . . . . 0.0 112.321 173.006 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 . . . . . 0 CA--C 1.541 0.623 0 C-N-CA 123.428 0.691 . . . . 0.0 111.94 173.04 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 12.0 mpt_? . . . . . 0 CA--C 1.543 0.707 0 CA-C-O 122.01 0.909 . . . . 0.0 110.363 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.0 mptt -86.2 132.65 33.96 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.102 1.361 . . . . 0.0 110.099 -178.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -163.14 164.24 25.38 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.258 1.023 . . . . 0.0 113.689 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 30.3 pt -144.37 154.53 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 126.736 2.014 . . . . 0.0 110.508 177.331 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 14.8 mt -120.0 130.71 73.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 125.907 1.683 . . . . 0.0 109.394 -178.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -130.49 145.26 51.82 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 124.485 1.114 . . . . 0.0 111.437 176.117 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -70.58 125.53 27.07 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 122.043 -0.41 . . . . 0.0 111.159 176.405 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.58 -29.82 66.35 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -177.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 56.3 mtm180 -80.03 36.66 0.35 Allowed 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.64 1.576 . . . . 0.0 112.86 -172.383 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 60.5 t -145.62 135.51 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 126.839 2.056 . . . . 0.0 108.87 -169.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -59.13 -45.08 91.87 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.14 0.976 . . . . 0.0 112.726 -174.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -82.79 -12.72 57.26 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 90.9 m 48.65 62.96 2.3 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.375 1.47 . . . . 0.0 111.283 -167.532 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.81 136.26 55.18 Favored 'General case' 0 CA--C 1.547 0.843 0 O-C-N 121.514 -0.741 . . . . 0.0 111.869 -177.359 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.2 t -64.23 126.43 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 122.996 0.518 . . . . 0.0 109.873 176.486 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.1 pt -104.35 -23.16 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.586 1.154 . . . . 0.0 112.49 174.536 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -147.41 140.65 25.25 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.534 0.733 . . . . 0.0 111.349 178.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.516 ' HB3' ' CE1' ' A' ' 48' ' ' PHE . 2.0 m -131.59 147.62 52.54 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.097 0.959 . . . . 0.0 111.558 -177.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -78.33 -173.24 3.19 Favored 'General case' 0 CA--C 1.554 1.118 0 CA-C-N 119.255 0.934 . . . . 0.0 111.752 172.365 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -98.71 -22.72 15.75 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.027 1.331 . . . . 0.0 112.353 171.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -73.37 -39.53 50.9 Favored Glycine 0 C--N 1.342 0.873 0 O-C-N 121.815 -0.553 . . . . 0.0 112.455 -177.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.516 ' CE1' ' HB3' ' A' ' 44' ' ' CYS . 0.4 OUTLIER -66.07 -32.32 73.72 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.256 0.623 . . . . 0.0 111.854 -179.345 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 91.2 m -51.29 -55.31 18.93 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.252 1.421 . . . . 0.0 111.587 174.363 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -71.75 -22.33 61.62 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.876 0.871 . . . . 0.0 113.032 -179.259 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.16 -52.68 62.87 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.11 1.364 . . . . 0.0 110.873 178.664 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 76.8 m -98.68 -21.2 16.55 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.51 2.23 58.84 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 125.035 1.302 . . . . 0.0 114.355 179.07 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -85.81 -152.43 0.16 Allowed 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 124.607 1.163 . . . . 0.0 112.102 171.072 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 80.8 p -157.11 168.87 26.17 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 120.478 -1.389 . . . . 0.0 111.928 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -52.07 -51.65 56.24 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 119.1 -0.476 . . . . 0.0 110.48 168.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.28 -32.45 56.29 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 119.39 0.996 . . . . 0.0 113.52 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -86.4 -39.42 16.4 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.009 0.924 . . . . 0.0 113.295 177.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 79.5 t -80.46 -12.75 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 124.674 1.189 . . . . 0.0 111.639 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 66.1 mmm -66.27 137.1 56.71 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 120.522 -1.361 . . . . 0.0 111.261 173.415 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 76.43 4.71 3.6 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 127.064 2.145 . . . . 0.0 113.531 -176.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 42.7 mtt180 -92.42 156.21 41.7 Favored Pre-proline 0 N--CA 1.476 0.851 0 C-N-CA 124.257 1.023 . . . . 0.0 112.412 -179.335 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -67.57 134.91 34.4 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.697 2.931 . . . . 0.0 110.585 170.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 5.1 t -66.97 -18.6 65.46 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -173.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 39.7 p -56.2 -30.05 61.76 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.304 1.442 . . . . 0.0 112.458 172.681 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 79.1 m 54.05 36.94 25.85 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.25 1.42 . . . . 0.0 112.357 -176.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -57.1 -30.64 64.53 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.85 1.26 . . . . 0.0 112.462 -176.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -58.8 -15.31 11.72 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.912 1.285 . . . . 0.0 114.193 175.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.2 mt -75.21 -6.2 48.46 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.579 1.152 . . . . 0.0 113.694 172.072 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -65.83 147.81 52.78 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 119.988 1.267 . . . . 0.0 112.492 173.5 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -125.97 -155.31 8.93 Favored Glycine 0 CA--C 1.537 1.447 0 C-N-CA 125.7 1.619 . . . . 0.0 111.071 165.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.25 -26.91 17.12 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 123.116 2.544 . . . . 0.0 113.712 179.104 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 53.7 ttm-85 -87.4 -15.35 38.04 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 119.327 0.967 . . . . 0.0 113.1 -177.095 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 19.8 m -65.07 134.66 54.3 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.311 1.444 . . . . 0.0 110.926 -176.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.438 ' HG3' ' CB ' ' A' ' 78' ' ' ALA . 5.9 pt20 -87.31 125.61 34.34 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -176.332 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 18.5 tpp85 -60.36 -35.24 75.22 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.206 1.003 . . . . 0.0 112.447 -178.115 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 24.6 tpp180 -60.23 -46.44 89.76 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.368 1.067 . . . . 0.0 111.715 174.53 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.438 ' CB ' ' HG3' ' A' ' 75' ' ' GLN . . . -69.46 -42.6 74.68 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 121.043 -1.036 . . . . 0.0 111.981 176.205 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.13 -35.03 64.25 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 173.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -74.67 -44.84 48.25 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.331 1.452 . . . . 0.0 112.999 173.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -59.16 -34.69 72.39 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 118.868 0.758 . . . . 0.0 111.538 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 86.6 mt -62.19 -37.44 78.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 CA-C-N 119.969 1.259 . . . . 0.0 112.198 172.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.8 -39.88 69.58 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 119.1 0.863 . . . . 0.0 112.143 174.353 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -64.88 -32.43 74.13 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.598 0.759 . . . . 0.0 111.867 175.19 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.47 -23.15 65.68 Favored 'General case' 0 CA--C 1.548 0.88 0 O-C-N 121.367 -0.833 . . . . 0.0 112.903 176.536 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 27.9 mt -85.94 -14.29 45.15 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.112 1.365 . . . . 0.0 113.258 174.179 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 80.8 mt -88.92 -17.59 29.24 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.139 0.976 . . . . 0.0 111.822 171.404 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -83.85 152.0 28.17 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 125.3 1.428 . . . . 0.0 112.696 175.321 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -99.51 11.69 38.46 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.905 1.282 . . . . 0.0 113.857 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -137.71 163.67 30.73 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.963 1.705 . . . . 0.0 111.834 -175.364 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.97 137.87 57.98 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.282 1.033 . . . . 0.0 111.767 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.69 124.97 10.85 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.297 1.039 . . . . 0.0 111.239 -175.579 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 43.3 mtmt -100.85 140.78 34.66 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.206 1.402 . . . . 0.0 112.271 171.171 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 46.2 t -136.44 136.56 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 126.094 1.758 . . . . 0.0 108.526 175.461 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -102.86 128.78 49.5 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.983 0.913 . . . . 0.0 110.647 178.41 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.2 tt -151.81 149.28 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.21 1.004 . . . . 0.0 112.207 -168.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -84.29 116.74 23.15 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 120.899 -1.125 . . . . 0.0 111.496 173.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 9.7 m-30 -103.08 140.9 36.71 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.419 1.488 . . . . 0.0 111.055 174.249 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -105.1 133.12 50.41 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.454 1.502 . . . . 0.0 111.813 178.01 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 73.9 mtp85 -77.37 163.16 26.67 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.667 1.587 . . . . 0.0 112.267 175.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -65.21 -23.65 67.14 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.722 1.209 . . . . 0.0 113.336 173.311 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -77.72 -7.7 56.9 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.841 1.257 . . . . 0.0 113.598 174.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 94.11 -1.83 68.05 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 125.425 1.488 . . . . 0.0 114.574 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 48.7 m -80.09 167.77 19.99 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 118.335 1.067 . . . . 0.0 111.756 175.012 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 20.5 p -148.35 170.33 18.19 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 120.886 -1.134 . . . . 0.0 113.399 176.166 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -170.21 166.52 8.86 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 126.258 1.823 . . . . 0.0 111.255 -178.437 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -79.35 123.0 27.07 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.16 0.505 . . . . 0.0 111.103 170.026 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 6.0 m -106.84 136.46 46.63 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.051 1.74 . . . . 0.0 110.1 168.211 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 19.0 tp -86.47 123.18 31.4 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 125.033 1.333 . . . . 0.0 107.602 162.285 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 91.6 t -103.61 117.94 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 169.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -112.16 107.11 15.89 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 126.462 1.905 . . . . 0.0 108.54 177.425 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 69.7 t -80.67 125.65 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 172.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 45.0 t -109.06 110.62 60.72 Favored Pre-proline 0 C--N 1.328 -0.359 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 169.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.41 132.79 16.68 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.559 2.172 . . . . 0.0 109.546 176.333 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 73.1 t -99.91 120.75 49.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 172.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 68.9 mttt -92.94 154.99 17.85 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.651 0.78 . . . . 0.0 112.698 171.161 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -93.66 -173.64 3.23 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.105 0.962 . . . . 0.0 111.641 174.143 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -61.04 -22.01 64.16 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.015 1.326 . . . . 0.0 114.152 178.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -90.3 -5.4 56.32 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.783 1.233 . . . . 0.0 113.043 178.226 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 79.32 20.62 69.06 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 124.455 1.026 . . . . 0.0 114.388 -178.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -99.63 146.21 26.72 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.94 1.296 . . . . 0.0 109.621 173.071 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 61.5 t -76.79 125.34 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 177.164 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 3.0 pt -121.28 -21.79 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 C-N-CA 124.905 1.282 . . . . 0.0 113.981 -172.593 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 44.7 mtm -145.52 151.35 38.01 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.72 1.608 . . . . 0.0 110.478 177.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -114.33 129.61 56.65 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 124.595 1.158 . . . . 0.0 109.084 169.254 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 33.5 mt -99.09 117.45 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 165.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -94.91 117.4 30.07 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 174.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -104.32 127.09 51.91 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 123.259 0.349 . . . . 0.0 111.476 176.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 13.7 m-30 -102.93 134.65 46.0 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.372 1.469 . . . . 0.0 111.146 -179.268 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -141.83 112.33 7.1 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.71 1.204 . . . . 0.0 109.092 176.193 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.7 p -64.46 112.7 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 O-C-N 121.186 -0.946 . . . . 0.0 109.399 173.359 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.0 p -98.83 -26.61 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.511 1.524 . . . . 0.0 112.954 -167.41 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 24.3 ptp -161.14 154.26 21.3 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.879 1.272 . . . . 0.0 111.241 166.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -77.12 156.48 31.63 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 122.126 0.965 . . . . 0.0 111.713 175.062 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.455 ' HA ' ' HE3' ' A' ' 135' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.288 0 C-N-CA 125.743 1.617 . . . . 0.0 112.822 161.377 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 46.6 p . . . . . 0 N--CA 1.481 1.123 0 N-CA-C 114.398 1.259 . . . . 0.0 114.398 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -64.49 -50.73 66.3 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.517 0.727 . . . . 0.0 111.491 176.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 60.8 tp -65.59 -37.97 88.16 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.56 1.144 . . . . 0.0 111.312 175.019 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -61.34 -29.03 69.64 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.153 0.981 . . . . 0.0 112.409 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 29.3 m -71.25 -25.65 62.56 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.823 1.249 . . . . 0.0 111.455 173.452 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.8 mm -82.38 -43.14 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.932 0.893 . . . . 0.0 110.252 173.047 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 97.0 mt -56.22 -44.25 78.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 123.628 0.771 . . . . 0.0 110.804 177.001 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 49.9 ptt85 -70.73 -19.64 62.72 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -78.47 -36.88 44.64 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.036 0.934 . . . . 0.0 111.766 169.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -79.53 -37.32 36.83 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.731 1.212 . . . . 0.0 112.525 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 . . . . . 0 CA--C 1.545 0.784 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -171.648 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? . . . . . 0 CA--C 1.541 0.6 0 CA-C-O 122.141 0.972 . . . . 0.0 111.705 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.5 mptt -90.99 137.22 32.53 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.388 1.075 . . . . 0.0 111.133 -174.504 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -165.16 162.59 20.15 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.01 1.324 . . . . 0.0 113.329 175.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 14.7 pt -142.18 152.4 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 126.295 1.838 . . . . 0.0 110.662 174.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 11.8 mt -108.61 130.46 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 125.973 1.709 . . . . 0.0 108.977 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -129.0 142.27 50.97 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 124.98 1.312 . . . . 0.0 110.975 177.38 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -70.36 125.7 27.54 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.75 -0.593 . . . . 0.0 111.087 177.108 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.39 -31.86 64.13 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.545 0.738 . . . . 0.0 112.355 -178.463 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 27.7 mmm180 -80.46 37.29 0.39 Allowed 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.922 1.689 . . . . 0.0 112.682 -174.337 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 98.4 t -143.93 134.78 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 126.911 2.084 . . . . 0.0 108.719 -172.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -56.13 -35.11 66.74 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 115.324 1.602 . . . . 0.0 115.324 -170.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -105.77 -2.33 23.32 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.287 1.435 . . . . 0.0 113.091 -178.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 89.6 m 50.43 68.78 0.71 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 126.074 1.75 . . . . 0.0 112.303 -174.307 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.22 137.94 57.33 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.04 0.936 . . . . 0.0 112.111 -178.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 37.1 t -65.21 123.75 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 123.587 0.755 . . . . 0.0 109.354 174.064 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 44.8 pt -103.92 -19.59 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 125.125 1.37 . . . . 0.0 112.52 176.559 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -156.42 145.64 20.53 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.233 1.013 . . . . 0.0 111.658 178.156 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 4.7 m -125.7 158.53 34.59 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.359 1.064 . . . . 0.0 112.341 176.231 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -74.87 -152.37 0.03 OUTLIER 'General case' 0 CA--C 1.559 1.306 0 CA-C-N 118.524 0.602 . . . . 0.0 111.167 166.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -115.05 -21.55 9.97 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.325 1.45 . . . . 0.0 113.215 165.136 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -74.85 -35.21 51.14 Favored Glycine 0 N--CA 1.471 1.012 0 C-N-CA 124.12 0.867 . . . . 0.0 112.813 -178.052 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -58.03 -37.31 74.12 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 124.837 1.255 . . . . 0.0 111.861 177.301 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 38.4 t -58.91 -52.0 67.61 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.405 1.482 . . . . 0.0 111.499 174.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -70.68 -25.97 63.22 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -179.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 38.6 tp -62.87 -40.54 97.83 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.376 1.07 . . . . 0.0 111.973 172.054 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 50.2 m -106.73 -32.08 8.14 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 115.054 1.502 . . . . 0.0 115.054 -168.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.61 9.51 66.46 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 125.932 1.729 . . . . 0.0 114.437 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -86.17 -144.85 0.11 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 124.609 1.164 . . . . 0.0 111.591 170.17 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 13.3 t -163.6 167.06 21.75 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.986 1.314 . . . . 0.0 111.065 169.35 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -54.65 -44.24 73.07 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.582 0.753 . . . . 0.0 110.801 176.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.23 -28.03 50.33 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 176.464 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -91.18 -39.18 12.26 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.982 1.313 . . . . 0.0 111.83 177.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 99.5 t -80.27 -17.6 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 125.671 1.588 . . . . 0.0 112.295 -177.648 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 80.9 mtp -61.55 133.13 55.32 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 120.85 -1.156 . . . . 0.0 111.309 170.489 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 23.7 tp60 74.05 3.67 4.45 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 127.08 2.152 . . . . 0.0 113.731 -178.483 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 33.2 mmt180 -84.55 151.46 58.82 Favored Pre-proline 0 N--CA 1.473 0.686 0 O-C-N 121.016 -1.052 . . . . 0.0 110.934 178.054 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.83 132.98 24.34 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.526 2.151 . . . . 0.0 109.598 169.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 32.0 p -66.76 -7.55 22.02 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 -176.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 41.3 p -59.7 -27.1 66.15 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.353 1.461 . . . . 0.0 112.536 168.43 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 67.5 m 57.23 40.56 27.88 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.022 1.329 . . . . 0.0 112.707 178.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -56.51 -29.77 62.22 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.361 1.464 . . . . 0.0 113.006 -175.272 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 29.2 p90 -62.26 -16.8 55.99 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.806 1.242 . . . . 0.0 114.107 175.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 87.8 mt -79.08 -10.42 59.82 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 174.263 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -69.44 118.78 12.74 Favored 'General case' 0 CA--C 1.546 0.827 0 CA-C-N 119.597 1.09 . . . . 0.0 111.402 -177.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -100.98 -163.14 27.75 Favored Glycine 0 CA--C 1.539 1.556 0 C-N-CA 126.166 1.841 . . . . 0.0 112.129 173.578 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -70.58 -28.41 21.34 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 123.153 2.569 . . . . 0.0 113.149 -179.398 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 30.4 tpt180 -84.61 -17.35 38.98 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 50.6 m -60.43 132.55 54.25 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.95 1.3 . . . . 0.0 111.876 -170.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 22.9 mp0 -85.26 111.59 19.99 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.546 1.138 . . . . 0.0 110.404 -171.407 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 -58.24 -33.86 69.81 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.59 0.756 . . . . 0.0 112.463 177.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 21.5 tpp180 -62.03 -39.91 93.93 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.591 1.157 . . . . 0.0 112.244 175.282 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -77.01 -41.46 42.64 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.526 1.13 . . . . 0.0 112.31 176.151 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -53.15 -33.36 52.12 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 118.842 0.747 . . . . 0.0 112.797 175.437 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.01 -41.3 82.4 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 124.969 1.308 . . . . 0.0 112.712 172.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 80.3 mm-40 -64.38 -32.6 74.28 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 118.507 -0.758 . . . . 0.0 111.48 178.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 45.9 mt -59.33 -41.35 83.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 CA-C-N 119.56 1.073 . . . . 0.0 110.586 170.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.16 -35.08 68.93 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 176.085 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 71.6 mm-40 -64.66 -35.58 81.49 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.439 -0.788 . . . . 0.0 111.446 172.468 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.15 -21.35 63.69 Favored 'General case' 0 CA--C 1.549 0.922 0 O-C-N 121.383 -0.823 . . . . 0.0 113.189 178.173 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 57.6 mt -87.9 -11.14 48.55 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 125.925 1.69 . . . . 0.0 114.009 178.182 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.7 pp -103.94 -2.73 25.7 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 170.21 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -90.3 144.22 17.38 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 125.039 1.305 . . . . 0.0 112.564 175.212 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.9 -2.12 58.12 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.7 1.2 . . . . 0.0 113.931 176.186 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -124.09 159.27 30.34 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.035 1.734 . . . . 0.0 110.739 -174.163 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 46.4 mp0 -57.28 135.88 56.49 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.522 1.129 . . . . 0.0 111.708 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.58 121.23 11.83 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.229 1.011 . . . . 0.0 110.322 -173.606 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt -105.05 142.81 34.17 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.358 1.463 . . . . 0.0 111.7 178.232 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 61.8 t -138.29 131.74 41.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 125.858 1.663 . . . . 0.0 108.91 -177.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -103.88 129.76 51.41 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.682 0.793 . . . . 0.0 110.811 177.236 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.3 tt -159.78 142.75 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 123.553 0.741 . . . . 0.0 112.149 -166.258 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -86.38 121.73 29.35 Favored 'General case' 0 N--CA 1.465 0.303 0 O-C-N 121.405 -0.809 . . . . 0.0 110.83 174.11 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -109.63 154.89 22.16 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.63 1.172 . . . . 0.0 111.844 172.428 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -113.79 130.85 56.4 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.796 1.638 . . . . 0.0 110.52 175.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 14.8 mmt180 -106.42 166.17 10.73 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.438 1.495 . . . . 0.0 112.811 -168.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -61.14 -26.41 67.66 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.153 0.981 . . . . 0.0 113.59 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -69.77 -9.66 55.39 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.162 1.385 . . . . 0.0 113.813 178.054 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 87.67 0.85 83.66 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 124.999 1.285 . . . . 0.0 113.241 -171.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 18.4 m -85.95 154.15 21.68 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.159 1.383 . . . . 0.0 111.855 179.257 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 31.1 p -133.04 153.8 51.14 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.778 0.831 . . . . 0.0 111.513 166.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 19.3 p90 -167.82 157.6 10.18 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 125.053 1.341 . . . . 0.0 112.814 -177.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -75.81 119.49 19.88 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.514 1.126 . . . . 0.0 110.514 176.492 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 26.8 t -103.74 144.86 30.91 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 125.607 1.563 . . . . 0.0 110.462 172.615 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 8.7 tp -98.4 112.95 24.79 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 162.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 46.6 t -92.64 115.56 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 124.794 1.238 . . . . 0.0 107.812 171.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -112.98 109.53 19.0 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 124.758 1.223 . . . . 0.0 107.777 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.426 HG22 HD13 ' A' ' 127' ' ' LEU . 79.4 t -82.36 128.95 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 172.305 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 55.2 t -111.37 112.38 54.62 Favored Pre-proline 0 CA--C 1.536 0.41 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 171.133 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -74.36 129.24 12.75 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 123.246 2.631 . . . . 0.0 109.88 178.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 80.2 t -102.13 118.66 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 123.9 0.88 . . . . 0.0 108.887 176.051 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 60.7 mttt -87.84 152.71 21.89 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.583 0.753 . . . . 0.0 112.397 172.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -91.17 -173.76 3.74 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.25 1.02 . . . . 0.0 111.519 175.362 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -60.31 -21.8 62.44 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.999 1.319 . . . . 0.0 114.394 178.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -90.84 -5.51 55.49 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.14 1.376 . . . . 0.0 113.023 178.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 80.58 22.2 62.65 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 124.403 1.001 . . . . 0.0 114.522 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -107.92 148.6 29.41 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.18 1.392 . . . . 0.0 109.904 172.122 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.1 p -80.15 126.27 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 123.654 0.782 . . . . 0.0 110.704 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.7 -23.28 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -174.074 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 55.4 mtm -130.25 150.9 51.29 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.028 1.331 . . . . 0.0 112.038 169.282 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -110.51 134.46 52.35 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 125.41 1.484 . . . . 0.0 109.189 167.059 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 72.6 mt -98.1 116.98 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 163.524 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.426 HD13 HG22 ' A' ' 112' ' ' VAL . 1.4 mm? -89.56 118.52 29.25 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 105.685 -1.968 . . . . 0.0 105.685 169.238 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -103.91 143.45 32.83 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 119.219 -0.42 . . . . 0.0 110.763 173.534 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -119.6 135.37 54.83 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.594 1.158 . . . . 0.0 110.434 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -138.41 150.49 46.57 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 125.541 1.536 . . . . 0.0 108.29 173.568 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.2 t -94.23 112.72 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.251 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.7 p -91.88 -25.75 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -177.434 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 32.0 ttm -165.44 124.93 1.75 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.589 1.156 . . . . 0.0 110.813 -175.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -84.33 128.11 34.38 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.584 -0.697 . . . . 0.0 110.481 175.243 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.457 ' HA ' ' HE2' ' A' ' 135' ' ' LYS . 7.8 mmpt? . . . . . 0 C--O 1.252 1.231 0 CA-C-O 117.644 -1.17 . . . . 0.0 113.11 174.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 40.5 p . . . . . 0 N--CA 1.478 0.949 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -79.94 -47.29 15.25 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.979 0.912 . . . . 0.0 112.076 177.293 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 69.3 tp -61.02 -35.15 76.11 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.522 0.729 . . . . 0.0 110.968 177.201 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -55.18 -28.8 55.55 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 176.011 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 36.5 m -70.69 -27.61 64.14 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.623 1.169 . . . . 0.0 111.484 174.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 15.4 mm -79.44 -34.77 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 124.265 1.026 . . . . 0.0 109.801 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.9 mp -53.88 -40.22 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 123.265 0.626 . . . . 0.0 110.735 170.357 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 24.2 mmm-85 -63.46 -29.75 70.98 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 119.058 0.845 . . . . 0.0 112.627 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -73.91 -39.01 64.15 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.353 1.061 . . . . 0.0 111.438 174.46 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -76.71 -21.88 54.69 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.67 1.188 . . . . 0.0 113.189 178.282 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 . . . . . 0 N--CA 1.475 0.792 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 168.984 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 9.3 mmt180 . . . . . 0 N--CA 1.469 0.523 0 CA-C-O 122.332 1.063 . . . . 0.0 113.148 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -107.66 133.37 52.19 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.861 1.264 . . . . 0.0 110.671 177.649 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -161.48 158.72 27.0 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 124.333 1.053 . . . . 0.0 112.908 177.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.5 pt -140.46 149.19 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 125.58 1.552 . . . . 0.0 110.767 176.542 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.1 mp -109.45 127.63 66.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 C-N-CA 125.914 1.685 . . . . 0.0 108.86 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -126.23 140.22 52.72 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 124.827 1.251 . . . . 0.0 111.23 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -71.43 121.79 19.23 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 122.729 0.412 . . . . 0.0 110.818 177.3 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.94 -28.64 61.61 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.335 0.654 . . . . 0.0 112.461 -178.384 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 -77.9 37.83 0.25 Allowed 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 126.084 1.753 . . . . 0.0 112.675 -178.169 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 98.0 t -145.19 136.55 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 127.042 2.137 . . . . 0.0 108.572 -172.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -54.84 -34.42 62.84 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 115.554 1.687 . . . . 0.0 115.554 -170.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -107.49 -0.15 22.37 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.241 1.416 . . . . 0.0 113.136 -178.13 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 99.4 m 53.83 71.67 0.49 Allowed 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.988 1.715 . . . . 0.0 111.984 -171.19 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.85 131.07 44.53 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.017 0.927 . . . . 0.0 112.168 -176.025 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 41.3 t -64.47 123.29 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 123.86 0.864 . . . . 0.0 109.254 172.168 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 38.3 pt -104.95 -19.04 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 124.869 1.268 . . . . 0.0 112.362 178.093 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -158.91 141.28 14.01 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.67 1.188 . . . . 0.0 111.145 -178.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 4.0 m -122.63 166.41 14.9 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 121.224 -0.922 . . . . 0.0 112.397 172.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -74.74 -151.64 0.03 OUTLIER 'General case' 0 CA--C 1.557 1.237 0 C-N-CA 122.51 0.324 . . . . 0.0 111.613 169.514 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -113.56 -22.5 10.27 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 120.472 -1.392 . . . . 0.0 113.2 163.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -74.44 -33.88 55.41 Favored Glycine 0 N--CA 1.47 0.941 0 O-C-N 121.355 -0.841 . . . . 0.0 112.876 -177.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -57.35 -37.84 73.21 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.673 1.189 . . . . 0.0 111.624 176.583 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 10.2 t -60.85 -53.05 62.11 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.354 1.462 . . . . 0.0 111.61 175.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -71.01 -25.21 62.58 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -178.273 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 31.8 tp -62.02 -45.23 94.52 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.609 1.164 . . . . 0.0 111.648 170.366 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 64.2 m -104.65 -32.55 8.86 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 -166.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.05 4.54 63.03 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 126.017 1.77 . . . . 0.0 114.541 -179.05 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -83.79 -156.22 0.21 Allowed 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 124.814 1.246 . . . . 0.0 112.185 170.727 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 9.5 t -152.17 168.77 24.26 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 120.286 -1.509 . . . . 0.0 111.135 170.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.1 ttp180 -58.63 -45.5 89.1 Favored 'General case' 0 C--O 1.22 -0.472 0 O-C-N 121.535 -0.728 . . . . 0.0 111.812 -173.485 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.44 -25.72 37.97 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 175.279 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -88.56 -39.14 14.35 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.746 1.218 . . . . 0.0 111.645 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 84.4 t -85.67 -24.48 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 125.053 1.341 . . . . 0.0 112.376 -177.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 86.6 mtp -63.44 139.11 58.74 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 120.979 -1.076 . . . . 0.0 110.819 171.459 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 13.7 tm0? 75.65 -4.1 2.44 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 126.789 2.036 . . . . 0.0 113.784 -177.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 36.9 mmt180 -79.32 157.33 75.49 Favored Pre-proline 0 N--CA 1.473 0.687 0 C-N-CA 124.657 1.183 . . . . 0.0 111.088 173.606 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -67.22 136.23 39.76 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.398 2.065 . . . . 0.0 109.999 166.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 26.7 p -68.01 -2.2 7.22 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 -179.118 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 57.1 p -65.32 -29.42 70.16 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.578 1.551 . . . . 0.0 112.231 169.128 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 74.2 m 58.32 42.76 21.07 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.585 1.554 . . . . 0.0 112.517 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -57.73 -27.01 62.6 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.858 1.263 . . . . 0.0 113.209 -176.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -61.71 -16.21 47.14 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.546 1.138 . . . . 0.0 113.927 174.069 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 79.9 mt -83.73 -11.45 57.13 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.365 1.066 . . . . 0.0 113.78 172.307 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 40.0 m170 -73.11 115.45 12.45 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 119.823 1.192 . . . . 0.0 110.65 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -101.66 -162.63 27.03 Favored Glycine 0 CA--C 1.539 1.576 0 C-N-CA 126.157 1.836 . . . . 0.0 112.464 177.437 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -70.07 -25.79 26.8 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 123.133 2.555 . . . . 0.0 113.132 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.2 tpm_? -82.75 -17.51 44.01 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.883 0.873 . . . . 0.0 113.195 179.039 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 40.9 m -65.96 138.95 58.17 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.991 1.316 . . . . 0.0 112.384 -168.571 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 22.3 mp0 -84.48 117.99 24.02 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.338 1.455 . . . . 0.0 110.545 -172.164 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -60.25 -33.76 72.76 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -177.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 36.6 mmt180 -63.4 -53.27 55.0 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.397 0.679 . . . . 0.0 111.202 172.337 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.8 -36.89 84.78 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 120.491 -1.381 . . . . 0.0 113.09 -178.158 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -54.69 -35.49 63.66 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.848 0.859 . . . . 0.0 112.378 171.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -76.81 -45.7 27.67 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 124.555 1.142 . . . . 0.0 112.527 173.11 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -58.46 -36.94 74.47 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 118.809 0.732 . . . . 0.0 111.15 -176.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 89.3 mt -61.18 -40.17 84.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 CA-C-N 119.825 1.193 . . . . 0.0 111.845 173.111 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.43 -37.11 68.68 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.526 0.731 . . . . 0.0 112.65 176.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 54.8 mm-40 -67.82 -33.26 74.44 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.987 0.915 . . . . 0.0 111.469 174.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -57.98 -26.02 61.8 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 121.19 -0.944 . . . . 0.0 113.105 178.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 55.3 mt -78.58 -18.13 55.07 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.737 1.615 . . . . 0.0 113.545 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.1 pp -83.38 -20.69 33.75 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 119.473 1.033 . . . . 0.0 112.1 173.339 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -81.38 154.87 35.27 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 125.075 1.322 . . . . 0.0 112.85 176.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -95.5 1.31 53.9 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.882 1.273 . . . . 0.0 114.214 -178.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -126.91 161.12 29.04 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.179 1.792 . . . . 0.0 111.725 -169.416 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -62.49 141.67 58.3 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.072 1.349 . . . . 0.0 112.304 -177.583 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 -152.19 125.54 8.76 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.818 0.847 . . . . 0.0 112.86 -171.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 44.3 mtmt -101.24 139.02 37.49 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.204 1.402 . . . . 0.0 111.592 171.331 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 67.7 t -134.16 143.66 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 126.082 1.753 . . . . 0.0 108.166 170.241 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -114.48 136.18 53.29 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.461 1.104 . . . . 0.0 110.9 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.1 tt -161.57 146.45 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 123.561 0.744 . . . . 0.0 112.659 -163.536 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -84.49 122.35 28.86 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 121.02 -1.05 . . . . 0.0 111.047 172.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 14.7 m-30 -108.42 147.01 32.23 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.232 1.413 . . . . 0.0 112.091 173.383 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -109.18 132.45 54.11 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.138 1.775 . . . . 0.0 110.627 177.472 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -107.08 160.23 15.71 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.718 1.607 . . . . 0.0 112.116 -166.007 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -64.28 -22.93 67.12 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -177.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -76.23 -7.25 54.46 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 124.633 1.173 . . . . 0.0 113.387 175.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 94.97 0.11 64.03 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 125.725 1.631 . . . . 0.0 114.28 -178.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 59.2 m -88.63 162.16 16.49 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.575 1.15 . . . . 0.0 112.421 179.204 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 26.5 p -138.27 155.64 48.42 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 121.147 -0.971 . . . . 0.0 112.031 168.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -166.04 157.07 13.33 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.982 1.313 . . . . 0.0 112.796 -176.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -75.49 123.04 24.77 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.803 0.811 . . . . 0.0 110.754 177.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 9.0 t -109.93 138.55 46.15 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.312 1.845 . . . . 0.0 109.681 174.063 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.545 HD13 ' N ' ' A' ' 110' ' ' VAL . 1.2 tm? -83.19 140.46 32.56 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 156.782 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.545 ' N ' HD13 ' A' ' 109' ' ' LEU . 13.8 t -124.01 112.36 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 125.336 1.454 . . . . 0.0 108.625 169.283 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -103.36 121.87 43.66 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.978 1.311 . . . . 0.0 109.994 172.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.1 p -91.48 124.38 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 166.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 81.6 t -109.02 111.79 60.35 Favored Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 175.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.31 130.34 13.94 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.875 2.383 . . . . 0.0 109.95 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 63.7 t -101.72 124.25 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 124.096 0.959 . . . . 0.0 108.604 173.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 35.1 mttp -98.09 153.75 18.21 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 175.206 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -93.11 -174.58 3.6 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.166 0.986 . . . . 0.0 111.294 176.673 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -59.82 -21.73 61.28 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.039 1.335 . . . . 0.0 114.421 178.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -91.4 -6.04 53.48 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.115 1.366 . . . . 0.0 113.181 179.207 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 78.62 25.63 60.38 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 124.239 0.923 . . . . 0.0 114.142 -178.525 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -108.53 152.22 25.03 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.198 1.399 . . . . 0.0 109.899 172.177 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 10.6 t -80.56 125.77 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 123.306 0.642 . . . . 0.0 109.318 -179.231 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.8 -24.83 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -176.774 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 56.6 mtm -130.76 152.91 49.6 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.558 1.143 . . . . 0.0 112.374 167.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -113.26 134.3 54.67 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 125.721 1.608 . . . . 0.0 109.172 168.089 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 46.1 mt -101.76 117.9 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 165.056 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -100.16 128.38 46.25 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 106.895 -1.521 . . . . 0.0 106.895 173.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -123.3 130.04 52.18 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.43 1.092 . . . . 0.0 110.313 -172.523 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -106.38 137.7 43.89 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.889 1.276 . . . . 0.0 111.08 -174.235 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -142.76 133.09 24.76 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.846 1.258 . . . . 0.0 109.463 177.316 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 59.4 t -80.27 115.29 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 5.2 p -97.94 -28.85 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -176.03 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 25.4 ptp -164.13 148.87 10.15 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.367 1.067 . . . . 0.0 113.337 167.524 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -90.91 130.3 36.86 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.036 0.934 . . . . 0.0 110.741 178.224 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.255 1.344 0 CA-C-O 115.806 -2.045 . . . . 0.0 115.587 -176.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 57.4 p . . . . . 0 N--CA 1.479 1.016 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -64.76 -53.96 38.88 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.989 0.915 . . . . 0.0 111.783 173.676 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 58.8 tp -60.7 -35.96 77.6 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.612 1.165 . . . . 0.0 111.175 176.513 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -62.31 -26.03 68.19 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 177.705 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 99.2 m -75.55 -28.13 58.9 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.554 1.141 . . . . 0.0 111.245 171.459 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 16.1 mm -77.68 -41.76 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 O-C-N 121.417 -0.802 . . . . 0.0 110.702 174.335 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 90.1 mt -56.19 -48.47 79.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 123.994 0.917 . . . . 0.0 110.564 177.204 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 16.2 ptp180 -67.08 -23.96 65.91 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -75.94 -33.46 59.82 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 119.523 1.056 . . . . 0.0 112.615 170.545 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -76.45 -32.01 58.17 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.533 1.133 . . . . 0.0 111.908 175.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 . . . . . 0 CA--C 1.543 0.688 0 CA-C-N 118.602 0.637 . . . . 0.0 111.322 172.382 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 6.0 mmt-85 . . . . . 0 N--CA 1.472 0.643 0 CA-C-O 122.607 1.194 . . . . 0.0 113.075 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.2 mptt -94.08 133.98 36.99 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.947 1.299 . . . . 0.0 110.412 178.239 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -163.27 161.88 24.97 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.482 1.113 . . . . 0.0 112.805 177.385 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.2 pt -139.74 158.61 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 126.06 1.744 . . . . 0.0 110.521 173.516 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 28.3 mt -118.54 132.97 66.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 125.601 1.56 . . . . 0.0 108.868 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -131.33 143.26 50.38 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.349 1.059 . . . . 0.0 111.585 176.262 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -72.15 123.76 23.58 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.246 0.618 . . . . 0.0 111.489 179.25 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -79.03 -21.16 47.31 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -178.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 63.7 mtp85 -75.97 28.28 0.11 Allowed 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 126.185 1.794 . . . . 0.0 113.367 -173.714 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.4 t -151.09 137.64 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 127.114 2.165 . . . . 0.0 108.426 -166.312 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -63.35 -39.93 95.88 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -175.701 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 24.9 p30 -81.68 -15.21 55.2 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 114.377 1.251 . . . . 0.0 114.377 179.173 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 86.2 m 51.56 56.57 7.68 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.439 1.496 . . . . 0.0 113.351 -176.696 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.87 138.47 55.69 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 12.7 t -60.41 125.07 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 170.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 42.4 pt -104.93 -18.59 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 124.871 1.268 . . . . 0.0 112.619 174.642 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -156.16 144.99 20.31 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.091 0.956 . . . . 0.0 111.855 177.54 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 8.1 m -123.94 154.66 39.43 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.294 1.038 . . . . 0.0 110.588 171.259 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -73.15 -149.16 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.288 0 CA-C-N 118.958 0.799 . . . . 0.0 111.885 172.584 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -115.66 -22.67 9.08 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 120.248 -1.533 . . . . 0.0 112.885 164.182 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -74.5 -33.84 55.32 Favored Glycine 0 C--N 1.343 0.962 0 C-N-CA 124.231 0.919 . . . . 0.0 112.791 -178.43 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -56.94 -38.17 72.54 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.319 1.048 . . . . 0.0 111.292 176.614 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 51.2 t -59.01 -51.56 69.55 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.108 1.363 . . . . 0.0 111.659 178.764 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -67.56 -20.28 65.38 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.925 0.89 . . . . 0.0 113.093 178.692 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.06 -35.56 81.53 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.622 1.169 . . . . 0.0 112.4 176.815 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 45.4 m -123.09 -24.1 4.79 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 115.578 1.696 . . . . 0.0 115.578 -176.08 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 87.9 15.46 61.19 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-N 119.77 1.168 . . . . 0.0 114.075 -177.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -85.59 -144.63 0.1 Allowed 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.699 1.199 . . . . 0.0 111.338 170.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 77.8 p -158.22 165.94 33.61 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 124.771 1.228 . . . . 0.0 111.765 174.035 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 44.8 ttm180 -54.83 -47.3 74.29 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 118.889 -0.577 . . . . 0.0 110.606 171.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.65 -32.58 52.04 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 119.611 1.096 . . . . 0.0 113.932 177.221 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -89.08 -34.53 16.73 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.942 0.897 . . . . 0.0 113.258 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 99.5 t -84.43 -14.39 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.278 1.031 . . . . 0.0 112.035 178.432 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 79.5 mmm -76.95 147.38 36.96 Favored 'General case' 0 N--CA 1.474 0.725 0 O-C-N 120.841 -1.162 . . . . 0.0 111.977 175.159 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 31.8 tp60 69.19 4.42 4.57 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 126.451 1.9 . . . . 0.0 113.433 -175.023 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 32.3 mmt180 -77.96 153.96 80.3 Favored Pre-proline 0 N--CA 1.47 0.561 0 C-N-CA 124.843 1.257 . . . . 0.0 109.875 174.153 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -73.55 11.62 1.02 Allowed 'Trans proline' 0 CA--C 1.546 1.118 0 C-N-CA 124.106 3.204 . . . . 0.0 115.205 176.005 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.478 ' SG ' HD13 ' A' ' 127' ' ' LEU . 7.8 t 77.84 -23.8 0.24 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 126.585 1.954 . . . . 0.0 114.453 163.152 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 37.7 p -58.05 -20.6 40.38 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 126.6 1.96 . . . . 0.0 113.376 172.485 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 90.6 m 60.53 28.45 18.13 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.388 1.475 . . . . 0.0 112.824 178.627 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -58.87 -27.72 65.45 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.635 1.174 . . . . 0.0 112.515 -177.679 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -59.81 -13.86 12.31 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 174.567 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 92.2 mt -84.02 -3.54 58.09 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.802 1.241 . . . . 0.0 113.891 172.79 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 9.4 p-80 -66.1 145.6 55.63 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 120.169 1.35 . . . . 0.0 113.415 178.491 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -128.83 -161.55 10.68 Favored Glycine 0 CA--C 1.538 1.506 0 C-N-CA 126.557 2.027 . . . . 0.0 111.225 166.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.26 -21.34 35.94 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.937 2.425 . . . . 0.0 113.194 177.222 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 21.6 tpt180 -89.86 -8.75 51.24 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.272 1.029 . . . . 0.0 113.491 -178.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 24.3 m -72.39 141.83 48.72 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.917 1.287 . . . . 0.0 110.579 -176.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 64.4 mm-40 -91.8 122.77 34.64 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.506 0.722 . . . . 0.0 110.04 -173.608 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 28.7 mmm180 -58.62 -39.36 80.26 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.803 0.841 . . . . 0.0 112.296 -178.476 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -64.86 -39.5 93.65 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.318 1.047 . . . . 0.0 112.081 176.26 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -69.2 -43.07 74.9 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.101 -1.0 . . . . 0.0 112.633 178.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -56.89 -34.92 68.36 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 122.95 0.5 . . . . 0.0 112.04 173.701 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -72.35 -46.75 54.05 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 124.82 1.248 . . . . 0.0 112.549 173.098 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -61.1 -34.86 75.61 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 118.563 -0.732 . . . . 0.0 111.565 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 87.4 mt -63.1 -38.87 83.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 CA-C-N 120.104 1.32 . . . . 0.0 111.749 171.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.92 -36.87 78.49 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 119.33 0.968 . . . . 0.0 112.296 173.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -65.84 -31.91 73.13 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 121.347 -0.846 . . . . 0.0 111.773 172.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.69 -20.59 65.83 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 119.203 0.911 . . . . 0.0 112.604 175.438 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 44.6 mt -88.32 -10.75 48.46 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.927 1.691 . . . . 0.0 113.374 172.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 84.5 mt -96.98 -14.64 21.55 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.529 1.132 . . . . 0.0 112.075 172.041 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -86.48 150.73 23.7 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 125.389 1.471 . . . . 0.0 113.162 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -100.28 8.94 43.4 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.136 1.374 . . . . 0.0 113.678 178.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -134.21 164.83 26.5 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.428 1.891 . . . . 0.0 111.476 -178.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -61.29 138.16 58.24 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.833 0.853 . . . . 0.0 111.854 -179.089 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 19.7 tpt180 -145.92 128.68 16.26 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.91 0.884 . . . . 0.0 112.058 -178.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 43.1 mtmt -107.34 139.86 41.16 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.76 1.624 . . . . 0.0 111.424 175.366 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 45.1 t -138.24 138.69 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 125.52 1.528 . . . . 0.0 109.251 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -102.92 127.76 50.0 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.221 1.008 . . . . 0.0 110.962 177.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 19.5 tt -150.71 146.32 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 124.208 1.003 . . . . 0.0 112.352 -171.32 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -89.9 119.05 29.94 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 121.055 -1.028 . . . . 0.0 111.578 176.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 20.0 m-30 -115.73 157.12 24.77 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.598 1.959 . . . . 0.0 111.314 175.248 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -114.05 151.9 31.8 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 178.237 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.54 158.79 28.45 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.493 1.517 . . . . 0.0 110.395 167.167 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -61.81 -23.78 66.44 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.235 1.014 . . . . 0.0 113.219 166.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -72.31 -9.02 57.95 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.739 1.616 . . . . 0.0 113.709 170.398 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 97.94 -6.4 62.17 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 126.127 1.822 . . . . 0.0 114.778 179.624 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 22.1 m -82.12 130.23 35.03 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 118.952 1.376 . . . . 0.0 112.627 -172.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 25.3 p -104.87 153.65 21.09 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.761 1.224 . . . . 0.0 112.46 -177.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -165.61 163.79 19.24 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 126.088 1.755 . . . . 0.0 112.672 169.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -77.87 124.88 28.54 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.37 1.068 . . . . 0.0 111.119 175.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 42.1 t -104.25 137.31 42.35 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.82 2.048 . . . . 0.0 110.128 170.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 6.8 tp -90.28 118.0 29.45 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 161.116 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 94.9 t -100.87 114.67 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 125.457 1.503 . . . . 0.0 107.903 173.483 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -115.45 108.72 16.85 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 125.606 1.562 . . . . 0.0 107.129 -175.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.452 HG22 ' HG ' ' A' ' 127' ' ' LEU . 17.1 t -93.52 127.37 45.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 -179.008 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 69.6 t -111.15 112.1 55.41 Favored Pre-proline 0 CA--C 1.535 0.374 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.88 131.6 15.92 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.64 2.227 . . . . 0.0 109.61 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 60.6 t -92.8 105.42 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 169.555 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 61.5 mttt -82.16 151.7 26.81 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.268 0.556 . . . . 0.0 111.202 166.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -92.96 -173.42 3.28 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.8 0.84 . . . . 0.0 111.831 174.014 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -60.14 -21.79 62.04 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.128 1.371 . . . . 0.0 114.693 178.746 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -93.73 -0.72 55.83 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.695 1.198 . . . . 0.0 113.155 177.095 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 77.87 20.55 73.27 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 124.301 0.953 . . . . 0.0 114.556 178.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -99.22 142.22 30.98 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.462 1.105 . . . . 0.0 109.12 171.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.7 p -76.55 118.97 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-O 122.089 0.947 . . . . 0.0 109.903 174.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.4 pt -106.91 -19.51 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 125.64 1.576 . . . . 0.0 113.29 -174.047 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 3.6 mtp -157.36 156.33 32.12 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 126.561 1.944 . . . . 0.0 110.512 -174.679 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -122.56 133.51 54.56 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 125.086 1.355 . . . . 0.0 109.563 175.432 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 56.8 mt -102.59 114.81 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 166.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.478 HD13 ' SG ' ' A' ' 64' ' ' CYS . 7.4 mp -98.57 119.77 37.85 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 177.727 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -110.82 135.81 50.82 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 123.354 0.409 . . . . 0.0 111.47 -178.144 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -111.86 138.37 48.55 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.12 1.368 . . . . 0.0 111.433 -175.268 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -144.03 136.34 26.68 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.42 1.488 . . . . 0.0 109.908 175.651 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 42.5 t -76.15 114.58 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 176.325 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.0 p -98.61 -25.61 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -173.255 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 44.4 tpp -165.2 128.21 2.23 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.154 0.981 . . . . 0.0 111.725 179.379 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -84.39 127.9 34.27 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.631 0.772 . . . . 0.0 111.386 -179.374 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.48 ' HA ' ' HE2' ' A' ' 135' ' ' LYS . 11.1 mmpt? . . . . . 0 C--O 1.254 1.299 0 C-N-CA 124.789 1.236 . . . . 0.0 113.103 174.514 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 39.7 p . . . . . 0 N--CA 1.479 0.985 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -62.14 -49.9 74.01 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.058 0.943 . . . . 0.0 111.954 175.544 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 58.2 tp -69.64 -39.93 76.83 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.343 1.457 . . . . 0.0 111.593 174.167 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -60.15 -28.41 67.87 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 176.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 95.1 m -69.03 -29.82 68.05 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.294 1.038 . . . . 0.0 110.739 173.232 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.8 mm -78.13 -41.92 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 123.683 0.793 . . . . 0.0 110.047 174.816 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 96.5 mt -56.9 -46.53 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 123.437 0.695 . . . . 0.0 110.661 176.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -70.66 -21.39 62.61 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.2 mtpt -78.57 -34.85 46.62 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.53 1.132 . . . . 0.0 112.606 170.105 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -78.02 -30.48 49.99 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.901 0.88 . . . . 0.0 111.82 175.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 . . . . . 0 CA--C 1.546 0.802 0 C-N-CA 123.903 0.881 . . . . 0.0 111.772 165.744 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.541 0.597 0 CA-C-O 122.738 1.256 . . . . 0.0 113.213 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.3 mptt -109.4 145.91 35.34 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.948 2.099 . . . . 0.0 110.376 -173.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -167.04 163.41 15.84 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.493 1.117 . . . . 0.0 113.333 178.387 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 20.2 pt -139.71 155.71 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 126.212 1.805 . . . . 0.0 110.327 172.377 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 17.2 mt -114.63 133.25 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 126.046 1.738 . . . . 0.0 108.688 -177.792 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -135.29 144.0 46.55 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.454 1.101 . . . . 0.0 112.171 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 57.8 t-20 -76.09 112.59 12.7 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.266 1.027 . . . . 0.0 112.151 -176.145 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -71.15 -19.69 62.39 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.293 1.037 . . . . 0.0 113.434 -177.59 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -75.32 -19.59 59.55 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.559 1.144 . . . . 0.0 113.256 179.494 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 95.4 t -89.42 136.36 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 125.769 1.627 . . . . 0.0 109.171 177.106 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -55.86 -41.2 74.01 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.789 1.236 . . . . 0.0 113.023 -175.182 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -79.42 -11.47 59.91 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.394 1.078 . . . . 0.0 113.717 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 88.4 m 52.8 57.85 5.94 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.355 1.462 . . . . 0.0 112.08 -170.513 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.39 137.07 57.7 Favored 'General case' 0 CA--C 1.548 0.87 0 O-C-N 121.405 -0.809 . . . . 0.0 112.616 -176.536 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.9 t -60.8 123.81 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 172.358 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.2 pt -105.03 -17.95 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 125.153 1.381 . . . . 0.0 112.547 175.065 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -157.2 145.75 19.61 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.065 0.946 . . . . 0.0 112.204 178.209 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 4.4 m -124.51 156.41 37.35 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.562 1.145 . . . . 0.0 111.504 172.557 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -73.79 -150.71 0.03 OUTLIER 'General case' 0 CA--C 1.56 1.349 0 CA-C-N 118.86 0.754 . . . . 0.0 111.397 171.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -116.23 -21.45 9.35 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 120.365 -1.459 . . . . 0.0 112.98 163.314 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -73.73 -34.01 57.11 Favored Glycine 0 N--CA 1.471 1.033 0 C-N-CA 124.126 0.869 . . . . 0.0 112.691 -178.294 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -58.69 -38.02 77.35 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.52 1.128 . . . . 0.0 111.652 177.638 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 33.5 t -55.58 -51.73 66.15 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.626 1.57 . . . . 0.0 111.758 178.544 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -69.27 -18.17 63.83 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 178.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.507 HD11 HG23 ' A' ' 131' ' ' VAL . 10.6 tp -66.99 -44.06 81.33 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.447 1.099 . . . . 0.0 112.317 178.554 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 80.3 m -112.68 -21.46 11.23 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 114.513 1.301 . . . . 0.0 114.513 -176.045 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 87.16 14.08 64.95 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 124.417 1.008 . . . . 0.0 114.2 -178.075 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -87.81 -154.65 0.27 Allowed 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 124.889 1.276 . . . . 0.0 111.857 172.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 70.1 m -150.61 159.47 44.48 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.951 1.3 . . . . 0.0 110.39 178.431 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 -50.59 -47.0 58.23 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 121.571 -0.706 . . . . 0.0 111.5 175.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.36 -27.53 36.87 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 177.172 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -91.71 -33.99 14.82 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.991 1.316 . . . . 0.0 112.368 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 57.4 t -88.21 -16.11 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 124.829 1.252 . . . . 0.0 111.947 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 84.0 mmm -73.62 148.06 43.2 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 120.96 -1.088 . . . . 0.0 111.344 171.174 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 9.7 tm0? 70.98 4.1 4.93 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 126.076 1.75 . . . . 0.0 113.068 -176.013 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 32.7 mmt180 -82.04 154.84 70.12 Favored Pre-proline 0 N--CA 1.472 0.63 0 C-N-CA 125.021 1.328 . . . . 0.0 110.375 175.048 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -75.16 11.8 1.4 Allowed 'Trans proline' 0 CA--C 1.548 1.215 0 C-N-CA 124.268 3.312 . . . . 0.0 115.72 176.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 8.3 t 73.89 -17.02 0.47 Allowed 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 126.348 1.859 . . . . 0.0 114.666 166.717 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 41.1 p -62.05 -23.48 66.5 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 126.095 1.758 . . . . 0.0 113.146 170.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 98.3 m 57.78 28.7 16.32 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.093 1.357 . . . . 0.0 113.004 -176.628 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -56.78 -31.91 65.11 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.595 1.158 . . . . 0.0 112.22 178.552 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -60.87 -12.54 11.37 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.995 1.318 . . . . 0.0 114.314 177.239 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.2 mt -83.74 -2.4 56.19 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 114.101 1.149 . . . . 0.0 114.101 174.501 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 18.3 p-80 -59.79 143.05 52.08 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 119.781 1.173 . . . . 0.0 113.617 179.187 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -123.94 -161.64 11.19 Favored Glycine 0 CA--C 1.539 1.551 0 C-N-CA 126.363 1.935 . . . . 0.0 111.517 169.395 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.22 -20.4 32.72 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 123.069 2.513 . . . . 0.0 113.184 177.08 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 -88.13 -12.04 45.21 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.245 1.018 . . . . 0.0 113.592 -179.503 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 18.6 m -72.38 138.83 47.48 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.994 1.317 . . . . 0.0 110.584 -175.186 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -102.87 131.11 50.01 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.295 1.038 . . . . 0.0 110.544 -177.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 19.9 tpp85 -60.76 -36.34 78.69 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.809 0.844 . . . . 0.0 112.538 -175.508 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 85.3 mmt-85 -60.67 -41.99 96.17 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.039 0.935 . . . . 0.0 112.448 175.104 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.64 -45.5 75.18 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 119.144 0.884 . . . . 0.0 112.112 177.217 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -57.18 -33.6 67.63 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.106 0.562 . . . . 0.0 112.318 173.727 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -73.28 -46.24 50.97 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 124.696 1.198 . . . . 0.0 112.293 175.155 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 12.9 mm-40 -61.42 -33.86 74.42 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 119.091 0.859 . . . . 0.0 111.715 -177.729 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 76.1 mt -63.96 -35.63 74.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 CA-C-N 120.307 1.412 . . . . 0.0 111.958 171.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.75 -35.56 67.5 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 119.112 0.869 . . . . 0.0 112.498 173.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 51.8 mm-40 -67.89 -33.67 75.16 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.564 0.745 . . . . 0.0 111.581 173.363 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -58.7 -22.05 56.34 Favored 'General case' 0 CA--C 1.547 0.847 0 O-C-N 121.063 -1.023 . . . . 0.0 113.392 178.148 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 57.7 mt -82.03 -14.55 55.74 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.751 1.621 . . . . 0.0 113.839 177.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.1 pp -85.65 -18.52 32.99 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 119.606 1.094 . . . . 0.0 112.643 173.58 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -79.82 167.26 51.27 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 124.919 1.247 . . . . 0.0 113.718 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -110.87 -7.57 14.58 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.011 1.725 . . . . 0.0 112.746 175.26 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -112.25 164.97 12.6 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 127.704 2.401 . . . . 0.0 111.642 179.262 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 44.1 mp0 -62.58 143.59 57.08 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.903 1.281 . . . . 0.0 112.141 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 16.0 mmt85 -140.64 130.05 23.88 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.891 1.276 . . . . 0.0 111.267 173.269 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 39.7 mtmt -104.81 136.04 45.06 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.297 1.439 . . . . 0.0 110.847 168.104 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 66.7 t -135.95 136.79 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 125.345 1.458 . . . . 0.0 108.742 176.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -101.01 131.82 46.71 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.987 0.915 . . . . 0.0 110.882 178.228 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.1 tt -154.11 150.05 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 124.612 1.165 . . . . 0.0 111.751 -170.295 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -89.22 125.85 35.25 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.243 -0.911 . . . . 0.0 111.825 174.297 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 20.0 m-30 -113.99 146.0 40.75 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.737 2.015 . . . . 0.0 111.115 173.405 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -86.52 156.36 20.12 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 169.257 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 58.3 ttm-85 -101.22 149.11 24.34 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 126.152 1.781 . . . . 0.0 109.332 166.7 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -54.37 -28.15 41.22 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 114.441 1.274 . . . . 0.0 114.441 177.824 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -73.68 -6.98 50.18 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.926 1.69 . . . . 0.0 114.088 176.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 99.17 -1.28 57.49 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 125.763 1.649 . . . . 0.0 114.229 -177.758 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -73.57 168.98 18.2 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 118.407 1.104 . . . . 0.0 112.215 177.041 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 34.9 t -143.02 151.66 41.06 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.341 1.056 . . . . 0.0 111.36 176.605 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -157.36 151.85 25.16 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.673 1.189 . . . . 0.0 111.587 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -76.57 123.18 25.69 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.411 0.624 . . . . 0.0 110.466 165.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 21.4 t -104.79 137.68 42.21 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.988 1.715 . . . . 0.0 110.377 170.158 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.3 tp -92.24 116.37 28.89 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 162.157 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 22.3 t -100.06 115.39 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 124.829 1.252 . . . . 0.0 108.468 176.308 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -110.79 110.61 21.31 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.721 1.208 . . . . 0.0 108.273 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 71.3 t -78.39 128.75 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 169.5 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 56.0 t -112.98 113.01 49.8 Favored Pre-proline 0 CA--C 1.538 0.496 0 N-CA-C 107.591 -1.262 . . . . 0.0 107.591 168.735 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.32 127.82 10.76 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 123.273 2.648 . . . . 0.0 109.741 178.647 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 79.3 t -102.02 119.7 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 123.912 0.885 . . . . 0.0 109.45 176.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 61.1 mttt -88.52 153.57 21.04 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.693 0.797 . . . . 0.0 112.635 172.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -92.35 -173.58 3.45 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.475 1.11 . . . . 0.0 111.663 175.37 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -60.11 -22.12 62.4 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.11 1.364 . . . . 0.0 114.465 178.293 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -90.66 -5.47 55.77 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.119 1.368 . . . . 0.0 112.991 178.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 80.43 22.35 62.71 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 124.396 0.998 . . . . 0.0 114.456 -179.57 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -108.16 148.24 30.17 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.193 1.397 . . . . 0.0 109.916 172.247 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.8 p -78.79 126.19 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 123.703 0.801 . . . . 0.0 110.525 178.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.47 -22.82 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 -174.786 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 56.0 mtm -130.18 149.91 51.67 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.848 1.259 . . . . 0.0 111.977 169.094 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -107.52 136.04 47.96 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 124.766 1.226 . . . . 0.0 109.126 164.261 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 75.9 mt -99.26 118.45 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 162.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -93.68 116.76 29.27 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 170.2 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -101.53 144.53 30.18 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 119.122 -0.466 . . . . 0.0 110.894 176.54 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -122.46 133.01 54.61 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.63 1.172 . . . . 0.0 111.151 -176.731 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -137.7 131.09 30.87 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 125.271 1.428 . . . . 0.0 109.2 176.138 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.507 HG23 HD11 ' A' ' 51' ' ' LEU . 71.3 t -76.86 110.95 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 175.836 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.2 p -93.9 -24.23 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 123.628 0.771 . . . . 0.0 112.744 -174.081 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 37.9 tpp -163.53 111.69 1.21 Allowed 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.769 1.228 . . . . 0.0 110.572 178.242 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -82.28 118.91 23.49 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.388 0.675 . . . . 0.0 109.919 176.713 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt . . . . . 0 C--O 1.254 1.306 0 C-N-CA 125.201 1.4 . . . . 0.0 113.475 -175.456 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 32.2 p . . . . . 0 N--CA 1.477 0.925 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -86.36 -56.98 3.18 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.88 0.872 . . . . 0.0 111.762 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 48.1 tp -57.87 -35.06 70.45 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.226 1.01 . . . . 0.0 111.065 178.189 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -44.77 -37.41 3.77 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 170.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 99.8 m -77.69 -31.64 52.54 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.39 1.076 . . . . 0.0 110.775 179.262 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 12.2 mm -75.38 -36.22 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 124.675 1.19 . . . . 0.0 110.661 177.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 94.0 mt -54.83 -41.46 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 123.547 0.739 . . . . 0.0 110.529 174.26 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 7.0 mmt85 -59.31 -32.91 70.48 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 118.864 0.756 . . . . 0.0 112.869 178.205 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -77.16 -36.75 54.95 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.888 1.275 . . . . 0.0 111.631 177.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -74.85 -25.9 59.31 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.65 1.18 . . . . 0.0 112.688 175.315 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 . . . . . 0 N--CA 1.475 0.809 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 173.178 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 22.8 mmm180 . . . . . 0 N--CA 1.469 0.496 0 CA-C-O 122.128 0.966 . . . . 0.0 111.239 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.6 mptt -92.85 123.24 35.97 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.128 -0.982 . . . . 0.0 110.935 -170.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -159.72 163.88 34.36 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.183 0.993 . . . . 0.0 113.096 177.194 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 32.6 pt -140.97 156.22 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 126.5 1.92 . . . . 0.0 110.006 173.535 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 10.7 mt -118.27 132.75 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 125.416 1.486 . . . . 0.0 109.006 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -130.87 148.54 52.65 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.44 1.096 . . . . 0.0 111.775 177.622 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 52.7 t-20 -71.22 125.3 26.57 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.863 0.865 . . . . 0.0 111.045 178.303 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.06 -26.78 59.65 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 121.463 -0.773 . . . . 0.0 112.824 175.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 77.4 mtp180 -76.41 23.59 0.15 Allowed 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 126.137 1.775 . . . . 0.0 114.462 -170.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.4 m -149.93 148.5 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 126.748 2.019 . . . . 0.0 110.563 -171.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -63.72 -41.01 98.15 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.414 1.086 . . . . 0.0 113.26 -169.631 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -83.55 -12.67 55.86 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -175.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 90.4 m 49.21 64.3 1.79 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.353 1.461 . . . . 0.0 111.489 -167.604 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.14 136.18 54.7 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.59 0.756 . . . . 0.0 112.027 -177.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 17.5 t -63.52 123.69 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 C-N-CA 122.869 0.467 . . . . 0.0 109.842 175.227 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.0 pt -103.67 -21.68 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 125.291 1.436 . . . . 0.0 112.551 175.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -151.07 144.55 24.91 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.187 0.995 . . . . 0.0 111.217 178.066 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.457 ' HB3' ' CE1' ' A' ' 48' ' ' PHE . 0.3 OUTLIER -135.46 140.65 45.02 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.411 1.084 . . . . 0.0 111.136 -177.685 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -78.96 -175.35 4.48 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 119.97 1.259 . . . . 0.0 112.403 176.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -90.95 -27.2 18.86 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 120.455 -1.403 . . . . 0.0 111.955 172.168 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -70.93 -41.64 61.49 Favored Glycine 0 C--N 1.343 0.95 0 O-C-N 121.869 -0.52 . . . . 0.0 112.248 -174.091 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.457 ' CE1' ' HB3' ' A' ' 44' ' ' CYS . 0.4 OUTLIER -69.39 -28.56 66.27 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.185 0.594 . . . . 0.0 112.332 -179.307 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 93.2 m -53.89 -51.76 62.65 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.18 0.992 . . . . 0.0 111.32 177.078 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -70.99 -19.72 62.5 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.111 0.964 . . . . 0.0 113.582 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 15.2 tp -62.81 -46.43 87.98 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.989 1.316 . . . . 0.0 111.788 -179.07 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 44.1 t -95.68 -33.52 12.29 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.167 0.987 . . . . 0.0 113.035 171.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.38 7.57 51.52 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 124.753 1.168 . . . . 0.0 114.091 -173.688 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -84.89 -158.3 0.35 Allowed 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 118.775 1.287 . . . . 0.0 112.36 168.442 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 10.5 t -155.83 170.24 22.55 Favored 'General case' 0 C--O 1.24 0.581 0 O-C-N 120.772 -1.205 . . . . 0.0 111.643 176.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 -47.46 -47.76 27.04 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.091 1.356 . . . . 0.0 111.44 176.218 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.05 -26.82 64.92 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -89.5 -36.07 15.6 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.192 0.997 . . . . 0.0 112.487 174.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 80.8 t -84.46 -17.12 10.32 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 C-N-CA 124.962 1.305 . . . . 0.0 111.914 -176.411 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 44.6 mtm -67.59 140.58 56.92 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 120.524 -1.36 . . . . 0.0 110.453 173.34 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 12.4 mt-30 67.77 9.64 7.24 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.566 1.546 . . . . 0.0 114.061 -178.557 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -83.86 155.11 64.82 Favored Pre-proline 0 N--CA 1.472 0.654 0 C-N-CA 124.611 1.165 . . . . 0.0 110.428 170.676 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.27 133.99 25.87 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.614 2.209 . . . . 0.0 109.029 166.125 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 3.9 t -65.6 -15.26 62.56 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -171.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 40.8 p -57.67 -28.26 63.61 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.586 1.554 . . . . 0.0 112.581 169.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 86.2 m 56.65 41.6 28.16 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.303 1.441 . . . . 0.0 112.099 -178.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -57.84 -27.45 63.21 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.687 1.195 . . . . 0.0 113.232 -175.645 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -62.47 -15.6 50.71 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 174.74 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 80.4 mt -79.47 -13.68 59.41 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 173.086 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 31.0 m170 -73.25 118.93 16.79 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 119.211 0.914 . . . . 0.0 110.911 -179.556 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -99.65 -164.32 29.26 Favored Glycine 0 CA--C 1.539 1.534 0 C-N-CA 125.841 1.686 . . . . 0.0 112.574 177.036 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -70.07 -25.15 27.46 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 123.096 2.531 . . . . 0.0 113.019 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 40.2 ttt180 -84.39 -14.84 48.32 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.898 0.879 . . . . 0.0 112.974 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 31.7 m -69.28 143.99 53.71 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.083 1.353 . . . . 0.0 112.074 -171.195 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 19.9 mp0 -91.19 118.08 30.16 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.308 1.443 . . . . 0.0 110.257 -168.317 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 57.6 mmm-85 -58.92 -36.46 74.76 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 121.414 -0.804 . . . . 0.0 113.011 -178.453 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 25.1 tpp180 -61.58 -45.27 94.82 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.212 1.005 . . . . 0.0 111.528 175.265 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -72.08 -40.46 68.25 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.104 -0.998 . . . . 0.0 112.724 179.161 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.42 -34.9 64.83 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.504 0.721 . . . . 0.0 112.017 173.033 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -73.38 -48.2 35.96 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 124.572 1.149 . . . . 0.0 112.291 172.749 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -58.62 -35.29 72.25 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 118.536 -0.745 . . . . 0.0 111.998 -178.451 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 80.7 mt -63.49 -35.63 73.23 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 CA-C-N 120.191 1.36 . . . . 0.0 112.293 172.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.13 -36.63 66.72 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 118.888 0.767 . . . . 0.0 112.339 173.576 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 48.3 mm-40 -68.91 -32.93 72.91 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.491 0.717 . . . . 0.0 111.74 175.26 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -58.61 -21.08 52.49 Favored 'General case' 0 CA--C 1.548 0.88 0 O-C-N 121.168 -0.957 . . . . 0.0 113.358 177.78 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 57.6 mt -83.74 -15.3 49.1 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.669 1.588 . . . . 0.0 113.89 177.223 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -85.69 -20.87 28.73 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 119.611 1.096 . . . . 0.0 112.183 173.729 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -82.36 149.75 27.89 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 125.042 1.306 . . . . 0.0 113.444 -178.267 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.66 -2.22 57.85 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.013 1.325 . . . . 0.0 114.008 178.068 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -126.27 162.53 25.25 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 126.177 1.791 . . . . 0.0 111.386 -173.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -59.75 136.03 57.87 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.559 1.144 . . . . 0.0 111.931 -178.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.2 129.99 22.96 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.674 1.19 . . . . 0.0 110.311 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 30.9 mtmt -109.26 140.57 42.74 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.565 1.546 . . . . 0.0 111.715 176.676 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 41.4 t -139.51 136.35 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 126.173 1.789 . . . . 0.0 108.849 178.521 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -104.31 135.41 45.82 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.262 1.025 . . . . 0.0 110.594 176.747 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.0 tt -161.11 150.57 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 123.623 0.769 . . . . 0.0 112.554 -165.544 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -86.72 123.36 31.8 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 121.402 -0.811 . . . . 0.0 112.165 173.151 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 12.0 m-30 -114.04 140.21 48.64 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 127.157 2.183 . . . . 0.0 111.6 175.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -77.7 162.61 26.86 Favored 'General case' 0 CA--C 1.55 0.942 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 172.193 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 13.2 ptt180 -122.64 155.66 35.92 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.758 1.223 . . . . 0.0 112.723 166.468 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -52.87 -28.21 22.02 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 126.354 1.861 . . . . 0.0 114.453 -176.068 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -68.06 -12.87 61.62 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.178 1.391 . . . . 0.0 113.683 177.094 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 94.79 22.95 22.22 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 125.007 1.289 . . . . 0.0 113.569 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 7.9 t -120.36 -173.1 2.5 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.595 1.158 . . . . 0.0 111.576 177.01 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 16.8 t -144.91 154.33 42.49 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.007 1.323 . . . . 0.0 112.514 -169.193 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -150.55 148.71 29.0 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.765 1.626 . . . . 0.0 110.97 177.369 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -74.72 134.26 41.92 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.712 0.768 . . . . 0.0 109.827 166.064 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 35.1 t -129.55 145.62 51.45 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.827 2.051 . . . . 0.0 110.235 -177.426 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 14.8 tp -93.9 127.31 39.6 Favored 'General case' 0 N--CA 1.463 0.175 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 161.62 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 68.7 t -101.87 127.23 55.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 161.323 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -122.3 121.77 37.51 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 119.289 0.95 . . . . 0.0 109.568 165.618 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 57.0 t -84.74 133.0 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 175.568 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 49.8 t -113.67 110.71 49.43 Favored Pre-proline 0 N--CA 1.467 0.411 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 170.259 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.85 129.99 12.06 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.903 2.402 . . . . 0.0 109.645 178.246 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 74.3 t -103.46 125.04 58.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.074 0.949 . . . . 0.0 109.587 178.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 66.7 mttt -94.11 153.98 17.84 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 172.381 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -93.49 -173.89 3.33 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.55 1.14 . . . . 0.0 111.506 176.324 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -60.27 -22.05 62.65 Favored 'General case' 0 CA--C 1.548 0.865 0 C-N-CA 125.038 1.335 . . . . 0.0 114.406 178.514 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -90.81 -5.52 55.51 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.144 1.377 . . . . 0.0 112.981 178.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 79.9 22.44 63.75 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 124.476 1.036 . . . . 0.0 114.458 -179.525 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -107.26 150.06 27.08 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.065 1.346 . . . . 0.0 110.001 173.098 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 86.8 t -78.25 125.95 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 123.551 0.74 . . . . 0.0 109.353 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.53 -23.27 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 -176.272 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 56.1 mtm -131.49 151.6 51.43 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.621 1.168 . . . . 0.0 112.155 170.1 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -110.63 135.25 51.55 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 124.985 1.314 . . . . 0.0 109.108 166.143 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 64.4 mt -102.19 119.15 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 165.611 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -95.31 118.09 31.45 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 172.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -107.58 131.92 53.84 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 123.338 0.399 . . . . 0.0 110.475 177.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 13.3 m-30 -108.76 147.94 31.26 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 125.724 1.609 . . . . 0.0 111.585 -177.207 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -148.63 141.9 25.12 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 125.3 1.44 . . . . 0.0 109.168 176.241 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 45.3 t -76.6 122.54 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 175.143 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.7 t -89.94 -39.74 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 125.025 1.33 . . . . 0.0 111.089 175.736 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 24.7 ttm -171.53 126.43 0.63 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.39 1.076 . . . . 0.0 110.957 -175.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -78.17 125.89 30.01 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 121.303 -0.873 . . . . 0.0 110.016 169.22 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt . . . . . 0 C--O 1.254 1.336 0 C-N-CA 125.038 1.335 . . . . 0.0 113.58 179.225 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 41.2 p . . . . . 0 N--CA 1.481 1.117 0 N-CA-C 114.136 1.162 . . . . 0.0 114.136 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -69.81 -50.62 41.2 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.033 0.933 . . . . 0.0 111.911 175.528 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 58.9 tp -61.84 -35.75 79.19 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.903 1.281 . . . . 0.0 111.154 176.306 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -56.69 -31.45 64.47 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.125 0.97 . . . . 0.0 112.671 177.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.2 m -72.13 -31.98 66.51 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.376 0.67 . . . . 0.0 111.175 174.273 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 16.1 mm -73.04 -41.8 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.889 0.876 . . . . 0.0 110.366 176.733 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 97.1 mt -54.47 -48.15 69.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.0 0.92 . . . . 0.0 110.019 174.487 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 81.6 mtt-85 -59.68 -27.18 66.19 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -78.18 -24.39 47.23 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.593 1.157 . . . . 0.0 113.112 177.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -90.31 -29.34 18.18 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.252 1.021 . . . . 0.0 112.75 170.071 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 . . . . . 0 CA--C 1.548 0.878 0 C-N-CA 124.688 1.195 . . . . 0.0 112.755 172.219 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? . . . . . 0 CA--C 1.543 0.696 0 CA-C-O 122.554 1.169 . . . . 0.0 111.3 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -104.46 142.09 35.21 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.285 1.434 . . . . 0.0 111.09 -163.201 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -166.03 162.24 17.81 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.366 1.066 . . . . 0.0 113.751 -178.438 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 31.4 pt -147.13 156.11 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 127.406 2.282 . . . . 0.0 110.081 -178.623 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.9 mp -122.03 131.61 72.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 125.126 1.371 . . . . 0.0 109.505 176.584 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -125.21 147.79 48.92 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 124.959 1.304 . . . . 0.0 111.499 176.503 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -77.88 130.0 36.07 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.105 0.478 . . . . 0.0 111.454 175.233 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.37 -21.01 62.92 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.632 1.173 . . . . 0.0 113.902 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 82.3 mtm180 -89.63 -4.56 57.75 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 114.622 1.342 . . . . 0.0 114.622 -167.411 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 32.4 m -108.99 150.49 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 125.114 1.366 . . . . 0.0 111.7 -173.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -50.21 -55.02 16.96 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 126.163 1.785 . . . . 0.0 114.03 -167.322 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -105.51 30.74 5.46 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.956 1.703 . . . . 0.0 111.689 -177.142 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 70.8 m 39.25 54.3 2.23 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 126.24 1.816 . . . . 0.0 113.299 170.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.8 141.04 56.63 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.773 0.829 . . . . 0.0 111.759 -168.528 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.5 t -65.18 121.51 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 174.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.1 pt -100.51 -15.61 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 125.171 1.389 . . . . 0.0 112.648 177.091 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -156.24 141.85 17.76 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.616 1.167 . . . . 0.0 111.198 176.711 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.534 ' HB3' ' CE1' ' A' ' 48' ' ' PHE . 3.3 m -129.66 156.56 44.04 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.971 0.909 . . . . 0.0 111.311 -178.83 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -78.71 -166.13 0.83 Allowed 'General case' 0 CA--C 1.558 1.272 0 CA-C-N 118.922 0.783 . . . . 0.0 111.274 164.787 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -111.54 -19.57 12.49 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 125.565 1.546 . . . . 0.0 112.77 168.091 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.19 -38.98 94.34 Favored Glycine 0 N--CA 1.472 1.047 0 C-N-CA 124.604 1.097 . . . . 0.0 111.942 176.391 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.534 ' CE1' ' HB3' ' A' ' 44' ' ' CYS . 0.6 OUTLIER -69.42 -30.87 68.91 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.73 0.812 . . . . 0.0 111.444 -176.454 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 83.4 m -49.63 -54.62 17.37 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.2 1.4 . . . . 0.0 111.905 174.697 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -72.74 -19.91 61.3 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -178.664 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 16.5 tp -65.01 -49.2 71.12 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.48 1.112 . . . . 0.0 111.461 179.148 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 79.0 m -107.8 -15.94 14.44 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 -177.363 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.39 -0.29 59.87 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 125.453 1.502 . . . . 0.0 114.428 172.384 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -84.39 -154.95 0.18 Allowed 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 124.757 1.223 . . . . 0.0 112.314 171.395 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.0 t -159.11 168.49 26.49 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 120.604 -1.31 . . . . 0.0 111.652 173.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 36.5 ttm180 -49.56 -49.49 46.12 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.247 1.419 . . . . 0.0 111.044 176.384 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.82 -27.87 53.47 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -87.98 -49.26 7.18 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.447 1.099 . . . . 0.0 110.651 175.231 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 69.2 t -72.16 -19.25 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 124.363 1.065 . . . . 0.0 112.13 -172.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 5.4 mmt -64.21 -2.13 1.96 Allowed 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 5.8 tm0? -132.87 14.95 4.32 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.667 1.187 . . . . 0.0 112.341 173.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 37.4 mmt180 -98.48 155.43 36.82 Favored Pre-proline 0 C--O 1.24 0.588 0 C-N-CA 125.459 1.504 . . . . 0.0 111.395 178.426 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.17 142.07 37.22 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.206 2.604 . . . . 0.0 110.192 172.537 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 3.2 t -66.15 -11.02 46.62 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 -177.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 40.0 p -68.79 -25.66 64.81 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.344 1.458 . . . . 0.0 112.223 171.665 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 83.6 m 51.41 42.89 29.65 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.464 1.506 . . . . 0.0 113.013 -177.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -56.42 -31.74 64.2 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.455 1.502 . . . . 0.0 112.978 -175.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -64.85 -15.57 62.02 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.493 1.117 . . . . 0.0 113.932 177.509 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 87.1 mt -80.69 -11.12 59.68 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.212 1.005 . . . . 0.0 113.019 172.064 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -76.8 119.48 20.62 Favored 'General case' 0 CA--C 1.546 0.789 0 O-C-N 121.063 -1.023 . . . . 0.0 110.492 -178.122 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -97.8 -167.26 32.05 Favored Glycine 0 CA--C 1.539 1.546 0 C-N-CA 125.684 1.612 . . . . 0.0 112.366 175.715 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -68.21 -25.59 36.81 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 123.045 2.497 . . . . 0.0 112.96 177.484 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -87.61 -5.34 58.78 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.076 0.951 . . . . 0.0 112.847 178.587 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 63.4 m -70.33 133.44 46.95 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 120.986 -1.071 . . . . 0.0 109.942 179.084 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 49.8 mm-40 -80.99 123.16 28.11 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -171.273 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -64.65 -32.8 74.63 Favored 'General case' 0 N--CA 1.476 0.839 0 O-C-N 121.721 -0.612 . . . . 0.0 112.529 -172.304 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 23.5 tpp180 -61.57 -48.33 81.44 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.298 1.039 . . . . 0.0 111.429 170.421 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.36 -39.59 81.76 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 121.199 -0.938 . . . . 0.0 112.949 -177.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -54.82 -37.31 65.98 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.234 0.614 . . . . 0.0 112.541 171.543 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -72.6 -41.39 65.67 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.116 0.967 . . . . 0.0 112.821 173.139 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.461 ' HB2' HG21 ' A' ' 94' ' ' VAL . 47.9 mt-30 -56.25 -34.4 66.36 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 118.024 -0.989 . . . . 0.0 112.096 179.532 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 74.9 mt -61.79 -50.24 81.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 CA-C-N 120.197 1.362 . . . . 0.0 110.667 173.013 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.15 -37.0 83.03 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.825 0.85 . . . . 0.0 112.647 -178.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 79.4 mm-40 -72.71 -31.5 65.05 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.318 1.047 . . . . 0.0 111.776 175.594 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.54 -29.96 70.95 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 119.592 1.087 . . . . 0.0 112.512 179.41 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 64.6 mt -65.81 -16.58 63.94 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.914 1.286 . . . . 0.0 113.001 175.339 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 60.3 mt -80.62 -14.23 58.36 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 121.266 -0.896 . . . . 0.0 112.52 173.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -89.85 145.81 18.46 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 125.159 1.361 . . . . 0.0 113.23 -178.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.17 -2.8 58.11 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.974 1.31 . . . . 0.0 113.942 176.047 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -125.45 163.9 21.63 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.475 1.91 . . . . 0.0 110.984 -177.472 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -62.13 146.58 50.12 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.411 1.084 . . . . 0.0 112.907 -175.74 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.56 127.17 10.86 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.597 1.159 . . . . 0.0 110.514 -170.719 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.4 mttt -112.46 142.07 45.44 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.997 0.919 . . . . 0.0 112.463 172.772 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.461 HG21 ' HB2' ' A' ' 81' ' ' GLN . 7.6 p -134.13 133.39 55.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 126.255 1.822 . . . . 0.0 111.275 171.818 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -93.51 129.56 39.67 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.712 1.605 . . . . 0.0 110.023 172.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.7 tt -158.13 147.77 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.497 1.119 . . . . 0.0 111.339 -166.398 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -84.64 127.79 34.26 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 120.723 -1.236 . . . . 0.0 111.6 174.658 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 9.7 m-30 -107.69 140.14 41.19 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.686 1.594 . . . . 0.0 110.134 171.426 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -108.14 124.16 49.82 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.989 1.715 . . . . 0.0 110.651 175.555 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 2.5 ptp180 -92.23 159.9 15.41 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.821 1.249 . . . . 0.0 113.755 -177.636 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -58.81 -22.46 58.6 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 125.272 1.429 . . . . 0.0 114.322 179.157 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -70.61 -12.34 61.5 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.501 1.12 . . . . 0.0 113.349 176.388 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 95.35 27.15 11.03 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 124.53 1.062 . . . . 0.0 113.693 178.242 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 69.0 m -132.8 169.07 17.25 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.735 1.214 . . . . 0.0 111.414 -177.159 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 22.8 p -139.82 169.9 16.86 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 179.073 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -164.82 154.62 13.52 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 126.308 1.843 . . . . 0.0 110.348 -176.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -76.81 121.4 23.3 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.952 0.882 . . . . 0.0 110.124 168.208 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 49.5 t -104.7 140.44 38.06 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 127.755 2.422 . . . . 0.0 109.92 174.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 14.2 tp -93.0 119.0 31.8 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 160.547 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 44.2 t -103.45 117.19 48.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 124.476 1.11 . . . . 0.0 108.452 172.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -105.33 120.85 42.61 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.375 1.47 . . . . 0.0 108.314 174.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.2 p -93.64 131.09 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 119.483 1.038 . . . . 0.0 109.365 164.043 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 99.5 t -119.43 103.85 46.26 Favored Pre-proline 0 CA--C 1.537 0.46 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 176.633 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -75.78 139.76 22.66 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.906 2.404 . . . . 0.0 110.574 -175.592 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 96.3 t -112.37 125.33 69.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.353 1.061 . . . . 0.0 109.76 -178.705 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 67.2 mttt -93.55 154.54 17.82 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.036 0.934 . . . . 0.0 113.26 171.075 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -93.09 -174.21 3.49 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.497 1.119 . . . . 0.0 111.521 176.618 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -61.67 -20.69 63.71 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.013 1.325 . . . . 0.0 114.548 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -95.39 0.02 53.04 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.856 1.263 . . . . 0.0 113.162 177.026 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 79.31 22.55 64.9 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 124.155 0.883 . . . . 0.0 114.788 176.43 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -107.24 150.41 26.68 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.134 1.374 . . . . 0.0 109.987 172.622 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 59.1 t -79.1 124.97 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 123.565 0.746 . . . . 0.0 109.284 -179.225 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -127.01 -22.41 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 -176.101 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 53.8 mtm -133.46 154.51 50.74 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.905 1.282 . . . . 0.0 112.552 172.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -119.18 132.94 56.02 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 125.581 1.552 . . . . 0.0 109.556 170.587 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 41.6 mt -100.66 117.39 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 167.648 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -102.98 135.42 44.69 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 173.551 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -130.48 127.44 39.2 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.321 1.049 . . . . 0.0 110.129 -171.825 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -108.02 139.39 42.73 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.817 1.647 . . . . 0.0 111.647 -173.678 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -147.72 135.03 20.61 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.129 1.372 . . . . 0.0 109.728 175.194 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 49.9 t -73.39 117.71 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 CA-C-N 119.365 0.984 . . . . 0.0 108.611 174.006 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.9 p -95.51 -24.62 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 123.597 0.759 . . . . 0.0 112.666 178.711 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 14.5 tpt -165.8 134.98 3.26 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.358 1.463 . . . . 0.0 110.411 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -92.28 130.4 37.98 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.482 -0.761 . . . . 0.0 110.979 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt . . . . . 0 C--O 1.253 1.272 0 C-N-CA 125.332 1.453 . . . . 0.0 113.941 178.394 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.8 t . . . . . 0 N--CA 1.485 1.295 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -65.01 -50.81 64.83 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.197 0.599 . . . . 0.0 111.567 176.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 54.5 tp -64.33 -35.98 82.62 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.201 1.4 . . . . 0.0 111.022 172.46 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.5 -28.6 67.19 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.677 1.191 . . . . 0.0 112.688 178.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 94.4 m -74.29 -33.34 63.2 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.47 1.108 . . . . 0.0 110.869 173.56 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.2 mm -73.6 -36.22 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 124.351 1.06 . . . . 0.0 111.108 176.266 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 96.5 mt -57.04 -42.59 79.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 123.488 0.715 . . . . 0.0 110.818 176.196 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 89.3 mtt-85 -61.54 -22.05 64.81 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 176.463 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -76.07 -35.96 59.2 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 120.885 -1.134 . . . . 0.0 112.131 177.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -96.99 -11.85 24.04 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 114.559 1.318 . . . . 0.0 114.559 176.731 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 . . . . . 0 CA--C 1.546 0.817 0 CA-C-N 119.537 1.062 . . . . 0.0 111.91 162.59 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.3 mpt_? . . . . . 0 N--CA 1.472 0.672 0 CA-C-O 122.217 1.008 . . . . 0.0 111.243 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -87.29 139.92 30.07 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.235 1.014 . . . . 0.0 110.667 -177.893 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -164.43 163.24 22.3 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 124.588 1.155 . . . . 0.0 112.889 177.116 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 20.5 pt -139.57 155.35 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 125.852 1.661 . . . . 0.0 110.576 173.184 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 16.0 mt -113.2 129.55 68.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 125.687 1.595 . . . . 0.0 108.479 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -127.07 144.87 50.92 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 124.53 1.132 . . . . 0.0 111.249 176.568 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 42.8 t-20 -68.16 127.61 33.54 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.344 0.657 . . . . 0.0 111.146 178.18 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -83.04 -20.21 35.42 Favored 'General case' 0 CA--C 1.546 0.812 0 O-C-N 121.364 -0.835 . . . . 0.0 113.085 176.768 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 75.2 mtp180 -77.73 41.01 0.32 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 126.345 1.858 . . . . 0.0 112.759 -175.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.5 p -170.37 138.24 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 126.895 2.078 . . . . 0.0 109.985 -168.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -61.07 -44.67 97.03 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.043 0.937 . . . . 0.0 112.286 -176.76 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -72.55 -23.18 60.95 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -176.586 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 89.3 m 57.87 58.95 3.37 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.755 1.222 . . . . 0.0 112.411 -175.56 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.0 135.83 56.8 Favored 'General case' 0 CA--C 1.551 0.998 0 O-C-N 121.203 -0.936 . . . . 0.0 112.528 -177.398 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 11.5 t -62.52 123.65 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 C-N-CA 123.473 0.709 . . . . 0.0 109.502 174.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.6 pt -104.61 -19.93 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 125.181 1.392 . . . . 0.0 112.354 176.321 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 21.3 t80 -153.98 146.17 23.78 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.864 0.866 . . . . 0.0 111.866 177.256 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 6.9 m -125.35 155.42 40.32 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.185 0.994 . . . . 0.0 111.161 171.775 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -71.34 -152.35 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.285 0 CA-C-N 118.362 0.528 . . . . 0.0 111.487 170.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -117.11 -17.52 10.26 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 120.229 -1.544 . . . . 0.0 113.205 164.442 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -76.3 -33.55 48.54 Favored Glycine 0 N--CA 1.471 1.007 0 O-C-N 121.324 -0.86 . . . . 0.0 112.852 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -58.13 -38.44 76.53 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.6 1.16 . . . . 0.0 111.599 177.425 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 9.9 t -53.0 -51.16 62.54 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.362 1.465 . . . . 0.0 111.825 173.258 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -74.02 -22.86 59.41 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -178.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 49.5 tp -65.16 -50.0 67.67 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.292 1.037 . . . . 0.0 111.815 176.168 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 80.6 m -105.86 -20.47 13.43 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 -174.645 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.77 6.01 70.56 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 124.585 1.088 . . . . 0.0 114.032 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -88.61 -175.72 5.03 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.578 1.151 . . . . 0.0 112.295 171.744 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 66.5 m -135.41 161.25 35.97 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.104 0.962 . . . . 0.0 111.104 -179.548 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 46.7 ttm180 -53.37 -42.49 66.95 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 121.497 -0.752 . . . . 0.0 111.842 178.664 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.04 -28.1 49.61 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 175.044 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -92.96 -35.2 13.42 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.818 1.247 . . . . 0.0 112.324 178.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 99.3 t -83.64 -12.52 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 124.509 1.123 . . . . 0.0 112.181 178.754 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 21.3 mmt -68.57 141.86 55.35 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 120.798 -1.189 . . . . 0.0 112.278 172.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 68.74 7.3 6.04 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 126.011 1.724 . . . . 0.0 113.609 -178.788 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -78.13 152.77 79.56 Favored Pre-proline 0 N--CA 1.472 0.667 0 CA-C-O 117.921 -1.038 . . . . 0.0 109.904 175.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -74.37 13.02 0.95 Allowed 'Trans proline' 0 CA--C 1.549 1.229 0 C-N-CA 124.319 3.346 . . . . 0.0 115.356 176.487 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 7.5 t 75.14 -27.6 0.19 Allowed 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 126.86 2.064 . . . . 0.0 113.922 167.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 38.8 p -58.92 -19.3 41.2 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 127.162 2.185 . . . . 0.0 113.92 173.331 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . 0.277 28.5 p 42.81 40.29 2.04 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 127.308 2.243 . . . . 0.0 114.31 178.624 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -57.59 -32.91 67.65 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.026 0.931 . . . . 0.0 111.765 -177.612 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -57.04 -15.75 5.79 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.155 1.382 . . . . 0.0 114.253 177.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 89.9 mt -75.18 -2.29 27.17 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 171.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 31.4 p-80 -60.55 133.22 55.89 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 119.826 1.194 . . . . 0.0 112.946 174.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -107.39 -161.95 21.55 Favored Glycine 0 CA--C 1.54 1.651 0 C-N-CA 126.229 1.871 . . . . 0.0 111.468 168.239 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.05 -26.02 18.75 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 123.083 2.522 . . . . 0.0 113.153 178.711 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 29.8 ttm180 -94.38 -8.09 39.74 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.547 1.139 . . . . 0.0 113.715 -176.609 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 25.8 m -64.6 139.41 58.76 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.254 1.421 . . . . 0.0 110.555 179.036 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -102.43 123.03 45.46 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.174 0.989 . . . . 0.0 109.735 179.651 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 42.5 mmt180 -61.58 -26.91 68.27 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 24.6 tpp180 -56.21 -46.0 79.65 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.472 1.109 . . . . 0.0 111.797 171.524 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.36 -45.57 65.82 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.449 1.1 . . . . 0.0 111.954 175.236 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.52 -33.34 63.68 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 121.62 -0.675 . . . . 0.0 112.709 177.124 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.59 -41.85 71.78 Favored 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 125.1 1.36 . . . . 0.0 112.502 173.832 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 24.5 mm-40 -60.81 -33.48 73.08 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 118.328 -0.844 . . . . 0.0 111.347 179.143 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 46.1 mt -59.36 -43.66 90.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 CA-C-N 120.042 1.292 . . . . 0.0 111.026 171.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.2 -35.8 74.16 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.327 0.651 . . . . 0.0 112.71 177.478 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 78.4 mm-40 -69.27 -32.52 71.76 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 121.604 -0.685 . . . . 0.0 111.861 174.2 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.71 -23.21 67.04 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.936 0.894 . . . . 0.0 112.771 178.536 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 61.1 mt -77.26 -15.04 59.63 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.677 1.591 . . . . 0.0 113.45 174.169 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 64.2 mt -89.97 -14.67 33.56 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.124 0.969 . . . . 0.0 112.426 179.154 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -92.64 148.48 19.11 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 125.164 1.364 . . . . 0.0 113.15 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.84 -1.57 58.02 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.721 1.208 . . . . 0.0 113.83 175.551 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -115.33 161.32 18.66 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.711 2.004 . . . . 0.0 111.208 176.372 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.79 154.34 39.37 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 178.15 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 29.9 tpt180 -155.07 129.14 8.82 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.635 1.174 . . . . 0.0 111.148 -175.242 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 39.5 mtmt -102.68 137.63 40.65 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.598 1.559 . . . . 0.0 111.622 174.272 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 64.4 t -132.97 134.94 57.7 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 C-N-CA 126.414 1.885 . . . . 0.0 108.025 177.099 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -106.0 130.61 53.9 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.765 0.826 . . . . 0.0 110.381 177.394 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.0 tt -156.98 147.2 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 124.022 0.929 . . . . 0.0 112.217 -166.137 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -85.73 126.66 34.15 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.027 -1.046 . . . . 0.0 111.858 174.394 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 18.3 m-30 -111.92 147.8 35.07 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.528 1.931 . . . . 0.0 111.116 172.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -101.25 150.14 23.29 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.8 0.84 . . . . 0.0 112.538 166.415 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 40.9 mtm180 -89.59 159.03 17.38 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.956 1.302 . . . . 0.0 112.283 169.311 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 5.9 mptp? -59.19 -27.16 65.44 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.02 0.928 . . . . 0.0 112.639 166.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -69.93 -11.46 60.89 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 126.255 1.822 . . . . 0.0 114.067 173.269 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 90.39 -0.67 78.22 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 125.472 1.51 . . . . 0.0 114.471 -176.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -76.74 154.63 33.9 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.533 1.133 . . . . 0.0 111.451 176.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 95.5 m -126.99 156.96 40.78 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 119.382 0.992 . . . . 0.0 112.176 174.587 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -161.42 154.68 21.25 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.851 1.26 . . . . 0.0 111.998 177.657 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -77.72 122.78 25.83 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.627 0.771 . . . . 0.0 110.392 165.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 8.2 t -107.55 140.95 39.75 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 126.083 1.753 . . . . 0.0 110.224 173.667 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.3 tt -92.16 121.59 33.84 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 125.158 1.383 . . . . 0.0 107.491 162.34 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 48.0 t -101.0 111.37 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 125.068 1.347 . . . . 0.0 108.484 169.121 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -107.75 107.78 18.71 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.612 1.565 . . . . 0.0 108.997 174.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.407 HG22 ' HG ' ' A' ' 127' ' ' LEU . 50.4 t -78.43 126.91 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 170.642 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 75.6 t -114.36 116.3 44.19 Favored Pre-proline 0 CA--C 1.538 0.51 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 170.434 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.69 127.0 9.9 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 123.238 2.625 . . . . 0.0 109.736 179.168 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 63.0 t -97.18 118.64 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 123.736 0.815 . . . . 0.0 109.279 174.487 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 60.4 mttt -88.48 153.51 21.1 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.675 0.79 . . . . 0.0 112.587 171.801 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -93.02 -173.52 3.3 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.518 1.127 . . . . 0.0 111.747 175.734 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -60.7 -21.36 62.8 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 125.206 1.402 . . . . 0.0 114.705 178.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -93.93 -0.82 55.43 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.854 1.262 . . . . 0.0 113.22 177.153 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 79.11 22.05 66.46 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 124.222 0.915 . . . . 0.0 114.537 177.688 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -107.29 147.89 29.69 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 125.119 1.368 . . . . 0.0 109.923 172.103 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.6 p -77.82 126.38 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 123.405 0.682 . . . . 0.0 110.273 178.349 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.58 -22.45 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 -175.557 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 57.7 mtm -131.99 150.96 52.01 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.779 1.231 . . . . 0.0 112.068 168.657 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -107.92 133.7 51.89 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 125.06 1.344 . . . . 0.0 109.215 165.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 69.2 mt -97.15 119.0 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 163.027 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.407 ' HG ' HG22 ' A' ' 112' ' ' VAL . 8.6 mp -96.47 119.09 34.32 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 169.313 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -102.81 124.88 49.16 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 123.547 0.529 . . . . 0.0 110.984 177.603 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -100.9 126.88 47.55 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.232 1.413 . . . . 0.0 109.998 179.232 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -141.53 103.94 4.48 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.38 1.072 . . . . 0.0 108.246 -172.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.2 p -61.51 116.9 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 O-C-N 120.981 -1.074 . . . . 0.0 110.473 178.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.9 p -96.76 -27.54 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.817 1.247 . . . . 0.0 113.102 -174.201 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 24.7 ptp -161.41 147.17 14.02 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.24 1.016 . . . . 0.0 112.64 166.672 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -88.93 134.31 34.0 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.705 0.802 . . . . 0.0 110.845 177.645 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt . . . . . 0 C--O 1.253 1.246 0 C-N-CA 125.36 1.464 . . . . 0.0 112.473 177.114 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.8 t . . . . . 0 N--CA 1.48 1.031 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -75.28 -45.09 42.07 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.252 -0.905 . . . . 0.0 112.018 172.655 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 52.9 tp -63.18 -35.94 81.96 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.764 1.226 . . . . 0.0 111.16 171.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -52.1 -33.31 39.01 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.548 1.539 . . . . 0.0 112.583 175.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 21.4 m -72.65 -21.56 61.07 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.546 1.538 . . . . 0.0 112.02 176.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.6 mm -82.22 -39.56 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 124.168 0.987 . . . . 0.0 109.953 177.411 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.9 mp -55.21 -38.95 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 123.422 0.689 . . . . 0.0 111.367 177.127 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 50.0 ptt85 -73.45 -16.86 61.3 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -178.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -85.69 -36.77 20.04 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.121 1.368 . . . . 0.0 111.297 171.628 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -70.74 -28.83 65.0 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.485 1.114 . . . . 0.0 112.029 174.021 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 . . . . . 0 CA--C 1.541 0.626 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 167.405 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.54 0.565 0 CA-C-O 122.557 1.17 . . . . 0.0 111.477 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.7 mptt -97.74 139.09 34.14 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.512 1.525 . . . . 0.0 110.351 -179.015 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -162.15 160.93 27.8 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 124.072 0.949 . . . . 0.0 113.127 173.474 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 12.8 pt -139.72 153.22 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 125.996 1.718 . . . . 0.0 109.937 175.755 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.2 mp -116.5 133.31 63.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 C-N-CA 125.337 1.455 . . . . 0.0 109.146 -179.092 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -132.54 142.81 49.35 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 124.825 1.25 . . . . 0.0 111.815 -176.176 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -65.56 121.69 15.51 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.518 1.127 . . . . 0.0 111.944 177.522 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -78.82 -19.87 51.03 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 178.473 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 26.0 mmm180 -73.31 -40.65 64.34 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.468 1.107 . . . . 0.0 112.527 -175.066 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 32.6 m -73.55 147.78 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 124.013 0.925 . . . . 0.0 111.892 175.694 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -62.22 -42.02 98.92 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.574 1.149 . . . . 0.0 113.225 -172.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -77.32 -11.32 59.82 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 113.785 1.032 . . . . 0.0 113.785 -176.266 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 81.6 m 51.03 60.31 3.97 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.451 1.5 . . . . 0.0 111.776 -170.188 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.06 137.51 55.07 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.749 0.82 . . . . 0.0 112.023 -176.608 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 41.4 t -63.71 123.79 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 123.723 0.809 . . . . 0.0 109.263 174.085 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.6 pt -103.83 -19.74 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.727 1.211 . . . . 0.0 112.298 175.37 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -154.08 143.72 21.66 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.34 1.056 . . . . 0.0 111.506 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 4.2 m -125.62 157.63 36.73 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.816 1.246 . . . . 0.0 111.594 174.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -73.79 -149.95 0.02 OUTLIER 'General case' 0 CA--C 1.56 1.364 0 CA-C-N 118.622 0.646 . . . . 0.0 111.399 169.091 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -116.72 -18.69 10.2 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 120.425 -1.422 . . . . 0.0 113.266 163.736 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -76.0 -34.98 45.83 Favored Glycine 0 N--CA 1.471 0.99 0 O-C-N 121.276 -0.89 . . . . 0.0 112.684 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -55.29 -39.12 69.5 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.857 1.263 . . . . 0.0 111.605 177.011 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 2.8 t -54.6 -56.76 15.65 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.69 1.596 . . . . 0.0 112.09 176.59 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -71.31 -20.54 62.18 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -179.177 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.8 -53.51 56.96 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.64 1.176 . . . . 0.0 110.947 175.129 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 75.9 m -104.94 -31.97 8.99 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 -174.124 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 109.72 0.12 30.55 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 127.207 2.337 . . . . 0.0 115.945 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -79.58 -160.75 0.28 Allowed 'General case' 0 CA--C 1.554 1.102 0 CA-C-N 118.786 1.293 . . . . 0.0 112.466 177.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 69.8 m -145.01 160.91 40.62 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.055 1.342 . . . . 0.0 110.582 174.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -53.03 -44.11 67.09 Favored 'General case' 0 N--CA 1.478 0.956 0 O-C-N 121.355 -0.841 . . . . 0.0 111.668 177.349 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.69 -25.95 42.45 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 176.594 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -91.69 -39.46 11.82 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.024 1.33 . . . . 0.0 112.176 177.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 87.4 t -80.81 -15.84 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 124.502 1.121 . . . . 0.0 112.277 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 68.2 mmm -65.72 137.87 57.58 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 120.843 -1.16 . . . . 0.0 111.34 172.08 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 29.7 tp60 72.92 6.14 5.29 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 126.508 1.923 . . . . 0.0 113.633 -177.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 34.6 mmt180 -86.88 153.1 54.61 Favored Pre-proline 0 N--CA 1.473 0.699 0 C-N-CA 124.548 1.139 . . . . 0.0 110.84 176.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -71.52 136.01 27.56 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.109 2.539 . . . . 0.0 110.092 171.287 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 19.0 p -68.69 -7.67 35.53 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -176.075 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 41.2 p -62.3 -23.97 67.04 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.065 1.346 . . . . 0.0 112.124 168.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 84.0 m 57.69 36.5 26.69 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.617 1.567 . . . . 0.0 113.009 178.307 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -56.16 -29.44 60.81 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.766 1.226 . . . . 0.0 112.24 177.186 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -60.62 -13.68 15.84 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.852 1.261 . . . . 0.0 114.357 175.437 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.3 mt -90.35 -0.65 57.73 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.112 1.365 . . . . 0.0 113.853 174.423 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -70.96 161.52 30.95 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 -178.576 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -160.85 -164.62 16.08 Favored Glycine 0 CA--C 1.538 1.52 0 C-N-CA 126.857 2.17 . . . . 0.0 111.052 166.382 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -63.54 -20.47 69.6 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 123.083 2.522 . . . . 0.0 114.523 -176.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 27.1 mmt85 -88.66 -8.54 54.43 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 119.298 0.954 . . . . 0.0 113.306 175.648 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 28.7 m -73.7 132.4 42.65 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 119.464 1.029 . . . . 0.0 109.502 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 -87.07 122.16 30.52 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.366 0.666 . . . . 0.0 109.761 -169.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 31.9 mmm180 -58.86 -39.17 80.53 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.771 0.828 . . . . 0.0 112.608 -175.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 17.6 ttm180 -67.99 -35.79 78.93 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.649 0.779 . . . . 0.0 112.31 176.234 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -71.6 -43.07 66.87 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.061 -1.024 . . . . 0.0 112.217 179.112 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -56.15 -33.38 65.16 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.161 0.584 . . . . 0.0 111.83 171.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -72.37 -47.65 47.78 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 124.703 1.201 . . . . 0.0 112.259 172.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 13.6 mm-40 -62.28 -34.25 76.2 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 118.404 -0.808 . . . . 0.0 111.775 -179.037 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 90.7 mt -62.61 -40.06 86.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 CA-C-N 120.198 1.363 . . . . 0.0 111.557 171.748 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.86 -37.08 81.39 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 119.296 0.953 . . . . 0.0 112.361 174.544 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 -67.65 -32.18 72.69 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 121.591 -0.693 . . . . 0.0 112.04 173.519 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.43 -21.97 66.61 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 119.239 0.927 . . . . 0.0 112.761 176.179 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 41.1 mt -83.38 -14.87 51.82 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.282 1.433 . . . . 0.0 113.134 172.254 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 74.8 mt -89.9 -16.89 29.07 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.003 0.921 . . . . 0.0 112.01 171.507 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -83.31 145.52 23.16 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 125.159 1.361 . . . . 0.0 112.5 176.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.81 -4.63 56.49 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -179.222 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -125.57 160.92 28.37 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.452 1.901 . . . . 0.0 110.652 -178.54 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -65.11 147.17 53.95 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -176.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.48 123.84 5.91 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.627 1.171 . . . . 0.0 111.147 -164.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 44.1 mtmt -97.65 141.84 30.19 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.2 1.4 . . . . 0.0 112.735 176.613 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 56.8 t -139.2 138.63 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 126.356 1.863 . . . . 0.0 108.738 174.729 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -102.15 129.93 48.65 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.163 0.985 . . . . 0.0 110.713 177.027 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.8 tt -153.22 148.2 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 124.614 1.166 . . . . 0.0 111.847 -168.722 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -87.78 119.06 27.74 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 120.969 -1.082 . . . . 0.0 111.472 176.571 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 13.7 m-30 -106.46 140.25 39.66 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.991 1.716 . . . . 0.0 110.9 174.366 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -92.69 142.3 27.52 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.022 0.929 . . . . 0.0 112.805 176.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 43.0 ttm-85 -80.2 156.57 26.86 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.629 1.972 . . . . 0.0 110.404 174.03 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 25.6 mmmt -58.02 -26.53 62.55 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 176.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -78.58 -5.98 54.3 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.635 1.574 . . . . 0.0 113.984 177.652 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 92.14 1.46 69.71 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 125.039 1.304 . . . . 0.0 114.455 -176.577 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 8.6 t -77.45 178.44 7.19 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 118.319 1.059 . . . . 0.0 111.763 171.11 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 39.4 t -151.42 154.77 37.27 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.78 1.232 . . . . 0.0 112.376 -170.797 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -158.81 154.4 26.08 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.232 1.813 . . . . 0.0 110.882 179.123 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -81.22 124.78 29.58 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 121.815 0.817 . . . . 0.0 110.403 170.445 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 36.6 t -111.59 140.8 45.91 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.638 1.975 . . . . 0.0 110.801 177.433 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 18.8 tp -93.15 115.72 28.35 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.996 1.318 . . . . 0.0 108.163 165.75 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 81.4 t -99.37 118.22 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 171.226 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -109.69 109.42 20.14 Favored 'General case' 0 C--O 1.225 -0.198 0 C-N-CA 125.689 1.596 . . . . 0.0 108.411 172.059 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 71.5 t -78.66 130.43 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 169.04 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 78.1 t -117.22 111.33 40.4 Favored Pre-proline 0 N--CA 1.466 0.361 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 167.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.83 133.79 18.99 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.751 2.301 . . . . 0.0 109.884 179.395 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 41.1 t -91.74 119.62 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 173.189 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 66.0 mttt -92.96 151.9 19.65 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.649 0.738 . . . . 0.0 112.365 167.677 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -92.2 -173.87 3.57 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.959 0.904 . . . . 0.0 111.7 175.174 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -60.81 -21.3 62.99 Favored 'General case' 0 CA--C 1.548 0.865 0 C-N-CA 125.083 1.353 . . . . 0.0 114.553 178.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -93.99 -0.42 55.54 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.396 1.078 . . . . 0.0 113.105 177.168 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 77.48 19.87 75.56 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 124.173 0.892 . . . . 0.0 114.465 179.063 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -98.73 146.81 25.51 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.796 1.238 . . . . 0.0 109.393 172.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 84.1 t -77.2 127.97 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 177.183 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 3.3 pt -123.39 -23.15 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 -171.461 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 72.2 mtm -150.58 157.42 42.97 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.855 1.662 . . . . 0.0 110.487 178.421 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -115.24 132.22 56.68 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 124.683 1.193 . . . . 0.0 109.98 173.165 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 46.7 mt -97.18 114.84 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 105.647 -1.983 . . . . 0.0 105.647 164.555 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -92.98 117.91 30.58 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 171.098 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -107.53 129.76 54.94 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 119.478 -0.296 . . . . 0.0 111.02 178.216 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -109.39 143.18 39.31 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.111 1.364 . . . . 0.0 111.928 -176.794 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -145.36 145.34 31.15 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 126.007 1.723 . . . . 0.0 108.553 172.653 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 60.7 t -84.49 117.02 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 174.54 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.0 p -93.17 -25.97 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -179.263 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 44.6 tpp -165.28 123.68 1.65 Allowed 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.799 1.24 . . . . 0.0 110.75 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -84.36 123.51 30.27 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 121.562 -0.711 . . . . 0.0 109.819 174.249 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.255 1.357 0 CA-C-O 115.744 -2.074 . . . . 0.0 115.463 -170.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 43.2 p . . . . . 0 N--CA 1.48 1.048 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -67.87 -47.72 68.11 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.94 0.896 . . . . 0.0 112.116 175.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 39.4 tp -63.15 -36.53 83.92 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.88 1.272 . . . . 0.0 111.072 175.487 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -59.93 -29.61 68.5 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.667 0.787 . . . . 0.0 112.815 179.151 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 73.8 m -72.74 -21.43 61.03 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.227 1.411 . . . . 0.0 111.935 173.275 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.7 mm -87.42 -42.71 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.087 1.355 . . . . 0.0 110.819 173.381 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 93.5 mt -53.68 -45.25 60.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 124.036 0.934 . . . . 0.0 110.598 178.725 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -66.09 -24.6 66.73 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 -179.336 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -79.06 -33.41 44.64 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.602 1.161 . . . . 0.0 111.949 175.737 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -73.56 -34.17 65.02 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.144 0.978 . . . . 0.0 111.496 170.303 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.544 0.747 0 N-CA-C 114.395 1.257 . . . . 0.0 114.395 178.683 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? . . . . . 0 N--CA 1.474 0.757 0 CA-C-O 122.518 1.151 . . . . 0.0 111.883 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.5 mptt -89.96 134.83 34.0 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.351 1.46 . . . . 0.0 110.393 -177.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -159.4 161.7 35.65 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 124.289 1.036 . . . . 0.0 113.17 178.766 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 20.7 pt -140.02 161.46 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 126.671 1.988 . . . . 0.0 109.733 173.145 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.9 mp -126.26 133.88 67.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 C-N-CA 124.813 1.245 . . . . 0.0 109.545 177.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -130.85 144.71 51.65 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.673 1.189 . . . . 0.0 111.477 178.495 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -72.78 125.06 26.63 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 122.844 0.458 . . . . 0.0 111.436 178.069 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.22 -32.6 70.55 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.341 1.056 . . . . 0.0 112.412 -177.037 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 25.0 mmm180 -80.11 36.52 0.35 Allowed 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 126.082 1.753 . . . . 0.0 112.796 -173.221 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 70.3 t -144.07 133.38 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 126.719 2.008 . . . . 0.0 108.977 -171.37 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -56.61 -35.92 68.83 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 -172.757 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -103.05 -3.86 25.38 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.544 1.538 . . . . 0.0 113.05 -178.309 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 5.9 t 52.14 71.37 0.47 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 126.372 1.869 . . . . 0.0 111.664 -174.652 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.74 133.82 50.94 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 121.254 -0.904 . . . . 0.0 111.658 -176.316 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 15.6 t -62.62 120.66 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 CA-C-N 118.705 0.684 . . . . 0.0 109.159 171.711 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 42.9 pt -102.08 -21.68 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 124.766 1.227 . . . . 0.0 112.26 176.811 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -152.18 144.42 23.95 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.363 1.065 . . . . 0.0 111.575 178.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.468 ' HB3' ' CE1' ' A' ' 48' ' ' PHE . 0.6 OUTLIER -135.04 149.14 50.08 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.491 1.116 . . . . 0.0 111.53 -178.942 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -76.57 -168.96 1.1 Allowed 'General case' 0 CA--C 1.555 1.164 0 CA-C-N 119.226 0.921 . . . . 0.0 111.367 169.51 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -103.84 -21.63 13.63 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.248 1.419 . . . . 0.0 112.553 169.799 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.23 -36.18 60.09 Favored Glycine 0 C--N 1.343 0.917 0 O-C-N 121.578 -0.701 . . . . 0.0 112.551 -178.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.468 ' CE1' ' HB3' ' A' ' 44' ' ' CYS . 0.6 OUTLIER -67.68 -30.45 69.98 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 122.98 0.512 . . . . 0.0 111.869 179.53 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 77.6 m -53.53 -52.29 60.14 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.712 1.205 . . . . 0.0 111.757 174.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -71.38 -19.06 62.32 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.966 0.906 . . . . 0.0 113.211 -179.266 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.428 HD11 HG23 ' A' ' 131' ' ' VAL . 10.3 tp -64.21 -52.83 56.96 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.809 1.244 . . . . 0.0 111.313 179.259 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 71.0 m -101.87 -19.09 15.43 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 95.12 2.11 62.5 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 125.813 1.673 . . . . 0.0 114.344 177.586 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -83.95 -175.27 5.72 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.778 1.231 . . . . 0.0 113.224 170.41 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.443 ' H ' ' CG ' ' A' ' 58' ' ' GLU . 69.1 m -137.34 160.13 39.95 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 121.317 -0.865 . . . . 0.0 111.663 -179.076 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 36.1 ttm180 -46.28 -42.25 14.26 Favored 'General case' 0 N--CA 1.48 1.035 0 O-C-N 121.421 -0.799 . . . . 0.0 112.029 171.422 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.73 -32.84 63.72 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.899 1.28 . . . . 0.0 113.652 178.558 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.443 ' CG ' ' H ' ' A' ' 55' ' ' SER . 14.2 pt-20 -99.6 -23.65 14.99 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 177.05 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 85.3 t -85.26 -20.49 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 C-N-CA 124.83 1.252 . . . . 0.0 112.659 176.193 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 53.3 mmm -63.2 138.12 58.44 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 120.403 -1.436 . . . . 0.0 110.843 175.489 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 67.97 10.06 7.56 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.429 1.492 . . . . 0.0 114.094 179.18 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 -85.33 156.43 59.68 Favored Pre-proline 0 N--CA 1.472 0.668 0 C-N-CA 124.716 1.206 . . . . 0.0 111.059 174.286 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -67.27 127.17 16.17 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.495 2.13 . . . . 0.0 109.415 167.333 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.402 ' SG ' HD13 ' A' ' 127' ' ' LEU . 9.1 t -69.69 -8.88 51.62 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -172.321 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 37.5 p -59.83 -28.1 67.19 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.893 1.277 . . . . 0.0 112.163 169.797 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 80.9 m 52.35 36.24 19.32 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.208 1.403 . . . . 0.0 112.726 -177.704 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -57.67 -30.1 65.18 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.624 1.17 . . . . 0.0 112.327 -177.159 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -59.03 -14.26 9.05 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.186 1.395 . . . . 0.0 114.211 175.758 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 89.5 mt -78.73 -4.14 47.72 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 173.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 15.9 p-80 -60.71 150.57 31.83 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-N 120.123 1.328 . . . . 0.0 114.268 178.143 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -142.84 -162.76 9.42 Favored Glycine 0 CA--C 1.54 1.605 0 C-N-CA 126.64 2.067 . . . . 0.0 112.42 173.184 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -71.04 -8.83 24.45 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 123.623 2.882 . . . . 0.0 114.122 -178.2 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 84.8 mmt-85 -107.27 8.04 29.64 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.045 1.338 . . . . 0.0 113.531 175.427 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 22.2 m -89.95 133.24 34.9 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.89 1.276 . . . . 0.0 109.803 178.058 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -102.45 137.52 40.58 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.295 1.038 . . . . 0.0 109.871 -179.166 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 27.8 mmt85 -58.84 -37.88 77.45 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.987 0.915 . . . . 0.0 112.199 -177.25 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 31.6 tpt180 -59.73 -43.99 93.94 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.486 1.115 . . . . 0.0 112.258 176.842 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.49 -45.9 74.5 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 121.42 -0.8 . . . . 0.0 112.147 178.351 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -57.28 -35.66 70.06 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 121.645 -0.659 . . . . 0.0 112.522 174.463 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -72.15 -44.85 62.47 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 125.186 1.394 . . . . 0.0 112.377 175.161 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.3 mm100 -60.85 -34.98 75.42 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.946 0.899 . . . . 0.0 111.227 -179.009 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 93.0 mt -60.63 -41.57 88.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 CA-C-N 119.702 1.137 . . . . 0.0 111.841 169.446 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.78 -32.22 70.59 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 119.562 1.074 . . . . 0.0 112.805 174.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 73.9 mm-40 -64.19 -37.35 87.14 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 121.475 -0.765 . . . . 0.0 111.232 171.451 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.96 -23.13 65.1 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 113.229 0.826 . . . . 0.0 113.229 177.185 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 70.3 mt -87.53 -14.09 41.24 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.433 1.493 . . . . 0.0 114.059 178.682 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.1 pp -100.84 -8.14 22.89 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 168.625 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -86.26 146.09 20.85 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 125.18 1.371 . . . . 0.0 112.344 175.686 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -93.42 1.32 56.9 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.57 1.148 . . . . 0.0 113.601 176.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.14 159.92 23.08 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.071 1.748 . . . . 0.0 111.604 -178.567 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -62.23 135.24 57.39 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.281 1.432 . . . . 0.0 111.937 178.712 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -138.82 127.9 23.95 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.506 1.122 . . . . 0.0 112.44 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 37.1 mtmt -101.18 132.26 46.75 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.496 1.518 . . . . 0.0 110.465 167.481 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 46.8 t -133.38 134.5 57.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 125.597 1.559 . . . . 0.0 108.231 177.444 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -103.85 132.03 50.49 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.761 0.824 . . . . 0.0 110.666 179.624 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.3 tt -154.79 150.15 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 124.288 1.035 . . . . 0.0 111.729 -168.157 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -86.98 127.43 35.09 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 120.998 -1.064 . . . . 0.0 111.747 172.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 17.6 m-30 -114.05 138.92 49.74 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.612 1.965 . . . . 0.0 110.719 171.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -85.5 156.31 20.84 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.382 0.673 . . . . 0.0 112.13 167.156 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -115.02 157.61 23.23 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.061 1.344 . . . . 0.0 113.246 172.163 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -48.84 -33.59 10.87 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 127.141 2.176 . . . . 0.0 114.637 -178.726 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -70.57 -10.48 59.39 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.259 1.423 . . . . 0.0 113.895 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 97.09 13.05 47.28 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 125.29 1.424 . . . . 0.0 114.264 178.108 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 22.9 m -107.51 -177.49 3.36 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.696 1.198 . . . . 0.0 111.242 177.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 25.1 p -148.33 171.14 16.48 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 120.878 -1.138 . . . . 0.0 113.291 176.764 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 18.2 p90 -160.76 159.98 30.75 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.764 1.626 . . . . 0.0 111.468 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -80.44 123.2 27.85 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 123.528 0.731 . . . . 0.0 110.328 167.358 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 19.0 t -106.93 134.63 49.79 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.212 1.805 . . . . 0.0 110.356 172.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.0 tt -88.13 118.48 27.74 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 161.342 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 59.7 t -99.78 110.55 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 124.881 1.272 . . . . 0.0 108.217 169.119 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -102.89 111.47 23.81 Favored 'General case' 0 C--O 1.227 -0.081 0 C-N-CA 125.426 1.49 . . . . 0.0 108.055 172.322 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.449 HG22 ' HG ' ' A' ' 127' ' ' LEU . 28.0 t -95.17 124.1 47.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.048 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 74.7 t -110.34 115.38 54.38 Favored Pre-proline 0 CA--C 1.537 0.466 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 -178.55 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -73.96 124.18 8.95 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.947 2.431 . . . . 0.0 109.904 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 88.3 t -98.48 117.12 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 123.328 0.651 . . . . 0.0 109.724 173.719 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 61.5 mttt -87.39 154.33 20.75 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.883 0.873 . . . . 0.0 112.581 172.277 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -92.57 -173.53 3.39 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.386 1.075 . . . . 0.0 111.629 175.289 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -60.18 -22.25 62.69 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.039 1.336 . . . . 0.0 114.416 178.422 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -90.68 -5.39 55.86 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.058 1.343 . . . . 0.0 113.026 178.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 80.5 22.56 62.12 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 124.425 1.012 . . . . 0.0 114.48 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -108.33 148.38 30.14 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.281 1.432 . . . . 0.0 109.88 172.265 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.0 p -79.51 125.67 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 123.56 0.744 . . . . 0.0 110.615 179.398 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.23 -22.86 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 -174.718 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 56.8 mtm -132.19 154.83 49.17 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.288 1.435 . . . . 0.0 111.857 170.131 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -117.14 133.52 55.9 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 124.957 1.303 . . . . 0.0 109.27 168.33 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 55.4 mt -96.59 118.98 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 105.647 -1.982 . . . . 0.0 105.647 166.163 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.449 ' HG ' HG22 ' A' ' 112' ' ' VAL . 6.9 mp -103.88 117.32 34.06 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 177.66 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -107.71 126.62 52.83 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 123.417 0.448 . . . . 0.0 110.842 -176.418 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 16.5 m-30 -102.67 134.07 46.65 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.094 1.358 . . . . 0.0 110.49 -177.548 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -138.08 127.61 24.92 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 124.885 1.274 . . . . 0.0 109.369 176.01 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.428 HG23 HD11 ' A' ' 51' ' ' LEU . 71.5 t -74.43 110.75 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 175.248 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.3 p -93.99 -23.58 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 123.711 0.804 . . . . 0.0 112.705 -173.681 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 14.3 tpt -164.4 129.4 2.74 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.113 1.365 . . . . 0.0 110.461 179.086 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -89.22 124.33 34.27 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.551 0.74 . . . . 0.0 110.339 178.739 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 6.7 mmpt? . . . . . 0 C--O 1.253 1.273 0 CA-C-O 117.67 -1.157 . . . . 0.0 112.911 178.648 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 39.0 p . . . . . 0 N--CA 1.476 0.872 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -80.0 -48.01 14.02 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.658 0.783 . . . . 0.0 111.642 177.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 61.8 tp -61.67 -33.39 73.9 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.457 1.103 . . . . 0.0 111.314 177.359 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -55.22 -32.61 62.41 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.405 1.082 . . . . 0.0 113.271 174.329 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 27.8 m -76.56 -24.73 53.58 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.437 1.495 . . . . 0.0 111.369 176.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 17.0 mm -81.91 -42.32 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 124.059 0.944 . . . . 0.0 110.522 175.538 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 81.9 mt -54.34 -48.29 68.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 123.862 0.865 . . . . 0.0 110.61 177.155 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 36.7 ptt180 -65.85 -19.8 66.01 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 -178.63 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 24.6 mtpp -77.28 -33.1 55.9 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.52 1.055 . . . . 0.0 112.447 172.108 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -92.97 -12.07 31.68 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.145 1.378 . . . . 0.0 114.293 178.679 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 . . . . . 0 CA--C 1.552 1.056 0 CA-C-O 122.353 1.073 . . . . 0.0 112.943 165.481 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? . . . . . 0 N--CA 1.471 0.6 0 CA-C-O 122.107 0.956 . . . . 0.0 111.645 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.3 mptt -98.88 138.61 35.76 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.32 1.448 . . . . 0.0 111.071 -171.809 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -162.93 161.93 25.96 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.229 1.012 . . . . 0.0 113.57 179.117 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 18.0 pt -140.88 157.52 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 126.529 1.931 . . . . 0.0 110.37 174.135 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 13.5 mt -119.27 134.51 62.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 125.897 1.679 . . . . 0.0 109.062 -178.309 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -135.86 151.27 49.86 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.205 1.402 . . . . 0.0 112.148 -178.288 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 34.7 p30 -80.3 111.55 16.78 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.133 0.973 . . . . 0.0 113.335 -174.728 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.8 -25.0 66.25 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 120.594 -1.316 . . . . 0.0 113.815 -173.27 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 52.3 mtm180 -84.2 -3.17 57.99 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 -173.564 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.4 t -109.49 137.16 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 125.434 1.494 . . . . 0.0 108.789 178.237 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -55.63 -41.58 73.73 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.447 1.099 . . . . 0.0 113.292 -172.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.3 p30 -78.03 -14.82 59.37 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 178.061 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 96.3 m 49.59 61.92 2.91 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.372 1.469 . . . . 0.0 112.492 -174.63 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.68 136.13 57.97 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.693 0.797 . . . . 0.0 112.448 179.221 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 43.7 t -60.8 119.4 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 169.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 45.4 pt -100.8 -17.55 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 125.534 1.533 . . . . 0.0 112.315 176.06 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -157.93 146.83 19.35 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.336 1.055 . . . . 0.0 112.099 178.631 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.528 ' HB3' ' CE1' ' A' ' 48' ' ' PHE . 1.9 m -131.24 153.8 49.13 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.462 1.105 . . . . 0.0 111.947 177.114 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -76.84 -166.9 0.75 Allowed 'General case' 0 CA--C 1.556 1.201 0 CA-C-N 118.939 0.79 . . . . 0.0 111.673 169.347 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -105.61 -19.16 13.86 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.496 1.518 . . . . 0.0 112.759 169.548 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -75.35 -35.99 46.18 Favored Glycine 0 C--N 1.343 0.968 0 O-C-N 121.488 -0.758 . . . . 0.0 112.549 -179.555 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.528 ' CE1' ' HB3' ' A' ' 44' ' ' CYS . 0.6 OUTLIER -65.4 -34.38 78.16 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.586 0.754 . . . . 0.0 111.59 179.72 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 57.2 m -51.42 -52.24 47.83 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.192 1.397 . . . . 0.0 111.799 172.51 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -71.85 -20.14 61.86 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -179.146 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.52 -54.06 42.13 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.51 1.124 . . . . 0.0 110.618 177.015 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 41.9 t -92.83 -32.64 14.56 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.53 1.84 55.47 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.447 1.499 . . . . 0.0 114.185 -175.017 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -81.69 -165.99 1.1 Allowed 'General case' 0 CA--C 1.555 1.151 0 CA-C-N 118.706 1.253 . . . . 0.0 113.055 171.097 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 32.8 m -142.39 160.02 41.09 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.894 1.278 . . . . 0.0 111.424 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -47.99 -49.16 31.71 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.018 0.927 . . . . 0.0 111.967 178.245 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.34 -25.9 37.58 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 179.417 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -89.62 -35.52 15.81 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.856 1.262 . . . . 0.0 112.124 178.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 18.9 t -93.67 -11.03 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.372 1.069 . . . . 0.0 112.659 -176.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 75.4 mmm -68.46 142.72 55.25 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 120.586 -1.321 . . . . 0.0 111.302 170.639 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 71.14 5.17 5.37 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 126.268 1.827 . . . . 0.0 113.77 -177.389 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -76.63 155.26 83.5 Favored Pre-proline 0 N--CA 1.475 0.817 0 C-N-CA 124.483 1.113 . . . . 0.0 110.317 173.691 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -74.58 12.23 1.16 Allowed 'Trans proline' 0 CA--C 1.549 1.234 0 C-N-CA 124.016 3.144 . . . . 0.0 116.273 179.064 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 5.8 t 75.24 -23.46 0.24 Allowed 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 126.6 1.96 . . . . 0.0 114.154 169.383 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 39.3 p -64.05 -21.73 66.64 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 127.561 2.344 . . . . 0.0 113.442 173.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 89.0 m 59.55 36.53 22.85 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.85 1.26 . . . . 0.0 113.168 -178.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -52.14 -36.39 51.27 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.797 1.639 . . . . 0.0 112.434 177.202 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -66.9 -11.39 55.96 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.715 1.206 . . . . 0.0 114.041 179.009 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 33.7 mt -93.75 -3.15 52.69 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.976 1.31 . . . . 0.0 113.649 171.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.417 ' CG ' HG21 ' A' ' 74' ' ' THR . 0.3 OUTLIER -77.95 118.82 20.62 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 121.092 -1.005 . . . . 0.0 110.318 -178.384 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -107.97 -162.95 21.19 Favored Glycine 0 CA--C 1.538 1.529 0 C-N-CA 126.189 1.852 . . . . 0.0 112.605 178.619 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -69.12 -22.43 35.04 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 123.339 2.693 . . . . 0.0 113.162 179.034 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 85.5 mtt85 -84.89 -12.2 53.97 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.16 0.984 . . . . 0.0 113.297 177.101 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.417 HG21 ' CG ' ' A' ' 70' ' ' HIS . 18.4 m -76.93 151.73 35.61 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.645 1.178 . . . . 0.0 111.244 -173.594 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.8 109.25 18.99 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.027 1.331 . . . . 0.0 109.144 -170.115 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 36.5 mmt180 -64.46 -24.24 67.55 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 121.449 -0.782 . . . . 0.0 112.996 179.74 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 20.5 tpp180 -58.71 -40.16 82.9 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.344 1.058 . . . . 0.0 112.327 168.629 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -77.8 -42.05 35.18 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.493 1.517 . . . . 0.0 112.161 175.774 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -54.18 -37.1 64.12 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 121.559 -0.713 . . . . 0.0 112.167 174.579 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.95 -47.81 76.32 Favored 'General case' 0 C--O 1.227 -0.113 0 C-N-CA 125.213 1.405 . . . . 0.0 111.291 175.419 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 22.3 mm-40 -61.51 -38.27 86.76 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 118.136 -0.935 . . . . 0.0 111.039 178.407 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 96.8 mt -63.16 -45.63 98.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 CA-C-N 120.439 1.472 . . . . 0.0 111.629 172.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.31 -39.48 92.51 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 118.898 0.772 . . . . 0.0 112.779 178.645 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -76.2 -25.75 55.46 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 124.049 0.94 . . . . 0.0 112.233 176.631 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -58.74 -29.92 67.09 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 120.172 1.351 . . . . 0.0 112.368 175.254 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 51.6 mt -67.51 -13.34 61.96 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.998 1.719 . . . . 0.0 113.442 175.84 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 66.9 mt -87.87 -13.62 41.57 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.307 1.043 . . . . 0.0 112.443 174.011 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -90.8 146.53 18.48 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 125.102 1.334 . . . . 0.0 113.542 -175.679 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -86.8 -7.74 57.97 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.899 1.279 . . . . 0.0 113.737 173.241 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -118.32 162.4 18.35 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.491 1.916 . . . . 0.0 111.428 -175.418 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -64.6 143.14 58.13 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.613 1.165 . . . . 0.0 112.912 -175.417 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 27.6 mmt180 -139.52 132.42 29.31 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.101 1.36 . . . . 0.0 111.546 176.43 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 38.3 mtmt -110.72 131.22 55.23 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.413 1.485 . . . . 0.0 109.854 167.586 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 64.3 t -132.44 137.08 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 125.126 1.371 . . . . 0.0 108.51 177.624 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -102.2 131.12 48.93 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.139 0.975 . . . . 0.0 110.762 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.3 tt -156.57 147.58 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.005 0.922 . . . . 0.0 112.033 -169.344 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -88.97 124.39 34.2 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 120.921 -1.112 . . . . 0.0 111.843 178.114 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 15.2 m-30 -113.02 134.3 54.58 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.702 1.601 . . . . 0.0 111.678 177.184 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -73.2 146.08 45.8 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.135 1.374 . . . . 0.0 112.308 169.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 32.4 ptt-85 -117.96 150.69 38.82 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.781 1.632 . . . . 0.0 112.609 173.125 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -61.83 -13.81 27.6 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.974 1.71 . . . . 0.0 114.373 -179.487 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -67.33 -12.9 61.35 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.548 1.139 . . . . 0.0 112.797 169.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 100.21 30.1 6.46 Favored Glycine 0 C--N 1.341 0.859 0 C-N-CA 124.914 1.245 . . . . 0.0 113.328 174.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 16.5 t -153.4 -168.33 2.97 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 118.303 1.051 . . . . 0.0 111.991 -174.749 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 27.0 t -146.64 161.13 41.2 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.203 1.401 . . . . 0.0 111.924 -166.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -165.16 163.35 20.36 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.202 1.801 . . . . 0.0 112.301 173.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -79.53 124.74 28.77 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 123.484 0.714 . . . . 0.0 110.783 176.326 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 34.0 t -107.2 136.85 46.33 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.254 1.822 . . . . 0.0 109.528 170.107 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 14.2 tp -88.08 123.28 32.6 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 161.325 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 60.5 t -108.75 116.91 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 125.336 1.454 . . . . 0.0 108.763 177.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -113.13 112.88 24.57 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.348 1.059 . . . . 0.0 108.991 -178.144 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.3 p -88.74 120.36 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 121.276 0.56 . . . . 0.0 109.706 172.507 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 90.5 t -104.25 111.76 65.26 Favored Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 125.341 1.456 . . . . 0.0 107.432 175.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.5 122.76 7.65 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 123.093 2.528 . . . . 0.0 109.418 177.42 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 60.2 t -94.59 117.8 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 174.376 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 20.3 mtpt -88.68 149.17 23.64 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.469 0.652 . . . . 0.0 111.175 172.741 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 51.2 p30 -77.77 -173.39 3.02 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.065 1.346 . . . . 0.0 111.997 175.701 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -66.24 -15.74 63.43 Favored 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 114.749 1.388 . . . . 0.0 114.749 175.068 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -97.25 -17.14 20.0 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.567 1.147 . . . . 0.0 113.271 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 86.36 40.48 7.36 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 125.846 1.689 . . . . 0.0 113.636 -174.372 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -115.06 151.31 34.48 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.267 1.427 . . . . 0.0 109.879 159.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.6 p -83.5 126.58 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 CA-C-N 119.055 0.843 . . . . 0.0 110.532 179.38 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.69 -27.04 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 -173.43 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 61.2 mtm -129.86 150.72 51.03 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.875 1.27 . . . . 0.0 112.117 171.064 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -110.75 133.22 53.52 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 125.458 1.503 . . . . 0.0 109.104 167.243 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 32.9 mt -102.8 119.94 51.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 165.331 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -100.35 119.62 38.71 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 175.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -107.31 127.8 53.88 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.437 1.095 . . . . 0.0 109.505 -177.438 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 16.1 m-30 -104.37 133.65 48.91 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.084 1.354 . . . . 0.0 110.571 -178.278 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -142.34 118.68 10.85 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 123.899 0.88 . . . . 0.0 109.758 173.36 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.0 p -68.27 115.01 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 O-C-N 121.437 -0.79 . . . . 0.0 109.525 176.589 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.3 p -99.57 -26.61 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 125.283 1.433 . . . . 0.0 113.315 -169.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 24.9 ptp -161.43 148.01 14.43 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.173 0.989 . . . . 0.0 112.898 168.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -90.46 130.04 36.57 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.019 0.927 . . . . 0.0 110.732 -179.48 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 7.0 mmpt? . . . . . 0 C--O 1.254 1.29 0 C-N-CA 124.355 1.062 . . . . 0.0 112.723 175.046 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 37.1 p . . . . . 0 N--CA 1.479 1.014 0 N-CA-C 111.719 0.266 . . . . 0.0 111.719 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -71.54 -46.77 58.62 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.498 0.719 . . . . 0.0 111.221 176.14 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 64.5 tp -63.15 -36.09 82.46 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.081 0.953 . . . . 0.0 111.138 176.534 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -59.85 -29.26 68.16 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 174.273 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 66.3 m -77.04 -19.88 56.6 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.014 1.325 . . . . 0.0 111.505 175.078 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 22.5 mm -84.33 -43.64 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 125.258 1.423 . . . . 0.0 111.351 170.39 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 71.6 mt -58.38 -35.54 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 O-C-N 121.424 -0.798 . . . . 0.0 111.022 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -72.47 -7.95 52.53 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 179.402 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 17.6 mtmt -84.32 -42.08 16.14 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.215 1.406 . . . . 0.0 110.731 171.305 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -79.72 -40.18 29.49 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.045 1.338 . . . . 0.0 113.054 179.166 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 . . . . . 0 N--CA 1.475 0.816 0 CA-C-N 118.972 0.806 . . . . 0.0 112.231 -179.846 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? . . . . . 0 N--CA 1.468 0.457 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.78 134.61 34.89 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 120.753 -1.217 . . . . 0.0 111.394 178.573 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -157.89 153.64 26.63 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.311 1.044 . . . . 0.0 112.928 178.9 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 15.2 pt -140.62 150.14 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 125.871 1.668 . . . . 0.0 109.758 175.473 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.7 mp -114.27 132.29 63.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 125.364 1.466 . . . . 0.0 108.983 -178.138 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -132.72 147.42 52.32 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 124.9 1.28 . . . . 0.0 111.849 -176.725 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 24.2 p30 -73.71 119.25 17.67 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.566 0.746 . . . . 0.0 112.217 -178.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.81 -29.13 61.99 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 120.705 -1.247 . . . . 0.0 112.191 -178.599 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 29.6 mmm180 -74.61 27.48 0.08 Allowed 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 126.486 1.914 . . . . 0.0 114.039 -176.339 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 84.9 t -147.33 136.61 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 126.942 2.097 . . . . 0.0 108.805 -171.174 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -56.93 -43.17 81.18 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.596 1.159 . . . . 0.0 113.019 -173.751 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -80.2 -14.97 58.02 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -177.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 96.5 m 49.85 68.34 0.76 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.614 1.566 . . . . 0.0 111.487 -168.655 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.26 136.23 44.56 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.562 0.745 . . . . 0.0 111.516 -174.485 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 39.8 t -63.74 122.48 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 174.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.6 pt -102.99 -19.66 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 124.987 1.315 . . . . 0.0 112.312 175.364 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -155.3 144.73 21.13 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.886 0.874 . . . . 0.0 112.54 178.717 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.44 ' HB3' ' CE1' ' A' ' 48' ' ' PHE . 1.8 m -130.63 152.95 49.44 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.767 1.227 . . . . 0.0 112.656 -179.551 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -75.22 -166.8 0.54 Allowed 'General case' 0 CA--C 1.557 1.216 0 C-N-CA 122.905 0.482 . . . . 0.0 112.074 170.151 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -102.9 -23.07 13.76 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.296 1.438 . . . . 0.0 112.705 168.745 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.85 -34.0 59.58 Favored Glycine 0 N--CA 1.47 0.917 0 C-N-CA 124.892 1.234 . . . . 0.0 112.754 -177.875 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.44 ' CE1' ' HB3' ' A' ' 44' ' ' CYS . 0.6 OUTLIER -71.4 -32.87 68.93 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 123.904 0.882 . . . . 0.0 111.268 -176.98 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 6.2 t -53.74 -49.26 68.54 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.637 1.175 . . . . 0.0 111.658 171.707 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -75.56 -21.19 58.1 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -179.082 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 47.6 tp -63.6 -48.59 76.73 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 121.488 -0.757 . . . . 0.0 111.198 172.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 17.8 t -103.76 -30.63 10.28 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 -172.757 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.25 6.79 58.67 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 124.307 0.955 . . . . 0.0 114.568 -176.712 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -88.42 -155.54 0.33 Allowed 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 118.698 1.249 . . . . 0.0 111.655 169.523 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 12.2 t -162.06 169.12 21.54 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 120.564 -1.335 . . . . 0.0 111.006 175.27 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -53.51 -44.74 69.32 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.12 0.968 . . . . 0.0 111.394 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.85 -28.49 56.66 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 119.811 1.187 . . . . 0.0 114.025 177.151 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -92.01 -38.12 12.42 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.854 1.262 . . . . 0.0 112.018 177.454 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 79.1 t -79.38 -19.07 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 126.057 1.743 . . . . 0.0 111.508 -177.414 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.39 131.56 50.67 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 120.895 -1.128 . . . . 0.0 110.788 172.842 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 8.0 tm0? 75.49 5.76 4.05 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 126.229 1.812 . . . . 0.0 113.561 179.366 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 34.7 mmt180 -85.71 153.01 57.83 Favored Pre-proline 0 N--CA 1.473 0.696 0 C-N-CA 124.536 1.134 . . . . 0.0 111.352 176.525 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -69.98 134.92 28.66 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 123.133 2.555 . . . . 0.0 109.978 171.316 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 20.6 p -67.52 -11.57 58.31 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 114.848 1.425 . . . . 0.0 114.848 -174.325 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 46.9 p -58.44 -30.53 66.98 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.379 1.472 . . . . 0.0 112.114 172.669 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 91.7 m 51.82 35.21 14.89 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.041 1.336 . . . . 0.0 112.604 -173.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -58.4 -29.72 66.27 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.427 1.091 . . . . 0.0 112.331 -179.297 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -60.91 -10.36 5.57 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.371 1.468 . . . . 0.0 114.307 175.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 58.0 mt -84.8 2.01 44.18 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.937 1.295 . . . . 0.0 113.952 173.237 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 13.8 p-80 -66.29 154.5 39.79 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 114.724 1.379 . . . . 0.0 114.724 177.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -151.9 -163.94 11.88 Favored Glycine 0 CA--C 1.54 1.609 0 C-N-CA 127.359 2.409 . . . . 0.0 111.231 167.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.95 -23.08 62.12 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 123.01 2.473 . . . . 0.0 114.916 -173.481 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 40.1 mmt180 -89.75 -4.28 57.75 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 119.509 1.049 . . . . 0.0 113.644 174.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 31.5 m -73.3 134.18 44.11 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 119.534 1.061 . . . . 0.0 109.532 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 81.2 mm-40 -91.03 117.53 29.66 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -174.089 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 7.9 tmm_? -59.6 -37.07 77.57 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 121.535 -0.728 . . . . 0.0 112.013 -176.758 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 25.7 tpt180 -61.22 -40.22 93.2 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.184 0.994 . . . . 0.0 112.087 173.629 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -71.68 -41.45 68.66 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 120.755 -1.216 . . . . 0.0 112.706 177.106 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -56.16 -35.03 66.71 Favored 'General case' 0 CA--C 1.546 0.815 0 O-C-N 121.644 -0.66 . . . . 0.0 111.846 172.056 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.1 -47.76 56.27 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.8 1.24 . . . . 0.0 112.571 172.634 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -57.71 -37.27 73.23 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 118.764 0.711 . . . . 0.0 111.402 178.502 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 85.5 mt -62.46 -38.83 82.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 CA-C-N 120.098 1.317 . . . . 0.0 112.068 173.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.71 -38.07 76.8 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 119.326 0.966 . . . . 0.0 112.169 174.46 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 94.4 mm-40 -66.86 -31.8 72.65 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.55 0.74 . . . . 0.0 111.916 174.271 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.48 -23.52 66.97 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.997 0.919 . . . . 0.0 112.718 177.162 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 41.6 mt -82.81 -15.06 53.11 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.255 1.422 . . . . 0.0 113.257 173.295 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 73.7 mt -90.19 -16.2 29.94 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.236 1.015 . . . . 0.0 112.002 173.253 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -85.33 148.35 22.96 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 125.238 1.399 . . . . 0.0 112.754 176.651 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -96.69 4.34 51.91 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 114.279 1.215 . . . . 0.0 114.279 -179.568 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.32 160.9 30.75 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.349 1.86 . . . . 0.0 110.324 177.214 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -64.53 145.89 55.44 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -178.377 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 12.5 tpt180 -148.22 129.57 14.77 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.114 1.366 . . . . 0.0 110.94 -172.091 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 39.7 mtmt -104.55 138.42 40.94 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.514 1.525 . . . . 0.0 111.274 178.476 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 45.0 t -139.23 134.67 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 125.163 1.385 . . . . 0.0 109.292 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -101.43 128.41 47.64 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.835 0.854 . . . . 0.0 111.082 178.608 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.5 tt -153.95 147.2 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 124.924 1.29 . . . . 0.0 111.694 -167.712 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -84.84 123.88 30.96 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 120.716 -1.24 . . . . 0.0 111.462 173.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 10.2 m-30 -105.64 145.32 31.18 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.807 1.643 . . . . 0.0 110.695 172.803 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -110.61 131.24 55.22 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.232 1.413 . . . . 0.0 111.716 175.625 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 59.4 mtt180 -71.21 165.5 23.49 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.922 1.689 . . . . 0.0 112.54 174.609 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -66.47 -23.02 66.2 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.088 0.955 . . . . 0.0 112.753 170.089 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -73.36 -11.71 60.58 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.626 1.571 . . . . 0.0 113.814 172.597 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 90.27 -3.95 82.44 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 125.267 1.413 . . . . 0.0 114.352 -175.531 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 30.4 m -77.25 164.51 25.52 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 118.213 1.007 . . . . 0.0 111.644 175.332 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 30.6 p -145.91 166.07 27.09 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 120.9 -1.125 . . . . 0.0 114.007 -178.311 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -165.44 160.49 18.0 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.154 1.781 . . . . 0.0 110.918 -178.624 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -79.72 121.69 25.64 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.746 0.818 . . . . 0.0 110.453 169.058 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 44.5 t -105.64 138.48 41.77 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 127.463 2.305 . . . . 0.0 109.687 174.154 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 15.4 tp -96.65 112.88 24.45 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 164.649 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 95.7 t -94.51 114.36 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 124.994 1.318 . . . . 0.0 108.564 174.245 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -106.23 107.59 18.67 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.991 1.316 . . . . 0.0 107.835 175.076 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 61.3 t -77.78 130.1 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 166.13 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 88.6 t -119.55 112.49 35.53 Favored Pre-proline 0 CA--C 1.537 0.462 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 167.498 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -74.59 134.59 18.75 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.738 2.292 . . . . 0.0 109.91 -179.467 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 45.5 t -92.81 119.4 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 171.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 66.1 mttt -93.01 151.95 19.59 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 121.648 0.737 . . . . 0.0 112.294 168.251 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -91.61 -173.78 3.66 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.887 0.875 . . . . 0.0 111.66 174.766 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -60.26 -22.11 62.68 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.986 1.315 . . . . 0.0 114.347 178.399 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -90.44 -5.6 55.9 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.747 1.219 . . . . 0.0 113.055 178.479 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 79.15 20.14 70.59 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 124.371 0.986 . . . . 0.0 114.262 -178.113 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -98.99 146.49 25.97 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.788 1.235 . . . . 0.0 109.46 172.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 96.5 t -76.09 128.49 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 176.336 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 3.3 pt -122.91 -24.87 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 113.863 1.061 . . . . 0.0 113.863 -172.487 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 71.4 mtm -147.82 155.09 41.29 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.492 1.517 . . . . 0.0 110.473 177.281 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -112.26 132.65 54.82 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.453 1.101 . . . . 0.0 109.774 171.244 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 56.6 mt -97.57 115.93 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 163.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -95.19 125.78 40.07 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 171.613 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -114.42 123.6 49.86 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 118.65 -0.691 . . . . 0.0 111.713 179.189 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 17.9 m-30 -108.9 97.6 7.21 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.409 1.484 . . . . 0.0 113.435 -170.667 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -109.26 112.9 25.31 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 120.231 -1.543 . . . . 0.0 109.743 -177.159 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.3 p -62.86 108.09 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 O-C-N 121.236 -0.915 . . . . 0.0 110.105 173.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.3 p -85.59 -23.77 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 125.199 1.4 . . . . 0.0 112.749 -176.408 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 32.5 ttm -163.43 124.89 2.41 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.71 1.204 . . . . 0.0 110.686 -175.284 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -81.12 127.02 32.18 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.216 0.606 . . . . 0.0 109.943 172.571 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 6.4 mmpt? . . . . . 0 C--O 1.253 1.284 0 C-N-CA 124.701 1.201 . . . . 0.0 112.81 177.232 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 62.3 p . . . . . 0 N--CA 1.48 1.072 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -68.97 -52.01 33.58 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.839 0.856 . . . . 0.0 111.715 173.598 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 57.3 tp -61.61 -35.61 78.35 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.83 1.252 . . . . 0.0 111.155 176.671 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -57.84 -31.16 66.37 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.829 0.851 . . . . 0.0 113.049 176.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 94.7 m -72.91 -29.64 63.29 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.199 1.0 . . . . 0.0 110.929 174.527 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 12.3 mm -77.07 -41.88 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 O-C-N 121.606 -0.684 . . . . 0.0 110.163 175.29 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 92.0 mt -55.36 -49.63 71.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 124.07 0.948 . . . . 0.0 110.435 175.067 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 11.4 ptm180 -71.85 -19.23 62.0 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -176.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -75.49 -39.92 57.91 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.046 0.939 . . . . 0.0 112.443 168.257 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -82.29 -27.66 32.2 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.516 1.126 . . . . 0.0 113.199 -179.459 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 . . . . . 0 CA--C 1.538 0.514 0 C-N-CA 123.933 0.893 . . . . 0.0 111.855 174.114 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? . . . . . 0 N--CA 1.477 0.902 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.52 149.13 30.07 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.537 1.135 . . . . 0.0 112.328 -173.544 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -165.46 165.52 19.09 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.764 1.226 . . . . 0.0 114.232 -178.796 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 15.2 pt -144.0 153.1 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 126.978 2.111 . . . . 0.0 109.708 171.349 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.9 mp -119.57 128.1 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 124.858 1.263 . . . . 0.0 108.795 176.691 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -120.63 144.56 48.08 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 124.87 1.268 . . . . 0.0 111.413 175.331 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -68.72 129.51 40.14 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.298 0.639 . . . . 0.0 110.818 172.792 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -78.44 -26.13 46.13 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 175.8 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 29.8 mmm180 -76.87 29.06 0.13 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 126.312 1.845 . . . . 0.0 113.894 -174.158 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.0 m -148.45 148.83 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 126.811 2.044 . . . . 0.0 110.099 -176.083 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -63.57 -38.13 89.95 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.202 1.001 . . . . 0.0 113.61 -168.559 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 -89.33 -9.25 51.17 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -174.463 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 97.6 m 50.65 57.71 6.32 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.603 1.161 . . . . 0.0 111.301 -167.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.26 136.92 52.62 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.028 0.931 . . . . 0.0 112.039 -176.528 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 46.3 t -63.48 123.03 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.809 0.844 . . . . 0.0 109.723 175.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 38.8 pt -103.18 -19.39 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 125.369 1.468 . . . . 0.0 112.361 175.199 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -151.91 139.91 20.11 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.537 1.135 . . . . 0.0 110.915 178.663 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.418 ' HB3' ' CE1' ' A' ' 48' ' ' PHE . 8.2 m -120.9 157.78 29.11 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.713 0.805 . . . . 0.0 111.818 177.906 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -69.93 -173.15 0.6 Allowed 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 122.707 0.403 . . . . 0.0 111.324 160.62 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -116.98 -13.34 10.62 Favored 'General case' 0 N--CA 1.481 1.076 0 O-C-N 120.715 -1.241 . . . . 0.0 112.643 167.591 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -68.31 -41.07 86.86 Favored Glycine 0 N--CA 1.469 0.837 0 C-N-CA 127.492 2.472 . . . . 0.0 112.951 168.087 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.418 ' CE1' ' HB3' ' A' ' 44' ' ' CYS . 0.4 OUTLIER -65.09 -32.27 73.89 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 123.873 0.869 . . . . 0.0 111.709 -175.729 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 35.3 t -56.3 -50.61 70.92 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.455 1.902 . . . . 0.0 111.374 170.6 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -74.39 -25.35 59.43 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 178.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 38.2 tp -62.56 -47.59 83.18 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.955 0.902 . . . . 0.0 111.249 170.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 69.0 m -99.76 -32.9 10.8 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 -168.131 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 93.39 6.77 62.5 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 125.865 1.697 . . . . 0.0 114.089 -178.488 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -86.69 -144.93 0.12 Allowed 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.642 1.177 . . . . 0.0 111.397 170.377 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 78.2 p -158.36 165.25 35.19 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.901 1.281 . . . . 0.0 112.302 170.667 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 45.9 ttm105 -52.39 -46.78 66.4 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.242 0.617 . . . . 0.0 111.278 169.575 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.04 -30.79 60.32 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 119.467 1.031 . . . . 0.0 113.772 177.394 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -90.05 -38.53 13.52 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.811 0.844 . . . . 0.0 112.927 178.239 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 41.0 t -82.21 -11.7 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 124.059 0.943 . . . . 0.0 112.302 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 66.1 mmm -67.07 135.08 53.1 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 120.614 -1.304 . . . . 0.0 110.687 171.018 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 8.8 tm0? 75.2 4.97 4.22 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 126.614 1.966 . . . . 0.0 113.38 -176.343 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -88.65 155.14 50.84 Favored Pre-proline 0 N--CA 1.476 0.827 0 C-N-CA 124.657 1.183 . . . . 0.0 111.285 175.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -68.42 139.83 46.39 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 123.271 2.647 . . . . 0.0 110.609 170.54 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 32.1 p -68.41 -2.96 9.67 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 -178.568 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 40.6 p -63.47 -31.5 72.68 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.154 1.382 . . . . 0.0 112.236 172.586 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 81.4 m 51.07 34.86 11.65 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.755 1.222 . . . . 0.0 112.862 -173.784 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -57.98 -31.17 66.65 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.834 1.253 . . . . 0.0 112.58 -175.364 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -58.11 -15.6 10.1 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.484 1.514 . . . . 0.0 114.311 176.645 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 87.9 mt -74.51 -7.65 53.73 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 173.251 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 17.6 p-80 -60.99 140.19 57.87 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 120.197 1.362 . . . . 0.0 113.259 178.513 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -124.73 -163.57 11.69 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 126.546 2.022 . . . . 0.0 111.786 171.309 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -69.91 -21.15 33.17 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 123.15 2.567 . . . . 0.0 113.333 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.15 3.0 55.89 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.501 1.12 . . . . 0.0 113.355 178.754 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 17.3 m -85.76 137.17 32.98 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.092 1.357 . . . . 0.0 109.946 178.843 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -102.82 131.58 49.6 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.234 1.014 . . . . 0.0 109.997 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 22.4 tpp85 -58.1 -35.17 71.05 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.019 0.927 . . . . 0.0 112.618 -177.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -57.09 -42.02 79.94 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.645 1.178 . . . . 0.0 112.463 177.668 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -73.12 -43.9 61.02 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.437 -0.789 . . . . 0.0 112.202 177.29 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.07 -36.15 72.4 Favored 'General case' 0 CA--C 1.545 0.758 0 O-C-N 121.405 -0.809 . . . . 0.0 111.99 174.653 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.36 -48.02 65.91 Favored 'General case' 0 C--O 1.224 -0.24 0 C-N-CA 125.543 1.537 . . . . 0.0 111.927 173.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -57.43 -39.52 76.4 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 118.286 -0.864 . . . . 0.0 111.215 178.185 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 97.4 mt -59.92 -45.87 94.61 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 CA-C-N 120.256 1.389 . . . . 0.0 112.003 172.26 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.9 -36.85 80.92 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 118.827 0.74 . . . . 0.0 112.862 179.097 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 96.4 mm-40 -69.7 -32.81 71.62 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.707 1.203 . . . . 0.0 111.593 175.401 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.42 ' HB1' HG11 ' A' ' 112' ' ' VAL . . . -59.74 -29.99 68.53 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 119.09 0.859 . . . . 0.0 112.786 179.275 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 56.1 mt -70.86 -15.93 62.67 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.342 1.457 . . . . 0.0 113.215 177.162 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 60.5 mt -86.25 -13.04 47.97 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.105 0.962 . . . . 0.0 112.351 174.294 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -91.6 151.79 21.12 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 125.41 1.481 . . . . 0.0 113.078 178.471 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -93.39 0.07 56.72 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.91 1.284 . . . . 0.0 113.906 177.452 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -123.16 160.25 26.89 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.946 1.698 . . . . 0.0 111.208 -173.618 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -60.06 144.79 48.67 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.106 0.963 . . . . 0.0 112.567 -178.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 13.6 tpt180 -150.36 130.71 13.74 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.199 0.999 . . . . 0.0 111.597 -178.112 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 38.6 mtmt -110.44 132.27 54.32 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.226 1.41 . . . . 0.0 110.412 173.625 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 42.6 t -130.24 133.23 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 124.989 1.316 . . . . 0.0 108.466 177.439 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -102.41 134.92 44.94 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.099 0.96 . . . . 0.0 110.482 -179.001 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.0 tt -159.32 146.22 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.551 0.741 . . . . 0.0 112.08 -166.392 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -88.38 122.81 32.3 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 121.516 -0.74 . . . . 0.0 110.466 172.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -110.45 148.34 32.25 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.676 1.191 . . . . 0.0 112.092 173.517 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -107.63 134.38 50.71 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.995 1.718 . . . . 0.0 110.616 177.105 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -108.6 156.72 19.21 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.822 1.649 . . . . 0.0 111.394 -166.596 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -64.59 -20.89 66.52 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 -176.275 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -76.14 -7.26 54.38 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.525 1.13 . . . . 0.0 113.561 175.272 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 97.06 0.57 59.96 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 125.581 1.562 . . . . 0.0 114.362 -179.016 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 25.5 m -90.37 164.04 14.47 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.759 1.223 . . . . 0.0 112.383 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 28.3 p -140.23 158.72 43.59 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 121.103 -0.998 . . . . 0.0 111.734 167.136 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -167.86 160.1 12.08 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.081 1.352 . . . . 0.0 113.019 -178.043 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -77.81 121.57 24.26 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 124.186 0.994 . . . . 0.0 110.827 176.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 10.6 t -106.24 141.26 37.88 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.056 1.742 . . . . 0.0 109.566 172.606 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -86.9 133.42 33.61 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 156.343 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.4 t -117.57 117.18 54.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 124.527 1.131 . . . . 0.0 108.446 171.414 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -113.52 114.01 25.92 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.288 1.035 . . . . 0.0 108.74 -176.094 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.42 HG11 ' HB1' ' A' ' 85' ' ' ALA . 2.4 p -86.0 126.94 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 169.159 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 97.6 t -114.59 106.43 52.31 Favored Pre-proline 0 CA--C 1.537 0.447 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 173.616 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -74.77 132.56 15.88 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.027 2.485 . . . . 0.0 109.819 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 99.1 t -97.14 110.62 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 172.316 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 63.4 mttt -82.89 152.81 25.4 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.356 0.598 . . . . 0.0 111.556 167.714 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -92.68 -173.88 3.48 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.922 0.889 . . . . 0.0 111.829 172.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -60.3 -22.06 62.71 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.158 1.383 . . . . 0.0 114.379 178.123 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -89.7 -5.61 56.87 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.873 1.269 . . . . 0.0 112.993 177.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 78.65 21.53 68.89 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 124.588 1.089 . . . . 0.0 114.27 -178.457 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -100.3 143.33 30.62 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.678 1.191 . . . . 0.0 109.216 171.053 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.7 p -76.69 125.22 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-O 121.806 0.812 . . . . 0.0 110.175 174.843 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 3.9 pt -116.49 -22.66 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 125.378 1.471 . . . . 0.0 113.543 -171.499 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 55.4 mtm -145.93 150.2 35.63 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.595 1.558 . . . . 0.0 110.799 175.899 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -114.43 124.54 52.19 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 125.197 1.399 . . . . 0.0 109.504 172.511 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 47.3 mt -98.39 114.68 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 169.615 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -102.17 125.22 48.81 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 175.713 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -117.74 130.21 56.18 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.142 0.977 . . . . 0.0 110.389 -173.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -106.65 135.42 48.2 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.017 1.327 . . . . 0.0 110.554 -177.012 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -145.17 136.28 24.86 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.757 1.223 . . . . 0.0 109.27 175.549 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 43.5 t -74.32 117.63 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 177.652 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.3 p -96.17 -27.53 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -179.383 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 47.2 tpp -167.45 141.67 3.68 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.064 1.346 . . . . 0.0 110.723 -178.177 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -88.91 140.12 29.76 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 121.229 -0.919 . . . . 0.0 111.117 177.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.265 0 CA-C-O 117.468 -1.254 . . . . 0.0 112.951 169.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 N--CA 1.499 1.981 0 CA-C-O 118.461 -0.781 . . . . 0.0 110.565 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -77.23 -24.05 9.76 Favored 'Trans proline' 0 C--N 1.358 1.036 0 C-N-CA 123.933 3.089 . . . . 0.0 114.236 -177.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.5 p -157.78 151.89 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 125.091 1.356 . . . . 0.0 110.443 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 52.6 ptt85 -153.23 154.78 35.36 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.192 1.397 . . . . 0.0 112.195 -176.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 77.0 mtp85 -116.88 135.56 53.64 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.234 1.414 . . . . 0.0 111.13 178.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.31 -109.82 3.03 Favored Glycine 0 N--CA 1.472 1.064 0 C-N-CA 125.955 1.741 . . . . 0.0 111.15 176.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 10.4 t-80 77.56 11.12 2.2 Favored 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 126.47 1.908 . . . . 0.0 113.792 169.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 78.3 t -79.95 113.3 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 O-C-N 120.85 -1.157 . . . . 0.0 109.431 178.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -77.93 148.31 75.27 Favored Pre-proline 0 CA--C 1.551 0.995 0 C-N-CA 124.269 1.027 . . . . 0.0 111.638 174.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -68.77 126.17 13.63 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.149 2.566 . . . . 0.0 110.848 -178.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 23.0 mp0 -85.74 172.0 11.16 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.946 1.298 . . . . 0.0 111.205 176.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -66.8 151.11 48.12 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 121.308 -0.87 . . . . 0.0 110.54 161.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 29.1 p -117.01 -50.22 2.59 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.699 1.2 . . . . 0.0 112.965 -172.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -71.21 -45.31 63.64 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.848 0.859 . . . . 0.0 111.997 178.244 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 61.5 tp -63.0 -37.08 85.77 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.742 0.817 . . . . 0.0 110.947 176.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -59.17 -28.34 66.51 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 178.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.9 m -67.98 -29.24 68.22 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.839 0.856 . . . . 0.0 111.108 173.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 17.6 mm -74.16 -41.45 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-N 119.017 0.826 . . . . 0.0 109.23 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 3.1 mp -58.94 -46.72 91.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 122.971 0.508 . . . . 0.0 110.269 170.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 84.8 mtm180 -63.49 -35.1 79.33 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 119.125 0.875 . . . . 0.0 113.069 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -69.8 -39.1 76.77 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.172 0.989 . . . . 0.0 112.671 174.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -77.37 -33.82 55.13 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.507 1.123 . . . . 0.0 111.988 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -88.31 169.31 11.95 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -175.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -78.47 50.61 3.53 Favored Glycine 0 N--CA 1.473 1.149 0 C-N-CA 125.737 1.636 . . . . 0.0 112.86 178.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -67.93 -9.55 46.09 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 126.974 2.11 . . . . 0.0 113.834 -172.124 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 8.5 m -67.47 -6.8 21.11 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.679 1.591 . . . . 0.0 114.927 -168.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -111.5 167.68 10.13 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.695 1.198 . . . . 0.0 111.665 177.527 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.7 mptt -93.14 133.21 36.55 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 120.911 -1.118 . . . . 0.0 110.693 -177.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -161.17 155.05 22.32 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.689 1.196 . . . . 0.0 113.279 178.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 18.4 pt -140.74 152.61 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 125.777 1.631 . . . . 0.0 110.766 177.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 14.0 mt -111.05 132.4 59.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 125.856 1.663 . . . . 0.0 108.818 179.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -131.47 143.26 50.29 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.673 1.189 . . . . 0.0 111.489 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -67.78 119.22 12.14 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.518 0.727 . . . . 0.0 111.862 176.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -79.67 -19.59 48.67 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -178.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -77.97 -36.62 48.82 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.522 1.129 . . . . 0.0 112.359 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 55.0 t -70.5 130.5 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 125.361 1.464 . . . . 0.0 109.486 171.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -60.18 -43.26 96.01 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.289 1.036 . . . . 0.0 113.516 -169.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 20.0 p30 -74.94 -10.04 59.11 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 113.842 1.052 . . . . 0.0 113.842 178.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 79.7 m 55.68 65.16 1.53 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.927 1.691 . . . . 0.0 112.662 -175.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.61 136.01 57.85 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.472 0.709 . . . . 0.0 112.015 178.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 41.4 t -61.9 121.04 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 169.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 42.9 pt -103.68 -17.08 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 125.063 1.345 . . . . 0.0 112.221 175.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -159.62 152.32 21.49 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.278 1.031 . . . . 0.0 112.014 175.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 8.1 p -146.49 155.07 42.26 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.51 1.124 . . . . 0.0 112.756 178.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -75.96 -154.18 0.05 OUTLIER 'General case' 0 CA--C 1.558 1.266 0 C-N-CA 123.407 0.683 . . . . 0.0 112.317 -176.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -108.73 -21.83 12.5 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 120.271 -1.518 . . . . 0.0 112.896 165.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -75.84 -37.75 38.26 Favored Glycine 0 C--N 1.343 0.959 0 O-C-N 121.513 -0.742 . . . . 0.0 112.479 -176.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -56.92 -41.47 78.23 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.224 1.009 . . . . 0.0 111.109 177.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 40.5 t -57.12 -53.04 62.65 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.978 1.711 . . . . 0.0 112.214 177.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -73.23 -29.1 62.55 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -179.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -64.31 -42.25 96.43 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.296 1.438 . . . . 0.0 111.832 177.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 9.1 t -100.06 -28.96 12.79 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.88 11.87 62.95 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 124.916 1.246 . . . . 0.0 114.047 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -87.58 -154.14 0.25 Allowed 'General case' 0 CA--C 1.552 1.036 0 CA-C-N 118.524 1.162 . . . . 0.0 111.419 170.068 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 64.4 m -149.65 158.47 44.2 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.676 1.19 . . . . 0.0 110.787 177.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -48.67 -48.86 39.56 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.976 0.911 . . . . 0.0 111.333 173.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.77 -26.54 35.1 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 177.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -92.39 -37.62 12.48 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.61 1.164 . . . . 0.0 112.004 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 93.2 t -86.33 -16.26 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 124.665 1.186 . . . . 0.0 112.205 -178.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 87.0 mmm -76.27 143.28 41.02 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 120.91 -1.119 . . . . 0.0 111.058 171.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 24.8 mp0 59.21 36.6 23.86 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.69 1.196 . . . . 0.0 111.15 -169.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 88.5 mmt-85 -123.72 154.41 66.95 Favored Pre-proline 0 N--CA 1.472 0.656 0 C-N-CA 125.075 1.35 . . . . 0.0 110.5 169.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -68.56 137.17 38.46 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 123.191 2.594 . . . . 0.0 109.67 172.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 21.2 p -65.83 -11.89 49.97 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 -175.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 42.5 p -58.18 -26.06 62.31 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 126.242 1.817 . . . . 0.0 112.967 173.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 74.9 m 57.8 38.63 27.32 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.741 1.216 . . . . 0.0 112.816 178.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -56.1 -28.66 58.61 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.143 1.377 . . . . 0.0 113.366 -175.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -57.95 -23.99 56.01 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.828 1.651 . . . . 0.0 113.18 176.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 40.1 mt -82.03 -8.67 59.68 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -176.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -71.75 125.32 26.83 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.857 0.863 . . . . 0.0 111.693 -178.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -107.83 -162.16 21.17 Favored Glycine 0 CA--C 1.54 1.618 0 C-N-CA 126.452 1.977 . . . . 0.0 112.505 174.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -70.31 -26.23 25.2 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 123.276 2.651 . . . . 0.0 113.14 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 37.2 mmt180 -80.88 -14.24 58.19 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 177.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 38.1 m -70.64 138.08 50.45 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.177 0.991 . . . . 0.0 112.281 -167.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -88.65 110.45 20.96 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.514 1.526 . . . . 0.0 109.781 -171.194 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 50.9 tpt85 -61.57 -30.18 70.5 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 121.369 -0.832 . . . . 0.0 112.933 -177.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 20.6 tpt180 -66.96 -38.42 86.06 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.093 1.357 . . . . 0.0 111.64 174.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -72.51 -41.54 65.8 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.835 0.854 . . . . 0.0 111.774 175.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -54.95 -35.14 63.93 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.173 0.589 . . . . 0.0 111.849 171.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.58 -49.71 51.54 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.403 1.081 . . . . 0.0 111.66 173.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 21.9 mm-40 -59.55 -36.63 76.55 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 118.256 -0.878 . . . . 0.0 111.891 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 89.8 mt -60.35 -44.98 97.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 CA-C-N 120.234 1.379 . . . . 0.0 111.613 171.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.89 -40.15 91.29 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 118.88 0.764 . . . . 0.0 112.423 177.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -70.07 -28.4 65.4 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.319 0.648 . . . . 0.0 112.333 175.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.475 ' HB1' HG11 ' A' ' 112' ' ' VAL . . . -60.58 -28.99 68.91 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 119.908 1.231 . . . . 0.0 112.47 175.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 43.4 mt -74.22 -13.11 60.74 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.624 1.569 . . . . 0.0 113.381 175.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 67.3 mt -88.47 -16.58 32.37 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.107 0.963 . . . . 0.0 112.203 173.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -88.88 153.62 23.94 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 125.133 1.349 . . . . 0.0 113.425 -179.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -93.11 -1.07 56.8 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.102 1.361 . . . . 0.0 113.858 176.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -124.34 159.82 29.47 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 126.173 1.789 . . . . 0.0 111.583 -171.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -63.37 141.28 58.82 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.876 1.271 . . . . 0.0 112.201 -178.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 23.6 tpt180 -150.86 127.72 11.0 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.281 1.033 . . . . 0.0 112.06 -171.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 40.8 mtmt -106.29 140.66 38.88 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.735 1.214 . . . . 0.0 111.91 171.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 66.6 t -137.13 139.18 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 126.074 1.75 . . . . 0.0 108.575 175.336 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -107.37 133.55 51.74 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.242 1.017 . . . . 0.0 111.303 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.2 tt -160.34 146.4 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 123.882 0.873 . . . . 0.0 112.547 -166.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -84.68 125.5 32.56 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.122 -0.986 . . . . 0.0 112.154 174.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 20.2 m-30 -115.59 154.05 30.13 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.71 2.004 . . . . 0.0 111.395 171.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -94.26 155.07 17.21 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 123.726 0.81 . . . . 0.0 113.016 166.667 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -104.17 151.29 23.5 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 127.578 2.351 . . . . 0.0 109.729 168.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -60.27 -24.85 65.25 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 -174.118 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 53.2 p-10 -71.53 -12.89 61.61 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.185 1.394 . . . . 0.0 114.476 174.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 103.76 0.78 45.93 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 126.575 2.036 . . . . 0.0 114.524 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 70.5 m -82.86 162.04 21.73 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 119.406 1.603 . . . . 0.0 112.228 175.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 94.2 m -127.35 164.6 21.45 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.477 1.111 . . . . 0.0 112.014 178.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -165.03 149.51 9.02 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.899 1.28 . . . . 0.0 111.787 177.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -74.3 118.94 17.84 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 123.707 0.803 . . . . 0.0 109.558 164.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 16.3 t -101.3 137.92 39.01 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 126.444 1.898 . . . . 0.0 109.609 173.115 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 20.4 tp -90.44 119.71 30.95 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 159.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 29.6 t -100.88 122.84 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 172.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -119.53 111.76 18.51 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.175 1.39 . . . . 0.0 109.761 178.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.475 HG11 ' HB1' ' A' ' 85' ' ' ALA . 7.2 p -87.81 127.12 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-O 121.227 0.537 . . . . 0.0 109.837 172.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 90.6 t -113.59 112.09 48.7 Favored Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 125.908 1.683 . . . . 0.0 106.886 177.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.43 131.95 14.35 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.984 2.456 . . . . 0.0 110.276 -178.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 76.6 t -104.91 116.6 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 123.935 0.894 . . . . 0.0 109.083 174.023 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 62.4 mttt -87.32 153.69 21.27 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.624 0.77 . . . . 0.0 112.4 172.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -91.93 -173.77 3.59 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.313 1.045 . . . . 0.0 111.58 175.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -61.36 -20.81 63.42 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 179.251 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -95.11 -0.12 53.75 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.878 1.271 . . . . 0.0 113.148 177.244 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 79.71 22.22 64.66 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 124.173 0.892 . . . . 0.0 114.719 176.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -107.69 148.49 29.33 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.136 1.374 . . . . 0.0 109.92 171.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.6 p -81.02 122.25 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 123.701 0.8 . . . . 0.0 110.652 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -121.86 -23.79 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -174.096 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 60.9 mtm -129.74 150.5 51.02 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.07 1.348 . . . . 0.0 112.172 169.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -110.63 135.39 51.32 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 125.522 1.529 . . . . 0.0 108.978 166.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 53.2 mt -101.01 122.05 52.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 163.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 9.2 mp -103.89 123.62 47.47 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 172.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -101.83 150.43 23.17 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.375 1.07 . . . . 0.0 110.858 174.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -123.37 135.85 54.36 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.031 1.333 . . . . 0.0 110.601 178.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -142.38 134.12 26.92 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.245 1.418 . . . . 0.0 109.061 179.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 57.8 t -79.82 115.85 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 176.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.3 p -95.23 -24.91 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 39.1 tpp -163.94 111.87 1.16 Allowed 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.873 1.269 . . . . 0.0 110.882 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -79.81 127.88 32.76 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 121.16 -0.963 . . . . 0.0 110.99 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 41.8 mttt . . . . . 0 C--O 1.258 1.506 0 C-N-CA 125.245 1.418 . . . . 0.0 112.527 -179.843 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 mmt . . . . . 0 N--CA 1.496 1.833 0 CA-C-O 118.397 -0.811 . . . . 0.0 110.604 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -75.79 131.12 13.08 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 123.095 2.53 . . . . 0.0 111.02 178.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.8 p -168.01 149.07 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 125.48 1.512 . . . . 0.0 110.841 -178.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 6.0 mmp_? -90.5 135.74 33.5 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.575 1.15 . . . . 0.0 111.253 173.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -100.86 152.77 20.13 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.435 1.494 . . . . 0.0 112.21 -175.093 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -90.14 -153.45 28.54 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 125.618 1.58 . . . . 0.0 112.691 175.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 40.1 m80 -65.69 138.44 57.97 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.585 0.754 . . . . 0.0 111.557 175.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.2 p -70.25 -34.4 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -171.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 64.98 159.41 0.12 Allowed Pre-proline 0 CA--C 1.556 1.186 0 C-N-CA 127.209 2.204 . . . . 0.0 113.392 -176.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -74.06 125.51 9.88 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.567 2.178 . . . . 0.0 110.513 172.167 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 10.5 mp0 -87.9 -63.66 1.27 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 122.01 0.91 . . . . 0.0 109.793 169.017 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.1 p-10 -85.9 147.68 26.15 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 126.245 1.818 . . . . 0.0 110.732 -174.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 31.1 p -131.1 -49.48 1.01 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 126.419 1.888 . . . . 0.0 111.701 -176.161 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -65.06 -42.98 93.72 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.614 0.766 . . . . 0.0 111.629 177.079 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 64.7 tp -71.05 -39.78 72.04 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.557 0.743 . . . . 0.0 111.032 172.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -59.79 -27.25 66.4 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 177.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 92.6 m -69.54 -23.69 63.62 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.746 1.218 . . . . 0.0 111.641 174.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 23.6 mm -76.48 -38.16 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 123.923 0.889 . . . . 0.0 109.806 176.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.1 mp -57.7 -33.58 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 O-C-N 121.702 -0.624 . . . . 0.0 110.91 173.271 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 48.5 mtp85 -69.59 -18.95 63.66 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 119.455 1.025 . . . . 0.0 113.332 177.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 78.1 mttt -87.68 -38.87 15.48 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 125.096 1.358 . . . . 0.0 111.053 173.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -73.88 -18.88 60.86 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.929 1.292 . . . . 0.0 113.337 174.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -52.34 147.72 7.57 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.237 1.415 . . . . 0.0 112.828 172.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -90.75 52.69 3.32 Favored Glycine 0 C--N 1.34 0.761 0 C-N-CA 125.586 1.565 . . . . 0.0 110.379 -179.026 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 60.82 41.74 14.21 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.9 1.68 . . . . 0.0 111.579 178.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 8.1 m -76.31 7.45 4.3 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.864 1.266 . . . . 0.0 114.296 -170.113 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.0 mmt-85 -76.52 -167.81 0.87 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.747 1.219 . . . . 0.0 111.928 175.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -120.99 139.02 53.86 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.107 1.363 . . . . 0.0 110.427 -173.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -165.07 152.77 11.3 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -177.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 13.2 pt -140.93 149.35 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 125.969 1.708 . . . . 0.0 110.47 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 19.0 mt -108.87 133.75 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.343 1.457 . . . . 0.0 108.8 179.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -131.81 142.87 49.85 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.758 1.223 . . . . 0.0 111.634 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -70.47 124.81 25.1 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.342 0.657 . . . . 0.0 111.698 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.8 -15.77 60.2 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 120.922 -1.111 . . . . 0.0 113.218 -178.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 3.1 mpp_? -98.94 4.81 47.43 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.999 1.72 . . . . 0.0 113.336 -171.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 70.9 t -110.26 138.4 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 126.681 1.993 . . . . 0.0 108.898 179.053 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -54.14 -34.63 60.84 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 116.048 1.87 . . . . 0.0 116.048 -167.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -105.86 0.31 25.85 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.168 1.387 . . . . 0.0 113.027 -178.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 91.2 m 50.43 66.86 1.03 Allowed 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.875 1.67 . . . . 0.0 111.954 -171.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.88 140.53 58.82 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.154 0.982 . . . . 0.0 111.967 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 63.7 t -63.86 119.88 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 171.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 38.3 pt -101.09 -20.64 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.689 1.195 . . . . 0.0 112.341 174.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -154.46 147.57 24.71 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.43 1.092 . . . . 0.0 111.127 177.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.453 ' HB2' ' CE1' ' A' ' 48' ' ' PHE . 22.4 p -152.14 154.78 36.54 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 121.024 -1.047 . . . . 0.0 113.424 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -78.77 -168.81 1.53 Allowed 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 123.457 0.703 . . . . 0.0 112.321 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -104.12 -18.6 14.46 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.566 1.546 . . . . 0.0 112.59 169.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.61 -42.46 71.97 Favored Glycine 0 N--CA 1.469 0.895 0 C-N-CA 124.146 0.879 . . . . 0.0 112.253 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.453 ' CE1' ' HB2' ' A' ' 44' ' ' CYS . 0.9 OUTLIER -67.05 -29.31 69.06 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.315 0.646 . . . . 0.0 111.788 -175.853 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 83.7 m -52.64 -51.81 58.42 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.181 1.392 . . . . 0.0 111.808 172.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -74.57 -20.46 59.93 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.842 0.857 . . . . 0.0 113.179 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.38 -58.38 7.27 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.031 1.332 . . . . 0.0 110.253 176.164 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 69.2 m -97.73 -15.43 20.34 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 -175.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.37 2.16 68.37 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 125.519 1.533 . . . . 0.0 114.046 173.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -85.56 -154.52 0.2 Allowed 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 124.798 1.239 . . . . 0.0 111.811 170.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 9.5 t -161.22 170.07 20.99 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 120.498 -1.376 . . . . 0.0 111.61 175.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -50.34 -47.91 55.68 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.824 1.25 . . . . 0.0 111.48 177.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.63 -25.96 54.63 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 178.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -92.33 -39.79 11.28 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.284 1.434 . . . . 0.0 111.848 177.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 71.3 t -80.7 -17.41 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 125.742 1.617 . . . . 0.0 112.243 -177.089 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 70.0 mtp -60.97 131.15 49.72 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 120.549 -1.344 . . . . 0.0 109.843 173.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 14.0 mt-30 70.34 13.11 7.58 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.713 1.605 . . . . 0.0 114.105 -178.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -89.97 153.56 47.2 Favored Pre-proline 0 N--CA 1.475 0.778 0 C-N-CA 124.356 1.062 . . . . 0.0 110.991 172.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.53 132.28 23.36 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.995 2.464 . . . . 0.0 110.23 170.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 27.3 p -68.42 -9.9 51.64 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 115.105 1.521 . . . . 0.0 115.105 -175.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 38.3 p -62.3 -27.45 69.04 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.93 1.292 . . . . 0.0 111.588 168.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 73.4 m 48.89 42.53 20.5 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.506 1.522 . . . . 0.0 112.6 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -56.72 -32.03 65.1 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.159 1.383 . . . . 0.0 112.59 -175.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -59.1 -16.17 17.93 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.965 1.306 . . . . 0.0 114.501 175.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 97.2 mt -76.45 -3.95 39.93 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 174.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -59.7 134.08 56.69 Favored 'General case' 0 CA--C 1.549 0.942 0 CA-C-N 120.382 1.446 . . . . 0.0 113.051 176.431 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -105.2 -175.4 24.35 Favored Glycine 0 CA--C 1.538 1.499 0 C-N-CA 125.435 1.493 . . . . 0.0 111.42 167.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -66.57 -16.61 51.31 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 122.92 2.413 . . . . 0.0 113.674 176.143 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -90.08 -9.27 49.07 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 175.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 53.3 m -68.88 132.49 46.83 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 119.651 1.114 . . . . 0.0 110.852 -175.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -90.03 130.33 36.23 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.112 0.965 . . . . 0.0 110.323 -179.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -63.42 -31.9 73.18 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.581 0.753 . . . . 0.0 112.261 -175.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 36.5 mmt180 -61.81 -50.57 71.79 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.69 0.796 . . . . 0.0 111.797 172.365 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.24 -37.74 88.18 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 120.331 -1.481 . . . . 0.0 112.964 -178.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -56.93 -34.23 67.78 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 170.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -76.19 -42.53 46.03 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 124.886 1.274 . . . . 0.0 112.878 174.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -61.49 -33.51 73.9 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 118.598 0.636 . . . . 0.0 110.925 -178.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 91.3 mt -62.07 -36.84 76.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 CA-C-N 119.679 1.127 . . . . 0.0 112.315 170.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.89 -37.47 67.29 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 119.343 0.974 . . . . 0.0 112.186 173.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -62.97 -33.13 74.73 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 121.418 -0.802 . . . . 0.0 111.473 172.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.52 -19.76 65.05 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 175.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 43.8 mt -88.43 -18.32 28.55 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.229 1.411 . . . . 0.0 112.799 172.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 83.1 mt -85.12 -21.64 29.19 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.006 0.922 . . . . 0.0 111.667 171.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -81.94 143.1 22.95 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 125.156 1.36 . . . . 0.0 112.308 176.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -91.21 -3.18 57.2 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.347 1.059 . . . . 0.0 113.841 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -117.02 161.87 18.7 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.658 1.983 . . . . 0.0 110.804 174.067 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -64.61 145.94 55.42 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 122.276 1.036 . . . . 0.0 113.045 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 44.9 mmt-85 -142.08 135.8 29.5 Favored 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 125.314 1.446 . . . . 0.0 110.442 173.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.4 ptpp? -113.76 134.83 54.53 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 167.3 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 78.2 t -129.05 135.16 62.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 126.144 1.777 . . . . 0.0 107.908 -173.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -99.56 128.84 45.68 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.986 0.914 . . . . 0.0 110.319 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.1 tt -151.14 148.8 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.359 1.063 . . . . 0.0 111.463 -168.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -80.15 124.06 28.45 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 120.774 -1.204 . . . . 0.0 111.304 173.041 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 6.8 m-30 -107.29 136.92 46.28 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.883 1.673 . . . . 0.0 110.384 172.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -101.44 128.47 47.63 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.68 1.592 . . . . 0.0 110.955 177.079 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 57.4 ttp180 -94.56 152.55 18.44 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.203 1.801 . . . . 0.0 111.396 -174.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -59.68 -22.7 62.32 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 -174.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -79.91 -13.07 59.64 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.702 1.201 . . . . 0.0 114.069 176.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 107.13 0.59 35.66 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 126.269 1.89 . . . . 0.0 114.699 -178.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 75.0 m -80.42 160.19 25.41 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 119.489 1.644 . . . . 0.0 112.876 176.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 15.9 t -136.12 152.45 50.85 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.884 1.273 . . . . 0.0 110.574 176.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -166.97 161.38 14.96 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.369 1.468 . . . . 0.0 111.303 -176.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -80.4 121.02 25.19 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.912 0.885 . . . . 0.0 111.129 172.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 49.6 t -102.45 135.69 43.62 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.61 1.964 . . . . 0.0 110.423 171.216 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.1 tt -89.24 116.05 27.19 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 125.627 1.571 . . . . 0.0 107.033 163.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 66.5 t -103.06 111.78 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 169.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -101.84 113.6 26.95 Favored 'General case' 0 C--O 1.224 -0.246 0 C-N-CA 126.085 1.754 . . . . 0.0 109.547 172.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.416 HG22 HD13 ' A' ' 127' ' ' LEU . 67.5 t -85.99 126.32 40.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 169.579 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 89.7 t -113.22 116.22 46.92 Favored Pre-proline 0 CA--C 1.537 0.469 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 170.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -73.84 133.86 19.07 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 123.43 2.753 . . . . 0.0 110.079 -179.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 87.8 t -102.39 116.92 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 N-CA-C 107.902 -1.148 . . . . 0.0 107.902 171.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 33.2 mttp -88.86 161.13 16.87 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.447 0.699 . . . . 0.0 112.196 171.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -98.75 -174.13 2.71 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.384 1.074 . . . . 0.0 111.969 172.061 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -60.27 -22.58 63.27 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.276 1.43 . . . . 0.0 114.689 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -90.8 -1.49 57.85 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.161 0.984 . . . . 0.0 113.138 177.391 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 74.86 26.61 66.55 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 124.1 0.857 . . . . 0.0 113.932 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -103.63 146.12 29.05 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.98 1.312 . . . . 0.0 108.79 169.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 11.4 p -78.2 131.02 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-O 121.425 0.631 . . . . 0.0 110.529 175.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 2.8 pt -126.6 -21.16 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 124.652 1.181 . . . . 0.0 113.926 -169.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 73.6 mtm -148.8 155.65 41.24 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 126.09 1.756 . . . . 0.0 110.132 176.244 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -118.71 131.9 56.15 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 125.085 1.354 . . . . 0.0 109.514 174.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 56.6 mt -97.07 115.32 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 106.244 -1.761 . . . . 0.0 106.244 166.143 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.416 HD13 HG22 ' A' ' 112' ' ' VAL . 1.7 mm? -91.76 121.39 33.35 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 171.402 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -113.18 124.79 53.37 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 119.462 -0.304 . . . . 0.0 111.121 178.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 12.2 m-30 -103.46 144.06 31.89 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.301 1.441 . . . . 0.0 111.813 -177.417 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -150.63 135.68 17.63 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.726 1.611 . . . . 0.0 109.281 172.126 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 60.2 t -75.61 115.47 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 CA-C-N 119.53 1.059 . . . . 0.0 108.447 171.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.4 p -93.0 -25.3 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 123.539 0.735 . . . . 0.0 112.646 -178.55 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 30.5 ttm -162.17 118.42 2.01 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.552 1.141 . . . . 0.0 110.567 -176.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -82.08 124.16 29.58 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.679 -0.638 . . . . 0.0 110.021 174.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.255 1.355 0 CA-C-O 115.464 -2.208 . . . . 0.0 116.177 -172.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.6 mtt . . . . . 0 N--CA 1.494 1.763 0 CA-C-O 118.594 -0.717 . . . . 0.0 110.757 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -77.91 164.51 27.49 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 123.815 3.01 . . . . 0.0 112.159 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.6 p -161.66 135.77 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 125.295 1.438 . . . . 0.0 110.518 174.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -141.97 158.55 43.64 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.597 1.559 . . . . 0.0 111.87 -177.213 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.33 169.31 15.97 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 127.079 2.152 . . . . 0.0 111.756 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 152.97 -27.08 0.81 Allowed Glycine 0 N--CA 1.477 1.376 0 C-N-CA 124.591 1.091 . . . . 0.0 115.33 174.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 37.9 m80 -76.02 150.35 37.4 Favored 'General case' 0 CA--C 1.551 1.005 0 CA-C-N 118.387 1.093 . . . . 0.0 111.857 174.133 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.7 p -69.36 -32.9 55.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -177.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 68.63 160.51 0.15 Allowed Pre-proline 0 CA--C 1.556 1.189 0 C-N-CA 127.473 2.309 . . . . 0.0 113.452 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -64.36 123.63 12.09 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 122.413 2.076 . . . . 0.0 108.885 165.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -110.46 170.07 8.33 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.49 1.116 . . . . 0.0 112.326 -171.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -78.27 40.38 0.35 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.698 1.599 . . . . 0.0 113.93 -175.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 13.1 t -52.65 -29.76 28.04 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 127.812 2.445 . . . . 0.0 114.539 -168.392 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -72.43 -46.28 55.78 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 118.813 0.733 . . . . 0.0 111.746 175.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 53.9 tp -64.67 -34.04 77.36 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.978 1.311 . . . . 0.0 111.229 171.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -56.4 -31.12 63.56 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.731 1.212 . . . . 0.0 112.638 176.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 33.3 m -70.48 -29.98 66.66 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.939 1.296 . . . . 0.0 111.227 174.302 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.2 mm -78.66 -40.13 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 124.325 1.05 . . . . 0.0 110.221 176.299 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.45 ' HA ' ' CE2' ' A' ' 22' ' ' PHE . 87.6 mt -59.79 -44.27 93.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.308 0.643 . . . . 0.0 111.122 176.726 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 51.8 ptt85 -67.51 -24.26 65.55 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -179.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -69.03 -42.82 75.83 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.809 0.843 . . . . 0.0 111.671 174.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.45 ' CE2' ' HA ' ' A' ' 19' ' ' ILE . 17.0 p90 -87.0 -31.29 20.65 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 113.75 1.018 . . . . 0.0 113.75 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.29 -39.54 68.24 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 120.386 1.448 . . . . 0.0 111.388 178.51 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -70.02 -7.2 59.02 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 125.799 1.666 . . . . 0.0 114.528 176.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -80.7 -3.42 50.64 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 124.683 1.193 . . . . 0.0 111.948 169.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.2 t 84.59 25.18 0.09 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 126.735 2.014 . . . . 0.0 112.518 164.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 18.8 mmm180 -76.92 165.59 24.47 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.206 1.002 . . . . 0.0 111.646 -175.096 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.6 mptt -91.93 125.95 36.83 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.312 -0.868 . . . . 0.0 110.577 -175.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -159.14 161.99 36.36 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.1 pt -144.91 155.7 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 127.171 2.188 . . . . 0.0 109.905 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.8 mp -120.51 135.01 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 125.021 1.329 . . . . 0.0 109.334 179.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -132.58 153.22 51.22 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.007 1.323 . . . . 0.0 112.32 -176.115 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 29.0 p30 -76.47 118.92 19.64 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.409 1.084 . . . . 0.0 112.738 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.23 -17.22 61.37 Favored 'General case' 0 CA--C 1.547 0.829 0 O-C-N 120.724 -1.235 . . . . 0.0 113.517 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 65.7 mtm-85 -86.23 5.67 33.16 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.701 1.601 . . . . 0.0 114.813 -168.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 13.0 m -133.81 158.33 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 125.59 1.556 . . . . 0.0 111.116 -173.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -62.46 -40.73 97.58 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.088 0.955 . . . . 0.0 113.505 -173.119 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -85.9 -14.59 44.36 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 114.285 1.216 . . . . 0.0 114.285 -173.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 84.2 m 41.55 69.49 0.35 Allowed 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.777 1.631 . . . . 0.0 112.306 -165.013 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.31 143.18 47.05 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.064 0.945 . . . . 0.0 111.757 -176.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 23.8 t -65.98 122.45 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 175.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.5 pt -104.25 -14.84 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 125.629 1.572 . . . . 0.0 112.468 176.18 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -157.67 142.79 16.85 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.533 1.133 . . . . 0.0 111.376 176.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.539 ' HB3' ' CE1' ' A' ' 48' ' ' PHE . 2.7 m -130.67 153.3 49.11 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.125 0.97 . . . . 0.0 112.101 -178.157 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -78.46 -168.96 1.5 Allowed 'General case' 0 CA--C 1.554 1.132 0 CA-C-N 118.973 0.806 . . . . 0.0 111.496 165.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -104.01 -21.76 13.56 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.162 1.385 . . . . 0.0 112.975 169.35 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.31 -35.02 60.44 Favored Glycine 0 C--N 1.343 0.95 0 O-C-N 121.5 -0.75 . . . . 0.0 112.436 -177.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.539 ' CE1' ' HB3' ' A' ' 44' ' ' CYS . 0.4 OUTLIER -68.78 -30.86 69.53 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.491 0.716 . . . . 0.0 111.885 178.979 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 86.4 m -50.7 -55.32 17.08 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.217 1.407 . . . . 0.0 111.944 176.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -70.1 -18.81 63.26 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.168 0.987 . . . . 0.0 113.334 -178.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.2 tp -63.89 -46.29 85.53 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.853 1.261 . . . . 0.0 111.878 -178.608 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 73.9 m -110.53 -16.2 13.72 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 178.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.72 -0.06 57.84 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 125.59 1.567 . . . . 0.0 114.395 174.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -82.46 -157.59 0.22 Allowed 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 124.812 1.245 . . . . 0.0 112.217 171.442 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 10.0 t -162.52 170.45 18.63 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 120.522 -1.361 . . . . 0.0 111.485 176.242 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -47.6 -50.99 22.72 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.199 1.4 . . . . 0.0 111.454 176.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.99 -25.86 32.85 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -95.78 -38.83 10.15 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.309 1.444 . . . . 0.0 112.241 178.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 76.7 t -83.08 -19.01 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 125.756 1.622 . . . . 0.0 111.938 -176.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 77.1 mmm -66.19 132.38 48.3 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 120.566 -1.334 . . . . 0.0 109.481 173.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 73.59 7.97 5.04 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 126.129 1.771 . . . . 0.0 114.292 -175.003 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 -90.03 154.28 47.29 Favored Pre-proline 0 N--CA 1.478 0.934 0 C-N-CA 124.832 1.253 . . . . 0.0 110.427 169.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.46 134.31 26.22 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 123.091 2.527 . . . . 0.0 110.245 175.18 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 24.3 p -69.79 -4.98 22.4 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 114.888 1.44 . . . . 0.0 114.888 -176.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 56.0 p -62.05 -30.22 70.83 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.91 1.284 . . . . 0.0 111.398 165.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 77.9 m 50.62 38.73 19.69 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.003 1.721 . . . . 0.0 112.563 -174.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -57.41 -30.11 64.68 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.615 1.166 . . . . 0.0 112.441 -176.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -59.42 -15.14 15.18 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.743 1.217 . . . . 0.0 114.085 176.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 90.9 mt -77.51 -4.76 47.26 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.617 1.167 . . . . 0.0 113.955 172.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 11.4 p-80 -66.86 158.86 29.52 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 120.275 1.398 . . . . 0.0 114.511 179.273 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -155.17 -162.59 11.38 Favored Glycine 0 CA--C 1.537 1.456 0 C-N-CA 126.274 1.893 . . . . 0.0 111.875 168.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.85 -13.88 41.94 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 123.272 2.648 . . . . 0.0 115.143 -175.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -97.0 2.14 51.11 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 119.845 1.202 . . . . 0.0 113.742 173.334 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 20.3 m -87.61 127.43 35.27 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 119.593 1.088 . . . . 0.0 110.553 -177.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -86.73 126.41 34.56 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.719 0.807 . . . . 0.0 109.674 -178.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 11.7 mpt_? -65.38 -31.93 73.3 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.437 0.695 . . . . 0.0 111.584 -175.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 25.1 tpp180 -58.46 -42.89 88.44 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.542 1.137 . . . . 0.0 112.024 172.142 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -71.03 -43.88 66.97 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.259 -0.901 . . . . 0.0 112.32 177.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -56.99 -36.63 70.61 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 121.826 -0.546 . . . . 0.0 112.039 174.364 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.93 -48.66 57.61 Favored 'General case' 0 C--O 1.223 -0.299 0 C-N-CA 125.101 1.36 . . . . 0.0 111.953 173.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.8 mm100 -58.44 -37.54 75.62 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 118.369 -0.824 . . . . 0.0 111.495 -178.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 93.5 mt -61.08 -45.6 98.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 CA-C-N 120.128 1.331 . . . . 0.0 111.65 170.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.97 -34.21 74.95 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 119.006 0.821 . . . . 0.0 113.09 179.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 86.4 mm-40 -71.98 -32.18 66.99 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.164 0.986 . . . . 0.0 111.58 174.185 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -58.3 -32.19 68.22 Favored 'General case' 0 CA--C 1.547 0.857 0 O-C-N 121.213 -0.929 . . . . 0.0 112.214 177.154 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 58.7 mt -70.41 -16.6 62.97 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.952 1.701 . . . . 0.0 113.946 178.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.6 pp -104.29 -1.33 27.15 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 119.331 0.969 . . . . 0.0 113.33 170.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -84.68 -20.44 58.18 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 124.719 1.152 . . . . 0.0 114.702 -178.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 56.88 32.19 21.01 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 125.789 1.635 . . . . 0.0 113.385 179.122 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -144.82 163.77 33.07 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.825 1.65 . . . . 0.0 111.246 -171.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -68.67 128.68 37.49 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.897 -0.502 . . . . 0.0 110.674 174.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -142.35 133.93 26.68 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.788 1.235 . . . . 0.0 111.841 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 37.6 mtmt -111.06 130.15 55.69 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.285 1.434 . . . . 0.0 109.965 168.226 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.8 t -133.05 137.06 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 125.203 1.401 . . . . 0.0 108.441 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -106.32 130.88 54.08 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.137 0.975 . . . . 0.0 111.249 -175.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.4 tt -155.19 146.92 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 124.065 0.946 . . . . 0.0 112.314 -165.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -83.45 121.02 26.63 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 120.949 -1.094 . . . . 0.0 111.815 174.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 13.8 m-30 -109.27 146.85 33.6 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.569 1.947 . . . . 0.0 111.29 173.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -110.65 137.31 48.49 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.564 1.546 . . . . 0.0 112.03 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -92.09 154.98 18.38 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 126.472 1.909 . . . . 0.0 111.252 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -58.5 -25.8 62.75 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.559 1.144 . . . . 0.0 113.833 175.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -69.7 -10.83 59.83 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.322 1.449 . . . . 0.0 113.572 176.133 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 93.98 4.28 63.33 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 125.334 1.445 . . . . 0.0 113.93 -178.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 63.7 p -92.04 170.87 9.5 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.789 1.236 . . . . 0.0 112.024 175.444 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 22.1 p -147.36 168.25 22.3 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 121.11 -0.994 . . . . 0.0 112.722 176.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -164.64 155.53 14.86 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.961 1.304 . . . . 0.0 110.722 -173.007 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -77.15 123.55 26.57 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.277 0.56 . . . . 0.0 110.238 167.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 19.1 t -106.53 136.03 47.01 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.128 1.771 . . . . 0.0 110.306 172.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.0 tp -89.7 120.6 31.11 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 161.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 59.8 t -106.36 117.91 53.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 124.764 1.226 . . . . 0.0 108.521 175.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -111.23 113.02 25.21 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.659 1.184 . . . . 0.0 108.436 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.2 p -88.75 128.06 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 168.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 96.1 t -116.8 116.84 38.09 Favored Pre-proline 0 CA--C 1.538 0.507 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 175.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -76.13 138.27 20.2 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 123.038 2.492 . . . . 0.0 110.373 -176.349 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 84.0 t -111.35 123.15 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.836 0.854 . . . . 0.0 109.708 174.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 65.0 mttt -95.25 154.73 17.05 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.258 1.023 . . . . 0.0 113.42 173.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -93.66 -173.62 3.23 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.603 1.161 . . . . 0.0 111.872 177.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -58.31 -23.28 55.99 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.374 1.469 . . . . 0.0 114.42 177.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -93.02 -4.63 52.24 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.322 1.449 . . . . 0.0 113.173 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 80.46 22.29 62.74 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 124.226 0.917 . . . . 0.0 114.592 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -107.61 149.66 27.8 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.987 1.315 . . . . 0.0 109.981 173.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 64.0 t -77.26 125.51 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.24 -23.9 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -177.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 62.1 mtm -132.57 155.92 47.8 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.407 1.483 . . . . 0.0 112.479 171.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -119.16 134.09 55.4 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 125.87 1.668 . . . . 0.0 109.443 169.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 54.3 mt -97.39 120.02 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 165.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -103.61 127.51 51.03 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 173.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -119.98 128.05 53.21 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.402 1.081 . . . . 0.0 109.819 -176.268 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 16.9 m-30 -103.9 138.31 40.65 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.326 1.45 . . . . 0.0 111.016 -176.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -142.4 131.3 22.97 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.622 1.169 . . . . 0.0 109.879 174.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 94.1 t -76.92 111.85 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 176.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 5.0 p -95.86 -26.27 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 123.8 0.84 . . . . 0.0 112.963 -174.054 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 25.0 ptp -162.21 148.06 13.06 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.41 1.084 . . . . 0.0 112.789 163.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -90.37 130.01 36.51 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.953 0.901 . . . . 0.0 110.585 178.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 13.1 mmmm . . . . . 0 C--O 1.253 1.263 0 C-N-CA 125.297 1.439 . . . . 0.0 113.805 178.452 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.0 mmt . . . . . 0 N--CA 1.496 1.868 0 CA-C-O 118.642 -0.694 . . . . 0.0 111.238 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -68.29 134.75 32.16 Favored 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 123.59 2.86 . . . . 0.0 111.376 178.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 57.9 t -99.52 115.19 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 124.53 1.132 . . . . 0.0 110.566 -173.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 6.7 mpt_? -85.8 174.88 9.01 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.825 1.25 . . . . 0.0 111.803 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 13.6 ptp180 -55.39 147.89 16.29 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.856 1.263 . . . . 0.0 112.142 173.013 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -92.02 108.57 3.64 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 123.955 0.788 . . . . 0.0 112.175 -176.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -166.83 167.13 15.22 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 126.476 1.911 . . . . 0.0 110.86 175.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 59.8 t -137.07 134.9 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 124.606 1.163 . . . . 0.0 109.591 172.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -157.67 154.22 24.55 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 127.095 2.158 . . . . 0.0 108.881 174.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -65.03 110.39 1.5 Allowed 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.892 2.395 . . . . 0.0 110.23 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -69.81 165.12 22.16 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.652 1.181 . . . . 0.0 111.498 176.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -69.31 147.36 51.24 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 121.244 -0.91 . . . . 0.0 111.019 171.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 38.2 p -117.45 -40.57 3.04 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 125.509 1.523 . . . . 0.0 112.389 -174.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -76.02 -52.6 9.85 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.062 0.945 . . . . 0.0 111.553 176.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 60.4 tp -58.63 -34.47 71.21 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.43 1.092 . . . . 0.0 111.259 178.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -56.71 -30.97 64.03 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 176.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 89.7 m -77.01 -32.75 57.37 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.255 1.022 . . . . 0.0 110.89 175.205 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 20.9 mm -71.64 -39.42 69.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 123.541 0.736 . . . . 0.0 110.5 176.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 71.8 mt -56.31 -44.13 78.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 124.13 0.972 . . . . 0.0 110.753 175.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 39.9 mtt180 -59.75 -36.87 77.51 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 119.212 0.915 . . . . 0.0 112.489 177.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -74.0 -37.29 64.47 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.532 1.133 . . . . 0.0 112.071 177.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -79.57 -22.18 44.12 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.998 1.319 . . . . 0.0 112.954 178.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -62.01 -31.71 72.12 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 118.817 0.735 . . . . 0.0 112.003 170.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.52 44.65 40.11 Favored Glycine 0 C--N 1.341 0.838 0 N-CA-C 114.848 0.699 . . . . 0.0 114.848 156.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -58.36 -25.31 61.85 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 114.568 1.321 . . . . 0.0 114.568 -176.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.9 t -91.64 -5.71 53.4 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 177.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -91.01 171.36 9.32 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.8 1.24 . . . . 0.0 110.715 175.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.4 mptt -88.27 136.51 32.95 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.506 1.123 . . . . 0.0 111.252 -175.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -163.47 167.06 22.02 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.412 1.085 . . . . 0.0 113.544 178.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 25.7 pt -144.76 152.1 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 126.617 1.967 . . . . 0.0 109.865 172.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 10.7 mt -117.68 133.61 63.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 125.538 1.535 . . . . 0.0 109.008 -178.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -134.78 152.18 51.55 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.393 1.077 . . . . 0.0 112.353 178.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 14.3 m-20 -74.68 117.99 17.13 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.334 0.653 . . . . 0.0 111.527 178.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.32 -20.21 66.03 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.934 0.894 . . . . 0.0 112.274 170.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 78.7 mtp85 -66.79 -11.87 56.72 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.825 2.05 . . . . 0.0 115.352 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 20.6 m -124.79 142.03 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 125.357 1.463 . . . . 0.0 111.01 -179.07 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -61.4 -40.68 95.26 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.718 1.207 . . . . 0.0 112.904 -170.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 22.2 p30 -72.32 -14.59 61.78 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 177.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 4.8 t 50.98 61.67 3.12 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.716 1.606 . . . . 0.0 111.695 -173.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.64 134.86 56.18 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 120.936 -1.103 . . . . 0.0 112.278 -179.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 40.5 t -63.79 122.66 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 C-N-CA 123.07 0.548 . . . . 0.0 109.912 173.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.1 pt -101.46 -21.37 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 125.404 1.482 . . . . 0.0 112.424 175.401 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -152.36 144.09 23.58 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.293 1.037 . . . . 0.0 111.816 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.507 ' HB3' ' CE1' ' A' ' 48' ' ' PHE . 3.1 m -128.07 155.07 44.96 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.056 0.942 . . . . 0.0 112.592 -179.38 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -73.88 -174.22 1.77 Allowed 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 123.159 0.584 . . . . 0.0 111.475 167.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -107.52 -17.97 13.97 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.58 1.152 . . . . 0.0 112.801 166.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -73.92 -38.81 48.18 Favored Glycine 0 C--N 1.337 0.599 0 C-N-CA 125.821 1.676 . . . . 0.0 112.734 176.13 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.507 ' CE1' ' HB3' ' A' ' 44' ' ' CYS . 0.3 OUTLIER -62.62 -34.51 77.17 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.207 0.603 . . . . 0.0 111.244 179.606 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 76.6 m -48.19 -56.13 8.67 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.942 1.697 . . . . 0.0 111.941 170.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -70.93 -19.79 62.54 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -177.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.95 -49.48 72.4 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.641 1.177 . . . . 0.0 111.43 177.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 76.6 m -107.61 -21.63 12.82 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 -176.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.02 -0.4 57.46 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 125.426 1.488 . . . . 0.0 114.348 178.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -83.08 -171.52 3.61 Favored 'General case' 0 CA--C 1.55 0.964 0 CA-C-N 118.499 1.15 . . . . 0.0 112.698 170.615 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 74.2 m -140.95 162.59 35.12 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.409 1.084 . . . . 0.0 111.312 178.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -46.37 -49.55 17.7 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.282 1.033 . . . . 0.0 112.025 176.192 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.96 -24.78 59.47 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -89.21 -39.31 13.63 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.765 1.226 . . . . 0.0 111.67 177.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 19.8 t -88.63 -12.46 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 124.107 0.963 . . . . 0.0 112.513 -176.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 75.4 mtp -64.35 139.33 58.75 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 120.463 -1.398 . . . . 0.0 111.276 168.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 69.37 6.89 5.93 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 126.301 1.841 . . . . 0.0 113.896 -177.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 32.4 mmt180 -83.85 154.58 64.65 Favored Pre-proline 0 N--CA 1.472 0.643 0 C-N-CA 124.23 1.012 . . . . 0.0 110.59 172.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -68.94 131.04 21.5 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.866 2.377 . . . . 0.0 109.671 170.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 6.7 t -66.04 -14.41 61.64 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.165 1.386 . . . . 0.0 114.069 -172.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 33.9 p -59.39 -24.27 63.3 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.863 1.665 . . . . 0.0 112.908 169.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 76.9 m 57.51 42.81 23.82 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.186 1.394 . . . . 0.0 111.76 -178.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -71.97 18.79 0.08 Allowed 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 127.519 2.328 . . . . 0.0 113.39 -175.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -112.46 -12.3 13.52 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 126.889 2.076 . . . . 0.0 112.747 170.334 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 78.6 mt -81.18 -9.62 59.76 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 114.801 1.408 . . . . 0.0 114.801 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 12.0 p80 -69.02 160.33 31.16 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 179.065 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -151.96 -161.37 10.12 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 126.1 1.81 . . . . 0.0 111.357 168.03 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -65.74 -18.54 58.58 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 122.961 2.441 . . . . 0.0 114.287 -177.07 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.5 tpm_? -88.15 -6.95 57.58 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 119.273 0.942 . . . . 0.0 113.106 176.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.8 m -85.92 137.81 32.47 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.382 1.473 . . . . 0.0 109.77 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -102.5 135.41 44.19 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.21 1.004 . . . . 0.0 110.269 -178.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 19.3 tpp180 -58.6 -36.37 73.9 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.359 1.064 . . . . 0.0 112.383 -178.077 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 21.1 tpp85 -55.5 -45.91 77.01 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.15 1.38 . . . . 0.0 112.118 176.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.77 -46.4 68.84 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.753 0.821 . . . . 0.0 111.773 178.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.82 -34.44 65.38 Favored 'General case' 0 CA--C 1.545 0.784 0 O-C-N 121.488 -0.758 . . . . 0.0 112.359 175.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.41 -40.57 70.4 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 125.27 1.428 . . . . 0.0 113.033 173.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -61.17 -30.55 70.47 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 118.061 -0.971 . . . . 0.0 112.174 178.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 58.0 mt -63.76 -47.28 91.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 CA-C-N 120.039 1.29 . . . . 0.0 110.273 172.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.89 -34.43 77.38 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 121.582 -0.699 . . . . 0.0 112.483 176.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 73.7 mm-40 -69.64 -31.32 69.34 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 121.481 -0.762 . . . . 0.0 112.194 171.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.5 -28.12 66.73 Favored 'General case' 0 CA--C 1.545 0.778 0 O-C-N 120.98 -1.075 . . . . 0.0 111.666 176.058 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 74.4 mt -73.97 -14.25 61.0 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.94 1.296 . . . . 0.0 113.655 169.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 94.3 mt -94.89 -10.64 30.58 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.249 1.02 . . . . 0.0 112.653 172.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -87.65 143.8 18.62 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 125.077 1.322 . . . . 0.0 112.9 177.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.5 -3.5 58.34 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.751 1.22 . . . . 0.0 113.801 175.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -125.62 165.17 19.03 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.578 1.951 . . . . 0.0 110.974 -175.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -61.62 139.79 58.23 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.014 0.926 . . . . 0.0 112.039 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.17 123.75 8.47 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.318 1.047 . . . . 0.0 110.872 -173.078 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -89.18 153.0 21.29 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.399 1.079 . . . . 0.0 113.719 169.108 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 46.1 t -138.73 134.48 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 126.808 2.043 . . . . 0.0 107.628 167.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -102.98 121.2 42.05 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.609 0.763 . . . . 0.0 109.15 173.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.5 tt -147.25 145.46 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 123.925 0.89 . . . . 0.0 112.212 -169.261 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -84.29 119.51 25.14 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.332 -0.855 . . . . 0.0 111.75 175.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 15.9 m-30 -107.07 150.43 26.55 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.544 1.938 . . . . 0.0 110.908 172.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -109.89 136.7 48.77 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.983 1.313 . . . . 0.0 111.871 175.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -86.37 168.24 14.01 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.744 0.818 . . . . 0.0 112.593 173.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -58.23 -30.96 66.91 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 125.684 1.593 . . . . 0.0 113.511 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -76.37 -6.32 51.07 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.946 1.299 . . . . 0.0 113.439 178.257 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 93.63 1.34 66.07 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 125.63 1.586 . . . . 0.0 114.541 178.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.4 m -80.32 154.02 28.04 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 118.766 1.283 . . . . 0.0 111.743 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 39.1 t -117.42 150.6 38.61 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.822 1.249 . . . . 0.0 111.733 -178.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -159.56 146.14 16.43 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.968 1.307 . . . . 0.0 111.412 178.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -71.02 123.86 23.04 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.279 0.632 . . . . 0.0 110.974 165.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 47.0 t -106.78 133.71 51.03 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.627 1.971 . . . . 0.0 109.672 169.48 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.0 tt -85.41 113.61 21.83 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.515 1.526 . . . . 0.0 107.075 162.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 63.9 t -98.1 110.93 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 124.82 1.248 . . . . 0.0 107.646 170.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -102.33 120.07 39.87 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 120.435 1.47 . . . . 0.0 108.733 167.032 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.407 HG22 HD13 ' A' ' 127' ' ' LEU . 67.5 t -82.66 135.79 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 170.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 48.5 t -115.25 111.2 44.73 Favored Pre-proline 0 CA--C 1.535 0.403 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 169.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.45 133.25 14.28 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.011 2.474 . . . . 0.0 109.741 178.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 94.6 t -107.8 123.55 63.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 123.98 0.912 . . . . 0.0 109.783 179.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 67.2 mttt -91.6 154.08 19.29 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.242 0.831 . . . . 0.0 113.242 170.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -92.7 -174.56 3.68 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.285 1.034 . . . . 0.0 110.765 173.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -66.1 -18.93 65.66 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -85.34 -5.79 59.28 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.318 1.047 . . . . 0.0 112.455 174.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 78.68 23.05 65.41 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 124.581 1.086 . . . . 0.0 114.385 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -107.88 150.31 27.21 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.542 1.537 . . . . 0.0 109.937 172.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 90.4 t -78.61 124.93 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 123.684 0.794 . . . . 0.0 109.202 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.22 -24.74 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 -175.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 51.9 mtm -130.2 152.22 49.86 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.822 1.249 . . . . 0.0 112.473 171.077 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -113.34 135.81 53.45 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 125.164 1.386 . . . . 0.0 109.081 166.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 49.6 mt -103.07 119.56 51.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 166.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.407 HD13 HG22 ' A' ' 112' ' ' VAL . 1.6 mm? -95.84 117.97 31.59 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 173.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -111.08 129.42 55.93 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 117.773 0.261 . . . . 0.0 110.978 -179.452 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 17.6 m-30 -107.62 137.91 44.79 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.481 1.512 . . . . 0.0 111.7 -171.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -144.54 116.99 8.55 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.568 1.147 . . . . 0.0 109.779 172.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.1 p -66.68 115.63 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 O-C-N 121.363 -0.836 . . . . 0.0 109.883 175.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 9.2 p -99.83 -27.04 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.904 1.281 . . . . 0.0 113.394 -171.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 25.1 ptp -162.69 149.93 13.4 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.328 1.051 . . . . 0.0 113.104 167.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -89.18 136.46 33.01 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.722 0.809 . . . . 0.0 111.037 177.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt . . . . . 0 C--O 1.254 1.326 0 C-N-CA 125.317 1.447 . . . . 0.0 112.732 175.875 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.1 ttm . . . . . 0 N--CA 1.494 1.743 0 CA-C-O 118.341 -0.837 . . . . 0.0 110.731 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -75.56 143.34 27.24 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 123.224 2.616 . . . . 0.0 110.688 175.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 17.4 m -149.43 152.99 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 125.018 1.327 . . . . 0.0 111.303 -178.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 18.5 ptp180 -68.3 160.96 28.36 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.039 0.936 . . . . 0.0 112.702 173.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 19.0 ptp180 -157.76 160.71 38.13 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.669 1.588 . . . . 0.0 112.413 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -173.31 -144.19 4.56 Favored Glycine 0 N--CA 1.471 1.02 0 C-N-CA 125.539 1.543 . . . . 0.0 112.573 -177.23 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -64.89 124.43 21.99 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 123.518 0.727 . . . . 0.0 111.227 176.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.5 p -75.89 -19.9 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 N-CA-C 113.761 1.022 . . . . 0.0 113.761 -173.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 71.55 162.63 0.15 Allowed Pre-proline 0 CA--C 1.555 1.164 0 C-N-CA 127.485 2.314 . . . . 0.0 112.716 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -70.88 139.16 35.76 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.518 2.146 . . . . 0.0 110.494 170.028 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -168.07 179.33 4.65 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.649 1.58 . . . . 0.0 111.865 -175.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -75.58 63.34 1.53 Allowed 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 126.661 1.984 . . . . 0.0 114.701 -172.535 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 25.9 p -42.18 -45.4 4.06 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 128.025 2.53 . . . . 0.0 114.372 -178.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -65.01 -41.65 95.13 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.848 0.859 . . . . 0.0 112.481 -177.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 61.5 tp -72.79 -40.01 66.24 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.563 1.145 . . . . 0.0 111.098 173.368 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -62.66 -25.11 67.97 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.178 0.991 . . . . 0.0 112.459 178.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 95.0 m -67.85 -21.86 65.16 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.597 1.559 . . . . 0.0 111.487 171.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 11.5 mm -86.6 -37.41 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 124.749 1.22 . . . . 0.0 110.791 174.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.456 ' HA ' ' CE2' ' A' ' 22' ' ' PHE . 1.9 mp -58.31 -49.89 80.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 123.1 0.56 . . . . 0.0 110.397 174.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 16.3 ptp180 -67.43 -16.77 64.41 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 114.22 1.193 . . . . 0.0 114.22 -175.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.5 mtpt -70.59 -36.24 73.46 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.937 0.895 . . . . 0.0 111.986 171.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.456 ' CE2' ' HA ' ' A' ' 19' ' ' ILE . 6.2 p90 -93.74 -23.85 18.05 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 178.594 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -77.94 160.79 27.99 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 173.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -108.52 5.79 33.39 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 126.089 1.804 . . . . 0.0 115.537 178.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -91.77 -23.84 19.61 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 119.259 1.529 . . . . 0.0 114.334 -175.125 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.8 m -86.6 11.53 12.58 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 114.074 1.139 . . . . 0.0 114.074 -170.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 21.5 mmt85 -79.72 165.77 22.47 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.06 1.344 . . . . 0.0 113.666 -167.106 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -94.82 129.77 41.65 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.906 1.282 . . . . 0.0 110.93 -172.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -160.35 161.63 33.21 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.323 1.049 . . . . 0.0 113.712 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.6 pt -141.79 153.68 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 127.125 2.17 . . . . 0.0 110.441 176.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.6 mp -116.43 132.61 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 124.732 1.213 . . . . 0.0 109.205 176.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.726 ' HB2' ' SG ' ' A' ' 64' ' ' CYS . . . -123.15 142.92 50.37 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 126.078 1.751 . . . . 0.0 110.603 -174.073 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -71.32 124.05 23.68 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 121.82 -0.55 . . . . 0.0 111.105 171.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.01 -33.93 63.97 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 121.142 -0.974 . . . . 0.0 111.986 177.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 60.6 mtm180 -80.31 33.68 0.3 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 126.007 1.723 . . . . 0.0 113.115 -174.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 79.8 t -145.15 133.42 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 127.142 2.177 . . . . 0.0 108.492 -173.221 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -57.93 -41.09 82.03 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.685 1.194 . . . . 0.0 113.336 -171.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 75.7 m-80 -84.76 -11.0 56.69 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -178.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 69.8 m 45.9 62.04 2.4 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.246 1.419 . . . . 0.0 111.95 -165.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.52 143.37 57.26 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.089 0.955 . . . . 0.0 111.955 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.656 HG22 ' SG ' ' A' ' 64' ' ' CYS . 56.6 t -61.47 116.33 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 124.534 1.134 . . . . 0.0 108.734 173.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 37.3 pt -98.47 -20.85 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 123.147 0.579 . . . . 0.0 112.326 170.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -156.72 152.61 27.24 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.106 0.962 . . . . 0.0 111.697 175.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.514 ' HB2' ' CE1' ' A' ' 48' ' ' PHE . 24.9 p -153.16 153.94 33.76 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.015 -1.053 . . . . 0.0 113.287 -179.33 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -79.89 -168.84 1.75 Allowed 'General case' 0 CA--C 1.553 1.091 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -179.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -101.33 -22.93 14.47 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.171 1.388 . . . . 0.0 112.57 169.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.45 -37.0 58.84 Favored Glycine 0 C--N 1.343 0.944 0 O-C-N 121.532 -0.73 . . . . 0.0 112.825 -177.068 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.514 ' CE1' ' HB2' ' A' ' 44' ' ' CYS . 0.8 OUTLIER -67.03 -30.38 70.44 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 117.451 0.626 . . . . 0.0 111.779 179.206 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 80.0 m -56.05 -52.02 65.76 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.608 1.163 . . . . 0.0 111.78 175.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -71.44 -20.36 62.11 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.739 0.816 . . . . 0.0 112.952 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.5 tp -64.92 -56.02 15.79 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.511 1.124 . . . . 0.0 111.116 176.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 62.0 m -98.64 -13.73 20.2 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -175.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 91.79 2.61 69.33 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 125.624 1.583 . . . . 0.0 114.152 171.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -85.64 -153.64 0.18 Allowed 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 124.899 1.28 . . . . 0.0 112.133 171.243 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 82.7 p -153.8 167.8 28.46 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 120.389 -1.444 . . . . 0.0 111.63 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -50.85 -52.96 36.45 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 118.817 -0.611 . . . . 0.0 110.512 169.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.55 -32.55 58.55 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -178.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -85.84 -37.63 18.99 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.887 0.875 . . . . 0.0 112.953 177.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 68.1 t -77.73 -15.76 14.21 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 C-N-CA 124.882 1.273 . . . . 0.0 111.625 178.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 75.1 mtp -60.59 131.35 50.45 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 120.468 -1.395 . . . . 0.0 111.508 175.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 71.92 14.01 5.93 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 126.587 1.955 . . . . 0.0 113.656 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 38.5 mtt180 -94.81 158.89 34.44 Favored Pre-proline 0 N--CA 1.474 0.761 0 C-N-CA 124.634 1.174 . . . . 0.0 111.214 174.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -70.3 136.83 32.51 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 123.307 2.672 . . . . 0.0 110.56 170.364 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.726 ' SG ' ' HB2' ' A' ' 32' ' ' ALA . 56.6 m -67.03 -8.58 31.25 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.46 1.281 . . . . 0.0 114.46 177.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 76.4 p -61.15 -28.37 69.07 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.351 1.061 . . . . 0.0 111.89 172.132 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 75.6 m 50.36 35.95 11.96 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.014 1.326 . . . . 0.0 113.104 -176.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -56.14 -33.28 65.02 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.362 1.465 . . . . 0.0 112.501 -176.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -60.26 -14.55 18.55 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.388 1.475 . . . . 0.0 114.35 177.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 92.7 mt -76.65 -2.97 35.42 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 174.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 3.6 p80 -59.87 145.3 46.18 Favored 'General case' 0 CA--C 1.552 1.026 0 CA-C-N 119.5 1.046 . . . . 0.0 113.41 176.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -118.51 -164.88 13.12 Favored Glycine 0 CA--C 1.539 1.591 0 C-N-CA 126.03 1.776 . . . . 0.0 111.525 165.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.84 -20.65 29.47 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 123.277 2.651 . . . . 0.0 112.937 174.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 29.3 ttm180 -93.59 2.2 56.44 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.26 1.424 . . . . 0.0 113.006 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 28.1 m -83.85 136.76 33.99 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.376 1.47 . . . . 0.0 110.011 177.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -96.89 123.62 40.65 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.021 0.928 . . . . 0.0 109.518 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 14.0 tpt180 -60.4 -30.57 69.69 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.721 0.809 . . . . 0.0 112.76 -176.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 21.4 tpp85 -56.9 -41.32 77.88 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.854 1.261 . . . . 0.0 112.504 173.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -72.73 -43.09 63.4 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 121.348 -0.845 . . . . 0.0 111.962 177.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -57.75 -36.49 72.16 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 121.545 -0.722 . . . . 0.0 112.038 174.274 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.95 -47.94 64.42 Favored 'General case' 0 C--O 1.225 -0.237 0 C-N-CA 125.197 1.399 . . . . 0.0 111.997 173.363 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.5 mm100 -58.25 -37.0 74.06 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 118.616 -0.707 . . . . 0.0 111.681 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 95.6 mt -59.54 -42.1 86.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 CA-C-N 119.829 1.195 . . . . 0.0 111.83 171.224 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.72 -34.98 70.04 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.458 0.703 . . . . 0.0 112.891 176.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -68.22 -32.83 73.31 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.981 0.912 . . . . 0.0 111.687 174.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.401 ' HB1' HG11 ' A' ' 112' ' ' VAL . . . -59.79 -27.91 66.97 Favored 'General case' 0 CA--C 1.547 0.827 0 CA-C-N 119.201 0.91 . . . . 0.0 113.035 178.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 53.7 mt -72.55 -14.7 61.7 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.648 1.579 . . . . 0.0 113.134 177.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 70.0 mt -81.86 -20.41 38.97 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.055 0.942 . . . . 0.0 112.268 174.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -89.44 152.74 22.83 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.139 1.352 . . . . 0.0 113.311 -178.301 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -95.83 7.9 45.04 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.088 1.355 . . . . 0.0 113.509 176.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -126.62 162.31 26.01 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.091 1.756 . . . . 0.0 112.082 -176.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -64.23 141.68 58.69 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.636 1.175 . . . . 0.0 112.063 -179.274 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 9.9 tpt180 -152.13 138.21 18.24 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.012 1.325 . . . . 0.0 110.646 -173.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -129.24 148.16 51.15 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 168.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 58.3 t -138.79 135.71 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 126.282 1.833 . . . . 0.0 108.232 -171.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -104.69 130.08 52.79 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.931 0.892 . . . . 0.0 110.98 -176.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.2 tt -152.26 147.36 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 123.999 0.919 . . . . 0.0 112.19 -168.131 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -81.59 121.08 25.88 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 120.872 -1.143 . . . . 0.0 111.601 171.19 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 10.1 m-30 -109.19 132.15 54.39 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.656 1.982 . . . . 0.0 111.147 173.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -78.31 162.15 26.71 Favored 'General case' 0 CA--C 1.549 0.906 0 O-C-N 121.89 -0.506 . . . . 0.0 112.084 167.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 23.9 ttp180 -115.39 147.56 40.38 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.766 1.626 . . . . 0.0 110.41 173.082 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -55.77 -24.92 38.41 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 178.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -64.08 -17.82 63.78 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.578 1.551 . . . . 0.0 113.77 173.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 100.41 4.43 54.98 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 125.849 1.69 . . . . 0.0 113.858 -175.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 86.3 p -92.77 -178.94 5.0 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 118.626 1.213 . . . . 0.0 112.569 176.291 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 21.8 t -150.02 156.67 42.1 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.681 1.192 . . . . 0.0 111.625 -177.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -161.2 164.63 30.32 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.316 1.846 . . . . 0.0 110.657 178.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.68 126.18 35.9 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 123.667 0.787 . . . . 0.0 112.459 170.296 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 43.4 t -105.07 135.34 46.59 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.837 2.055 . . . . 0.0 110.844 174.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 38.8 tp -93.42 112.79 24.78 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.786 1.235 . . . . 0.0 107.74 160.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 61.1 t -95.39 119.67 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 173.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -113.65 119.44 37.45 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 125.35 1.46 . . . . 0.0 109.598 174.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.401 HG11 ' HB1' ' A' ' 85' ' ' ALA . 5.8 p -94.44 127.64 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 123.897 0.879 . . . . 0.0 109.506 173.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 96.9 t -115.91 111.03 43.38 Favored Pre-proline 0 CA--C 1.537 0.452 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 178.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -73.61 130.71 15.13 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.684 2.256 . . . . 0.0 110.109 -178.347 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 58.6 t -100.26 124.93 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 123.942 0.897 . . . . 0.0 109.331 176.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 21.4 mtpt -94.58 150.82 19.85 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.665 0.745 . . . . 0.0 112.389 174.022 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 54.0 p30 -78.96 -173.43 3.54 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.832 1.253 . . . . 0.0 111.694 174.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -67.64 -15.36 63.61 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 175.163 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -96.59 -18.31 19.84 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.646 1.178 . . . . 0.0 113.206 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 86.67 43.98 5.94 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 125.966 1.746 . . . . 0.0 113.577 -174.163 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -118.69 154.27 32.99 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.394 1.477 . . . . 0.0 110.175 161.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 57.3 t -80.27 126.44 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 C-N-CA 123.413 0.685 . . . . 0.0 109.29 178.171 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.8 -24.63 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 N-CA-C 114.217 1.191 . . . . 0.0 114.217 -178.181 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 64.0 mtm -133.79 157.44 45.89 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.151 1.381 . . . . 0.0 112.205 172.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -117.56 137.08 52.82 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 125.532 1.533 . . . . 0.0 109.298 169.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 47.4 mt -101.54 121.34 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 164.079 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 8.2 mp -104.99 133.19 50.2 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 172.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -126.03 132.97 51.87 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.481 1.113 . . . . 0.0 110.114 -174.061 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 15.1 m-30 -107.46 128.21 54.29 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.02 1.328 . . . . 0.0 110.754 -176.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -124.19 131.88 53.57 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.177 1.391 . . . . 0.0 107.396 169.663 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 71.4 t -78.49 112.09 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 CA-C-N 119.415 1.007 . . . . 0.0 108.293 173.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.4 p -89.13 -24.5 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.429 1.091 . . . . 0.0 112.631 -174.337 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 13.4 tpt -161.16 119.24 2.4 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.721 1.209 . . . . 0.0 110.609 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -85.18 115.08 22.76 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.489 0.716 . . . . 0.0 109.767 176.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt . . . . . 0 C--O 1.255 1.348 0 C-N-CA 125.025 1.33 . . . . 0.0 113.733 -175.702 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 91.5 mmm . . . . . 0 N--CA 1.495 1.791 0 CA-C-O 118.607 -0.711 . . . . 0.0 110.829 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -80.18 167.69 19.43 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 123.815 3.01 . . . . 0.0 111.88 177.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.5 p -161.07 132.13 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 125.095 1.358 . . . . 0.0 110.619 173.121 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 31.0 tpt85 -92.09 102.87 15.41 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.165 0.986 . . . . 0.0 110.091 175.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -83.0 169.99 15.37 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.073 1.349 . . . . 0.0 111.117 174.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 128.58 123.48 2.58 Favored Glycine 0 N--CA 1.472 1.073 0 C-N-CA 125.69 1.614 . . . . 0.0 113.028 175.006 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 48.2 m80 -149.26 172.93 14.07 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 127.214 2.205 . . . . 0.0 109.97 178.178 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.5 p -151.44 141.59 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 124.09 0.956 . . . . 0.0 111.531 177.087 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.24 154.15 92.15 Favored Pre-proline 0 CA--C 1.552 1.034 0 C-N-CA 124.666 1.187 . . . . 0.0 112.453 178.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -65.74 128.42 19.92 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 123.298 2.665 . . . . 0.0 110.601 176.21 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 23.0 mp0 -80.77 169.95 16.92 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.115 1.366 . . . . 0.0 110.953 176.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 16.0 p30 -71.61 148.22 46.8 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.187 -0.946 . . . . 0.0 110.865 169.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 40.0 p -122.63 -40.54 2.44 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 125.48 1.512 . . . . 0.0 112.122 -174.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -69.94 -55.57 9.31 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.982 0.913 . . . . 0.0 111.11 173.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 62.7 tp -59.34 -35.24 73.48 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.255 1.022 . . . . 0.0 111.255 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -58.56 -31.84 68.37 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 176.088 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 90.9 m -77.14 -32.89 56.7 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.13 0.972 . . . . 0.0 110.48 175.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 24.8 mm -68.58 -41.86 83.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 123.062 0.545 . . . . 0.0 110.367 173.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 76.1 mt -57.4 -46.67 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 124.384 1.074 . . . . 0.0 110.506 174.395 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 78.8 mtt-85 -58.71 -31.72 68.52 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 179.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -71.02 -30.51 66.75 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.08 0.952 . . . . 0.0 112.756 177.103 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -88.83 -26.13 21.83 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.487 1.115 . . . . 0.0 113.371 173.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -67.0 153.89 42.54 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 122.155 0.978 . . . . 0.0 113.369 178.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -79.81 61.21 4.32 Favored Glycine 0 C--N 1.34 0.764 0 C-N-CA 126.074 1.797 . . . . 0.0 110.695 173.179 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -62.11 -21.36 64.93 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.165 1.386 . . . . 0.0 112.624 -178.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 7.8 t -83.45 -20.11 34.67 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 175.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.1 mpt_? -90.55 179.61 5.8 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.892 1.277 . . . . 0.0 110.309 170.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -122.84 128.65 50.68 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 121.002 -1.061 . . . . 0.0 111.766 -174.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 26.9 p90 -163.93 163.52 23.55 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.084 1.353 . . . . 0.0 112.96 175.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 14.3 pt -141.06 154.84 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 126.062 1.745 . . . . 0.0 110.19 175.128 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 15.9 mt -110.14 129.07 65.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 124.814 1.246 . . . . 0.0 108.67 177.364 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -122.5 142.76 50.24 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 124.897 1.279 . . . . 0.0 111.236 178.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -65.55 126.51 28.56 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.163 0.585 . . . . 0.0 111.435 172.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -80.93 -25.02 37.75 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 28.7 mmm180 -80.12 -36.82 34.76 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.616 1.166 . . . . 0.0 112.938 -173.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 52.9 t -68.98 131.85 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 C-N-CA 125.439 1.495 . . . . 0.0 109.753 173.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -59.63 -44.81 93.34 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.518 1.127 . . . . 0.0 113.309 -170.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 20.2 p30 -74.53 -9.54 58.68 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 113.78 1.029 . . . . 0.0 113.78 177.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 72.1 m 54.79 64.34 1.84 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.89 1.676 . . . . 0.0 112.23 -176.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.88 135.56 57.73 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.66 0.784 . . . . 0.0 111.735 179.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 42.3 t -64.33 118.17 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 168.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 36.0 pt -100.17 -19.77 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 124.718 1.207 . . . . 0.0 112.367 177.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -155.24 146.43 22.73 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.246 1.018 . . . . 0.0 111.547 177.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -130.15 149.64 51.77 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.367 1.067 . . . . 0.0 111.858 178.636 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -74.13 -164.16 0.23 Allowed 'General case' 0 CA--C 1.554 1.134 0 CA-C-N 118.249 0.477 . . . . 0.0 111.128 169.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -107.26 -21.46 12.94 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.935 1.294 . . . . 0.0 112.713 169.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.8 -40.26 58.35 Favored Glycine 0 C--N 1.342 0.915 0 O-C-N 121.678 -0.639 . . . . 0.0 112.585 -178.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -64.39 -31.41 72.61 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 123.966 0.906 . . . . 0.0 112.365 -178.357 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 36.1 t -60.63 -53.42 57.72 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.373 1.469 . . . . 0.0 110.939 176.018 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -70.61 -26.7 63.62 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.531 0.732 . . . . 0.0 112.765 178.031 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 27.4 tp -61.52 -38.35 87.05 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.324 1.05 . . . . 0.0 112.343 173.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 39.1 m -106.3 -35.93 7.01 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 114.686 1.365 . . . . 0.0 114.686 -171.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.83 10.21 55.46 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 125.68 1.61 . . . . 0.0 114.266 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -89.58 -147.89 0.18 Allowed 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 118.558 1.179 . . . . 0.0 111.728 170.545 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.9 m -161.59 161.07 29.61 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 126.042 1.737 . . . . 0.0 110.606 176.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -53.67 -43.72 69.09 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 121.561 -0.712 . . . . 0.0 111.582 178.222 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.11 -30.43 36.54 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 175.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -92.85 -36.81 12.63 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.001 1.32 . . . . 0.0 112.193 178.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 53.8 t -73.12 -21.15 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 125.829 1.651 . . . . 0.0 111.504 177.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 57.0 mmm -65.07 135.07 55.12 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 121.014 -1.054 . . . . 0.0 112.126 179.267 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.0 tp60 69.87 10.33 7.45 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 126.438 1.895 . . . . 0.0 113.577 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 36.4 mmt180 -83.49 151.24 61.78 Favored Pre-proline 0 N--CA 1.471 0.621 0 C-N-CA 124.261 1.024 . . . . 0.0 110.879 177.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.23 131.71 21.13 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.982 2.454 . . . . 0.0 108.758 167.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 22.3 p -67.54 -9.97 47.49 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -172.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 30.8 p -61.17 -26.35 67.65 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.194 1.398 . . . . 0.0 112.269 170.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 94.3 m 52.16 46.9 25.82 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.147 1.379 . . . . 0.0 112.777 175.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -59.23 -23.46 62.34 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.663 1.185 . . . . 0.0 112.867 -178.084 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -54.6 -25.65 27.79 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.733 1.613 . . . . 0.0 112.96 172.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 74.1 mt -78.36 -7.41 57.27 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 178.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 7.4 t60 -63.66 141.89 58.6 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.48 1.112 . . . . 0.0 112.258 175.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -148.39 -170.17 16.02 Favored Glycine 0 CA--C 1.537 1.434 0 C-N-CA 127.252 2.358 . . . . 0.0 111.857 176.236 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -64.11 -21.95 67.69 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 123.221 2.614 . . . . 0.0 113.848 -175.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.85 -6.9 50.79 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 176.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 26.7 m -74.96 142.18 43.96 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-N 119.959 1.254 . . . . 0.0 110.474 -174.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 69.0 mm-40 -100.74 124.96 47.1 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.17 0.988 . . . . 0.0 110.133 -170.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -61.47 -40.22 93.75 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.572 0.749 . . . . 0.0 112.797 -176.124 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 36.1 mmt180 -66.24 -36.04 81.98 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.454 0.701 . . . . 0.0 112.62 175.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.78 -43.73 68.13 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 119.176 0.898 . . . . 0.0 112.045 177.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -57.89 -32.17 67.46 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.17 0.588 . . . . 0.0 112.044 173.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -72.32 -49.76 31.99 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.637 1.175 . . . . 0.0 111.847 172.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 11.6 mm-40 -59.96 -34.37 73.18 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 118.914 0.779 . . . . 0.0 111.738 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 83.1 mt -61.89 -34.89 64.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 CA-C-N 120.034 1.288 . . . . 0.0 112.749 170.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.26 -41.34 63.76 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 119.648 1.113 . . . . 0.0 112.101 172.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -65.44 -28.75 69.46 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 121.29 -0.881 . . . . 0.0 112.095 175.283 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.66 -20.99 62.3 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 119.353 0.978 . . . . 0.0 113.116 172.084 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 32.1 mt -90.03 -11.67 40.82 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.79 1.636 . . . . 0.0 112.93 175.391 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 82.0 mt -93.1 -17.03 24.28 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.605 1.162 . . . . 0.0 111.891 171.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -87.04 144.32 19.3 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 125.165 1.364 . . . . 0.0 113.331 -176.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -87.2 -8.07 57.27 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.751 1.22 . . . . 0.0 113.738 174.417 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -119.78 161.14 21.27 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.593 1.957 . . . . 0.0 111.01 -177.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -61.76 141.86 57.63 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.458 1.103 . . . . 0.0 112.401 -175.239 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 71.3 mmt-85 -137.98 131.65 31.1 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.183 0.993 . . . . 0.0 112.529 174.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 38.8 mtmt -108.95 131.51 54.98 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.756 1.622 . . . . 0.0 110.075 169.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 57.3 t -134.26 134.7 54.97 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 125.032 1.333 . . . . 0.0 108.926 -178.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -100.91 131.9 46.57 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.096 0.959 . . . . 0.0 110.776 178.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 19.7 tt -155.46 145.5 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 124.141 0.976 . . . . 0.0 111.82 -169.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -86.38 118.21 25.67 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.101 -0.999 . . . . 0.0 110.682 173.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 11.4 m-30 -105.19 140.6 38.11 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.714 1.605 . . . . 0.0 111.677 175.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -94.01 149.71 20.99 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.312 1.445 . . . . 0.0 111.078 174.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -108.22 156.2 19.61 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 125.735 1.614 . . . . 0.0 112.422 -175.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -64.03 -23.59 67.39 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 113.302 0.852 . . . . 0.0 113.302 175.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -78.87 -6.24 55.59 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.854 1.262 . . . . 0.0 113.618 177.266 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 94.21 -2.07 68.06 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 125.453 1.501 . . . . 0.0 114.3 -177.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 50.7 m -83.06 176.08 9.51 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.737 1.215 . . . . 0.0 112.244 175.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 23.3 p -154.14 165.78 35.16 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 120.918 -1.114 . . . . 0.0 112.106 172.17 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -164.91 167.76 18.3 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.214 1.405 . . . . 0.0 113.287 176.52 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -82.09 122.21 27.56 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.73 0.812 . . . . 0.0 110.141 169.257 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 45.5 t -105.09 141.25 36.98 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.659 1.984 . . . . 0.0 109.977 173.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 11.3 tp -96.74 118.19 32.66 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.954 1.302 . . . . 0.0 107.716 162.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 65.4 t -100.83 115.63 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 124.835 1.254 . . . . 0.0 108.316 173.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -111.44 110.57 21.08 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 125.278 1.431 . . . . 0.0 107.305 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 34.7 t -97.15 122.01 48.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 73.2 t -106.53 114.67 61.77 Favored Pre-proline 0 CA--C 1.536 0.417 0 N-CA-C 107.653 -1.239 . . . . 0.0 107.653 -177.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -73.46 120.35 6.45 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 123.078 2.518 . . . . 0.0 109.575 179.082 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 98.3 t -95.15 118.4 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.299 0.639 . . . . 0.0 109.53 175.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 60.8 mttt -87.62 153.42 21.4 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.692 0.797 . . . . 0.0 112.468 171.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -91.4 -173.57 3.63 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.425 1.09 . . . . 0.0 111.584 175.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -60.66 -21.74 63.12 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.05 1.34 . . . . 0.0 114.37 178.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -91.0 -5.45 55.34 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.072 1.349 . . . . 0.0 113.003 178.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 80.94 22.09 61.99 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 124.327 0.965 . . . . 0.0 114.554 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -108.25 148.86 29.37 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.193 1.397 . . . . 0.0 109.99 172.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.7 p -80.23 126.77 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 123.837 0.855 . . . . 0.0 110.703 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -128.31 -23.82 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -173.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 62.6 mtm -132.01 155.51 47.89 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.467 1.507 . . . . 0.0 111.993 171.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -114.83 135.86 53.73 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 125.251 1.421 . . . . 0.0 109.27 167.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 50.9 mt -98.94 115.99 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 163.229 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 6.2 mp -96.26 117.8 31.52 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 174.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -110.04 131.72 54.8 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 119.366 -0.349 . . . . 0.0 111.252 -177.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 11.2 m-30 -106.84 139.61 40.98 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.954 1.302 . . . . 0.0 111.129 -177.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -144.42 135.34 25.07 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.189 1.396 . . . . 0.0 109.482 175.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 27.5 t -77.46 114.95 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 176.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.9 p -95.44 -24.94 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -176.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 42.8 tpp -164.7 125.33 2.04 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.075 1.35 . . . . 0.0 110.425 179.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -83.81 125.22 31.73 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.574 0.749 . . . . 0.0 110.341 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.32 0 CA-C-O 115.836 -2.031 . . . . 0.0 114.568 -177.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.3 mpp? . . . . . 0 N--CA 1.495 1.789 0 CA-C-O 118.719 -0.658 . . . . 0.0 110.772 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -74.57 157.45 44.58 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 123.67 2.914 . . . . 0.0 111.578 177.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 95.3 t -86.89 110.9 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 174.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 31.8 mmm180 -76.26 139.36 41.08 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.382 1.073 . . . . 0.0 111.159 177.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 9.5 ptp180 -165.13 157.33 15.53 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.873 1.669 . . . . 0.0 112.38 -178.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -107.03 -173.27 22.62 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 125.686 1.612 . . . . 0.0 112.34 168.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 51.7 m80 -83.45 159.16 21.82 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 123.769 0.828 . . . . 0.0 111.547 170.269 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.3 p -64.8 141.33 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 O-C-N 121.513 -0.742 . . . . 0.0 111.974 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -126.2 154.3 74.41 Favored Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 126.075 1.75 . . . . 0.0 110.994 177.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -65.0 126.1 15.9 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 123.141 2.56 . . . . 0.0 110.891 -179.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 20.9 mp0 -82.64 170.31 15.28 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.299 1.439 . . . . 0.0 110.938 178.052 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 16.0 p30 -72.12 147.88 46.25 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 121.137 -0.977 . . . . 0.0 110.661 169.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 38.0 p -120.87 -41.24 2.57 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 125.4 1.48 . . . . 0.0 112.141 -174.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -71.04 -56.05 6.96 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 123.922 0.889 . . . . 0.0 111.136 174.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 65.7 tp -57.84 -34.14 69.39 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.607 1.163 . . . . 0.0 111.49 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -60.64 -25.41 66.29 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 176.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 84.9 m -82.93 -33.0 26.9 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.728 1.211 . . . . 0.0 110.852 172.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 26.7 mm -73.05 -38.22 55.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 123.734 0.814 . . . . 0.0 111.496 178.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 54.9 mt -53.81 -38.56 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 123.857 0.863 . . . . 0.0 111.193 176.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 56.2 mtt180 -61.8 -26.2 67.95 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.488 1.115 . . . . 0.0 112.892 178.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -74.84 -38.56 61.97 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.805 1.242 . . . . 0.0 111.339 174.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -81.18 -21.63 39.53 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.245 1.418 . . . . 0.0 113.714 177.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -62.3 -29.48 70.46 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.806 0.842 . . . . 0.0 112.556 173.262 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 111.97 92.75 2.09 Favored Glycine 0 C--N 1.341 0.843 0 C-N-CA 125.474 1.511 . . . . 0.0 111.288 171.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 61.43 37.69 16.52 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.335 1.454 . . . . 0.0 112.354 166.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 17.4 t -71.78 -25.2 61.92 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -173.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.8 mpp_? -74.63 156.64 36.51 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 122.225 1.012 . . . . 0.0 111.026 174.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.04 140.09 29.98 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.054 0.942 . . . . 0.0 111.058 -176.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -162.79 156.99 20.92 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.555 1.142 . . . . 0.0 113.279 178.141 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.4 pt -141.34 150.35 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 126.318 1.847 . . . . 0.0 110.439 176.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 16.9 mt -109.67 134.96 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 125.699 1.6 . . . . 0.0 108.444 177.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -130.82 148.25 52.57 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 125.022 1.329 . . . . 0.0 111.09 177.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 15.4 m-20 -67.06 127.89 34.28 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 170.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.74 -30.55 59.24 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 121.864 -0.522 . . . . 0.0 112.355 172.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 64.8 mtm180 -80.68 44.49 0.73 Allowed 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.878 1.671 . . . . 0.0 112.992 -172.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.8 p -162.05 138.62 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 126.448 1.899 . . . . 0.0 110.0 -179.303 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -58.17 -40.99 82.88 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.168 0.987 . . . . 0.0 112.971 -172.121 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 24.1 p30 -77.77 -19.47 55.05 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 96.5 m 51.51 57.82 6.16 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.502 1.121 . . . . 0.0 112.43 -172.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.23 141.23 57.67 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.526 1.13 . . . . 0.0 113.098 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 61.8 t -63.75 124.71 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 124.018 0.927 . . . . 0.0 109.847 173.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 45.3 pt -103.51 -20.23 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 125.034 1.334 . . . . 0.0 112.315 172.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 15.1 t80 -155.62 150.61 26.55 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.057 0.943 . . . . 0.0 112.141 177.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 11.2 p -146.75 154.73 41.74 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 120.953 -1.092 . . . . 0.0 113.002 178.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 31.8 t-20 -74.14 -158.52 0.07 Allowed 'General case' 0 CA--C 1.56 1.339 0 C-N-CA 123.225 0.61 . . . . 0.0 112.167 -178.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -111.75 -18.37 12.75 Favored 'General case' 0 N--CA 1.48 1.04 0 O-C-N 120.249 -1.532 . . . . 0.0 112.966 166.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -75.6 -33.21 52.79 Favored Glycine 0 N--CA 1.47 0.911 0 C-N-CA 124.391 0.996 . . . . 0.0 112.632 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -65.47 -36.26 83.35 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.122 0.969 . . . . 0.0 110.989 -178.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 8.1 t -52.21 -47.19 65.76 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.48 1.512 . . . . 0.0 111.859 170.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -76.74 -21.75 54.79 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -178.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 51.9 tp -66.32 -53.84 31.73 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.95 0.9 . . . . 0.0 111.356 174.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 79.9 m -102.48 -17.43 15.79 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -172.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 87.1 6.38 78.96 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.985 1.279 . . . . 0.0 114.167 176.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -86.29 -153.61 0.2 Allowed 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.969 1.308 . . . . 0.0 111.81 171.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 12.0 t -162.8 170.1 18.82 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 120.562 -1.336 . . . . 0.0 111.521 176.185 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 44.5 ttm180 -53.36 -45.83 69.33 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.417 1.087 . . . . 0.0 111.257 178.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.0 -26.66 49.59 Favored 'General case' 0 CA--C 1.551 0.993 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 176.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -93.99 -38.34 11.22 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.991 1.316 . . . . 0.0 112.268 179.088 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 51.2 t -86.2 -11.15 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 125.07 1.348 . . . . 0.0 112.297 -177.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 20.0 mmt -65.28 135.44 55.36 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 120.395 -1.441 . . . . 0.0 111.242 168.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.8 tm0? 70.98 8.16 6.43 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 126.298 1.839 . . . . 0.0 113.198 -177.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 37.7 mmt180 -88.88 152.17 48.28 Favored Pre-proline 0 N--CA 1.472 0.673 0 C-N-CA 124.484 1.113 . . . . 0.0 110.837 175.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -70.1 136.04 31.11 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 123.203 2.602 . . . . 0.0 109.404 171.047 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 30.8 p -68.07 -3.57 10.7 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 -179.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 52.6 p -61.53 -30.99 70.99 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.575 1.15 . . . . 0.0 111.665 166.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 81.8 m 50.62 38.27 18.51 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.633 1.573 . . . . 0.0 112.77 -177.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -58.2 -30.02 66.13 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.641 1.176 . . . . 0.0 112.418 -176.052 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -59.56 -14.51 13.48 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.04 1.336 . . . . 0.0 114.121 175.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 99.4 mt -75.38 -4.64 40.58 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.369 1.068 . . . . 0.0 113.721 171.252 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 13.5 p-80 -63.61 140.53 58.88 Favored 'General case' 0 CA--C 1.548 0.888 0 CA-C-N 120.194 1.361 . . . . 0.0 112.911 175.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -115.18 -164.87 14.54 Favored Glycine 0 CA--C 1.539 1.562 0 C-N-CA 125.988 1.756 . . . . 0.0 111.144 165.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -68.96 -21.72 36.88 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.952 2.435 . . . . 0.0 113.008 175.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 83.4 mtt85 -89.28 -9.56 50.16 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.483 1.113 . . . . 0.0 113.869 -178.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 56.7 m -68.91 136.73 53.05 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.756 1.222 . . . . 0.0 111.272 -173.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 21.5 mp0 -83.7 118.63 24.0 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.808 1.243 . . . . 0.0 109.475 -174.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -63.7 -37.72 88.4 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 121.639 -0.663 . . . . 0.0 112.408 -173.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -64.02 -38.05 89.64 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.414 0.686 . . . . 0.0 112.374 173.155 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.13 -44.25 69.29 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.308 0.958 . . . . 0.0 111.849 177.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.59 -35.47 65.84 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.145 0.578 . . . . 0.0 112.002 173.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.14 -44.99 64.46 Favored 'General case' 0 C--O 1.224 -0.243 0 C-N-CA 124.303 1.041 . . . . 0.0 112.636 172.308 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.41 ' HB2' HG21 ' A' ' 94' ' ' VAL . 15.6 mm-40 -59.91 -30.83 69.29 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 117.719 -1.134 . . . . 0.0 112.465 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 69.0 mt -59.43 -48.94 85.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 CA-C-N 120.622 1.555 . . . . 0.0 110.773 169.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.41 -37.24 74.43 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.838 0.855 . . . . 0.0 112.824 -178.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 77.5 mm-40 -70.92 -31.38 67.98 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.168 0.987 . . . . 0.0 111.518 175.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -59.58 -31.74 69.73 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 119.464 1.029 . . . . 0.0 112.636 177.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 56.7 mt -68.17 -15.63 63.66 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.386 1.475 . . . . 0.0 113.12 177.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 61.3 mt -83.39 -15.74 48.65 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.041 0.936 . . . . 0.0 112.446 174.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -93.32 153.18 21.25 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 125.377 1.465 . . . . 0.0 113.115 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -97.21 5.7 49.64 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.025 1.33 . . . . 0.0 113.742 177.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.61 159.72 25.86 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.82 1.648 . . . . 0.0 111.416 -179.106 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -61.21 141.19 57.68 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.753 1.621 . . . . 0.0 112.239 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.48 121.75 8.39 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.058 0.943 . . . . 0.0 111.514 -168.215 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 37.8 mtmt -106.3 137.34 44.43 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.852 1.261 . . . . 0.0 112.107 172.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.41 HG21 ' HB2' ' A' ' 81' ' ' GLN . 8.3 p -132.16 135.85 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 127.298 2.239 . . . . 0.0 110.136 171.353 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -101.99 133.74 46.31 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.399 1.48 . . . . 0.0 110.164 176.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 19.1 tt -159.99 144.71 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 124.202 1.001 . . . . 0.0 111.904 -163.313 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -82.21 121.64 26.89 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 120.911 -1.118 . . . . 0.0 111.872 173.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 11.2 m-30 -103.01 149.9 24.09 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.155 1.782 . . . . 0.0 111.412 172.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -106.28 136.12 46.56 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.299 1.84 . . . . 0.0 111.344 175.093 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 46.4 ttp180 -99.89 148.98 23.87 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 126.138 1.775 . . . . 0.0 111.3 -176.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -59.13 -22.14 60.4 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 177.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -73.58 -6.63 47.83 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.311 1.444 . . . . 0.0 113.732 174.101 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 95.95 -1.67 63.4 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 125.955 1.74 . . . . 0.0 113.86 -176.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -80.16 169.47 17.76 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.373 1.469 . . . . 0.0 112.823 -178.462 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 28.6 p -147.63 158.04 43.83 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.149 -0.969 . . . . 0.0 112.457 168.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -162.89 156.12 19.66 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.787 1.235 . . . . 0.0 111.531 -174.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -75.66 124.1 26.67 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 123.076 0.55 . . . . 0.0 110.162 168.164 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 12.8 t -111.61 146.51 37.27 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.708 2.003 . . . . 0.0 109.82 173.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 20.0 tp -96.33 124.95 40.51 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 125.514 1.526 . . . . 0.0 108.106 163.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 47.1 t -105.77 121.35 57.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 169.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -114.96 116.06 27.88 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.59 1.556 . . . . 0.0 109.101 173.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.1 p -89.77 125.84 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-O 121.066 0.46 . . . . 0.0 109.897 169.302 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 88.8 t -109.39 108.54 60.08 Favored Pre-proline 0 CA--C 1.536 0.414 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 174.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.85 126.46 10.71 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.666 2.244 . . . . 0.0 109.462 177.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 52.3 t -96.64 123.26 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 177.098 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 20.4 mtpt -94.03 149.88 20.84 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.554 0.692 . . . . 0.0 112.269 174.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 54.7 p30 -79.29 -173.64 3.76 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.65 1.18 . . . . 0.0 111.682 174.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -67.27 -15.55 63.76 Favored 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 114.614 1.338 . . . . 0.0 114.614 175.219 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -96.65 -18.1 19.93 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.812 1.245 . . . . 0.0 113.206 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 85.96 42.85 6.57 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 125.911 1.719 . . . . 0.0 113.563 -173.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -116.27 154.37 30.27 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.277 1.431 . . . . 0.0 110.145 160.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 49.5 t -80.67 125.8 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 178.022 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.02 -27.03 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -177.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 61.5 mtm -131.42 153.25 49.9 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.784 1.234 . . . . 0.0 112.359 170.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -111.44 137.04 49.76 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 125.303 1.441 . . . . 0.0 109.063 166.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 48.2 mt -104.4 119.09 52.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 163.277 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -101.23 124.7 47.34 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 173.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -116.14 124.53 50.56 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 124.331 1.053 . . . . 0.0 109.346 -176.39 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -102.88 143.84 31.96 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.16 1.384 . . . . 0.0 110.571 -178.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.39 128.9 11.4 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.616 0.766 . . . . 0.0 110.361 171.556 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.4 p -72.69 116.08 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 O-C-N 121.383 -0.823 . . . . 0.0 109.771 175.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.2 p -94.24 -27.6 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 124.767 1.227 . . . . 0.0 112.759 -175.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 25.4 ptp -162.3 147.02 12.39 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.411 1.085 . . . . 0.0 112.618 166.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -89.99 131.49 35.86 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.794 0.838 . . . . 0.0 110.311 178.145 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.253 1.258 0 N-CA-C 115.492 1.664 . . . . 0.0 115.492 -175.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 pmm? . . . . . 0 N--CA 1.497 1.879 0 CA-C-O 118.778 -0.63 . . . . 0.0 111.511 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -78.7 91.64 1.19 Allowed 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 123.324 2.683 . . . . 0.0 111.064 -177.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 35.3 m -141.13 152.64 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 124.931 1.292 . . . . 0.0 111.778 177.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 76.7 mtp85 -62.7 136.3 57.8 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.796 1.239 . . . . 0.0 111.857 177.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 33.6 ptt-85 -170.37 152.27 3.99 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 126.518 1.927 . . . . 0.0 111.903 -176.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.87 117.22 5.8 Favored Glycine 0 N--CA 1.472 1.096 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 168.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 22.9 t-80 -63.24 -45.56 91.02 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 117.978 0.889 . . . . 0.0 113.11 -170.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.3 p -167.23 141.59 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 125.007 1.323 . . . . 0.0 111.122 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -85.57 145.27 41.62 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 123.751 0.82 . . . . 0.0 110.46 167.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -67.26 158.31 57.59 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.771 2.314 . . . . 0.0 111.656 -179.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -151.22 158.74 44.3 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.717 1.207 . . . . 0.0 111.753 -173.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -80.82 59.7 3.8 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.994 1.718 . . . . 0.0 113.853 -171.488 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 42.2 p -49.82 -36.46 26.64 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 127.231 2.212 . . . . 0.0 113.969 -176.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -65.79 -50.01 66.23 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.671 0.788 . . . . 0.0 111.838 176.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 61.9 tp -64.9 -36.05 83.1 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.58 1.152 . . . . 0.0 111.299 176.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -59.96 -30.55 69.17 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.75 0.82 . . . . 0.0 112.638 177.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 44.4 m -71.6 -24.12 61.84 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.803 1.241 . . . . 0.0 111.48 173.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 11.1 mm -83.93 -43.97 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.216 1.007 . . . . 0.0 110.434 173.347 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 97.5 mt -54.31 -47.35 69.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.669 0.787 . . . . 0.0 110.531 177.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 32.9 ptt180 -69.7 -12.22 61.46 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -178.185 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -83.19 -34.43 25.95 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.441 1.096 . . . . 0.0 112.045 170.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -78.58 -33.77 47.4 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.257 1.023 . . . . 0.0 112.321 173.006 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -72.32 141.39 48.83 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.428 0.691 . . . . 0.0 111.94 173.04 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -99.54 -6.72 54.73 Favored Glycine 0 N--CA 1.476 1.317 0 C-N-CA 124.728 1.156 . . . . 0.0 114.114 172.112 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -89.77 63.28 6.06 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.174 1.39 . . . . 0.0 110.641 -172.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.6 t -77.02 40.98 0.27 Allowed 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 125.27 1.428 . . . . 0.0 112.858 178.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 12.0 mpt_? -91.62 -163.85 1.1 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 128.596 2.759 . . . . 0.0 110.363 177.382 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.0 mptt -86.2 132.65 33.96 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.102 1.361 . . . . 0.0 110.099 -178.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -163.14 164.24 25.38 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.258 1.023 . . . . 0.0 113.689 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 30.3 pt -144.37 154.53 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 126.736 2.014 . . . . 0.0 110.508 177.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 14.8 mt -120.0 130.71 73.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 125.907 1.683 . . . . 0.0 109.394 -178.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -130.49 145.26 51.82 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 124.485 1.114 . . . . 0.0 111.437 176.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -70.58 125.53 27.07 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 122.043 -0.41 . . . . 0.0 111.159 176.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.58 -29.82 66.35 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -177.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 56.3 mtm180 -80.03 36.66 0.35 Allowed 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.64 1.576 . . . . 0.0 112.86 -172.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 60.5 t -145.62 135.51 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 126.839 2.056 . . . . 0.0 108.87 -169.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -59.13 -45.08 91.87 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.14 0.976 . . . . 0.0 112.726 -174.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -82.79 -12.72 57.26 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 90.9 m 48.65 62.96 2.3 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.375 1.47 . . . . 0.0 111.283 -167.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.81 136.26 55.18 Favored 'General case' 0 CA--C 1.547 0.843 0 O-C-N 121.514 -0.741 . . . . 0.0 111.869 -177.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.2 t -64.23 126.43 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 122.996 0.518 . . . . 0.0 109.873 176.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.1 pt -104.35 -23.16 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.586 1.154 . . . . 0.0 112.49 174.536 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -147.41 140.65 25.25 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.534 0.733 . . . . 0.0 111.349 178.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.516 ' HB3' ' CE1' ' A' ' 48' ' ' PHE . 2.0 m -131.59 147.62 52.54 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.097 0.959 . . . . 0.0 111.558 -177.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -78.33 -173.24 3.19 Favored 'General case' 0 CA--C 1.554 1.118 0 CA-C-N 119.255 0.934 . . . . 0.0 111.752 172.365 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -98.71 -22.72 15.75 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.027 1.331 . . . . 0.0 112.353 171.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -73.37 -39.53 50.9 Favored Glycine 0 C--N 1.342 0.873 0 O-C-N 121.815 -0.553 . . . . 0.0 112.455 -177.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.516 ' CE1' ' HB3' ' A' ' 44' ' ' CYS . 0.4 OUTLIER -66.07 -32.32 73.72 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.256 0.623 . . . . 0.0 111.854 -179.345 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 91.2 m -51.29 -55.31 18.93 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.252 1.421 . . . . 0.0 111.587 174.363 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -71.75 -22.33 61.62 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.876 0.871 . . . . 0.0 113.032 -179.259 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.16 -52.68 62.87 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.11 1.364 . . . . 0.0 110.873 178.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 76.8 m -98.68 -21.2 16.55 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.51 2.23 58.84 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 125.035 1.302 . . . . 0.0 114.355 179.07 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -85.81 -152.43 0.16 Allowed 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 124.607 1.163 . . . . 0.0 112.102 171.072 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 80.8 p -157.11 168.87 26.17 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 120.478 -1.389 . . . . 0.0 111.928 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -52.07 -51.65 56.24 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 119.1 -0.476 . . . . 0.0 110.48 168.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.28 -32.45 56.29 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 119.39 0.996 . . . . 0.0 113.52 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -86.4 -39.42 16.4 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.009 0.924 . . . . 0.0 113.295 177.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 79.5 t -80.46 -12.75 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 124.674 1.189 . . . . 0.0 111.639 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 66.1 mmm -66.27 137.1 56.71 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 120.522 -1.361 . . . . 0.0 111.261 173.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 76.43 4.71 3.6 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 127.064 2.145 . . . . 0.0 113.531 -176.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 42.7 mtt180 -92.42 156.21 41.7 Favored Pre-proline 0 N--CA 1.476 0.851 0 C-N-CA 124.257 1.023 . . . . 0.0 112.412 -179.335 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -67.57 134.91 34.4 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.697 2.931 . . . . 0.0 110.585 170.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 5.1 t -66.97 -18.6 65.46 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -173.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 39.7 p -56.2 -30.05 61.76 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.304 1.442 . . . . 0.0 112.458 172.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 79.1 m 54.05 36.94 25.85 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.25 1.42 . . . . 0.0 112.357 -176.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -57.1 -30.64 64.53 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.85 1.26 . . . . 0.0 112.462 -176.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -58.8 -15.31 11.72 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.912 1.285 . . . . 0.0 114.193 175.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.2 mt -75.21 -6.2 48.46 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.579 1.152 . . . . 0.0 113.694 172.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -65.83 147.81 52.78 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 119.988 1.267 . . . . 0.0 112.492 173.5 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -125.97 -155.31 8.93 Favored Glycine 0 CA--C 1.537 1.447 0 C-N-CA 125.7 1.619 . . . . 0.0 111.071 165.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.25 -26.91 17.12 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 123.116 2.544 . . . . 0.0 113.712 179.104 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 53.7 ttm-85 -87.4 -15.35 38.04 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 119.327 0.967 . . . . 0.0 113.1 -177.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 19.8 m -65.07 134.66 54.3 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.311 1.444 . . . . 0.0 110.926 -176.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.438 ' HG3' ' CB ' ' A' ' 78' ' ' ALA . 5.9 pt20 -87.31 125.61 34.34 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -176.332 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 18.5 tpp85 -60.36 -35.24 75.22 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.206 1.003 . . . . 0.0 112.447 -178.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 24.6 tpp180 -60.23 -46.44 89.76 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.368 1.067 . . . . 0.0 111.715 174.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.438 ' CB ' ' HG3' ' A' ' 75' ' ' GLN . . . -69.46 -42.6 74.68 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 121.043 -1.036 . . . . 0.0 111.981 176.205 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.13 -35.03 64.25 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 173.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -74.67 -44.84 48.25 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.331 1.452 . . . . 0.0 112.999 173.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -59.16 -34.69 72.39 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 118.868 0.758 . . . . 0.0 111.538 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 86.6 mt -62.19 -37.44 78.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 CA-C-N 119.969 1.259 . . . . 0.0 112.198 172.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.8 -39.88 69.58 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 119.1 0.863 . . . . 0.0 112.143 174.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -64.88 -32.43 74.13 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.598 0.759 . . . . 0.0 111.867 175.19 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.47 -23.15 65.68 Favored 'General case' 0 CA--C 1.548 0.88 0 O-C-N 121.367 -0.833 . . . . 0.0 112.903 176.536 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 27.9 mt -85.94 -14.29 45.15 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.112 1.365 . . . . 0.0 113.258 174.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 80.8 mt -88.92 -17.59 29.24 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.139 0.976 . . . . 0.0 111.822 171.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -83.85 152.0 28.17 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 125.3 1.428 . . . . 0.0 112.696 175.321 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -99.51 11.69 38.46 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.905 1.282 . . . . 0.0 113.857 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -137.71 163.67 30.73 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.963 1.705 . . . . 0.0 111.834 -175.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.97 137.87 57.98 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.282 1.033 . . . . 0.0 111.767 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.69 124.97 10.85 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.297 1.039 . . . . 0.0 111.239 -175.579 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 43.3 mtmt -100.85 140.78 34.66 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.206 1.402 . . . . 0.0 112.271 171.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 46.2 t -136.44 136.56 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 126.094 1.758 . . . . 0.0 108.526 175.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -102.86 128.78 49.5 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.983 0.913 . . . . 0.0 110.647 178.41 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.2 tt -151.81 149.28 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.21 1.004 . . . . 0.0 112.207 -168.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -84.29 116.74 23.15 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 120.899 -1.125 . . . . 0.0 111.496 173.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 9.7 m-30 -103.08 140.9 36.71 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.419 1.488 . . . . 0.0 111.055 174.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -105.1 133.12 50.41 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.454 1.502 . . . . 0.0 111.813 178.01 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 73.9 mtp85 -77.37 163.16 26.67 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.667 1.587 . . . . 0.0 112.267 175.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -65.21 -23.65 67.14 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.722 1.209 . . . . 0.0 113.336 173.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -77.72 -7.7 56.9 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.841 1.257 . . . . 0.0 113.598 174.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 94.11 -1.83 68.05 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 125.425 1.488 . . . . 0.0 114.574 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 48.7 m -80.09 167.77 19.99 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 118.335 1.067 . . . . 0.0 111.756 175.012 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 20.5 p -148.35 170.33 18.19 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 120.886 -1.134 . . . . 0.0 113.399 176.166 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -170.21 166.52 8.86 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 126.258 1.823 . . . . 0.0 111.255 -178.437 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -79.35 123.0 27.07 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.16 0.505 . . . . 0.0 111.103 170.026 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 6.0 m -106.84 136.46 46.63 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.051 1.74 . . . . 0.0 110.1 168.211 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 19.0 tp -86.47 123.18 31.4 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 125.033 1.333 . . . . 0.0 107.602 162.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 91.6 t -103.61 117.94 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 169.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -112.16 107.11 15.89 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 126.462 1.905 . . . . 0.0 108.54 177.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 69.7 t -80.67 125.65 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 172.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 45.0 t -109.06 110.62 60.72 Favored Pre-proline 0 C--N 1.328 -0.359 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 169.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.41 132.79 16.68 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.559 2.172 . . . . 0.0 109.546 176.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 73.1 t -99.91 120.75 49.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 172.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 68.9 mttt -92.94 154.99 17.85 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.651 0.78 . . . . 0.0 112.698 171.161 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -93.66 -173.64 3.23 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.105 0.962 . . . . 0.0 111.641 174.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -61.04 -22.01 64.16 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.015 1.326 . . . . 0.0 114.152 178.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -90.3 -5.4 56.32 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.783 1.233 . . . . 0.0 113.043 178.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 79.32 20.62 69.06 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 124.455 1.026 . . . . 0.0 114.388 -178.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -99.63 146.21 26.72 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.94 1.296 . . . . 0.0 109.621 173.071 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 61.5 t -76.79 125.34 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 177.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 3.0 pt -121.28 -21.79 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 C-N-CA 124.905 1.282 . . . . 0.0 113.981 -172.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 44.7 mtm -145.52 151.35 38.01 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.72 1.608 . . . . 0.0 110.478 177.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -114.33 129.61 56.65 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 124.595 1.158 . . . . 0.0 109.084 169.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 33.5 mt -99.09 117.45 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 165.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -94.91 117.4 30.07 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 174.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -104.32 127.09 51.91 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 123.259 0.349 . . . . 0.0 111.476 176.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 13.7 m-30 -102.93 134.65 46.0 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.372 1.469 . . . . 0.0 111.146 -179.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -141.83 112.33 7.1 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.71 1.204 . . . . 0.0 109.092 176.193 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.7 p -64.46 112.7 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 O-C-N 121.186 -0.946 . . . . 0.0 109.399 173.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.0 p -98.83 -26.61 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.511 1.524 . . . . 0.0 112.954 -167.41 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 24.3 ptp -161.14 154.26 21.3 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.879 1.272 . . . . 0.0 111.241 166.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -77.12 156.48 31.63 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 122.126 0.965 . . . . 0.0 111.713 175.062 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.455 ' HA ' ' HE3' ' A' ' 135' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.288 0 C-N-CA 125.743 1.617 . . . . 0.0 112.822 161.377 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.496 1.869 0 CA-C-O 118.874 -0.584 . . . . 0.0 110.992 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -73.67 173.57 13.69 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 123.829 3.019 . . . . 0.0 111.748 173.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 8.5 p -152.39 128.33 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 123.751 0.82 . . . . 0.0 111.252 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 7.3 ppt_? -85.96 -23.29 26.97 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 114.252 1.204 . . . . 0.0 114.252 -175.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 81.8 mtp180 -74.37 142.83 45.04 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.633 1.173 . . . . 0.0 111.595 -178.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -164.9 159.8 32.93 Favored Glycine 0 N--CA 1.47 0.96 0 C-N-CA 124.753 1.168 . . . . 0.0 113.5 178.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 65.4 t60 -160.03 147.99 16.81 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.627 1.571 . . . . 0.0 110.6 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.9 p -165.14 146.09 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 125.557 1.543 . . . . 0.0 110.157 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.25 147.37 98.63 Favored Pre-proline 0 CA--C 1.553 1.082 0 C-N-CA 123.405 0.682 . . . . 0.0 111.646 174.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -67.12 128.88 19.37 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.025 2.484 . . . . 0.0 110.58 -178.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 27.2 mp0 -81.45 155.75 25.7 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.286 1.034 . . . . 0.0 111.742 -176.307 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -79.77 47.75 0.88 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.292 1.437 . . . . 0.0 113.509 179.158 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 46.6 p -50.15 -35.76 27.36 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 127.882 2.473 . . . . 0.0 114.398 -171.002 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -64.49 -50.73 66.3 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.517 0.727 . . . . 0.0 111.491 176.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 60.8 tp -65.59 -37.97 88.16 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.56 1.144 . . . . 0.0 111.312 175.019 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -61.34 -29.03 69.64 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.153 0.981 . . . . 0.0 112.409 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 29.3 m -71.25 -25.65 62.56 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.823 1.249 . . . . 0.0 111.455 173.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.8 mm -82.38 -43.14 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.932 0.893 . . . . 0.0 110.252 173.047 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 97.0 mt -56.22 -44.25 78.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 123.628 0.771 . . . . 0.0 110.804 177.001 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 49.9 ptt85 -70.73 -19.64 62.72 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -78.47 -36.88 44.64 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.036 0.934 . . . . 0.0 111.766 169.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -79.53 -37.32 36.83 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.731 1.212 . . . . 0.0 112.525 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.44 ' HG3' ' H ' ' A' ' 25' ' ' GLN . 10.7 pt-20 -87.11 158.23 19.22 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -171.648 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -94.72 13.74 66.62 Favored Glycine 0 N--CA 1.477 1.408 0 C-N-CA 125.554 1.549 . . . . 0.0 114.637 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.44 ' H ' ' HG3' ' A' ' 23' ' ' GLU . 56.8 mm-40 -83.49 55.02 3.03 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.447 1.499 . . . . 0.0 111.441 -175.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.1 m -70.69 -3.69 19.82 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.041 1.336 . . . . 0.0 114.189 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -79.59 170.12 17.02 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.226 1.411 . . . . 0.0 111.705 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.5 mptt -90.99 137.22 32.53 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.388 1.075 . . . . 0.0 111.133 -174.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -165.16 162.59 20.15 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.01 1.324 . . . . 0.0 113.329 175.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 14.7 pt -142.18 152.4 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 126.295 1.838 . . . . 0.0 110.662 174.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 11.8 mt -108.61 130.46 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 125.973 1.709 . . . . 0.0 108.977 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -129.0 142.27 50.97 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 124.98 1.312 . . . . 0.0 110.975 177.38 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -70.36 125.7 27.54 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.75 -0.593 . . . . 0.0 111.087 177.108 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.39 -31.86 64.13 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.545 0.738 . . . . 0.0 112.355 -178.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 27.7 mmm180 -80.46 37.29 0.39 Allowed 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.922 1.689 . . . . 0.0 112.682 -174.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 98.4 t -143.93 134.78 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 126.911 2.084 . . . . 0.0 108.719 -172.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -56.13 -35.11 66.74 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 115.324 1.602 . . . . 0.0 115.324 -170.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -105.77 -2.33 23.32 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.287 1.435 . . . . 0.0 113.091 -178.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 89.6 m 50.43 68.78 0.71 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 126.074 1.75 . . . . 0.0 112.303 -174.307 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.22 137.94 57.33 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.04 0.936 . . . . 0.0 112.111 -178.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 37.1 t -65.21 123.75 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 123.587 0.755 . . . . 0.0 109.354 174.064 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 44.8 pt -103.92 -19.59 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 125.125 1.37 . . . . 0.0 112.52 176.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -156.42 145.64 20.53 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.233 1.013 . . . . 0.0 111.658 178.156 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 4.7 m -125.7 158.53 34.59 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.359 1.064 . . . . 0.0 112.341 176.231 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -74.87 -152.37 0.03 OUTLIER 'General case' 0 CA--C 1.559 1.306 0 CA-C-N 118.524 0.602 . . . . 0.0 111.167 166.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -115.05 -21.55 9.97 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.325 1.45 . . . . 0.0 113.215 165.136 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -74.85 -35.21 51.14 Favored Glycine 0 N--CA 1.471 1.012 0 C-N-CA 124.12 0.867 . . . . 0.0 112.813 -178.052 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -58.03 -37.31 74.12 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 124.837 1.255 . . . . 0.0 111.861 177.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 38.4 t -58.91 -52.0 67.61 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.405 1.482 . . . . 0.0 111.499 174.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -70.68 -25.97 63.22 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -179.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 38.6 tp -62.87 -40.54 97.83 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.376 1.07 . . . . 0.0 111.973 172.054 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 50.2 m -106.73 -32.08 8.14 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 115.054 1.502 . . . . 0.0 115.054 -168.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.61 9.51 66.46 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 125.932 1.729 . . . . 0.0 114.437 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -86.17 -144.85 0.11 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 124.609 1.164 . . . . 0.0 111.591 170.17 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 13.3 t -163.6 167.06 21.75 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.986 1.314 . . . . 0.0 111.065 169.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -54.65 -44.24 73.07 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.582 0.753 . . . . 0.0 110.801 176.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.23 -28.03 50.33 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 176.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -91.18 -39.18 12.26 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.982 1.313 . . . . 0.0 111.83 177.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 99.5 t -80.27 -17.6 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 125.671 1.588 . . . . 0.0 112.295 -177.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 80.9 mtp -61.55 133.13 55.32 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 120.85 -1.156 . . . . 0.0 111.309 170.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 23.7 tp60 74.05 3.67 4.45 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 127.08 2.152 . . . . 0.0 113.731 -178.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 33.2 mmt180 -84.55 151.46 58.82 Favored Pre-proline 0 N--CA 1.473 0.686 0 O-C-N 121.016 -1.052 . . . . 0.0 110.934 178.054 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.83 132.98 24.34 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.526 2.151 . . . . 0.0 109.598 169.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 32.0 p -66.76 -7.55 22.02 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 -176.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 41.3 p -59.7 -27.1 66.15 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.353 1.461 . . . . 0.0 112.536 168.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 67.5 m 57.23 40.56 27.88 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.022 1.329 . . . . 0.0 112.707 178.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -56.51 -29.77 62.22 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.361 1.464 . . . . 0.0 113.006 -175.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 29.2 p90 -62.26 -16.8 55.99 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.806 1.242 . . . . 0.0 114.107 175.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 87.8 mt -79.08 -10.42 59.82 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 174.263 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -69.44 118.78 12.74 Favored 'General case' 0 CA--C 1.546 0.827 0 CA-C-N 119.597 1.09 . . . . 0.0 111.402 -177.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -100.98 -163.14 27.75 Favored Glycine 0 CA--C 1.539 1.556 0 C-N-CA 126.166 1.841 . . . . 0.0 112.129 173.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -70.58 -28.41 21.34 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 123.153 2.569 . . . . 0.0 113.149 -179.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 30.4 tpt180 -84.61 -17.35 38.98 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 50.6 m -60.43 132.55 54.25 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.95 1.3 . . . . 0.0 111.876 -170.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 22.9 mp0 -85.26 111.59 19.99 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.546 1.138 . . . . 0.0 110.404 -171.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 -58.24 -33.86 69.81 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.59 0.756 . . . . 0.0 112.463 177.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 21.5 tpp180 -62.03 -39.91 93.93 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.591 1.157 . . . . 0.0 112.244 175.282 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -77.01 -41.46 42.64 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.526 1.13 . . . . 0.0 112.31 176.151 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -53.15 -33.36 52.12 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 118.842 0.747 . . . . 0.0 112.797 175.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.01 -41.3 82.4 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 124.969 1.308 . . . . 0.0 112.712 172.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 80.3 mm-40 -64.38 -32.6 74.28 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 118.507 -0.758 . . . . 0.0 111.48 178.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 45.9 mt -59.33 -41.35 83.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 CA-C-N 119.56 1.073 . . . . 0.0 110.586 170.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.16 -35.08 68.93 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 176.085 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 71.6 mm-40 -64.66 -35.58 81.49 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.439 -0.788 . . . . 0.0 111.446 172.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.15 -21.35 63.69 Favored 'General case' 0 CA--C 1.549 0.922 0 O-C-N 121.383 -0.823 . . . . 0.0 113.189 178.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 57.6 mt -87.9 -11.14 48.55 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 125.925 1.69 . . . . 0.0 114.009 178.182 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.7 pp -103.94 -2.73 25.7 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 170.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -90.3 144.22 17.38 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 125.039 1.305 . . . . 0.0 112.564 175.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.9 -2.12 58.12 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.7 1.2 . . . . 0.0 113.931 176.186 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -124.09 159.27 30.34 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.035 1.734 . . . . 0.0 110.739 -174.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 46.4 mp0 -57.28 135.88 56.49 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.522 1.129 . . . . 0.0 111.708 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.58 121.23 11.83 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.229 1.011 . . . . 0.0 110.322 -173.606 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt -105.05 142.81 34.17 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.358 1.463 . . . . 0.0 111.7 178.232 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 61.8 t -138.29 131.74 41.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 125.858 1.663 . . . . 0.0 108.91 -177.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -103.88 129.76 51.41 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.682 0.793 . . . . 0.0 110.811 177.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.3 tt -159.78 142.75 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 123.553 0.741 . . . . 0.0 112.149 -166.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -86.38 121.73 29.35 Favored 'General case' 0 N--CA 1.465 0.303 0 O-C-N 121.405 -0.809 . . . . 0.0 110.83 174.11 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -109.63 154.89 22.16 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.63 1.172 . . . . 0.0 111.844 172.428 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -113.79 130.85 56.4 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.796 1.638 . . . . 0.0 110.52 175.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 14.8 mmt180 -106.42 166.17 10.73 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.438 1.495 . . . . 0.0 112.811 -168.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -61.14 -26.41 67.66 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.153 0.981 . . . . 0.0 113.59 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -69.77 -9.66 55.39 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.162 1.385 . . . . 0.0 113.813 178.054 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 87.67 0.85 83.66 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 124.999 1.285 . . . . 0.0 113.241 -171.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 18.4 m -85.95 154.15 21.68 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.159 1.383 . . . . 0.0 111.855 179.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 31.1 p -133.04 153.8 51.14 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.778 0.831 . . . . 0.0 111.513 166.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 19.3 p90 -167.82 157.6 10.18 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 125.053 1.341 . . . . 0.0 112.814 -177.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -75.81 119.49 19.88 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.514 1.126 . . . . 0.0 110.514 176.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 26.8 t -103.74 144.86 30.91 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 125.607 1.563 . . . . 0.0 110.462 172.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 8.7 tp -98.4 112.95 24.79 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 162.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 46.6 t -92.64 115.56 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 124.794 1.238 . . . . 0.0 107.812 171.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -112.98 109.53 19.0 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 124.758 1.223 . . . . 0.0 107.777 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.426 HG22 HD13 ' A' ' 127' ' ' LEU . 79.4 t -82.36 128.95 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 172.305 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 55.2 t -111.37 112.38 54.62 Favored Pre-proline 0 CA--C 1.536 0.41 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 171.133 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -74.36 129.24 12.75 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 123.246 2.631 . . . . 0.0 109.88 178.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 80.2 t -102.13 118.66 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 123.9 0.88 . . . . 0.0 108.887 176.051 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 60.7 mttt -87.84 152.71 21.89 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.583 0.753 . . . . 0.0 112.397 172.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -91.17 -173.76 3.74 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.25 1.02 . . . . 0.0 111.519 175.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -60.31 -21.8 62.44 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.999 1.319 . . . . 0.0 114.394 178.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -90.84 -5.51 55.49 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.14 1.376 . . . . 0.0 113.023 178.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 80.58 22.2 62.65 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 124.403 1.001 . . . . 0.0 114.522 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -107.92 148.6 29.41 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.18 1.392 . . . . 0.0 109.904 172.122 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.1 p -80.15 126.27 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 123.654 0.782 . . . . 0.0 110.704 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.7 -23.28 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -174.074 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 55.4 mtm -130.25 150.9 51.29 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.028 1.331 . . . . 0.0 112.038 169.282 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -110.51 134.46 52.35 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 125.41 1.484 . . . . 0.0 109.189 167.059 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 72.6 mt -98.1 116.98 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 163.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.426 HD13 HG22 ' A' ' 112' ' ' VAL . 1.4 mm? -89.56 118.52 29.25 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 105.685 -1.968 . . . . 0.0 105.685 169.238 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -103.91 143.45 32.83 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 119.219 -0.42 . . . . 0.0 110.763 173.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -119.6 135.37 54.83 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.594 1.158 . . . . 0.0 110.434 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -138.41 150.49 46.57 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 125.541 1.536 . . . . 0.0 108.29 173.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.2 t -94.23 112.72 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.7 p -91.88 -25.75 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -177.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 32.0 ttm -165.44 124.93 1.75 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.589 1.156 . . . . 0.0 110.813 -175.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -84.33 128.11 34.38 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.584 -0.697 . . . . 0.0 110.481 175.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.457 ' HA ' ' HE2' ' A' ' 135' ' ' LYS . 7.8 mmpt? . . . . . 0 C--O 1.252 1.231 0 CA-C-O 117.644 -1.17 . . . . 0.0 113.11 174.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 N--CA 1.495 1.82 0 CA-C-O 118.748 -0.644 . . . . 0.0 110.823 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -72.76 159.48 48.38 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 123.717 2.945 . . . . 0.0 111.867 177.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 40.2 t -138.18 134.95 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 124.923 1.289 . . . . 0.0 109.462 179.161 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.73 36.33 1.54 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.502 1.521 . . . . 0.0 113.419 -175.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 -118.51 155.0 31.6 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 126.354 1.862 . . . . 0.0 111.115 178.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -87.96 98.02 2.36 Favored Glycine 0 N--CA 1.473 1.104 0 C-N-CA 124.731 1.158 . . . . 0.0 112.464 -176.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 32.6 p80 -167.07 167.43 14.51 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 126.52 1.928 . . . . 0.0 110.839 175.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 86.9 t -73.67 142.23 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 123.39 0.676 . . . . 0.0 109.785 171.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -154.66 159.88 31.45 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 126.405 1.882 . . . . 0.0 109.947 178.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -67.91 106.21 1.28 Allowed 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.779 2.319 . . . . 0.0 109.787 174.025 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -80.13 166.91 21.01 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.689 1.196 . . . . 0.0 111.608 178.088 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -68.85 147.22 52.04 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 121.611 -0.68 . . . . 0.0 111.309 172.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 40.5 p -116.24 -38.89 3.49 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.772 1.629 . . . . 0.0 112.818 -174.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -79.94 -47.29 15.25 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.979 0.912 . . . . 0.0 112.076 177.293 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 69.3 tp -61.02 -35.15 76.11 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.522 0.729 . . . . 0.0 110.968 177.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -55.18 -28.8 55.55 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 176.011 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 36.5 m -70.69 -27.61 64.14 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.623 1.169 . . . . 0.0 111.484 174.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 15.4 mm -79.44 -34.77 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 124.265 1.026 . . . . 0.0 109.801 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.9 mp -53.88 -40.22 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 123.265 0.626 . . . . 0.0 110.735 170.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 24.2 mmm-85 -63.46 -29.75 70.98 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 119.058 0.845 . . . . 0.0 112.627 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -73.91 -39.01 64.15 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.353 1.061 . . . . 0.0 111.438 174.46 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -76.71 -21.88 54.69 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.67 1.188 . . . . 0.0 113.189 178.282 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -62.18 -15.41 46.15 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 168.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -76.07 43.42 1.72 Allowed Glycine 0 CA--C 1.532 1.113 0 C-N-CA 126.531 2.015 . . . . 0.0 112.969 174.287 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.4 tp-100 78.89 13.98 1.22 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 127.484 2.313 . . . . 0.0 113.196 171.193 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 8.6 m -80.99 -5.72 57.91 Favored 'General case' 0 N--CA 1.476 0.868 0 O-C-N 120.384 -1.447 . . . . 0.0 113.758 -173.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 9.3 mmt180 -81.2 171.44 14.87 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.519 1.128 . . . . 0.0 113.148 -175.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -107.66 133.37 52.19 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.861 1.264 . . . . 0.0 110.671 177.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -161.48 158.72 27.0 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 124.333 1.053 . . . . 0.0 112.908 177.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.5 pt -140.46 149.19 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 125.58 1.552 . . . . 0.0 110.767 176.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.1 mp -109.45 127.63 66.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 C-N-CA 125.914 1.685 . . . . 0.0 108.86 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -126.23 140.22 52.72 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 124.827 1.251 . . . . 0.0 111.23 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -71.43 121.79 19.23 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 122.729 0.412 . . . . 0.0 110.818 177.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.94 -28.64 61.61 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.335 0.654 . . . . 0.0 112.461 -178.384 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 -77.9 37.83 0.25 Allowed 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 126.084 1.753 . . . . 0.0 112.675 -178.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 98.0 t -145.19 136.55 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 127.042 2.137 . . . . 0.0 108.572 -172.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -54.84 -34.42 62.84 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 115.554 1.687 . . . . 0.0 115.554 -170.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -107.49 -0.15 22.37 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.241 1.416 . . . . 0.0 113.136 -178.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 99.4 m 53.83 71.67 0.49 Allowed 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.988 1.715 . . . . 0.0 111.984 -171.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.85 131.07 44.53 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.017 0.927 . . . . 0.0 112.168 -176.025 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 41.3 t -64.47 123.29 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 123.86 0.864 . . . . 0.0 109.254 172.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 38.3 pt -104.95 -19.04 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 124.869 1.268 . . . . 0.0 112.362 178.093 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -158.91 141.28 14.01 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.67 1.188 . . . . 0.0 111.145 -178.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 4.0 m -122.63 166.41 14.9 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 121.224 -0.922 . . . . 0.0 112.397 172.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -74.74 -151.64 0.03 OUTLIER 'General case' 0 CA--C 1.557 1.237 0 C-N-CA 122.51 0.324 . . . . 0.0 111.613 169.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -113.56 -22.5 10.27 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 120.472 -1.392 . . . . 0.0 113.2 163.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -74.44 -33.88 55.41 Favored Glycine 0 N--CA 1.47 0.941 0 O-C-N 121.355 -0.841 . . . . 0.0 112.876 -177.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -57.35 -37.84 73.21 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.673 1.189 . . . . 0.0 111.624 176.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 10.2 t -60.85 -53.05 62.11 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.354 1.462 . . . . 0.0 111.61 175.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -71.01 -25.21 62.58 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -178.273 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 31.8 tp -62.02 -45.23 94.52 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.609 1.164 . . . . 0.0 111.648 170.366 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 64.2 m -104.65 -32.55 8.86 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 -166.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.05 4.54 63.03 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 126.017 1.77 . . . . 0.0 114.541 -179.05 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -83.79 -156.22 0.21 Allowed 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 124.814 1.246 . . . . 0.0 112.185 170.727 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 9.5 t -152.17 168.77 24.26 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 120.286 -1.509 . . . . 0.0 111.135 170.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.1 ttp180 -58.63 -45.5 89.1 Favored 'General case' 0 C--O 1.22 -0.472 0 O-C-N 121.535 -0.728 . . . . 0.0 111.812 -173.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.44 -25.72 37.97 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 175.279 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -88.56 -39.14 14.35 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.746 1.218 . . . . 0.0 111.645 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 84.4 t -85.67 -24.48 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 125.053 1.341 . . . . 0.0 112.376 -177.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 86.6 mtp -63.44 139.11 58.74 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 120.979 -1.076 . . . . 0.0 110.819 171.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 13.7 tm0? 75.65 -4.1 2.44 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 126.789 2.036 . . . . 0.0 113.784 -177.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 36.9 mmt180 -79.32 157.33 75.49 Favored Pre-proline 0 N--CA 1.473 0.687 0 C-N-CA 124.657 1.183 . . . . 0.0 111.088 173.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -67.22 136.23 39.76 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.398 2.065 . . . . 0.0 109.999 166.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 26.7 p -68.01 -2.2 7.22 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 -179.118 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 57.1 p -65.32 -29.42 70.16 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.578 1.551 . . . . 0.0 112.231 169.128 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 74.2 m 58.32 42.76 21.07 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.585 1.554 . . . . 0.0 112.517 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -57.73 -27.01 62.6 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.858 1.263 . . . . 0.0 113.209 -176.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -61.71 -16.21 47.14 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.546 1.138 . . . . 0.0 113.927 174.069 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 79.9 mt -83.73 -11.45 57.13 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.365 1.066 . . . . 0.0 113.78 172.307 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 40.0 m170 -73.11 115.45 12.45 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 119.823 1.192 . . . . 0.0 110.65 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -101.66 -162.63 27.03 Favored Glycine 0 CA--C 1.539 1.576 0 C-N-CA 126.157 1.836 . . . . 0.0 112.464 177.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -70.07 -25.79 26.8 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 123.133 2.555 . . . . 0.0 113.132 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.2 tpm_? -82.75 -17.51 44.01 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.883 0.873 . . . . 0.0 113.195 179.039 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 40.9 m -65.96 138.95 58.17 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.991 1.316 . . . . 0.0 112.384 -168.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 22.3 mp0 -84.48 117.99 24.02 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.338 1.455 . . . . 0.0 110.545 -172.164 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -60.25 -33.76 72.76 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -177.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 36.6 mmt180 -63.4 -53.27 55.0 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.397 0.679 . . . . 0.0 111.202 172.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.8 -36.89 84.78 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 120.491 -1.381 . . . . 0.0 113.09 -178.158 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -54.69 -35.49 63.66 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.848 0.859 . . . . 0.0 112.378 171.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -76.81 -45.7 27.67 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 124.555 1.142 . . . . 0.0 112.527 173.11 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -58.46 -36.94 74.47 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 118.809 0.732 . . . . 0.0 111.15 -176.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 89.3 mt -61.18 -40.17 84.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 CA-C-N 119.825 1.193 . . . . 0.0 111.845 173.111 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.43 -37.11 68.68 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.526 0.731 . . . . 0.0 112.65 176.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 54.8 mm-40 -67.82 -33.26 74.44 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.987 0.915 . . . . 0.0 111.469 174.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -57.98 -26.02 61.8 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 121.19 -0.944 . . . . 0.0 113.105 178.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 55.3 mt -78.58 -18.13 55.07 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.737 1.615 . . . . 0.0 113.545 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.1 pp -83.38 -20.69 33.75 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 119.473 1.033 . . . . 0.0 112.1 173.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -81.38 154.87 35.27 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 125.075 1.322 . . . . 0.0 112.85 176.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -95.5 1.31 53.9 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.882 1.273 . . . . 0.0 114.214 -178.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -126.91 161.12 29.04 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.179 1.792 . . . . 0.0 111.725 -169.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -62.49 141.67 58.3 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.072 1.349 . . . . 0.0 112.304 -177.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 -152.19 125.54 8.76 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.818 0.847 . . . . 0.0 112.86 -171.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 44.3 mtmt -101.24 139.02 37.49 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.204 1.402 . . . . 0.0 111.592 171.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 67.7 t -134.16 143.66 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 126.082 1.753 . . . . 0.0 108.166 170.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -114.48 136.18 53.29 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.461 1.104 . . . . 0.0 110.9 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.1 tt -161.57 146.45 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 123.561 0.744 . . . . 0.0 112.659 -163.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -84.49 122.35 28.86 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 121.02 -1.05 . . . . 0.0 111.047 172.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 14.7 m-30 -108.42 147.01 32.23 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.232 1.413 . . . . 0.0 112.091 173.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -109.18 132.45 54.11 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.138 1.775 . . . . 0.0 110.627 177.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -107.08 160.23 15.71 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.718 1.607 . . . . 0.0 112.116 -166.007 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -64.28 -22.93 67.12 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -177.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -76.23 -7.25 54.46 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 124.633 1.173 . . . . 0.0 113.387 175.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 94.97 0.11 64.03 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 125.725 1.631 . . . . 0.0 114.28 -178.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 59.2 m -88.63 162.16 16.49 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.575 1.15 . . . . 0.0 112.421 179.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 26.5 p -138.27 155.64 48.42 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 121.147 -0.971 . . . . 0.0 112.031 168.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -166.04 157.07 13.33 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.982 1.313 . . . . 0.0 112.796 -176.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -75.49 123.04 24.77 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.803 0.811 . . . . 0.0 110.754 177.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 9.0 t -109.93 138.55 46.15 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.312 1.845 . . . . 0.0 109.681 174.063 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.545 HD13 ' N ' ' A' ' 110' ' ' VAL . 1.2 tm? -83.19 140.46 32.56 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 156.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.545 ' N ' HD13 ' A' ' 109' ' ' LEU . 13.8 t -124.01 112.36 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 125.336 1.454 . . . . 0.0 108.625 169.283 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -103.36 121.87 43.66 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.978 1.311 . . . . 0.0 109.994 172.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.1 p -91.48 124.38 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 166.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 81.6 t -109.02 111.79 60.35 Favored Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 175.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.31 130.34 13.94 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.875 2.383 . . . . 0.0 109.95 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 63.7 t -101.72 124.25 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 124.096 0.959 . . . . 0.0 108.604 173.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 35.1 mttp -98.09 153.75 18.21 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 175.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -93.11 -174.58 3.6 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.166 0.986 . . . . 0.0 111.294 176.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -59.82 -21.73 61.28 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.039 1.335 . . . . 0.0 114.421 178.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -91.4 -6.04 53.48 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.115 1.366 . . . . 0.0 113.181 179.207 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 78.62 25.63 60.38 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 124.239 0.923 . . . . 0.0 114.142 -178.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -108.53 152.22 25.03 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.198 1.399 . . . . 0.0 109.899 172.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 10.6 t -80.56 125.77 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 123.306 0.642 . . . . 0.0 109.318 -179.231 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.8 -24.83 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -176.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 56.6 mtm -130.76 152.91 49.6 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.558 1.143 . . . . 0.0 112.374 167.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -113.26 134.3 54.67 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 125.721 1.608 . . . . 0.0 109.172 168.089 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 46.1 mt -101.76 117.9 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 165.056 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -100.16 128.38 46.25 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 106.895 -1.521 . . . . 0.0 106.895 173.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -123.3 130.04 52.18 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.43 1.092 . . . . 0.0 110.313 -172.523 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -106.38 137.7 43.89 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.889 1.276 . . . . 0.0 111.08 -174.235 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -142.76 133.09 24.76 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.846 1.258 . . . . 0.0 109.463 177.316 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 59.4 t -80.27 115.29 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 5.2 p -97.94 -28.85 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -176.03 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 25.4 ptp -164.13 148.87 10.15 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.367 1.067 . . . . 0.0 113.337 167.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -90.91 130.3 36.86 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.036 0.934 . . . . 0.0 110.741 178.224 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.255 1.344 0 CA-C-O 115.806 -2.045 . . . . 0.0 115.587 -176.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.2 mtt . . . . . 0 N--CA 1.496 1.856 0 CA-C-O 116.428 -1.749 . . . . 0.0 112.23 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -70.19 151.91 66.82 Favored 'Trans proline' 0 C--N 1.357 1.017 0 C-N-CA 122.432 2.088 . . . . 0.0 111.568 177.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 57.2 t -93.07 127.59 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 123.942 0.897 . . . . 0.0 109.774 -178.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 31.2 mmm180 -89.65 54.38 2.86 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.347 1.459 . . . . 0.0 111.7 -179.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 75.7 ttt-85 -64.21 140.56 58.88 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.459 1.503 . . . . 0.0 111.85 -177.42 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 145.47 163.72 10.34 Favored Glycine 0 N--CA 1.474 1.173 0 C-N-CA 125.509 1.528 . . . . 0.0 113.647 179.06 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 60.3 m80 -141.54 170.67 15.28 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 125.917 1.687 . . . . 0.0 111.147 -178.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.5 p -59.6 139.74 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 123.778 0.831 . . . . 0.0 112.23 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.62 153.13 95.53 Favored Pre-proline 0 CA--C 1.552 1.035 0 C-N-CA 124.063 0.945 . . . . 0.0 112.005 174.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -66.69 151.64 82.23 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.91 2.407 . . . . 0.0 111.245 176.306 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 72.8 mm-40 -66.45 160.27 25.29 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.839 0.856 . . . . 0.0 112.503 177.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -82.72 46.52 1.09 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.27 1.428 . . . . 0.0 113.351 -173.441 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 57.4 p -51.13 -33.68 27.62 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 127.419 2.287 . . . . 0.0 113.572 -174.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -64.76 -53.96 38.88 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.989 0.915 . . . . 0.0 111.783 173.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 58.8 tp -60.7 -35.96 77.6 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.612 1.165 . . . . 0.0 111.175 176.513 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -62.31 -26.03 68.19 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 177.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 99.2 m -75.55 -28.13 58.9 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.554 1.141 . . . . 0.0 111.245 171.459 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 16.1 mm -77.68 -41.76 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 O-C-N 121.417 -0.802 . . . . 0.0 110.702 174.335 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 90.1 mt -56.19 -48.47 79.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 123.994 0.917 . . . . 0.0 110.564 177.204 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 16.2 ptp180 -67.08 -23.96 65.91 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -75.94 -33.46 59.82 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 119.523 1.056 . . . . 0.0 112.615 170.545 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -76.45 -32.01 58.17 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.533 1.133 . . . . 0.0 111.908 175.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -63.45 129.94 42.32 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 118.602 0.637 . . . . 0.0 111.322 172.382 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.73 8.59 84.55 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 124.457 1.027 . . . . 0.0 115.222 177.513 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 25.8 tp60 -83.82 52.95 2.41 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.564 1.545 . . . . 0.0 111.952 -171.466 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 67.8 m -89.04 0.75 56.42 Favored 'General case' 0 N--CA 1.48 1.038 0 O-C-N 120.938 -1.101 . . . . 0.0 113.434 -179.106 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 6.0 mmt-85 -79.8 177.62 8.77 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.015 1.326 . . . . 0.0 113.075 -176.612 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.2 mptt -94.08 133.98 36.99 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.947 1.299 . . . . 0.0 110.412 178.239 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -163.27 161.88 24.97 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.482 1.113 . . . . 0.0 112.805 177.385 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.2 pt -139.74 158.61 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 126.06 1.744 . . . . 0.0 110.521 173.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 28.3 mt -118.54 132.97 66.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 125.601 1.56 . . . . 0.0 108.868 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -131.33 143.26 50.38 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.349 1.059 . . . . 0.0 111.585 176.262 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -72.15 123.76 23.58 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.246 0.618 . . . . 0.0 111.489 179.25 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -79.03 -21.16 47.31 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -178.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 63.7 mtp85 -75.97 28.28 0.11 Allowed 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 126.185 1.794 . . . . 0.0 113.367 -173.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.4 t -151.09 137.64 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 127.114 2.165 . . . . 0.0 108.426 -166.312 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -63.35 -39.93 95.88 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -175.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 24.9 p30 -81.68 -15.21 55.2 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 114.377 1.251 . . . . 0.0 114.377 179.173 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 86.2 m 51.56 56.57 7.68 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.439 1.496 . . . . 0.0 113.351 -176.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.87 138.47 55.69 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 12.7 t -60.41 125.07 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 170.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 42.4 pt -104.93 -18.59 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 124.871 1.268 . . . . 0.0 112.619 174.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -156.16 144.99 20.31 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.091 0.956 . . . . 0.0 111.855 177.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 8.1 m -123.94 154.66 39.43 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.294 1.038 . . . . 0.0 110.588 171.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -73.15 -149.16 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.288 0 CA-C-N 118.958 0.799 . . . . 0.0 111.885 172.584 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -115.66 -22.67 9.08 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 120.248 -1.533 . . . . 0.0 112.885 164.182 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -74.5 -33.84 55.32 Favored Glycine 0 C--N 1.343 0.962 0 C-N-CA 124.231 0.919 . . . . 0.0 112.791 -178.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -56.94 -38.17 72.54 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.319 1.048 . . . . 0.0 111.292 176.614 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 51.2 t -59.01 -51.56 69.55 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.108 1.363 . . . . 0.0 111.659 178.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -67.56 -20.28 65.38 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.925 0.89 . . . . 0.0 113.093 178.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.06 -35.56 81.53 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.622 1.169 . . . . 0.0 112.4 176.815 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 45.4 m -123.09 -24.1 4.79 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 115.578 1.696 . . . . 0.0 115.578 -176.08 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 87.9 15.46 61.19 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-N 119.77 1.168 . . . . 0.0 114.075 -177.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -85.59 -144.63 0.1 Allowed 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.699 1.199 . . . . 0.0 111.338 170.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 77.8 p -158.22 165.94 33.61 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 124.771 1.228 . . . . 0.0 111.765 174.035 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 44.8 ttm180 -54.83 -47.3 74.29 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 118.889 -0.577 . . . . 0.0 110.606 171.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.65 -32.58 52.04 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 119.611 1.096 . . . . 0.0 113.932 177.221 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -89.08 -34.53 16.73 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.942 0.897 . . . . 0.0 113.258 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 99.5 t -84.43 -14.39 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.278 1.031 . . . . 0.0 112.035 178.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 79.5 mmm -76.95 147.38 36.96 Favored 'General case' 0 N--CA 1.474 0.725 0 O-C-N 120.841 -1.162 . . . . 0.0 111.977 175.159 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 31.8 tp60 69.19 4.42 4.57 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 126.451 1.9 . . . . 0.0 113.433 -175.023 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 32.3 mmt180 -77.96 153.96 80.3 Favored Pre-proline 0 N--CA 1.47 0.561 0 C-N-CA 124.843 1.257 . . . . 0.0 109.875 174.153 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -73.55 11.62 1.02 Allowed 'Trans proline' 0 CA--C 1.546 1.118 0 C-N-CA 124.106 3.204 . . . . 0.0 115.205 176.005 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.478 ' SG ' HD13 ' A' ' 127' ' ' LEU . 7.8 t 77.84 -23.8 0.24 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 126.585 1.954 . . . . 0.0 114.453 163.152 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 37.7 p -58.05 -20.6 40.38 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 126.6 1.96 . . . . 0.0 113.376 172.485 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 90.6 m 60.53 28.45 18.13 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.388 1.475 . . . . 0.0 112.824 178.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -58.87 -27.72 65.45 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.635 1.174 . . . . 0.0 112.515 -177.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -59.81 -13.86 12.31 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 174.567 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 92.2 mt -84.02 -3.54 58.09 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.802 1.241 . . . . 0.0 113.891 172.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 9.4 p-80 -66.1 145.6 55.63 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 120.169 1.35 . . . . 0.0 113.415 178.491 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -128.83 -161.55 10.68 Favored Glycine 0 CA--C 1.538 1.506 0 C-N-CA 126.557 2.027 . . . . 0.0 111.225 166.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.26 -21.34 35.94 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.937 2.425 . . . . 0.0 113.194 177.222 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 21.6 tpt180 -89.86 -8.75 51.24 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.272 1.029 . . . . 0.0 113.491 -178.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 24.3 m -72.39 141.83 48.72 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.917 1.287 . . . . 0.0 110.579 -176.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 64.4 mm-40 -91.8 122.77 34.64 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.506 0.722 . . . . 0.0 110.04 -173.608 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 28.7 mmm180 -58.62 -39.36 80.26 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.803 0.841 . . . . 0.0 112.296 -178.476 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -64.86 -39.5 93.65 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.318 1.047 . . . . 0.0 112.081 176.26 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -69.2 -43.07 74.9 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.101 -1.0 . . . . 0.0 112.633 178.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -56.89 -34.92 68.36 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 122.95 0.5 . . . . 0.0 112.04 173.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -72.35 -46.75 54.05 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 124.82 1.248 . . . . 0.0 112.549 173.098 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -61.1 -34.86 75.61 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 118.563 -0.732 . . . . 0.0 111.565 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 87.4 mt -63.1 -38.87 83.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 CA-C-N 120.104 1.32 . . . . 0.0 111.749 171.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.92 -36.87 78.49 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 119.33 0.968 . . . . 0.0 112.296 173.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -65.84 -31.91 73.13 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 121.347 -0.846 . . . . 0.0 111.773 172.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.69 -20.59 65.83 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 119.203 0.911 . . . . 0.0 112.604 175.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 44.6 mt -88.32 -10.75 48.46 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.927 1.691 . . . . 0.0 113.374 172.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 84.5 mt -96.98 -14.64 21.55 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.529 1.132 . . . . 0.0 112.075 172.041 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -86.48 150.73 23.7 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 125.389 1.471 . . . . 0.0 113.162 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -100.28 8.94 43.4 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.136 1.374 . . . . 0.0 113.678 178.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -134.21 164.83 26.5 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.428 1.891 . . . . 0.0 111.476 -178.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -61.29 138.16 58.24 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.833 0.853 . . . . 0.0 111.854 -179.089 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 19.7 tpt180 -145.92 128.68 16.26 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.91 0.884 . . . . 0.0 112.058 -178.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 43.1 mtmt -107.34 139.86 41.16 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.76 1.624 . . . . 0.0 111.424 175.366 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 45.1 t -138.24 138.69 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 125.52 1.528 . . . . 0.0 109.251 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -102.92 127.76 50.0 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.221 1.008 . . . . 0.0 110.962 177.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 19.5 tt -150.71 146.32 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 124.208 1.003 . . . . 0.0 112.352 -171.32 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -89.9 119.05 29.94 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 121.055 -1.028 . . . . 0.0 111.578 176.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 20.0 m-30 -115.73 157.12 24.77 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.598 1.959 . . . . 0.0 111.314 175.248 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -114.05 151.9 31.8 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 178.237 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.54 158.79 28.45 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.493 1.517 . . . . 0.0 110.395 167.167 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -61.81 -23.78 66.44 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.235 1.014 . . . . 0.0 113.219 166.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -72.31 -9.02 57.95 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.739 1.616 . . . . 0.0 113.709 170.398 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 97.94 -6.4 62.17 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 126.127 1.822 . . . . 0.0 114.778 179.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 22.1 m -82.12 130.23 35.03 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 118.952 1.376 . . . . 0.0 112.627 -172.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 25.3 p -104.87 153.65 21.09 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.761 1.224 . . . . 0.0 112.46 -177.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -165.61 163.79 19.24 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 126.088 1.755 . . . . 0.0 112.672 169.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -77.87 124.88 28.54 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.37 1.068 . . . . 0.0 111.119 175.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 42.1 t -104.25 137.31 42.35 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.82 2.048 . . . . 0.0 110.128 170.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 6.8 tp -90.28 118.0 29.45 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 161.116 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 94.9 t -100.87 114.67 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 125.457 1.503 . . . . 0.0 107.903 173.483 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -115.45 108.72 16.85 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 125.606 1.562 . . . . 0.0 107.129 -175.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.452 HG22 ' HG ' ' A' ' 127' ' ' LEU . 17.1 t -93.52 127.37 45.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 -179.008 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 69.6 t -111.15 112.1 55.41 Favored Pre-proline 0 CA--C 1.535 0.374 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.88 131.6 15.92 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.64 2.227 . . . . 0.0 109.61 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 60.6 t -92.8 105.42 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 169.555 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 61.5 mttt -82.16 151.7 26.81 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.268 0.556 . . . . 0.0 111.202 166.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -92.96 -173.42 3.28 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.8 0.84 . . . . 0.0 111.831 174.014 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -60.14 -21.79 62.04 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.128 1.371 . . . . 0.0 114.693 178.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -93.73 -0.72 55.83 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.695 1.198 . . . . 0.0 113.155 177.095 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 77.87 20.55 73.27 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 124.301 0.953 . . . . 0.0 114.556 178.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -99.22 142.22 30.98 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.462 1.105 . . . . 0.0 109.12 171.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.7 p -76.55 118.97 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-O 122.089 0.947 . . . . 0.0 109.903 174.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.4 pt -106.91 -19.51 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 125.64 1.576 . . . . 0.0 113.29 -174.047 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 3.6 mtp -157.36 156.33 32.12 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 126.561 1.944 . . . . 0.0 110.512 -174.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -122.56 133.51 54.56 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 125.086 1.355 . . . . 0.0 109.563 175.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 56.8 mt -102.59 114.81 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 166.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.478 HD13 ' SG ' ' A' ' 64' ' ' CYS . 7.4 mp -98.57 119.77 37.85 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 177.727 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -110.82 135.81 50.82 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 123.354 0.409 . . . . 0.0 111.47 -178.144 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -111.86 138.37 48.55 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.12 1.368 . . . . 0.0 111.433 -175.268 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -144.03 136.34 26.68 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.42 1.488 . . . . 0.0 109.908 175.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 42.5 t -76.15 114.58 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 176.325 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.0 p -98.61 -25.61 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -173.255 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 44.4 tpp -165.2 128.21 2.23 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.154 0.981 . . . . 0.0 111.725 179.379 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -84.39 127.9 34.27 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.631 0.772 . . . . 0.0 111.386 -179.374 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.48 ' HA ' ' HE2' ' A' ' 135' ' ' LYS . 11.1 mmpt? . . . . . 0 C--O 1.254 1.299 0 C-N-CA 124.789 1.236 . . . . 0.0 113.103 174.514 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.1 ttm . . . . . 0 N--CA 1.496 1.857 0 CA-C-O 118.356 -0.83 . . . . 0.0 110.704 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -83.25 -26.08 2.4 Favored 'Trans proline' 0 C--N 1.357 1.011 0 C-N-CA 123.334 2.689 . . . . 0.0 114.535 -175.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.4 t 68.14 54.37 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 125.449 1.5 . . . . 0.0 110.53 177.358 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -126.22 49.45 1.99 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 126.198 1.799 . . . . 0.0 110.478 -177.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 38.9 mmt180 -67.02 161.94 23.23 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.784 1.633 . . . . 0.0 112.872 -174.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 106.11 145.05 12.59 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 125.895 1.712 . . . . 0.0 112.737 178.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -80.53 58.04 3.07 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 125.231 1.412 . . . . 0.0 111.761 -176.441 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 36.9 t 79.9 118.2 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 129.106 2.962 . . . . 0.0 109.577 -171.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.23 153.2 94.34 Favored Pre-proline 0 CA--C 1.55 0.968 0 C-N-CA 124.09 0.956 . . . . 0.0 112.266 -178.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -72.8 -8.62 22.66 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 123.369 2.713 . . . . 0.0 114.13 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 68.15 0.89 2.6 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 127.001 2.12 . . . . 0.0 114.674 171.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 36.82 53.53 1.1 Allowed 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 131.398 3.879 . . . . 0.0 113.271 176.228 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 39.7 p -46.19 -38.09 7.89 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 127.758 2.423 . . . . 0.0 114.086 -169.713 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -62.14 -49.9 74.01 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.058 0.943 . . . . 0.0 111.954 175.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 58.2 tp -69.64 -39.93 76.83 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.343 1.457 . . . . 0.0 111.593 174.167 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -60.15 -28.41 67.87 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 176.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 95.1 m -69.03 -29.82 68.05 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.294 1.038 . . . . 0.0 110.739 173.232 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.8 mm -78.13 -41.92 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 123.683 0.793 . . . . 0.0 110.047 174.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 96.5 mt -56.9 -46.53 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 123.437 0.695 . . . . 0.0 110.661 176.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -70.66 -21.39 62.61 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.2 mtpt -78.57 -34.85 46.62 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.53 1.132 . . . . 0.0 112.606 170.105 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -78.02 -30.48 49.99 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.901 0.88 . . . . 0.0 111.82 175.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 -70.34 168.82 15.16 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.903 0.881 . . . . 0.0 111.772 165.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -81.74 7.5 62.11 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 124.614 1.102 . . . . 0.0 115.299 -177.335 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -68.16 -38.33 81.99 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 118.845 1.323 . . . . 0.0 113.04 -169.485 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 83.8 p -92.01 -2.67 56.59 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 -179.152 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -83.43 171.11 13.79 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 122.738 1.256 . . . . 0.0 113.213 -171.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.3 mptt -109.4 145.91 35.34 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.948 2.099 . . . . 0.0 110.376 -173.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -167.04 163.41 15.84 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.493 1.117 . . . . 0.0 113.333 178.387 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 20.2 pt -139.71 155.71 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 126.212 1.805 . . . . 0.0 110.327 172.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 17.2 mt -114.63 133.25 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 126.046 1.738 . . . . 0.0 108.688 -177.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -135.29 144.0 46.55 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.454 1.101 . . . . 0.0 112.171 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 57.8 t-20 -76.09 112.59 12.7 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.266 1.027 . . . . 0.0 112.151 -176.145 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -71.15 -19.69 62.39 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.293 1.037 . . . . 0.0 113.434 -177.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -75.32 -19.59 59.55 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.559 1.144 . . . . 0.0 113.256 179.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 95.4 t -89.42 136.36 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 125.769 1.627 . . . . 0.0 109.171 177.106 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -55.86 -41.2 74.01 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.789 1.236 . . . . 0.0 113.023 -175.182 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -79.42 -11.47 59.91 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.394 1.078 . . . . 0.0 113.717 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 88.4 m 52.8 57.85 5.94 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.355 1.462 . . . . 0.0 112.08 -170.513 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.39 137.07 57.7 Favored 'General case' 0 CA--C 1.548 0.87 0 O-C-N 121.405 -0.809 . . . . 0.0 112.616 -176.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.9 t -60.8 123.81 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 172.358 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.2 pt -105.03 -17.95 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 125.153 1.381 . . . . 0.0 112.547 175.065 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -157.2 145.75 19.61 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.065 0.946 . . . . 0.0 112.204 178.209 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 4.4 m -124.51 156.41 37.35 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.562 1.145 . . . . 0.0 111.504 172.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -73.79 -150.71 0.03 OUTLIER 'General case' 0 CA--C 1.56 1.349 0 CA-C-N 118.86 0.754 . . . . 0.0 111.397 171.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -116.23 -21.45 9.35 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 120.365 -1.459 . . . . 0.0 112.98 163.314 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -73.73 -34.01 57.11 Favored Glycine 0 N--CA 1.471 1.033 0 C-N-CA 124.126 0.869 . . . . 0.0 112.691 -178.294 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -58.69 -38.02 77.35 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.52 1.128 . . . . 0.0 111.652 177.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 33.5 t -55.58 -51.73 66.15 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.626 1.57 . . . . 0.0 111.758 178.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -69.27 -18.17 63.83 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 178.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.507 HD11 HG23 ' A' ' 131' ' ' VAL . 10.6 tp -66.99 -44.06 81.33 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.447 1.099 . . . . 0.0 112.317 178.554 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 80.3 m -112.68 -21.46 11.23 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 114.513 1.301 . . . . 0.0 114.513 -176.045 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 87.16 14.08 64.95 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 124.417 1.008 . . . . 0.0 114.2 -178.075 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -87.81 -154.65 0.27 Allowed 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 124.889 1.276 . . . . 0.0 111.857 172.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 70.1 m -150.61 159.47 44.48 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.951 1.3 . . . . 0.0 110.39 178.431 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 -50.59 -47.0 58.23 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 121.571 -0.706 . . . . 0.0 111.5 175.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.36 -27.53 36.87 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 177.172 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -91.71 -33.99 14.82 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.991 1.316 . . . . 0.0 112.368 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 57.4 t -88.21 -16.11 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 124.829 1.252 . . . . 0.0 111.947 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 84.0 mmm -73.62 148.06 43.2 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 120.96 -1.088 . . . . 0.0 111.344 171.174 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 9.7 tm0? 70.98 4.1 4.93 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 126.076 1.75 . . . . 0.0 113.068 -176.013 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 32.7 mmt180 -82.04 154.84 70.12 Favored Pre-proline 0 N--CA 1.472 0.63 0 C-N-CA 125.021 1.328 . . . . 0.0 110.375 175.048 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -75.16 11.8 1.4 Allowed 'Trans proline' 0 CA--C 1.548 1.215 0 C-N-CA 124.268 3.312 . . . . 0.0 115.72 176.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 8.3 t 73.89 -17.02 0.47 Allowed 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 126.348 1.859 . . . . 0.0 114.666 166.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 41.1 p -62.05 -23.48 66.5 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 126.095 1.758 . . . . 0.0 113.146 170.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 98.3 m 57.78 28.7 16.32 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.093 1.357 . . . . 0.0 113.004 -176.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -56.78 -31.91 65.11 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.595 1.158 . . . . 0.0 112.22 178.552 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -60.87 -12.54 11.37 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.995 1.318 . . . . 0.0 114.314 177.239 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.2 mt -83.74 -2.4 56.19 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 114.101 1.149 . . . . 0.0 114.101 174.501 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 18.3 p-80 -59.79 143.05 52.08 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 119.781 1.173 . . . . 0.0 113.617 179.187 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -123.94 -161.64 11.19 Favored Glycine 0 CA--C 1.539 1.551 0 C-N-CA 126.363 1.935 . . . . 0.0 111.517 169.395 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.22 -20.4 32.72 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 123.069 2.513 . . . . 0.0 113.184 177.08 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 -88.13 -12.04 45.21 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.245 1.018 . . . . 0.0 113.592 -179.503 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 18.6 m -72.38 138.83 47.48 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.994 1.317 . . . . 0.0 110.584 -175.186 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -102.87 131.11 50.01 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.295 1.038 . . . . 0.0 110.544 -177.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 19.9 tpp85 -60.76 -36.34 78.69 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.809 0.844 . . . . 0.0 112.538 -175.508 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 85.3 mmt-85 -60.67 -41.99 96.17 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.039 0.935 . . . . 0.0 112.448 175.104 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.64 -45.5 75.18 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 119.144 0.884 . . . . 0.0 112.112 177.217 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -57.18 -33.6 67.63 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.106 0.562 . . . . 0.0 112.318 173.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -73.28 -46.24 50.97 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 124.696 1.198 . . . . 0.0 112.293 175.155 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 12.9 mm-40 -61.42 -33.86 74.42 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 119.091 0.859 . . . . 0.0 111.715 -177.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 76.1 mt -63.96 -35.63 74.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 CA-C-N 120.307 1.412 . . . . 0.0 111.958 171.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.75 -35.56 67.5 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 119.112 0.869 . . . . 0.0 112.498 173.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 51.8 mm-40 -67.89 -33.67 75.16 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.564 0.745 . . . . 0.0 111.581 173.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -58.7 -22.05 56.34 Favored 'General case' 0 CA--C 1.547 0.847 0 O-C-N 121.063 -1.023 . . . . 0.0 113.392 178.148 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 57.7 mt -82.03 -14.55 55.74 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.751 1.621 . . . . 0.0 113.839 177.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.1 pp -85.65 -18.52 32.99 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 119.606 1.094 . . . . 0.0 112.643 173.58 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -79.82 167.26 51.27 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 124.919 1.247 . . . . 0.0 113.718 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -110.87 -7.57 14.58 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.011 1.725 . . . . 0.0 112.746 175.26 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -112.25 164.97 12.6 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 127.704 2.401 . . . . 0.0 111.642 179.262 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 44.1 mp0 -62.58 143.59 57.08 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.903 1.281 . . . . 0.0 112.141 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 16.0 mmt85 -140.64 130.05 23.88 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.891 1.276 . . . . 0.0 111.267 173.269 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 39.7 mtmt -104.81 136.04 45.06 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.297 1.439 . . . . 0.0 110.847 168.104 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 66.7 t -135.95 136.79 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 125.345 1.458 . . . . 0.0 108.742 176.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -101.01 131.82 46.71 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.987 0.915 . . . . 0.0 110.882 178.228 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.1 tt -154.11 150.05 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 124.612 1.165 . . . . 0.0 111.751 -170.295 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -89.22 125.85 35.25 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.243 -0.911 . . . . 0.0 111.825 174.297 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 20.0 m-30 -113.99 146.0 40.75 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.737 2.015 . . . . 0.0 111.115 173.405 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -86.52 156.36 20.12 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 169.257 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 58.3 ttm-85 -101.22 149.11 24.34 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 126.152 1.781 . . . . 0.0 109.332 166.7 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -54.37 -28.15 41.22 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 114.441 1.274 . . . . 0.0 114.441 177.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -73.68 -6.98 50.18 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.926 1.69 . . . . 0.0 114.088 176.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 99.17 -1.28 57.49 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 125.763 1.649 . . . . 0.0 114.229 -177.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -73.57 168.98 18.2 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 118.407 1.104 . . . . 0.0 112.215 177.041 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 34.9 t -143.02 151.66 41.06 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.341 1.056 . . . . 0.0 111.36 176.605 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -157.36 151.85 25.16 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.673 1.189 . . . . 0.0 111.587 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -76.57 123.18 25.69 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.411 0.624 . . . . 0.0 110.466 165.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 21.4 t -104.79 137.68 42.21 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.988 1.715 . . . . 0.0 110.377 170.158 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.3 tp -92.24 116.37 28.89 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 162.157 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 22.3 t -100.06 115.39 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 124.829 1.252 . . . . 0.0 108.468 176.308 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -110.79 110.61 21.31 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.721 1.208 . . . . 0.0 108.273 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 71.3 t -78.39 128.75 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 169.5 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 56.0 t -112.98 113.01 49.8 Favored Pre-proline 0 CA--C 1.538 0.496 0 N-CA-C 107.591 -1.262 . . . . 0.0 107.591 168.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.32 127.82 10.76 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 123.273 2.648 . . . . 0.0 109.741 178.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 79.3 t -102.02 119.7 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 123.912 0.885 . . . . 0.0 109.45 176.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 61.1 mttt -88.52 153.57 21.04 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.693 0.797 . . . . 0.0 112.635 172.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -92.35 -173.58 3.45 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.475 1.11 . . . . 0.0 111.663 175.37 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -60.11 -22.12 62.4 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.11 1.364 . . . . 0.0 114.465 178.293 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -90.66 -5.47 55.77 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.119 1.368 . . . . 0.0 112.991 178.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 80.43 22.35 62.71 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 124.396 0.998 . . . . 0.0 114.456 -179.57 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -108.16 148.24 30.17 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.193 1.397 . . . . 0.0 109.916 172.247 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.8 p -78.79 126.19 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 123.703 0.801 . . . . 0.0 110.525 178.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.47 -22.82 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 -174.786 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 56.0 mtm -130.18 149.91 51.67 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.848 1.259 . . . . 0.0 111.977 169.094 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -107.52 136.04 47.96 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 124.766 1.226 . . . . 0.0 109.126 164.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 75.9 mt -99.26 118.45 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 162.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -93.68 116.76 29.27 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 170.2 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -101.53 144.53 30.18 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 119.122 -0.466 . . . . 0.0 110.894 176.54 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -122.46 133.01 54.61 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.63 1.172 . . . . 0.0 111.151 -176.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -137.7 131.09 30.87 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 125.271 1.428 . . . . 0.0 109.2 176.138 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.507 HG23 HD11 ' A' ' 51' ' ' LEU . 71.3 t -76.86 110.95 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 175.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.2 p -93.9 -24.23 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 123.628 0.771 . . . . 0.0 112.744 -174.081 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 37.9 tpp -163.53 111.69 1.21 Allowed 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.769 1.228 . . . . 0.0 110.572 178.242 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -82.28 118.91 23.49 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.388 0.675 . . . . 0.0 109.919 176.713 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt . . . . . 0 C--O 1.254 1.306 0 C-N-CA 125.201 1.4 . . . . 0.0 113.475 -175.456 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 93.1 mtp . . . . . 0 N--CA 1.497 1.893 0 CA-C-O 116.441 -1.742 . . . . 0.0 112.254 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -71.31 157.58 56.54 Favored 'Trans proline' 0 C--N 1.359 1.095 0 C-N-CA 122.521 2.148 . . . . 0.0 111.933 178.089 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 90.2 t -86.9 125.19 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.031 0.932 . . . . 0.0 110.146 -179.248 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 35.4 mmt180 -80.21 138.4 36.83 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.615 1.166 . . . . 0.0 111.086 173.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -106.23 160.66 15.18 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.173 1.389 . . . . 0.0 111.275 177.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -85.37 102.18 2.6 Favored Glycine 0 N--CA 1.471 1.002 0 C-N-CA 124.571 1.081 . . . . 0.0 111.647 177.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -166.55 169.75 13.42 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.634 1.973 . . . . 0.0 111.169 177.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.6 p -155.02 133.68 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 124.461 1.104 . . . . 0.0 111.094 176.481 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -91.63 152.72 43.64 Favored Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 124.952 1.301 . . . . 0.0 111.866 177.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -66.02 118.21 5.31 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 123.267 2.645 . . . . 0.0 110.312 176.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -134.95 -65.97 0.6 Allowed 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.277 1.431 . . . . 0.0 109.74 -175.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -63.94 130.51 44.39 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.101 0.96 . . . . 0.0 110.954 173.276 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 32.2 p -117.54 -50.77 2.52 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.433 1.493 . . . . 0.0 112.216 172.09 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -86.36 -56.98 3.18 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.88 0.872 . . . . 0.0 111.762 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 48.1 tp -57.87 -35.06 70.45 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.226 1.01 . . . . 0.0 111.065 178.189 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -44.77 -37.41 3.77 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 170.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 99.8 m -77.69 -31.64 52.54 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.39 1.076 . . . . 0.0 110.775 179.262 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 12.2 mm -75.38 -36.22 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 124.675 1.19 . . . . 0.0 110.661 177.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 94.0 mt -54.83 -41.46 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 123.547 0.739 . . . . 0.0 110.529 174.26 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 7.0 mmt85 -59.31 -32.91 70.48 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 118.864 0.756 . . . . 0.0 112.869 178.205 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -77.16 -36.75 54.95 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.888 1.275 . . . . 0.0 111.631 177.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -74.85 -25.9 59.31 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.65 1.18 . . . . 0.0 112.688 175.315 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -60.58 -19.86 58.83 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 173.178 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -74.8 -10.3 83.39 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 124.632 1.111 . . . . 0.0 114.506 173.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -95.89 45.78 1.08 Allowed 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.772 1.629 . . . . 0.0 110.55 178.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.1 t -85.6 44.87 1.14 Allowed 'General case' 0 N--CA 1.476 0.854 0 O-C-N 120.567 -1.333 . . . . 0.0 112.273 -171.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 22.8 mmm180 -69.27 163.52 24.84 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.519 1.127 . . . . 0.0 111.239 176.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.6 mptt -92.85 123.24 35.97 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.128 -0.982 . . . . 0.0 110.935 -170.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -159.72 163.88 34.36 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.183 0.993 . . . . 0.0 113.096 177.194 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 32.6 pt -140.97 156.22 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 126.5 1.92 . . . . 0.0 110.006 173.535 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 10.7 mt -118.27 132.75 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 125.416 1.486 . . . . 0.0 109.006 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -130.87 148.54 52.65 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.44 1.096 . . . . 0.0 111.775 177.622 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 52.7 t-20 -71.22 125.3 26.57 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.863 0.865 . . . . 0.0 111.045 178.303 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.06 -26.78 59.65 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 121.463 -0.773 . . . . 0.0 112.824 175.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 77.4 mtp180 -76.41 23.59 0.15 Allowed 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 126.137 1.775 . . . . 0.0 114.462 -170.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.4 m -149.93 148.5 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 126.748 2.019 . . . . 0.0 110.563 -171.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -63.72 -41.01 98.15 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.414 1.086 . . . . 0.0 113.26 -169.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -83.55 -12.67 55.86 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -175.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 90.4 m 49.21 64.3 1.79 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.353 1.461 . . . . 0.0 111.489 -167.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.14 136.18 54.7 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.59 0.756 . . . . 0.0 112.027 -177.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 17.5 t -63.52 123.69 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 C-N-CA 122.869 0.467 . . . . 0.0 109.842 175.227 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.0 pt -103.67 -21.68 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 125.291 1.436 . . . . 0.0 112.551 175.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -151.07 144.55 24.91 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.187 0.995 . . . . 0.0 111.217 178.066 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.457 ' HB3' ' CE1' ' A' ' 48' ' ' PHE . 0.3 OUTLIER -135.46 140.65 45.02 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.411 1.084 . . . . 0.0 111.136 -177.685 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -78.96 -175.35 4.48 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 119.97 1.259 . . . . 0.0 112.403 176.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -90.95 -27.2 18.86 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 120.455 -1.403 . . . . 0.0 111.955 172.168 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -70.93 -41.64 61.49 Favored Glycine 0 C--N 1.343 0.95 0 O-C-N 121.869 -0.52 . . . . 0.0 112.248 -174.091 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.457 ' CE1' ' HB3' ' A' ' 44' ' ' CYS . 0.4 OUTLIER -69.39 -28.56 66.27 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.185 0.594 . . . . 0.0 112.332 -179.307 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 93.2 m -53.89 -51.76 62.65 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.18 0.992 . . . . 0.0 111.32 177.078 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -70.99 -19.72 62.5 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.111 0.964 . . . . 0.0 113.582 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 15.2 tp -62.81 -46.43 87.98 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.989 1.316 . . . . 0.0 111.788 -179.07 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 44.1 t -95.68 -33.52 12.29 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.167 0.987 . . . . 0.0 113.035 171.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.38 7.57 51.52 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 124.753 1.168 . . . . 0.0 114.091 -173.688 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -84.89 -158.3 0.35 Allowed 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 118.775 1.287 . . . . 0.0 112.36 168.442 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 10.5 t -155.83 170.24 22.55 Favored 'General case' 0 C--O 1.24 0.581 0 O-C-N 120.772 -1.205 . . . . 0.0 111.643 176.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 -47.46 -47.76 27.04 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.091 1.356 . . . . 0.0 111.44 176.218 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.05 -26.82 64.92 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -89.5 -36.07 15.6 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.192 0.997 . . . . 0.0 112.487 174.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 80.8 t -84.46 -17.12 10.32 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 C-N-CA 124.962 1.305 . . . . 0.0 111.914 -176.411 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 44.6 mtm -67.59 140.58 56.92 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 120.524 -1.36 . . . . 0.0 110.453 173.34 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 12.4 mt-30 67.77 9.64 7.24 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.566 1.546 . . . . 0.0 114.061 -178.557 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -83.86 155.11 64.82 Favored Pre-proline 0 N--CA 1.472 0.654 0 C-N-CA 124.611 1.165 . . . . 0.0 110.428 170.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.27 133.99 25.87 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.614 2.209 . . . . 0.0 109.029 166.125 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 3.9 t -65.6 -15.26 62.56 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -171.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 40.8 p -57.67 -28.26 63.61 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.586 1.554 . . . . 0.0 112.581 169.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 86.2 m 56.65 41.6 28.16 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.303 1.441 . . . . 0.0 112.099 -178.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -57.84 -27.45 63.21 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.687 1.195 . . . . 0.0 113.232 -175.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -62.47 -15.6 50.71 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 174.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 80.4 mt -79.47 -13.68 59.41 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 173.086 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 31.0 m170 -73.25 118.93 16.79 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 119.211 0.914 . . . . 0.0 110.911 -179.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -99.65 -164.32 29.26 Favored Glycine 0 CA--C 1.539 1.534 0 C-N-CA 125.841 1.686 . . . . 0.0 112.574 177.036 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -70.07 -25.15 27.46 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 123.096 2.531 . . . . 0.0 113.019 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 40.2 ttt180 -84.39 -14.84 48.32 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.898 0.879 . . . . 0.0 112.974 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 31.7 m -69.28 143.99 53.71 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.083 1.353 . . . . 0.0 112.074 -171.195 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 19.9 mp0 -91.19 118.08 30.16 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.308 1.443 . . . . 0.0 110.257 -168.317 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 57.6 mmm-85 -58.92 -36.46 74.76 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 121.414 -0.804 . . . . 0.0 113.011 -178.453 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 25.1 tpp180 -61.58 -45.27 94.82 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.212 1.005 . . . . 0.0 111.528 175.265 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -72.08 -40.46 68.25 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.104 -0.998 . . . . 0.0 112.724 179.161 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.42 -34.9 64.83 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.504 0.721 . . . . 0.0 112.017 173.033 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -73.38 -48.2 35.96 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 124.572 1.149 . . . . 0.0 112.291 172.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -58.62 -35.29 72.25 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 118.536 -0.745 . . . . 0.0 111.998 -178.451 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 80.7 mt -63.49 -35.63 73.23 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 CA-C-N 120.191 1.36 . . . . 0.0 112.293 172.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.13 -36.63 66.72 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 118.888 0.767 . . . . 0.0 112.339 173.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 48.3 mm-40 -68.91 -32.93 72.91 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.491 0.717 . . . . 0.0 111.74 175.26 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -58.61 -21.08 52.49 Favored 'General case' 0 CA--C 1.548 0.88 0 O-C-N 121.168 -0.957 . . . . 0.0 113.358 177.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 57.6 mt -83.74 -15.3 49.1 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.669 1.588 . . . . 0.0 113.89 177.223 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -85.69 -20.87 28.73 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 119.611 1.096 . . . . 0.0 112.183 173.729 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -82.36 149.75 27.89 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 125.042 1.306 . . . . 0.0 113.444 -178.267 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.66 -2.22 57.85 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.013 1.325 . . . . 0.0 114.008 178.068 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -126.27 162.53 25.25 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 126.177 1.791 . . . . 0.0 111.386 -173.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -59.75 136.03 57.87 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.559 1.144 . . . . 0.0 111.931 -178.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.2 129.99 22.96 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.674 1.19 . . . . 0.0 110.311 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 30.9 mtmt -109.26 140.57 42.74 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.565 1.546 . . . . 0.0 111.715 176.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 41.4 t -139.51 136.35 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 126.173 1.789 . . . . 0.0 108.849 178.521 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -104.31 135.41 45.82 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.262 1.025 . . . . 0.0 110.594 176.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.0 tt -161.11 150.57 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 123.623 0.769 . . . . 0.0 112.554 -165.544 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -86.72 123.36 31.8 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 121.402 -0.811 . . . . 0.0 112.165 173.151 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 12.0 m-30 -114.04 140.21 48.64 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 127.157 2.183 . . . . 0.0 111.6 175.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -77.7 162.61 26.86 Favored 'General case' 0 CA--C 1.55 0.942 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 172.193 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 13.2 ptt180 -122.64 155.66 35.92 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.758 1.223 . . . . 0.0 112.723 166.468 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -52.87 -28.21 22.02 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 126.354 1.861 . . . . 0.0 114.453 -176.068 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -68.06 -12.87 61.62 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.178 1.391 . . . . 0.0 113.683 177.094 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 94.79 22.95 22.22 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 125.007 1.289 . . . . 0.0 113.569 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 7.9 t -120.36 -173.1 2.5 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.595 1.158 . . . . 0.0 111.576 177.01 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 16.8 t -144.91 154.33 42.49 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.007 1.323 . . . . 0.0 112.514 -169.193 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -150.55 148.71 29.0 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.765 1.626 . . . . 0.0 110.97 177.369 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -74.72 134.26 41.92 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.712 0.768 . . . . 0.0 109.827 166.064 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 35.1 t -129.55 145.62 51.45 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.827 2.051 . . . . 0.0 110.235 -177.426 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 14.8 tp -93.9 127.31 39.6 Favored 'General case' 0 N--CA 1.463 0.175 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 161.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 68.7 t -101.87 127.23 55.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 161.323 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -122.3 121.77 37.51 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 119.289 0.95 . . . . 0.0 109.568 165.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 57.0 t -84.74 133.0 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 175.568 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 49.8 t -113.67 110.71 49.43 Favored Pre-proline 0 N--CA 1.467 0.411 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 170.259 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.85 129.99 12.06 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.903 2.402 . . . . 0.0 109.645 178.246 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 74.3 t -103.46 125.04 58.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.074 0.949 . . . . 0.0 109.587 178.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 66.7 mttt -94.11 153.98 17.84 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 172.381 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -93.49 -173.89 3.33 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.55 1.14 . . . . 0.0 111.506 176.324 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -60.27 -22.05 62.65 Favored 'General case' 0 CA--C 1.548 0.865 0 C-N-CA 125.038 1.335 . . . . 0.0 114.406 178.514 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -90.81 -5.52 55.51 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.144 1.377 . . . . 0.0 112.981 178.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 79.9 22.44 63.75 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 124.476 1.036 . . . . 0.0 114.458 -179.525 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -107.26 150.06 27.08 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.065 1.346 . . . . 0.0 110.001 173.098 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 86.8 t -78.25 125.95 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 123.551 0.74 . . . . 0.0 109.353 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.53 -23.27 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 -176.272 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 56.1 mtm -131.49 151.6 51.43 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.621 1.168 . . . . 0.0 112.155 170.1 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -110.63 135.25 51.55 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 124.985 1.314 . . . . 0.0 109.108 166.143 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 64.4 mt -102.19 119.15 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 165.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -95.31 118.09 31.45 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 172.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -107.58 131.92 53.84 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 123.338 0.399 . . . . 0.0 110.475 177.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 13.3 m-30 -108.76 147.94 31.26 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 125.724 1.609 . . . . 0.0 111.585 -177.207 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -148.63 141.9 25.12 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 125.3 1.44 . . . . 0.0 109.168 176.241 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 45.3 t -76.6 122.54 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 175.143 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.7 t -89.94 -39.74 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 125.025 1.33 . . . . 0.0 111.089 175.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 24.7 ttm -171.53 126.43 0.63 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.39 1.076 . . . . 0.0 110.957 -175.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -78.17 125.89 30.01 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 121.303 -0.873 . . . . 0.0 110.016 169.22 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt . . . . . 0 C--O 1.254 1.336 0 C-N-CA 125.038 1.335 . . . . 0.0 113.58 179.225 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.1 ttp . . . . . 0 N--CA 1.494 1.728 0 CA-C-O 118.429 -0.796 . . . . 0.0 110.709 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -76.63 155.03 35.38 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 123.53 2.82 . . . . 0.0 111.343 175.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.6 p -165.06 143.67 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.905 1.282 . . . . 0.0 110.971 -179.296 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 37.9 mmt180 -112.98 127.28 56.18 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.164 1.386 . . . . 0.0 110.396 174.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 84.4 mtp180 -84.92 165.78 17.37 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.127 1.371 . . . . 0.0 112.28 -178.168 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 102.41 -9.65 56.0 Favored Glycine 0 N--CA 1.477 1.424 0 C-N-CA 125.763 1.649 . . . . 0.0 115.085 176.152 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 59.4 m80 -142.69 156.93 45.1 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.793 1.637 . . . . 0.0 110.846 175.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.8 p -163.75 149.36 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 125.267 1.427 . . . . 0.0 110.696 -178.214 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.83 151.72 84.37 Favored Pre-proline 0 CA--C 1.552 1.05 0 C-N-CA 124.088 0.955 . . . . 0.0 112.248 174.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -67.38 114.78 3.38 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 123.134 2.556 . . . . 0.0 110.586 -179.11 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -76.67 -34.67 58.22 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.648 0.779 . . . . 0.0 112.933 -177.35 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -117.4 64.98 0.73 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 127.351 2.26 . . . . 0.0 110.151 -177.47 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 41.2 p -49.5 -32.24 11.81 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 127.327 2.251 . . . . 0.0 114.136 -177.116 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -69.81 -50.62 41.2 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.033 0.933 . . . . 0.0 111.911 175.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 58.9 tp -61.84 -35.75 79.19 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.903 1.281 . . . . 0.0 111.154 176.306 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -56.69 -31.45 64.47 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.125 0.97 . . . . 0.0 112.671 177.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.2 m -72.13 -31.98 66.51 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.376 0.67 . . . . 0.0 111.175 174.273 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 16.1 mm -73.04 -41.8 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.889 0.876 . . . . 0.0 110.366 176.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 97.1 mt -54.47 -48.15 69.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.0 0.92 . . . . 0.0 110.019 174.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 81.6 mtt-85 -59.68 -27.18 66.19 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -78.18 -24.39 47.23 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.593 1.157 . . . . 0.0 113.112 177.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -90.31 -29.34 18.18 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.252 1.021 . . . . 0.0 112.75 170.071 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -70.32 177.04 3.54 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.688 1.195 . . . . 0.0 112.755 172.219 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.96 14.09 82.53 Favored Glycine 0 N--CA 1.471 1.026 0 C-N-CA 124.367 0.984 . . . . 0.0 113.399 176.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 63.19 17.52 10.26 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 127.437 2.295 . . . . 0.0 112.261 -173.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 48.8 m -81.59 41.46 0.63 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 126.56 1.944 . . . . 0.0 112.559 -176.14 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -67.41 166.63 14.18 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 122.554 1.169 . . . . 0.0 111.3 174.139 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -104.46 142.09 35.21 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.285 1.434 . . . . 0.0 111.09 -163.201 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -166.03 162.24 17.81 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.366 1.066 . . . . 0.0 113.751 -178.438 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 31.4 pt -147.13 156.11 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 127.406 2.282 . . . . 0.0 110.081 -178.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.9 mp -122.03 131.61 72.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 125.126 1.371 . . . . 0.0 109.505 176.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -125.21 147.79 48.92 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 124.959 1.304 . . . . 0.0 111.499 176.503 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -77.88 130.0 36.07 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.105 0.478 . . . . 0.0 111.454 175.233 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.37 -21.01 62.92 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.632 1.173 . . . . 0.0 113.902 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 82.3 mtm180 -89.63 -4.56 57.75 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 114.622 1.342 . . . . 0.0 114.622 -167.411 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 32.4 m -108.99 150.49 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 125.114 1.366 . . . . 0.0 111.7 -173.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -50.21 -55.02 16.96 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 126.163 1.785 . . . . 0.0 114.03 -167.322 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -105.51 30.74 5.46 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.956 1.703 . . . . 0.0 111.689 -177.142 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 70.8 m 39.25 54.3 2.23 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 126.24 1.816 . . . . 0.0 113.299 170.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.8 141.04 56.63 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.773 0.829 . . . . 0.0 111.759 -168.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.5 t -65.18 121.51 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 174.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.1 pt -100.51 -15.61 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 125.171 1.389 . . . . 0.0 112.648 177.091 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -156.24 141.85 17.76 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.616 1.167 . . . . 0.0 111.198 176.711 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.534 ' HB3' ' CE1' ' A' ' 48' ' ' PHE . 3.3 m -129.66 156.56 44.04 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.971 0.909 . . . . 0.0 111.311 -178.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -78.71 -166.13 0.83 Allowed 'General case' 0 CA--C 1.558 1.272 0 CA-C-N 118.922 0.783 . . . . 0.0 111.274 164.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -111.54 -19.57 12.49 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 125.565 1.546 . . . . 0.0 112.77 168.091 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.19 -38.98 94.34 Favored Glycine 0 N--CA 1.472 1.047 0 C-N-CA 124.604 1.097 . . . . 0.0 111.942 176.391 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.534 ' CE1' ' HB3' ' A' ' 44' ' ' CYS . 0.6 OUTLIER -69.42 -30.87 68.91 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.73 0.812 . . . . 0.0 111.444 -176.454 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 83.4 m -49.63 -54.62 17.37 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.2 1.4 . . . . 0.0 111.905 174.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -72.74 -19.91 61.3 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -178.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 16.5 tp -65.01 -49.2 71.12 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.48 1.112 . . . . 0.0 111.461 179.148 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 79.0 m -107.8 -15.94 14.44 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 -177.363 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.39 -0.29 59.87 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 125.453 1.502 . . . . 0.0 114.428 172.384 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -84.39 -154.95 0.18 Allowed 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 124.757 1.223 . . . . 0.0 112.314 171.395 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.0 t -159.11 168.49 26.49 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 120.604 -1.31 . . . . 0.0 111.652 173.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 36.5 ttm180 -49.56 -49.49 46.12 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.247 1.419 . . . . 0.0 111.044 176.384 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.82 -27.87 53.47 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -87.98 -49.26 7.18 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.447 1.099 . . . . 0.0 110.651 175.231 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 69.2 t -72.16 -19.25 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 124.363 1.065 . . . . 0.0 112.13 -172.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 5.4 mmt -64.21 -2.13 1.96 Allowed 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 5.8 tm0? -132.87 14.95 4.32 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.667 1.187 . . . . 0.0 112.341 173.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 37.4 mmt180 -98.48 155.43 36.82 Favored Pre-proline 0 C--O 1.24 0.588 0 C-N-CA 125.459 1.504 . . . . 0.0 111.395 178.426 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.17 142.07 37.22 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.206 2.604 . . . . 0.0 110.192 172.537 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 3.2 t -66.15 -11.02 46.62 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 -177.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 40.0 p -68.79 -25.66 64.81 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.344 1.458 . . . . 0.0 112.223 171.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 83.6 m 51.41 42.89 29.65 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.464 1.506 . . . . 0.0 113.013 -177.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -56.42 -31.74 64.2 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.455 1.502 . . . . 0.0 112.978 -175.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -64.85 -15.57 62.02 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.493 1.117 . . . . 0.0 113.932 177.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 87.1 mt -80.69 -11.12 59.68 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.212 1.005 . . . . 0.0 113.019 172.064 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -76.8 119.48 20.62 Favored 'General case' 0 CA--C 1.546 0.789 0 O-C-N 121.063 -1.023 . . . . 0.0 110.492 -178.122 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -97.8 -167.26 32.05 Favored Glycine 0 CA--C 1.539 1.546 0 C-N-CA 125.684 1.612 . . . . 0.0 112.366 175.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -68.21 -25.59 36.81 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 123.045 2.497 . . . . 0.0 112.96 177.484 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -87.61 -5.34 58.78 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.076 0.951 . . . . 0.0 112.847 178.587 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 63.4 m -70.33 133.44 46.95 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 120.986 -1.071 . . . . 0.0 109.942 179.084 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 49.8 mm-40 -80.99 123.16 28.11 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -171.273 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -64.65 -32.8 74.63 Favored 'General case' 0 N--CA 1.476 0.839 0 O-C-N 121.721 -0.612 . . . . 0.0 112.529 -172.304 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 23.5 tpp180 -61.57 -48.33 81.44 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.298 1.039 . . . . 0.0 111.429 170.421 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.36 -39.59 81.76 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 121.199 -0.938 . . . . 0.0 112.949 -177.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -54.82 -37.31 65.98 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.234 0.614 . . . . 0.0 112.541 171.543 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -72.6 -41.39 65.67 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.116 0.967 . . . . 0.0 112.821 173.139 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.461 ' HB2' HG21 ' A' ' 94' ' ' VAL . 47.9 mt-30 -56.25 -34.4 66.36 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 118.024 -0.989 . . . . 0.0 112.096 179.532 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 74.9 mt -61.79 -50.24 81.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 CA-C-N 120.197 1.362 . . . . 0.0 110.667 173.013 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.15 -37.0 83.03 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.825 0.85 . . . . 0.0 112.647 -178.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 79.4 mm-40 -72.71 -31.5 65.05 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.318 1.047 . . . . 0.0 111.776 175.594 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.54 -29.96 70.95 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 119.592 1.087 . . . . 0.0 112.512 179.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 64.6 mt -65.81 -16.58 63.94 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.914 1.286 . . . . 0.0 113.001 175.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 60.3 mt -80.62 -14.23 58.36 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 121.266 -0.896 . . . . 0.0 112.52 173.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -89.85 145.81 18.46 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 125.159 1.361 . . . . 0.0 113.23 -178.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.17 -2.8 58.11 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.974 1.31 . . . . 0.0 113.942 176.047 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -125.45 163.9 21.63 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.475 1.91 . . . . 0.0 110.984 -177.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -62.13 146.58 50.12 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.411 1.084 . . . . 0.0 112.907 -175.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.56 127.17 10.86 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.597 1.159 . . . . 0.0 110.514 -170.719 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.4 mttt -112.46 142.07 45.44 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.997 0.919 . . . . 0.0 112.463 172.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.461 HG21 ' HB2' ' A' ' 81' ' ' GLN . 7.6 p -134.13 133.39 55.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 126.255 1.822 . . . . 0.0 111.275 171.818 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -93.51 129.56 39.67 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.712 1.605 . . . . 0.0 110.023 172.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.7 tt -158.13 147.77 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.497 1.119 . . . . 0.0 111.339 -166.398 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -84.64 127.79 34.26 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 120.723 -1.236 . . . . 0.0 111.6 174.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 9.7 m-30 -107.69 140.14 41.19 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.686 1.594 . . . . 0.0 110.134 171.426 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -108.14 124.16 49.82 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.989 1.715 . . . . 0.0 110.651 175.555 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 2.5 ptp180 -92.23 159.9 15.41 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.821 1.249 . . . . 0.0 113.755 -177.636 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -58.81 -22.46 58.6 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 125.272 1.429 . . . . 0.0 114.322 179.157 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -70.61 -12.34 61.5 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.501 1.12 . . . . 0.0 113.349 176.388 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 95.35 27.15 11.03 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 124.53 1.062 . . . . 0.0 113.693 178.242 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 69.0 m -132.8 169.07 17.25 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.735 1.214 . . . . 0.0 111.414 -177.159 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 22.8 p -139.82 169.9 16.86 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 179.073 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -164.82 154.62 13.52 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 126.308 1.843 . . . . 0.0 110.348 -176.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -76.81 121.4 23.3 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.952 0.882 . . . . 0.0 110.124 168.208 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 49.5 t -104.7 140.44 38.06 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 127.755 2.422 . . . . 0.0 109.92 174.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 14.2 tp -93.0 119.0 31.8 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 160.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 44.2 t -103.45 117.19 48.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 124.476 1.11 . . . . 0.0 108.452 172.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -105.33 120.85 42.61 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.375 1.47 . . . . 0.0 108.314 174.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.2 p -93.64 131.09 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 119.483 1.038 . . . . 0.0 109.365 164.043 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 99.5 t -119.43 103.85 46.26 Favored Pre-proline 0 CA--C 1.537 0.46 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 176.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -75.78 139.76 22.66 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.906 2.404 . . . . 0.0 110.574 -175.592 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 96.3 t -112.37 125.33 69.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.353 1.061 . . . . 0.0 109.76 -178.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 67.2 mttt -93.55 154.54 17.82 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.036 0.934 . . . . 0.0 113.26 171.075 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -93.09 -174.21 3.49 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.497 1.119 . . . . 0.0 111.521 176.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -61.67 -20.69 63.71 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.013 1.325 . . . . 0.0 114.548 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -95.39 0.02 53.04 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.856 1.263 . . . . 0.0 113.162 177.026 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 79.31 22.55 64.9 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 124.155 0.883 . . . . 0.0 114.788 176.43 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -107.24 150.41 26.68 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.134 1.374 . . . . 0.0 109.987 172.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 59.1 t -79.1 124.97 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 123.565 0.746 . . . . 0.0 109.284 -179.225 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -127.01 -22.41 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 -176.101 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 53.8 mtm -133.46 154.51 50.74 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.905 1.282 . . . . 0.0 112.552 172.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -119.18 132.94 56.02 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 125.581 1.552 . . . . 0.0 109.556 170.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 41.6 mt -100.66 117.39 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 167.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -102.98 135.42 44.69 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 173.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -130.48 127.44 39.2 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.321 1.049 . . . . 0.0 110.129 -171.825 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -108.02 139.39 42.73 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.817 1.647 . . . . 0.0 111.647 -173.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -147.72 135.03 20.61 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.129 1.372 . . . . 0.0 109.728 175.194 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 49.9 t -73.39 117.71 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 CA-C-N 119.365 0.984 . . . . 0.0 108.611 174.006 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.9 p -95.51 -24.62 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 123.597 0.759 . . . . 0.0 112.666 178.711 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 14.5 tpt -165.8 134.98 3.26 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.358 1.463 . . . . 0.0 110.411 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -92.28 130.4 37.98 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.482 -0.761 . . . . 0.0 110.979 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt . . . . . 0 C--O 1.253 1.272 0 C-N-CA 125.332 1.453 . . . . 0.0 113.941 178.394 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.4 ttm . . . . . 0 N--CA 1.494 1.751 0 CA-C-O 118.431 -0.795 . . . . 0.0 110.689 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -75.92 141.21 23.83 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 123.254 2.636 . . . . 0.0 110.85 175.562 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 19.4 m -139.34 38.88 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 124.832 1.253 . . . . 0.0 111.454 -177.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 12.3 ptp85 -65.77 -19.21 65.81 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 115.205 1.558 . . . . 0.0 115.205 -171.529 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 76.5 mtp85 -128.03 133.25 49.09 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.922 1.689 . . . . 0.0 110.378 174.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -89.93 -54.38 2.19 Favored Glycine 0 N--CA 1.475 1.262 0 C-N-CA 124.783 1.183 . . . . 0.0 112.726 -176.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 66.1 t60 69.22 -33.66 0.25 Allowed 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 128.319 2.647 . . . . 0.0 115.765 170.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.8 p -55.29 -42.97 69.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 126.098 1.759 . . . . 0.0 114.58 -173.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 164.57 157.98 0.07 OUTLIER Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 129.446 3.099 . . . . 0.0 108.392 -165.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -80.53 128.87 7.14 Favored 'Trans proline' 0 CA--C 1.538 0.725 0 C-N-CA 122.444 2.096 . . . . 0.0 111.632 178.002 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 14.3 mp0 -83.99 -31.89 25.26 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.98 0.912 . . . . 0.0 112.735 173.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -135.0 32.66 3.18 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.902 1.281 . . . . 0.0 113.755 -162.343 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.8 t -45.83 -35.52 4.51 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 128.186 2.594 . . . . 0.0 114.628 -172.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -65.01 -50.81 64.83 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.197 0.599 . . . . 0.0 111.567 176.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 54.5 tp -64.33 -35.98 82.62 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.201 1.4 . . . . 0.0 111.022 172.46 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.5 -28.6 67.19 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.677 1.191 . . . . 0.0 112.688 178.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 94.4 m -74.29 -33.34 63.2 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.47 1.108 . . . . 0.0 110.869 173.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.2 mm -73.6 -36.22 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 124.351 1.06 . . . . 0.0 111.108 176.266 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 96.5 mt -57.04 -42.59 79.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 123.488 0.715 . . . . 0.0 110.818 176.196 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 89.3 mtt-85 -61.54 -22.05 64.81 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 176.463 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -76.07 -35.96 59.2 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 120.885 -1.134 . . . . 0.0 112.131 177.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -96.99 -11.85 24.04 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 114.559 1.318 . . . . 0.0 114.559 176.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -64.1 162.33 14.48 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 119.537 1.062 . . . . 0.0 111.91 162.59 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -80.14 -7.11 88.82 Favored Glycine 0 N--CA 1.473 1.129 0 C-N-CA 124.8 1.191 . . . . 0.0 114.812 -174.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 64.07 30.02 14.02 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.826 1.651 . . . . 0.0 113.195 169.354 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.2 m -72.42 -9.88 59.08 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.498 1.119 . . . . 0.0 113.941 178.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.3 mpt_? -75.41 166.67 23.24 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.661 1.185 . . . . 0.0 111.243 176.023 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -87.29 139.92 30.07 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.235 1.014 . . . . 0.0 110.667 -177.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -164.43 163.24 22.3 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 124.588 1.155 . . . . 0.0 112.889 177.116 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 20.5 pt -139.57 155.35 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 125.852 1.661 . . . . 0.0 110.576 173.184 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 16.0 mt -113.2 129.55 68.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 125.687 1.595 . . . . 0.0 108.479 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -127.07 144.87 50.92 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 124.53 1.132 . . . . 0.0 111.249 176.568 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 42.8 t-20 -68.16 127.61 33.54 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.344 0.657 . . . . 0.0 111.146 178.18 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -83.04 -20.21 35.42 Favored 'General case' 0 CA--C 1.546 0.812 0 O-C-N 121.364 -0.835 . . . . 0.0 113.085 176.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 75.2 mtp180 -77.73 41.01 0.32 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 126.345 1.858 . . . . 0.0 112.759 -175.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.5 p -170.37 138.24 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 126.895 2.078 . . . . 0.0 109.985 -168.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -61.07 -44.67 97.03 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.043 0.937 . . . . 0.0 112.286 -176.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -72.55 -23.18 60.95 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -176.586 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 89.3 m 57.87 58.95 3.37 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.755 1.222 . . . . 0.0 112.411 -175.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.0 135.83 56.8 Favored 'General case' 0 CA--C 1.551 0.998 0 O-C-N 121.203 -0.936 . . . . 0.0 112.528 -177.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 11.5 t -62.52 123.65 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 C-N-CA 123.473 0.709 . . . . 0.0 109.502 174.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.6 pt -104.61 -19.93 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 125.181 1.392 . . . . 0.0 112.354 176.321 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 21.3 t80 -153.98 146.17 23.78 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.864 0.866 . . . . 0.0 111.866 177.256 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 6.9 m -125.35 155.42 40.32 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.185 0.994 . . . . 0.0 111.161 171.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -71.34 -152.35 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.285 0 CA-C-N 118.362 0.528 . . . . 0.0 111.487 170.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -117.11 -17.52 10.26 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 120.229 -1.544 . . . . 0.0 113.205 164.442 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -76.3 -33.55 48.54 Favored Glycine 0 N--CA 1.471 1.007 0 O-C-N 121.324 -0.86 . . . . 0.0 112.852 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -58.13 -38.44 76.53 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.6 1.16 . . . . 0.0 111.599 177.425 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 9.9 t -53.0 -51.16 62.54 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.362 1.465 . . . . 0.0 111.825 173.258 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -74.02 -22.86 59.41 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -178.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 49.5 tp -65.16 -50.0 67.67 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.292 1.037 . . . . 0.0 111.815 176.168 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 80.6 m -105.86 -20.47 13.43 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 -174.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.77 6.01 70.56 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 124.585 1.088 . . . . 0.0 114.032 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -88.61 -175.72 5.03 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.578 1.151 . . . . 0.0 112.295 171.744 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 66.5 m -135.41 161.25 35.97 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.104 0.962 . . . . 0.0 111.104 -179.548 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 46.7 ttm180 -53.37 -42.49 66.95 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 121.497 -0.752 . . . . 0.0 111.842 178.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.04 -28.1 49.61 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 175.044 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -92.96 -35.2 13.42 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.818 1.247 . . . . 0.0 112.324 178.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 99.3 t -83.64 -12.52 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 124.509 1.123 . . . . 0.0 112.181 178.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 21.3 mmt -68.57 141.86 55.35 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 120.798 -1.189 . . . . 0.0 112.278 172.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 68.74 7.3 6.04 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 126.011 1.724 . . . . 0.0 113.609 -178.788 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -78.13 152.77 79.56 Favored Pre-proline 0 N--CA 1.472 0.667 0 CA-C-O 117.921 -1.038 . . . . 0.0 109.904 175.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -74.37 13.02 0.95 Allowed 'Trans proline' 0 CA--C 1.549 1.229 0 C-N-CA 124.319 3.346 . . . . 0.0 115.356 176.487 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 7.5 t 75.14 -27.6 0.19 Allowed 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 126.86 2.064 . . . . 0.0 113.922 167.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 38.8 p -58.92 -19.3 41.2 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 127.162 2.185 . . . . 0.0 113.92 173.331 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . 0.277 28.5 p 42.81 40.29 2.04 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 127.308 2.243 . . . . 0.0 114.31 178.624 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -57.59 -32.91 67.65 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.026 0.931 . . . . 0.0 111.765 -177.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -57.04 -15.75 5.79 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.155 1.382 . . . . 0.0 114.253 177.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 89.9 mt -75.18 -2.29 27.17 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 171.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 31.4 p-80 -60.55 133.22 55.89 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 119.826 1.194 . . . . 0.0 112.946 174.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -107.39 -161.95 21.55 Favored Glycine 0 CA--C 1.54 1.651 0 C-N-CA 126.229 1.871 . . . . 0.0 111.468 168.239 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.05 -26.02 18.75 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 123.083 2.522 . . . . 0.0 113.153 178.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 29.8 ttm180 -94.38 -8.09 39.74 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.547 1.139 . . . . 0.0 113.715 -176.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 25.8 m -64.6 139.41 58.76 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.254 1.421 . . . . 0.0 110.555 179.036 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -102.43 123.03 45.46 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.174 0.989 . . . . 0.0 109.735 179.651 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 42.5 mmt180 -61.58 -26.91 68.27 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 24.6 tpp180 -56.21 -46.0 79.65 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.472 1.109 . . . . 0.0 111.797 171.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.36 -45.57 65.82 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.449 1.1 . . . . 0.0 111.954 175.236 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.52 -33.34 63.68 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 121.62 -0.675 . . . . 0.0 112.709 177.124 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.59 -41.85 71.78 Favored 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 125.1 1.36 . . . . 0.0 112.502 173.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 24.5 mm-40 -60.81 -33.48 73.08 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 118.328 -0.844 . . . . 0.0 111.347 179.143 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 46.1 mt -59.36 -43.66 90.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 CA-C-N 120.042 1.292 . . . . 0.0 111.026 171.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.2 -35.8 74.16 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.327 0.651 . . . . 0.0 112.71 177.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 78.4 mm-40 -69.27 -32.52 71.76 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 121.604 -0.685 . . . . 0.0 111.861 174.2 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.71 -23.21 67.04 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.936 0.894 . . . . 0.0 112.771 178.536 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 61.1 mt -77.26 -15.04 59.63 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.677 1.591 . . . . 0.0 113.45 174.169 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 64.2 mt -89.97 -14.67 33.56 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.124 0.969 . . . . 0.0 112.426 179.154 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -92.64 148.48 19.11 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 125.164 1.364 . . . . 0.0 113.15 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.84 -1.57 58.02 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.721 1.208 . . . . 0.0 113.83 175.551 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -115.33 161.32 18.66 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.711 2.004 . . . . 0.0 111.208 176.372 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.79 154.34 39.37 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 178.15 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 29.9 tpt180 -155.07 129.14 8.82 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.635 1.174 . . . . 0.0 111.148 -175.242 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 39.5 mtmt -102.68 137.63 40.65 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.598 1.559 . . . . 0.0 111.622 174.272 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 64.4 t -132.97 134.94 57.7 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 C-N-CA 126.414 1.885 . . . . 0.0 108.025 177.099 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -106.0 130.61 53.9 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.765 0.826 . . . . 0.0 110.381 177.394 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.0 tt -156.98 147.2 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 124.022 0.929 . . . . 0.0 112.217 -166.137 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -85.73 126.66 34.15 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.027 -1.046 . . . . 0.0 111.858 174.394 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 18.3 m-30 -111.92 147.8 35.07 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.528 1.931 . . . . 0.0 111.116 172.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -101.25 150.14 23.29 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.8 0.84 . . . . 0.0 112.538 166.415 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 40.9 mtm180 -89.59 159.03 17.38 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.956 1.302 . . . . 0.0 112.283 169.311 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 5.9 mptp? -59.19 -27.16 65.44 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.02 0.928 . . . . 0.0 112.639 166.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -69.93 -11.46 60.89 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 126.255 1.822 . . . . 0.0 114.067 173.269 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 90.39 -0.67 78.22 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 125.472 1.51 . . . . 0.0 114.471 -176.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -76.74 154.63 33.9 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.533 1.133 . . . . 0.0 111.451 176.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 95.5 m -126.99 156.96 40.78 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 119.382 0.992 . . . . 0.0 112.176 174.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -161.42 154.68 21.25 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.851 1.26 . . . . 0.0 111.998 177.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -77.72 122.78 25.83 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.627 0.771 . . . . 0.0 110.392 165.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 8.2 t -107.55 140.95 39.75 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 126.083 1.753 . . . . 0.0 110.224 173.667 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.3 tt -92.16 121.59 33.84 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 125.158 1.383 . . . . 0.0 107.491 162.34 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 48.0 t -101.0 111.37 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 125.068 1.347 . . . . 0.0 108.484 169.121 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -107.75 107.78 18.71 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.612 1.565 . . . . 0.0 108.997 174.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.407 HG22 ' HG ' ' A' ' 127' ' ' LEU . 50.4 t -78.43 126.91 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 170.642 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 75.6 t -114.36 116.3 44.19 Favored Pre-proline 0 CA--C 1.538 0.51 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 170.434 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.69 127.0 9.9 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 123.238 2.625 . . . . 0.0 109.736 179.168 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 63.0 t -97.18 118.64 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 123.736 0.815 . . . . 0.0 109.279 174.487 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 60.4 mttt -88.48 153.51 21.1 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.675 0.79 . . . . 0.0 112.587 171.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -93.02 -173.52 3.3 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.518 1.127 . . . . 0.0 111.747 175.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -60.7 -21.36 62.8 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 125.206 1.402 . . . . 0.0 114.705 178.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -93.93 -0.82 55.43 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.854 1.262 . . . . 0.0 113.22 177.153 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 79.11 22.05 66.46 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 124.222 0.915 . . . . 0.0 114.537 177.688 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -107.29 147.89 29.69 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 125.119 1.368 . . . . 0.0 109.923 172.103 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.6 p -77.82 126.38 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 123.405 0.682 . . . . 0.0 110.273 178.349 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.58 -22.45 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 -175.557 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 57.7 mtm -131.99 150.96 52.01 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.779 1.231 . . . . 0.0 112.068 168.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -107.92 133.7 51.89 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 125.06 1.344 . . . . 0.0 109.215 165.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 69.2 mt -97.15 119.0 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 163.027 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.407 ' HG ' HG22 ' A' ' 112' ' ' VAL . 8.6 mp -96.47 119.09 34.32 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 169.313 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -102.81 124.88 49.16 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 123.547 0.529 . . . . 0.0 110.984 177.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -100.9 126.88 47.55 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.232 1.413 . . . . 0.0 109.998 179.232 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -141.53 103.94 4.48 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.38 1.072 . . . . 0.0 108.246 -172.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.2 p -61.51 116.9 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 O-C-N 120.981 -1.074 . . . . 0.0 110.473 178.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.9 p -96.76 -27.54 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.817 1.247 . . . . 0.0 113.102 -174.201 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 24.7 ptp -161.41 147.17 14.02 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.24 1.016 . . . . 0.0 112.64 166.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -88.93 134.31 34.0 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.705 0.802 . . . . 0.0 110.845 177.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt . . . . . 0 C--O 1.253 1.246 0 C-N-CA 125.36 1.464 . . . . 0.0 112.473 177.114 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.8 mmt . . . . . 0 N--CA 1.495 1.78 0 CA-C-O 118.837 -0.602 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -75.35 162.15 36.67 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 123.713 2.942 . . . . 0.0 111.796 176.38 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 19.7 m -142.1 152.53 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 125.407 1.483 . . . . 0.0 110.707 175.173 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -161.67 143.69 11.6 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.464 1.106 . . . . 0.0 111.603 -176.153 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 7.2 ppt_? -159.76 157.57 29.61 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.97 1.708 . . . . 0.0 112.018 175.127 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -122.38 -144.94 6.88 Favored Glycine 0 N--CA 1.474 1.196 0 C-N-CA 125.987 1.756 . . . . 0.0 112.24 174.556 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 11.7 p-80 -83.95 151.29 25.14 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 124.049 0.94 . . . . 0.0 111.081 165.599 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.8 p -76.72 -37.5 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 O-C-N 121.279 -0.888 . . . . 0.0 113.384 -173.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 62.98 152.67 0.11 Allowed Pre-proline 0 CA--C 1.557 1.232 0 C-N-CA 127.234 2.213 . . . . 0.0 112.932 -169.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -68.88 120.4 7.31 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 122.556 2.171 . . . . 0.0 111.281 -177.617 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 80.5 mm-40 -109.39 -31.96 7.34 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.219 1.008 . . . . 0.0 112.681 179.344 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -140.92 41.99 1.82 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.795 1.638 . . . . 0.0 112.277 -168.089 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.8 t -55.95 -23.29 31.18 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 126.634 1.974 . . . . 0.0 114.815 -170.249 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -75.28 -45.09 42.07 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.252 -0.905 . . . . 0.0 112.018 172.655 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 52.9 tp -63.18 -35.94 81.96 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.764 1.226 . . . . 0.0 111.16 171.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -52.1 -33.31 39.01 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.548 1.539 . . . . 0.0 112.583 175.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 21.4 m -72.65 -21.56 61.07 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.546 1.538 . . . . 0.0 112.02 176.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.6 mm -82.22 -39.56 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 124.168 0.987 . . . . 0.0 109.953 177.411 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.9 mp -55.21 -38.95 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 123.422 0.689 . . . . 0.0 111.367 177.127 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 50.0 ptt85 -73.45 -16.86 61.3 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -178.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -85.69 -36.77 20.04 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.121 1.368 . . . . 0.0 111.297 171.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -70.74 -28.83 65.0 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.485 1.114 . . . . 0.0 112.029 174.021 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -76.43 168.34 20.24 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 167.405 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 122.6 -21.86 7.49 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 127.128 2.299 . . . . 0.0 112.554 -176.162 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 26.3 mp0 -92.5 -19.98 21.43 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.513 1.125 . . . . 0.0 112.256 173.091 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.9 m 79.66 16.19 0.86 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 126.984 2.113 . . . . 0.0 113.395 168.474 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.1 173.26 10.34 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 122.557 1.17 . . . . 0.0 111.477 172.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.7 mptt -97.74 139.09 34.14 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.512 1.525 . . . . 0.0 110.351 -179.015 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -162.15 160.93 27.8 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 124.072 0.949 . . . . 0.0 113.127 173.474 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 12.8 pt -139.72 153.22 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 125.996 1.718 . . . . 0.0 109.937 175.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.2 mp -116.5 133.31 63.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 C-N-CA 125.337 1.455 . . . . 0.0 109.146 -179.092 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -132.54 142.81 49.35 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 124.825 1.25 . . . . 0.0 111.815 -176.176 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -65.56 121.69 15.51 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.518 1.127 . . . . 0.0 111.944 177.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -78.82 -19.87 51.03 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 178.473 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 26.0 mmm180 -73.31 -40.65 64.34 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.468 1.107 . . . . 0.0 112.527 -175.066 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 32.6 m -73.55 147.78 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 124.013 0.925 . . . . 0.0 111.892 175.694 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -62.22 -42.02 98.92 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.574 1.149 . . . . 0.0 113.225 -172.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -77.32 -11.32 59.82 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 113.785 1.032 . . . . 0.0 113.785 -176.266 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 81.6 m 51.03 60.31 3.97 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.451 1.5 . . . . 0.0 111.776 -170.188 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.06 137.51 55.07 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.749 0.82 . . . . 0.0 112.023 -176.608 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 41.4 t -63.71 123.79 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 123.723 0.809 . . . . 0.0 109.263 174.085 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.6 pt -103.83 -19.74 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.727 1.211 . . . . 0.0 112.298 175.37 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -154.08 143.72 21.66 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.34 1.056 . . . . 0.0 111.506 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 4.2 m -125.62 157.63 36.73 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.816 1.246 . . . . 0.0 111.594 174.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -73.79 -149.95 0.02 OUTLIER 'General case' 0 CA--C 1.56 1.364 0 CA-C-N 118.622 0.646 . . . . 0.0 111.399 169.091 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -116.72 -18.69 10.2 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 120.425 -1.422 . . . . 0.0 113.266 163.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -76.0 -34.98 45.83 Favored Glycine 0 N--CA 1.471 0.99 0 O-C-N 121.276 -0.89 . . . . 0.0 112.684 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -55.29 -39.12 69.5 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.857 1.263 . . . . 0.0 111.605 177.011 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 2.8 t -54.6 -56.76 15.65 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.69 1.596 . . . . 0.0 112.09 176.59 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -71.31 -20.54 62.18 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -179.177 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.8 -53.51 56.96 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.64 1.176 . . . . 0.0 110.947 175.129 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 75.9 m -104.94 -31.97 8.99 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 -174.124 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 109.72 0.12 30.55 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 127.207 2.337 . . . . 0.0 115.945 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -79.58 -160.75 0.28 Allowed 'General case' 0 CA--C 1.554 1.102 0 CA-C-N 118.786 1.293 . . . . 0.0 112.466 177.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 69.8 m -145.01 160.91 40.62 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.055 1.342 . . . . 0.0 110.582 174.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -53.03 -44.11 67.09 Favored 'General case' 0 N--CA 1.478 0.956 0 O-C-N 121.355 -0.841 . . . . 0.0 111.668 177.349 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.69 -25.95 42.45 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 176.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -91.69 -39.46 11.82 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.024 1.33 . . . . 0.0 112.176 177.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 87.4 t -80.81 -15.84 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 124.502 1.121 . . . . 0.0 112.277 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 68.2 mmm -65.72 137.87 57.58 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 120.843 -1.16 . . . . 0.0 111.34 172.08 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 29.7 tp60 72.92 6.14 5.29 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 126.508 1.923 . . . . 0.0 113.633 -177.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 34.6 mmt180 -86.88 153.1 54.61 Favored Pre-proline 0 N--CA 1.473 0.699 0 C-N-CA 124.548 1.139 . . . . 0.0 110.84 176.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -71.52 136.01 27.56 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.109 2.539 . . . . 0.0 110.092 171.287 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 19.0 p -68.69 -7.67 35.53 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -176.075 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 41.2 p -62.3 -23.97 67.04 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.065 1.346 . . . . 0.0 112.124 168.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 84.0 m 57.69 36.5 26.69 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.617 1.567 . . . . 0.0 113.009 178.307 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -56.16 -29.44 60.81 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.766 1.226 . . . . 0.0 112.24 177.186 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -60.62 -13.68 15.84 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.852 1.261 . . . . 0.0 114.357 175.437 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.3 mt -90.35 -0.65 57.73 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.112 1.365 . . . . 0.0 113.853 174.423 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -70.96 161.52 30.95 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 -178.576 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -160.85 -164.62 16.08 Favored Glycine 0 CA--C 1.538 1.52 0 C-N-CA 126.857 2.17 . . . . 0.0 111.052 166.382 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -63.54 -20.47 69.6 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 123.083 2.522 . . . . 0.0 114.523 -176.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 27.1 mmt85 -88.66 -8.54 54.43 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 119.298 0.954 . . . . 0.0 113.306 175.648 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 28.7 m -73.7 132.4 42.65 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 119.464 1.029 . . . . 0.0 109.502 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 -87.07 122.16 30.52 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.366 0.666 . . . . 0.0 109.761 -169.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 31.9 mmm180 -58.86 -39.17 80.53 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.771 0.828 . . . . 0.0 112.608 -175.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 17.6 ttm180 -67.99 -35.79 78.93 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.649 0.779 . . . . 0.0 112.31 176.234 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -71.6 -43.07 66.87 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.061 -1.024 . . . . 0.0 112.217 179.112 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -56.15 -33.38 65.16 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.161 0.584 . . . . 0.0 111.83 171.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -72.37 -47.65 47.78 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 124.703 1.201 . . . . 0.0 112.259 172.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 13.6 mm-40 -62.28 -34.25 76.2 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 118.404 -0.808 . . . . 0.0 111.775 -179.037 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 90.7 mt -62.61 -40.06 86.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 CA-C-N 120.198 1.363 . . . . 0.0 111.557 171.748 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.86 -37.08 81.39 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 119.296 0.953 . . . . 0.0 112.361 174.544 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 -67.65 -32.18 72.69 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 121.591 -0.693 . . . . 0.0 112.04 173.519 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.43 -21.97 66.61 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 119.239 0.927 . . . . 0.0 112.761 176.179 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 41.1 mt -83.38 -14.87 51.82 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.282 1.433 . . . . 0.0 113.134 172.254 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 74.8 mt -89.9 -16.89 29.07 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.003 0.921 . . . . 0.0 112.01 171.507 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -83.31 145.52 23.16 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 125.159 1.361 . . . . 0.0 112.5 176.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.81 -4.63 56.49 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -179.222 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -125.57 160.92 28.37 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.452 1.901 . . . . 0.0 110.652 -178.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -65.11 147.17 53.95 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -176.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.48 123.84 5.91 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.627 1.171 . . . . 0.0 111.147 -164.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 44.1 mtmt -97.65 141.84 30.19 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.2 1.4 . . . . 0.0 112.735 176.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 56.8 t -139.2 138.63 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 126.356 1.863 . . . . 0.0 108.738 174.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -102.15 129.93 48.65 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.163 0.985 . . . . 0.0 110.713 177.027 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.8 tt -153.22 148.2 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 124.614 1.166 . . . . 0.0 111.847 -168.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -87.78 119.06 27.74 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 120.969 -1.082 . . . . 0.0 111.472 176.571 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 13.7 m-30 -106.46 140.25 39.66 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.991 1.716 . . . . 0.0 110.9 174.366 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -92.69 142.3 27.52 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.022 0.929 . . . . 0.0 112.805 176.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 43.0 ttm-85 -80.2 156.57 26.86 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.629 1.972 . . . . 0.0 110.404 174.03 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 25.6 mmmt -58.02 -26.53 62.55 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 176.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -78.58 -5.98 54.3 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.635 1.574 . . . . 0.0 113.984 177.652 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 92.14 1.46 69.71 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 125.039 1.304 . . . . 0.0 114.455 -176.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 8.6 t -77.45 178.44 7.19 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 118.319 1.059 . . . . 0.0 111.763 171.11 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 39.4 t -151.42 154.77 37.27 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.78 1.232 . . . . 0.0 112.376 -170.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -158.81 154.4 26.08 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.232 1.813 . . . . 0.0 110.882 179.123 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -81.22 124.78 29.58 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 121.815 0.817 . . . . 0.0 110.403 170.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 36.6 t -111.59 140.8 45.91 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.638 1.975 . . . . 0.0 110.801 177.433 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 18.8 tp -93.15 115.72 28.35 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.996 1.318 . . . . 0.0 108.163 165.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 81.4 t -99.37 118.22 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 171.226 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -109.69 109.42 20.14 Favored 'General case' 0 C--O 1.225 -0.198 0 C-N-CA 125.689 1.596 . . . . 0.0 108.411 172.059 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 71.5 t -78.66 130.43 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 169.04 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 78.1 t -117.22 111.33 40.4 Favored Pre-proline 0 N--CA 1.466 0.361 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 167.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.83 133.79 18.99 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.751 2.301 . . . . 0.0 109.884 179.395 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 41.1 t -91.74 119.62 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 173.189 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 66.0 mttt -92.96 151.9 19.65 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.649 0.738 . . . . 0.0 112.365 167.677 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -92.2 -173.87 3.57 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.959 0.904 . . . . 0.0 111.7 175.174 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -60.81 -21.3 62.99 Favored 'General case' 0 CA--C 1.548 0.865 0 C-N-CA 125.083 1.353 . . . . 0.0 114.553 178.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -93.99 -0.42 55.54 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.396 1.078 . . . . 0.0 113.105 177.168 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 77.48 19.87 75.56 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 124.173 0.892 . . . . 0.0 114.465 179.063 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -98.73 146.81 25.51 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.796 1.238 . . . . 0.0 109.393 172.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 84.1 t -77.2 127.97 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 177.183 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 3.3 pt -123.39 -23.15 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 -171.461 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 72.2 mtm -150.58 157.42 42.97 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.855 1.662 . . . . 0.0 110.487 178.421 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -115.24 132.22 56.68 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 124.683 1.193 . . . . 0.0 109.98 173.165 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 46.7 mt -97.18 114.84 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 105.647 -1.983 . . . . 0.0 105.647 164.555 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -92.98 117.91 30.58 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 171.098 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -107.53 129.76 54.94 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 119.478 -0.296 . . . . 0.0 111.02 178.216 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -109.39 143.18 39.31 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.111 1.364 . . . . 0.0 111.928 -176.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -145.36 145.34 31.15 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 126.007 1.723 . . . . 0.0 108.553 172.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 60.7 t -84.49 117.02 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 174.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.0 p -93.17 -25.97 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -179.263 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 44.6 tpp -165.28 123.68 1.65 Allowed 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.799 1.24 . . . . 0.0 110.75 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -84.36 123.51 30.27 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 121.562 -0.711 . . . . 0.0 109.819 174.249 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.255 1.357 0 CA-C-O 115.744 -2.074 . . . . 0.0 115.463 -170.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.4 mtt . . . . . 0 N--CA 1.497 1.882 0 CA-C-O 118.771 -0.633 . . . . 0.0 110.944 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -72.39 160.97 45.62 Favored 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 123.723 2.949 . . . . 0.0 112.149 179.654 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 67.9 t -83.55 125.33 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 123.883 0.873 . . . . 0.0 109.712 178.624 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 43.4 ttt-85 -66.63 113.52 4.86 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.272 1.029 . . . . 0.0 111.088 179.436 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 9.8 ttm-85 48.72 28.99 2.03 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 127.458 2.303 . . . . 0.0 116.787 176.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.86 117.4 5.8 Favored Glycine 0 N--CA 1.472 1.076 0 C-N-CA 124.988 1.28 . . . . 0.0 111.196 178.074 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 7.6 p-80 -167.98 165.93 13.44 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.856 1.662 . . . . 0.0 111.708 -178.39 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 42.0 t -139.05 141.65 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 125.909 1.684 . . . . 0.0 108.637 174.459 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.59 150.69 55.44 Favored Pre-proline 0 CA--C 1.551 0.99 0 C-N-CA 124.263 1.025 . . . . 0.0 112.354 176.481 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -64.46 116.36 3.72 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.857 2.371 . . . . 0.0 110.636 -176.758 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 72.5 mm-40 -75.39 -35.38 61.08 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.468 0.707 . . . . 0.0 110.974 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -86.49 58.5 5.1 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.625 1.97 . . . . 0.0 111.749 177.638 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 43.2 p -50.92 -33.35 23.95 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 126.869 2.067 . . . . 0.0 113.749 -178.437 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -67.87 -47.72 68.11 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.94 0.896 . . . . 0.0 112.116 175.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 39.4 tp -63.15 -36.53 83.92 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.88 1.272 . . . . 0.0 111.072 175.487 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -59.93 -29.61 68.5 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.667 0.787 . . . . 0.0 112.815 179.151 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 73.8 m -72.74 -21.43 61.03 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.227 1.411 . . . . 0.0 111.935 173.275 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.7 mm -87.42 -42.71 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.087 1.355 . . . . 0.0 110.819 173.381 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 93.5 mt -53.68 -45.25 60.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 124.036 0.934 . . . . 0.0 110.598 178.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -66.09 -24.6 66.73 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 -179.336 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -79.06 -33.41 44.64 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.602 1.161 . . . . 0.0 111.949 175.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -73.56 -34.17 65.02 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.144 0.978 . . . . 0.0 111.496 170.303 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.45 178.39 5.3 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 114.395 1.257 . . . . 0.0 114.395 178.683 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 102.79 12.09 33.25 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 126.596 2.046 . . . . 0.0 112.039 -160.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -133.64 -24.3 1.77 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.636 1.174 . . . . 0.0 113.177 -171.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 75.29 16.57 2.69 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 126.114 1.766 . . . . 0.0 114.38 168.074 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? -73.0 166.42 23.11 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 120.771 -1.206 . . . . 0.0 111.883 174.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.5 mptt -89.96 134.83 34.0 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.351 1.46 . . . . 0.0 110.393 -177.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -159.4 161.7 35.65 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 124.289 1.036 . . . . 0.0 113.17 178.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 20.7 pt -140.02 161.46 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 126.671 1.988 . . . . 0.0 109.733 173.145 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.9 mp -126.26 133.88 67.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 C-N-CA 124.813 1.245 . . . . 0.0 109.545 177.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -130.85 144.71 51.65 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.673 1.189 . . . . 0.0 111.477 178.495 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -72.78 125.06 26.63 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 122.844 0.458 . . . . 0.0 111.436 178.069 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.22 -32.6 70.55 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.341 1.056 . . . . 0.0 112.412 -177.037 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 25.0 mmm180 -80.11 36.52 0.35 Allowed 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 126.082 1.753 . . . . 0.0 112.796 -173.221 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 70.3 t -144.07 133.38 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 126.719 2.008 . . . . 0.0 108.977 -171.37 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -56.61 -35.92 68.83 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 -172.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -103.05 -3.86 25.38 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.544 1.538 . . . . 0.0 113.05 -178.309 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 5.9 t 52.14 71.37 0.47 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 126.372 1.869 . . . . 0.0 111.664 -174.652 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.74 133.82 50.94 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 121.254 -0.904 . . . . 0.0 111.658 -176.316 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 15.6 t -62.62 120.66 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 CA-C-N 118.705 0.684 . . . . 0.0 109.159 171.711 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 42.9 pt -102.08 -21.68 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 124.766 1.227 . . . . 0.0 112.26 176.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -152.18 144.42 23.95 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.363 1.065 . . . . 0.0 111.575 178.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.468 ' HB3' ' CE1' ' A' ' 48' ' ' PHE . 0.6 OUTLIER -135.04 149.14 50.08 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.491 1.116 . . . . 0.0 111.53 -178.942 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -76.57 -168.96 1.1 Allowed 'General case' 0 CA--C 1.555 1.164 0 CA-C-N 119.226 0.921 . . . . 0.0 111.367 169.51 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -103.84 -21.63 13.63 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.248 1.419 . . . . 0.0 112.553 169.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.23 -36.18 60.09 Favored Glycine 0 C--N 1.343 0.917 0 O-C-N 121.578 -0.701 . . . . 0.0 112.551 -178.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.468 ' CE1' ' HB3' ' A' ' 44' ' ' CYS . 0.6 OUTLIER -67.68 -30.45 69.98 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 122.98 0.512 . . . . 0.0 111.869 179.53 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 77.6 m -53.53 -52.29 60.14 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.712 1.205 . . . . 0.0 111.757 174.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -71.38 -19.06 62.32 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.966 0.906 . . . . 0.0 113.211 -179.266 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.428 HD11 HG23 ' A' ' 131' ' ' VAL . 10.3 tp -64.21 -52.83 56.96 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.809 1.244 . . . . 0.0 111.313 179.259 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 71.0 m -101.87 -19.09 15.43 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 95.12 2.11 62.5 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 125.813 1.673 . . . . 0.0 114.344 177.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -83.95 -175.27 5.72 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.778 1.231 . . . . 0.0 113.224 170.41 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.443 ' H ' ' CG ' ' A' ' 58' ' ' GLU . 69.1 m -137.34 160.13 39.95 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 121.317 -0.865 . . . . 0.0 111.663 -179.076 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 36.1 ttm180 -46.28 -42.25 14.26 Favored 'General case' 0 N--CA 1.48 1.035 0 O-C-N 121.421 -0.799 . . . . 0.0 112.029 171.422 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.73 -32.84 63.72 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.899 1.28 . . . . 0.0 113.652 178.558 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.443 ' CG ' ' H ' ' A' ' 55' ' ' SER . 14.2 pt-20 -99.6 -23.65 14.99 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 177.05 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 85.3 t -85.26 -20.49 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 C-N-CA 124.83 1.252 . . . . 0.0 112.659 176.193 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 53.3 mmm -63.2 138.12 58.44 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 120.403 -1.436 . . . . 0.0 110.843 175.489 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 67.97 10.06 7.56 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.429 1.492 . . . . 0.0 114.094 179.18 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 -85.33 156.43 59.68 Favored Pre-proline 0 N--CA 1.472 0.668 0 C-N-CA 124.716 1.206 . . . . 0.0 111.059 174.286 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -67.27 127.17 16.17 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.495 2.13 . . . . 0.0 109.415 167.333 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.402 ' SG ' HD13 ' A' ' 127' ' ' LEU . 9.1 t -69.69 -8.88 51.62 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -172.321 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 37.5 p -59.83 -28.1 67.19 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.893 1.277 . . . . 0.0 112.163 169.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 80.9 m 52.35 36.24 19.32 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.208 1.403 . . . . 0.0 112.726 -177.704 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -57.67 -30.1 65.18 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.624 1.17 . . . . 0.0 112.327 -177.159 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -59.03 -14.26 9.05 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.186 1.395 . . . . 0.0 114.211 175.758 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 89.5 mt -78.73 -4.14 47.72 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 173.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 15.9 p-80 -60.71 150.57 31.83 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-N 120.123 1.328 . . . . 0.0 114.268 178.143 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -142.84 -162.76 9.42 Favored Glycine 0 CA--C 1.54 1.605 0 C-N-CA 126.64 2.067 . . . . 0.0 112.42 173.184 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -71.04 -8.83 24.45 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 123.623 2.882 . . . . 0.0 114.122 -178.2 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 84.8 mmt-85 -107.27 8.04 29.64 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.045 1.338 . . . . 0.0 113.531 175.427 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 22.2 m -89.95 133.24 34.9 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.89 1.276 . . . . 0.0 109.803 178.058 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -102.45 137.52 40.58 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.295 1.038 . . . . 0.0 109.871 -179.166 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 27.8 mmt85 -58.84 -37.88 77.45 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.987 0.915 . . . . 0.0 112.199 -177.25 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 31.6 tpt180 -59.73 -43.99 93.94 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.486 1.115 . . . . 0.0 112.258 176.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.49 -45.9 74.5 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 121.42 -0.8 . . . . 0.0 112.147 178.351 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -57.28 -35.66 70.06 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 121.645 -0.659 . . . . 0.0 112.522 174.463 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -72.15 -44.85 62.47 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 125.186 1.394 . . . . 0.0 112.377 175.161 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.3 mm100 -60.85 -34.98 75.42 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.946 0.899 . . . . 0.0 111.227 -179.009 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 93.0 mt -60.63 -41.57 88.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 CA-C-N 119.702 1.137 . . . . 0.0 111.841 169.446 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.78 -32.22 70.59 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 119.562 1.074 . . . . 0.0 112.805 174.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 73.9 mm-40 -64.19 -37.35 87.14 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 121.475 -0.765 . . . . 0.0 111.232 171.451 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.96 -23.13 65.1 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 113.229 0.826 . . . . 0.0 113.229 177.185 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 70.3 mt -87.53 -14.09 41.24 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.433 1.493 . . . . 0.0 114.059 178.682 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.1 pp -100.84 -8.14 22.89 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 168.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -86.26 146.09 20.85 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 125.18 1.371 . . . . 0.0 112.344 175.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -93.42 1.32 56.9 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.57 1.148 . . . . 0.0 113.601 176.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.14 159.92 23.08 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.071 1.748 . . . . 0.0 111.604 -178.567 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -62.23 135.24 57.39 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.281 1.432 . . . . 0.0 111.937 178.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -138.82 127.9 23.95 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.506 1.122 . . . . 0.0 112.44 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 37.1 mtmt -101.18 132.26 46.75 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.496 1.518 . . . . 0.0 110.465 167.481 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 46.8 t -133.38 134.5 57.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 125.597 1.559 . . . . 0.0 108.231 177.444 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -103.85 132.03 50.49 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.761 0.824 . . . . 0.0 110.666 179.624 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.3 tt -154.79 150.15 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 124.288 1.035 . . . . 0.0 111.729 -168.157 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -86.98 127.43 35.09 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 120.998 -1.064 . . . . 0.0 111.747 172.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 17.6 m-30 -114.05 138.92 49.74 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.612 1.965 . . . . 0.0 110.719 171.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -85.5 156.31 20.84 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.382 0.673 . . . . 0.0 112.13 167.156 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -115.02 157.61 23.23 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.061 1.344 . . . . 0.0 113.246 172.163 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -48.84 -33.59 10.87 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 127.141 2.176 . . . . 0.0 114.637 -178.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -70.57 -10.48 59.39 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.259 1.423 . . . . 0.0 113.895 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 97.09 13.05 47.28 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 125.29 1.424 . . . . 0.0 114.264 178.108 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 22.9 m -107.51 -177.49 3.36 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.696 1.198 . . . . 0.0 111.242 177.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 25.1 p -148.33 171.14 16.48 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 120.878 -1.138 . . . . 0.0 113.291 176.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 18.2 p90 -160.76 159.98 30.75 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.764 1.626 . . . . 0.0 111.468 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -80.44 123.2 27.85 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 123.528 0.731 . . . . 0.0 110.328 167.358 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 19.0 t -106.93 134.63 49.79 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.212 1.805 . . . . 0.0 110.356 172.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.0 tt -88.13 118.48 27.74 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 161.342 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 59.7 t -99.78 110.55 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 124.881 1.272 . . . . 0.0 108.217 169.119 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -102.89 111.47 23.81 Favored 'General case' 0 C--O 1.227 -0.081 0 C-N-CA 125.426 1.49 . . . . 0.0 108.055 172.322 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.449 HG22 ' HG ' ' A' ' 127' ' ' LEU . 28.0 t -95.17 124.1 47.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.048 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 74.7 t -110.34 115.38 54.38 Favored Pre-proline 0 CA--C 1.537 0.466 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 -178.55 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -73.96 124.18 8.95 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.947 2.431 . . . . 0.0 109.904 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 88.3 t -98.48 117.12 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 123.328 0.651 . . . . 0.0 109.724 173.719 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 61.5 mttt -87.39 154.33 20.75 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.883 0.873 . . . . 0.0 112.581 172.277 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -92.57 -173.53 3.39 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.386 1.075 . . . . 0.0 111.629 175.289 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -60.18 -22.25 62.69 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.039 1.336 . . . . 0.0 114.416 178.422 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -90.68 -5.39 55.86 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.058 1.343 . . . . 0.0 113.026 178.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 80.5 22.56 62.12 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 124.425 1.012 . . . . 0.0 114.48 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -108.33 148.38 30.14 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.281 1.432 . . . . 0.0 109.88 172.265 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.0 p -79.51 125.67 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 123.56 0.744 . . . . 0.0 110.615 179.398 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.23 -22.86 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 -174.718 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 56.8 mtm -132.19 154.83 49.17 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.288 1.435 . . . . 0.0 111.857 170.131 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -117.14 133.52 55.9 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 124.957 1.303 . . . . 0.0 109.27 168.33 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 55.4 mt -96.59 118.98 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 105.647 -1.982 . . . . 0.0 105.647 166.163 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.449 ' HG ' HG22 ' A' ' 112' ' ' VAL . 6.9 mp -103.88 117.32 34.06 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 177.66 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -107.71 126.62 52.83 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 123.417 0.448 . . . . 0.0 110.842 -176.418 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 16.5 m-30 -102.67 134.07 46.65 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.094 1.358 . . . . 0.0 110.49 -177.548 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -138.08 127.61 24.92 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 124.885 1.274 . . . . 0.0 109.369 176.01 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.428 HG23 HD11 ' A' ' 51' ' ' LEU . 71.5 t -74.43 110.75 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 175.248 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.3 p -93.99 -23.58 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 123.711 0.804 . . . . 0.0 112.705 -173.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 14.3 tpt -164.4 129.4 2.74 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.113 1.365 . . . . 0.0 110.461 179.086 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -89.22 124.33 34.27 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.551 0.74 . . . . 0.0 110.339 178.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 6.7 mmpt? . . . . . 0 C--O 1.253 1.273 0 CA-C-O 117.67 -1.157 . . . . 0.0 112.911 178.648 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.5 ttm . . . . . 0 N--CA 1.495 1.8 0 CA-C-O 118.467 -0.777 . . . . 0.0 110.545 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -75.94 155.29 38.61 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 123.547 2.831 . . . . 0.0 111.889 179.001 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 58.3 t -141.07 134.69 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 125.252 1.421 . . . . 0.0 109.196 176.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 39.6 ptt180 -163.92 166.02 22.12 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.549 1.54 . . . . 0.0 112.575 -177.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 66.16 26.25 10.6 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 126.418 1.887 . . . . 0.0 113.823 169.073 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -140.45 167.9 25.36 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 125.729 1.633 . . . . 0.0 113.632 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 7.0 p-80 -80.39 172.22 14.05 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 124.916 1.287 . . . . 0.0 112.443 173.302 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.5 p -57.19 129.06 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 124.159 0.983 . . . . 0.0 112.658 -176.408 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -88.07 152.08 50.18 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 124.815 1.246 . . . . 0.0 111.971 178.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -63.75 134.55 44.33 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.948 2.432 . . . . 0.0 110.061 174.016 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -73.37 -66.49 0.68 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.905 0.86 . . . . 0.0 110.612 -177.435 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 52.1 p-10 -147.18 168.19 22.28 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 126.986 2.114 . . . . 0.0 111.026 -171.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 39.0 p -140.49 -51.76 0.48 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.927 1.691 . . . . 0.0 112.41 -170.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -80.0 -48.01 14.02 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.658 0.783 . . . . 0.0 111.642 177.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 61.8 tp -61.67 -33.39 73.9 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.457 1.103 . . . . 0.0 111.314 177.359 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -55.22 -32.61 62.41 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.405 1.082 . . . . 0.0 113.271 174.329 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 27.8 m -76.56 -24.73 53.58 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.437 1.495 . . . . 0.0 111.369 176.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 17.0 mm -81.91 -42.32 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 124.059 0.944 . . . . 0.0 110.522 175.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 81.9 mt -54.34 -48.29 68.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 123.862 0.865 . . . . 0.0 110.61 177.155 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 36.7 ptt180 -65.85 -19.8 66.01 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 -178.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 24.6 mtpp -77.28 -33.1 55.9 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.52 1.055 . . . . 0.0 112.447 172.108 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -92.97 -12.07 31.68 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.145 1.378 . . . . 0.0 114.293 178.679 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -59.47 165.08 3.02 Favored 'General case' 0 CA--C 1.552 1.056 0 CA-C-O 122.353 1.073 . . . . 0.0 112.943 165.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -96.67 42.72 2.16 Favored Glycine 0 N--CA 1.468 0.83 0 C-N-CA 125.878 1.704 . . . . 0.0 114.668 -164.371 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 25.7 mp0 -74.18 62.22 0.91 Allowed 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.151 1.38 . . . . 0.0 111.292 174.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.7 t 95.4 -2.18 0.07 Allowed 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 128.936 2.894 . . . . 0.0 113.828 165.722 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -82.45 165.53 20.13 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 122.107 0.956 . . . . 0.0 111.645 178.35 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.3 mptt -98.88 138.61 35.76 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.32 1.448 . . . . 0.0 111.071 -171.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -162.93 161.93 25.96 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.229 1.012 . . . . 0.0 113.57 179.117 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 18.0 pt -140.88 157.52 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 126.529 1.931 . . . . 0.0 110.37 174.135 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 13.5 mt -119.27 134.51 62.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 125.897 1.679 . . . . 0.0 109.062 -178.309 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -135.86 151.27 49.86 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.205 1.402 . . . . 0.0 112.148 -178.288 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 34.7 p30 -80.3 111.55 16.78 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.133 0.973 . . . . 0.0 113.335 -174.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.8 -25.0 66.25 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 120.594 -1.316 . . . . 0.0 113.815 -173.27 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 52.3 mtm180 -84.2 -3.17 57.99 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 -173.564 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.4 t -109.49 137.16 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 125.434 1.494 . . . . 0.0 108.789 178.237 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -55.63 -41.58 73.73 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.447 1.099 . . . . 0.0 113.292 -172.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.3 p30 -78.03 -14.82 59.37 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 178.061 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 96.3 m 49.59 61.92 2.91 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.372 1.469 . . . . 0.0 112.492 -174.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.68 136.13 57.97 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.693 0.797 . . . . 0.0 112.448 179.221 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 43.7 t -60.8 119.4 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 169.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 45.4 pt -100.8 -17.55 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 125.534 1.533 . . . . 0.0 112.315 176.06 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -157.93 146.83 19.35 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.336 1.055 . . . . 0.0 112.099 178.631 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.528 ' HB3' ' CE1' ' A' ' 48' ' ' PHE . 1.9 m -131.24 153.8 49.13 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.462 1.105 . . . . 0.0 111.947 177.114 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -76.84 -166.9 0.75 Allowed 'General case' 0 CA--C 1.556 1.201 0 CA-C-N 118.939 0.79 . . . . 0.0 111.673 169.347 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -105.61 -19.16 13.86 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.496 1.518 . . . . 0.0 112.759 169.548 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -75.35 -35.99 46.18 Favored Glycine 0 C--N 1.343 0.968 0 O-C-N 121.488 -0.758 . . . . 0.0 112.549 -179.555 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.528 ' CE1' ' HB3' ' A' ' 44' ' ' CYS . 0.6 OUTLIER -65.4 -34.38 78.16 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.586 0.754 . . . . 0.0 111.59 179.72 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 57.2 m -51.42 -52.24 47.83 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.192 1.397 . . . . 0.0 111.799 172.51 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -71.85 -20.14 61.86 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -179.146 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.52 -54.06 42.13 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.51 1.124 . . . . 0.0 110.618 177.015 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 41.9 t -92.83 -32.64 14.56 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.53 1.84 55.47 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.447 1.499 . . . . 0.0 114.185 -175.017 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -81.69 -165.99 1.1 Allowed 'General case' 0 CA--C 1.555 1.151 0 CA-C-N 118.706 1.253 . . . . 0.0 113.055 171.097 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 32.8 m -142.39 160.02 41.09 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.894 1.278 . . . . 0.0 111.424 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -47.99 -49.16 31.71 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.018 0.927 . . . . 0.0 111.967 178.245 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.34 -25.9 37.58 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 179.417 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -89.62 -35.52 15.81 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.856 1.262 . . . . 0.0 112.124 178.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 18.9 t -93.67 -11.03 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.372 1.069 . . . . 0.0 112.659 -176.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 75.4 mmm -68.46 142.72 55.25 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 120.586 -1.321 . . . . 0.0 111.302 170.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 71.14 5.17 5.37 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 126.268 1.827 . . . . 0.0 113.77 -177.389 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -76.63 155.26 83.5 Favored Pre-proline 0 N--CA 1.475 0.817 0 C-N-CA 124.483 1.113 . . . . 0.0 110.317 173.691 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -74.58 12.23 1.16 Allowed 'Trans proline' 0 CA--C 1.549 1.234 0 C-N-CA 124.016 3.144 . . . . 0.0 116.273 179.064 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 5.8 t 75.24 -23.46 0.24 Allowed 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 126.6 1.96 . . . . 0.0 114.154 169.383 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 39.3 p -64.05 -21.73 66.64 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 127.561 2.344 . . . . 0.0 113.442 173.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 89.0 m 59.55 36.53 22.85 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.85 1.26 . . . . 0.0 113.168 -178.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -52.14 -36.39 51.27 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.797 1.639 . . . . 0.0 112.434 177.202 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -66.9 -11.39 55.96 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.715 1.206 . . . . 0.0 114.041 179.009 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 33.7 mt -93.75 -3.15 52.69 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.976 1.31 . . . . 0.0 113.649 171.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.417 ' CG ' HG21 ' A' ' 74' ' ' THR . 0.3 OUTLIER -77.95 118.82 20.62 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 121.092 -1.005 . . . . 0.0 110.318 -178.384 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -107.97 -162.95 21.19 Favored Glycine 0 CA--C 1.538 1.529 0 C-N-CA 126.189 1.852 . . . . 0.0 112.605 178.619 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -69.12 -22.43 35.04 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 123.339 2.693 . . . . 0.0 113.162 179.034 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 85.5 mtt85 -84.89 -12.2 53.97 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.16 0.984 . . . . 0.0 113.297 177.101 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.417 HG21 ' CG ' ' A' ' 70' ' ' HIS . 18.4 m -76.93 151.73 35.61 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.645 1.178 . . . . 0.0 111.244 -173.594 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.8 109.25 18.99 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.027 1.331 . . . . 0.0 109.144 -170.115 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 36.5 mmt180 -64.46 -24.24 67.55 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 121.449 -0.782 . . . . 0.0 112.996 179.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 20.5 tpp180 -58.71 -40.16 82.9 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.344 1.058 . . . . 0.0 112.327 168.629 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -77.8 -42.05 35.18 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.493 1.517 . . . . 0.0 112.161 175.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -54.18 -37.1 64.12 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 121.559 -0.713 . . . . 0.0 112.167 174.579 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.95 -47.81 76.32 Favored 'General case' 0 C--O 1.227 -0.113 0 C-N-CA 125.213 1.405 . . . . 0.0 111.291 175.419 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 22.3 mm-40 -61.51 -38.27 86.76 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 118.136 -0.935 . . . . 0.0 111.039 178.407 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 96.8 mt -63.16 -45.63 98.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 CA-C-N 120.439 1.472 . . . . 0.0 111.629 172.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.31 -39.48 92.51 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 118.898 0.772 . . . . 0.0 112.779 178.645 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -76.2 -25.75 55.46 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 124.049 0.94 . . . . 0.0 112.233 176.631 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -58.74 -29.92 67.09 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 120.172 1.351 . . . . 0.0 112.368 175.254 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 51.6 mt -67.51 -13.34 61.96 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.998 1.719 . . . . 0.0 113.442 175.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 66.9 mt -87.87 -13.62 41.57 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.307 1.043 . . . . 0.0 112.443 174.011 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -90.8 146.53 18.48 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 125.102 1.334 . . . . 0.0 113.542 -175.679 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -86.8 -7.74 57.97 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.899 1.279 . . . . 0.0 113.737 173.241 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -118.32 162.4 18.35 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.491 1.916 . . . . 0.0 111.428 -175.418 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -64.6 143.14 58.13 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.613 1.165 . . . . 0.0 112.912 -175.417 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 27.6 mmt180 -139.52 132.42 29.31 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.101 1.36 . . . . 0.0 111.546 176.43 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 38.3 mtmt -110.72 131.22 55.23 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.413 1.485 . . . . 0.0 109.854 167.586 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 64.3 t -132.44 137.08 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 125.126 1.371 . . . . 0.0 108.51 177.624 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -102.2 131.12 48.93 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.139 0.975 . . . . 0.0 110.762 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.3 tt -156.57 147.58 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.005 0.922 . . . . 0.0 112.033 -169.344 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -88.97 124.39 34.2 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 120.921 -1.112 . . . . 0.0 111.843 178.114 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 15.2 m-30 -113.02 134.3 54.58 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.702 1.601 . . . . 0.0 111.678 177.184 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -73.2 146.08 45.8 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.135 1.374 . . . . 0.0 112.308 169.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 32.4 ptt-85 -117.96 150.69 38.82 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.781 1.632 . . . . 0.0 112.609 173.125 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -61.83 -13.81 27.6 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.974 1.71 . . . . 0.0 114.373 -179.487 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -67.33 -12.9 61.35 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.548 1.139 . . . . 0.0 112.797 169.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 100.21 30.1 6.46 Favored Glycine 0 C--N 1.341 0.859 0 C-N-CA 124.914 1.245 . . . . 0.0 113.328 174.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 16.5 t -153.4 -168.33 2.97 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 118.303 1.051 . . . . 0.0 111.991 -174.749 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 27.0 t -146.64 161.13 41.2 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.203 1.401 . . . . 0.0 111.924 -166.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -165.16 163.35 20.36 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.202 1.801 . . . . 0.0 112.301 173.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -79.53 124.74 28.77 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 123.484 0.714 . . . . 0.0 110.783 176.326 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 34.0 t -107.2 136.85 46.33 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.254 1.822 . . . . 0.0 109.528 170.107 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 14.2 tp -88.08 123.28 32.6 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 161.325 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 60.5 t -108.75 116.91 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 125.336 1.454 . . . . 0.0 108.763 177.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -113.13 112.88 24.57 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.348 1.059 . . . . 0.0 108.991 -178.144 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.3 p -88.74 120.36 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 121.276 0.56 . . . . 0.0 109.706 172.507 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 90.5 t -104.25 111.76 65.26 Favored Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 125.341 1.456 . . . . 0.0 107.432 175.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.5 122.76 7.65 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 123.093 2.528 . . . . 0.0 109.418 177.42 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 60.2 t -94.59 117.8 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 174.376 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 20.3 mtpt -88.68 149.17 23.64 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.469 0.652 . . . . 0.0 111.175 172.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 51.2 p30 -77.77 -173.39 3.02 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.065 1.346 . . . . 0.0 111.997 175.701 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -66.24 -15.74 63.43 Favored 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 114.749 1.388 . . . . 0.0 114.749 175.068 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -97.25 -17.14 20.0 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.567 1.147 . . . . 0.0 113.271 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 86.36 40.48 7.36 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 125.846 1.689 . . . . 0.0 113.636 -174.372 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -115.06 151.31 34.48 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.267 1.427 . . . . 0.0 109.879 159.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.6 p -83.5 126.58 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 CA-C-N 119.055 0.843 . . . . 0.0 110.532 179.38 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.69 -27.04 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 -173.43 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 61.2 mtm -129.86 150.72 51.03 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.875 1.27 . . . . 0.0 112.117 171.064 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -110.75 133.22 53.52 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 125.458 1.503 . . . . 0.0 109.104 167.243 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 32.9 mt -102.8 119.94 51.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 165.331 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -100.35 119.62 38.71 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 175.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -107.31 127.8 53.88 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.437 1.095 . . . . 0.0 109.505 -177.438 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 16.1 m-30 -104.37 133.65 48.91 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.084 1.354 . . . . 0.0 110.571 -178.278 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -142.34 118.68 10.85 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 123.899 0.88 . . . . 0.0 109.758 173.36 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.0 p -68.27 115.01 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 O-C-N 121.437 -0.79 . . . . 0.0 109.525 176.589 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.3 p -99.57 -26.61 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 125.283 1.433 . . . . 0.0 113.315 -169.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 24.9 ptp -161.43 148.01 14.43 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.173 0.989 . . . . 0.0 112.898 168.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -90.46 130.04 36.57 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.019 0.927 . . . . 0.0 110.732 -179.48 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 7.0 mmpt? . . . . . 0 C--O 1.254 1.29 0 C-N-CA 124.355 1.062 . . . . 0.0 112.723 175.046 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.3 mtp . . . . . 0 N--CA 1.496 1.866 0 CA-C-O 118.42 -0.8 . . . . 0.0 110.679 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -78.48 155.43 28.2 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 123.507 2.804 . . . . 0.0 111.512 176.557 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 62.9 t -91.8 86.57 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 170.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 20.9 tpp180 -64.32 -43.57 94.26 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.469 1.108 . . . . 0.0 112.948 -169.534 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -122.65 147.27 46.64 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.122 1.769 . . . . 0.0 109.692 170.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -81.11 164.47 46.15 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.477 1.037 . . . . 0.0 111.68 171.458 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 59.4 m-70 -81.55 161.01 23.73 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 124.283 1.033 . . . . 0.0 112.013 176.345 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -137.44 -67.87 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 C-N-CA 123.685 0.794 . . . . 0.0 111.523 -174.649 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 40.75 55.91 7.76 Favored Pre-proline 0 CA--C 1.562 1.409 0 N-CA-C 117.597 2.443 . . . . 0.0 117.597 -174.413 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -85.21 36.86 0.56 Allowed 'Trans proline' 0 CA--C 1.544 0.991 1 C-N-CA 126.731 4.954 . . . . 0.0 111.348 176.469 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 -83.97 -159.77 0.4 Allowed 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.716 0.807 . . . . 0.0 109.663 -178.574 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 22.1 p30 -73.88 140.98 46.06 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 120.113 -1.617 . . . . 0.0 109.919 167.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 37.1 p -120.98 -45.56 2.37 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.4 1.48 . . . . 0.0 111.719 -172.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -71.54 -46.77 58.62 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.498 0.719 . . . . 0.0 111.221 176.14 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 64.5 tp -63.15 -36.09 82.46 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.081 0.953 . . . . 0.0 111.138 176.534 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -59.85 -29.26 68.16 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 174.273 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 66.3 m -77.04 -19.88 56.6 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.014 1.325 . . . . 0.0 111.505 175.078 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 22.5 mm -84.33 -43.64 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 125.258 1.423 . . . . 0.0 111.351 170.39 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 71.6 mt -58.38 -35.54 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 O-C-N 121.424 -0.798 . . . . 0.0 111.022 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -72.47 -7.95 52.53 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 179.402 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 17.6 mtmt -84.32 -42.08 16.14 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.215 1.406 . . . . 0.0 110.731 171.305 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -79.72 -40.18 29.49 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.045 1.338 . . . . 0.0 113.054 179.166 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -81.5 -28.2 34.15 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 118.972 0.806 . . . . 0.0 112.231 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 99.98 97.88 2.21 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 126.436 1.969 . . . . 0.0 112.337 169.694 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -61.58 -13.76 24.47 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.228 1.411 . . . . 0.0 114.294 178.714 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.2 m -68.22 -23.74 64.84 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.191 0.996 . . . . 0.0 113.15 170.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -78.35 150.51 33.2 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.193 0.997 . . . . 0.0 109.872 170.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.78 134.61 34.89 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 120.753 -1.217 . . . . 0.0 111.394 178.573 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -157.89 153.64 26.63 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.311 1.044 . . . . 0.0 112.928 178.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 15.2 pt -140.62 150.14 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 125.871 1.668 . . . . 0.0 109.758 175.473 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.7 mp -114.27 132.29 63.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 125.364 1.466 . . . . 0.0 108.983 -178.138 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -132.72 147.42 52.32 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 124.9 1.28 . . . . 0.0 111.849 -176.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 24.2 p30 -73.71 119.25 17.67 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.566 0.746 . . . . 0.0 112.217 -178.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.81 -29.13 61.99 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 120.705 -1.247 . . . . 0.0 112.191 -178.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 29.6 mmm180 -74.61 27.48 0.08 Allowed 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 126.486 1.914 . . . . 0.0 114.039 -176.339 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 84.9 t -147.33 136.61 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 126.942 2.097 . . . . 0.0 108.805 -171.174 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -56.93 -43.17 81.18 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.596 1.159 . . . . 0.0 113.019 -173.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -80.2 -14.97 58.02 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -177.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 96.5 m 49.85 68.34 0.76 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.614 1.566 . . . . 0.0 111.487 -168.655 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.26 136.23 44.56 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.562 0.745 . . . . 0.0 111.516 -174.485 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 39.8 t -63.74 122.48 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 174.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.6 pt -102.99 -19.66 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 124.987 1.315 . . . . 0.0 112.312 175.364 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -155.3 144.73 21.13 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.886 0.874 . . . . 0.0 112.54 178.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.44 ' HB3' ' CE1' ' A' ' 48' ' ' PHE . 1.8 m -130.63 152.95 49.44 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.767 1.227 . . . . 0.0 112.656 -179.551 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -75.22 -166.8 0.54 Allowed 'General case' 0 CA--C 1.557 1.216 0 C-N-CA 122.905 0.482 . . . . 0.0 112.074 170.151 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -102.9 -23.07 13.76 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.296 1.438 . . . . 0.0 112.705 168.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.85 -34.0 59.58 Favored Glycine 0 N--CA 1.47 0.917 0 C-N-CA 124.892 1.234 . . . . 0.0 112.754 -177.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.44 ' CE1' ' HB3' ' A' ' 44' ' ' CYS . 0.6 OUTLIER -71.4 -32.87 68.93 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 123.904 0.882 . . . . 0.0 111.268 -176.98 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 6.2 t -53.74 -49.26 68.54 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.637 1.175 . . . . 0.0 111.658 171.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -75.56 -21.19 58.1 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -179.082 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 47.6 tp -63.6 -48.59 76.73 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 121.488 -0.757 . . . . 0.0 111.198 172.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 17.8 t -103.76 -30.63 10.28 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 -172.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.25 6.79 58.67 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 124.307 0.955 . . . . 0.0 114.568 -176.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -88.42 -155.54 0.33 Allowed 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 118.698 1.249 . . . . 0.0 111.655 169.523 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 12.2 t -162.06 169.12 21.54 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 120.564 -1.335 . . . . 0.0 111.006 175.27 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -53.51 -44.74 69.32 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.12 0.968 . . . . 0.0 111.394 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.85 -28.49 56.66 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 119.811 1.187 . . . . 0.0 114.025 177.151 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -92.01 -38.12 12.42 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.854 1.262 . . . . 0.0 112.018 177.454 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 79.1 t -79.38 -19.07 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 126.057 1.743 . . . . 0.0 111.508 -177.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.39 131.56 50.67 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 120.895 -1.128 . . . . 0.0 110.788 172.842 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 8.0 tm0? 75.49 5.76 4.05 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 126.229 1.812 . . . . 0.0 113.561 179.366 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 34.7 mmt180 -85.71 153.01 57.83 Favored Pre-proline 0 N--CA 1.473 0.696 0 C-N-CA 124.536 1.134 . . . . 0.0 111.352 176.525 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -69.98 134.92 28.66 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 123.133 2.555 . . . . 0.0 109.978 171.316 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 20.6 p -67.52 -11.57 58.31 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 114.848 1.425 . . . . 0.0 114.848 -174.325 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 46.9 p -58.44 -30.53 66.98 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.379 1.472 . . . . 0.0 112.114 172.669 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 91.7 m 51.82 35.21 14.89 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.041 1.336 . . . . 0.0 112.604 -173.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -58.4 -29.72 66.27 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.427 1.091 . . . . 0.0 112.331 -179.297 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -60.91 -10.36 5.57 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.371 1.468 . . . . 0.0 114.307 175.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 58.0 mt -84.8 2.01 44.18 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.937 1.295 . . . . 0.0 113.952 173.237 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 13.8 p-80 -66.29 154.5 39.79 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 114.724 1.379 . . . . 0.0 114.724 177.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -151.9 -163.94 11.88 Favored Glycine 0 CA--C 1.54 1.609 0 C-N-CA 127.359 2.409 . . . . 0.0 111.231 167.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.95 -23.08 62.12 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 123.01 2.473 . . . . 0.0 114.916 -173.481 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 40.1 mmt180 -89.75 -4.28 57.75 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 119.509 1.049 . . . . 0.0 113.644 174.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 31.5 m -73.3 134.18 44.11 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 119.534 1.061 . . . . 0.0 109.532 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 81.2 mm-40 -91.03 117.53 29.66 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -174.089 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 7.9 tmm_? -59.6 -37.07 77.57 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 121.535 -0.728 . . . . 0.0 112.013 -176.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 25.7 tpt180 -61.22 -40.22 93.2 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.184 0.994 . . . . 0.0 112.087 173.629 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -71.68 -41.45 68.66 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 120.755 -1.216 . . . . 0.0 112.706 177.106 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -56.16 -35.03 66.71 Favored 'General case' 0 CA--C 1.546 0.815 0 O-C-N 121.644 -0.66 . . . . 0.0 111.846 172.056 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.1 -47.76 56.27 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.8 1.24 . . . . 0.0 112.571 172.634 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -57.71 -37.27 73.23 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 118.764 0.711 . . . . 0.0 111.402 178.502 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 85.5 mt -62.46 -38.83 82.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 CA-C-N 120.098 1.317 . . . . 0.0 112.068 173.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.71 -38.07 76.8 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 119.326 0.966 . . . . 0.0 112.169 174.46 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 94.4 mm-40 -66.86 -31.8 72.65 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.55 0.74 . . . . 0.0 111.916 174.271 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.48 -23.52 66.97 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.997 0.919 . . . . 0.0 112.718 177.162 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 41.6 mt -82.81 -15.06 53.11 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.255 1.422 . . . . 0.0 113.257 173.295 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 73.7 mt -90.19 -16.2 29.94 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.236 1.015 . . . . 0.0 112.002 173.253 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -85.33 148.35 22.96 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 125.238 1.399 . . . . 0.0 112.754 176.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -96.69 4.34 51.91 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 114.279 1.215 . . . . 0.0 114.279 -179.568 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.32 160.9 30.75 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.349 1.86 . . . . 0.0 110.324 177.214 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -64.53 145.89 55.44 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -178.377 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 12.5 tpt180 -148.22 129.57 14.77 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.114 1.366 . . . . 0.0 110.94 -172.091 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 39.7 mtmt -104.55 138.42 40.94 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.514 1.525 . . . . 0.0 111.274 178.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 45.0 t -139.23 134.67 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 125.163 1.385 . . . . 0.0 109.292 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -101.43 128.41 47.64 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.835 0.854 . . . . 0.0 111.082 178.608 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.5 tt -153.95 147.2 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 124.924 1.29 . . . . 0.0 111.694 -167.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -84.84 123.88 30.96 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 120.716 -1.24 . . . . 0.0 111.462 173.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 10.2 m-30 -105.64 145.32 31.18 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.807 1.643 . . . . 0.0 110.695 172.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -110.61 131.24 55.22 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.232 1.413 . . . . 0.0 111.716 175.625 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 59.4 mtt180 -71.21 165.5 23.49 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.922 1.689 . . . . 0.0 112.54 174.609 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -66.47 -23.02 66.2 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.088 0.955 . . . . 0.0 112.753 170.089 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -73.36 -11.71 60.58 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.626 1.571 . . . . 0.0 113.814 172.597 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 90.27 -3.95 82.44 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 125.267 1.413 . . . . 0.0 114.352 -175.531 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 30.4 m -77.25 164.51 25.52 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 118.213 1.007 . . . . 0.0 111.644 175.332 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 30.6 p -145.91 166.07 27.09 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 120.9 -1.125 . . . . 0.0 114.007 -178.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -165.44 160.49 18.0 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.154 1.781 . . . . 0.0 110.918 -178.624 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -79.72 121.69 25.64 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.746 0.818 . . . . 0.0 110.453 169.058 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 44.5 t -105.64 138.48 41.77 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 127.463 2.305 . . . . 0.0 109.687 174.154 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 15.4 tp -96.65 112.88 24.45 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 164.649 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 95.7 t -94.51 114.36 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 124.994 1.318 . . . . 0.0 108.564 174.245 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -106.23 107.59 18.67 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.991 1.316 . . . . 0.0 107.835 175.076 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 61.3 t -77.78 130.1 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 166.13 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 88.6 t -119.55 112.49 35.53 Favored Pre-proline 0 CA--C 1.537 0.462 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 167.498 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -74.59 134.59 18.75 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.738 2.292 . . . . 0.0 109.91 -179.467 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 45.5 t -92.81 119.4 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 171.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 66.1 mttt -93.01 151.95 19.59 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 121.648 0.737 . . . . 0.0 112.294 168.251 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -91.61 -173.78 3.66 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.887 0.875 . . . . 0.0 111.66 174.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -60.26 -22.11 62.68 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.986 1.315 . . . . 0.0 114.347 178.399 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -90.44 -5.6 55.9 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.747 1.219 . . . . 0.0 113.055 178.479 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 79.15 20.14 70.59 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 124.371 0.986 . . . . 0.0 114.262 -178.113 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -98.99 146.49 25.97 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.788 1.235 . . . . 0.0 109.46 172.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 96.5 t -76.09 128.49 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 176.336 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 3.3 pt -122.91 -24.87 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 113.863 1.061 . . . . 0.0 113.863 -172.487 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 71.4 mtm -147.82 155.09 41.29 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.492 1.517 . . . . 0.0 110.473 177.281 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -112.26 132.65 54.82 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.453 1.101 . . . . 0.0 109.774 171.244 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 56.6 mt -97.57 115.93 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 163.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -95.19 125.78 40.07 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 171.613 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -114.42 123.6 49.86 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 118.65 -0.691 . . . . 0.0 111.713 179.189 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 17.9 m-30 -108.9 97.6 7.21 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.409 1.484 . . . . 0.0 113.435 -170.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -109.26 112.9 25.31 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 120.231 -1.543 . . . . 0.0 109.743 -177.159 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.3 p -62.86 108.09 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 O-C-N 121.236 -0.915 . . . . 0.0 110.105 173.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.3 p -85.59 -23.77 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 125.199 1.4 . . . . 0.0 112.749 -176.408 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 32.5 ttm -163.43 124.89 2.41 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.71 1.204 . . . . 0.0 110.686 -175.284 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -81.12 127.02 32.18 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.216 0.606 . . . . 0.0 109.943 172.571 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 6.4 mmpt? . . . . . 0 C--O 1.253 1.284 0 C-N-CA 124.701 1.201 . . . . 0.0 112.81 177.232 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.8 mtp . . . . . 0 N--CA 1.496 1.848 0 CA-C-O 116.543 -1.694 . . . . 0.0 112.424 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.61 138.65 32.6 Favored 'Trans proline' 0 C--N 1.359 1.114 0 C-N-CA 122.324 2.016 . . . . 0.0 111.994 -176.594 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 96.8 t -145.42 129.67 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 125.617 1.567 . . . . 0.0 108.584 175.035 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 74.6 mtp85 -103.01 125.63 49.85 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.449 1.099 . . . . 0.0 110.432 175.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 51.5 ptt85 -169.13 167.44 10.46 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 126.895 2.078 . . . . 0.0 111.725 -174.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 131.47 -108.87 0.83 Allowed Glycine 0 N--CA 1.473 1.137 0 C-N-CA 125.489 1.519 . . . . 0.0 111.158 -174.568 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 33.8 p80 -139.83 164.42 30.03 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.925 1.29 . . . . 0.0 111.945 177.139 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.0 p -69.99 147.06 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 123.83 0.852 . . . . 0.0 111.431 176.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.16 153.28 95.67 Favored Pre-proline 0 CA--C 1.554 1.11 0 C-N-CA 124.216 1.006 . . . . 0.0 112.059 172.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -67.54 152.33 78.55 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 123.15 2.567 . . . . 0.0 111.697 178.335 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 23.5 mp0 -71.06 160.28 33.18 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.837 1.255 . . . . 0.0 112.333 -177.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -83.01 47.39 1.22 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.374 1.47 . . . . 0.0 113.181 -175.583 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 62.3 p -52.74 -30.52 33.07 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 127.543 2.337 . . . . 0.0 114.117 -173.397 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -68.97 -52.01 33.58 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.839 0.856 . . . . 0.0 111.715 173.598 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 57.3 tp -61.61 -35.61 78.35 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.83 1.252 . . . . 0.0 111.155 176.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -57.84 -31.16 66.37 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.829 0.851 . . . . 0.0 113.049 176.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 94.7 m -72.91 -29.64 63.29 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.199 1.0 . . . . 0.0 110.929 174.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 12.3 mm -77.07 -41.88 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 O-C-N 121.606 -0.684 . . . . 0.0 110.163 175.29 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 92.0 mt -55.36 -49.63 71.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 124.07 0.948 . . . . 0.0 110.435 175.067 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 11.4 ptm180 -71.85 -19.23 62.0 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -176.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -75.49 -39.92 57.91 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.046 0.939 . . . . 0.0 112.443 168.257 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -82.29 -27.66 32.2 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.516 1.126 . . . . 0.0 113.199 -179.459 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -64.73 146.62 54.52 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.933 0.893 . . . . 0.0 111.855 174.114 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -80.37 52.15 4.29 Favored Glycine 0 N--CA 1.467 0.757 0 C-N-CA 125.433 1.492 . . . . 0.0 113.231 -174.031 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -76.96 -27.57 54.85 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.087 0.555 . . . . 0.0 112.13 170.156 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 47.0 m -106.4 -34.97 7.26 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -175.491 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -113.59 149.42 34.54 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.342 1.457 . . . . 0.0 110.216 178.228 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.52 149.13 30.07 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.537 1.135 . . . . 0.0 112.328 -173.544 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -165.46 165.52 19.09 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.764 1.226 . . . . 0.0 114.232 -178.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 15.2 pt -144.0 153.1 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 126.978 2.111 . . . . 0.0 109.708 171.349 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.9 mp -119.57 128.1 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 124.858 1.263 . . . . 0.0 108.795 176.691 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -120.63 144.56 48.08 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 124.87 1.268 . . . . 0.0 111.413 175.331 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -68.72 129.51 40.14 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.298 0.639 . . . . 0.0 110.818 172.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -78.44 -26.13 46.13 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 175.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 29.8 mmm180 -76.87 29.06 0.13 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 126.312 1.845 . . . . 0.0 113.894 -174.158 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.0 m -148.45 148.83 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 126.811 2.044 . . . . 0.0 110.099 -176.083 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -63.57 -38.13 89.95 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.202 1.001 . . . . 0.0 113.61 -168.559 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 -89.33 -9.25 51.17 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -174.463 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 97.6 m 50.65 57.71 6.32 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.603 1.161 . . . . 0.0 111.301 -167.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.26 136.92 52.62 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.028 0.931 . . . . 0.0 112.039 -176.528 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 46.3 t -63.48 123.03 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.809 0.844 . . . . 0.0 109.723 175.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 38.8 pt -103.18 -19.39 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 125.369 1.468 . . . . 0.0 112.361 175.199 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -151.91 139.91 20.11 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.537 1.135 . . . . 0.0 110.915 178.663 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.418 ' HB3' ' CE1' ' A' ' 48' ' ' PHE . 8.2 m -120.9 157.78 29.11 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.713 0.805 . . . . 0.0 111.818 177.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -69.93 -173.15 0.6 Allowed 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 122.707 0.403 . . . . 0.0 111.324 160.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -116.98 -13.34 10.62 Favored 'General case' 0 N--CA 1.481 1.076 0 O-C-N 120.715 -1.241 . . . . 0.0 112.643 167.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -68.31 -41.07 86.86 Favored Glycine 0 N--CA 1.469 0.837 0 C-N-CA 127.492 2.472 . . . . 0.0 112.951 168.087 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.418 ' CE1' ' HB3' ' A' ' 44' ' ' CYS . 0.4 OUTLIER -65.09 -32.27 73.89 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 123.873 0.869 . . . . 0.0 111.709 -175.729 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 35.3 t -56.3 -50.61 70.92 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.455 1.902 . . . . 0.0 111.374 170.6 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -74.39 -25.35 59.43 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 178.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 38.2 tp -62.56 -47.59 83.18 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.955 0.902 . . . . 0.0 111.249 170.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 69.0 m -99.76 -32.9 10.8 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 -168.131 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 93.39 6.77 62.5 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 125.865 1.697 . . . . 0.0 114.089 -178.488 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -86.69 -144.93 0.12 Allowed 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.642 1.177 . . . . 0.0 111.397 170.377 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 78.2 p -158.36 165.25 35.19 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.901 1.281 . . . . 0.0 112.302 170.667 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 45.9 ttm105 -52.39 -46.78 66.4 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.242 0.617 . . . . 0.0 111.278 169.575 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.04 -30.79 60.32 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 119.467 1.031 . . . . 0.0 113.772 177.394 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -90.05 -38.53 13.52 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.811 0.844 . . . . 0.0 112.927 178.239 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 41.0 t -82.21 -11.7 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 124.059 0.943 . . . . 0.0 112.302 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 66.1 mmm -67.07 135.08 53.1 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 120.614 -1.304 . . . . 0.0 110.687 171.018 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 8.8 tm0? 75.2 4.97 4.22 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 126.614 1.966 . . . . 0.0 113.38 -176.343 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -88.65 155.14 50.84 Favored Pre-proline 0 N--CA 1.476 0.827 0 C-N-CA 124.657 1.183 . . . . 0.0 111.285 175.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -68.42 139.83 46.39 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 123.271 2.647 . . . . 0.0 110.609 170.54 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 32.1 p -68.41 -2.96 9.67 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 -178.568 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 40.6 p -63.47 -31.5 72.68 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.154 1.382 . . . . 0.0 112.236 172.586 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 81.4 m 51.07 34.86 11.65 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.755 1.222 . . . . 0.0 112.862 -173.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -57.98 -31.17 66.65 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.834 1.253 . . . . 0.0 112.58 -175.364 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -58.11 -15.6 10.1 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.484 1.514 . . . . 0.0 114.311 176.645 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 87.9 mt -74.51 -7.65 53.73 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 173.251 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 17.6 p-80 -60.99 140.19 57.87 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 120.197 1.362 . . . . 0.0 113.259 178.513 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -124.73 -163.57 11.69 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 126.546 2.022 . . . . 0.0 111.786 171.309 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -69.91 -21.15 33.17 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 123.15 2.567 . . . . 0.0 113.333 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.15 3.0 55.89 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.501 1.12 . . . . 0.0 113.355 178.754 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 17.3 m -85.76 137.17 32.98 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.092 1.357 . . . . 0.0 109.946 178.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -102.82 131.58 49.6 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.234 1.014 . . . . 0.0 109.997 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 22.4 tpp85 -58.1 -35.17 71.05 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.019 0.927 . . . . 0.0 112.618 -177.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -57.09 -42.02 79.94 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.645 1.178 . . . . 0.0 112.463 177.668 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -73.12 -43.9 61.02 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.437 -0.789 . . . . 0.0 112.202 177.29 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.07 -36.15 72.4 Favored 'General case' 0 CA--C 1.545 0.758 0 O-C-N 121.405 -0.809 . . . . 0.0 111.99 174.653 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.36 -48.02 65.91 Favored 'General case' 0 C--O 1.224 -0.24 0 C-N-CA 125.543 1.537 . . . . 0.0 111.927 173.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -57.43 -39.52 76.4 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 118.286 -0.864 . . . . 0.0 111.215 178.185 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 97.4 mt -59.92 -45.87 94.61 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 CA-C-N 120.256 1.389 . . . . 0.0 112.003 172.26 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.9 -36.85 80.92 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 118.827 0.74 . . . . 0.0 112.862 179.097 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 96.4 mm-40 -69.7 -32.81 71.62 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.707 1.203 . . . . 0.0 111.593 175.401 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.42 ' HB1' HG11 ' A' ' 112' ' ' VAL . . . -59.74 -29.99 68.53 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 119.09 0.859 . . . . 0.0 112.786 179.275 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 56.1 mt -70.86 -15.93 62.67 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.342 1.457 . . . . 0.0 113.215 177.162 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 60.5 mt -86.25 -13.04 47.97 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.105 0.962 . . . . 0.0 112.351 174.294 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -91.6 151.79 21.12 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 125.41 1.481 . . . . 0.0 113.078 178.471 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -93.39 0.07 56.72 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.91 1.284 . . . . 0.0 113.906 177.452 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -123.16 160.25 26.89 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.946 1.698 . . . . 0.0 111.208 -173.618 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -60.06 144.79 48.67 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.106 0.963 . . . . 0.0 112.567 -178.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 13.6 tpt180 -150.36 130.71 13.74 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.199 0.999 . . . . 0.0 111.597 -178.112 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 38.6 mtmt -110.44 132.27 54.32 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.226 1.41 . . . . 0.0 110.412 173.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 42.6 t -130.24 133.23 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 124.989 1.316 . . . . 0.0 108.466 177.439 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -102.41 134.92 44.94 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.099 0.96 . . . . 0.0 110.482 -179.001 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.0 tt -159.32 146.22 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.551 0.741 . . . . 0.0 112.08 -166.392 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -88.38 122.81 32.3 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 121.516 -0.74 . . . . 0.0 110.466 172.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -110.45 148.34 32.25 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.676 1.191 . . . . 0.0 112.092 173.517 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -107.63 134.38 50.71 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.995 1.718 . . . . 0.0 110.616 177.105 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -108.6 156.72 19.21 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.822 1.649 . . . . 0.0 111.394 -166.596 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -64.59 -20.89 66.52 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 -176.275 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -76.14 -7.26 54.38 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.525 1.13 . . . . 0.0 113.561 175.272 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 97.06 0.57 59.96 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 125.581 1.562 . . . . 0.0 114.362 -179.016 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 25.5 m -90.37 164.04 14.47 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.759 1.223 . . . . 0.0 112.383 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 28.3 p -140.23 158.72 43.59 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 121.103 -0.998 . . . . 0.0 111.734 167.136 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -167.86 160.1 12.08 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.081 1.352 . . . . 0.0 113.019 -178.043 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -77.81 121.57 24.26 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 124.186 0.994 . . . . 0.0 110.827 176.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 10.6 t -106.24 141.26 37.88 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.056 1.742 . . . . 0.0 109.566 172.606 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -86.9 133.42 33.61 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 156.343 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.4 t -117.57 117.18 54.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 124.527 1.131 . . . . 0.0 108.446 171.414 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -113.52 114.01 25.92 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.288 1.035 . . . . 0.0 108.74 -176.094 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.42 HG11 ' HB1' ' A' ' 85' ' ' ALA . 2.4 p -86.0 126.94 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 169.159 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 97.6 t -114.59 106.43 52.31 Favored Pre-proline 0 CA--C 1.537 0.447 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 173.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -74.77 132.56 15.88 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.027 2.485 . . . . 0.0 109.819 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 99.1 t -97.14 110.62 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 172.316 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 63.4 mttt -82.89 152.81 25.4 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.356 0.598 . . . . 0.0 111.556 167.714 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -92.68 -173.88 3.48 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.922 0.889 . . . . 0.0 111.829 172.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -60.3 -22.06 62.71 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.158 1.383 . . . . 0.0 114.379 178.123 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -89.7 -5.61 56.87 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.873 1.269 . . . . 0.0 112.993 177.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 78.65 21.53 68.89 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 124.588 1.089 . . . . 0.0 114.27 -178.457 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -100.3 143.33 30.62 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.678 1.191 . . . . 0.0 109.216 171.053 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.7 p -76.69 125.22 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-O 121.806 0.812 . . . . 0.0 110.175 174.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 3.9 pt -116.49 -22.66 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 125.378 1.471 . . . . 0.0 113.543 -171.499 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 55.4 mtm -145.93 150.2 35.63 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.595 1.558 . . . . 0.0 110.799 175.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -114.43 124.54 52.19 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 125.197 1.399 . . . . 0.0 109.504 172.511 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 47.3 mt -98.39 114.68 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 169.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -102.17 125.22 48.81 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 175.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -117.74 130.21 56.18 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.142 0.977 . . . . 0.0 110.389 -173.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -106.65 135.42 48.2 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.017 1.327 . . . . 0.0 110.554 -177.012 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -145.17 136.28 24.86 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.757 1.223 . . . . 0.0 109.27 175.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 43.5 t -74.32 117.63 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 177.652 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.3 p -96.17 -27.53 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -179.383 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 47.2 tpp -167.45 141.67 3.68 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.064 1.346 . . . . 0.0 110.723 -178.177 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -88.91 140.12 29.76 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 121.229 -0.919 . . . . 0.0 111.117 177.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.265 0 CA-C-O 117.468 -1.254 . . . . 0.0 112.951 169.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 29.1 p . . . . . 0 N--CA 1.479 1.023 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -71.21 -45.31 63.64 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.848 0.859 . . . . 0.0 111.997 178.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 61.5 tp -63.0 -37.08 85.77 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.742 0.817 . . . . 0.0 110.947 176.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -59.17 -28.34 66.51 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 178.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.9 m -67.98 -29.24 68.22 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.839 0.856 . . . . 0.0 111.108 173.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 17.6 mm -74.16 -41.45 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-N 119.017 0.826 . . . . 0.0 109.23 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 3.1 mp -58.94 -46.72 91.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 122.971 0.508 . . . . 0.0 110.269 170.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 84.8 mtm180 -63.49 -35.1 79.33 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 119.125 0.875 . . . . 0.0 113.069 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -69.8 -39.1 76.77 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.172 0.989 . . . . 0.0 112.671 174.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -77.37 -33.82 55.13 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.507 1.123 . . . . 0.0 111.988 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 . . . . . 0 CA--C 1.546 0.815 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -175.216 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.47 0.564 0 CA-C-O 122.09 0.947 . . . . 0.0 111.665 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.7 mptt -93.14 133.21 36.55 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 120.911 -1.118 . . . . 0.0 110.693 -177.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -161.17 155.05 22.32 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.689 1.196 . . . . 0.0 113.279 178.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 18.4 pt -140.74 152.61 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 125.777 1.631 . . . . 0.0 110.766 177.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 14.0 mt -111.05 132.4 59.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 125.856 1.663 . . . . 0.0 108.818 179.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -131.47 143.26 50.29 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.673 1.189 . . . . 0.0 111.489 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -67.78 119.22 12.14 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.518 0.727 . . . . 0.0 111.862 176.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -79.67 -19.59 48.67 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -178.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -77.97 -36.62 48.82 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.522 1.129 . . . . 0.0 112.359 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 55.0 t -70.5 130.5 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 125.361 1.464 . . . . 0.0 109.486 171.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -60.18 -43.26 96.01 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.289 1.036 . . . . 0.0 113.516 -169.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 20.0 p30 -74.94 -10.04 59.11 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 113.842 1.052 . . . . 0.0 113.842 178.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 79.7 m 55.68 65.16 1.53 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.927 1.691 . . . . 0.0 112.662 -175.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.61 136.01 57.85 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.472 0.709 . . . . 0.0 112.015 178.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 41.4 t -61.9 121.04 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 169.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 42.9 pt -103.68 -17.08 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 125.063 1.345 . . . . 0.0 112.221 175.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -159.62 152.32 21.49 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.278 1.031 . . . . 0.0 112.014 175.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 8.1 p -146.49 155.07 42.26 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.51 1.124 . . . . 0.0 112.756 178.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -75.96 -154.18 0.05 OUTLIER 'General case' 0 CA--C 1.558 1.266 0 C-N-CA 123.407 0.683 . . . . 0.0 112.317 -176.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -108.73 -21.83 12.5 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 120.271 -1.518 . . . . 0.0 112.896 165.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -75.84 -37.75 38.26 Favored Glycine 0 C--N 1.343 0.959 0 O-C-N 121.513 -0.742 . . . . 0.0 112.479 -176.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -56.92 -41.47 78.23 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.224 1.009 . . . . 0.0 111.109 177.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 40.5 t -57.12 -53.04 62.65 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.978 1.711 . . . . 0.0 112.214 177.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -73.23 -29.1 62.55 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -179.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -64.31 -42.25 96.43 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.296 1.438 . . . . 0.0 111.832 177.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 9.1 t -100.06 -28.96 12.79 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.88 11.87 62.95 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 124.916 1.246 . . . . 0.0 114.047 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -87.58 -154.14 0.25 Allowed 'General case' 0 CA--C 1.552 1.036 0 CA-C-N 118.524 1.162 . . . . 0.0 111.419 170.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 64.4 m -149.65 158.47 44.2 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.676 1.19 . . . . 0.0 110.787 177.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -48.67 -48.86 39.56 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.976 0.911 . . . . 0.0 111.333 173.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.77 -26.54 35.1 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 177.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -92.39 -37.62 12.48 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.61 1.164 . . . . 0.0 112.004 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 93.2 t -86.33 -16.26 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 124.665 1.186 . . . . 0.0 112.205 -178.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 87.0 mmm -76.27 143.28 41.02 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 120.91 -1.119 . . . . 0.0 111.058 171.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 24.8 mp0 59.21 36.6 23.86 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.69 1.196 . . . . 0.0 111.15 -169.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 88.5 mmt-85 -123.72 154.41 66.95 Favored Pre-proline 0 N--CA 1.472 0.656 0 C-N-CA 125.075 1.35 . . . . 0.0 110.5 169.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -68.56 137.17 38.46 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 123.191 2.594 . . . . 0.0 109.67 172.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 21.2 p -65.83 -11.89 49.97 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 -175.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 42.5 p -58.18 -26.06 62.31 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 126.242 1.817 . . . . 0.0 112.967 173.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 74.9 m 57.8 38.63 27.32 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.741 1.216 . . . . 0.0 112.816 178.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -56.1 -28.66 58.61 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.143 1.377 . . . . 0.0 113.366 -175.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -57.95 -23.99 56.01 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.828 1.651 . . . . 0.0 113.18 176.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 40.1 mt -82.03 -8.67 59.68 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -176.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 43.2 m170 -71.75 125.32 26.83 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.857 0.863 . . . . 0.0 111.693 -178.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -107.83 -162.16 21.17 Favored Glycine 0 CA--C 1.54 1.618 0 C-N-CA 126.452 1.977 . . . . 0.0 112.505 174.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -70.31 -26.23 25.2 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 123.276 2.651 . . . . 0.0 113.14 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 37.2 mmt180 -80.88 -14.24 58.19 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 177.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 38.1 m -70.64 138.08 50.45 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.177 0.991 . . . . 0.0 112.281 -167.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -88.65 110.45 20.96 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.514 1.526 . . . . 0.0 109.781 -171.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 50.9 tpt85 -61.57 -30.18 70.5 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 121.369 -0.832 . . . . 0.0 112.933 -177.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 20.6 tpt180 -66.96 -38.42 86.06 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.093 1.357 . . . . 0.0 111.64 174.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -72.51 -41.54 65.8 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.835 0.854 . . . . 0.0 111.774 175.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -54.95 -35.14 63.93 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.173 0.589 . . . . 0.0 111.849 171.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.58 -49.71 51.54 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.403 1.081 . . . . 0.0 111.66 173.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 21.9 mm-40 -59.55 -36.63 76.55 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 118.256 -0.878 . . . . 0.0 111.891 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 89.8 mt -60.35 -44.98 97.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 CA-C-N 120.234 1.379 . . . . 0.0 111.613 171.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.89 -40.15 91.29 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 118.88 0.764 . . . . 0.0 112.423 177.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -70.07 -28.4 65.4 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.319 0.648 . . . . 0.0 112.333 175.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.475 ' HB1' HG11 ' A' ' 112' ' ' VAL . . . -60.58 -28.99 68.91 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 119.908 1.231 . . . . 0.0 112.47 175.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 43.4 mt -74.22 -13.11 60.74 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.624 1.569 . . . . 0.0 113.381 175.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 67.3 mt -88.47 -16.58 32.37 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.107 0.963 . . . . 0.0 112.203 173.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -88.88 153.62 23.94 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 125.133 1.349 . . . . 0.0 113.425 -179.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -93.11 -1.07 56.8 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.102 1.361 . . . . 0.0 113.858 176.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -124.34 159.82 29.47 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 126.173 1.789 . . . . 0.0 111.583 -171.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -63.37 141.28 58.82 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.876 1.271 . . . . 0.0 112.201 -178.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 23.6 tpt180 -150.86 127.72 11.0 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.281 1.033 . . . . 0.0 112.06 -171.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 40.8 mtmt -106.29 140.66 38.88 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.735 1.214 . . . . 0.0 111.91 171.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 66.6 t -137.13 139.18 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 126.074 1.75 . . . . 0.0 108.575 175.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -107.37 133.55 51.74 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.242 1.017 . . . . 0.0 111.303 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.2 tt -160.34 146.4 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 123.882 0.873 . . . . 0.0 112.547 -166.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -84.68 125.5 32.56 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.122 -0.986 . . . . 0.0 112.154 174.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 20.2 m-30 -115.59 154.05 30.13 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.71 2.004 . . . . 0.0 111.395 171.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -94.26 155.07 17.21 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 123.726 0.81 . . . . 0.0 113.016 166.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -104.17 151.29 23.5 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 127.578 2.351 . . . . 0.0 109.729 168.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -60.27 -24.85 65.25 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 -174.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 53.2 p-10 -71.53 -12.89 61.61 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.185 1.394 . . . . 0.0 114.476 174.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 103.76 0.78 45.93 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 126.575 2.036 . . . . 0.0 114.524 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 70.5 m -82.86 162.04 21.73 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 119.406 1.603 . . . . 0.0 112.228 175.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 94.2 m -127.35 164.6 21.45 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.477 1.111 . . . . 0.0 112.014 178.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -165.03 149.51 9.02 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.899 1.28 . . . . 0.0 111.787 177.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -74.3 118.94 17.84 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 123.707 0.803 . . . . 0.0 109.558 164.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 16.3 t -101.3 137.92 39.01 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 126.444 1.898 . . . . 0.0 109.609 173.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 20.4 tp -90.44 119.71 30.95 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 159.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 29.6 t -100.88 122.84 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 172.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -119.53 111.76 18.51 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.175 1.39 . . . . 0.0 109.761 178.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.475 HG11 ' HB1' ' A' ' 85' ' ' ALA . 7.2 p -87.81 127.12 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-O 121.227 0.537 . . . . 0.0 109.837 172.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 90.6 t -113.59 112.09 48.7 Favored Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 125.908 1.683 . . . . 0.0 106.886 177.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.43 131.95 14.35 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.984 2.456 . . . . 0.0 110.276 -178.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 76.6 t -104.91 116.6 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 123.935 0.894 . . . . 0.0 109.083 174.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 62.4 mttt -87.32 153.69 21.27 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.624 0.77 . . . . 0.0 112.4 172.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -91.93 -173.77 3.59 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.313 1.045 . . . . 0.0 111.58 175.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -61.36 -20.81 63.42 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 179.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -95.11 -0.12 53.75 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.878 1.271 . . . . 0.0 113.148 177.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 79.71 22.22 64.66 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 124.173 0.892 . . . . 0.0 114.719 176.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -107.69 148.49 29.33 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.136 1.374 . . . . 0.0 109.92 171.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.6 p -81.02 122.25 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 123.701 0.8 . . . . 0.0 110.652 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -121.86 -23.79 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -174.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 60.9 mtm -129.74 150.5 51.02 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.07 1.348 . . . . 0.0 112.172 169.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -110.63 135.39 51.32 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 125.522 1.529 . . . . 0.0 108.978 166.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 53.2 mt -101.01 122.05 52.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 163.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 9.2 mp -103.89 123.62 47.47 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 172.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -101.83 150.43 23.17 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.375 1.07 . . . . 0.0 110.858 174.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -123.37 135.85 54.36 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.031 1.333 . . . . 0.0 110.601 178.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -142.38 134.12 26.92 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.245 1.418 . . . . 0.0 109.061 179.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 57.8 t -79.82 115.85 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 176.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.3 p -95.23 -24.91 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 39.1 tpp -163.94 111.87 1.16 Allowed 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.873 1.269 . . . . 0.0 110.882 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -79.81 127.88 32.76 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 121.16 -0.963 . . . . 0.0 110.99 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 41.8 mttt . . . . . 0 C--O 1.258 1.506 0 C-N-CA 125.245 1.418 . . . . 0.0 112.527 -179.843 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 31.1 p . . . . . 0 N--CA 1.479 0.989 0 N-CA-C 111.701 0.26 . . . . 0.0 111.701 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -65.06 -42.98 93.72 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.614 0.766 . . . . 0.0 111.629 177.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 64.7 tp -71.05 -39.78 72.04 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.557 0.743 . . . . 0.0 111.032 172.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -59.79 -27.25 66.4 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 177.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 92.6 m -69.54 -23.69 63.62 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.746 1.218 . . . . 0.0 111.641 174.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 23.6 mm -76.48 -38.16 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 123.923 0.889 . . . . 0.0 109.806 176.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.1 mp -57.7 -33.58 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 O-C-N 121.702 -0.624 . . . . 0.0 110.91 173.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 48.5 mtp85 -69.59 -18.95 63.66 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 119.455 1.025 . . . . 0.0 113.332 177.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 78.1 mttt -87.68 -38.87 15.48 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 125.096 1.358 . . . . 0.0 111.053 173.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -73.88 -18.88 60.86 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.929 1.292 . . . . 0.0 113.337 174.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 . . . . . 0 CA--C 1.543 0.701 0 C-N-CA 125.237 1.415 . . . . 0.0 112.828 172.222 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.0 mmt-85 . . . . . 0 CA--C 1.542 0.65 0 CA-C-O 121.984 0.897 . . . . 0.0 111.928 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -120.99 139.02 53.86 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.107 1.363 . . . . 0.0 110.427 -173.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -165.07 152.77 11.3 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -177.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 13.2 pt -140.93 149.35 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 125.969 1.708 . . . . 0.0 110.47 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 19.0 mt -108.87 133.75 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.343 1.457 . . . . 0.0 108.8 179.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -131.81 142.87 49.85 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.758 1.223 . . . . 0.0 111.634 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -70.47 124.81 25.1 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.342 0.657 . . . . 0.0 111.698 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.8 -15.77 60.2 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 120.922 -1.111 . . . . 0.0 113.218 -178.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 3.1 mpp_? -98.94 4.81 47.43 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.999 1.72 . . . . 0.0 113.336 -171.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 70.9 t -110.26 138.4 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 126.681 1.993 . . . . 0.0 108.898 179.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -54.14 -34.63 60.84 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 116.048 1.87 . . . . 0.0 116.048 -167.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -105.86 0.31 25.85 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.168 1.387 . . . . 0.0 113.027 -178.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 91.2 m 50.43 66.86 1.03 Allowed 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.875 1.67 . . . . 0.0 111.954 -171.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.88 140.53 58.82 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.154 0.982 . . . . 0.0 111.967 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 63.7 t -63.86 119.88 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 171.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 38.3 pt -101.09 -20.64 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.689 1.195 . . . . 0.0 112.341 174.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -154.46 147.57 24.71 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.43 1.092 . . . . 0.0 111.127 177.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.453 ' HB2' ' CE1' ' A' ' 48' ' ' PHE . 22.4 p -152.14 154.78 36.54 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 121.024 -1.047 . . . . 0.0 113.424 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -78.77 -168.81 1.53 Allowed 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 123.457 0.703 . . . . 0.0 112.321 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -104.12 -18.6 14.46 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.566 1.546 . . . . 0.0 112.59 169.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.61 -42.46 71.97 Favored Glycine 0 N--CA 1.469 0.895 0 C-N-CA 124.146 0.879 . . . . 0.0 112.253 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.453 ' CE1' ' HB2' ' A' ' 44' ' ' CYS . 0.9 OUTLIER -67.05 -29.31 69.06 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.315 0.646 . . . . 0.0 111.788 -175.853 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 83.7 m -52.64 -51.81 58.42 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.181 1.392 . . . . 0.0 111.808 172.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -74.57 -20.46 59.93 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.842 0.857 . . . . 0.0 113.179 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.38 -58.38 7.27 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.031 1.332 . . . . 0.0 110.253 176.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 69.2 m -97.73 -15.43 20.34 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 -175.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.37 2.16 68.37 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 125.519 1.533 . . . . 0.0 114.046 173.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -85.56 -154.52 0.2 Allowed 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 124.798 1.239 . . . . 0.0 111.811 170.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 9.5 t -161.22 170.07 20.99 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 120.498 -1.376 . . . . 0.0 111.61 175.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -50.34 -47.91 55.68 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.824 1.25 . . . . 0.0 111.48 177.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.63 -25.96 54.63 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 178.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -92.33 -39.79 11.28 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.284 1.434 . . . . 0.0 111.848 177.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 71.3 t -80.7 -17.41 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 125.742 1.617 . . . . 0.0 112.243 -177.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 70.0 mtp -60.97 131.15 49.72 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 120.549 -1.344 . . . . 0.0 109.843 173.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 14.0 mt-30 70.34 13.11 7.58 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.713 1.605 . . . . 0.0 114.105 -178.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -89.97 153.56 47.2 Favored Pre-proline 0 N--CA 1.475 0.778 0 C-N-CA 124.356 1.062 . . . . 0.0 110.991 172.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.53 132.28 23.36 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.995 2.464 . . . . 0.0 110.23 170.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 27.3 p -68.42 -9.9 51.64 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 115.105 1.521 . . . . 0.0 115.105 -175.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 38.3 p -62.3 -27.45 69.04 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.93 1.292 . . . . 0.0 111.588 168.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 73.4 m 48.89 42.53 20.5 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.506 1.522 . . . . 0.0 112.6 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -56.72 -32.03 65.1 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.159 1.383 . . . . 0.0 112.59 -175.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -59.1 -16.17 17.93 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.965 1.306 . . . . 0.0 114.501 175.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 97.2 mt -76.45 -3.95 39.93 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 174.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -59.7 134.08 56.69 Favored 'General case' 0 CA--C 1.549 0.942 0 CA-C-N 120.382 1.446 . . . . 0.0 113.051 176.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -105.2 -175.4 24.35 Favored Glycine 0 CA--C 1.538 1.499 0 C-N-CA 125.435 1.493 . . . . 0.0 111.42 167.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -66.57 -16.61 51.31 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 122.92 2.413 . . . . 0.0 113.674 176.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -90.08 -9.27 49.07 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 175.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 53.3 m -68.88 132.49 46.83 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 119.651 1.114 . . . . 0.0 110.852 -175.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -90.03 130.33 36.23 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.112 0.965 . . . . 0.0 110.323 -179.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -63.42 -31.9 73.18 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.581 0.753 . . . . 0.0 112.261 -175.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 36.5 mmt180 -61.81 -50.57 71.79 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.69 0.796 . . . . 0.0 111.797 172.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.24 -37.74 88.18 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 120.331 -1.481 . . . . 0.0 112.964 -178.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -56.93 -34.23 67.78 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 170.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -76.19 -42.53 46.03 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 124.886 1.274 . . . . 0.0 112.878 174.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -61.49 -33.51 73.9 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 118.598 0.636 . . . . 0.0 110.925 -178.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 91.3 mt -62.07 -36.84 76.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 CA-C-N 119.679 1.127 . . . . 0.0 112.315 170.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.89 -37.47 67.29 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 119.343 0.974 . . . . 0.0 112.186 173.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -62.97 -33.13 74.73 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 121.418 -0.802 . . . . 0.0 111.473 172.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.52 -19.76 65.05 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 175.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 43.8 mt -88.43 -18.32 28.55 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.229 1.411 . . . . 0.0 112.799 172.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 83.1 mt -85.12 -21.64 29.19 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.006 0.922 . . . . 0.0 111.667 171.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -81.94 143.1 22.95 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 125.156 1.36 . . . . 0.0 112.308 176.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -91.21 -3.18 57.2 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.347 1.059 . . . . 0.0 113.841 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -117.02 161.87 18.7 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.658 1.983 . . . . 0.0 110.804 174.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -64.61 145.94 55.42 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 122.276 1.036 . . . . 0.0 113.045 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 44.9 mmt-85 -142.08 135.8 29.5 Favored 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 125.314 1.446 . . . . 0.0 110.442 173.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.4 ptpp? -113.76 134.83 54.53 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 167.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 78.2 t -129.05 135.16 62.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 126.144 1.777 . . . . 0.0 107.908 -173.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -99.56 128.84 45.68 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.986 0.914 . . . . 0.0 110.319 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.1 tt -151.14 148.8 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.359 1.063 . . . . 0.0 111.463 -168.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -80.15 124.06 28.45 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 120.774 -1.204 . . . . 0.0 111.304 173.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 6.8 m-30 -107.29 136.92 46.28 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.883 1.673 . . . . 0.0 110.384 172.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -101.44 128.47 47.63 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.68 1.592 . . . . 0.0 110.955 177.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 57.4 ttp180 -94.56 152.55 18.44 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.203 1.801 . . . . 0.0 111.396 -174.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -59.68 -22.7 62.32 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 -174.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -79.91 -13.07 59.64 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.702 1.201 . . . . 0.0 114.069 176.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 107.13 0.59 35.66 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 126.269 1.89 . . . . 0.0 114.699 -178.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 75.0 m -80.42 160.19 25.41 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 119.489 1.644 . . . . 0.0 112.876 176.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 15.9 t -136.12 152.45 50.85 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.884 1.273 . . . . 0.0 110.574 176.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -166.97 161.38 14.96 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.369 1.468 . . . . 0.0 111.303 -176.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -80.4 121.02 25.19 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.912 0.885 . . . . 0.0 111.129 172.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 49.6 t -102.45 135.69 43.62 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.61 1.964 . . . . 0.0 110.423 171.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.1 tt -89.24 116.05 27.19 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 125.627 1.571 . . . . 0.0 107.033 163.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 66.5 t -103.06 111.78 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 169.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -101.84 113.6 26.95 Favored 'General case' 0 C--O 1.224 -0.246 0 C-N-CA 126.085 1.754 . . . . 0.0 109.547 172.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.416 HG22 HD13 ' A' ' 127' ' ' LEU . 67.5 t -85.99 126.32 40.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 169.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 89.7 t -113.22 116.22 46.92 Favored Pre-proline 0 CA--C 1.537 0.469 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 170.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -73.84 133.86 19.07 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 123.43 2.753 . . . . 0.0 110.079 -179.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 87.8 t -102.39 116.92 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 N-CA-C 107.902 -1.148 . . . . 0.0 107.902 171.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 33.2 mttp -88.86 161.13 16.87 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.447 0.699 . . . . 0.0 112.196 171.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -98.75 -174.13 2.71 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.384 1.074 . . . . 0.0 111.969 172.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -60.27 -22.58 63.27 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.276 1.43 . . . . 0.0 114.689 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -90.8 -1.49 57.85 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.161 0.984 . . . . 0.0 113.138 177.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 74.86 26.61 66.55 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 124.1 0.857 . . . . 0.0 113.932 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -103.63 146.12 29.05 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.98 1.312 . . . . 0.0 108.79 169.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 11.4 p -78.2 131.02 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-O 121.425 0.631 . . . . 0.0 110.529 175.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 2.8 pt -126.6 -21.16 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 124.652 1.181 . . . . 0.0 113.926 -169.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 73.6 mtm -148.8 155.65 41.24 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 126.09 1.756 . . . . 0.0 110.132 176.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -118.71 131.9 56.15 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 125.085 1.354 . . . . 0.0 109.514 174.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 56.6 mt -97.07 115.32 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 106.244 -1.761 . . . . 0.0 106.244 166.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.416 HD13 HG22 ' A' ' 112' ' ' VAL . 1.7 mm? -91.76 121.39 33.35 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 171.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -113.18 124.79 53.37 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 119.462 -0.304 . . . . 0.0 111.121 178.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 12.2 m-30 -103.46 144.06 31.89 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.301 1.441 . . . . 0.0 111.813 -177.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -150.63 135.68 17.63 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.726 1.611 . . . . 0.0 109.281 172.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 60.2 t -75.61 115.47 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 CA-C-N 119.53 1.059 . . . . 0.0 108.447 171.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.4 p -93.0 -25.3 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 123.539 0.735 . . . . 0.0 112.646 -178.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 30.5 ttm -162.17 118.42 2.01 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.552 1.141 . . . . 0.0 110.567 -176.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -82.08 124.16 29.58 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.679 -0.638 . . . . 0.0 110.021 174.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.255 1.355 0 CA-C-O 115.464 -2.208 . . . . 0.0 116.177 -172.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 13.1 t . . . . . 0 N--CA 1.481 1.1 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -72.43 -46.28 55.78 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 118.813 0.733 . . . . 0.0 111.746 175.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 53.9 tp -64.67 -34.04 77.36 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.978 1.311 . . . . 0.0 111.229 171.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -56.4 -31.12 63.56 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.731 1.212 . . . . 0.0 112.638 176.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 33.3 m -70.48 -29.98 66.66 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.939 1.296 . . . . 0.0 111.227 174.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.2 mm -78.66 -40.13 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 124.325 1.05 . . . . 0.0 110.221 176.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.45 ' HA ' ' CE2' ' A' ' 22' ' ' PHE . 87.6 mt -59.79 -44.27 93.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.308 0.643 . . . . 0.0 111.122 176.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 51.8 ptt85 -67.51 -24.26 65.55 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -179.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -69.03 -42.82 75.83 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.809 0.843 . . . . 0.0 111.671 174.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.45 ' CE2' ' HA ' ' A' ' 19' ' ' ILE . 17.0 p90 -87.0 -31.29 20.65 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 113.75 1.018 . . . . 0.0 113.75 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.908 0 CA-C-N 120.386 1.448 . . . . 0.0 111.388 178.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 18.8 mmm180 . . . . . 0 N--CA 1.47 0.527 0 CA-C-O 122.065 0.936 . . . . 0.0 111.646 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.6 mptt -91.93 125.95 36.83 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.312 -0.868 . . . . 0.0 110.577 -175.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -159.14 161.99 36.36 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.1 pt -144.91 155.7 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 127.171 2.188 . . . . 0.0 109.905 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.8 mp -120.51 135.01 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 125.021 1.329 . . . . 0.0 109.334 179.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -132.58 153.22 51.22 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.007 1.323 . . . . 0.0 112.32 -176.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 29.0 p30 -76.47 118.92 19.64 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.409 1.084 . . . . 0.0 112.738 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.23 -17.22 61.37 Favored 'General case' 0 CA--C 1.547 0.829 0 O-C-N 120.724 -1.235 . . . . 0.0 113.517 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 65.7 mtm-85 -86.23 5.67 33.16 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.701 1.601 . . . . 0.0 114.813 -168.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 13.0 m -133.81 158.33 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 125.59 1.556 . . . . 0.0 111.116 -173.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -62.46 -40.73 97.58 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.088 0.955 . . . . 0.0 113.505 -173.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -85.9 -14.59 44.36 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 114.285 1.216 . . . . 0.0 114.285 -173.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 84.2 m 41.55 69.49 0.35 Allowed 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.777 1.631 . . . . 0.0 112.306 -165.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.31 143.18 47.05 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.064 0.945 . . . . 0.0 111.757 -176.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 23.8 t -65.98 122.45 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 175.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.5 pt -104.25 -14.84 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 125.629 1.572 . . . . 0.0 112.468 176.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -157.67 142.79 16.85 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.533 1.133 . . . . 0.0 111.376 176.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.539 ' HB3' ' CE1' ' A' ' 48' ' ' PHE . 2.7 m -130.67 153.3 49.11 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.125 0.97 . . . . 0.0 112.101 -178.157 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -78.46 -168.96 1.5 Allowed 'General case' 0 CA--C 1.554 1.132 0 CA-C-N 118.973 0.806 . . . . 0.0 111.496 165.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -104.01 -21.76 13.56 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.162 1.385 . . . . 0.0 112.975 169.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.31 -35.02 60.44 Favored Glycine 0 C--N 1.343 0.95 0 O-C-N 121.5 -0.75 . . . . 0.0 112.436 -177.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.539 ' CE1' ' HB3' ' A' ' 44' ' ' CYS . 0.4 OUTLIER -68.78 -30.86 69.53 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.491 0.716 . . . . 0.0 111.885 178.979 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 86.4 m -50.7 -55.32 17.08 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.217 1.407 . . . . 0.0 111.944 176.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -70.1 -18.81 63.26 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.168 0.987 . . . . 0.0 113.334 -178.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.2 tp -63.89 -46.29 85.53 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.853 1.261 . . . . 0.0 111.878 -178.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 73.9 m -110.53 -16.2 13.72 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 178.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.72 -0.06 57.84 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 125.59 1.567 . . . . 0.0 114.395 174.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -82.46 -157.59 0.22 Allowed 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 124.812 1.245 . . . . 0.0 112.217 171.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 10.0 t -162.52 170.45 18.63 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 120.522 -1.361 . . . . 0.0 111.485 176.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -47.6 -50.99 22.72 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.199 1.4 . . . . 0.0 111.454 176.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.99 -25.86 32.85 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -95.78 -38.83 10.15 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.309 1.444 . . . . 0.0 112.241 178.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 76.7 t -83.08 -19.01 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 125.756 1.622 . . . . 0.0 111.938 -176.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 77.1 mmm -66.19 132.38 48.3 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 120.566 -1.334 . . . . 0.0 109.481 173.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 73.59 7.97 5.04 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 126.129 1.771 . . . . 0.0 114.292 -175.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 -90.03 154.28 47.29 Favored Pre-proline 0 N--CA 1.478 0.934 0 C-N-CA 124.832 1.253 . . . . 0.0 110.427 169.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.46 134.31 26.22 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 123.091 2.527 . . . . 0.0 110.245 175.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 24.3 p -69.79 -4.98 22.4 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 114.888 1.44 . . . . 0.0 114.888 -176.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 56.0 p -62.05 -30.22 70.83 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.91 1.284 . . . . 0.0 111.398 165.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 77.9 m 50.62 38.73 19.69 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.003 1.721 . . . . 0.0 112.563 -174.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -57.41 -30.11 64.68 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.615 1.166 . . . . 0.0 112.441 -176.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -59.42 -15.14 15.18 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.743 1.217 . . . . 0.0 114.085 176.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 90.9 mt -77.51 -4.76 47.26 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.617 1.167 . . . . 0.0 113.955 172.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 11.4 p-80 -66.86 158.86 29.52 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 120.275 1.398 . . . . 0.0 114.511 179.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -155.17 -162.59 11.38 Favored Glycine 0 CA--C 1.537 1.456 0 C-N-CA 126.274 1.893 . . . . 0.0 111.875 168.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.85 -13.88 41.94 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 123.272 2.648 . . . . 0.0 115.143 -175.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -97.0 2.14 51.11 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 119.845 1.202 . . . . 0.0 113.742 173.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 20.3 m -87.61 127.43 35.27 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 119.593 1.088 . . . . 0.0 110.553 -177.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -86.73 126.41 34.56 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.719 0.807 . . . . 0.0 109.674 -178.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 11.7 mpt_? -65.38 -31.93 73.3 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.437 0.695 . . . . 0.0 111.584 -175.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 25.1 tpp180 -58.46 -42.89 88.44 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.542 1.137 . . . . 0.0 112.024 172.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -71.03 -43.88 66.97 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.259 -0.901 . . . . 0.0 112.32 177.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -56.99 -36.63 70.61 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 121.826 -0.546 . . . . 0.0 112.039 174.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.93 -48.66 57.61 Favored 'General case' 0 C--O 1.223 -0.299 0 C-N-CA 125.101 1.36 . . . . 0.0 111.953 173.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.8 mm100 -58.44 -37.54 75.62 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 118.369 -0.824 . . . . 0.0 111.495 -178.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 93.5 mt -61.08 -45.6 98.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 CA-C-N 120.128 1.331 . . . . 0.0 111.65 170.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.97 -34.21 74.95 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 119.006 0.821 . . . . 0.0 113.09 179.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 86.4 mm-40 -71.98 -32.18 66.99 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.164 0.986 . . . . 0.0 111.58 174.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -58.3 -32.19 68.22 Favored 'General case' 0 CA--C 1.547 0.857 0 O-C-N 121.213 -0.929 . . . . 0.0 112.214 177.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 58.7 mt -70.41 -16.6 62.97 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.952 1.701 . . . . 0.0 113.946 178.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.6 pp -104.29 -1.33 27.15 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 119.331 0.969 . . . . 0.0 113.33 170.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -84.68 -20.44 58.18 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 124.719 1.152 . . . . 0.0 114.702 -178.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 56.88 32.19 21.01 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 125.789 1.635 . . . . 0.0 113.385 179.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -144.82 163.77 33.07 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.825 1.65 . . . . 0.0 111.246 -171.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -68.67 128.68 37.49 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.897 -0.502 . . . . 0.0 110.674 174.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -142.35 133.93 26.68 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.788 1.235 . . . . 0.0 111.841 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 37.6 mtmt -111.06 130.15 55.69 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.285 1.434 . . . . 0.0 109.965 168.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.8 t -133.05 137.06 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 125.203 1.401 . . . . 0.0 108.441 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -106.32 130.88 54.08 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.137 0.975 . . . . 0.0 111.249 -175.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.4 tt -155.19 146.92 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 124.065 0.946 . . . . 0.0 112.314 -165.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -83.45 121.02 26.63 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 120.949 -1.094 . . . . 0.0 111.815 174.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 13.8 m-30 -109.27 146.85 33.6 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.569 1.947 . . . . 0.0 111.29 173.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -110.65 137.31 48.49 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.564 1.546 . . . . 0.0 112.03 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -92.09 154.98 18.38 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 126.472 1.909 . . . . 0.0 111.252 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -58.5 -25.8 62.75 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.559 1.144 . . . . 0.0 113.833 175.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -69.7 -10.83 59.83 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.322 1.449 . . . . 0.0 113.572 176.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 93.98 4.28 63.33 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 125.334 1.445 . . . . 0.0 113.93 -178.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 63.7 p -92.04 170.87 9.5 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.789 1.236 . . . . 0.0 112.024 175.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 22.1 p -147.36 168.25 22.3 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 121.11 -0.994 . . . . 0.0 112.722 176.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -164.64 155.53 14.86 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.961 1.304 . . . . 0.0 110.722 -173.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -77.15 123.55 26.57 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.277 0.56 . . . . 0.0 110.238 167.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 19.1 t -106.53 136.03 47.01 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.128 1.771 . . . . 0.0 110.306 172.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.0 tp -89.7 120.6 31.11 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 161.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 59.8 t -106.36 117.91 53.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 124.764 1.226 . . . . 0.0 108.521 175.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -111.23 113.02 25.21 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.659 1.184 . . . . 0.0 108.436 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.2 p -88.75 128.06 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 168.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 96.1 t -116.8 116.84 38.09 Favored Pre-proline 0 CA--C 1.538 0.507 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 175.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -76.13 138.27 20.2 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 123.038 2.492 . . . . 0.0 110.373 -176.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 84.0 t -111.35 123.15 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.836 0.854 . . . . 0.0 109.708 174.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 65.0 mttt -95.25 154.73 17.05 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.258 1.023 . . . . 0.0 113.42 173.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -93.66 -173.62 3.23 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.603 1.161 . . . . 0.0 111.872 177.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -58.31 -23.28 55.99 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.374 1.469 . . . . 0.0 114.42 177.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -93.02 -4.63 52.24 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.322 1.449 . . . . 0.0 113.173 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 80.46 22.29 62.74 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 124.226 0.917 . . . . 0.0 114.592 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -107.61 149.66 27.8 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.987 1.315 . . . . 0.0 109.981 173.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 64.0 t -77.26 125.51 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.24 -23.9 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -177.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 62.1 mtm -132.57 155.92 47.8 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.407 1.483 . . . . 0.0 112.479 171.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -119.16 134.09 55.4 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 125.87 1.668 . . . . 0.0 109.443 169.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 54.3 mt -97.39 120.02 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 165.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -103.61 127.51 51.03 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 173.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -119.98 128.05 53.21 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.402 1.081 . . . . 0.0 109.819 -176.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 16.9 m-30 -103.9 138.31 40.65 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.326 1.45 . . . . 0.0 111.016 -176.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -142.4 131.3 22.97 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.622 1.169 . . . . 0.0 109.879 174.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 94.1 t -76.92 111.85 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 176.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 5.0 p -95.86 -26.27 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 123.8 0.84 . . . . 0.0 112.963 -174.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 25.0 ptp -162.21 148.06 13.06 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.41 1.084 . . . . 0.0 112.789 163.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -90.37 130.01 36.51 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.953 0.901 . . . . 0.0 110.585 178.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 13.1 mmmm . . . . . 0 C--O 1.253 1.263 0 C-N-CA 125.297 1.439 . . . . 0.0 113.805 178.452 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 38.2 p . . . . . 0 N--CA 1.478 0.952 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -76.02 -52.6 9.85 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.062 0.945 . . . . 0.0 111.553 176.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 60.4 tp -58.63 -34.47 71.21 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.43 1.092 . . . . 0.0 111.259 178.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -56.71 -30.97 64.03 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 176.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 89.7 m -77.01 -32.75 57.37 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.255 1.022 . . . . 0.0 110.89 175.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 20.9 mm -71.64 -39.42 69.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 123.541 0.736 . . . . 0.0 110.5 176.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 71.8 mt -56.31 -44.13 78.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 124.13 0.972 . . . . 0.0 110.753 175.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 39.9 mtt180 -59.75 -36.87 77.51 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 119.212 0.915 . . . . 0.0 112.489 177.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -74.0 -37.29 64.47 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.532 1.133 . . . . 0.0 112.071 177.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -79.57 -22.18 44.12 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.998 1.319 . . . . 0.0 112.954 178.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 . . . . . 0 N--CA 1.472 0.667 0 CA-C-N 118.817 0.735 . . . . 0.0 112.003 170.927 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? . . . . . 0 N--CA 1.477 0.888 0 CA-C-O 121.458 0.647 . . . . 0.0 110.715 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.4 mptt -88.27 136.51 32.95 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.506 1.123 . . . . 0.0 111.252 -175.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -163.47 167.06 22.02 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.412 1.085 . . . . 0.0 113.544 178.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 25.7 pt -144.76 152.1 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 126.617 1.967 . . . . 0.0 109.865 172.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 10.7 mt -117.68 133.61 63.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 125.538 1.535 . . . . 0.0 109.008 -178.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -134.78 152.18 51.55 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.393 1.077 . . . . 0.0 112.353 178.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 14.3 m-20 -74.68 117.99 17.13 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.334 0.653 . . . . 0.0 111.527 178.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.32 -20.21 66.03 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.934 0.894 . . . . 0.0 112.274 170.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 78.7 mtp85 -66.79 -11.87 56.72 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.825 2.05 . . . . 0.0 115.352 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 20.6 m -124.79 142.03 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 125.357 1.463 . . . . 0.0 111.01 -179.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -61.4 -40.68 95.26 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.718 1.207 . . . . 0.0 112.904 -170.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 22.2 p30 -72.32 -14.59 61.78 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 177.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 4.8 t 50.98 61.67 3.12 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.716 1.606 . . . . 0.0 111.695 -173.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.64 134.86 56.18 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 120.936 -1.103 . . . . 0.0 112.278 -179.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 40.5 t -63.79 122.66 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 C-N-CA 123.07 0.548 . . . . 0.0 109.912 173.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.1 pt -101.46 -21.37 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 125.404 1.482 . . . . 0.0 112.424 175.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -152.36 144.09 23.58 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.293 1.037 . . . . 0.0 111.816 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.507 ' HB3' ' CE1' ' A' ' 48' ' ' PHE . 3.1 m -128.07 155.07 44.96 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.056 0.942 . . . . 0.0 112.592 -179.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -73.88 -174.22 1.77 Allowed 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 123.159 0.584 . . . . 0.0 111.475 167.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -107.52 -17.97 13.97 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.58 1.152 . . . . 0.0 112.801 166.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -73.92 -38.81 48.18 Favored Glycine 0 C--N 1.337 0.599 0 C-N-CA 125.821 1.676 . . . . 0.0 112.734 176.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.507 ' CE1' ' HB3' ' A' ' 44' ' ' CYS . 0.3 OUTLIER -62.62 -34.51 77.17 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.207 0.603 . . . . 0.0 111.244 179.606 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 76.6 m -48.19 -56.13 8.67 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.942 1.697 . . . . 0.0 111.941 170.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -70.93 -19.79 62.54 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -177.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.95 -49.48 72.4 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.641 1.177 . . . . 0.0 111.43 177.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 76.6 m -107.61 -21.63 12.82 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 -176.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.02 -0.4 57.46 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 125.426 1.488 . . . . 0.0 114.348 178.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -83.08 -171.52 3.61 Favored 'General case' 0 CA--C 1.55 0.964 0 CA-C-N 118.499 1.15 . . . . 0.0 112.698 170.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 74.2 m -140.95 162.59 35.12 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.409 1.084 . . . . 0.0 111.312 178.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -46.37 -49.55 17.7 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.282 1.033 . . . . 0.0 112.025 176.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.96 -24.78 59.47 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -89.21 -39.31 13.63 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.765 1.226 . . . . 0.0 111.67 177.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 19.8 t -88.63 -12.46 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 124.107 0.963 . . . . 0.0 112.513 -176.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 75.4 mtp -64.35 139.33 58.75 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 120.463 -1.398 . . . . 0.0 111.276 168.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 69.37 6.89 5.93 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 126.301 1.841 . . . . 0.0 113.896 -177.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 32.4 mmt180 -83.85 154.58 64.65 Favored Pre-proline 0 N--CA 1.472 0.643 0 C-N-CA 124.23 1.012 . . . . 0.0 110.59 172.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -68.94 131.04 21.5 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.866 2.377 . . . . 0.0 109.671 170.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 6.7 t -66.04 -14.41 61.64 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.165 1.386 . . . . 0.0 114.069 -172.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 33.9 p -59.39 -24.27 63.3 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.863 1.665 . . . . 0.0 112.908 169.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 76.9 m 57.51 42.81 23.82 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.186 1.394 . . . . 0.0 111.76 -178.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -71.97 18.79 0.08 Allowed 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 127.519 2.328 . . . . 0.0 113.39 -175.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -112.46 -12.3 13.52 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 126.889 2.076 . . . . 0.0 112.747 170.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 78.6 mt -81.18 -9.62 59.76 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 114.801 1.408 . . . . 0.0 114.801 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 12.0 p80 -69.02 160.33 31.16 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 179.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -151.96 -161.37 10.12 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 126.1 1.81 . . . . 0.0 111.357 168.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -65.74 -18.54 58.58 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 122.961 2.441 . . . . 0.0 114.287 -177.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.5 tpm_? -88.15 -6.95 57.58 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 119.273 0.942 . . . . 0.0 113.106 176.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.8 m -85.92 137.81 32.47 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.382 1.473 . . . . 0.0 109.77 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -102.5 135.41 44.19 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.21 1.004 . . . . 0.0 110.269 -178.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 19.3 tpp180 -58.6 -36.37 73.9 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.359 1.064 . . . . 0.0 112.383 -178.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 21.1 tpp85 -55.5 -45.91 77.01 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.15 1.38 . . . . 0.0 112.118 176.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.77 -46.4 68.84 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.753 0.821 . . . . 0.0 111.773 178.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.82 -34.44 65.38 Favored 'General case' 0 CA--C 1.545 0.784 0 O-C-N 121.488 -0.758 . . . . 0.0 112.359 175.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.41 -40.57 70.4 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 125.27 1.428 . . . . 0.0 113.033 173.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -61.17 -30.55 70.47 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 118.061 -0.971 . . . . 0.0 112.174 178.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 58.0 mt -63.76 -47.28 91.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 CA-C-N 120.039 1.29 . . . . 0.0 110.273 172.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.89 -34.43 77.38 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 121.582 -0.699 . . . . 0.0 112.483 176.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 73.7 mm-40 -69.64 -31.32 69.34 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 121.481 -0.762 . . . . 0.0 112.194 171.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.5 -28.12 66.73 Favored 'General case' 0 CA--C 1.545 0.778 0 O-C-N 120.98 -1.075 . . . . 0.0 111.666 176.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 74.4 mt -73.97 -14.25 61.0 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.94 1.296 . . . . 0.0 113.655 169.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 94.3 mt -94.89 -10.64 30.58 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.249 1.02 . . . . 0.0 112.653 172.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -87.65 143.8 18.62 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 125.077 1.322 . . . . 0.0 112.9 177.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.5 -3.5 58.34 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.751 1.22 . . . . 0.0 113.801 175.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -125.62 165.17 19.03 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.578 1.951 . . . . 0.0 110.974 -175.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -61.62 139.79 58.23 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.014 0.926 . . . . 0.0 112.039 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.17 123.75 8.47 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.318 1.047 . . . . 0.0 110.872 -173.078 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -89.18 153.0 21.29 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.399 1.079 . . . . 0.0 113.719 169.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 46.1 t -138.73 134.48 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 126.808 2.043 . . . . 0.0 107.628 167.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -102.98 121.2 42.05 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.609 0.763 . . . . 0.0 109.15 173.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.5 tt -147.25 145.46 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 123.925 0.89 . . . . 0.0 112.212 -169.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -84.29 119.51 25.14 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.332 -0.855 . . . . 0.0 111.75 175.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 15.9 m-30 -107.07 150.43 26.55 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.544 1.938 . . . . 0.0 110.908 172.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -109.89 136.7 48.77 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.983 1.313 . . . . 0.0 111.871 175.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -86.37 168.24 14.01 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.744 0.818 . . . . 0.0 112.593 173.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -58.23 -30.96 66.91 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 125.684 1.593 . . . . 0.0 113.511 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -76.37 -6.32 51.07 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.946 1.299 . . . . 0.0 113.439 178.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 93.63 1.34 66.07 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 125.63 1.586 . . . . 0.0 114.541 178.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.4 m -80.32 154.02 28.04 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 118.766 1.283 . . . . 0.0 111.743 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 39.1 t -117.42 150.6 38.61 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.822 1.249 . . . . 0.0 111.733 -178.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -159.56 146.14 16.43 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.968 1.307 . . . . 0.0 111.412 178.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -71.02 123.86 23.04 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.279 0.632 . . . . 0.0 110.974 165.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 47.0 t -106.78 133.71 51.03 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.627 1.971 . . . . 0.0 109.672 169.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.0 tt -85.41 113.61 21.83 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.515 1.526 . . . . 0.0 107.075 162.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 63.9 t -98.1 110.93 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 124.82 1.248 . . . . 0.0 107.646 170.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -102.33 120.07 39.87 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 120.435 1.47 . . . . 0.0 108.733 167.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.407 HG22 HD13 ' A' ' 127' ' ' LEU . 67.5 t -82.66 135.79 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 170.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 48.5 t -115.25 111.2 44.73 Favored Pre-proline 0 CA--C 1.535 0.403 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 169.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.45 133.25 14.28 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.011 2.474 . . . . 0.0 109.741 178.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 94.6 t -107.8 123.55 63.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 123.98 0.912 . . . . 0.0 109.783 179.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 67.2 mttt -91.6 154.08 19.29 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.242 0.831 . . . . 0.0 113.242 170.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -92.7 -174.56 3.68 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.285 1.034 . . . . 0.0 110.765 173.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -66.1 -18.93 65.66 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -85.34 -5.79 59.28 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.318 1.047 . . . . 0.0 112.455 174.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 78.68 23.05 65.41 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 124.581 1.086 . . . . 0.0 114.385 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -107.88 150.31 27.21 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.542 1.537 . . . . 0.0 109.937 172.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 90.4 t -78.61 124.93 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 123.684 0.794 . . . . 0.0 109.202 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.22 -24.74 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 -175.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 51.9 mtm -130.2 152.22 49.86 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.822 1.249 . . . . 0.0 112.473 171.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -113.34 135.81 53.45 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 125.164 1.386 . . . . 0.0 109.081 166.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 49.6 mt -103.07 119.56 51.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 166.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.407 HD13 HG22 ' A' ' 112' ' ' VAL . 1.6 mm? -95.84 117.97 31.59 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 173.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -111.08 129.42 55.93 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 117.773 0.261 . . . . 0.0 110.978 -179.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 17.6 m-30 -107.62 137.91 44.79 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.481 1.512 . . . . 0.0 111.7 -171.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -144.54 116.99 8.55 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.568 1.147 . . . . 0.0 109.779 172.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.1 p -66.68 115.63 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 O-C-N 121.363 -0.836 . . . . 0.0 109.883 175.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 9.2 p -99.83 -27.04 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.904 1.281 . . . . 0.0 113.394 -171.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 25.1 ptp -162.69 149.93 13.4 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.328 1.051 . . . . 0.0 113.104 167.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -89.18 136.46 33.01 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.722 0.809 . . . . 0.0 111.037 177.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt . . . . . 0 C--O 1.254 1.326 0 C-N-CA 125.317 1.447 . . . . 0.0 112.732 175.875 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 25.9 p . . . . . 0 N--CA 1.484 1.252 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -65.01 -41.65 95.13 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.848 0.859 . . . . 0.0 112.481 -177.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 61.5 tp -72.79 -40.01 66.24 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.563 1.145 . . . . 0.0 111.098 173.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -62.66 -25.11 67.97 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.178 0.991 . . . . 0.0 112.459 178.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 95.0 m -67.85 -21.86 65.16 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.597 1.559 . . . . 0.0 111.487 171.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 11.5 mm -86.6 -37.41 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 124.749 1.22 . . . . 0.0 110.791 174.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.456 ' HA ' ' CE2' ' A' ' 22' ' ' PHE . 1.9 mp -58.31 -49.89 80.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 123.1 0.56 . . . . 0.0 110.397 174.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 16.3 ptp180 -67.43 -16.77 64.41 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 114.22 1.193 . . . . 0.0 114.22 -175.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.5 mtpt -70.59 -36.24 73.46 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.937 0.895 . . . . 0.0 111.986 171.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.456 ' CE2' ' HA ' ' A' ' 19' ' ' ILE . 6.2 p90 -93.74 -23.85 18.05 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 178.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 . . . . . 0 N--CA 1.474 0.738 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 173.705 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 21.5 mmt85 . . . . . 0 N--CA 1.47 0.529 0 CA-C-O 122.386 1.089 . . . . 0.0 113.666 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -94.82 129.77 41.65 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.906 1.282 . . . . 0.0 110.93 -172.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -160.35 161.63 33.21 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.323 1.049 . . . . 0.0 113.712 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.6 pt -141.79 153.68 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 127.125 2.17 . . . . 0.0 110.441 176.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.6 mp -116.43 132.61 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 124.732 1.213 . . . . 0.0 109.205 176.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.726 ' HB2' ' SG ' ' A' ' 64' ' ' CYS . . . -123.15 142.92 50.37 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 126.078 1.751 . . . . 0.0 110.603 -174.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -71.32 124.05 23.68 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 121.82 -0.55 . . . . 0.0 111.105 171.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.01 -33.93 63.97 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 121.142 -0.974 . . . . 0.0 111.986 177.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 60.6 mtm180 -80.31 33.68 0.3 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 126.007 1.723 . . . . 0.0 113.115 -174.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 79.8 t -145.15 133.42 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 127.142 2.177 . . . . 0.0 108.492 -173.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -57.93 -41.09 82.03 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.685 1.194 . . . . 0.0 113.336 -171.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 75.7 m-80 -84.76 -11.0 56.69 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -178.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 69.8 m 45.9 62.04 2.4 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.246 1.419 . . . . 0.0 111.95 -165.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.52 143.37 57.26 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.089 0.955 . . . . 0.0 111.955 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.656 HG22 ' SG ' ' A' ' 64' ' ' CYS . 56.6 t -61.47 116.33 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 124.534 1.134 . . . . 0.0 108.734 173.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 37.3 pt -98.47 -20.85 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 123.147 0.579 . . . . 0.0 112.326 170.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -156.72 152.61 27.24 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.106 0.962 . . . . 0.0 111.697 175.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.514 ' HB2' ' CE1' ' A' ' 48' ' ' PHE . 24.9 p -153.16 153.94 33.76 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.015 -1.053 . . . . 0.0 113.287 -179.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -79.89 -168.84 1.75 Allowed 'General case' 0 CA--C 1.553 1.091 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -179.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -101.33 -22.93 14.47 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.171 1.388 . . . . 0.0 112.57 169.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.45 -37.0 58.84 Favored Glycine 0 C--N 1.343 0.944 0 O-C-N 121.532 -0.73 . . . . 0.0 112.825 -177.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.514 ' CE1' ' HB2' ' A' ' 44' ' ' CYS . 0.8 OUTLIER -67.03 -30.38 70.44 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 117.451 0.626 . . . . 0.0 111.779 179.206 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 80.0 m -56.05 -52.02 65.76 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.608 1.163 . . . . 0.0 111.78 175.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -71.44 -20.36 62.11 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.739 0.816 . . . . 0.0 112.952 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.5 tp -64.92 -56.02 15.79 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.511 1.124 . . . . 0.0 111.116 176.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 62.0 m -98.64 -13.73 20.2 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -175.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 91.79 2.61 69.33 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 125.624 1.583 . . . . 0.0 114.152 171.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -85.64 -153.64 0.18 Allowed 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 124.899 1.28 . . . . 0.0 112.133 171.243 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 82.7 p -153.8 167.8 28.46 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 120.389 -1.444 . . . . 0.0 111.63 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -50.85 -52.96 36.45 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 118.817 -0.611 . . . . 0.0 110.512 169.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.55 -32.55 58.55 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -178.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -85.84 -37.63 18.99 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.887 0.875 . . . . 0.0 112.953 177.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 68.1 t -77.73 -15.76 14.21 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 C-N-CA 124.882 1.273 . . . . 0.0 111.625 178.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 75.1 mtp -60.59 131.35 50.45 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 120.468 -1.395 . . . . 0.0 111.508 175.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 71.92 14.01 5.93 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 126.587 1.955 . . . . 0.0 113.656 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 38.5 mtt180 -94.81 158.89 34.44 Favored Pre-proline 0 N--CA 1.474 0.761 0 C-N-CA 124.634 1.174 . . . . 0.0 111.214 174.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -70.3 136.83 32.51 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 123.307 2.672 . . . . 0.0 110.56 170.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.726 ' SG ' ' HB2' ' A' ' 32' ' ' ALA . 56.6 m -67.03 -8.58 31.25 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.46 1.281 . . . . 0.0 114.46 177.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 76.4 p -61.15 -28.37 69.07 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.351 1.061 . . . . 0.0 111.89 172.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 75.6 m 50.36 35.95 11.96 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.014 1.326 . . . . 0.0 113.104 -176.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -56.14 -33.28 65.02 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.362 1.465 . . . . 0.0 112.501 -176.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -60.26 -14.55 18.55 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.388 1.475 . . . . 0.0 114.35 177.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 92.7 mt -76.65 -2.97 35.42 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 174.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 3.6 p80 -59.87 145.3 46.18 Favored 'General case' 0 CA--C 1.552 1.026 0 CA-C-N 119.5 1.046 . . . . 0.0 113.41 176.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -118.51 -164.88 13.12 Favored Glycine 0 CA--C 1.539 1.591 0 C-N-CA 126.03 1.776 . . . . 0.0 111.525 165.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.84 -20.65 29.47 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 123.277 2.651 . . . . 0.0 112.937 174.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 29.3 ttm180 -93.59 2.2 56.44 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.26 1.424 . . . . 0.0 113.006 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 28.1 m -83.85 136.76 33.99 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.376 1.47 . . . . 0.0 110.011 177.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -96.89 123.62 40.65 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.021 0.928 . . . . 0.0 109.518 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 14.0 tpt180 -60.4 -30.57 69.69 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.721 0.809 . . . . 0.0 112.76 -176.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 21.4 tpp85 -56.9 -41.32 77.88 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.854 1.261 . . . . 0.0 112.504 173.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -72.73 -43.09 63.4 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 121.348 -0.845 . . . . 0.0 111.962 177.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -57.75 -36.49 72.16 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 121.545 -0.722 . . . . 0.0 112.038 174.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.95 -47.94 64.42 Favored 'General case' 0 C--O 1.225 -0.237 0 C-N-CA 125.197 1.399 . . . . 0.0 111.997 173.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.5 mm100 -58.25 -37.0 74.06 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 118.616 -0.707 . . . . 0.0 111.681 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 95.6 mt -59.54 -42.1 86.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 CA-C-N 119.829 1.195 . . . . 0.0 111.83 171.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.72 -34.98 70.04 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.458 0.703 . . . . 0.0 112.891 176.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -68.22 -32.83 73.31 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.981 0.912 . . . . 0.0 111.687 174.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.401 ' HB1' HG11 ' A' ' 112' ' ' VAL . . . -59.79 -27.91 66.97 Favored 'General case' 0 CA--C 1.547 0.827 0 CA-C-N 119.201 0.91 . . . . 0.0 113.035 178.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 53.7 mt -72.55 -14.7 61.7 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.648 1.579 . . . . 0.0 113.134 177.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 70.0 mt -81.86 -20.41 38.97 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.055 0.942 . . . . 0.0 112.268 174.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -89.44 152.74 22.83 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.139 1.352 . . . . 0.0 113.311 -178.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -95.83 7.9 45.04 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.088 1.355 . . . . 0.0 113.509 176.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -126.62 162.31 26.01 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.091 1.756 . . . . 0.0 112.082 -176.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -64.23 141.68 58.69 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.636 1.175 . . . . 0.0 112.063 -179.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 9.9 tpt180 -152.13 138.21 18.24 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.012 1.325 . . . . 0.0 110.646 -173.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -129.24 148.16 51.15 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 168.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 58.3 t -138.79 135.71 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 126.282 1.833 . . . . 0.0 108.232 -171.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -104.69 130.08 52.79 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.931 0.892 . . . . 0.0 110.98 -176.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.2 tt -152.26 147.36 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 123.999 0.919 . . . . 0.0 112.19 -168.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -81.59 121.08 25.88 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 120.872 -1.143 . . . . 0.0 111.601 171.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 10.1 m-30 -109.19 132.15 54.39 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.656 1.982 . . . . 0.0 111.147 173.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -78.31 162.15 26.71 Favored 'General case' 0 CA--C 1.549 0.906 0 O-C-N 121.89 -0.506 . . . . 0.0 112.084 167.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 23.9 ttp180 -115.39 147.56 40.38 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.766 1.626 . . . . 0.0 110.41 173.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -55.77 -24.92 38.41 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 178.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -64.08 -17.82 63.78 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.578 1.551 . . . . 0.0 113.77 173.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 100.41 4.43 54.98 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 125.849 1.69 . . . . 0.0 113.858 -175.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 86.3 p -92.77 -178.94 5.0 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 118.626 1.213 . . . . 0.0 112.569 176.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 21.8 t -150.02 156.67 42.1 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.681 1.192 . . . . 0.0 111.625 -177.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -161.2 164.63 30.32 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.316 1.846 . . . . 0.0 110.657 178.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.68 126.18 35.9 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 123.667 0.787 . . . . 0.0 112.459 170.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 43.4 t -105.07 135.34 46.59 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.837 2.055 . . . . 0.0 110.844 174.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 38.8 tp -93.42 112.79 24.78 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.786 1.235 . . . . 0.0 107.74 160.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 61.1 t -95.39 119.67 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 173.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -113.65 119.44 37.45 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 125.35 1.46 . . . . 0.0 109.598 174.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.401 HG11 ' HB1' ' A' ' 85' ' ' ALA . 5.8 p -94.44 127.64 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 123.897 0.879 . . . . 0.0 109.506 173.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 96.9 t -115.91 111.03 43.38 Favored Pre-proline 0 CA--C 1.537 0.452 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 178.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -73.61 130.71 15.13 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.684 2.256 . . . . 0.0 110.109 -178.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 58.6 t -100.26 124.93 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 123.942 0.897 . . . . 0.0 109.331 176.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 21.4 mtpt -94.58 150.82 19.85 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.665 0.745 . . . . 0.0 112.389 174.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 54.0 p30 -78.96 -173.43 3.54 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.832 1.253 . . . . 0.0 111.694 174.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -67.64 -15.36 63.61 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 175.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -96.59 -18.31 19.84 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.646 1.178 . . . . 0.0 113.206 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 86.67 43.98 5.94 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 125.966 1.746 . . . . 0.0 113.577 -174.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -118.69 154.27 32.99 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.394 1.477 . . . . 0.0 110.175 161.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 57.3 t -80.27 126.44 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 C-N-CA 123.413 0.685 . . . . 0.0 109.29 178.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.8 -24.63 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 N-CA-C 114.217 1.191 . . . . 0.0 114.217 -178.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 64.0 mtm -133.79 157.44 45.89 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.151 1.381 . . . . 0.0 112.205 172.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -117.56 137.08 52.82 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 125.532 1.533 . . . . 0.0 109.298 169.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 47.4 mt -101.54 121.34 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 164.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 8.2 mp -104.99 133.19 50.2 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 172.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -126.03 132.97 51.87 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.481 1.113 . . . . 0.0 110.114 -174.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 15.1 m-30 -107.46 128.21 54.29 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.02 1.328 . . . . 0.0 110.754 -176.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -124.19 131.88 53.57 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.177 1.391 . . . . 0.0 107.396 169.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 71.4 t -78.49 112.09 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 CA-C-N 119.415 1.007 . . . . 0.0 108.293 173.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.4 p -89.13 -24.5 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.429 1.091 . . . . 0.0 112.631 -174.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 13.4 tpt -161.16 119.24 2.4 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.721 1.209 . . . . 0.0 110.609 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -85.18 115.08 22.76 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.489 0.716 . . . . 0.0 109.767 176.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt . . . . . 0 C--O 1.255 1.348 0 C-N-CA 125.025 1.33 . . . . 0.0 113.733 -175.702 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 40.0 p . . . . . 0 N--CA 1.478 0.974 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -69.94 -55.57 9.31 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.982 0.913 . . . . 0.0 111.11 173.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 62.7 tp -59.34 -35.24 73.48 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.255 1.022 . . . . 0.0 111.255 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -58.56 -31.84 68.37 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 176.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 90.9 m -77.14 -32.89 56.7 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.13 0.972 . . . . 0.0 110.48 175.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 24.8 mm -68.58 -41.86 83.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 123.062 0.545 . . . . 0.0 110.367 173.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 76.1 mt -57.4 -46.67 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 124.384 1.074 . . . . 0.0 110.506 174.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 78.8 mtt-85 -58.71 -31.72 68.52 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 179.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -71.02 -30.51 66.75 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.08 0.952 . . . . 0.0 112.756 177.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -88.83 -26.13 21.83 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.487 1.115 . . . . 0.0 113.371 173.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 . . . . . 0 N--CA 1.472 0.651 0 CA-C-O 122.155 0.978 . . . . 0.0 113.369 178.244 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.1 mpt_? . . . . . 0 N--CA 1.476 0.826 0 CA-C-O 121.221 0.534 . . . . 0.0 110.309 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -122.84 128.65 50.68 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 121.002 -1.061 . . . . 0.0 111.766 -174.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 26.9 p90 -163.93 163.52 23.55 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.084 1.353 . . . . 0.0 112.96 175.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 14.3 pt -141.06 154.84 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 126.062 1.745 . . . . 0.0 110.19 175.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 15.9 mt -110.14 129.07 65.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 124.814 1.246 . . . . 0.0 108.67 177.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -122.5 142.76 50.24 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 124.897 1.279 . . . . 0.0 111.236 178.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -65.55 126.51 28.56 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.163 0.585 . . . . 0.0 111.435 172.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -80.93 -25.02 37.75 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 28.7 mmm180 -80.12 -36.82 34.76 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.616 1.166 . . . . 0.0 112.938 -173.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 52.9 t -68.98 131.85 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 C-N-CA 125.439 1.495 . . . . 0.0 109.753 173.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -59.63 -44.81 93.34 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.518 1.127 . . . . 0.0 113.309 -170.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 20.2 p30 -74.53 -9.54 58.68 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 113.78 1.029 . . . . 0.0 113.78 177.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 72.1 m 54.79 64.34 1.84 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.89 1.676 . . . . 0.0 112.23 -176.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.88 135.56 57.73 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.66 0.784 . . . . 0.0 111.735 179.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 42.3 t -64.33 118.17 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 168.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 36.0 pt -100.17 -19.77 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 124.718 1.207 . . . . 0.0 112.367 177.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -155.24 146.43 22.73 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.246 1.018 . . . . 0.0 111.547 177.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -130.15 149.64 51.77 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.367 1.067 . . . . 0.0 111.858 178.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -74.13 -164.16 0.23 Allowed 'General case' 0 CA--C 1.554 1.134 0 CA-C-N 118.249 0.477 . . . . 0.0 111.128 169.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -107.26 -21.46 12.94 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.935 1.294 . . . . 0.0 112.713 169.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.8 -40.26 58.35 Favored Glycine 0 C--N 1.342 0.915 0 O-C-N 121.678 -0.639 . . . . 0.0 112.585 -178.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -64.39 -31.41 72.61 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 123.966 0.906 . . . . 0.0 112.365 -178.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 36.1 t -60.63 -53.42 57.72 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.373 1.469 . . . . 0.0 110.939 176.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -70.61 -26.7 63.62 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.531 0.732 . . . . 0.0 112.765 178.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 27.4 tp -61.52 -38.35 87.05 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.324 1.05 . . . . 0.0 112.343 173.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 39.1 m -106.3 -35.93 7.01 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 114.686 1.365 . . . . 0.0 114.686 -171.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.83 10.21 55.46 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 125.68 1.61 . . . . 0.0 114.266 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -89.58 -147.89 0.18 Allowed 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 118.558 1.179 . . . . 0.0 111.728 170.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.9 m -161.59 161.07 29.61 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 126.042 1.737 . . . . 0.0 110.606 176.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -53.67 -43.72 69.09 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 121.561 -0.712 . . . . 0.0 111.582 178.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.11 -30.43 36.54 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 175.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -92.85 -36.81 12.63 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.001 1.32 . . . . 0.0 112.193 178.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 53.8 t -73.12 -21.15 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 125.829 1.651 . . . . 0.0 111.504 177.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 57.0 mmm -65.07 135.07 55.12 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 121.014 -1.054 . . . . 0.0 112.126 179.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.0 tp60 69.87 10.33 7.45 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 126.438 1.895 . . . . 0.0 113.577 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 36.4 mmt180 -83.49 151.24 61.78 Favored Pre-proline 0 N--CA 1.471 0.621 0 C-N-CA 124.261 1.024 . . . . 0.0 110.879 177.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.23 131.71 21.13 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.982 2.454 . . . . 0.0 108.758 167.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 22.3 p -67.54 -9.97 47.49 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -172.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 30.8 p -61.17 -26.35 67.65 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.194 1.398 . . . . 0.0 112.269 170.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 94.3 m 52.16 46.9 25.82 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.147 1.379 . . . . 0.0 112.777 175.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -59.23 -23.46 62.34 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.663 1.185 . . . . 0.0 112.867 -178.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -54.6 -25.65 27.79 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.733 1.613 . . . . 0.0 112.96 172.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 74.1 mt -78.36 -7.41 57.27 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 178.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 7.4 t60 -63.66 141.89 58.6 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.48 1.112 . . . . 0.0 112.258 175.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -148.39 -170.17 16.02 Favored Glycine 0 CA--C 1.537 1.434 0 C-N-CA 127.252 2.358 . . . . 0.0 111.857 176.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -64.11 -21.95 67.69 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 123.221 2.614 . . . . 0.0 113.848 -175.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.85 -6.9 50.79 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 176.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 26.7 m -74.96 142.18 43.96 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-N 119.959 1.254 . . . . 0.0 110.474 -174.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 69.0 mm-40 -100.74 124.96 47.1 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.17 0.988 . . . . 0.0 110.133 -170.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -61.47 -40.22 93.75 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.572 0.749 . . . . 0.0 112.797 -176.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 36.1 mmt180 -66.24 -36.04 81.98 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.454 0.701 . . . . 0.0 112.62 175.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.78 -43.73 68.13 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 119.176 0.898 . . . . 0.0 112.045 177.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -57.89 -32.17 67.46 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.17 0.588 . . . . 0.0 112.044 173.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -72.32 -49.76 31.99 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.637 1.175 . . . . 0.0 111.847 172.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 11.6 mm-40 -59.96 -34.37 73.18 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 118.914 0.779 . . . . 0.0 111.738 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 83.1 mt -61.89 -34.89 64.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 CA-C-N 120.034 1.288 . . . . 0.0 112.749 170.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.26 -41.34 63.76 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 119.648 1.113 . . . . 0.0 112.101 172.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -65.44 -28.75 69.46 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 121.29 -0.881 . . . . 0.0 112.095 175.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.66 -20.99 62.3 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 119.353 0.978 . . . . 0.0 113.116 172.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 32.1 mt -90.03 -11.67 40.82 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.79 1.636 . . . . 0.0 112.93 175.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 82.0 mt -93.1 -17.03 24.28 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.605 1.162 . . . . 0.0 111.891 171.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -87.04 144.32 19.3 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 125.165 1.364 . . . . 0.0 113.331 -176.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -87.2 -8.07 57.27 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.751 1.22 . . . . 0.0 113.738 174.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -119.78 161.14 21.27 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.593 1.957 . . . . 0.0 111.01 -177.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -61.76 141.86 57.63 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.458 1.103 . . . . 0.0 112.401 -175.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 71.3 mmt-85 -137.98 131.65 31.1 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.183 0.993 . . . . 0.0 112.529 174.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 38.8 mtmt -108.95 131.51 54.98 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.756 1.622 . . . . 0.0 110.075 169.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 57.3 t -134.26 134.7 54.97 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 125.032 1.333 . . . . 0.0 108.926 -178.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -100.91 131.9 46.57 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.096 0.959 . . . . 0.0 110.776 178.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 19.7 tt -155.46 145.5 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 124.141 0.976 . . . . 0.0 111.82 -169.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -86.38 118.21 25.67 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.101 -0.999 . . . . 0.0 110.682 173.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 11.4 m-30 -105.19 140.6 38.11 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.714 1.605 . . . . 0.0 111.677 175.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -94.01 149.71 20.99 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.312 1.445 . . . . 0.0 111.078 174.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -108.22 156.2 19.61 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 125.735 1.614 . . . . 0.0 112.422 -175.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -64.03 -23.59 67.39 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 113.302 0.852 . . . . 0.0 113.302 175.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -78.87 -6.24 55.59 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.854 1.262 . . . . 0.0 113.618 177.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 94.21 -2.07 68.06 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 125.453 1.501 . . . . 0.0 114.3 -177.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 50.7 m -83.06 176.08 9.51 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.737 1.215 . . . . 0.0 112.244 175.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 23.3 p -154.14 165.78 35.16 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 120.918 -1.114 . . . . 0.0 112.106 172.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -164.91 167.76 18.3 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.214 1.405 . . . . 0.0 113.287 176.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -82.09 122.21 27.56 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.73 0.812 . . . . 0.0 110.141 169.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 45.5 t -105.09 141.25 36.98 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.659 1.984 . . . . 0.0 109.977 173.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 11.3 tp -96.74 118.19 32.66 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.954 1.302 . . . . 0.0 107.716 162.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 65.4 t -100.83 115.63 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 124.835 1.254 . . . . 0.0 108.316 173.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -111.44 110.57 21.08 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 125.278 1.431 . . . . 0.0 107.305 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 34.7 t -97.15 122.01 48.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 73.2 t -106.53 114.67 61.77 Favored Pre-proline 0 CA--C 1.536 0.417 0 N-CA-C 107.653 -1.239 . . . . 0.0 107.653 -177.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -73.46 120.35 6.45 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 123.078 2.518 . . . . 0.0 109.575 179.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 98.3 t -95.15 118.4 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.299 0.639 . . . . 0.0 109.53 175.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 60.8 mttt -87.62 153.42 21.4 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.692 0.797 . . . . 0.0 112.468 171.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -91.4 -173.57 3.63 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.425 1.09 . . . . 0.0 111.584 175.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -60.66 -21.74 63.12 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.05 1.34 . . . . 0.0 114.37 178.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -91.0 -5.45 55.34 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.072 1.349 . . . . 0.0 113.003 178.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 80.94 22.09 61.99 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 124.327 0.965 . . . . 0.0 114.554 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -108.25 148.86 29.37 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.193 1.397 . . . . 0.0 109.99 172.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.7 p -80.23 126.77 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 123.837 0.855 . . . . 0.0 110.703 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -128.31 -23.82 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -173.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 62.6 mtm -132.01 155.51 47.89 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.467 1.507 . . . . 0.0 111.993 171.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -114.83 135.86 53.73 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 125.251 1.421 . . . . 0.0 109.27 167.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 50.9 mt -98.94 115.99 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 163.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 6.2 mp -96.26 117.8 31.52 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 174.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -110.04 131.72 54.8 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 119.366 -0.349 . . . . 0.0 111.252 -177.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 11.2 m-30 -106.84 139.61 40.98 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.954 1.302 . . . . 0.0 111.129 -177.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -144.42 135.34 25.07 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.189 1.396 . . . . 0.0 109.482 175.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 27.5 t -77.46 114.95 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 176.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.9 p -95.44 -24.94 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -176.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 42.8 tpp -164.7 125.33 2.04 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.075 1.35 . . . . 0.0 110.425 179.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -83.81 125.22 31.73 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.574 0.749 . . . . 0.0 110.341 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.32 0 CA-C-O 115.836 -2.031 . . . . 0.0 114.568 -177.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 38.0 p . . . . . 0 N--CA 1.48 1.029 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -71.04 -56.05 6.96 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 123.922 0.889 . . . . 0.0 111.136 174.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 65.7 tp -57.84 -34.14 69.39 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.607 1.163 . . . . 0.0 111.49 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -60.64 -25.41 66.29 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 176.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 84.9 m -82.93 -33.0 26.9 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.728 1.211 . . . . 0.0 110.852 172.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 26.7 mm -73.05 -38.22 55.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 123.734 0.814 . . . . 0.0 111.496 178.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 54.9 mt -53.81 -38.56 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 123.857 0.863 . . . . 0.0 111.193 176.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 56.2 mtt180 -61.8 -26.2 67.95 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.488 1.115 . . . . 0.0 112.892 178.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -74.84 -38.56 61.97 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.805 1.242 . . . . 0.0 111.339 174.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -81.18 -21.63 39.53 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.245 1.418 . . . . 0.0 113.714 177.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 . . . . . 0 N--CA 1.475 0.81 0 C-N-CA 123.806 0.842 . . . . 0.0 112.556 173.262 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.8 mpp_? . . . . . 0 N--CA 1.47 0.571 0 CA-C-O 122.225 1.012 . . . . 0.0 111.026 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.04 140.09 29.98 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.054 0.942 . . . . 0.0 111.058 -176.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -162.79 156.99 20.92 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.555 1.142 . . . . 0.0 113.279 178.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.4 pt -141.34 150.35 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 126.318 1.847 . . . . 0.0 110.439 176.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 16.9 mt -109.67 134.96 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 125.699 1.6 . . . . 0.0 108.444 177.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -130.82 148.25 52.57 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 125.022 1.329 . . . . 0.0 111.09 177.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 15.4 m-20 -67.06 127.89 34.28 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 170.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.74 -30.55 59.24 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 121.864 -0.522 . . . . 0.0 112.355 172.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 64.8 mtm180 -80.68 44.49 0.73 Allowed 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.878 1.671 . . . . 0.0 112.992 -172.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.8 p -162.05 138.62 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 126.448 1.899 . . . . 0.0 110.0 -179.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -58.17 -40.99 82.88 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.168 0.987 . . . . 0.0 112.971 -172.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 24.1 p30 -77.77 -19.47 55.05 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 96.5 m 51.51 57.82 6.16 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.502 1.121 . . . . 0.0 112.43 -172.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.23 141.23 57.67 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.526 1.13 . . . . 0.0 113.098 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 61.8 t -63.75 124.71 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 124.018 0.927 . . . . 0.0 109.847 173.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 45.3 pt -103.51 -20.23 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 125.034 1.334 . . . . 0.0 112.315 172.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 15.1 t80 -155.62 150.61 26.55 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.057 0.943 . . . . 0.0 112.141 177.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 11.2 p -146.75 154.73 41.74 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 120.953 -1.092 . . . . 0.0 113.002 178.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 31.8 t-20 -74.14 -158.52 0.07 Allowed 'General case' 0 CA--C 1.56 1.339 0 C-N-CA 123.225 0.61 . . . . 0.0 112.167 -178.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -111.75 -18.37 12.75 Favored 'General case' 0 N--CA 1.48 1.04 0 O-C-N 120.249 -1.532 . . . . 0.0 112.966 166.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -75.6 -33.21 52.79 Favored Glycine 0 N--CA 1.47 0.911 0 C-N-CA 124.391 0.996 . . . . 0.0 112.632 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -65.47 -36.26 83.35 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.122 0.969 . . . . 0.0 110.989 -178.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 8.1 t -52.21 -47.19 65.76 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.48 1.512 . . . . 0.0 111.859 170.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -76.74 -21.75 54.79 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -178.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 51.9 tp -66.32 -53.84 31.73 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.95 0.9 . . . . 0.0 111.356 174.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 79.9 m -102.48 -17.43 15.79 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -172.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 87.1 6.38 78.96 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.985 1.279 . . . . 0.0 114.167 176.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -86.29 -153.61 0.2 Allowed 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.969 1.308 . . . . 0.0 111.81 171.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 12.0 t -162.8 170.1 18.82 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 120.562 -1.336 . . . . 0.0 111.521 176.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 44.5 ttm180 -53.36 -45.83 69.33 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.417 1.087 . . . . 0.0 111.257 178.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.0 -26.66 49.59 Favored 'General case' 0 CA--C 1.551 0.993 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 176.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -93.99 -38.34 11.22 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.991 1.316 . . . . 0.0 112.268 179.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 51.2 t -86.2 -11.15 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 125.07 1.348 . . . . 0.0 112.297 -177.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 20.0 mmt -65.28 135.44 55.36 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 120.395 -1.441 . . . . 0.0 111.242 168.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.8 tm0? 70.98 8.16 6.43 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 126.298 1.839 . . . . 0.0 113.198 -177.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 37.7 mmt180 -88.88 152.17 48.28 Favored Pre-proline 0 N--CA 1.472 0.673 0 C-N-CA 124.484 1.113 . . . . 0.0 110.837 175.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -70.1 136.04 31.11 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 123.203 2.602 . . . . 0.0 109.404 171.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 30.8 p -68.07 -3.57 10.7 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 -179.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 52.6 p -61.53 -30.99 70.99 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.575 1.15 . . . . 0.0 111.665 166.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 81.8 m 50.62 38.27 18.51 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.633 1.573 . . . . 0.0 112.77 -177.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -58.2 -30.02 66.13 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.641 1.176 . . . . 0.0 112.418 -176.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -59.56 -14.51 13.48 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.04 1.336 . . . . 0.0 114.121 175.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 99.4 mt -75.38 -4.64 40.58 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.369 1.068 . . . . 0.0 113.721 171.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 13.5 p-80 -63.61 140.53 58.88 Favored 'General case' 0 CA--C 1.548 0.888 0 CA-C-N 120.194 1.361 . . . . 0.0 112.911 175.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -115.18 -164.87 14.54 Favored Glycine 0 CA--C 1.539 1.562 0 C-N-CA 125.988 1.756 . . . . 0.0 111.144 165.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -68.96 -21.72 36.88 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.952 2.435 . . . . 0.0 113.008 175.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 83.4 mtt85 -89.28 -9.56 50.16 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.483 1.113 . . . . 0.0 113.869 -178.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 56.7 m -68.91 136.73 53.05 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.756 1.222 . . . . 0.0 111.272 -173.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 21.5 mp0 -83.7 118.63 24.0 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.808 1.243 . . . . 0.0 109.475 -174.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -63.7 -37.72 88.4 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 121.639 -0.663 . . . . 0.0 112.408 -173.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -64.02 -38.05 89.64 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.414 0.686 . . . . 0.0 112.374 173.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.13 -44.25 69.29 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.308 0.958 . . . . 0.0 111.849 177.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.59 -35.47 65.84 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.145 0.578 . . . . 0.0 112.002 173.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.14 -44.99 64.46 Favored 'General case' 0 C--O 1.224 -0.243 0 C-N-CA 124.303 1.041 . . . . 0.0 112.636 172.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.41 ' HB2' HG21 ' A' ' 94' ' ' VAL . 15.6 mm-40 -59.91 -30.83 69.29 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 117.719 -1.134 . . . . 0.0 112.465 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 69.0 mt -59.43 -48.94 85.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 CA-C-N 120.622 1.555 . . . . 0.0 110.773 169.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.41 -37.24 74.43 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.838 0.855 . . . . 0.0 112.824 -178.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 77.5 mm-40 -70.92 -31.38 67.98 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.168 0.987 . . . . 0.0 111.518 175.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -59.58 -31.74 69.73 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 119.464 1.029 . . . . 0.0 112.636 177.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 56.7 mt -68.17 -15.63 63.66 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.386 1.475 . . . . 0.0 113.12 177.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 61.3 mt -83.39 -15.74 48.65 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.041 0.936 . . . . 0.0 112.446 174.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -93.32 153.18 21.25 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 125.377 1.465 . . . . 0.0 113.115 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -97.21 5.7 49.64 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.025 1.33 . . . . 0.0 113.742 177.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.61 159.72 25.86 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.82 1.648 . . . . 0.0 111.416 -179.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -61.21 141.19 57.68 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.753 1.621 . . . . 0.0 112.239 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.48 121.75 8.39 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.058 0.943 . . . . 0.0 111.514 -168.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 37.8 mtmt -106.3 137.34 44.43 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.852 1.261 . . . . 0.0 112.107 172.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.41 HG21 ' HB2' ' A' ' 81' ' ' GLN . 8.3 p -132.16 135.85 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 127.298 2.239 . . . . 0.0 110.136 171.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -101.99 133.74 46.31 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.399 1.48 . . . . 0.0 110.164 176.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 19.1 tt -159.99 144.71 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 124.202 1.001 . . . . 0.0 111.904 -163.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -82.21 121.64 26.89 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 120.911 -1.118 . . . . 0.0 111.872 173.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 11.2 m-30 -103.01 149.9 24.09 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.155 1.782 . . . . 0.0 111.412 172.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -106.28 136.12 46.56 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.299 1.84 . . . . 0.0 111.344 175.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 46.4 ttp180 -99.89 148.98 23.87 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 126.138 1.775 . . . . 0.0 111.3 -176.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -59.13 -22.14 60.4 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 177.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -73.58 -6.63 47.83 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.311 1.444 . . . . 0.0 113.732 174.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 95.95 -1.67 63.4 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 125.955 1.74 . . . . 0.0 113.86 -176.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -80.16 169.47 17.76 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.373 1.469 . . . . 0.0 112.823 -178.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 28.6 p -147.63 158.04 43.83 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.149 -0.969 . . . . 0.0 112.457 168.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -162.89 156.12 19.66 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.787 1.235 . . . . 0.0 111.531 -174.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -75.66 124.1 26.67 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 123.076 0.55 . . . . 0.0 110.162 168.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 12.8 t -111.61 146.51 37.27 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.708 2.003 . . . . 0.0 109.82 173.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 20.0 tp -96.33 124.95 40.51 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 125.514 1.526 . . . . 0.0 108.106 163.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 47.1 t -105.77 121.35 57.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 169.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -114.96 116.06 27.88 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.59 1.556 . . . . 0.0 109.101 173.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.1 p -89.77 125.84 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-O 121.066 0.46 . . . . 0.0 109.897 169.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 88.8 t -109.39 108.54 60.08 Favored Pre-proline 0 CA--C 1.536 0.414 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 174.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.85 126.46 10.71 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.666 2.244 . . . . 0.0 109.462 177.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 52.3 t -96.64 123.26 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 177.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 20.4 mtpt -94.03 149.88 20.84 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.554 0.692 . . . . 0.0 112.269 174.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 54.7 p30 -79.29 -173.64 3.76 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.65 1.18 . . . . 0.0 111.682 174.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -67.27 -15.55 63.76 Favored 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 114.614 1.338 . . . . 0.0 114.614 175.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -96.65 -18.1 19.93 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.812 1.245 . . . . 0.0 113.206 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 85.96 42.85 6.57 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 125.911 1.719 . . . . 0.0 113.563 -173.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -116.27 154.37 30.27 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.277 1.431 . . . . 0.0 110.145 160.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 49.5 t -80.67 125.8 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 178.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.02 -27.03 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -177.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 61.5 mtm -131.42 153.25 49.9 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.784 1.234 . . . . 0.0 112.359 170.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -111.44 137.04 49.76 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 125.303 1.441 . . . . 0.0 109.063 166.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 48.2 mt -104.4 119.09 52.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 163.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -101.23 124.7 47.34 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 173.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -116.14 124.53 50.56 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 124.331 1.053 . . . . 0.0 109.346 -176.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -102.88 143.84 31.96 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.16 1.384 . . . . 0.0 110.571 -178.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.39 128.9 11.4 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.616 0.766 . . . . 0.0 110.361 171.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.4 p -72.69 116.08 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 O-C-N 121.383 -0.823 . . . . 0.0 109.771 175.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.2 p -94.24 -27.6 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 124.767 1.227 . . . . 0.0 112.759 -175.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 25.4 ptp -162.3 147.02 12.39 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.411 1.085 . . . . 0.0 112.618 166.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -89.99 131.49 35.86 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.794 0.838 . . . . 0.0 110.311 178.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.253 1.258 0 N-CA-C 115.492 1.664 . . . . 0.0 115.492 -175.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 42.2 p . . . . . 0 N--CA 1.482 1.141 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -65.79 -50.01 66.23 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.671 0.788 . . . . 0.0 111.838 176.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 61.9 tp -64.9 -36.05 83.1 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.58 1.152 . . . . 0.0 111.299 176.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -59.96 -30.55 69.17 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.75 0.82 . . . . 0.0 112.638 177.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 44.4 m -71.6 -24.12 61.84 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.803 1.241 . . . . 0.0 111.48 173.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 11.1 mm -83.93 -43.97 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.216 1.007 . . . . 0.0 110.434 173.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 97.5 mt -54.31 -47.35 69.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.669 0.787 . . . . 0.0 110.531 177.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 32.9 ptt180 -69.7 -12.22 61.46 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -178.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -83.19 -34.43 25.95 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.441 1.096 . . . . 0.0 112.045 170.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -78.58 -33.77 47.4 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.257 1.023 . . . . 0.0 112.321 173.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 . . . . . 0 CA--C 1.541 0.623 0 C-N-CA 123.428 0.691 . . . . 0.0 111.94 173.04 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 12.0 mpt_? . . . . . 0 CA--C 1.543 0.707 0 CA-C-O 122.01 0.909 . . . . 0.0 110.363 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.0 mptt -86.2 132.65 33.96 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.102 1.361 . . . . 0.0 110.099 -178.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -163.14 164.24 25.38 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.258 1.023 . . . . 0.0 113.689 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 30.3 pt -144.37 154.53 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 126.736 2.014 . . . . 0.0 110.508 177.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 14.8 mt -120.0 130.71 73.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 125.907 1.683 . . . . 0.0 109.394 -178.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -130.49 145.26 51.82 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 124.485 1.114 . . . . 0.0 111.437 176.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -70.58 125.53 27.07 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 122.043 -0.41 . . . . 0.0 111.159 176.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.58 -29.82 66.35 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -177.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 56.3 mtm180 -80.03 36.66 0.35 Allowed 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.64 1.576 . . . . 0.0 112.86 -172.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 60.5 t -145.62 135.51 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 126.839 2.056 . . . . 0.0 108.87 -169.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -59.13 -45.08 91.87 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.14 0.976 . . . . 0.0 112.726 -174.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -82.79 -12.72 57.26 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 90.9 m 48.65 62.96 2.3 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.375 1.47 . . . . 0.0 111.283 -167.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.81 136.26 55.18 Favored 'General case' 0 CA--C 1.547 0.843 0 O-C-N 121.514 -0.741 . . . . 0.0 111.869 -177.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.2 t -64.23 126.43 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 122.996 0.518 . . . . 0.0 109.873 176.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.1 pt -104.35 -23.16 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.586 1.154 . . . . 0.0 112.49 174.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -147.41 140.65 25.25 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.534 0.733 . . . . 0.0 111.349 178.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.516 ' HB3' ' CE1' ' A' ' 48' ' ' PHE . 2.0 m -131.59 147.62 52.54 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.097 0.959 . . . . 0.0 111.558 -177.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -78.33 -173.24 3.19 Favored 'General case' 0 CA--C 1.554 1.118 0 CA-C-N 119.255 0.934 . . . . 0.0 111.752 172.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -98.71 -22.72 15.75 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.027 1.331 . . . . 0.0 112.353 171.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -73.37 -39.53 50.9 Favored Glycine 0 C--N 1.342 0.873 0 O-C-N 121.815 -0.553 . . . . 0.0 112.455 -177.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.516 ' CE1' ' HB3' ' A' ' 44' ' ' CYS . 0.4 OUTLIER -66.07 -32.32 73.72 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.256 0.623 . . . . 0.0 111.854 -179.345 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 91.2 m -51.29 -55.31 18.93 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.252 1.421 . . . . 0.0 111.587 174.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -71.75 -22.33 61.62 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.876 0.871 . . . . 0.0 113.032 -179.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.16 -52.68 62.87 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.11 1.364 . . . . 0.0 110.873 178.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 76.8 m -98.68 -21.2 16.55 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.51 2.23 58.84 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 125.035 1.302 . . . . 0.0 114.355 179.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -85.81 -152.43 0.16 Allowed 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 124.607 1.163 . . . . 0.0 112.102 171.072 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 80.8 p -157.11 168.87 26.17 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 120.478 -1.389 . . . . 0.0 111.928 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -52.07 -51.65 56.24 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 119.1 -0.476 . . . . 0.0 110.48 168.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.28 -32.45 56.29 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 119.39 0.996 . . . . 0.0 113.52 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -86.4 -39.42 16.4 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.009 0.924 . . . . 0.0 113.295 177.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 79.5 t -80.46 -12.75 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 124.674 1.189 . . . . 0.0 111.639 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 66.1 mmm -66.27 137.1 56.71 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 120.522 -1.361 . . . . 0.0 111.261 173.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 76.43 4.71 3.6 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 127.064 2.145 . . . . 0.0 113.531 -176.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 42.7 mtt180 -92.42 156.21 41.7 Favored Pre-proline 0 N--CA 1.476 0.851 0 C-N-CA 124.257 1.023 . . . . 0.0 112.412 -179.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -67.57 134.91 34.4 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.697 2.931 . . . . 0.0 110.585 170.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 5.1 t -66.97 -18.6 65.46 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -173.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 39.7 p -56.2 -30.05 61.76 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.304 1.442 . . . . 0.0 112.458 172.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 79.1 m 54.05 36.94 25.85 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.25 1.42 . . . . 0.0 112.357 -176.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -57.1 -30.64 64.53 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.85 1.26 . . . . 0.0 112.462 -176.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -58.8 -15.31 11.72 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.912 1.285 . . . . 0.0 114.193 175.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.2 mt -75.21 -6.2 48.46 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.579 1.152 . . . . 0.0 113.694 172.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -65.83 147.81 52.78 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 119.988 1.267 . . . . 0.0 112.492 173.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -125.97 -155.31 8.93 Favored Glycine 0 CA--C 1.537 1.447 0 C-N-CA 125.7 1.619 . . . . 0.0 111.071 165.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.25 -26.91 17.12 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 123.116 2.544 . . . . 0.0 113.712 179.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 53.7 ttm-85 -87.4 -15.35 38.04 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 119.327 0.967 . . . . 0.0 113.1 -177.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 19.8 m -65.07 134.66 54.3 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.311 1.444 . . . . 0.0 110.926 -176.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.438 ' HG3' ' CB ' ' A' ' 78' ' ' ALA . 5.9 pt20 -87.31 125.61 34.34 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -176.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 18.5 tpp85 -60.36 -35.24 75.22 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.206 1.003 . . . . 0.0 112.447 -178.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 24.6 tpp180 -60.23 -46.44 89.76 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.368 1.067 . . . . 0.0 111.715 174.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.438 ' CB ' ' HG3' ' A' ' 75' ' ' GLN . . . -69.46 -42.6 74.68 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 121.043 -1.036 . . . . 0.0 111.981 176.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.13 -35.03 64.25 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 173.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -74.67 -44.84 48.25 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.331 1.452 . . . . 0.0 112.999 173.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -59.16 -34.69 72.39 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 118.868 0.758 . . . . 0.0 111.538 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 86.6 mt -62.19 -37.44 78.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 CA-C-N 119.969 1.259 . . . . 0.0 112.198 172.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.8 -39.88 69.58 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 119.1 0.863 . . . . 0.0 112.143 174.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -64.88 -32.43 74.13 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.598 0.759 . . . . 0.0 111.867 175.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.47 -23.15 65.68 Favored 'General case' 0 CA--C 1.548 0.88 0 O-C-N 121.367 -0.833 . . . . 0.0 112.903 176.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 27.9 mt -85.94 -14.29 45.15 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.112 1.365 . . . . 0.0 113.258 174.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 80.8 mt -88.92 -17.59 29.24 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.139 0.976 . . . . 0.0 111.822 171.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -83.85 152.0 28.17 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 125.3 1.428 . . . . 0.0 112.696 175.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -99.51 11.69 38.46 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.905 1.282 . . . . 0.0 113.857 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -137.71 163.67 30.73 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.963 1.705 . . . . 0.0 111.834 -175.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.97 137.87 57.98 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.282 1.033 . . . . 0.0 111.767 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.69 124.97 10.85 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.297 1.039 . . . . 0.0 111.239 -175.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 43.3 mtmt -100.85 140.78 34.66 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.206 1.402 . . . . 0.0 112.271 171.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 46.2 t -136.44 136.56 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 126.094 1.758 . . . . 0.0 108.526 175.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -102.86 128.78 49.5 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.983 0.913 . . . . 0.0 110.647 178.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.2 tt -151.81 149.28 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.21 1.004 . . . . 0.0 112.207 -168.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -84.29 116.74 23.15 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 120.899 -1.125 . . . . 0.0 111.496 173.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 9.7 m-30 -103.08 140.9 36.71 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.419 1.488 . . . . 0.0 111.055 174.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -105.1 133.12 50.41 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.454 1.502 . . . . 0.0 111.813 178.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 73.9 mtp85 -77.37 163.16 26.67 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.667 1.587 . . . . 0.0 112.267 175.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -65.21 -23.65 67.14 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.722 1.209 . . . . 0.0 113.336 173.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -77.72 -7.7 56.9 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.841 1.257 . . . . 0.0 113.598 174.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 94.11 -1.83 68.05 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 125.425 1.488 . . . . 0.0 114.574 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 48.7 m -80.09 167.77 19.99 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 118.335 1.067 . . . . 0.0 111.756 175.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 20.5 p -148.35 170.33 18.19 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 120.886 -1.134 . . . . 0.0 113.399 176.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -170.21 166.52 8.86 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 126.258 1.823 . . . . 0.0 111.255 -178.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -79.35 123.0 27.07 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.16 0.505 . . . . 0.0 111.103 170.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 6.0 m -106.84 136.46 46.63 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.051 1.74 . . . . 0.0 110.1 168.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 19.0 tp -86.47 123.18 31.4 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 125.033 1.333 . . . . 0.0 107.602 162.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 91.6 t -103.61 117.94 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 169.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -112.16 107.11 15.89 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 126.462 1.905 . . . . 0.0 108.54 177.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 69.7 t -80.67 125.65 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 172.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 45.0 t -109.06 110.62 60.72 Favored Pre-proline 0 C--N 1.328 -0.359 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 169.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.41 132.79 16.68 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.559 2.172 . . . . 0.0 109.546 176.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 73.1 t -99.91 120.75 49.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 172.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 68.9 mttt -92.94 154.99 17.85 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.651 0.78 . . . . 0.0 112.698 171.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -93.66 -173.64 3.23 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.105 0.962 . . . . 0.0 111.641 174.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -61.04 -22.01 64.16 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.015 1.326 . . . . 0.0 114.152 178.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -90.3 -5.4 56.32 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.783 1.233 . . . . 0.0 113.043 178.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 79.32 20.62 69.06 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 124.455 1.026 . . . . 0.0 114.388 -178.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -99.63 146.21 26.72 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.94 1.296 . . . . 0.0 109.621 173.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 61.5 t -76.79 125.34 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 177.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 3.0 pt -121.28 -21.79 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 C-N-CA 124.905 1.282 . . . . 0.0 113.981 -172.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 44.7 mtm -145.52 151.35 38.01 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.72 1.608 . . . . 0.0 110.478 177.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -114.33 129.61 56.65 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 124.595 1.158 . . . . 0.0 109.084 169.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 33.5 mt -99.09 117.45 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 165.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -94.91 117.4 30.07 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 174.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -104.32 127.09 51.91 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 123.259 0.349 . . . . 0.0 111.476 176.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 13.7 m-30 -102.93 134.65 46.0 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.372 1.469 . . . . 0.0 111.146 -179.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -141.83 112.33 7.1 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.71 1.204 . . . . 0.0 109.092 176.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.7 p -64.46 112.7 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 O-C-N 121.186 -0.946 . . . . 0.0 109.399 173.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.0 p -98.83 -26.61 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.511 1.524 . . . . 0.0 112.954 -167.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 24.3 ptp -161.14 154.26 21.3 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.879 1.272 . . . . 0.0 111.241 166.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -77.12 156.48 31.63 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 122.126 0.965 . . . . 0.0 111.713 175.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.455 ' HA ' ' HE3' ' A' ' 135' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.288 0 C-N-CA 125.743 1.617 . . . . 0.0 112.822 161.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 46.6 p . . . . . 0 N--CA 1.481 1.123 0 N-CA-C 114.398 1.259 . . . . 0.0 114.398 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -64.49 -50.73 66.3 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.517 0.727 . . . . 0.0 111.491 176.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 60.8 tp -65.59 -37.97 88.16 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.56 1.144 . . . . 0.0 111.312 175.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -61.34 -29.03 69.64 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.153 0.981 . . . . 0.0 112.409 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 29.3 m -71.25 -25.65 62.56 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.823 1.249 . . . . 0.0 111.455 173.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.8 mm -82.38 -43.14 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.932 0.893 . . . . 0.0 110.252 173.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 97.0 mt -56.22 -44.25 78.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 123.628 0.771 . . . . 0.0 110.804 177.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 49.9 ptt85 -70.73 -19.64 62.72 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -78.47 -36.88 44.64 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.036 0.934 . . . . 0.0 111.766 169.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -79.53 -37.32 36.83 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.731 1.212 . . . . 0.0 112.525 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 . . . . . 0 CA--C 1.545 0.784 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -171.648 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? . . . . . 0 CA--C 1.541 0.6 0 CA-C-O 122.141 0.972 . . . . 0.0 111.705 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.5 mptt -90.99 137.22 32.53 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.388 1.075 . . . . 0.0 111.133 -174.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -165.16 162.59 20.15 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.01 1.324 . . . . 0.0 113.329 175.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 14.7 pt -142.18 152.4 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 126.295 1.838 . . . . 0.0 110.662 174.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 11.8 mt -108.61 130.46 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 125.973 1.709 . . . . 0.0 108.977 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -129.0 142.27 50.97 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 124.98 1.312 . . . . 0.0 110.975 177.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -70.36 125.7 27.54 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.75 -0.593 . . . . 0.0 111.087 177.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.39 -31.86 64.13 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.545 0.738 . . . . 0.0 112.355 -178.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 27.7 mmm180 -80.46 37.29 0.39 Allowed 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.922 1.689 . . . . 0.0 112.682 -174.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 98.4 t -143.93 134.78 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 126.911 2.084 . . . . 0.0 108.719 -172.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -56.13 -35.11 66.74 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 115.324 1.602 . . . . 0.0 115.324 -170.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -105.77 -2.33 23.32 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.287 1.435 . . . . 0.0 113.091 -178.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 89.6 m 50.43 68.78 0.71 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 126.074 1.75 . . . . 0.0 112.303 -174.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.22 137.94 57.33 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.04 0.936 . . . . 0.0 112.111 -178.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 37.1 t -65.21 123.75 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 123.587 0.755 . . . . 0.0 109.354 174.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 44.8 pt -103.92 -19.59 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 125.125 1.37 . . . . 0.0 112.52 176.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -156.42 145.64 20.53 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.233 1.013 . . . . 0.0 111.658 178.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 4.7 m -125.7 158.53 34.59 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.359 1.064 . . . . 0.0 112.341 176.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -74.87 -152.37 0.03 OUTLIER 'General case' 0 CA--C 1.559 1.306 0 CA-C-N 118.524 0.602 . . . . 0.0 111.167 166.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -115.05 -21.55 9.97 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.325 1.45 . . . . 0.0 113.215 165.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -74.85 -35.21 51.14 Favored Glycine 0 N--CA 1.471 1.012 0 C-N-CA 124.12 0.867 . . . . 0.0 112.813 -178.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -58.03 -37.31 74.12 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 124.837 1.255 . . . . 0.0 111.861 177.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 38.4 t -58.91 -52.0 67.61 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.405 1.482 . . . . 0.0 111.499 174.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -70.68 -25.97 63.22 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -179.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 38.6 tp -62.87 -40.54 97.83 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.376 1.07 . . . . 0.0 111.973 172.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 50.2 m -106.73 -32.08 8.14 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 115.054 1.502 . . . . 0.0 115.054 -168.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.61 9.51 66.46 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 125.932 1.729 . . . . 0.0 114.437 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -86.17 -144.85 0.11 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 124.609 1.164 . . . . 0.0 111.591 170.17 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 13.3 t -163.6 167.06 21.75 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.986 1.314 . . . . 0.0 111.065 169.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -54.65 -44.24 73.07 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.582 0.753 . . . . 0.0 110.801 176.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.23 -28.03 50.33 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 176.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -91.18 -39.18 12.26 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.982 1.313 . . . . 0.0 111.83 177.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 99.5 t -80.27 -17.6 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 125.671 1.588 . . . . 0.0 112.295 -177.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 80.9 mtp -61.55 133.13 55.32 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 120.85 -1.156 . . . . 0.0 111.309 170.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 23.7 tp60 74.05 3.67 4.45 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 127.08 2.152 . . . . 0.0 113.731 -178.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 33.2 mmt180 -84.55 151.46 58.82 Favored Pre-proline 0 N--CA 1.473 0.686 0 O-C-N 121.016 -1.052 . . . . 0.0 110.934 178.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.83 132.98 24.34 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.526 2.151 . . . . 0.0 109.598 169.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 32.0 p -66.76 -7.55 22.02 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 -176.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 41.3 p -59.7 -27.1 66.15 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.353 1.461 . . . . 0.0 112.536 168.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 67.5 m 57.23 40.56 27.88 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.022 1.329 . . . . 0.0 112.707 178.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -56.51 -29.77 62.22 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.361 1.464 . . . . 0.0 113.006 -175.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 29.2 p90 -62.26 -16.8 55.99 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.806 1.242 . . . . 0.0 114.107 175.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 87.8 mt -79.08 -10.42 59.82 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 174.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.412 ' CD2' HG21 ' A' ' 74' ' ' THR . 47.2 m170 -69.44 118.78 12.74 Favored 'General case' 0 CA--C 1.546 0.827 0 CA-C-N 119.597 1.09 . . . . 0.0 111.402 -177.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -100.98 -163.14 27.75 Favored Glycine 0 CA--C 1.539 1.556 0 C-N-CA 126.166 1.841 . . . . 0.0 112.129 173.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -70.58 -28.41 21.34 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 123.153 2.569 . . . . 0.0 113.149 -179.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 30.4 tpt180 -84.61 -17.35 38.98 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.412 HG21 ' CD2' ' A' ' 70' ' ' HIS . 50.6 m -60.43 132.55 54.25 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.95 1.3 . . . . 0.0 111.876 -170.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 22.9 mp0 -85.26 111.59 19.99 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.546 1.138 . . . . 0.0 110.404 -171.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 -58.24 -33.86 69.81 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.59 0.756 . . . . 0.0 112.463 177.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 21.5 tpp180 -62.03 -39.91 93.93 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.591 1.157 . . . . 0.0 112.244 175.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -77.01 -41.46 42.64 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.526 1.13 . . . . 0.0 112.31 176.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -53.15 -33.36 52.12 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 118.842 0.747 . . . . 0.0 112.797 175.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.01 -41.3 82.4 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 124.969 1.308 . . . . 0.0 112.712 172.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 80.3 mm-40 -64.38 -32.6 74.28 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 118.507 -0.758 . . . . 0.0 111.48 178.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 45.9 mt -59.33 -41.35 83.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 CA-C-N 119.56 1.073 . . . . 0.0 110.586 170.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.16 -35.08 68.93 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 176.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 71.6 mm-40 -64.66 -35.58 81.49 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.439 -0.788 . . . . 0.0 111.446 172.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.15 -21.35 63.69 Favored 'General case' 0 CA--C 1.549 0.922 0 O-C-N 121.383 -0.823 . . . . 0.0 113.189 178.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 57.6 mt -87.9 -11.14 48.55 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 125.925 1.69 . . . . 0.0 114.009 178.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.7 pp -103.94 -2.73 25.7 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 170.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -90.3 144.22 17.38 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 125.039 1.305 . . . . 0.0 112.564 175.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.9 -2.12 58.12 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.7 1.2 . . . . 0.0 113.931 176.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -124.09 159.27 30.34 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.035 1.734 . . . . 0.0 110.739 -174.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 46.4 mp0 -57.28 135.88 56.49 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.522 1.129 . . . . 0.0 111.708 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.58 121.23 11.83 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.229 1.011 . . . . 0.0 110.322 -173.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt -105.05 142.81 34.17 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.358 1.463 . . . . 0.0 111.7 178.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 61.8 t -138.29 131.74 41.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 125.858 1.663 . . . . 0.0 108.91 -177.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -103.88 129.76 51.41 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.682 0.793 . . . . 0.0 110.811 177.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.3 tt -159.78 142.75 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 123.553 0.741 . . . . 0.0 112.149 -166.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -86.38 121.73 29.35 Favored 'General case' 0 N--CA 1.465 0.303 0 O-C-N 121.405 -0.809 . . . . 0.0 110.83 174.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -109.63 154.89 22.16 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.63 1.172 . . . . 0.0 111.844 172.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -113.79 130.85 56.4 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.796 1.638 . . . . 0.0 110.52 175.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 14.8 mmt180 -106.42 166.17 10.73 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.438 1.495 . . . . 0.0 112.811 -168.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -61.14 -26.41 67.66 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.153 0.981 . . . . 0.0 113.59 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -69.77 -9.66 55.39 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.162 1.385 . . . . 0.0 113.813 178.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 87.67 0.85 83.66 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 124.999 1.285 . . . . 0.0 113.241 -171.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 18.4 m -85.95 154.15 21.68 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.159 1.383 . . . . 0.0 111.855 179.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 31.1 p -133.04 153.8 51.14 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.778 0.831 . . . . 0.0 111.513 166.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 19.3 p90 -167.82 157.6 10.18 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 125.053 1.341 . . . . 0.0 112.814 -177.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -75.81 119.49 19.88 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.514 1.126 . . . . 0.0 110.514 176.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 26.8 t -103.74 144.86 30.91 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 125.607 1.563 . . . . 0.0 110.462 172.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 8.7 tp -98.4 112.95 24.79 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 162.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 46.6 t -92.64 115.56 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 124.794 1.238 . . . . 0.0 107.812 171.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -112.98 109.53 19.0 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 124.758 1.223 . . . . 0.0 107.777 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.426 HG22 HD13 ' A' ' 127' ' ' LEU . 79.4 t -82.36 128.95 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 172.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 55.2 t -111.37 112.38 54.62 Favored Pre-proline 0 CA--C 1.536 0.41 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 171.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -74.36 129.24 12.75 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 123.246 2.631 . . . . 0.0 109.88 178.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 80.2 t -102.13 118.66 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 123.9 0.88 . . . . 0.0 108.887 176.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 60.7 mttt -87.84 152.71 21.89 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.583 0.753 . . . . 0.0 112.397 172.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -91.17 -173.76 3.74 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.25 1.02 . . . . 0.0 111.519 175.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -60.31 -21.8 62.44 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.999 1.319 . . . . 0.0 114.394 178.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -90.84 -5.51 55.49 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.14 1.376 . . . . 0.0 113.023 178.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 80.58 22.2 62.65 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 124.403 1.001 . . . . 0.0 114.522 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -107.92 148.6 29.41 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.18 1.392 . . . . 0.0 109.904 172.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.1 p -80.15 126.27 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 123.654 0.782 . . . . 0.0 110.704 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.7 -23.28 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -174.074 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 55.4 mtm -130.25 150.9 51.29 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.028 1.331 . . . . 0.0 112.038 169.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -110.51 134.46 52.35 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 125.41 1.484 . . . . 0.0 109.189 167.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 72.6 mt -98.1 116.98 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 163.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.426 HD13 HG22 ' A' ' 112' ' ' VAL . 1.4 mm? -89.56 118.52 29.25 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 105.685 -1.968 . . . . 0.0 105.685 169.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -103.91 143.45 32.83 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 119.219 -0.42 . . . . 0.0 110.763 173.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -119.6 135.37 54.83 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.594 1.158 . . . . 0.0 110.434 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -138.41 150.49 46.57 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 125.541 1.536 . . . . 0.0 108.29 173.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.2 t -94.23 112.72 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.7 p -91.88 -25.75 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -177.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 32.0 ttm -165.44 124.93 1.75 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.589 1.156 . . . . 0.0 110.813 -175.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -84.33 128.11 34.38 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.584 -0.697 . . . . 0.0 110.481 175.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.457 ' HA ' ' HE2' ' A' ' 135' ' ' LYS . 7.8 mmpt? . . . . . 0 C--O 1.252 1.231 0 CA-C-O 117.644 -1.17 . . . . 0.0 113.11 174.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 40.5 p . . . . . 0 N--CA 1.478 0.949 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -79.94 -47.29 15.25 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.979 0.912 . . . . 0.0 112.076 177.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 69.3 tp -61.02 -35.15 76.11 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.522 0.729 . . . . 0.0 110.968 177.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -55.18 -28.8 55.55 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 176.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 36.5 m -70.69 -27.61 64.14 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.623 1.169 . . . . 0.0 111.484 174.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 15.4 mm -79.44 -34.77 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 124.265 1.026 . . . . 0.0 109.801 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.9 mp -53.88 -40.22 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 123.265 0.626 . . . . 0.0 110.735 170.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 24.2 mmm-85 -63.46 -29.75 70.98 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 119.058 0.845 . . . . 0.0 112.627 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -73.91 -39.01 64.15 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.353 1.061 . . . . 0.0 111.438 174.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -76.71 -21.88 54.69 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.67 1.188 . . . . 0.0 113.189 178.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 . . . . . 0 N--CA 1.475 0.792 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 168.984 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 9.3 mmt180 . . . . . 0 N--CA 1.469 0.523 0 CA-C-O 122.332 1.063 . . . . 0.0 113.148 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -107.66 133.37 52.19 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.861 1.264 . . . . 0.0 110.671 177.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -161.48 158.72 27.0 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 124.333 1.053 . . . . 0.0 112.908 177.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.5 pt -140.46 149.19 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 125.58 1.552 . . . . 0.0 110.767 176.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.1 mp -109.45 127.63 66.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 C-N-CA 125.914 1.685 . . . . 0.0 108.86 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -126.23 140.22 52.72 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 124.827 1.251 . . . . 0.0 111.23 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -71.43 121.79 19.23 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 122.729 0.412 . . . . 0.0 110.818 177.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.94 -28.64 61.61 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.335 0.654 . . . . 0.0 112.461 -178.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 -77.9 37.83 0.25 Allowed 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 126.084 1.753 . . . . 0.0 112.675 -178.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 98.0 t -145.19 136.55 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 127.042 2.137 . . . . 0.0 108.572 -172.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -54.84 -34.42 62.84 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 115.554 1.687 . . . . 0.0 115.554 -170.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -107.49 -0.15 22.37 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.241 1.416 . . . . 0.0 113.136 -178.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 99.4 m 53.83 71.67 0.49 Allowed 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.988 1.715 . . . . 0.0 111.984 -171.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.85 131.07 44.53 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.017 0.927 . . . . 0.0 112.168 -176.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 41.3 t -64.47 123.29 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 123.86 0.864 . . . . 0.0 109.254 172.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 38.3 pt -104.95 -19.04 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 124.869 1.268 . . . . 0.0 112.362 178.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -158.91 141.28 14.01 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.67 1.188 . . . . 0.0 111.145 -178.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 4.0 m -122.63 166.41 14.9 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 121.224 -0.922 . . . . 0.0 112.397 172.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -74.74 -151.64 0.03 OUTLIER 'General case' 0 CA--C 1.557 1.237 0 C-N-CA 122.51 0.324 . . . . 0.0 111.613 169.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -113.56 -22.5 10.27 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 120.472 -1.392 . . . . 0.0 113.2 163.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -74.44 -33.88 55.41 Favored Glycine 0 N--CA 1.47 0.941 0 O-C-N 121.355 -0.841 . . . . 0.0 112.876 -177.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -57.35 -37.84 73.21 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.673 1.189 . . . . 0.0 111.624 176.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 10.2 t -60.85 -53.05 62.11 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.354 1.462 . . . . 0.0 111.61 175.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -71.01 -25.21 62.58 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -178.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 31.8 tp -62.02 -45.23 94.52 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.609 1.164 . . . . 0.0 111.648 170.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 64.2 m -104.65 -32.55 8.86 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 -166.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.05 4.54 63.03 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 126.017 1.77 . . . . 0.0 114.541 -179.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -83.79 -156.22 0.21 Allowed 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 124.814 1.246 . . . . 0.0 112.185 170.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 9.5 t -152.17 168.77 24.26 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 120.286 -1.509 . . . . 0.0 111.135 170.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.1 ttp180 -58.63 -45.5 89.1 Favored 'General case' 0 C--O 1.22 -0.472 0 O-C-N 121.535 -0.728 . . . . 0.0 111.812 -173.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.44 -25.72 37.97 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 175.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -88.56 -39.14 14.35 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.746 1.218 . . . . 0.0 111.645 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 84.4 t -85.67 -24.48 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 125.053 1.341 . . . . 0.0 112.376 -177.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 86.6 mtp -63.44 139.11 58.74 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 120.979 -1.076 . . . . 0.0 110.819 171.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 13.7 tm0? 75.65 -4.1 2.44 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 126.789 2.036 . . . . 0.0 113.784 -177.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 36.9 mmt180 -79.32 157.33 75.49 Favored Pre-proline 0 N--CA 1.473 0.687 0 C-N-CA 124.657 1.183 . . . . 0.0 111.088 173.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -67.22 136.23 39.76 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.398 2.065 . . . . 0.0 109.999 166.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 26.7 p -68.01 -2.2 7.22 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 -179.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 57.1 p -65.32 -29.42 70.16 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.578 1.551 . . . . 0.0 112.231 169.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 74.2 m 58.32 42.76 21.07 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.585 1.554 . . . . 0.0 112.517 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -57.73 -27.01 62.6 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.858 1.263 . . . . 0.0 113.209 -176.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -61.71 -16.21 47.14 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.546 1.138 . . . . 0.0 113.927 174.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 79.9 mt -83.73 -11.45 57.13 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.365 1.066 . . . . 0.0 113.78 172.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 40.0 m170 -73.11 115.45 12.45 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 119.823 1.192 . . . . 0.0 110.65 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -101.66 -162.63 27.03 Favored Glycine 0 CA--C 1.539 1.576 0 C-N-CA 126.157 1.836 . . . . 0.0 112.464 177.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -70.07 -25.79 26.8 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 123.133 2.555 . . . . 0.0 113.132 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.2 tpm_? -82.75 -17.51 44.01 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.883 0.873 . . . . 0.0 113.195 179.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 40.9 m -65.96 138.95 58.17 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.991 1.316 . . . . 0.0 112.384 -168.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 22.3 mp0 -84.48 117.99 24.02 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.338 1.455 . . . . 0.0 110.545 -172.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -60.25 -33.76 72.76 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -177.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 36.6 mmt180 -63.4 -53.27 55.0 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.397 0.679 . . . . 0.0 111.202 172.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.8 -36.89 84.78 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 120.491 -1.381 . . . . 0.0 113.09 -178.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -54.69 -35.49 63.66 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.848 0.859 . . . . 0.0 112.378 171.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -76.81 -45.7 27.67 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 124.555 1.142 . . . . 0.0 112.527 173.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -58.46 -36.94 74.47 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 118.809 0.732 . . . . 0.0 111.15 -176.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 89.3 mt -61.18 -40.17 84.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 CA-C-N 119.825 1.193 . . . . 0.0 111.845 173.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.43 -37.11 68.68 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.526 0.731 . . . . 0.0 112.65 176.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 54.8 mm-40 -67.82 -33.26 74.44 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.987 0.915 . . . . 0.0 111.469 174.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -57.98 -26.02 61.8 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 121.19 -0.944 . . . . 0.0 113.105 178.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 55.3 mt -78.58 -18.13 55.07 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.737 1.615 . . . . 0.0 113.545 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.1 pp -83.38 -20.69 33.75 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 119.473 1.033 . . . . 0.0 112.1 173.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -81.38 154.87 35.27 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 125.075 1.322 . . . . 0.0 112.85 176.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -95.5 1.31 53.9 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.882 1.273 . . . . 0.0 114.214 -178.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -126.91 161.12 29.04 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.179 1.792 . . . . 0.0 111.725 -169.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -62.49 141.67 58.3 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.072 1.349 . . . . 0.0 112.304 -177.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 -152.19 125.54 8.76 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.818 0.847 . . . . 0.0 112.86 -171.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 44.3 mtmt -101.24 139.02 37.49 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.204 1.402 . . . . 0.0 111.592 171.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 67.7 t -134.16 143.66 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 126.082 1.753 . . . . 0.0 108.166 170.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -114.48 136.18 53.29 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.461 1.104 . . . . 0.0 110.9 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.1 tt -161.57 146.45 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 123.561 0.744 . . . . 0.0 112.659 -163.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -84.49 122.35 28.86 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 121.02 -1.05 . . . . 0.0 111.047 172.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 14.7 m-30 -108.42 147.01 32.23 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.232 1.413 . . . . 0.0 112.091 173.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -109.18 132.45 54.11 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.138 1.775 . . . . 0.0 110.627 177.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -107.08 160.23 15.71 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.718 1.607 . . . . 0.0 112.116 -166.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -64.28 -22.93 67.12 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -177.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -76.23 -7.25 54.46 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 124.633 1.173 . . . . 0.0 113.387 175.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 94.97 0.11 64.03 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 125.725 1.631 . . . . 0.0 114.28 -178.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 59.2 m -88.63 162.16 16.49 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.575 1.15 . . . . 0.0 112.421 179.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 26.5 p -138.27 155.64 48.42 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 121.147 -0.971 . . . . 0.0 112.031 168.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -166.04 157.07 13.33 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.982 1.313 . . . . 0.0 112.796 -176.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -75.49 123.04 24.77 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.803 0.811 . . . . 0.0 110.754 177.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 9.0 t -109.93 138.55 46.15 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.312 1.845 . . . . 0.0 109.681 174.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.545 HD13 ' N ' ' A' ' 110' ' ' VAL . 1.2 tm? -83.19 140.46 32.56 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 156.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.545 ' N ' HD13 ' A' ' 109' ' ' LEU . 13.8 t -124.01 112.36 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 125.336 1.454 . . . . 0.0 108.625 169.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -103.36 121.87 43.66 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.978 1.311 . . . . 0.0 109.994 172.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.1 p -91.48 124.38 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 166.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 81.6 t -109.02 111.79 60.35 Favored Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 175.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.31 130.34 13.94 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.875 2.383 . . . . 0.0 109.95 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 63.7 t -101.72 124.25 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 124.096 0.959 . . . . 0.0 108.604 173.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 35.1 mttp -98.09 153.75 18.21 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 175.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -93.11 -174.58 3.6 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.166 0.986 . . . . 0.0 111.294 176.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -59.82 -21.73 61.28 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.039 1.335 . . . . 0.0 114.421 178.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -91.4 -6.04 53.48 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.115 1.366 . . . . 0.0 113.181 179.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 78.62 25.63 60.38 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 124.239 0.923 . . . . 0.0 114.142 -178.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -108.53 152.22 25.03 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.198 1.399 . . . . 0.0 109.899 172.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 10.6 t -80.56 125.77 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 123.306 0.642 . . . . 0.0 109.318 -179.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.8 -24.83 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -176.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 56.6 mtm -130.76 152.91 49.6 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.558 1.143 . . . . 0.0 112.374 167.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -113.26 134.3 54.67 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 125.721 1.608 . . . . 0.0 109.172 168.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 46.1 mt -101.76 117.9 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 165.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -100.16 128.38 46.25 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 106.895 -1.521 . . . . 0.0 106.895 173.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -123.3 130.04 52.18 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.43 1.092 . . . . 0.0 110.313 -172.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -106.38 137.7 43.89 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.889 1.276 . . . . 0.0 111.08 -174.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -142.76 133.09 24.76 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.846 1.258 . . . . 0.0 109.463 177.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 59.4 t -80.27 115.29 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 5.2 p -97.94 -28.85 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -176.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 25.4 ptp -164.13 148.87 10.15 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.367 1.067 . . . . 0.0 113.337 167.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -90.91 130.3 36.86 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.036 0.934 . . . . 0.0 110.741 178.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.255 1.344 0 CA-C-O 115.806 -2.045 . . . . 0.0 115.587 -176.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 57.4 p . . . . . 0 N--CA 1.479 1.016 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -64.76 -53.96 38.88 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.989 0.915 . . . . 0.0 111.783 173.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 58.8 tp -60.7 -35.96 77.6 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.612 1.165 . . . . 0.0 111.175 176.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -62.31 -26.03 68.19 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 177.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 99.2 m -75.55 -28.13 58.9 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.554 1.141 . . . . 0.0 111.245 171.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 16.1 mm -77.68 -41.76 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 O-C-N 121.417 -0.802 . . . . 0.0 110.702 174.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 90.1 mt -56.19 -48.47 79.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 123.994 0.917 . . . . 0.0 110.564 177.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 16.2 ptp180 -67.08 -23.96 65.91 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -75.94 -33.46 59.82 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 119.523 1.056 . . . . 0.0 112.615 170.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -76.45 -32.01 58.17 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.533 1.133 . . . . 0.0 111.908 175.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 . . . . . 0 CA--C 1.543 0.688 0 CA-C-N 118.602 0.637 . . . . 0.0 111.322 172.382 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 6.0 mmt-85 . . . . . 0 N--CA 1.472 0.643 0 CA-C-O 122.607 1.194 . . . . 0.0 113.075 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.2 mptt -94.08 133.98 36.99 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.947 1.299 . . . . 0.0 110.412 178.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -163.27 161.88 24.97 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.482 1.113 . . . . 0.0 112.805 177.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.2 pt -139.74 158.61 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 126.06 1.744 . . . . 0.0 110.521 173.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 28.3 mt -118.54 132.97 66.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 125.601 1.56 . . . . 0.0 108.868 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -131.33 143.26 50.38 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.349 1.059 . . . . 0.0 111.585 176.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -72.15 123.76 23.58 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.246 0.618 . . . . 0.0 111.489 179.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -79.03 -21.16 47.31 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -178.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 63.7 mtp85 -75.97 28.28 0.11 Allowed 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 126.185 1.794 . . . . 0.0 113.367 -173.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.4 t -151.09 137.64 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 127.114 2.165 . . . . 0.0 108.426 -166.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -63.35 -39.93 95.88 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -175.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 24.9 p30 -81.68 -15.21 55.2 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 114.377 1.251 . . . . 0.0 114.377 179.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 86.2 m 51.56 56.57 7.68 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.439 1.496 . . . . 0.0 113.351 -176.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.87 138.47 55.69 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 12.7 t -60.41 125.07 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 170.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 42.4 pt -104.93 -18.59 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 124.871 1.268 . . . . 0.0 112.619 174.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -156.16 144.99 20.31 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.091 0.956 . . . . 0.0 111.855 177.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 8.1 m -123.94 154.66 39.43 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.294 1.038 . . . . 0.0 110.588 171.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -73.15 -149.16 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.288 0 CA-C-N 118.958 0.799 . . . . 0.0 111.885 172.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -115.66 -22.67 9.08 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 120.248 -1.533 . . . . 0.0 112.885 164.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -74.5 -33.84 55.32 Favored Glycine 0 C--N 1.343 0.962 0 C-N-CA 124.231 0.919 . . . . 0.0 112.791 -178.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -56.94 -38.17 72.54 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.319 1.048 . . . . 0.0 111.292 176.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 51.2 t -59.01 -51.56 69.55 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.108 1.363 . . . . 0.0 111.659 178.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -67.56 -20.28 65.38 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.925 0.89 . . . . 0.0 113.093 178.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.06 -35.56 81.53 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.622 1.169 . . . . 0.0 112.4 176.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 45.4 m -123.09 -24.1 4.79 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 115.578 1.696 . . . . 0.0 115.578 -176.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 87.9 15.46 61.19 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-N 119.77 1.168 . . . . 0.0 114.075 -177.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -85.59 -144.63 0.1 Allowed 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.699 1.199 . . . . 0.0 111.338 170.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 77.8 p -158.22 165.94 33.61 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 124.771 1.228 . . . . 0.0 111.765 174.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 44.8 ttm180 -54.83 -47.3 74.29 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 118.889 -0.577 . . . . 0.0 110.606 171.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.65 -32.58 52.04 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 119.611 1.096 . . . . 0.0 113.932 177.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -89.08 -34.53 16.73 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.942 0.897 . . . . 0.0 113.258 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 99.5 t -84.43 -14.39 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.278 1.031 . . . . 0.0 112.035 178.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 79.5 mmm -76.95 147.38 36.96 Favored 'General case' 0 N--CA 1.474 0.725 0 O-C-N 120.841 -1.162 . . . . 0.0 111.977 175.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 31.8 tp60 69.19 4.42 4.57 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 126.451 1.9 . . . . 0.0 113.433 -175.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 32.3 mmt180 -77.96 153.96 80.3 Favored Pre-proline 0 N--CA 1.47 0.561 0 C-N-CA 124.843 1.257 . . . . 0.0 109.875 174.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -73.55 11.62 1.02 Allowed 'Trans proline' 0 CA--C 1.546 1.118 0 C-N-CA 124.106 3.204 . . . . 0.0 115.205 176.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.478 ' SG ' HD13 ' A' ' 127' ' ' LEU . 7.8 t 77.84 -23.8 0.24 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 126.585 1.954 . . . . 0.0 114.453 163.152 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 37.7 p -58.05 -20.6 40.38 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 126.6 1.96 . . . . 0.0 113.376 172.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 90.6 m 60.53 28.45 18.13 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.388 1.475 . . . . 0.0 112.824 178.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -58.87 -27.72 65.45 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.635 1.174 . . . . 0.0 112.515 -177.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -59.81 -13.86 12.31 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 174.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 92.2 mt -84.02 -3.54 58.09 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.802 1.241 . . . . 0.0 113.891 172.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 9.4 p-80 -66.1 145.6 55.63 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 120.169 1.35 . . . . 0.0 113.415 178.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -128.83 -161.55 10.68 Favored Glycine 0 CA--C 1.538 1.506 0 C-N-CA 126.557 2.027 . . . . 0.0 111.225 166.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.26 -21.34 35.94 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.937 2.425 . . . . 0.0 113.194 177.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 21.6 tpt180 -89.86 -8.75 51.24 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.272 1.029 . . . . 0.0 113.491 -178.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 24.3 m -72.39 141.83 48.72 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.917 1.287 . . . . 0.0 110.579 -176.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 64.4 mm-40 -91.8 122.77 34.64 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.506 0.722 . . . . 0.0 110.04 -173.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 28.7 mmm180 -58.62 -39.36 80.26 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.803 0.841 . . . . 0.0 112.296 -178.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -64.86 -39.5 93.65 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.318 1.047 . . . . 0.0 112.081 176.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -69.2 -43.07 74.9 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.101 -1.0 . . . . 0.0 112.633 178.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -56.89 -34.92 68.36 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 122.95 0.5 . . . . 0.0 112.04 173.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -72.35 -46.75 54.05 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 124.82 1.248 . . . . 0.0 112.549 173.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -61.1 -34.86 75.61 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 118.563 -0.732 . . . . 0.0 111.565 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 87.4 mt -63.1 -38.87 83.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 CA-C-N 120.104 1.32 . . . . 0.0 111.749 171.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.92 -36.87 78.49 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 119.33 0.968 . . . . 0.0 112.296 173.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -65.84 -31.91 73.13 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 121.347 -0.846 . . . . 0.0 111.773 172.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.69 -20.59 65.83 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 119.203 0.911 . . . . 0.0 112.604 175.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 44.6 mt -88.32 -10.75 48.46 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.927 1.691 . . . . 0.0 113.374 172.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 84.5 mt -96.98 -14.64 21.55 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.529 1.132 . . . . 0.0 112.075 172.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -86.48 150.73 23.7 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 125.389 1.471 . . . . 0.0 113.162 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -100.28 8.94 43.4 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.136 1.374 . . . . 0.0 113.678 178.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -134.21 164.83 26.5 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.428 1.891 . . . . 0.0 111.476 -178.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -61.29 138.16 58.24 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.833 0.853 . . . . 0.0 111.854 -179.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 19.7 tpt180 -145.92 128.68 16.26 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.91 0.884 . . . . 0.0 112.058 -178.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 43.1 mtmt -107.34 139.86 41.16 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.76 1.624 . . . . 0.0 111.424 175.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 45.1 t -138.24 138.69 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 125.52 1.528 . . . . 0.0 109.251 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -102.92 127.76 50.0 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.221 1.008 . . . . 0.0 110.962 177.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 19.5 tt -150.71 146.32 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 124.208 1.003 . . . . 0.0 112.352 -171.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -89.9 119.05 29.94 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 121.055 -1.028 . . . . 0.0 111.578 176.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 20.0 m-30 -115.73 157.12 24.77 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.598 1.959 . . . . 0.0 111.314 175.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -114.05 151.9 31.8 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 178.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.54 158.79 28.45 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.493 1.517 . . . . 0.0 110.395 167.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -61.81 -23.78 66.44 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.235 1.014 . . . . 0.0 113.219 166.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -72.31 -9.02 57.95 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.739 1.616 . . . . 0.0 113.709 170.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 97.94 -6.4 62.17 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 126.127 1.822 . . . . 0.0 114.778 179.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 22.1 m -82.12 130.23 35.03 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 118.952 1.376 . . . . 0.0 112.627 -172.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 25.3 p -104.87 153.65 21.09 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.761 1.224 . . . . 0.0 112.46 -177.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -165.61 163.79 19.24 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 126.088 1.755 . . . . 0.0 112.672 169.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -77.87 124.88 28.54 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.37 1.068 . . . . 0.0 111.119 175.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 42.1 t -104.25 137.31 42.35 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.82 2.048 . . . . 0.0 110.128 170.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 6.8 tp -90.28 118.0 29.45 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 161.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 94.9 t -100.87 114.67 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 125.457 1.503 . . . . 0.0 107.903 173.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -115.45 108.72 16.85 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 125.606 1.562 . . . . 0.0 107.129 -175.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.452 HG22 ' HG ' ' A' ' 127' ' ' LEU . 17.1 t -93.52 127.37 45.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 -179.008 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 69.6 t -111.15 112.1 55.41 Favored Pre-proline 0 CA--C 1.535 0.374 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.88 131.6 15.92 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.64 2.227 . . . . 0.0 109.61 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 60.6 t -92.8 105.42 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 169.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 61.5 mttt -82.16 151.7 26.81 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.268 0.556 . . . . 0.0 111.202 166.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -92.96 -173.42 3.28 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.8 0.84 . . . . 0.0 111.831 174.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -60.14 -21.79 62.04 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.128 1.371 . . . . 0.0 114.693 178.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -93.73 -0.72 55.83 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.695 1.198 . . . . 0.0 113.155 177.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 77.87 20.55 73.27 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 124.301 0.953 . . . . 0.0 114.556 178.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -99.22 142.22 30.98 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.462 1.105 . . . . 0.0 109.12 171.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.7 p -76.55 118.97 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-O 122.089 0.947 . . . . 0.0 109.903 174.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.4 pt -106.91 -19.51 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 125.64 1.576 . . . . 0.0 113.29 -174.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 3.6 mtp -157.36 156.33 32.12 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 126.561 1.944 . . . . 0.0 110.512 -174.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -122.56 133.51 54.56 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 125.086 1.355 . . . . 0.0 109.563 175.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 56.8 mt -102.59 114.81 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 166.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.478 HD13 ' SG ' ' A' ' 64' ' ' CYS . 7.4 mp -98.57 119.77 37.85 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 177.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -110.82 135.81 50.82 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 123.354 0.409 . . . . 0.0 111.47 -178.144 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -111.86 138.37 48.55 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.12 1.368 . . . . 0.0 111.433 -175.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -144.03 136.34 26.68 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.42 1.488 . . . . 0.0 109.908 175.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 42.5 t -76.15 114.58 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 176.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.0 p -98.61 -25.61 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -173.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 44.4 tpp -165.2 128.21 2.23 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.154 0.981 . . . . 0.0 111.725 179.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -84.39 127.9 34.27 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.631 0.772 . . . . 0.0 111.386 -179.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.48 ' HA ' ' HE2' ' A' ' 135' ' ' LYS . 11.1 mmpt? . . . . . 0 C--O 1.254 1.299 0 C-N-CA 124.789 1.236 . . . . 0.0 113.103 174.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 39.7 p . . . . . 0 N--CA 1.479 0.985 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -62.14 -49.9 74.01 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.058 0.943 . . . . 0.0 111.954 175.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 58.2 tp -69.64 -39.93 76.83 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.343 1.457 . . . . 0.0 111.593 174.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -60.15 -28.41 67.87 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 176.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 95.1 m -69.03 -29.82 68.05 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.294 1.038 . . . . 0.0 110.739 173.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.8 mm -78.13 -41.92 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 123.683 0.793 . . . . 0.0 110.047 174.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 96.5 mt -56.9 -46.53 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 123.437 0.695 . . . . 0.0 110.661 176.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -70.66 -21.39 62.61 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.2 mtpt -78.57 -34.85 46.62 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.53 1.132 . . . . 0.0 112.606 170.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -78.02 -30.48 49.99 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.901 0.88 . . . . 0.0 111.82 175.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 . . . . . 0 CA--C 1.546 0.802 0 C-N-CA 123.903 0.881 . . . . 0.0 111.772 165.744 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.541 0.597 0 CA-C-O 122.738 1.256 . . . . 0.0 113.213 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.3 mptt -109.4 145.91 35.34 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.948 2.099 . . . . 0.0 110.376 -173.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -167.04 163.41 15.84 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.493 1.117 . . . . 0.0 113.333 178.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 20.2 pt -139.71 155.71 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 126.212 1.805 . . . . 0.0 110.327 172.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 17.2 mt -114.63 133.25 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 126.046 1.738 . . . . 0.0 108.688 -177.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -135.29 144.0 46.55 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.454 1.101 . . . . 0.0 112.171 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 57.8 t-20 -76.09 112.59 12.7 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.266 1.027 . . . . 0.0 112.151 -176.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -71.15 -19.69 62.39 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.293 1.037 . . . . 0.0 113.434 -177.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -75.32 -19.59 59.55 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.559 1.144 . . . . 0.0 113.256 179.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 95.4 t -89.42 136.36 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 125.769 1.627 . . . . 0.0 109.171 177.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -55.86 -41.2 74.01 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.789 1.236 . . . . 0.0 113.023 -175.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -79.42 -11.47 59.91 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.394 1.078 . . . . 0.0 113.717 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 88.4 m 52.8 57.85 5.94 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.355 1.462 . . . . 0.0 112.08 -170.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.39 137.07 57.7 Favored 'General case' 0 CA--C 1.548 0.87 0 O-C-N 121.405 -0.809 . . . . 0.0 112.616 -176.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.9 t -60.8 123.81 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 172.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.2 pt -105.03 -17.95 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 125.153 1.381 . . . . 0.0 112.547 175.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -157.2 145.75 19.61 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.065 0.946 . . . . 0.0 112.204 178.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 4.4 m -124.51 156.41 37.35 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.562 1.145 . . . . 0.0 111.504 172.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -73.79 -150.71 0.03 OUTLIER 'General case' 0 CA--C 1.56 1.349 0 CA-C-N 118.86 0.754 . . . . 0.0 111.397 171.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -116.23 -21.45 9.35 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 120.365 -1.459 . . . . 0.0 112.98 163.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -73.73 -34.01 57.11 Favored Glycine 0 N--CA 1.471 1.033 0 C-N-CA 124.126 0.869 . . . . 0.0 112.691 -178.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -58.69 -38.02 77.35 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.52 1.128 . . . . 0.0 111.652 177.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 33.5 t -55.58 -51.73 66.15 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.626 1.57 . . . . 0.0 111.758 178.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -69.27 -18.17 63.83 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 178.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.507 HD11 HG23 ' A' ' 131' ' ' VAL . 10.6 tp -66.99 -44.06 81.33 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.447 1.099 . . . . 0.0 112.317 178.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 80.3 m -112.68 -21.46 11.23 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 114.513 1.301 . . . . 0.0 114.513 -176.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 87.16 14.08 64.95 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 124.417 1.008 . . . . 0.0 114.2 -178.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -87.81 -154.65 0.27 Allowed 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 124.889 1.276 . . . . 0.0 111.857 172.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 70.1 m -150.61 159.47 44.48 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.951 1.3 . . . . 0.0 110.39 178.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 -50.59 -47.0 58.23 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 121.571 -0.706 . . . . 0.0 111.5 175.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.36 -27.53 36.87 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 177.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -91.71 -33.99 14.82 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.991 1.316 . . . . 0.0 112.368 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 57.4 t -88.21 -16.11 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 124.829 1.252 . . . . 0.0 111.947 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 84.0 mmm -73.62 148.06 43.2 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 120.96 -1.088 . . . . 0.0 111.344 171.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 9.7 tm0? 70.98 4.1 4.93 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 126.076 1.75 . . . . 0.0 113.068 -176.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 32.7 mmt180 -82.04 154.84 70.12 Favored Pre-proline 0 N--CA 1.472 0.63 0 C-N-CA 125.021 1.328 . . . . 0.0 110.375 175.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -75.16 11.8 1.4 Allowed 'Trans proline' 0 CA--C 1.548 1.215 0 C-N-CA 124.268 3.312 . . . . 0.0 115.72 176.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 8.3 t 73.89 -17.02 0.47 Allowed 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 126.348 1.859 . . . . 0.0 114.666 166.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 41.1 p -62.05 -23.48 66.5 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 126.095 1.758 . . . . 0.0 113.146 170.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 98.3 m 57.78 28.7 16.32 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.093 1.357 . . . . 0.0 113.004 -176.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -56.78 -31.91 65.11 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.595 1.158 . . . . 0.0 112.22 178.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -60.87 -12.54 11.37 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.995 1.318 . . . . 0.0 114.314 177.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.2 mt -83.74 -2.4 56.19 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 114.101 1.149 . . . . 0.0 114.101 174.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 18.3 p-80 -59.79 143.05 52.08 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 119.781 1.173 . . . . 0.0 113.617 179.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -123.94 -161.64 11.19 Favored Glycine 0 CA--C 1.539 1.551 0 C-N-CA 126.363 1.935 . . . . 0.0 111.517 169.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.22 -20.4 32.72 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 123.069 2.513 . . . . 0.0 113.184 177.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 -88.13 -12.04 45.21 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.245 1.018 . . . . 0.0 113.592 -179.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 18.6 m -72.38 138.83 47.48 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.994 1.317 . . . . 0.0 110.584 -175.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -102.87 131.11 50.01 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.295 1.038 . . . . 0.0 110.544 -177.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 19.9 tpp85 -60.76 -36.34 78.69 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.809 0.844 . . . . 0.0 112.538 -175.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 85.3 mmt-85 -60.67 -41.99 96.17 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.039 0.935 . . . . 0.0 112.448 175.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.64 -45.5 75.18 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 119.144 0.884 . . . . 0.0 112.112 177.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -57.18 -33.6 67.63 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.106 0.562 . . . . 0.0 112.318 173.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -73.28 -46.24 50.97 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 124.696 1.198 . . . . 0.0 112.293 175.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 12.9 mm-40 -61.42 -33.86 74.42 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 119.091 0.859 . . . . 0.0 111.715 -177.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 76.1 mt -63.96 -35.63 74.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 CA-C-N 120.307 1.412 . . . . 0.0 111.958 171.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.75 -35.56 67.5 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 119.112 0.869 . . . . 0.0 112.498 173.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 51.8 mm-40 -67.89 -33.67 75.16 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.564 0.745 . . . . 0.0 111.581 173.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -58.7 -22.05 56.34 Favored 'General case' 0 CA--C 1.547 0.847 0 O-C-N 121.063 -1.023 . . . . 0.0 113.392 178.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 57.7 mt -82.03 -14.55 55.74 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.751 1.621 . . . . 0.0 113.839 177.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.1 pp -85.65 -18.52 32.99 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 119.606 1.094 . . . . 0.0 112.643 173.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -79.82 167.26 51.27 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 124.919 1.247 . . . . 0.0 113.718 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -110.87 -7.57 14.58 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.011 1.725 . . . . 0.0 112.746 175.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -112.25 164.97 12.6 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 127.704 2.401 . . . . 0.0 111.642 179.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 44.1 mp0 -62.58 143.59 57.08 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.903 1.281 . . . . 0.0 112.141 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 16.0 mmt85 -140.64 130.05 23.88 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.891 1.276 . . . . 0.0 111.267 173.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 39.7 mtmt -104.81 136.04 45.06 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.297 1.439 . . . . 0.0 110.847 168.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 66.7 t -135.95 136.79 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 125.345 1.458 . . . . 0.0 108.742 176.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -101.01 131.82 46.71 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.987 0.915 . . . . 0.0 110.882 178.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.1 tt -154.11 150.05 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 124.612 1.165 . . . . 0.0 111.751 -170.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -89.22 125.85 35.25 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.243 -0.911 . . . . 0.0 111.825 174.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 20.0 m-30 -113.99 146.0 40.75 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.737 2.015 . . . . 0.0 111.115 173.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -86.52 156.36 20.12 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 169.257 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 58.3 ttm-85 -101.22 149.11 24.34 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 126.152 1.781 . . . . 0.0 109.332 166.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -54.37 -28.15 41.22 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 114.441 1.274 . . . . 0.0 114.441 177.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -73.68 -6.98 50.18 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.926 1.69 . . . . 0.0 114.088 176.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 99.17 -1.28 57.49 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 125.763 1.649 . . . . 0.0 114.229 -177.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -73.57 168.98 18.2 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 118.407 1.104 . . . . 0.0 112.215 177.041 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 34.9 t -143.02 151.66 41.06 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.341 1.056 . . . . 0.0 111.36 176.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -157.36 151.85 25.16 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.673 1.189 . . . . 0.0 111.587 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -76.57 123.18 25.69 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.411 0.624 . . . . 0.0 110.466 165.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 21.4 t -104.79 137.68 42.21 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.988 1.715 . . . . 0.0 110.377 170.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.3 tp -92.24 116.37 28.89 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 162.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 22.3 t -100.06 115.39 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 124.829 1.252 . . . . 0.0 108.468 176.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -110.79 110.61 21.31 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.721 1.208 . . . . 0.0 108.273 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 71.3 t -78.39 128.75 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 169.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 56.0 t -112.98 113.01 49.8 Favored Pre-proline 0 CA--C 1.538 0.496 0 N-CA-C 107.591 -1.262 . . . . 0.0 107.591 168.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.32 127.82 10.76 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 123.273 2.648 . . . . 0.0 109.741 178.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 79.3 t -102.02 119.7 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 123.912 0.885 . . . . 0.0 109.45 176.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 61.1 mttt -88.52 153.57 21.04 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.693 0.797 . . . . 0.0 112.635 172.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -92.35 -173.58 3.45 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.475 1.11 . . . . 0.0 111.663 175.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -60.11 -22.12 62.4 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.11 1.364 . . . . 0.0 114.465 178.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -90.66 -5.47 55.77 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.119 1.368 . . . . 0.0 112.991 178.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 80.43 22.35 62.71 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 124.396 0.998 . . . . 0.0 114.456 -179.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -108.16 148.24 30.17 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.193 1.397 . . . . 0.0 109.916 172.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.8 p -78.79 126.19 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 123.703 0.801 . . . . 0.0 110.525 178.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.47 -22.82 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 -174.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 56.0 mtm -130.18 149.91 51.67 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.848 1.259 . . . . 0.0 111.977 169.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -107.52 136.04 47.96 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 124.766 1.226 . . . . 0.0 109.126 164.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 75.9 mt -99.26 118.45 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 162.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -93.68 116.76 29.27 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 170.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -101.53 144.53 30.18 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 119.122 -0.466 . . . . 0.0 110.894 176.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -122.46 133.01 54.61 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.63 1.172 . . . . 0.0 111.151 -176.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -137.7 131.09 30.87 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 125.271 1.428 . . . . 0.0 109.2 176.138 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.507 HG23 HD11 ' A' ' 51' ' ' LEU . 71.3 t -76.86 110.95 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 175.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.2 p -93.9 -24.23 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 123.628 0.771 . . . . 0.0 112.744 -174.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 37.9 tpp -163.53 111.69 1.21 Allowed 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.769 1.228 . . . . 0.0 110.572 178.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -82.28 118.91 23.49 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.388 0.675 . . . . 0.0 109.919 176.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt . . . . . 0 C--O 1.254 1.306 0 C-N-CA 125.201 1.4 . . . . 0.0 113.475 -175.456 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 32.2 p . . . . . 0 N--CA 1.477 0.925 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -86.36 -56.98 3.18 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.88 0.872 . . . . 0.0 111.762 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 48.1 tp -57.87 -35.06 70.45 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.226 1.01 . . . . 0.0 111.065 178.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -44.77 -37.41 3.77 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 170.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 99.8 m -77.69 -31.64 52.54 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.39 1.076 . . . . 0.0 110.775 179.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 12.2 mm -75.38 -36.22 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 124.675 1.19 . . . . 0.0 110.661 177.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 94.0 mt -54.83 -41.46 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 123.547 0.739 . . . . 0.0 110.529 174.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 7.0 mmt85 -59.31 -32.91 70.48 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 118.864 0.756 . . . . 0.0 112.869 178.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -77.16 -36.75 54.95 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.888 1.275 . . . . 0.0 111.631 177.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -74.85 -25.9 59.31 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.65 1.18 . . . . 0.0 112.688 175.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 . . . . . 0 N--CA 1.475 0.809 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 173.178 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 22.8 mmm180 . . . . . 0 N--CA 1.469 0.496 0 CA-C-O 122.128 0.966 . . . . 0.0 111.239 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.6 mptt -92.85 123.24 35.97 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.128 -0.982 . . . . 0.0 110.935 -170.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -159.72 163.88 34.36 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.183 0.993 . . . . 0.0 113.096 177.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 32.6 pt -140.97 156.22 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 126.5 1.92 . . . . 0.0 110.006 173.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 10.7 mt -118.27 132.75 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 125.416 1.486 . . . . 0.0 109.006 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -130.87 148.54 52.65 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.44 1.096 . . . . 0.0 111.775 177.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 52.7 t-20 -71.22 125.3 26.57 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.863 0.865 . . . . 0.0 111.045 178.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.06 -26.78 59.65 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 121.463 -0.773 . . . . 0.0 112.824 175.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 77.4 mtp180 -76.41 23.59 0.15 Allowed 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 126.137 1.775 . . . . 0.0 114.462 -170.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.4 m -149.93 148.5 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 126.748 2.019 . . . . 0.0 110.563 -171.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -63.72 -41.01 98.15 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.414 1.086 . . . . 0.0 113.26 -169.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -83.55 -12.67 55.86 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -175.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 90.4 m 49.21 64.3 1.79 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.353 1.461 . . . . 0.0 111.489 -167.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.14 136.18 54.7 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.59 0.756 . . . . 0.0 112.027 -177.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 17.5 t -63.52 123.69 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 C-N-CA 122.869 0.467 . . . . 0.0 109.842 175.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.0 pt -103.67 -21.68 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 125.291 1.436 . . . . 0.0 112.551 175.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -151.07 144.55 24.91 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.187 0.995 . . . . 0.0 111.217 178.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.457 ' HB3' ' CE1' ' A' ' 48' ' ' PHE . 0.3 OUTLIER -135.46 140.65 45.02 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.411 1.084 . . . . 0.0 111.136 -177.685 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -78.96 -175.35 4.48 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 119.97 1.259 . . . . 0.0 112.403 176.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -90.95 -27.2 18.86 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 120.455 -1.403 . . . . 0.0 111.955 172.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -70.93 -41.64 61.49 Favored Glycine 0 C--N 1.343 0.95 0 O-C-N 121.869 -0.52 . . . . 0.0 112.248 -174.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.457 ' CE1' ' HB3' ' A' ' 44' ' ' CYS . 0.4 OUTLIER -69.39 -28.56 66.27 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.185 0.594 . . . . 0.0 112.332 -179.307 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 93.2 m -53.89 -51.76 62.65 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.18 0.992 . . . . 0.0 111.32 177.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -70.99 -19.72 62.5 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.111 0.964 . . . . 0.0 113.582 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 15.2 tp -62.81 -46.43 87.98 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.989 1.316 . . . . 0.0 111.788 -179.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 44.1 t -95.68 -33.52 12.29 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.167 0.987 . . . . 0.0 113.035 171.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.38 7.57 51.52 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 124.753 1.168 . . . . 0.0 114.091 -173.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -84.89 -158.3 0.35 Allowed 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 118.775 1.287 . . . . 0.0 112.36 168.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 10.5 t -155.83 170.24 22.55 Favored 'General case' 0 C--O 1.24 0.581 0 O-C-N 120.772 -1.205 . . . . 0.0 111.643 176.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 -47.46 -47.76 27.04 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.091 1.356 . . . . 0.0 111.44 176.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.05 -26.82 64.92 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -89.5 -36.07 15.6 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.192 0.997 . . . . 0.0 112.487 174.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 80.8 t -84.46 -17.12 10.32 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 C-N-CA 124.962 1.305 . . . . 0.0 111.914 -176.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 44.6 mtm -67.59 140.58 56.92 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 120.524 -1.36 . . . . 0.0 110.453 173.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 12.4 mt-30 67.77 9.64 7.24 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.566 1.546 . . . . 0.0 114.061 -178.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -83.86 155.11 64.82 Favored Pre-proline 0 N--CA 1.472 0.654 0 C-N-CA 124.611 1.165 . . . . 0.0 110.428 170.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.27 133.99 25.87 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.614 2.209 . . . . 0.0 109.029 166.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 3.9 t -65.6 -15.26 62.56 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -171.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 40.8 p -57.67 -28.26 63.61 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.586 1.554 . . . . 0.0 112.581 169.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 86.2 m 56.65 41.6 28.16 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.303 1.441 . . . . 0.0 112.099 -178.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -57.84 -27.45 63.21 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.687 1.195 . . . . 0.0 113.232 -175.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -62.47 -15.6 50.71 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 174.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 80.4 mt -79.47 -13.68 59.41 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 173.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 31.0 m170 -73.25 118.93 16.79 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 119.211 0.914 . . . . 0.0 110.911 -179.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -99.65 -164.32 29.26 Favored Glycine 0 CA--C 1.539 1.534 0 C-N-CA 125.841 1.686 . . . . 0.0 112.574 177.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -70.07 -25.15 27.46 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 123.096 2.531 . . . . 0.0 113.019 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 40.2 ttt180 -84.39 -14.84 48.32 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.898 0.879 . . . . 0.0 112.974 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 31.7 m -69.28 143.99 53.71 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.083 1.353 . . . . 0.0 112.074 -171.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 19.9 mp0 -91.19 118.08 30.16 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.308 1.443 . . . . 0.0 110.257 -168.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 57.6 mmm-85 -58.92 -36.46 74.76 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 121.414 -0.804 . . . . 0.0 113.011 -178.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 25.1 tpp180 -61.58 -45.27 94.82 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.212 1.005 . . . . 0.0 111.528 175.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -72.08 -40.46 68.25 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.104 -0.998 . . . . 0.0 112.724 179.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.42 -34.9 64.83 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.504 0.721 . . . . 0.0 112.017 173.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -73.38 -48.2 35.96 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 124.572 1.149 . . . . 0.0 112.291 172.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -58.62 -35.29 72.25 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 118.536 -0.745 . . . . 0.0 111.998 -178.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 80.7 mt -63.49 -35.63 73.23 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 CA-C-N 120.191 1.36 . . . . 0.0 112.293 172.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.13 -36.63 66.72 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 118.888 0.767 . . . . 0.0 112.339 173.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 48.3 mm-40 -68.91 -32.93 72.91 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.491 0.717 . . . . 0.0 111.74 175.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -58.61 -21.08 52.49 Favored 'General case' 0 CA--C 1.548 0.88 0 O-C-N 121.168 -0.957 . . . . 0.0 113.358 177.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 57.6 mt -83.74 -15.3 49.1 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.669 1.588 . . . . 0.0 113.89 177.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -85.69 -20.87 28.73 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 119.611 1.096 . . . . 0.0 112.183 173.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -82.36 149.75 27.89 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 125.042 1.306 . . . . 0.0 113.444 -178.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.66 -2.22 57.85 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.013 1.325 . . . . 0.0 114.008 178.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -126.27 162.53 25.25 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 126.177 1.791 . . . . 0.0 111.386 -173.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -59.75 136.03 57.87 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.559 1.144 . . . . 0.0 111.931 -178.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.2 129.99 22.96 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.674 1.19 . . . . 0.0 110.311 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 30.9 mtmt -109.26 140.57 42.74 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.565 1.546 . . . . 0.0 111.715 176.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 41.4 t -139.51 136.35 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 126.173 1.789 . . . . 0.0 108.849 178.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -104.31 135.41 45.82 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.262 1.025 . . . . 0.0 110.594 176.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.0 tt -161.11 150.57 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 123.623 0.769 . . . . 0.0 112.554 -165.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -86.72 123.36 31.8 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 121.402 -0.811 . . . . 0.0 112.165 173.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 12.0 m-30 -114.04 140.21 48.64 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 127.157 2.183 . . . . 0.0 111.6 175.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -77.7 162.61 26.86 Favored 'General case' 0 CA--C 1.55 0.942 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 172.193 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 13.2 ptt180 -122.64 155.66 35.92 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.758 1.223 . . . . 0.0 112.723 166.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -52.87 -28.21 22.02 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 126.354 1.861 . . . . 0.0 114.453 -176.068 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -68.06 -12.87 61.62 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.178 1.391 . . . . 0.0 113.683 177.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 94.79 22.95 22.22 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 125.007 1.289 . . . . 0.0 113.569 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 7.9 t -120.36 -173.1 2.5 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.595 1.158 . . . . 0.0 111.576 177.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 16.8 t -144.91 154.33 42.49 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.007 1.323 . . . . 0.0 112.514 -169.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -150.55 148.71 29.0 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.765 1.626 . . . . 0.0 110.97 177.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -74.72 134.26 41.92 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.712 0.768 . . . . 0.0 109.827 166.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 35.1 t -129.55 145.62 51.45 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.827 2.051 . . . . 0.0 110.235 -177.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 14.8 tp -93.9 127.31 39.6 Favored 'General case' 0 N--CA 1.463 0.175 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 161.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 68.7 t -101.87 127.23 55.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 161.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -122.3 121.77 37.51 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 119.289 0.95 . . . . 0.0 109.568 165.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 57.0 t -84.74 133.0 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 175.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 49.8 t -113.67 110.71 49.43 Favored Pre-proline 0 N--CA 1.467 0.411 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 170.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.85 129.99 12.06 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.903 2.402 . . . . 0.0 109.645 178.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 74.3 t -103.46 125.04 58.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.074 0.949 . . . . 0.0 109.587 178.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 66.7 mttt -94.11 153.98 17.84 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 172.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -93.49 -173.89 3.33 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.55 1.14 . . . . 0.0 111.506 176.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -60.27 -22.05 62.65 Favored 'General case' 0 CA--C 1.548 0.865 0 C-N-CA 125.038 1.335 . . . . 0.0 114.406 178.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -90.81 -5.52 55.51 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.144 1.377 . . . . 0.0 112.981 178.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 79.9 22.44 63.75 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 124.476 1.036 . . . . 0.0 114.458 -179.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -107.26 150.06 27.08 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.065 1.346 . . . . 0.0 110.001 173.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 86.8 t -78.25 125.95 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 123.551 0.74 . . . . 0.0 109.353 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.53 -23.27 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 -176.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 56.1 mtm -131.49 151.6 51.43 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.621 1.168 . . . . 0.0 112.155 170.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -110.63 135.25 51.55 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 124.985 1.314 . . . . 0.0 109.108 166.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 64.4 mt -102.19 119.15 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 165.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -95.31 118.09 31.45 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 172.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -107.58 131.92 53.84 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 123.338 0.399 . . . . 0.0 110.475 177.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 13.3 m-30 -108.76 147.94 31.26 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 125.724 1.609 . . . . 0.0 111.585 -177.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -148.63 141.9 25.12 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 125.3 1.44 . . . . 0.0 109.168 176.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 45.3 t -76.6 122.54 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 175.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.7 t -89.94 -39.74 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 125.025 1.33 . . . . 0.0 111.089 175.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 24.7 ttm -171.53 126.43 0.63 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.39 1.076 . . . . 0.0 110.957 -175.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -78.17 125.89 30.01 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 121.303 -0.873 . . . . 0.0 110.016 169.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt . . . . . 0 C--O 1.254 1.336 0 C-N-CA 125.038 1.335 . . . . 0.0 113.58 179.225 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 41.2 p . . . . . 0 N--CA 1.481 1.117 0 N-CA-C 114.136 1.162 . . . . 0.0 114.136 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -69.81 -50.62 41.2 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.033 0.933 . . . . 0.0 111.911 175.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 58.9 tp -61.84 -35.75 79.19 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.903 1.281 . . . . 0.0 111.154 176.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -56.69 -31.45 64.47 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.125 0.97 . . . . 0.0 112.671 177.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.2 m -72.13 -31.98 66.51 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.376 0.67 . . . . 0.0 111.175 174.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 16.1 mm -73.04 -41.8 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.889 0.876 . . . . 0.0 110.366 176.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 97.1 mt -54.47 -48.15 69.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.0 0.92 . . . . 0.0 110.019 174.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 81.6 mtt-85 -59.68 -27.18 66.19 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -78.18 -24.39 47.23 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.593 1.157 . . . . 0.0 113.112 177.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -90.31 -29.34 18.18 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.252 1.021 . . . . 0.0 112.75 170.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 . . . . . 0 CA--C 1.548 0.878 0 C-N-CA 124.688 1.195 . . . . 0.0 112.755 172.219 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? . . . . . 0 CA--C 1.543 0.696 0 CA-C-O 122.554 1.169 . . . . 0.0 111.3 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -104.46 142.09 35.21 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.285 1.434 . . . . 0.0 111.09 -163.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -166.03 162.24 17.81 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.366 1.066 . . . . 0.0 113.751 -178.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 31.4 pt -147.13 156.11 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 127.406 2.282 . . . . 0.0 110.081 -178.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.9 mp -122.03 131.61 72.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 125.126 1.371 . . . . 0.0 109.505 176.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -125.21 147.79 48.92 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 124.959 1.304 . . . . 0.0 111.499 176.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -77.88 130.0 36.07 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.105 0.478 . . . . 0.0 111.454 175.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.37 -21.01 62.92 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.632 1.173 . . . . 0.0 113.902 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 82.3 mtm180 -89.63 -4.56 57.75 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 114.622 1.342 . . . . 0.0 114.622 -167.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 32.4 m -108.99 150.49 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 125.114 1.366 . . . . 0.0 111.7 -173.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -50.21 -55.02 16.96 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 126.163 1.785 . . . . 0.0 114.03 -167.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -105.51 30.74 5.46 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.956 1.703 . . . . 0.0 111.689 -177.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 70.8 m 39.25 54.3 2.23 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 126.24 1.816 . . . . 0.0 113.299 170.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.8 141.04 56.63 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.773 0.829 . . . . 0.0 111.759 -168.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.5 t -65.18 121.51 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 174.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.1 pt -100.51 -15.61 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 125.171 1.389 . . . . 0.0 112.648 177.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -156.24 141.85 17.76 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.616 1.167 . . . . 0.0 111.198 176.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.534 ' HB3' ' CE1' ' A' ' 48' ' ' PHE . 3.3 m -129.66 156.56 44.04 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.971 0.909 . . . . 0.0 111.311 -178.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -78.71 -166.13 0.83 Allowed 'General case' 0 CA--C 1.558 1.272 0 CA-C-N 118.922 0.783 . . . . 0.0 111.274 164.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -111.54 -19.57 12.49 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 125.565 1.546 . . . . 0.0 112.77 168.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.19 -38.98 94.34 Favored Glycine 0 N--CA 1.472 1.047 0 C-N-CA 124.604 1.097 . . . . 0.0 111.942 176.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.534 ' CE1' ' HB3' ' A' ' 44' ' ' CYS . 0.6 OUTLIER -69.42 -30.87 68.91 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.73 0.812 . . . . 0.0 111.444 -176.454 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 83.4 m -49.63 -54.62 17.37 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.2 1.4 . . . . 0.0 111.905 174.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -72.74 -19.91 61.3 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -178.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 16.5 tp -65.01 -49.2 71.12 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.48 1.112 . . . . 0.0 111.461 179.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 79.0 m -107.8 -15.94 14.44 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 -177.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.39 -0.29 59.87 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 125.453 1.502 . . . . 0.0 114.428 172.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -84.39 -154.95 0.18 Allowed 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 124.757 1.223 . . . . 0.0 112.314 171.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.0 t -159.11 168.49 26.49 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 120.604 -1.31 . . . . 0.0 111.652 173.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 36.5 ttm180 -49.56 -49.49 46.12 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.247 1.419 . . . . 0.0 111.044 176.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.82 -27.87 53.47 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -87.98 -49.26 7.18 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.447 1.099 . . . . 0.0 110.651 175.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 69.2 t -72.16 -19.25 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 124.363 1.065 . . . . 0.0 112.13 -172.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 5.4 mmt -64.21 -2.13 1.96 Allowed 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 5.8 tm0? -132.87 14.95 4.32 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.667 1.187 . . . . 0.0 112.341 173.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 37.4 mmt180 -98.48 155.43 36.82 Favored Pre-proline 0 C--O 1.24 0.588 0 C-N-CA 125.459 1.504 . . . . 0.0 111.395 178.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.17 142.07 37.22 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.206 2.604 . . . . 0.0 110.192 172.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 3.2 t -66.15 -11.02 46.62 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 -177.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 40.0 p -68.79 -25.66 64.81 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.344 1.458 . . . . 0.0 112.223 171.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 83.6 m 51.41 42.89 29.65 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.464 1.506 . . . . 0.0 113.013 -177.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -56.42 -31.74 64.2 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.455 1.502 . . . . 0.0 112.978 -175.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -64.85 -15.57 62.02 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.493 1.117 . . . . 0.0 113.932 177.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 87.1 mt -80.69 -11.12 59.68 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.212 1.005 . . . . 0.0 113.019 172.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -76.8 119.48 20.62 Favored 'General case' 0 CA--C 1.546 0.789 0 O-C-N 121.063 -1.023 . . . . 0.0 110.492 -178.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -97.8 -167.26 32.05 Favored Glycine 0 CA--C 1.539 1.546 0 C-N-CA 125.684 1.612 . . . . 0.0 112.366 175.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -68.21 -25.59 36.81 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 123.045 2.497 . . . . 0.0 112.96 177.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -87.61 -5.34 58.78 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.076 0.951 . . . . 0.0 112.847 178.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 63.4 m -70.33 133.44 46.95 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 120.986 -1.071 . . . . 0.0 109.942 179.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 49.8 mm-40 -80.99 123.16 28.11 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -171.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -64.65 -32.8 74.63 Favored 'General case' 0 N--CA 1.476 0.839 0 O-C-N 121.721 -0.612 . . . . 0.0 112.529 -172.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 23.5 tpp180 -61.57 -48.33 81.44 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.298 1.039 . . . . 0.0 111.429 170.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.36 -39.59 81.76 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 121.199 -0.938 . . . . 0.0 112.949 -177.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -54.82 -37.31 65.98 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.234 0.614 . . . . 0.0 112.541 171.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -72.6 -41.39 65.67 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.116 0.967 . . . . 0.0 112.821 173.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.461 ' HB2' HG21 ' A' ' 94' ' ' VAL . 47.9 mt-30 -56.25 -34.4 66.36 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 118.024 -0.989 . . . . 0.0 112.096 179.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 74.9 mt -61.79 -50.24 81.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 CA-C-N 120.197 1.362 . . . . 0.0 110.667 173.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.15 -37.0 83.03 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.825 0.85 . . . . 0.0 112.647 -178.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 79.4 mm-40 -72.71 -31.5 65.05 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.318 1.047 . . . . 0.0 111.776 175.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.54 -29.96 70.95 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 119.592 1.087 . . . . 0.0 112.512 179.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 64.6 mt -65.81 -16.58 63.94 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.914 1.286 . . . . 0.0 113.001 175.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 60.3 mt -80.62 -14.23 58.36 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 121.266 -0.896 . . . . 0.0 112.52 173.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -89.85 145.81 18.46 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 125.159 1.361 . . . . 0.0 113.23 -178.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.17 -2.8 58.11 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.974 1.31 . . . . 0.0 113.942 176.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -125.45 163.9 21.63 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.475 1.91 . . . . 0.0 110.984 -177.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -62.13 146.58 50.12 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.411 1.084 . . . . 0.0 112.907 -175.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.56 127.17 10.86 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.597 1.159 . . . . 0.0 110.514 -170.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.4 mttt -112.46 142.07 45.44 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.997 0.919 . . . . 0.0 112.463 172.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.461 HG21 ' HB2' ' A' ' 81' ' ' GLN . 7.6 p -134.13 133.39 55.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 126.255 1.822 . . . . 0.0 111.275 171.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -93.51 129.56 39.67 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.712 1.605 . . . . 0.0 110.023 172.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.7 tt -158.13 147.77 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.497 1.119 . . . . 0.0 111.339 -166.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -84.64 127.79 34.26 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 120.723 -1.236 . . . . 0.0 111.6 174.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 9.7 m-30 -107.69 140.14 41.19 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.686 1.594 . . . . 0.0 110.134 171.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -108.14 124.16 49.82 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.989 1.715 . . . . 0.0 110.651 175.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 2.5 ptp180 -92.23 159.9 15.41 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.821 1.249 . . . . 0.0 113.755 -177.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -58.81 -22.46 58.6 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 125.272 1.429 . . . . 0.0 114.322 179.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -70.61 -12.34 61.5 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.501 1.12 . . . . 0.0 113.349 176.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 95.35 27.15 11.03 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 124.53 1.062 . . . . 0.0 113.693 178.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 69.0 m -132.8 169.07 17.25 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.735 1.214 . . . . 0.0 111.414 -177.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 22.8 p -139.82 169.9 16.86 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 179.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -164.82 154.62 13.52 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 126.308 1.843 . . . . 0.0 110.348 -176.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -76.81 121.4 23.3 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.952 0.882 . . . . 0.0 110.124 168.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 49.5 t -104.7 140.44 38.06 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 127.755 2.422 . . . . 0.0 109.92 174.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 14.2 tp -93.0 119.0 31.8 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 160.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 44.2 t -103.45 117.19 48.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 124.476 1.11 . . . . 0.0 108.452 172.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -105.33 120.85 42.61 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.375 1.47 . . . . 0.0 108.314 174.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.2 p -93.64 131.09 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 119.483 1.038 . . . . 0.0 109.365 164.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 99.5 t -119.43 103.85 46.26 Favored Pre-proline 0 CA--C 1.537 0.46 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 176.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -75.78 139.76 22.66 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.906 2.404 . . . . 0.0 110.574 -175.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 96.3 t -112.37 125.33 69.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.353 1.061 . . . . 0.0 109.76 -178.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 67.2 mttt -93.55 154.54 17.82 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.036 0.934 . . . . 0.0 113.26 171.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -93.09 -174.21 3.49 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.497 1.119 . . . . 0.0 111.521 176.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -61.67 -20.69 63.71 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.013 1.325 . . . . 0.0 114.548 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -95.39 0.02 53.04 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.856 1.263 . . . . 0.0 113.162 177.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 79.31 22.55 64.9 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 124.155 0.883 . . . . 0.0 114.788 176.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -107.24 150.41 26.68 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.134 1.374 . . . . 0.0 109.987 172.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 59.1 t -79.1 124.97 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 123.565 0.746 . . . . 0.0 109.284 -179.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -127.01 -22.41 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 -176.101 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 53.8 mtm -133.46 154.51 50.74 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.905 1.282 . . . . 0.0 112.552 172.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -119.18 132.94 56.02 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 125.581 1.552 . . . . 0.0 109.556 170.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 41.6 mt -100.66 117.39 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 167.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -102.98 135.42 44.69 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 173.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -130.48 127.44 39.2 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.321 1.049 . . . . 0.0 110.129 -171.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -108.02 139.39 42.73 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.817 1.647 . . . . 0.0 111.647 -173.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -147.72 135.03 20.61 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.129 1.372 . . . . 0.0 109.728 175.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 49.9 t -73.39 117.71 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 CA-C-N 119.365 0.984 . . . . 0.0 108.611 174.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.9 p -95.51 -24.62 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 123.597 0.759 . . . . 0.0 112.666 178.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 14.5 tpt -165.8 134.98 3.26 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.358 1.463 . . . . 0.0 110.411 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -92.28 130.4 37.98 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.482 -0.761 . . . . 0.0 110.979 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt . . . . . 0 C--O 1.253 1.272 0 C-N-CA 125.332 1.453 . . . . 0.0 113.941 178.394 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.8 t . . . . . 0 N--CA 1.485 1.295 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -65.01 -50.81 64.83 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.197 0.599 . . . . 0.0 111.567 176.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 54.5 tp -64.33 -35.98 82.62 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.201 1.4 . . . . 0.0 111.022 172.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.5 -28.6 67.19 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.677 1.191 . . . . 0.0 112.688 178.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 94.4 m -74.29 -33.34 63.2 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.47 1.108 . . . . 0.0 110.869 173.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.2 mm -73.6 -36.22 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 124.351 1.06 . . . . 0.0 111.108 176.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 96.5 mt -57.04 -42.59 79.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 123.488 0.715 . . . . 0.0 110.818 176.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 89.3 mtt-85 -61.54 -22.05 64.81 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 176.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -76.07 -35.96 59.2 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 120.885 -1.134 . . . . 0.0 112.131 177.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -96.99 -11.85 24.04 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 114.559 1.318 . . . . 0.0 114.559 176.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 . . . . . 0 CA--C 1.546 0.817 0 CA-C-N 119.537 1.062 . . . . 0.0 111.91 162.59 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.3 mpt_? . . . . . 0 N--CA 1.472 0.672 0 CA-C-O 122.217 1.008 . . . . 0.0 111.243 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -87.29 139.92 30.07 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.235 1.014 . . . . 0.0 110.667 -177.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -164.43 163.24 22.3 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 124.588 1.155 . . . . 0.0 112.889 177.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 20.5 pt -139.57 155.35 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 125.852 1.661 . . . . 0.0 110.576 173.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 16.0 mt -113.2 129.55 68.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 125.687 1.595 . . . . 0.0 108.479 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -127.07 144.87 50.92 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 124.53 1.132 . . . . 0.0 111.249 176.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 42.8 t-20 -68.16 127.61 33.54 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.344 0.657 . . . . 0.0 111.146 178.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -83.04 -20.21 35.42 Favored 'General case' 0 CA--C 1.546 0.812 0 O-C-N 121.364 -0.835 . . . . 0.0 113.085 176.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 75.2 mtp180 -77.73 41.01 0.32 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 126.345 1.858 . . . . 0.0 112.759 -175.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.5 p -170.37 138.24 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 126.895 2.078 . . . . 0.0 109.985 -168.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -61.07 -44.67 97.03 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.043 0.937 . . . . 0.0 112.286 -176.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -72.55 -23.18 60.95 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -176.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 89.3 m 57.87 58.95 3.37 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.755 1.222 . . . . 0.0 112.411 -175.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.0 135.83 56.8 Favored 'General case' 0 CA--C 1.551 0.998 0 O-C-N 121.203 -0.936 . . . . 0.0 112.528 -177.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 11.5 t -62.52 123.65 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 C-N-CA 123.473 0.709 . . . . 0.0 109.502 174.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.6 pt -104.61 -19.93 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 125.181 1.392 . . . . 0.0 112.354 176.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 21.3 t80 -153.98 146.17 23.78 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.864 0.866 . . . . 0.0 111.866 177.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 6.9 m -125.35 155.42 40.32 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.185 0.994 . . . . 0.0 111.161 171.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -71.34 -152.35 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.285 0 CA-C-N 118.362 0.528 . . . . 0.0 111.487 170.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -117.11 -17.52 10.26 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 120.229 -1.544 . . . . 0.0 113.205 164.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -76.3 -33.55 48.54 Favored Glycine 0 N--CA 1.471 1.007 0 O-C-N 121.324 -0.86 . . . . 0.0 112.852 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -58.13 -38.44 76.53 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.6 1.16 . . . . 0.0 111.599 177.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 9.9 t -53.0 -51.16 62.54 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.362 1.465 . . . . 0.0 111.825 173.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -74.02 -22.86 59.41 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -178.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 49.5 tp -65.16 -50.0 67.67 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.292 1.037 . . . . 0.0 111.815 176.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 80.6 m -105.86 -20.47 13.43 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 -174.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.77 6.01 70.56 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 124.585 1.088 . . . . 0.0 114.032 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -88.61 -175.72 5.03 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.578 1.151 . . . . 0.0 112.295 171.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 66.5 m -135.41 161.25 35.97 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.104 0.962 . . . . 0.0 111.104 -179.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 46.7 ttm180 -53.37 -42.49 66.95 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 121.497 -0.752 . . . . 0.0 111.842 178.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.04 -28.1 49.61 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 175.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -92.96 -35.2 13.42 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.818 1.247 . . . . 0.0 112.324 178.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 99.3 t -83.64 -12.52 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 124.509 1.123 . . . . 0.0 112.181 178.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 21.3 mmt -68.57 141.86 55.35 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 120.798 -1.189 . . . . 0.0 112.278 172.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 68.74 7.3 6.04 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 126.011 1.724 . . . . 0.0 113.609 -178.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -78.13 152.77 79.56 Favored Pre-proline 0 N--CA 1.472 0.667 0 CA-C-O 117.921 -1.038 . . . . 0.0 109.904 175.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -74.37 13.02 0.95 Allowed 'Trans proline' 0 CA--C 1.549 1.229 0 C-N-CA 124.319 3.346 . . . . 0.0 115.356 176.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 7.5 t 75.14 -27.6 0.19 Allowed 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 126.86 2.064 . . . . 0.0 113.922 167.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 38.8 p -58.92 -19.3 41.2 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 127.162 2.185 . . . . 0.0 113.92 173.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . 0.277 28.5 p 42.81 40.29 2.04 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 127.308 2.243 . . . . 0.0 114.31 178.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -57.59 -32.91 67.65 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.026 0.931 . . . . 0.0 111.765 -177.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -57.04 -15.75 5.79 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.155 1.382 . . . . 0.0 114.253 177.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 89.9 mt -75.18 -2.29 27.17 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 171.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 31.4 p-80 -60.55 133.22 55.89 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 119.826 1.194 . . . . 0.0 112.946 174.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -107.39 -161.95 21.55 Favored Glycine 0 CA--C 1.54 1.651 0 C-N-CA 126.229 1.871 . . . . 0.0 111.468 168.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.05 -26.02 18.75 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 123.083 2.522 . . . . 0.0 113.153 178.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 29.8 ttm180 -94.38 -8.09 39.74 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.547 1.139 . . . . 0.0 113.715 -176.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 25.8 m -64.6 139.41 58.76 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.254 1.421 . . . . 0.0 110.555 179.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -102.43 123.03 45.46 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.174 0.989 . . . . 0.0 109.735 179.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 42.5 mmt180 -61.58 -26.91 68.27 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 24.6 tpp180 -56.21 -46.0 79.65 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.472 1.109 . . . . 0.0 111.797 171.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.36 -45.57 65.82 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.449 1.1 . . . . 0.0 111.954 175.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.52 -33.34 63.68 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 121.62 -0.675 . . . . 0.0 112.709 177.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.59 -41.85 71.78 Favored 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 125.1 1.36 . . . . 0.0 112.502 173.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 24.5 mm-40 -60.81 -33.48 73.08 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 118.328 -0.844 . . . . 0.0 111.347 179.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 46.1 mt -59.36 -43.66 90.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 CA-C-N 120.042 1.292 . . . . 0.0 111.026 171.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.2 -35.8 74.16 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.327 0.651 . . . . 0.0 112.71 177.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 78.4 mm-40 -69.27 -32.52 71.76 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 121.604 -0.685 . . . . 0.0 111.861 174.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.71 -23.21 67.04 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.936 0.894 . . . . 0.0 112.771 178.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 61.1 mt -77.26 -15.04 59.63 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.677 1.591 . . . . 0.0 113.45 174.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 64.2 mt -89.97 -14.67 33.56 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.124 0.969 . . . . 0.0 112.426 179.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -92.64 148.48 19.11 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 125.164 1.364 . . . . 0.0 113.15 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.84 -1.57 58.02 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.721 1.208 . . . . 0.0 113.83 175.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -115.33 161.32 18.66 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.711 2.004 . . . . 0.0 111.208 176.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.79 154.34 39.37 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 178.15 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 29.9 tpt180 -155.07 129.14 8.82 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.635 1.174 . . . . 0.0 111.148 -175.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 39.5 mtmt -102.68 137.63 40.65 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.598 1.559 . . . . 0.0 111.622 174.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 64.4 t -132.97 134.94 57.7 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 C-N-CA 126.414 1.885 . . . . 0.0 108.025 177.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -106.0 130.61 53.9 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.765 0.826 . . . . 0.0 110.381 177.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.0 tt -156.98 147.2 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 124.022 0.929 . . . . 0.0 112.217 -166.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -85.73 126.66 34.15 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.027 -1.046 . . . . 0.0 111.858 174.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 18.3 m-30 -111.92 147.8 35.07 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.528 1.931 . . . . 0.0 111.116 172.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -101.25 150.14 23.29 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.8 0.84 . . . . 0.0 112.538 166.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 40.9 mtm180 -89.59 159.03 17.38 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.956 1.302 . . . . 0.0 112.283 169.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 5.9 mptp? -59.19 -27.16 65.44 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.02 0.928 . . . . 0.0 112.639 166.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -69.93 -11.46 60.89 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 126.255 1.822 . . . . 0.0 114.067 173.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 90.39 -0.67 78.22 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 125.472 1.51 . . . . 0.0 114.471 -176.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -76.74 154.63 33.9 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.533 1.133 . . . . 0.0 111.451 176.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 95.5 m -126.99 156.96 40.78 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 119.382 0.992 . . . . 0.0 112.176 174.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -161.42 154.68 21.25 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.851 1.26 . . . . 0.0 111.998 177.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -77.72 122.78 25.83 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.627 0.771 . . . . 0.0 110.392 165.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 8.2 t -107.55 140.95 39.75 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 126.083 1.753 . . . . 0.0 110.224 173.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.3 tt -92.16 121.59 33.84 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 125.158 1.383 . . . . 0.0 107.491 162.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 48.0 t -101.0 111.37 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 125.068 1.347 . . . . 0.0 108.484 169.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -107.75 107.78 18.71 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.612 1.565 . . . . 0.0 108.997 174.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.407 HG22 ' HG ' ' A' ' 127' ' ' LEU . 50.4 t -78.43 126.91 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 170.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 75.6 t -114.36 116.3 44.19 Favored Pre-proline 0 CA--C 1.538 0.51 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 170.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.69 127.0 9.9 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 123.238 2.625 . . . . 0.0 109.736 179.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 63.0 t -97.18 118.64 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 123.736 0.815 . . . . 0.0 109.279 174.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 60.4 mttt -88.48 153.51 21.1 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.675 0.79 . . . . 0.0 112.587 171.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -93.02 -173.52 3.3 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.518 1.127 . . . . 0.0 111.747 175.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -60.7 -21.36 62.8 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 125.206 1.402 . . . . 0.0 114.705 178.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -93.93 -0.82 55.43 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.854 1.262 . . . . 0.0 113.22 177.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 79.11 22.05 66.46 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 124.222 0.915 . . . . 0.0 114.537 177.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -107.29 147.89 29.69 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 125.119 1.368 . . . . 0.0 109.923 172.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.6 p -77.82 126.38 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 123.405 0.682 . . . . 0.0 110.273 178.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.58 -22.45 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 -175.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 57.7 mtm -131.99 150.96 52.01 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.779 1.231 . . . . 0.0 112.068 168.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -107.92 133.7 51.89 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 125.06 1.344 . . . . 0.0 109.215 165.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 69.2 mt -97.15 119.0 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 163.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.407 ' HG ' HG22 ' A' ' 112' ' ' VAL . 8.6 mp -96.47 119.09 34.32 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 169.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -102.81 124.88 49.16 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 123.547 0.529 . . . . 0.0 110.984 177.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -100.9 126.88 47.55 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.232 1.413 . . . . 0.0 109.998 179.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -141.53 103.94 4.48 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.38 1.072 . . . . 0.0 108.246 -172.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.2 p -61.51 116.9 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 O-C-N 120.981 -1.074 . . . . 0.0 110.473 178.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.9 p -96.76 -27.54 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.817 1.247 . . . . 0.0 113.102 -174.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 24.7 ptp -161.41 147.17 14.02 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.24 1.016 . . . . 0.0 112.64 166.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -88.93 134.31 34.0 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.705 0.802 . . . . 0.0 110.845 177.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt . . . . . 0 C--O 1.253 1.246 0 C-N-CA 125.36 1.464 . . . . 0.0 112.473 177.114 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.8 t . . . . . 0 N--CA 1.48 1.031 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -75.28 -45.09 42.07 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.252 -0.905 . . . . 0.0 112.018 172.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 52.9 tp -63.18 -35.94 81.96 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.764 1.226 . . . . 0.0 111.16 171.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -52.1 -33.31 39.01 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.548 1.539 . . . . 0.0 112.583 175.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 21.4 m -72.65 -21.56 61.07 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.546 1.538 . . . . 0.0 112.02 176.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.6 mm -82.22 -39.56 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 124.168 0.987 . . . . 0.0 109.953 177.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.9 mp -55.21 -38.95 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 123.422 0.689 . . . . 0.0 111.367 177.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 50.0 ptt85 -73.45 -16.86 61.3 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -178.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -85.69 -36.77 20.04 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.121 1.368 . . . . 0.0 111.297 171.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -70.74 -28.83 65.0 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.485 1.114 . . . . 0.0 112.029 174.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 . . . . . 0 CA--C 1.541 0.626 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 167.405 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.54 0.565 0 CA-C-O 122.557 1.17 . . . . 0.0 111.477 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.7 mptt -97.74 139.09 34.14 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.512 1.525 . . . . 0.0 110.351 -179.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -162.15 160.93 27.8 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 124.072 0.949 . . . . 0.0 113.127 173.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 12.8 pt -139.72 153.22 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 125.996 1.718 . . . . 0.0 109.937 175.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.2 mp -116.5 133.31 63.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 C-N-CA 125.337 1.455 . . . . 0.0 109.146 -179.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -132.54 142.81 49.35 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 124.825 1.25 . . . . 0.0 111.815 -176.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -65.56 121.69 15.51 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.518 1.127 . . . . 0.0 111.944 177.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -78.82 -19.87 51.03 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 178.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 26.0 mmm180 -73.31 -40.65 64.34 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.468 1.107 . . . . 0.0 112.527 -175.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 32.6 m -73.55 147.78 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 124.013 0.925 . . . . 0.0 111.892 175.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -62.22 -42.02 98.92 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.574 1.149 . . . . 0.0 113.225 -172.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -77.32 -11.32 59.82 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 113.785 1.032 . . . . 0.0 113.785 -176.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 81.6 m 51.03 60.31 3.97 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.451 1.5 . . . . 0.0 111.776 -170.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.06 137.51 55.07 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.749 0.82 . . . . 0.0 112.023 -176.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 41.4 t -63.71 123.79 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 123.723 0.809 . . . . 0.0 109.263 174.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.6 pt -103.83 -19.74 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.727 1.211 . . . . 0.0 112.298 175.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -154.08 143.72 21.66 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.34 1.056 . . . . 0.0 111.506 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 4.2 m -125.62 157.63 36.73 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.816 1.246 . . . . 0.0 111.594 174.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -73.79 -149.95 0.02 OUTLIER 'General case' 0 CA--C 1.56 1.364 0 CA-C-N 118.622 0.646 . . . . 0.0 111.399 169.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -116.72 -18.69 10.2 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 120.425 -1.422 . . . . 0.0 113.266 163.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -76.0 -34.98 45.83 Favored Glycine 0 N--CA 1.471 0.99 0 O-C-N 121.276 -0.89 . . . . 0.0 112.684 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -55.29 -39.12 69.5 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.857 1.263 . . . . 0.0 111.605 177.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 2.8 t -54.6 -56.76 15.65 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.69 1.596 . . . . 0.0 112.09 176.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -71.31 -20.54 62.18 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -179.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.8 -53.51 56.96 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.64 1.176 . . . . 0.0 110.947 175.129 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 75.9 m -104.94 -31.97 8.99 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 -174.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 109.72 0.12 30.55 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 127.207 2.337 . . . . 0.0 115.945 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -79.58 -160.75 0.28 Allowed 'General case' 0 CA--C 1.554 1.102 0 CA-C-N 118.786 1.293 . . . . 0.0 112.466 177.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 69.8 m -145.01 160.91 40.62 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.055 1.342 . . . . 0.0 110.582 174.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -53.03 -44.11 67.09 Favored 'General case' 0 N--CA 1.478 0.956 0 O-C-N 121.355 -0.841 . . . . 0.0 111.668 177.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.69 -25.95 42.45 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 176.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -91.69 -39.46 11.82 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.024 1.33 . . . . 0.0 112.176 177.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 87.4 t -80.81 -15.84 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 124.502 1.121 . . . . 0.0 112.277 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 68.2 mmm -65.72 137.87 57.58 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 120.843 -1.16 . . . . 0.0 111.34 172.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 29.7 tp60 72.92 6.14 5.29 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 126.508 1.923 . . . . 0.0 113.633 -177.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 34.6 mmt180 -86.88 153.1 54.61 Favored Pre-proline 0 N--CA 1.473 0.699 0 C-N-CA 124.548 1.139 . . . . 0.0 110.84 176.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -71.52 136.01 27.56 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.109 2.539 . . . . 0.0 110.092 171.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 19.0 p -68.69 -7.67 35.53 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -176.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 41.2 p -62.3 -23.97 67.04 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.065 1.346 . . . . 0.0 112.124 168.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 84.0 m 57.69 36.5 26.69 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.617 1.567 . . . . 0.0 113.009 178.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -56.16 -29.44 60.81 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.766 1.226 . . . . 0.0 112.24 177.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -60.62 -13.68 15.84 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.852 1.261 . . . . 0.0 114.357 175.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.3 mt -90.35 -0.65 57.73 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.112 1.365 . . . . 0.0 113.853 174.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -70.96 161.52 30.95 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 -178.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -160.85 -164.62 16.08 Favored Glycine 0 CA--C 1.538 1.52 0 C-N-CA 126.857 2.17 . . . . 0.0 111.052 166.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -63.54 -20.47 69.6 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 123.083 2.522 . . . . 0.0 114.523 -176.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 27.1 mmt85 -88.66 -8.54 54.43 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 119.298 0.954 . . . . 0.0 113.306 175.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 28.7 m -73.7 132.4 42.65 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 119.464 1.029 . . . . 0.0 109.502 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 -87.07 122.16 30.52 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.366 0.666 . . . . 0.0 109.761 -169.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 31.9 mmm180 -58.86 -39.17 80.53 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.771 0.828 . . . . 0.0 112.608 -175.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 17.6 ttm180 -67.99 -35.79 78.93 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.649 0.779 . . . . 0.0 112.31 176.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -71.6 -43.07 66.87 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.061 -1.024 . . . . 0.0 112.217 179.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -56.15 -33.38 65.16 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.161 0.584 . . . . 0.0 111.83 171.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -72.37 -47.65 47.78 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 124.703 1.201 . . . . 0.0 112.259 172.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 13.6 mm-40 -62.28 -34.25 76.2 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 118.404 -0.808 . . . . 0.0 111.775 -179.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 90.7 mt -62.61 -40.06 86.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 CA-C-N 120.198 1.363 . . . . 0.0 111.557 171.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.86 -37.08 81.39 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 119.296 0.953 . . . . 0.0 112.361 174.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 -67.65 -32.18 72.69 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 121.591 -0.693 . . . . 0.0 112.04 173.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.43 -21.97 66.61 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 119.239 0.927 . . . . 0.0 112.761 176.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 41.1 mt -83.38 -14.87 51.82 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.282 1.433 . . . . 0.0 113.134 172.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 74.8 mt -89.9 -16.89 29.07 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.003 0.921 . . . . 0.0 112.01 171.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -83.31 145.52 23.16 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 125.159 1.361 . . . . 0.0 112.5 176.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.81 -4.63 56.49 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -179.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -125.57 160.92 28.37 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.452 1.901 . . . . 0.0 110.652 -178.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -65.11 147.17 53.95 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -176.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.48 123.84 5.91 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.627 1.171 . . . . 0.0 111.147 -164.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 44.1 mtmt -97.65 141.84 30.19 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.2 1.4 . . . . 0.0 112.735 176.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 56.8 t -139.2 138.63 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 126.356 1.863 . . . . 0.0 108.738 174.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -102.15 129.93 48.65 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.163 0.985 . . . . 0.0 110.713 177.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.8 tt -153.22 148.2 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 124.614 1.166 . . . . 0.0 111.847 -168.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -87.78 119.06 27.74 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 120.969 -1.082 . . . . 0.0 111.472 176.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 13.7 m-30 -106.46 140.25 39.66 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.991 1.716 . . . . 0.0 110.9 174.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -92.69 142.3 27.52 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.022 0.929 . . . . 0.0 112.805 176.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 43.0 ttm-85 -80.2 156.57 26.86 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.629 1.972 . . . . 0.0 110.404 174.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 25.6 mmmt -58.02 -26.53 62.55 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 176.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -78.58 -5.98 54.3 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.635 1.574 . . . . 0.0 113.984 177.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 92.14 1.46 69.71 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 125.039 1.304 . . . . 0.0 114.455 -176.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 8.6 t -77.45 178.44 7.19 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 118.319 1.059 . . . . 0.0 111.763 171.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 39.4 t -151.42 154.77 37.27 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.78 1.232 . . . . 0.0 112.376 -170.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -158.81 154.4 26.08 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.232 1.813 . . . . 0.0 110.882 179.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -81.22 124.78 29.58 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 121.815 0.817 . . . . 0.0 110.403 170.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 36.6 t -111.59 140.8 45.91 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.638 1.975 . . . . 0.0 110.801 177.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 18.8 tp -93.15 115.72 28.35 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.996 1.318 . . . . 0.0 108.163 165.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 81.4 t -99.37 118.22 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 171.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -109.69 109.42 20.14 Favored 'General case' 0 C--O 1.225 -0.198 0 C-N-CA 125.689 1.596 . . . . 0.0 108.411 172.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 71.5 t -78.66 130.43 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 169.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 78.1 t -117.22 111.33 40.4 Favored Pre-proline 0 N--CA 1.466 0.361 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 167.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.83 133.79 18.99 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.751 2.301 . . . . 0.0 109.884 179.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 41.1 t -91.74 119.62 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 173.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 66.0 mttt -92.96 151.9 19.65 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.649 0.738 . . . . 0.0 112.365 167.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -92.2 -173.87 3.57 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.959 0.904 . . . . 0.0 111.7 175.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -60.81 -21.3 62.99 Favored 'General case' 0 CA--C 1.548 0.865 0 C-N-CA 125.083 1.353 . . . . 0.0 114.553 178.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -93.99 -0.42 55.54 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.396 1.078 . . . . 0.0 113.105 177.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 77.48 19.87 75.56 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 124.173 0.892 . . . . 0.0 114.465 179.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -98.73 146.81 25.51 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.796 1.238 . . . . 0.0 109.393 172.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 84.1 t -77.2 127.97 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 177.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 3.3 pt -123.39 -23.15 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 -171.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 72.2 mtm -150.58 157.42 42.97 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.855 1.662 . . . . 0.0 110.487 178.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -115.24 132.22 56.68 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 124.683 1.193 . . . . 0.0 109.98 173.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 46.7 mt -97.18 114.84 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 105.647 -1.983 . . . . 0.0 105.647 164.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -92.98 117.91 30.58 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 171.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -107.53 129.76 54.94 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 119.478 -0.296 . . . . 0.0 111.02 178.216 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -109.39 143.18 39.31 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.111 1.364 . . . . 0.0 111.928 -176.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -145.36 145.34 31.15 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 126.007 1.723 . . . . 0.0 108.553 172.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 60.7 t -84.49 117.02 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 174.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.0 p -93.17 -25.97 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -179.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 44.6 tpp -165.28 123.68 1.65 Allowed 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.799 1.24 . . . . 0.0 110.75 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -84.36 123.51 30.27 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 121.562 -0.711 . . . . 0.0 109.819 174.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.255 1.357 0 CA-C-O 115.744 -2.074 . . . . 0.0 115.463 -170.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 43.2 p . . . . . 0 N--CA 1.48 1.048 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -67.87 -47.72 68.11 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.94 0.896 . . . . 0.0 112.116 175.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 39.4 tp -63.15 -36.53 83.92 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.88 1.272 . . . . 0.0 111.072 175.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -59.93 -29.61 68.5 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.667 0.787 . . . . 0.0 112.815 179.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 73.8 m -72.74 -21.43 61.03 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.227 1.411 . . . . 0.0 111.935 173.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.7 mm -87.42 -42.71 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.087 1.355 . . . . 0.0 110.819 173.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 93.5 mt -53.68 -45.25 60.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 124.036 0.934 . . . . 0.0 110.598 178.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -66.09 -24.6 66.73 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 -179.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -79.06 -33.41 44.64 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.602 1.161 . . . . 0.0 111.949 175.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -73.56 -34.17 65.02 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.144 0.978 . . . . 0.0 111.496 170.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.544 0.747 0 N-CA-C 114.395 1.257 . . . . 0.0 114.395 178.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? . . . . . 0 N--CA 1.474 0.757 0 CA-C-O 122.518 1.151 . . . . 0.0 111.883 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.5 mptt -89.96 134.83 34.0 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.351 1.46 . . . . 0.0 110.393 -177.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -159.4 161.7 35.65 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 124.289 1.036 . . . . 0.0 113.17 178.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 20.7 pt -140.02 161.46 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 126.671 1.988 . . . . 0.0 109.733 173.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.9 mp -126.26 133.88 67.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 C-N-CA 124.813 1.245 . . . . 0.0 109.545 177.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -130.85 144.71 51.65 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.673 1.189 . . . . 0.0 111.477 178.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -72.78 125.06 26.63 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 122.844 0.458 . . . . 0.0 111.436 178.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.22 -32.6 70.55 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.341 1.056 . . . . 0.0 112.412 -177.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 25.0 mmm180 -80.11 36.52 0.35 Allowed 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 126.082 1.753 . . . . 0.0 112.796 -173.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 70.3 t -144.07 133.38 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 126.719 2.008 . . . . 0.0 108.977 -171.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -56.61 -35.92 68.83 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 -172.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -103.05 -3.86 25.38 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.544 1.538 . . . . 0.0 113.05 -178.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 5.9 t 52.14 71.37 0.47 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 126.372 1.869 . . . . 0.0 111.664 -174.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.74 133.82 50.94 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 121.254 -0.904 . . . . 0.0 111.658 -176.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 15.6 t -62.62 120.66 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 CA-C-N 118.705 0.684 . . . . 0.0 109.159 171.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 42.9 pt -102.08 -21.68 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 124.766 1.227 . . . . 0.0 112.26 176.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -152.18 144.42 23.95 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.363 1.065 . . . . 0.0 111.575 178.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.468 ' HB3' ' CE1' ' A' ' 48' ' ' PHE . 0.6 OUTLIER -135.04 149.14 50.08 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.491 1.116 . . . . 0.0 111.53 -178.942 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -76.57 -168.96 1.1 Allowed 'General case' 0 CA--C 1.555 1.164 0 CA-C-N 119.226 0.921 . . . . 0.0 111.367 169.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -103.84 -21.63 13.63 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.248 1.419 . . . . 0.0 112.553 169.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.23 -36.18 60.09 Favored Glycine 0 C--N 1.343 0.917 0 O-C-N 121.578 -0.701 . . . . 0.0 112.551 -178.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.468 ' CE1' ' HB3' ' A' ' 44' ' ' CYS . 0.6 OUTLIER -67.68 -30.45 69.98 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 122.98 0.512 . . . . 0.0 111.869 179.53 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 77.6 m -53.53 -52.29 60.14 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.712 1.205 . . . . 0.0 111.757 174.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -71.38 -19.06 62.32 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.966 0.906 . . . . 0.0 113.211 -179.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.428 HD11 HG23 ' A' ' 131' ' ' VAL . 10.3 tp -64.21 -52.83 56.96 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.809 1.244 . . . . 0.0 111.313 179.259 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 71.0 m -101.87 -19.09 15.43 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 95.12 2.11 62.5 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 125.813 1.673 . . . . 0.0 114.344 177.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -83.95 -175.27 5.72 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.778 1.231 . . . . 0.0 113.224 170.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.443 ' H ' ' CG ' ' A' ' 58' ' ' GLU . 69.1 m -137.34 160.13 39.95 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 121.317 -0.865 . . . . 0.0 111.663 -179.076 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 36.1 ttm180 -46.28 -42.25 14.26 Favored 'General case' 0 N--CA 1.48 1.035 0 O-C-N 121.421 -0.799 . . . . 0.0 112.029 171.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.73 -32.84 63.72 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.899 1.28 . . . . 0.0 113.652 178.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.443 ' CG ' ' H ' ' A' ' 55' ' ' SER . 14.2 pt-20 -99.6 -23.65 14.99 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 177.05 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 85.3 t -85.26 -20.49 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 C-N-CA 124.83 1.252 . . . . 0.0 112.659 176.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 53.3 mmm -63.2 138.12 58.44 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 120.403 -1.436 . . . . 0.0 110.843 175.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 67.97 10.06 7.56 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.429 1.492 . . . . 0.0 114.094 179.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 -85.33 156.43 59.68 Favored Pre-proline 0 N--CA 1.472 0.668 0 C-N-CA 124.716 1.206 . . . . 0.0 111.059 174.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -67.27 127.17 16.17 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.495 2.13 . . . . 0.0 109.415 167.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.402 ' SG ' HD13 ' A' ' 127' ' ' LEU . 9.1 t -69.69 -8.88 51.62 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -172.321 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 37.5 p -59.83 -28.1 67.19 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.893 1.277 . . . . 0.0 112.163 169.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 80.9 m 52.35 36.24 19.32 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.208 1.403 . . . . 0.0 112.726 -177.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -57.67 -30.1 65.18 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.624 1.17 . . . . 0.0 112.327 -177.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -59.03 -14.26 9.05 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.186 1.395 . . . . 0.0 114.211 175.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 89.5 mt -78.73 -4.14 47.72 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 173.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 15.9 p-80 -60.71 150.57 31.83 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-N 120.123 1.328 . . . . 0.0 114.268 178.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -142.84 -162.76 9.42 Favored Glycine 0 CA--C 1.54 1.605 0 C-N-CA 126.64 2.067 . . . . 0.0 112.42 173.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -71.04 -8.83 24.45 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 123.623 2.882 . . . . 0.0 114.122 -178.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 84.8 mmt-85 -107.27 8.04 29.64 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.045 1.338 . . . . 0.0 113.531 175.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 22.2 m -89.95 133.24 34.9 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.89 1.276 . . . . 0.0 109.803 178.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -102.45 137.52 40.58 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.295 1.038 . . . . 0.0 109.871 -179.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 27.8 mmt85 -58.84 -37.88 77.45 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.987 0.915 . . . . 0.0 112.199 -177.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 31.6 tpt180 -59.73 -43.99 93.94 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.486 1.115 . . . . 0.0 112.258 176.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.49 -45.9 74.5 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 121.42 -0.8 . . . . 0.0 112.147 178.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -57.28 -35.66 70.06 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 121.645 -0.659 . . . . 0.0 112.522 174.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -72.15 -44.85 62.47 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 125.186 1.394 . . . . 0.0 112.377 175.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.3 mm100 -60.85 -34.98 75.42 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.946 0.899 . . . . 0.0 111.227 -179.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 93.0 mt -60.63 -41.57 88.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 CA-C-N 119.702 1.137 . . . . 0.0 111.841 169.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.78 -32.22 70.59 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 119.562 1.074 . . . . 0.0 112.805 174.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 73.9 mm-40 -64.19 -37.35 87.14 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 121.475 -0.765 . . . . 0.0 111.232 171.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.96 -23.13 65.1 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 113.229 0.826 . . . . 0.0 113.229 177.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 70.3 mt -87.53 -14.09 41.24 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.433 1.493 . . . . 0.0 114.059 178.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.1 pp -100.84 -8.14 22.89 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 168.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -86.26 146.09 20.85 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 125.18 1.371 . . . . 0.0 112.344 175.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -93.42 1.32 56.9 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.57 1.148 . . . . 0.0 113.601 176.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.14 159.92 23.08 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.071 1.748 . . . . 0.0 111.604 -178.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -62.23 135.24 57.39 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.281 1.432 . . . . 0.0 111.937 178.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -138.82 127.9 23.95 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.506 1.122 . . . . 0.0 112.44 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 37.1 mtmt -101.18 132.26 46.75 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.496 1.518 . . . . 0.0 110.465 167.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 46.8 t -133.38 134.5 57.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 125.597 1.559 . . . . 0.0 108.231 177.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -103.85 132.03 50.49 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.761 0.824 . . . . 0.0 110.666 179.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.3 tt -154.79 150.15 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 124.288 1.035 . . . . 0.0 111.729 -168.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -86.98 127.43 35.09 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 120.998 -1.064 . . . . 0.0 111.747 172.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 17.6 m-30 -114.05 138.92 49.74 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.612 1.965 . . . . 0.0 110.719 171.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -85.5 156.31 20.84 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.382 0.673 . . . . 0.0 112.13 167.156 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -115.02 157.61 23.23 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.061 1.344 . . . . 0.0 113.246 172.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -48.84 -33.59 10.87 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 127.141 2.176 . . . . 0.0 114.637 -178.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -70.57 -10.48 59.39 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.259 1.423 . . . . 0.0 113.895 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 97.09 13.05 47.28 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 125.29 1.424 . . . . 0.0 114.264 178.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 22.9 m -107.51 -177.49 3.36 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.696 1.198 . . . . 0.0 111.242 177.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 25.1 p -148.33 171.14 16.48 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 120.878 -1.138 . . . . 0.0 113.291 176.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 18.2 p90 -160.76 159.98 30.75 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.764 1.626 . . . . 0.0 111.468 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -80.44 123.2 27.85 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 123.528 0.731 . . . . 0.0 110.328 167.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 19.0 t -106.93 134.63 49.79 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.212 1.805 . . . . 0.0 110.356 172.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.0 tt -88.13 118.48 27.74 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 161.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 59.7 t -99.78 110.55 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 124.881 1.272 . . . . 0.0 108.217 169.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -102.89 111.47 23.81 Favored 'General case' 0 C--O 1.227 -0.081 0 C-N-CA 125.426 1.49 . . . . 0.0 108.055 172.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.449 HG22 ' HG ' ' A' ' 127' ' ' LEU . 28.0 t -95.17 124.1 47.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.048 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 74.7 t -110.34 115.38 54.38 Favored Pre-proline 0 CA--C 1.537 0.466 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 -178.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -73.96 124.18 8.95 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.947 2.431 . . . . 0.0 109.904 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 88.3 t -98.48 117.12 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 123.328 0.651 . . . . 0.0 109.724 173.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 61.5 mttt -87.39 154.33 20.75 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.883 0.873 . . . . 0.0 112.581 172.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -92.57 -173.53 3.39 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.386 1.075 . . . . 0.0 111.629 175.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -60.18 -22.25 62.69 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.039 1.336 . . . . 0.0 114.416 178.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -90.68 -5.39 55.86 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.058 1.343 . . . . 0.0 113.026 178.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 80.5 22.56 62.12 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 124.425 1.012 . . . . 0.0 114.48 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -108.33 148.38 30.14 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.281 1.432 . . . . 0.0 109.88 172.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.0 p -79.51 125.67 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 123.56 0.744 . . . . 0.0 110.615 179.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.23 -22.86 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 -174.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 56.8 mtm -132.19 154.83 49.17 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.288 1.435 . . . . 0.0 111.857 170.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -117.14 133.52 55.9 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 124.957 1.303 . . . . 0.0 109.27 168.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 55.4 mt -96.59 118.98 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 105.647 -1.982 . . . . 0.0 105.647 166.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.449 ' HG ' HG22 ' A' ' 112' ' ' VAL . 6.9 mp -103.88 117.32 34.06 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 177.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -107.71 126.62 52.83 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 123.417 0.448 . . . . 0.0 110.842 -176.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 16.5 m-30 -102.67 134.07 46.65 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.094 1.358 . . . . 0.0 110.49 -177.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -138.08 127.61 24.92 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 124.885 1.274 . . . . 0.0 109.369 176.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.428 HG23 HD11 ' A' ' 51' ' ' LEU . 71.5 t -74.43 110.75 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 175.248 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.3 p -93.99 -23.58 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 123.711 0.804 . . . . 0.0 112.705 -173.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 14.3 tpt -164.4 129.4 2.74 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.113 1.365 . . . . 0.0 110.461 179.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -89.22 124.33 34.27 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.551 0.74 . . . . 0.0 110.339 178.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 6.7 mmpt? . . . . . 0 C--O 1.253 1.273 0 CA-C-O 117.67 -1.157 . . . . 0.0 112.911 178.648 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 39.0 p . . . . . 0 N--CA 1.476 0.872 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -80.0 -48.01 14.02 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.658 0.783 . . . . 0.0 111.642 177.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 61.8 tp -61.67 -33.39 73.9 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.457 1.103 . . . . 0.0 111.314 177.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -55.22 -32.61 62.41 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.405 1.082 . . . . 0.0 113.271 174.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 27.8 m -76.56 -24.73 53.58 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.437 1.495 . . . . 0.0 111.369 176.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 17.0 mm -81.91 -42.32 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 124.059 0.944 . . . . 0.0 110.522 175.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 81.9 mt -54.34 -48.29 68.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 123.862 0.865 . . . . 0.0 110.61 177.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 36.7 ptt180 -65.85 -19.8 66.01 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 -178.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 24.6 mtpp -77.28 -33.1 55.9 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.52 1.055 . . . . 0.0 112.447 172.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -92.97 -12.07 31.68 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.145 1.378 . . . . 0.0 114.293 178.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 . . . . . 0 CA--C 1.552 1.056 0 CA-C-O 122.353 1.073 . . . . 0.0 112.943 165.481 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? . . . . . 0 N--CA 1.471 0.6 0 CA-C-O 122.107 0.956 . . . . 0.0 111.645 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.3 mptt -98.88 138.61 35.76 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.32 1.448 . . . . 0.0 111.071 -171.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -162.93 161.93 25.96 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.229 1.012 . . . . 0.0 113.57 179.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 18.0 pt -140.88 157.52 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 126.529 1.931 . . . . 0.0 110.37 174.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 13.5 mt -119.27 134.51 62.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 125.897 1.679 . . . . 0.0 109.062 -178.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -135.86 151.27 49.86 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.205 1.402 . . . . 0.0 112.148 -178.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 34.7 p30 -80.3 111.55 16.78 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.133 0.973 . . . . 0.0 113.335 -174.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.8 -25.0 66.25 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 120.594 -1.316 . . . . 0.0 113.815 -173.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 52.3 mtm180 -84.2 -3.17 57.99 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 -173.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.4 t -109.49 137.16 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 125.434 1.494 . . . . 0.0 108.789 178.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -55.63 -41.58 73.73 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.447 1.099 . . . . 0.0 113.292 -172.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.3 p30 -78.03 -14.82 59.37 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 178.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 96.3 m 49.59 61.92 2.91 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.372 1.469 . . . . 0.0 112.492 -174.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.68 136.13 57.97 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.693 0.797 . . . . 0.0 112.448 179.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 43.7 t -60.8 119.4 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 169.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 45.4 pt -100.8 -17.55 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 125.534 1.533 . . . . 0.0 112.315 176.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -157.93 146.83 19.35 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.336 1.055 . . . . 0.0 112.099 178.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.528 ' HB3' ' CE1' ' A' ' 48' ' ' PHE . 1.9 m -131.24 153.8 49.13 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.462 1.105 . . . . 0.0 111.947 177.114 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -76.84 -166.9 0.75 Allowed 'General case' 0 CA--C 1.556 1.201 0 CA-C-N 118.939 0.79 . . . . 0.0 111.673 169.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -105.61 -19.16 13.86 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.496 1.518 . . . . 0.0 112.759 169.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -75.35 -35.99 46.18 Favored Glycine 0 C--N 1.343 0.968 0 O-C-N 121.488 -0.758 . . . . 0.0 112.549 -179.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.528 ' CE1' ' HB3' ' A' ' 44' ' ' CYS . 0.6 OUTLIER -65.4 -34.38 78.16 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.586 0.754 . . . . 0.0 111.59 179.72 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 57.2 m -51.42 -52.24 47.83 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.192 1.397 . . . . 0.0 111.799 172.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -71.85 -20.14 61.86 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -179.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.52 -54.06 42.13 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.51 1.124 . . . . 0.0 110.618 177.015 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 41.9 t -92.83 -32.64 14.56 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.53 1.84 55.47 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.447 1.499 . . . . 0.0 114.185 -175.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -81.69 -165.99 1.1 Allowed 'General case' 0 CA--C 1.555 1.151 0 CA-C-N 118.706 1.253 . . . . 0.0 113.055 171.097 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 32.8 m -142.39 160.02 41.09 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.894 1.278 . . . . 0.0 111.424 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -47.99 -49.16 31.71 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.018 0.927 . . . . 0.0 111.967 178.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.34 -25.9 37.58 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 179.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -89.62 -35.52 15.81 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.856 1.262 . . . . 0.0 112.124 178.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 18.9 t -93.67 -11.03 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.372 1.069 . . . . 0.0 112.659 -176.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 75.4 mmm -68.46 142.72 55.25 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 120.586 -1.321 . . . . 0.0 111.302 170.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 71.14 5.17 5.37 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 126.268 1.827 . . . . 0.0 113.77 -177.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -76.63 155.26 83.5 Favored Pre-proline 0 N--CA 1.475 0.817 0 C-N-CA 124.483 1.113 . . . . 0.0 110.317 173.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -74.58 12.23 1.16 Allowed 'Trans proline' 0 CA--C 1.549 1.234 0 C-N-CA 124.016 3.144 . . . . 0.0 116.273 179.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 5.8 t 75.24 -23.46 0.24 Allowed 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 126.6 1.96 . . . . 0.0 114.154 169.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 39.3 p -64.05 -21.73 66.64 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 127.561 2.344 . . . . 0.0 113.442 173.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 89.0 m 59.55 36.53 22.85 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.85 1.26 . . . . 0.0 113.168 -178.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -52.14 -36.39 51.27 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.797 1.639 . . . . 0.0 112.434 177.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -66.9 -11.39 55.96 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.715 1.206 . . . . 0.0 114.041 179.009 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 33.7 mt -93.75 -3.15 52.69 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.976 1.31 . . . . 0.0 113.649 171.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.417 ' CG ' HG21 ' A' ' 74' ' ' THR . 0.3 OUTLIER -77.95 118.82 20.62 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 121.092 -1.005 . . . . 0.0 110.318 -178.384 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -107.97 -162.95 21.19 Favored Glycine 0 CA--C 1.538 1.529 0 C-N-CA 126.189 1.852 . . . . 0.0 112.605 178.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -69.12 -22.43 35.04 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 123.339 2.693 . . . . 0.0 113.162 179.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 85.5 mtt85 -84.89 -12.2 53.97 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.16 0.984 . . . . 0.0 113.297 177.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.417 HG21 ' CG ' ' A' ' 70' ' ' HIS . 18.4 m -76.93 151.73 35.61 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.645 1.178 . . . . 0.0 111.244 -173.594 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.8 109.25 18.99 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.027 1.331 . . . . 0.0 109.144 -170.115 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 36.5 mmt180 -64.46 -24.24 67.55 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 121.449 -0.782 . . . . 0.0 112.996 179.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 20.5 tpp180 -58.71 -40.16 82.9 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.344 1.058 . . . . 0.0 112.327 168.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -77.8 -42.05 35.18 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.493 1.517 . . . . 0.0 112.161 175.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -54.18 -37.1 64.12 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 121.559 -0.713 . . . . 0.0 112.167 174.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.95 -47.81 76.32 Favored 'General case' 0 C--O 1.227 -0.113 0 C-N-CA 125.213 1.405 . . . . 0.0 111.291 175.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 22.3 mm-40 -61.51 -38.27 86.76 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 118.136 -0.935 . . . . 0.0 111.039 178.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 96.8 mt -63.16 -45.63 98.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 CA-C-N 120.439 1.472 . . . . 0.0 111.629 172.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.31 -39.48 92.51 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 118.898 0.772 . . . . 0.0 112.779 178.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -76.2 -25.75 55.46 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 124.049 0.94 . . . . 0.0 112.233 176.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -58.74 -29.92 67.09 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 120.172 1.351 . . . . 0.0 112.368 175.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 51.6 mt -67.51 -13.34 61.96 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.998 1.719 . . . . 0.0 113.442 175.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 66.9 mt -87.87 -13.62 41.57 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.307 1.043 . . . . 0.0 112.443 174.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -90.8 146.53 18.48 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 125.102 1.334 . . . . 0.0 113.542 -175.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -86.8 -7.74 57.97 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.899 1.279 . . . . 0.0 113.737 173.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -118.32 162.4 18.35 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.491 1.916 . . . . 0.0 111.428 -175.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -64.6 143.14 58.13 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.613 1.165 . . . . 0.0 112.912 -175.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 27.6 mmt180 -139.52 132.42 29.31 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.101 1.36 . . . . 0.0 111.546 176.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 38.3 mtmt -110.72 131.22 55.23 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.413 1.485 . . . . 0.0 109.854 167.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 64.3 t -132.44 137.08 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 125.126 1.371 . . . . 0.0 108.51 177.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -102.2 131.12 48.93 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.139 0.975 . . . . 0.0 110.762 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.3 tt -156.57 147.58 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.005 0.922 . . . . 0.0 112.033 -169.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -88.97 124.39 34.2 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 120.921 -1.112 . . . . 0.0 111.843 178.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 15.2 m-30 -113.02 134.3 54.58 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.702 1.601 . . . . 0.0 111.678 177.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -73.2 146.08 45.8 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.135 1.374 . . . . 0.0 112.308 169.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 32.4 ptt-85 -117.96 150.69 38.82 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.781 1.632 . . . . 0.0 112.609 173.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -61.83 -13.81 27.6 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.974 1.71 . . . . 0.0 114.373 -179.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -67.33 -12.9 61.35 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.548 1.139 . . . . 0.0 112.797 169.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 100.21 30.1 6.46 Favored Glycine 0 C--N 1.341 0.859 0 C-N-CA 124.914 1.245 . . . . 0.0 113.328 174.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 16.5 t -153.4 -168.33 2.97 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 118.303 1.051 . . . . 0.0 111.991 -174.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 27.0 t -146.64 161.13 41.2 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.203 1.401 . . . . 0.0 111.924 -166.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -165.16 163.35 20.36 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.202 1.801 . . . . 0.0 112.301 173.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -79.53 124.74 28.77 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 123.484 0.714 . . . . 0.0 110.783 176.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 34.0 t -107.2 136.85 46.33 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.254 1.822 . . . . 0.0 109.528 170.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 14.2 tp -88.08 123.28 32.6 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 161.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 60.5 t -108.75 116.91 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 125.336 1.454 . . . . 0.0 108.763 177.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -113.13 112.88 24.57 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.348 1.059 . . . . 0.0 108.991 -178.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.3 p -88.74 120.36 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 121.276 0.56 . . . . 0.0 109.706 172.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 90.5 t -104.25 111.76 65.26 Favored Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 125.341 1.456 . . . . 0.0 107.432 175.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.5 122.76 7.65 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 123.093 2.528 . . . . 0.0 109.418 177.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 60.2 t -94.59 117.8 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 174.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 20.3 mtpt -88.68 149.17 23.64 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.469 0.652 . . . . 0.0 111.175 172.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 51.2 p30 -77.77 -173.39 3.02 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.065 1.346 . . . . 0.0 111.997 175.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -66.24 -15.74 63.43 Favored 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 114.749 1.388 . . . . 0.0 114.749 175.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -97.25 -17.14 20.0 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.567 1.147 . . . . 0.0 113.271 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 86.36 40.48 7.36 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 125.846 1.689 . . . . 0.0 113.636 -174.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -115.06 151.31 34.48 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.267 1.427 . . . . 0.0 109.879 159.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.6 p -83.5 126.58 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 CA-C-N 119.055 0.843 . . . . 0.0 110.532 179.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.69 -27.04 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 -173.43 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 61.2 mtm -129.86 150.72 51.03 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.875 1.27 . . . . 0.0 112.117 171.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -110.75 133.22 53.52 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 125.458 1.503 . . . . 0.0 109.104 167.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 32.9 mt -102.8 119.94 51.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 165.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -100.35 119.62 38.71 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 175.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -107.31 127.8 53.88 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.437 1.095 . . . . 0.0 109.505 -177.438 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 16.1 m-30 -104.37 133.65 48.91 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.084 1.354 . . . . 0.0 110.571 -178.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -142.34 118.68 10.85 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 123.899 0.88 . . . . 0.0 109.758 173.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.0 p -68.27 115.01 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 O-C-N 121.437 -0.79 . . . . 0.0 109.525 176.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.3 p -99.57 -26.61 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 125.283 1.433 . . . . 0.0 113.315 -169.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 24.9 ptp -161.43 148.01 14.43 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.173 0.989 . . . . 0.0 112.898 168.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -90.46 130.04 36.57 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.019 0.927 . . . . 0.0 110.732 -179.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 7.0 mmpt? . . . . . 0 C--O 1.254 1.29 0 C-N-CA 124.355 1.062 . . . . 0.0 112.723 175.046 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 37.1 p . . . . . 0 N--CA 1.479 1.014 0 N-CA-C 111.719 0.266 . . . . 0.0 111.719 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -71.54 -46.77 58.62 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.498 0.719 . . . . 0.0 111.221 176.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 64.5 tp -63.15 -36.09 82.46 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.081 0.953 . . . . 0.0 111.138 176.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -59.85 -29.26 68.16 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 174.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 66.3 m -77.04 -19.88 56.6 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.014 1.325 . . . . 0.0 111.505 175.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 22.5 mm -84.33 -43.64 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 125.258 1.423 . . . . 0.0 111.351 170.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 71.6 mt -58.38 -35.54 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 O-C-N 121.424 -0.798 . . . . 0.0 111.022 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -72.47 -7.95 52.53 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 179.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 17.6 mtmt -84.32 -42.08 16.14 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.215 1.406 . . . . 0.0 110.731 171.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -79.72 -40.18 29.49 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.045 1.338 . . . . 0.0 113.054 179.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 . . . . . 0 N--CA 1.475 0.816 0 CA-C-N 118.972 0.806 . . . . 0.0 112.231 -179.846 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? . . . . . 0 N--CA 1.468 0.457 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.78 134.61 34.89 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 120.753 -1.217 . . . . 0.0 111.394 178.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -157.89 153.64 26.63 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.311 1.044 . . . . 0.0 112.928 178.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 15.2 pt -140.62 150.14 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 125.871 1.668 . . . . 0.0 109.758 175.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.7 mp -114.27 132.29 63.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 125.364 1.466 . . . . 0.0 108.983 -178.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -132.72 147.42 52.32 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 124.9 1.28 . . . . 0.0 111.849 -176.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 24.2 p30 -73.71 119.25 17.67 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.566 0.746 . . . . 0.0 112.217 -178.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.81 -29.13 61.99 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 120.705 -1.247 . . . . 0.0 112.191 -178.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 29.6 mmm180 -74.61 27.48 0.08 Allowed 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 126.486 1.914 . . . . 0.0 114.039 -176.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 84.9 t -147.33 136.61 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 126.942 2.097 . . . . 0.0 108.805 -171.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -56.93 -43.17 81.18 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.596 1.159 . . . . 0.0 113.019 -173.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -80.2 -14.97 58.02 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -177.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 96.5 m 49.85 68.34 0.76 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.614 1.566 . . . . 0.0 111.487 -168.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.26 136.23 44.56 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.562 0.745 . . . . 0.0 111.516 -174.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 39.8 t -63.74 122.48 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 174.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.6 pt -102.99 -19.66 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 124.987 1.315 . . . . 0.0 112.312 175.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -155.3 144.73 21.13 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.886 0.874 . . . . 0.0 112.54 178.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.44 ' HB3' ' CE1' ' A' ' 48' ' ' PHE . 1.8 m -130.63 152.95 49.44 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.767 1.227 . . . . 0.0 112.656 -179.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -75.22 -166.8 0.54 Allowed 'General case' 0 CA--C 1.557 1.216 0 C-N-CA 122.905 0.482 . . . . 0.0 112.074 170.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -102.9 -23.07 13.76 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.296 1.438 . . . . 0.0 112.705 168.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.85 -34.0 59.58 Favored Glycine 0 N--CA 1.47 0.917 0 C-N-CA 124.892 1.234 . . . . 0.0 112.754 -177.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.44 ' CE1' ' HB3' ' A' ' 44' ' ' CYS . 0.6 OUTLIER -71.4 -32.87 68.93 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 123.904 0.882 . . . . 0.0 111.268 -176.98 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 6.2 t -53.74 -49.26 68.54 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.637 1.175 . . . . 0.0 111.658 171.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -75.56 -21.19 58.1 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -179.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 47.6 tp -63.6 -48.59 76.73 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 121.488 -0.757 . . . . 0.0 111.198 172.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 17.8 t -103.76 -30.63 10.28 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 -172.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.25 6.79 58.67 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 124.307 0.955 . . . . 0.0 114.568 -176.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -88.42 -155.54 0.33 Allowed 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 118.698 1.249 . . . . 0.0 111.655 169.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 12.2 t -162.06 169.12 21.54 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 120.564 -1.335 . . . . 0.0 111.006 175.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -53.51 -44.74 69.32 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.12 0.968 . . . . 0.0 111.394 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.85 -28.49 56.66 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 119.811 1.187 . . . . 0.0 114.025 177.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -92.01 -38.12 12.42 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.854 1.262 . . . . 0.0 112.018 177.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 79.1 t -79.38 -19.07 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 126.057 1.743 . . . . 0.0 111.508 -177.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.39 131.56 50.67 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 120.895 -1.128 . . . . 0.0 110.788 172.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 8.0 tm0? 75.49 5.76 4.05 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 126.229 1.812 . . . . 0.0 113.561 179.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 34.7 mmt180 -85.71 153.01 57.83 Favored Pre-proline 0 N--CA 1.473 0.696 0 C-N-CA 124.536 1.134 . . . . 0.0 111.352 176.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -69.98 134.92 28.66 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 123.133 2.555 . . . . 0.0 109.978 171.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 20.6 p -67.52 -11.57 58.31 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 114.848 1.425 . . . . 0.0 114.848 -174.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 46.9 p -58.44 -30.53 66.98 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.379 1.472 . . . . 0.0 112.114 172.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 91.7 m 51.82 35.21 14.89 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.041 1.336 . . . . 0.0 112.604 -173.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -58.4 -29.72 66.27 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.427 1.091 . . . . 0.0 112.331 -179.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -60.91 -10.36 5.57 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.371 1.468 . . . . 0.0 114.307 175.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 58.0 mt -84.8 2.01 44.18 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.937 1.295 . . . . 0.0 113.952 173.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 13.8 p-80 -66.29 154.5 39.79 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 114.724 1.379 . . . . 0.0 114.724 177.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -151.9 -163.94 11.88 Favored Glycine 0 CA--C 1.54 1.609 0 C-N-CA 127.359 2.409 . . . . 0.0 111.231 167.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.95 -23.08 62.12 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 123.01 2.473 . . . . 0.0 114.916 -173.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 40.1 mmt180 -89.75 -4.28 57.75 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 119.509 1.049 . . . . 0.0 113.644 174.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 31.5 m -73.3 134.18 44.11 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 119.534 1.061 . . . . 0.0 109.532 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 81.2 mm-40 -91.03 117.53 29.66 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -174.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 7.9 tmm_? -59.6 -37.07 77.57 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 121.535 -0.728 . . . . 0.0 112.013 -176.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 25.7 tpt180 -61.22 -40.22 93.2 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.184 0.994 . . . . 0.0 112.087 173.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -71.68 -41.45 68.66 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 120.755 -1.216 . . . . 0.0 112.706 177.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -56.16 -35.03 66.71 Favored 'General case' 0 CA--C 1.546 0.815 0 O-C-N 121.644 -0.66 . . . . 0.0 111.846 172.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.1 -47.76 56.27 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.8 1.24 . . . . 0.0 112.571 172.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -57.71 -37.27 73.23 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 118.764 0.711 . . . . 0.0 111.402 178.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 85.5 mt -62.46 -38.83 82.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 CA-C-N 120.098 1.317 . . . . 0.0 112.068 173.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.71 -38.07 76.8 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 119.326 0.966 . . . . 0.0 112.169 174.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 94.4 mm-40 -66.86 -31.8 72.65 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.55 0.74 . . . . 0.0 111.916 174.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.48 -23.52 66.97 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.997 0.919 . . . . 0.0 112.718 177.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 41.6 mt -82.81 -15.06 53.11 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.255 1.422 . . . . 0.0 113.257 173.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 73.7 mt -90.19 -16.2 29.94 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.236 1.015 . . . . 0.0 112.002 173.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -85.33 148.35 22.96 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 125.238 1.399 . . . . 0.0 112.754 176.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -96.69 4.34 51.91 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 114.279 1.215 . . . . 0.0 114.279 -179.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.32 160.9 30.75 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.349 1.86 . . . . 0.0 110.324 177.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -64.53 145.89 55.44 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -178.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 12.5 tpt180 -148.22 129.57 14.77 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.114 1.366 . . . . 0.0 110.94 -172.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 39.7 mtmt -104.55 138.42 40.94 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.514 1.525 . . . . 0.0 111.274 178.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 45.0 t -139.23 134.67 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 125.163 1.385 . . . . 0.0 109.292 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -101.43 128.41 47.64 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.835 0.854 . . . . 0.0 111.082 178.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.5 tt -153.95 147.2 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 124.924 1.29 . . . . 0.0 111.694 -167.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -84.84 123.88 30.96 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 120.716 -1.24 . . . . 0.0 111.462 173.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 10.2 m-30 -105.64 145.32 31.18 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.807 1.643 . . . . 0.0 110.695 172.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -110.61 131.24 55.22 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.232 1.413 . . . . 0.0 111.716 175.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 59.4 mtt180 -71.21 165.5 23.49 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.922 1.689 . . . . 0.0 112.54 174.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -66.47 -23.02 66.2 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.088 0.955 . . . . 0.0 112.753 170.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -73.36 -11.71 60.58 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.626 1.571 . . . . 0.0 113.814 172.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 90.27 -3.95 82.44 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 125.267 1.413 . . . . 0.0 114.352 -175.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 30.4 m -77.25 164.51 25.52 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 118.213 1.007 . . . . 0.0 111.644 175.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 30.6 p -145.91 166.07 27.09 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 120.9 -1.125 . . . . 0.0 114.007 -178.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -165.44 160.49 18.0 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.154 1.781 . . . . 0.0 110.918 -178.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -79.72 121.69 25.64 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.746 0.818 . . . . 0.0 110.453 169.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 44.5 t -105.64 138.48 41.77 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 127.463 2.305 . . . . 0.0 109.687 174.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 15.4 tp -96.65 112.88 24.45 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 164.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 95.7 t -94.51 114.36 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 124.994 1.318 . . . . 0.0 108.564 174.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -106.23 107.59 18.67 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.991 1.316 . . . . 0.0 107.835 175.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 61.3 t -77.78 130.1 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 166.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 88.6 t -119.55 112.49 35.53 Favored Pre-proline 0 CA--C 1.537 0.462 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 167.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -74.59 134.59 18.75 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.738 2.292 . . . . 0.0 109.91 -179.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 45.5 t -92.81 119.4 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 171.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 66.1 mttt -93.01 151.95 19.59 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 121.648 0.737 . . . . 0.0 112.294 168.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -91.61 -173.78 3.66 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.887 0.875 . . . . 0.0 111.66 174.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -60.26 -22.11 62.68 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.986 1.315 . . . . 0.0 114.347 178.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -90.44 -5.6 55.9 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.747 1.219 . . . . 0.0 113.055 178.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 79.15 20.14 70.59 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 124.371 0.986 . . . . 0.0 114.262 -178.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -98.99 146.49 25.97 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.788 1.235 . . . . 0.0 109.46 172.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 96.5 t -76.09 128.49 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 176.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 3.3 pt -122.91 -24.87 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 113.863 1.061 . . . . 0.0 113.863 -172.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 71.4 mtm -147.82 155.09 41.29 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.492 1.517 . . . . 0.0 110.473 177.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -112.26 132.65 54.82 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.453 1.101 . . . . 0.0 109.774 171.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 56.6 mt -97.57 115.93 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 163.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -95.19 125.78 40.07 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 171.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -114.42 123.6 49.86 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 118.65 -0.691 . . . . 0.0 111.713 179.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 17.9 m-30 -108.9 97.6 7.21 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.409 1.484 . . . . 0.0 113.435 -170.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -109.26 112.9 25.31 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 120.231 -1.543 . . . . 0.0 109.743 -177.159 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.3 p -62.86 108.09 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 O-C-N 121.236 -0.915 . . . . 0.0 110.105 173.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.3 p -85.59 -23.77 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 125.199 1.4 . . . . 0.0 112.749 -176.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 32.5 ttm -163.43 124.89 2.41 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.71 1.204 . . . . 0.0 110.686 -175.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -81.12 127.02 32.18 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.216 0.606 . . . . 0.0 109.943 172.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 6.4 mmpt? . . . . . 0 C--O 1.253 1.284 0 C-N-CA 124.701 1.201 . . . . 0.0 112.81 177.232 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 62.3 p . . . . . 0 N--CA 1.48 1.072 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -68.97 -52.01 33.58 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.839 0.856 . . . . 0.0 111.715 173.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 57.3 tp -61.61 -35.61 78.35 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.83 1.252 . . . . 0.0 111.155 176.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -57.84 -31.16 66.37 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.829 0.851 . . . . 0.0 113.049 176.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 94.7 m -72.91 -29.64 63.29 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.199 1.0 . . . . 0.0 110.929 174.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 12.3 mm -77.07 -41.88 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 O-C-N 121.606 -0.684 . . . . 0.0 110.163 175.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 92.0 mt -55.36 -49.63 71.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 124.07 0.948 . . . . 0.0 110.435 175.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 11.4 ptm180 -71.85 -19.23 62.0 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -176.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -75.49 -39.92 57.91 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.046 0.939 . . . . 0.0 112.443 168.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -82.29 -27.66 32.2 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.516 1.126 . . . . 0.0 113.199 -179.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 . . . . . 0 CA--C 1.538 0.514 0 C-N-CA 123.933 0.893 . . . . 0.0 111.855 174.114 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? . . . . . 0 N--CA 1.477 0.902 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.52 149.13 30.07 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.537 1.135 . . . . 0.0 112.328 -173.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -165.46 165.52 19.09 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.764 1.226 . . . . 0.0 114.232 -178.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 15.2 pt -144.0 153.1 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 126.978 2.111 . . . . 0.0 109.708 171.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.9 mp -119.57 128.1 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 124.858 1.263 . . . . 0.0 108.795 176.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -120.63 144.56 48.08 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 124.87 1.268 . . . . 0.0 111.413 175.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -68.72 129.51 40.14 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.298 0.639 . . . . 0.0 110.818 172.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -78.44 -26.13 46.13 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 175.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 29.8 mmm180 -76.87 29.06 0.13 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 126.312 1.845 . . . . 0.0 113.894 -174.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.0 m -148.45 148.83 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 126.811 2.044 . . . . 0.0 110.099 -176.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -63.57 -38.13 89.95 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.202 1.001 . . . . 0.0 113.61 -168.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 -89.33 -9.25 51.17 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -174.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 97.6 m 50.65 57.71 6.32 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.603 1.161 . . . . 0.0 111.301 -167.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.26 136.92 52.62 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.028 0.931 . . . . 0.0 112.039 -176.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 46.3 t -63.48 123.03 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.809 0.844 . . . . 0.0 109.723 175.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 38.8 pt -103.18 -19.39 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 125.369 1.468 . . . . 0.0 112.361 175.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -151.91 139.91 20.11 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.537 1.135 . . . . 0.0 110.915 178.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.418 ' HB3' ' CE1' ' A' ' 48' ' ' PHE . 8.2 m -120.9 157.78 29.11 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.713 0.805 . . . . 0.0 111.818 177.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -69.93 -173.15 0.6 Allowed 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 122.707 0.403 . . . . 0.0 111.324 160.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -116.98 -13.34 10.62 Favored 'General case' 0 N--CA 1.481 1.076 0 O-C-N 120.715 -1.241 . . . . 0.0 112.643 167.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -68.31 -41.07 86.86 Favored Glycine 0 N--CA 1.469 0.837 0 C-N-CA 127.492 2.472 . . . . 0.0 112.951 168.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.418 ' CE1' ' HB3' ' A' ' 44' ' ' CYS . 0.4 OUTLIER -65.09 -32.27 73.89 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 123.873 0.869 . . . . 0.0 111.709 -175.729 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 35.3 t -56.3 -50.61 70.92 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.455 1.902 . . . . 0.0 111.374 170.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -74.39 -25.35 59.43 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 178.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 38.2 tp -62.56 -47.59 83.18 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.955 0.902 . . . . 0.0 111.249 170.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 69.0 m -99.76 -32.9 10.8 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 -168.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 93.39 6.77 62.5 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 125.865 1.697 . . . . 0.0 114.089 -178.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -86.69 -144.93 0.12 Allowed 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.642 1.177 . . . . 0.0 111.397 170.377 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 78.2 p -158.36 165.25 35.19 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.901 1.281 . . . . 0.0 112.302 170.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 45.9 ttm105 -52.39 -46.78 66.4 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.242 0.617 . . . . 0.0 111.278 169.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.04 -30.79 60.32 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 119.467 1.031 . . . . 0.0 113.772 177.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -90.05 -38.53 13.52 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.811 0.844 . . . . 0.0 112.927 178.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 41.0 t -82.21 -11.7 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 124.059 0.943 . . . . 0.0 112.302 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 66.1 mmm -67.07 135.08 53.1 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 120.614 -1.304 . . . . 0.0 110.687 171.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 8.8 tm0? 75.2 4.97 4.22 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 126.614 1.966 . . . . 0.0 113.38 -176.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -88.65 155.14 50.84 Favored Pre-proline 0 N--CA 1.476 0.827 0 C-N-CA 124.657 1.183 . . . . 0.0 111.285 175.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -68.42 139.83 46.39 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 123.271 2.647 . . . . 0.0 110.609 170.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 32.1 p -68.41 -2.96 9.67 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 -178.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 40.6 p -63.47 -31.5 72.68 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.154 1.382 . . . . 0.0 112.236 172.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 81.4 m 51.07 34.86 11.65 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.755 1.222 . . . . 0.0 112.862 -173.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -57.98 -31.17 66.65 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.834 1.253 . . . . 0.0 112.58 -175.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -58.11 -15.6 10.1 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.484 1.514 . . . . 0.0 114.311 176.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 87.9 mt -74.51 -7.65 53.73 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 173.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 17.6 p-80 -60.99 140.19 57.87 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 120.197 1.362 . . . . 0.0 113.259 178.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -124.73 -163.57 11.69 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 126.546 2.022 . . . . 0.0 111.786 171.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -69.91 -21.15 33.17 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 123.15 2.567 . . . . 0.0 113.333 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.15 3.0 55.89 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.501 1.12 . . . . 0.0 113.355 178.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 17.3 m -85.76 137.17 32.98 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.092 1.357 . . . . 0.0 109.946 178.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -102.82 131.58 49.6 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.234 1.014 . . . . 0.0 109.997 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 22.4 tpp85 -58.1 -35.17 71.05 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.019 0.927 . . . . 0.0 112.618 -177.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -57.09 -42.02 79.94 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.645 1.178 . . . . 0.0 112.463 177.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -73.12 -43.9 61.02 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.437 -0.789 . . . . 0.0 112.202 177.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.07 -36.15 72.4 Favored 'General case' 0 CA--C 1.545 0.758 0 O-C-N 121.405 -0.809 . . . . 0.0 111.99 174.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.36 -48.02 65.91 Favored 'General case' 0 C--O 1.224 -0.24 0 C-N-CA 125.543 1.537 . . . . 0.0 111.927 173.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -57.43 -39.52 76.4 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 118.286 -0.864 . . . . 0.0 111.215 178.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 97.4 mt -59.92 -45.87 94.61 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 CA-C-N 120.256 1.389 . . . . 0.0 112.003 172.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.9 -36.85 80.92 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 118.827 0.74 . . . . 0.0 112.862 179.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 96.4 mm-40 -69.7 -32.81 71.62 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.707 1.203 . . . . 0.0 111.593 175.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.42 ' HB1' HG11 ' A' ' 112' ' ' VAL . . . -59.74 -29.99 68.53 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 119.09 0.859 . . . . 0.0 112.786 179.275 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 56.1 mt -70.86 -15.93 62.67 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.342 1.457 . . . . 0.0 113.215 177.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 60.5 mt -86.25 -13.04 47.97 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.105 0.962 . . . . 0.0 112.351 174.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -91.6 151.79 21.12 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 125.41 1.481 . . . . 0.0 113.078 178.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -93.39 0.07 56.72 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.91 1.284 . . . . 0.0 113.906 177.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -123.16 160.25 26.89 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.946 1.698 . . . . 0.0 111.208 -173.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -60.06 144.79 48.67 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.106 0.963 . . . . 0.0 112.567 -178.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 13.6 tpt180 -150.36 130.71 13.74 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.199 0.999 . . . . 0.0 111.597 -178.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 38.6 mtmt -110.44 132.27 54.32 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.226 1.41 . . . . 0.0 110.412 173.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 42.6 t -130.24 133.23 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 124.989 1.316 . . . . 0.0 108.466 177.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -102.41 134.92 44.94 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.099 0.96 . . . . 0.0 110.482 -179.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.0 tt -159.32 146.22 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.551 0.741 . . . . 0.0 112.08 -166.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -88.38 122.81 32.3 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 121.516 -0.74 . . . . 0.0 110.466 172.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -110.45 148.34 32.25 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.676 1.191 . . . . 0.0 112.092 173.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -107.63 134.38 50.71 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.995 1.718 . . . . 0.0 110.616 177.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -108.6 156.72 19.21 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.822 1.649 . . . . 0.0 111.394 -166.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -64.59 -20.89 66.52 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 -176.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -76.14 -7.26 54.38 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.525 1.13 . . . . 0.0 113.561 175.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 97.06 0.57 59.96 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 125.581 1.562 . . . . 0.0 114.362 -179.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 25.5 m -90.37 164.04 14.47 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.759 1.223 . . . . 0.0 112.383 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 28.3 p -140.23 158.72 43.59 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 121.103 -0.998 . . . . 0.0 111.734 167.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -167.86 160.1 12.08 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.081 1.352 . . . . 0.0 113.019 -178.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -77.81 121.57 24.26 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 124.186 0.994 . . . . 0.0 110.827 176.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 10.6 t -106.24 141.26 37.88 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.056 1.742 . . . . 0.0 109.566 172.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -86.9 133.42 33.61 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 156.343 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.4 t -117.57 117.18 54.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 124.527 1.131 . . . . 0.0 108.446 171.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -113.52 114.01 25.92 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.288 1.035 . . . . 0.0 108.74 -176.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.42 HG11 ' HB1' ' A' ' 85' ' ' ALA . 2.4 p -86.0 126.94 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 169.159 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 97.6 t -114.59 106.43 52.31 Favored Pre-proline 0 CA--C 1.537 0.447 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 173.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -74.77 132.56 15.88 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.027 2.485 . . . . 0.0 109.819 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 99.1 t -97.14 110.62 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 172.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 63.4 mttt -82.89 152.81 25.4 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.356 0.598 . . . . 0.0 111.556 167.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -92.68 -173.88 3.48 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.922 0.889 . . . . 0.0 111.829 172.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -60.3 -22.06 62.71 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.158 1.383 . . . . 0.0 114.379 178.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -89.7 -5.61 56.87 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.873 1.269 . . . . 0.0 112.993 177.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 78.65 21.53 68.89 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 124.588 1.089 . . . . 0.0 114.27 -178.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -100.3 143.33 30.62 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.678 1.191 . . . . 0.0 109.216 171.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.7 p -76.69 125.22 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-O 121.806 0.812 . . . . 0.0 110.175 174.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 3.9 pt -116.49 -22.66 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 125.378 1.471 . . . . 0.0 113.543 -171.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 55.4 mtm -145.93 150.2 35.63 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.595 1.558 . . . . 0.0 110.799 175.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -114.43 124.54 52.19 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 125.197 1.399 . . . . 0.0 109.504 172.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 47.3 mt -98.39 114.68 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 169.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -102.17 125.22 48.81 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 175.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -117.74 130.21 56.18 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.142 0.977 . . . . 0.0 110.389 -173.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -106.65 135.42 48.2 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.017 1.327 . . . . 0.0 110.554 -177.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -145.17 136.28 24.86 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.757 1.223 . . . . 0.0 109.27 175.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 43.5 t -74.32 117.63 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 177.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.3 p -96.17 -27.53 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -179.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 47.2 tpp -167.45 141.67 3.68 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.064 1.346 . . . . 0.0 110.723 -178.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -88.91 140.12 29.76 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 121.229 -0.919 . . . . 0.0 111.117 177.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.265 0 CA-C-O 117.468 -1.254 . . . . 0.0 112.951 169.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 N--CA 1.499 1.981 0 CA-C-O 118.461 -0.781 . . . . 0.0 110.565 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -77.23 -24.05 9.76 Favored 'Trans proline' 0 C--N 1.358 1.036 0 C-N-CA 123.933 3.089 . . . . 0.0 114.236 -177.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.5 p -157.78 151.89 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 125.091 1.356 . . . . 0.0 110.443 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 52.6 ptt85 -153.23 154.78 35.36 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.192 1.397 . . . . 0.0 112.195 -176.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 77.0 mtp85 -116.88 135.56 53.64 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.234 1.414 . . . . 0.0 111.13 178.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.31 -109.82 3.03 Favored Glycine 0 N--CA 1.472 1.064 0 C-N-CA 125.955 1.741 . . . . 0.0 111.15 176.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 10.4 t-80 77.56 11.12 2.2 Favored 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 126.47 1.908 . . . . 0.0 113.792 169.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 78.3 t -79.95 113.3 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 O-C-N 120.85 -1.157 . . . . 0.0 109.431 178.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -77.93 148.31 75.27 Favored Pre-proline 0 CA--C 1.551 0.995 0 C-N-CA 124.269 1.027 . . . . 0.0 111.638 174.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -68.77 126.17 13.63 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.149 2.566 . . . . 0.0 110.848 -178.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 23.0 mp0 -85.74 172.0 11.16 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.946 1.298 . . . . 0.0 111.205 176.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -66.8 151.11 48.12 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 121.308 -0.87 . . . . 0.0 110.54 161.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 29.1 p -117.01 -50.22 2.59 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.699 1.2 . . . . 0.0 112.965 -172.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -71.21 -45.31 63.64 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.848 0.859 . . . . 0.0 111.997 178.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 61.5 tp -63.0 -37.08 85.77 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.742 0.817 . . . . 0.0 110.947 176.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -59.17 -28.34 66.51 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 178.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.9 m -67.98 -29.24 68.22 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.839 0.856 . . . . 0.0 111.108 173.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 17.6 mm -74.16 -41.45 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-N 119.017 0.826 . . . . 0.0 109.23 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 3.1 mp -58.94 -46.72 91.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 122.971 0.508 . . . . 0.0 110.269 170.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 84.8 mtm180 -63.49 -35.1 79.33 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 119.125 0.875 . . . . 0.0 113.069 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -69.8 -39.1 76.77 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.172 0.989 . . . . 0.0 112.671 174.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -77.37 -33.82 55.13 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.507 1.123 . . . . 0.0 111.988 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -88.31 169.31 11.95 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -175.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -78.47 50.61 3.53 Favored Glycine 0 N--CA 1.473 1.149 0 C-N-CA 125.737 1.636 . . . . 0.0 112.86 178.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -67.93 -9.55 46.09 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 126.974 2.11 . . . . 0.0 113.834 -172.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 8.5 m -67.47 -6.8 21.11 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.679 1.591 . . . . 0.0 114.927 -168.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -111.5 167.68 10.13 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.695 1.198 . . . . 0.0 111.665 177.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.7 mptt -93.14 133.21 36.55 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 120.911 -1.118 . . . . 0.0 110.693 -177.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -161.17 155.05 22.32 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.689 1.196 . . . . 0.0 113.279 178.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 18.4 pt -140.74 152.61 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 125.777 1.631 . . . . 0.0 110.766 177.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 14.0 mt -111.05 132.4 59.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 125.856 1.663 . . . . 0.0 108.818 179.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -131.47 143.26 50.29 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.673 1.189 . . . . 0.0 111.489 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -67.78 119.22 12.14 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.518 0.727 . . . . 0.0 111.862 176.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -79.67 -19.59 48.67 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -178.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -77.97 -36.62 48.82 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.522 1.129 . . . . 0.0 112.359 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 55.0 t -70.5 130.5 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 125.361 1.464 . . . . 0.0 109.486 171.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -60.18 -43.26 96.01 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.289 1.036 . . . . 0.0 113.516 -169.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 20.0 p30 -74.94 -10.04 59.11 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 113.842 1.052 . . . . 0.0 113.842 178.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 79.7 m 55.68 65.16 1.53 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.927 1.691 . . . . 0.0 112.662 -175.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.61 136.01 57.85 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.472 0.709 . . . . 0.0 112.015 178.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 41.4 t -61.9 121.04 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 169.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 42.9 pt -103.68 -17.08 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 125.063 1.345 . . . . 0.0 112.221 175.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -159.62 152.32 21.49 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.278 1.031 . . . . 0.0 112.014 175.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 8.1 p -146.49 155.07 42.26 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.51 1.124 . . . . 0.0 112.756 178.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -75.96 -154.18 0.05 OUTLIER 'General case' 0 CA--C 1.558 1.266 0 C-N-CA 123.407 0.683 . . . . 0.0 112.317 -176.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -108.73 -21.83 12.5 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 120.271 -1.518 . . . . 0.0 112.896 165.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -75.84 -37.75 38.26 Favored Glycine 0 C--N 1.343 0.959 0 O-C-N 121.513 -0.742 . . . . 0.0 112.479 -176.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -56.92 -41.47 78.23 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.224 1.009 . . . . 0.0 111.109 177.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 40.5 t -57.12 -53.04 62.65 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.978 1.711 . . . . 0.0 112.214 177.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -73.23 -29.1 62.55 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -179.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -64.31 -42.25 96.43 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.296 1.438 . . . . 0.0 111.832 177.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 9.1 t -100.06 -28.96 12.79 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.88 11.87 62.95 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 124.916 1.246 . . . . 0.0 114.047 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -87.58 -154.14 0.25 Allowed 'General case' 0 CA--C 1.552 1.036 0 CA-C-N 118.524 1.162 . . . . 0.0 111.419 170.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 64.4 m -149.65 158.47 44.2 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.676 1.19 . . . . 0.0 110.787 177.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -48.67 -48.86 39.56 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.976 0.911 . . . . 0.0 111.333 173.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.77 -26.54 35.1 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 177.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -92.39 -37.62 12.48 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.61 1.164 . . . . 0.0 112.004 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 93.2 t -86.33 -16.26 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 124.665 1.186 . . . . 0.0 112.205 -178.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 87.0 mmm -76.27 143.28 41.02 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 120.91 -1.119 . . . . 0.0 111.058 171.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 24.8 mp0 59.21 36.6 23.86 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.69 1.196 . . . . 0.0 111.15 -169.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 88.5 mmt-85 -123.72 154.41 66.95 Favored Pre-proline 0 N--CA 1.472 0.656 0 C-N-CA 125.075 1.35 . . . . 0.0 110.5 169.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -68.56 137.17 38.46 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 123.191 2.594 . . . . 0.0 109.67 172.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 21.2 p -65.83 -11.89 49.97 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 -175.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 42.5 p -58.18 -26.06 62.31 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 126.242 1.817 . . . . 0.0 112.967 173.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 74.9 m 57.8 38.63 27.32 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.741 1.216 . . . . 0.0 112.816 178.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -56.1 -28.66 58.61 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.143 1.377 . . . . 0.0 113.366 -175.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -57.95 -23.99 56.01 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.828 1.651 . . . . 0.0 113.18 176.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 40.1 mt -82.03 -8.67 59.68 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -176.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 43.2 m170 -71.75 125.32 26.83 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.857 0.863 . . . . 0.0 111.693 -178.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -107.83 -162.16 21.17 Favored Glycine 0 CA--C 1.54 1.618 0 C-N-CA 126.452 1.977 . . . . 0.0 112.505 174.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -70.31 -26.23 25.2 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 123.276 2.651 . . . . 0.0 113.14 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 37.2 mmt180 -80.88 -14.24 58.19 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 177.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 38.1 m -70.64 138.08 50.45 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.177 0.991 . . . . 0.0 112.281 -167.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -88.65 110.45 20.96 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.514 1.526 . . . . 0.0 109.781 -171.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 50.9 tpt85 -61.57 -30.18 70.5 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 121.369 -0.832 . . . . 0.0 112.933 -177.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 20.6 tpt180 -66.96 -38.42 86.06 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.093 1.357 . . . . 0.0 111.64 174.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -72.51 -41.54 65.8 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.835 0.854 . . . . 0.0 111.774 175.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -54.95 -35.14 63.93 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.173 0.589 . . . . 0.0 111.849 171.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.58 -49.71 51.54 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.403 1.081 . . . . 0.0 111.66 173.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 21.9 mm-40 -59.55 -36.63 76.55 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 118.256 -0.878 . . . . 0.0 111.891 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 89.8 mt -60.35 -44.98 97.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 CA-C-N 120.234 1.379 . . . . 0.0 111.613 171.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.89 -40.15 91.29 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 118.88 0.764 . . . . 0.0 112.423 177.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -70.07 -28.4 65.4 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.319 0.648 . . . . 0.0 112.333 175.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.475 ' HB1' HG11 ' A' ' 112' ' ' VAL . . . -60.58 -28.99 68.91 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 119.908 1.231 . . . . 0.0 112.47 175.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 43.4 mt -74.22 -13.11 60.74 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.624 1.569 . . . . 0.0 113.381 175.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 67.3 mt -88.47 -16.58 32.37 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.107 0.963 . . . . 0.0 112.203 173.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -88.88 153.62 23.94 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 125.133 1.349 . . . . 0.0 113.425 -179.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -93.11 -1.07 56.8 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.102 1.361 . . . . 0.0 113.858 176.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -124.34 159.82 29.47 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 126.173 1.789 . . . . 0.0 111.583 -171.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -63.37 141.28 58.82 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.876 1.271 . . . . 0.0 112.201 -178.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 23.6 tpt180 -150.86 127.72 11.0 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.281 1.033 . . . . 0.0 112.06 -171.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 40.8 mtmt -106.29 140.66 38.88 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.735 1.214 . . . . 0.0 111.91 171.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 66.6 t -137.13 139.18 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 126.074 1.75 . . . . 0.0 108.575 175.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -107.37 133.55 51.74 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.242 1.017 . . . . 0.0 111.303 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.2 tt -160.34 146.4 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 123.882 0.873 . . . . 0.0 112.547 -166.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -84.68 125.5 32.56 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.122 -0.986 . . . . 0.0 112.154 174.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 20.2 m-30 -115.59 154.05 30.13 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.71 2.004 . . . . 0.0 111.395 171.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -94.26 155.07 17.21 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 123.726 0.81 . . . . 0.0 113.016 166.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -104.17 151.29 23.5 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 127.578 2.351 . . . . 0.0 109.729 168.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -60.27 -24.85 65.25 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 -174.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 53.2 p-10 -71.53 -12.89 61.61 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.185 1.394 . . . . 0.0 114.476 174.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 103.76 0.78 45.93 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 126.575 2.036 . . . . 0.0 114.524 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 70.5 m -82.86 162.04 21.73 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 119.406 1.603 . . . . 0.0 112.228 175.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 94.2 m -127.35 164.6 21.45 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.477 1.111 . . . . 0.0 112.014 178.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -165.03 149.51 9.02 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.899 1.28 . . . . 0.0 111.787 177.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -74.3 118.94 17.84 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 123.707 0.803 . . . . 0.0 109.558 164.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 16.3 t -101.3 137.92 39.01 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 126.444 1.898 . . . . 0.0 109.609 173.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 20.4 tp -90.44 119.71 30.95 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 159.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 29.6 t -100.88 122.84 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 172.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -119.53 111.76 18.51 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.175 1.39 . . . . 0.0 109.761 178.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.475 HG11 ' HB1' ' A' ' 85' ' ' ALA . 7.2 p -87.81 127.12 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-O 121.227 0.537 . . . . 0.0 109.837 172.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 90.6 t -113.59 112.09 48.7 Favored Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 125.908 1.683 . . . . 0.0 106.886 177.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.43 131.95 14.35 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.984 2.456 . . . . 0.0 110.276 -178.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 76.6 t -104.91 116.6 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 123.935 0.894 . . . . 0.0 109.083 174.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 62.4 mttt -87.32 153.69 21.27 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.624 0.77 . . . . 0.0 112.4 172.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -91.93 -173.77 3.59 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.313 1.045 . . . . 0.0 111.58 175.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -61.36 -20.81 63.42 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 179.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -95.11 -0.12 53.75 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.878 1.271 . . . . 0.0 113.148 177.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 79.71 22.22 64.66 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 124.173 0.892 . . . . 0.0 114.719 176.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -107.69 148.49 29.33 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.136 1.374 . . . . 0.0 109.92 171.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.6 p -81.02 122.25 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 123.701 0.8 . . . . 0.0 110.652 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -121.86 -23.79 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -174.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 60.9 mtm -129.74 150.5 51.02 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.07 1.348 . . . . 0.0 112.172 169.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -110.63 135.39 51.32 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 125.522 1.529 . . . . 0.0 108.978 166.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 53.2 mt -101.01 122.05 52.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 163.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 9.2 mp -103.89 123.62 47.47 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 172.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -101.83 150.43 23.17 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.375 1.07 . . . . 0.0 110.858 174.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -123.37 135.85 54.36 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.031 1.333 . . . . 0.0 110.601 178.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -142.38 134.12 26.92 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.245 1.418 . . . . 0.0 109.061 179.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 57.8 t -79.82 115.85 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 176.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.3 p -95.23 -24.91 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 39.1 tpp -163.94 111.87 1.16 Allowed 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.873 1.269 . . . . 0.0 110.882 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -79.81 127.88 32.76 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 121.16 -0.963 . . . . 0.0 110.99 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 41.8 mttt . . . . . 0 C--O 1.258 1.506 0 C-N-CA 125.245 1.418 . . . . 0.0 112.527 -179.843 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 mmt . . . . . 0 N--CA 1.496 1.833 0 CA-C-O 118.397 -0.811 . . . . 0.0 110.604 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -75.79 131.12 13.08 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 123.095 2.53 . . . . 0.0 111.02 178.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.8 p -168.01 149.07 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 125.48 1.512 . . . . 0.0 110.841 -178.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 6.0 mmp_? -90.5 135.74 33.5 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.575 1.15 . . . . 0.0 111.253 173.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -100.86 152.77 20.13 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.435 1.494 . . . . 0.0 112.21 -175.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -90.14 -153.45 28.54 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 125.618 1.58 . . . . 0.0 112.691 175.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 40.1 m80 -65.69 138.44 57.97 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.585 0.754 . . . . 0.0 111.557 175.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.2 p -70.25 -34.4 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -171.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 64.98 159.41 0.12 Allowed Pre-proline 0 CA--C 1.556 1.186 0 C-N-CA 127.209 2.204 . . . . 0.0 113.392 -176.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -74.06 125.51 9.88 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.567 2.178 . . . . 0.0 110.513 172.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 10.5 mp0 -87.9 -63.66 1.27 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 122.01 0.91 . . . . 0.0 109.793 169.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.1 p-10 -85.9 147.68 26.15 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 126.245 1.818 . . . . 0.0 110.732 -174.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 31.1 p -131.1 -49.48 1.01 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 126.419 1.888 . . . . 0.0 111.701 -176.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -65.06 -42.98 93.72 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.614 0.766 . . . . 0.0 111.629 177.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 64.7 tp -71.05 -39.78 72.04 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.557 0.743 . . . . 0.0 111.032 172.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -59.79 -27.25 66.4 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 177.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 92.6 m -69.54 -23.69 63.62 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.746 1.218 . . . . 0.0 111.641 174.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 23.6 mm -76.48 -38.16 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 123.923 0.889 . . . . 0.0 109.806 176.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.1 mp -57.7 -33.58 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 O-C-N 121.702 -0.624 . . . . 0.0 110.91 173.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 48.5 mtp85 -69.59 -18.95 63.66 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 119.455 1.025 . . . . 0.0 113.332 177.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 78.1 mttt -87.68 -38.87 15.48 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 125.096 1.358 . . . . 0.0 111.053 173.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -73.88 -18.88 60.86 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.929 1.292 . . . . 0.0 113.337 174.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -52.34 147.72 7.57 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.237 1.415 . . . . 0.0 112.828 172.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -90.75 52.69 3.32 Favored Glycine 0 C--N 1.34 0.761 0 C-N-CA 125.586 1.565 . . . . 0.0 110.379 -179.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 60.82 41.74 14.21 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.9 1.68 . . . . 0.0 111.579 178.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 8.1 m -76.31 7.45 4.3 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.864 1.266 . . . . 0.0 114.296 -170.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.0 mmt-85 -76.52 -167.81 0.87 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.747 1.219 . . . . 0.0 111.928 175.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -120.99 139.02 53.86 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.107 1.363 . . . . 0.0 110.427 -173.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -165.07 152.77 11.3 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -177.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 13.2 pt -140.93 149.35 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 125.969 1.708 . . . . 0.0 110.47 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 19.0 mt -108.87 133.75 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.343 1.457 . . . . 0.0 108.8 179.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -131.81 142.87 49.85 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.758 1.223 . . . . 0.0 111.634 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -70.47 124.81 25.1 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.342 0.657 . . . . 0.0 111.698 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.8 -15.77 60.2 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 120.922 -1.111 . . . . 0.0 113.218 -178.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 3.1 mpp_? -98.94 4.81 47.43 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.999 1.72 . . . . 0.0 113.336 -171.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 70.9 t -110.26 138.4 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 126.681 1.993 . . . . 0.0 108.898 179.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -54.14 -34.63 60.84 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 116.048 1.87 . . . . 0.0 116.048 -167.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -105.86 0.31 25.85 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.168 1.387 . . . . 0.0 113.027 -178.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 91.2 m 50.43 66.86 1.03 Allowed 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.875 1.67 . . . . 0.0 111.954 -171.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.88 140.53 58.82 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.154 0.982 . . . . 0.0 111.967 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 63.7 t -63.86 119.88 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 171.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 38.3 pt -101.09 -20.64 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.689 1.195 . . . . 0.0 112.341 174.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -154.46 147.57 24.71 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.43 1.092 . . . . 0.0 111.127 177.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.453 ' HB2' ' CE1' ' A' ' 48' ' ' PHE . 22.4 p -152.14 154.78 36.54 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 121.024 -1.047 . . . . 0.0 113.424 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -78.77 -168.81 1.53 Allowed 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 123.457 0.703 . . . . 0.0 112.321 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -104.12 -18.6 14.46 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.566 1.546 . . . . 0.0 112.59 169.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.61 -42.46 71.97 Favored Glycine 0 N--CA 1.469 0.895 0 C-N-CA 124.146 0.879 . . . . 0.0 112.253 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.453 ' CE1' ' HB2' ' A' ' 44' ' ' CYS . 0.9 OUTLIER -67.05 -29.31 69.06 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.315 0.646 . . . . 0.0 111.788 -175.853 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 83.7 m -52.64 -51.81 58.42 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.181 1.392 . . . . 0.0 111.808 172.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -74.57 -20.46 59.93 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.842 0.857 . . . . 0.0 113.179 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.38 -58.38 7.27 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.031 1.332 . . . . 0.0 110.253 176.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 69.2 m -97.73 -15.43 20.34 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 -175.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.37 2.16 68.37 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 125.519 1.533 . . . . 0.0 114.046 173.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -85.56 -154.52 0.2 Allowed 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 124.798 1.239 . . . . 0.0 111.811 170.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 9.5 t -161.22 170.07 20.99 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 120.498 -1.376 . . . . 0.0 111.61 175.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -50.34 -47.91 55.68 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.824 1.25 . . . . 0.0 111.48 177.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.63 -25.96 54.63 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 178.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -92.33 -39.79 11.28 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.284 1.434 . . . . 0.0 111.848 177.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 71.3 t -80.7 -17.41 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 125.742 1.617 . . . . 0.0 112.243 -177.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 70.0 mtp -60.97 131.15 49.72 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 120.549 -1.344 . . . . 0.0 109.843 173.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 14.0 mt-30 70.34 13.11 7.58 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.713 1.605 . . . . 0.0 114.105 -178.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -89.97 153.56 47.2 Favored Pre-proline 0 N--CA 1.475 0.778 0 C-N-CA 124.356 1.062 . . . . 0.0 110.991 172.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.53 132.28 23.36 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.995 2.464 . . . . 0.0 110.23 170.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 27.3 p -68.42 -9.9 51.64 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 115.105 1.521 . . . . 0.0 115.105 -175.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 38.3 p -62.3 -27.45 69.04 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.93 1.292 . . . . 0.0 111.588 168.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 73.4 m 48.89 42.53 20.5 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.506 1.522 . . . . 0.0 112.6 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -56.72 -32.03 65.1 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.159 1.383 . . . . 0.0 112.59 -175.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -59.1 -16.17 17.93 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.965 1.306 . . . . 0.0 114.501 175.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 97.2 mt -76.45 -3.95 39.93 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 174.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -59.7 134.08 56.69 Favored 'General case' 0 CA--C 1.549 0.942 0 CA-C-N 120.382 1.446 . . . . 0.0 113.051 176.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -105.2 -175.4 24.35 Favored Glycine 0 CA--C 1.538 1.499 0 C-N-CA 125.435 1.493 . . . . 0.0 111.42 167.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -66.57 -16.61 51.31 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 122.92 2.413 . . . . 0.0 113.674 176.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -90.08 -9.27 49.07 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 175.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 53.3 m -68.88 132.49 46.83 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 119.651 1.114 . . . . 0.0 110.852 -175.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -90.03 130.33 36.23 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.112 0.965 . . . . 0.0 110.323 -179.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -63.42 -31.9 73.18 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.581 0.753 . . . . 0.0 112.261 -175.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 36.5 mmt180 -61.81 -50.57 71.79 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.69 0.796 . . . . 0.0 111.797 172.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.24 -37.74 88.18 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 120.331 -1.481 . . . . 0.0 112.964 -178.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -56.93 -34.23 67.78 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 170.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -76.19 -42.53 46.03 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 124.886 1.274 . . . . 0.0 112.878 174.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -61.49 -33.51 73.9 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 118.598 0.636 . . . . 0.0 110.925 -178.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 91.3 mt -62.07 -36.84 76.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 CA-C-N 119.679 1.127 . . . . 0.0 112.315 170.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.89 -37.47 67.29 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 119.343 0.974 . . . . 0.0 112.186 173.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -62.97 -33.13 74.73 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 121.418 -0.802 . . . . 0.0 111.473 172.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.52 -19.76 65.05 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 175.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 43.8 mt -88.43 -18.32 28.55 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.229 1.411 . . . . 0.0 112.799 172.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 83.1 mt -85.12 -21.64 29.19 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.006 0.922 . . . . 0.0 111.667 171.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -81.94 143.1 22.95 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 125.156 1.36 . . . . 0.0 112.308 176.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -91.21 -3.18 57.2 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.347 1.059 . . . . 0.0 113.841 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -117.02 161.87 18.7 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.658 1.983 . . . . 0.0 110.804 174.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -64.61 145.94 55.42 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 122.276 1.036 . . . . 0.0 113.045 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 44.9 mmt-85 -142.08 135.8 29.5 Favored 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 125.314 1.446 . . . . 0.0 110.442 173.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.4 ptpp? -113.76 134.83 54.53 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 167.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 78.2 t -129.05 135.16 62.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 126.144 1.777 . . . . 0.0 107.908 -173.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -99.56 128.84 45.68 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.986 0.914 . . . . 0.0 110.319 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.1 tt -151.14 148.8 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.359 1.063 . . . . 0.0 111.463 -168.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -80.15 124.06 28.45 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 120.774 -1.204 . . . . 0.0 111.304 173.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 6.8 m-30 -107.29 136.92 46.28 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.883 1.673 . . . . 0.0 110.384 172.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -101.44 128.47 47.63 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.68 1.592 . . . . 0.0 110.955 177.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 57.4 ttp180 -94.56 152.55 18.44 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.203 1.801 . . . . 0.0 111.396 -174.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -59.68 -22.7 62.32 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 -174.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -79.91 -13.07 59.64 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.702 1.201 . . . . 0.0 114.069 176.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 107.13 0.59 35.66 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 126.269 1.89 . . . . 0.0 114.699 -178.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 75.0 m -80.42 160.19 25.41 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 119.489 1.644 . . . . 0.0 112.876 176.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 15.9 t -136.12 152.45 50.85 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.884 1.273 . . . . 0.0 110.574 176.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -166.97 161.38 14.96 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.369 1.468 . . . . 0.0 111.303 -176.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -80.4 121.02 25.19 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.912 0.885 . . . . 0.0 111.129 172.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 49.6 t -102.45 135.69 43.62 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.61 1.964 . . . . 0.0 110.423 171.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.1 tt -89.24 116.05 27.19 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 125.627 1.571 . . . . 0.0 107.033 163.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 66.5 t -103.06 111.78 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 169.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -101.84 113.6 26.95 Favored 'General case' 0 C--O 1.224 -0.246 0 C-N-CA 126.085 1.754 . . . . 0.0 109.547 172.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.416 HG22 HD13 ' A' ' 127' ' ' LEU . 67.5 t -85.99 126.32 40.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 169.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 89.7 t -113.22 116.22 46.92 Favored Pre-proline 0 CA--C 1.537 0.469 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 170.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -73.84 133.86 19.07 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 123.43 2.753 . . . . 0.0 110.079 -179.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 87.8 t -102.39 116.92 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 N-CA-C 107.902 -1.148 . . . . 0.0 107.902 171.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 33.2 mttp -88.86 161.13 16.87 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.447 0.699 . . . . 0.0 112.196 171.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -98.75 -174.13 2.71 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.384 1.074 . . . . 0.0 111.969 172.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -60.27 -22.58 63.27 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.276 1.43 . . . . 0.0 114.689 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -90.8 -1.49 57.85 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.161 0.984 . . . . 0.0 113.138 177.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 74.86 26.61 66.55 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 124.1 0.857 . . . . 0.0 113.932 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -103.63 146.12 29.05 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.98 1.312 . . . . 0.0 108.79 169.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 11.4 p -78.2 131.02 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-O 121.425 0.631 . . . . 0.0 110.529 175.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 2.8 pt -126.6 -21.16 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 124.652 1.181 . . . . 0.0 113.926 -169.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 73.6 mtm -148.8 155.65 41.24 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 126.09 1.756 . . . . 0.0 110.132 176.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -118.71 131.9 56.15 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 125.085 1.354 . . . . 0.0 109.514 174.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 56.6 mt -97.07 115.32 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 106.244 -1.761 . . . . 0.0 106.244 166.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.416 HD13 HG22 ' A' ' 112' ' ' VAL . 1.7 mm? -91.76 121.39 33.35 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 171.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -113.18 124.79 53.37 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 119.462 -0.304 . . . . 0.0 111.121 178.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 12.2 m-30 -103.46 144.06 31.89 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.301 1.441 . . . . 0.0 111.813 -177.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -150.63 135.68 17.63 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.726 1.611 . . . . 0.0 109.281 172.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 60.2 t -75.61 115.47 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 CA-C-N 119.53 1.059 . . . . 0.0 108.447 171.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.4 p -93.0 -25.3 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 123.539 0.735 . . . . 0.0 112.646 -178.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 30.5 ttm -162.17 118.42 2.01 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.552 1.141 . . . . 0.0 110.567 -176.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -82.08 124.16 29.58 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.679 -0.638 . . . . 0.0 110.021 174.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.255 1.355 0 CA-C-O 115.464 -2.208 . . . . 0.0 116.177 -172.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.6 mtt . . . . . 0 N--CA 1.494 1.763 0 CA-C-O 118.594 -0.717 . . . . 0.0 110.757 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -77.91 164.51 27.49 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 123.815 3.01 . . . . 0.0 112.159 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.6 p -161.66 135.77 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 125.295 1.438 . . . . 0.0 110.518 174.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -141.97 158.55 43.64 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.597 1.559 . . . . 0.0 111.87 -177.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.33 169.31 15.97 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 127.079 2.152 . . . . 0.0 111.756 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 152.97 -27.08 0.81 Allowed Glycine 0 N--CA 1.477 1.376 0 C-N-CA 124.591 1.091 . . . . 0.0 115.33 174.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 37.9 m80 -76.02 150.35 37.4 Favored 'General case' 0 CA--C 1.551 1.005 0 CA-C-N 118.387 1.093 . . . . 0.0 111.857 174.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.7 p -69.36 -32.9 55.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -177.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 68.63 160.51 0.15 Allowed Pre-proline 0 CA--C 1.556 1.189 0 C-N-CA 127.473 2.309 . . . . 0.0 113.452 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -64.36 123.63 12.09 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 122.413 2.076 . . . . 0.0 108.885 165.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -110.46 170.07 8.33 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.49 1.116 . . . . 0.0 112.326 -171.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -78.27 40.38 0.35 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.698 1.599 . . . . 0.0 113.93 -175.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 13.1 t -52.65 -29.76 28.04 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 127.812 2.445 . . . . 0.0 114.539 -168.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -72.43 -46.28 55.78 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 118.813 0.733 . . . . 0.0 111.746 175.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 53.9 tp -64.67 -34.04 77.36 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.978 1.311 . . . . 0.0 111.229 171.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -56.4 -31.12 63.56 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.731 1.212 . . . . 0.0 112.638 176.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 33.3 m -70.48 -29.98 66.66 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.939 1.296 . . . . 0.0 111.227 174.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.2 mm -78.66 -40.13 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 124.325 1.05 . . . . 0.0 110.221 176.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.45 ' HA ' ' CE2' ' A' ' 22' ' ' PHE . 87.6 mt -59.79 -44.27 93.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.308 0.643 . . . . 0.0 111.122 176.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 51.8 ptt85 -67.51 -24.26 65.55 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -179.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -69.03 -42.82 75.83 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.809 0.843 . . . . 0.0 111.671 174.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.45 ' CE2' ' HA ' ' A' ' 19' ' ' ILE . 17.0 p90 -87.0 -31.29 20.65 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 113.75 1.018 . . . . 0.0 113.75 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.29 -39.54 68.24 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 120.386 1.448 . . . . 0.0 111.388 178.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -70.02 -7.2 59.02 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 125.799 1.666 . . . . 0.0 114.528 176.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -80.7 -3.42 50.64 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 124.683 1.193 . . . . 0.0 111.948 169.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.2 t 84.59 25.18 0.09 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 126.735 2.014 . . . . 0.0 112.518 164.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 18.8 mmm180 -76.92 165.59 24.47 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.206 1.002 . . . . 0.0 111.646 -175.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.6 mptt -91.93 125.95 36.83 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.312 -0.868 . . . . 0.0 110.577 -175.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -159.14 161.99 36.36 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.1 pt -144.91 155.7 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 127.171 2.188 . . . . 0.0 109.905 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.8 mp -120.51 135.01 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 125.021 1.329 . . . . 0.0 109.334 179.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -132.58 153.22 51.22 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.007 1.323 . . . . 0.0 112.32 -176.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 29.0 p30 -76.47 118.92 19.64 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.409 1.084 . . . . 0.0 112.738 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.23 -17.22 61.37 Favored 'General case' 0 CA--C 1.547 0.829 0 O-C-N 120.724 -1.235 . . . . 0.0 113.517 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 65.7 mtm-85 -86.23 5.67 33.16 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.701 1.601 . . . . 0.0 114.813 -168.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 13.0 m -133.81 158.33 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 125.59 1.556 . . . . 0.0 111.116 -173.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -62.46 -40.73 97.58 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.088 0.955 . . . . 0.0 113.505 -173.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -85.9 -14.59 44.36 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 114.285 1.216 . . . . 0.0 114.285 -173.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 84.2 m 41.55 69.49 0.35 Allowed 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.777 1.631 . . . . 0.0 112.306 -165.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.31 143.18 47.05 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.064 0.945 . . . . 0.0 111.757 -176.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 23.8 t -65.98 122.45 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 175.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.5 pt -104.25 -14.84 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 125.629 1.572 . . . . 0.0 112.468 176.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -157.67 142.79 16.85 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.533 1.133 . . . . 0.0 111.376 176.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.539 ' HB3' ' CE1' ' A' ' 48' ' ' PHE . 2.7 m -130.67 153.3 49.11 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.125 0.97 . . . . 0.0 112.101 -178.157 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -78.46 -168.96 1.5 Allowed 'General case' 0 CA--C 1.554 1.132 0 CA-C-N 118.973 0.806 . . . . 0.0 111.496 165.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -104.01 -21.76 13.56 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.162 1.385 . . . . 0.0 112.975 169.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.31 -35.02 60.44 Favored Glycine 0 C--N 1.343 0.95 0 O-C-N 121.5 -0.75 . . . . 0.0 112.436 -177.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.539 ' CE1' ' HB3' ' A' ' 44' ' ' CYS . 0.4 OUTLIER -68.78 -30.86 69.53 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.491 0.716 . . . . 0.0 111.885 178.979 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 86.4 m -50.7 -55.32 17.08 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.217 1.407 . . . . 0.0 111.944 176.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -70.1 -18.81 63.26 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.168 0.987 . . . . 0.0 113.334 -178.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.2 tp -63.89 -46.29 85.53 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.853 1.261 . . . . 0.0 111.878 -178.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 73.9 m -110.53 -16.2 13.72 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 178.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.72 -0.06 57.84 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 125.59 1.567 . . . . 0.0 114.395 174.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -82.46 -157.59 0.22 Allowed 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 124.812 1.245 . . . . 0.0 112.217 171.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 10.0 t -162.52 170.45 18.63 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 120.522 -1.361 . . . . 0.0 111.485 176.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -47.6 -50.99 22.72 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.199 1.4 . . . . 0.0 111.454 176.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.99 -25.86 32.85 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -95.78 -38.83 10.15 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.309 1.444 . . . . 0.0 112.241 178.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 76.7 t -83.08 -19.01 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 125.756 1.622 . . . . 0.0 111.938 -176.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 77.1 mmm -66.19 132.38 48.3 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 120.566 -1.334 . . . . 0.0 109.481 173.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 73.59 7.97 5.04 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 126.129 1.771 . . . . 0.0 114.292 -175.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 -90.03 154.28 47.29 Favored Pre-proline 0 N--CA 1.478 0.934 0 C-N-CA 124.832 1.253 . . . . 0.0 110.427 169.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.46 134.31 26.22 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 123.091 2.527 . . . . 0.0 110.245 175.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 24.3 p -69.79 -4.98 22.4 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 114.888 1.44 . . . . 0.0 114.888 -176.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 56.0 p -62.05 -30.22 70.83 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.91 1.284 . . . . 0.0 111.398 165.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 77.9 m 50.62 38.73 19.69 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.003 1.721 . . . . 0.0 112.563 -174.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -57.41 -30.11 64.68 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.615 1.166 . . . . 0.0 112.441 -176.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -59.42 -15.14 15.18 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.743 1.217 . . . . 0.0 114.085 176.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 90.9 mt -77.51 -4.76 47.26 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.617 1.167 . . . . 0.0 113.955 172.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 11.4 p-80 -66.86 158.86 29.52 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 120.275 1.398 . . . . 0.0 114.511 179.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -155.17 -162.59 11.38 Favored Glycine 0 CA--C 1.537 1.456 0 C-N-CA 126.274 1.893 . . . . 0.0 111.875 168.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.85 -13.88 41.94 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 123.272 2.648 . . . . 0.0 115.143 -175.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -97.0 2.14 51.11 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 119.845 1.202 . . . . 0.0 113.742 173.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 20.3 m -87.61 127.43 35.27 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 119.593 1.088 . . . . 0.0 110.553 -177.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -86.73 126.41 34.56 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.719 0.807 . . . . 0.0 109.674 -178.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 11.7 mpt_? -65.38 -31.93 73.3 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.437 0.695 . . . . 0.0 111.584 -175.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 25.1 tpp180 -58.46 -42.89 88.44 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.542 1.137 . . . . 0.0 112.024 172.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -71.03 -43.88 66.97 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.259 -0.901 . . . . 0.0 112.32 177.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -56.99 -36.63 70.61 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 121.826 -0.546 . . . . 0.0 112.039 174.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.93 -48.66 57.61 Favored 'General case' 0 C--O 1.223 -0.299 0 C-N-CA 125.101 1.36 . . . . 0.0 111.953 173.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.8 mm100 -58.44 -37.54 75.62 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 118.369 -0.824 . . . . 0.0 111.495 -178.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 93.5 mt -61.08 -45.6 98.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 CA-C-N 120.128 1.331 . . . . 0.0 111.65 170.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.97 -34.21 74.95 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 119.006 0.821 . . . . 0.0 113.09 179.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 86.4 mm-40 -71.98 -32.18 66.99 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.164 0.986 . . . . 0.0 111.58 174.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -58.3 -32.19 68.22 Favored 'General case' 0 CA--C 1.547 0.857 0 O-C-N 121.213 -0.929 . . . . 0.0 112.214 177.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 58.7 mt -70.41 -16.6 62.97 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.952 1.701 . . . . 0.0 113.946 178.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.6 pp -104.29 -1.33 27.15 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 119.331 0.969 . . . . 0.0 113.33 170.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -84.68 -20.44 58.18 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 124.719 1.152 . . . . 0.0 114.702 -178.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 56.88 32.19 21.01 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 125.789 1.635 . . . . 0.0 113.385 179.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -144.82 163.77 33.07 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.825 1.65 . . . . 0.0 111.246 -171.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -68.67 128.68 37.49 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.897 -0.502 . . . . 0.0 110.674 174.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -142.35 133.93 26.68 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.788 1.235 . . . . 0.0 111.841 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 37.6 mtmt -111.06 130.15 55.69 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.285 1.434 . . . . 0.0 109.965 168.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.8 t -133.05 137.06 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 125.203 1.401 . . . . 0.0 108.441 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -106.32 130.88 54.08 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.137 0.975 . . . . 0.0 111.249 -175.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.4 tt -155.19 146.92 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 124.065 0.946 . . . . 0.0 112.314 -165.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -83.45 121.02 26.63 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 120.949 -1.094 . . . . 0.0 111.815 174.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 13.8 m-30 -109.27 146.85 33.6 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.569 1.947 . . . . 0.0 111.29 173.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -110.65 137.31 48.49 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.564 1.546 . . . . 0.0 112.03 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -92.09 154.98 18.38 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 126.472 1.909 . . . . 0.0 111.252 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -58.5 -25.8 62.75 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.559 1.144 . . . . 0.0 113.833 175.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -69.7 -10.83 59.83 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.322 1.449 . . . . 0.0 113.572 176.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 93.98 4.28 63.33 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 125.334 1.445 . . . . 0.0 113.93 -178.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 63.7 p -92.04 170.87 9.5 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.789 1.236 . . . . 0.0 112.024 175.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 22.1 p -147.36 168.25 22.3 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 121.11 -0.994 . . . . 0.0 112.722 176.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -164.64 155.53 14.86 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.961 1.304 . . . . 0.0 110.722 -173.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -77.15 123.55 26.57 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.277 0.56 . . . . 0.0 110.238 167.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 19.1 t -106.53 136.03 47.01 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.128 1.771 . . . . 0.0 110.306 172.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.0 tp -89.7 120.6 31.11 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 161.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 59.8 t -106.36 117.91 53.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 124.764 1.226 . . . . 0.0 108.521 175.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -111.23 113.02 25.21 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.659 1.184 . . . . 0.0 108.436 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.2 p -88.75 128.06 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 168.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 96.1 t -116.8 116.84 38.09 Favored Pre-proline 0 CA--C 1.538 0.507 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 175.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -76.13 138.27 20.2 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 123.038 2.492 . . . . 0.0 110.373 -176.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 84.0 t -111.35 123.15 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.836 0.854 . . . . 0.0 109.708 174.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 65.0 mttt -95.25 154.73 17.05 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.258 1.023 . . . . 0.0 113.42 173.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -93.66 -173.62 3.23 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.603 1.161 . . . . 0.0 111.872 177.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -58.31 -23.28 55.99 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.374 1.469 . . . . 0.0 114.42 177.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -93.02 -4.63 52.24 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.322 1.449 . . . . 0.0 113.173 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 80.46 22.29 62.74 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 124.226 0.917 . . . . 0.0 114.592 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -107.61 149.66 27.8 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.987 1.315 . . . . 0.0 109.981 173.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 64.0 t -77.26 125.51 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.24 -23.9 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -177.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 62.1 mtm -132.57 155.92 47.8 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.407 1.483 . . . . 0.0 112.479 171.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -119.16 134.09 55.4 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 125.87 1.668 . . . . 0.0 109.443 169.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 54.3 mt -97.39 120.02 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 165.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -103.61 127.51 51.03 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 173.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -119.98 128.05 53.21 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.402 1.081 . . . . 0.0 109.819 -176.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 16.9 m-30 -103.9 138.31 40.65 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.326 1.45 . . . . 0.0 111.016 -176.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -142.4 131.3 22.97 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.622 1.169 . . . . 0.0 109.879 174.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 94.1 t -76.92 111.85 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 176.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 5.0 p -95.86 -26.27 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 123.8 0.84 . . . . 0.0 112.963 -174.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 25.0 ptp -162.21 148.06 13.06 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.41 1.084 . . . . 0.0 112.789 163.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -90.37 130.01 36.51 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.953 0.901 . . . . 0.0 110.585 178.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 13.1 mmmm . . . . . 0 C--O 1.253 1.263 0 C-N-CA 125.297 1.439 . . . . 0.0 113.805 178.452 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.0 mmt . . . . . 0 N--CA 1.496 1.868 0 CA-C-O 118.642 -0.694 . . . . 0.0 111.238 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -68.29 134.75 32.16 Favored 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 123.59 2.86 . . . . 0.0 111.376 178.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 57.9 t -99.52 115.19 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 124.53 1.132 . . . . 0.0 110.566 -173.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 6.7 mpt_? -85.8 174.88 9.01 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.825 1.25 . . . . 0.0 111.803 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 13.6 ptp180 -55.39 147.89 16.29 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.856 1.263 . . . . 0.0 112.142 173.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -92.02 108.57 3.64 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 123.955 0.788 . . . . 0.0 112.175 -176.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -166.83 167.13 15.22 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 126.476 1.911 . . . . 0.0 110.86 175.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 59.8 t -137.07 134.9 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 124.606 1.163 . . . . 0.0 109.591 172.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -157.67 154.22 24.55 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 127.095 2.158 . . . . 0.0 108.881 174.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -65.03 110.39 1.5 Allowed 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.892 2.395 . . . . 0.0 110.23 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -69.81 165.12 22.16 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.652 1.181 . . . . 0.0 111.498 176.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -69.31 147.36 51.24 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 121.244 -0.91 . . . . 0.0 111.019 171.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 38.2 p -117.45 -40.57 3.04 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 125.509 1.523 . . . . 0.0 112.389 -174.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -76.02 -52.6 9.85 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.062 0.945 . . . . 0.0 111.553 176.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 60.4 tp -58.63 -34.47 71.21 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.43 1.092 . . . . 0.0 111.259 178.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -56.71 -30.97 64.03 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 176.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 89.7 m -77.01 -32.75 57.37 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.255 1.022 . . . . 0.0 110.89 175.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 20.9 mm -71.64 -39.42 69.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 123.541 0.736 . . . . 0.0 110.5 176.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 71.8 mt -56.31 -44.13 78.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 124.13 0.972 . . . . 0.0 110.753 175.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 39.9 mtt180 -59.75 -36.87 77.51 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 119.212 0.915 . . . . 0.0 112.489 177.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -74.0 -37.29 64.47 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.532 1.133 . . . . 0.0 112.071 177.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -79.57 -22.18 44.12 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.998 1.319 . . . . 0.0 112.954 178.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -62.01 -31.71 72.12 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 118.817 0.735 . . . . 0.0 112.003 170.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.52 44.65 40.11 Favored Glycine 0 C--N 1.341 0.838 0 N-CA-C 114.848 0.699 . . . . 0.0 114.848 156.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -58.36 -25.31 61.85 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 114.568 1.321 . . . . 0.0 114.568 -176.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.9 t -91.64 -5.71 53.4 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 177.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -91.01 171.36 9.32 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.8 1.24 . . . . 0.0 110.715 175.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.4 mptt -88.27 136.51 32.95 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.506 1.123 . . . . 0.0 111.252 -175.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -163.47 167.06 22.02 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.412 1.085 . . . . 0.0 113.544 178.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 25.7 pt -144.76 152.1 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 126.617 1.967 . . . . 0.0 109.865 172.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 10.7 mt -117.68 133.61 63.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 125.538 1.535 . . . . 0.0 109.008 -178.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -134.78 152.18 51.55 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.393 1.077 . . . . 0.0 112.353 178.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 14.3 m-20 -74.68 117.99 17.13 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.334 0.653 . . . . 0.0 111.527 178.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.32 -20.21 66.03 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.934 0.894 . . . . 0.0 112.274 170.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 78.7 mtp85 -66.79 -11.87 56.72 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.825 2.05 . . . . 0.0 115.352 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 20.6 m -124.79 142.03 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 125.357 1.463 . . . . 0.0 111.01 -179.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -61.4 -40.68 95.26 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.718 1.207 . . . . 0.0 112.904 -170.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 22.2 p30 -72.32 -14.59 61.78 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 177.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 4.8 t 50.98 61.67 3.12 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.716 1.606 . . . . 0.0 111.695 -173.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.64 134.86 56.18 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 120.936 -1.103 . . . . 0.0 112.278 -179.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 40.5 t -63.79 122.66 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 C-N-CA 123.07 0.548 . . . . 0.0 109.912 173.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.1 pt -101.46 -21.37 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 125.404 1.482 . . . . 0.0 112.424 175.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -152.36 144.09 23.58 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.293 1.037 . . . . 0.0 111.816 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.507 ' HB3' ' CE1' ' A' ' 48' ' ' PHE . 3.1 m -128.07 155.07 44.96 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.056 0.942 . . . . 0.0 112.592 -179.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -73.88 -174.22 1.77 Allowed 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 123.159 0.584 . . . . 0.0 111.475 167.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -107.52 -17.97 13.97 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.58 1.152 . . . . 0.0 112.801 166.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -73.92 -38.81 48.18 Favored Glycine 0 C--N 1.337 0.599 0 C-N-CA 125.821 1.676 . . . . 0.0 112.734 176.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.507 ' CE1' ' HB3' ' A' ' 44' ' ' CYS . 0.3 OUTLIER -62.62 -34.51 77.17 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.207 0.603 . . . . 0.0 111.244 179.606 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 76.6 m -48.19 -56.13 8.67 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.942 1.697 . . . . 0.0 111.941 170.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -70.93 -19.79 62.54 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -177.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.95 -49.48 72.4 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.641 1.177 . . . . 0.0 111.43 177.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 76.6 m -107.61 -21.63 12.82 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 -176.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.02 -0.4 57.46 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 125.426 1.488 . . . . 0.0 114.348 178.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -83.08 -171.52 3.61 Favored 'General case' 0 CA--C 1.55 0.964 0 CA-C-N 118.499 1.15 . . . . 0.0 112.698 170.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 74.2 m -140.95 162.59 35.12 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.409 1.084 . . . . 0.0 111.312 178.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -46.37 -49.55 17.7 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.282 1.033 . . . . 0.0 112.025 176.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.96 -24.78 59.47 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -89.21 -39.31 13.63 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.765 1.226 . . . . 0.0 111.67 177.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 19.8 t -88.63 -12.46 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 124.107 0.963 . . . . 0.0 112.513 -176.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 75.4 mtp -64.35 139.33 58.75 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 120.463 -1.398 . . . . 0.0 111.276 168.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 69.37 6.89 5.93 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 126.301 1.841 . . . . 0.0 113.896 -177.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 32.4 mmt180 -83.85 154.58 64.65 Favored Pre-proline 0 N--CA 1.472 0.643 0 C-N-CA 124.23 1.012 . . . . 0.0 110.59 172.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -68.94 131.04 21.5 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.866 2.377 . . . . 0.0 109.671 170.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 6.7 t -66.04 -14.41 61.64 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.165 1.386 . . . . 0.0 114.069 -172.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 33.9 p -59.39 -24.27 63.3 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.863 1.665 . . . . 0.0 112.908 169.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 76.9 m 57.51 42.81 23.82 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.186 1.394 . . . . 0.0 111.76 -178.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -71.97 18.79 0.08 Allowed 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 127.519 2.328 . . . . 0.0 113.39 -175.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -112.46 -12.3 13.52 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 126.889 2.076 . . . . 0.0 112.747 170.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 78.6 mt -81.18 -9.62 59.76 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 114.801 1.408 . . . . 0.0 114.801 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 12.0 p80 -69.02 160.33 31.16 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 179.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -151.96 -161.37 10.12 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 126.1 1.81 . . . . 0.0 111.357 168.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -65.74 -18.54 58.58 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 122.961 2.441 . . . . 0.0 114.287 -177.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.5 tpm_? -88.15 -6.95 57.58 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 119.273 0.942 . . . . 0.0 113.106 176.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.8 m -85.92 137.81 32.47 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.382 1.473 . . . . 0.0 109.77 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -102.5 135.41 44.19 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.21 1.004 . . . . 0.0 110.269 -178.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 19.3 tpp180 -58.6 -36.37 73.9 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.359 1.064 . . . . 0.0 112.383 -178.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 21.1 tpp85 -55.5 -45.91 77.01 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.15 1.38 . . . . 0.0 112.118 176.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.77 -46.4 68.84 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.753 0.821 . . . . 0.0 111.773 178.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.82 -34.44 65.38 Favored 'General case' 0 CA--C 1.545 0.784 0 O-C-N 121.488 -0.758 . . . . 0.0 112.359 175.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.41 -40.57 70.4 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 125.27 1.428 . . . . 0.0 113.033 173.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -61.17 -30.55 70.47 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 118.061 -0.971 . . . . 0.0 112.174 178.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 58.0 mt -63.76 -47.28 91.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 CA-C-N 120.039 1.29 . . . . 0.0 110.273 172.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.89 -34.43 77.38 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 121.582 -0.699 . . . . 0.0 112.483 176.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 73.7 mm-40 -69.64 -31.32 69.34 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 121.481 -0.762 . . . . 0.0 112.194 171.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.5 -28.12 66.73 Favored 'General case' 0 CA--C 1.545 0.778 0 O-C-N 120.98 -1.075 . . . . 0.0 111.666 176.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 74.4 mt -73.97 -14.25 61.0 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.94 1.296 . . . . 0.0 113.655 169.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 94.3 mt -94.89 -10.64 30.58 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.249 1.02 . . . . 0.0 112.653 172.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -87.65 143.8 18.62 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 125.077 1.322 . . . . 0.0 112.9 177.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.5 -3.5 58.34 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.751 1.22 . . . . 0.0 113.801 175.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -125.62 165.17 19.03 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.578 1.951 . . . . 0.0 110.974 -175.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -61.62 139.79 58.23 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.014 0.926 . . . . 0.0 112.039 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.17 123.75 8.47 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.318 1.047 . . . . 0.0 110.872 -173.078 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -89.18 153.0 21.29 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.399 1.079 . . . . 0.0 113.719 169.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 46.1 t -138.73 134.48 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 126.808 2.043 . . . . 0.0 107.628 167.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -102.98 121.2 42.05 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.609 0.763 . . . . 0.0 109.15 173.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.5 tt -147.25 145.46 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 123.925 0.89 . . . . 0.0 112.212 -169.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -84.29 119.51 25.14 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.332 -0.855 . . . . 0.0 111.75 175.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 15.9 m-30 -107.07 150.43 26.55 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.544 1.938 . . . . 0.0 110.908 172.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -109.89 136.7 48.77 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.983 1.313 . . . . 0.0 111.871 175.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -86.37 168.24 14.01 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.744 0.818 . . . . 0.0 112.593 173.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -58.23 -30.96 66.91 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 125.684 1.593 . . . . 0.0 113.511 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -76.37 -6.32 51.07 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.946 1.299 . . . . 0.0 113.439 178.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 93.63 1.34 66.07 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 125.63 1.586 . . . . 0.0 114.541 178.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.4 m -80.32 154.02 28.04 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 118.766 1.283 . . . . 0.0 111.743 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 39.1 t -117.42 150.6 38.61 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.822 1.249 . . . . 0.0 111.733 -178.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -159.56 146.14 16.43 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.968 1.307 . . . . 0.0 111.412 178.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -71.02 123.86 23.04 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.279 0.632 . . . . 0.0 110.974 165.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 47.0 t -106.78 133.71 51.03 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.627 1.971 . . . . 0.0 109.672 169.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.0 tt -85.41 113.61 21.83 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.515 1.526 . . . . 0.0 107.075 162.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 63.9 t -98.1 110.93 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 124.82 1.248 . . . . 0.0 107.646 170.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -102.33 120.07 39.87 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 120.435 1.47 . . . . 0.0 108.733 167.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.407 HG22 HD13 ' A' ' 127' ' ' LEU . 67.5 t -82.66 135.79 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 170.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 48.5 t -115.25 111.2 44.73 Favored Pre-proline 0 CA--C 1.535 0.403 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 169.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.45 133.25 14.28 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.011 2.474 . . . . 0.0 109.741 178.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 94.6 t -107.8 123.55 63.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 123.98 0.912 . . . . 0.0 109.783 179.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 67.2 mttt -91.6 154.08 19.29 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.242 0.831 . . . . 0.0 113.242 170.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -92.7 -174.56 3.68 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.285 1.034 . . . . 0.0 110.765 173.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -66.1 -18.93 65.66 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -85.34 -5.79 59.28 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.318 1.047 . . . . 0.0 112.455 174.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 78.68 23.05 65.41 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 124.581 1.086 . . . . 0.0 114.385 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -107.88 150.31 27.21 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.542 1.537 . . . . 0.0 109.937 172.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 90.4 t -78.61 124.93 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 123.684 0.794 . . . . 0.0 109.202 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.22 -24.74 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 -175.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 51.9 mtm -130.2 152.22 49.86 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.822 1.249 . . . . 0.0 112.473 171.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -113.34 135.81 53.45 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 125.164 1.386 . . . . 0.0 109.081 166.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 49.6 mt -103.07 119.56 51.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 166.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.407 HD13 HG22 ' A' ' 112' ' ' VAL . 1.6 mm? -95.84 117.97 31.59 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 173.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -111.08 129.42 55.93 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 117.773 0.261 . . . . 0.0 110.978 -179.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 17.6 m-30 -107.62 137.91 44.79 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.481 1.512 . . . . 0.0 111.7 -171.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -144.54 116.99 8.55 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.568 1.147 . . . . 0.0 109.779 172.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.1 p -66.68 115.63 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 O-C-N 121.363 -0.836 . . . . 0.0 109.883 175.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 9.2 p -99.83 -27.04 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.904 1.281 . . . . 0.0 113.394 -171.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 25.1 ptp -162.69 149.93 13.4 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.328 1.051 . . . . 0.0 113.104 167.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -89.18 136.46 33.01 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.722 0.809 . . . . 0.0 111.037 177.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt . . . . . 0 C--O 1.254 1.326 0 C-N-CA 125.317 1.447 . . . . 0.0 112.732 175.875 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.1 ttm . . . . . 0 N--CA 1.494 1.743 0 CA-C-O 118.341 -0.837 . . . . 0.0 110.731 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -75.56 143.34 27.24 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 123.224 2.616 . . . . 0.0 110.688 175.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 17.4 m -149.43 152.99 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 125.018 1.327 . . . . 0.0 111.303 -178.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 18.5 ptp180 -68.3 160.96 28.36 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.039 0.936 . . . . 0.0 112.702 173.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 19.0 ptp180 -157.76 160.71 38.13 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.669 1.588 . . . . 0.0 112.413 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -173.31 -144.19 4.56 Favored Glycine 0 N--CA 1.471 1.02 0 C-N-CA 125.539 1.543 . . . . 0.0 112.573 -177.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -64.89 124.43 21.99 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 123.518 0.727 . . . . 0.0 111.227 176.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.5 p -75.89 -19.9 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 N-CA-C 113.761 1.022 . . . . 0.0 113.761 -173.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 71.55 162.63 0.15 Allowed Pre-proline 0 CA--C 1.555 1.164 0 C-N-CA 127.485 2.314 . . . . 0.0 112.716 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -70.88 139.16 35.76 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.518 2.146 . . . . 0.0 110.494 170.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -168.07 179.33 4.65 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.649 1.58 . . . . 0.0 111.865 -175.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -75.58 63.34 1.53 Allowed 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 126.661 1.984 . . . . 0.0 114.701 -172.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 25.9 p -42.18 -45.4 4.06 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 128.025 2.53 . . . . 0.0 114.372 -178.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -65.01 -41.65 95.13 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.848 0.859 . . . . 0.0 112.481 -177.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 61.5 tp -72.79 -40.01 66.24 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.563 1.145 . . . . 0.0 111.098 173.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -62.66 -25.11 67.97 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.178 0.991 . . . . 0.0 112.459 178.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 95.0 m -67.85 -21.86 65.16 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.597 1.559 . . . . 0.0 111.487 171.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 11.5 mm -86.6 -37.41 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 124.749 1.22 . . . . 0.0 110.791 174.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.456 ' HA ' ' CE2' ' A' ' 22' ' ' PHE . 1.9 mp -58.31 -49.89 80.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 123.1 0.56 . . . . 0.0 110.397 174.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 16.3 ptp180 -67.43 -16.77 64.41 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 114.22 1.193 . . . . 0.0 114.22 -175.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.5 mtpt -70.59 -36.24 73.46 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.937 0.895 . . . . 0.0 111.986 171.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.456 ' CE2' ' HA ' ' A' ' 19' ' ' ILE . 6.2 p90 -93.74 -23.85 18.05 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 178.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -77.94 160.79 27.99 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 173.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -108.52 5.79 33.39 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 126.089 1.804 . . . . 0.0 115.537 178.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -91.77 -23.84 19.61 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 119.259 1.529 . . . . 0.0 114.334 -175.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.8 m -86.6 11.53 12.58 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 114.074 1.139 . . . . 0.0 114.074 -170.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 21.5 mmt85 -79.72 165.77 22.47 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.06 1.344 . . . . 0.0 113.666 -167.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -94.82 129.77 41.65 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.906 1.282 . . . . 0.0 110.93 -172.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -160.35 161.63 33.21 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.323 1.049 . . . . 0.0 113.712 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.6 pt -141.79 153.68 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 127.125 2.17 . . . . 0.0 110.441 176.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.6 mp -116.43 132.61 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 124.732 1.213 . . . . 0.0 109.205 176.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.726 ' HB2' ' SG ' ' A' ' 64' ' ' CYS . . . -123.15 142.92 50.37 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 126.078 1.751 . . . . 0.0 110.603 -174.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -71.32 124.05 23.68 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 121.82 -0.55 . . . . 0.0 111.105 171.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.01 -33.93 63.97 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 121.142 -0.974 . . . . 0.0 111.986 177.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 60.6 mtm180 -80.31 33.68 0.3 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 126.007 1.723 . . . . 0.0 113.115 -174.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 79.8 t -145.15 133.42 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 127.142 2.177 . . . . 0.0 108.492 -173.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -57.93 -41.09 82.03 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.685 1.194 . . . . 0.0 113.336 -171.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 75.7 m-80 -84.76 -11.0 56.69 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -178.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 69.8 m 45.9 62.04 2.4 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.246 1.419 . . . . 0.0 111.95 -165.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.52 143.37 57.26 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.089 0.955 . . . . 0.0 111.955 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.656 HG22 ' SG ' ' A' ' 64' ' ' CYS . 56.6 t -61.47 116.33 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 124.534 1.134 . . . . 0.0 108.734 173.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 37.3 pt -98.47 -20.85 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 123.147 0.579 . . . . 0.0 112.326 170.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -156.72 152.61 27.24 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.106 0.962 . . . . 0.0 111.697 175.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.514 ' HB2' ' CE1' ' A' ' 48' ' ' PHE . 24.9 p -153.16 153.94 33.76 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.015 -1.053 . . . . 0.0 113.287 -179.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -79.89 -168.84 1.75 Allowed 'General case' 0 CA--C 1.553 1.091 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -179.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -101.33 -22.93 14.47 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.171 1.388 . . . . 0.0 112.57 169.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.45 -37.0 58.84 Favored Glycine 0 C--N 1.343 0.944 0 O-C-N 121.532 -0.73 . . . . 0.0 112.825 -177.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.514 ' CE1' ' HB2' ' A' ' 44' ' ' CYS . 0.8 OUTLIER -67.03 -30.38 70.44 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 117.451 0.626 . . . . 0.0 111.779 179.206 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 80.0 m -56.05 -52.02 65.76 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.608 1.163 . . . . 0.0 111.78 175.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -71.44 -20.36 62.11 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.739 0.816 . . . . 0.0 112.952 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.5 tp -64.92 -56.02 15.79 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.511 1.124 . . . . 0.0 111.116 176.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 62.0 m -98.64 -13.73 20.2 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -175.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 91.79 2.61 69.33 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 125.624 1.583 . . . . 0.0 114.152 171.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -85.64 -153.64 0.18 Allowed 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 124.899 1.28 . . . . 0.0 112.133 171.243 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 82.7 p -153.8 167.8 28.46 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 120.389 -1.444 . . . . 0.0 111.63 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -50.85 -52.96 36.45 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 118.817 -0.611 . . . . 0.0 110.512 169.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.55 -32.55 58.55 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -178.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -85.84 -37.63 18.99 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.887 0.875 . . . . 0.0 112.953 177.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 68.1 t -77.73 -15.76 14.21 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 C-N-CA 124.882 1.273 . . . . 0.0 111.625 178.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 75.1 mtp -60.59 131.35 50.45 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 120.468 -1.395 . . . . 0.0 111.508 175.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 71.92 14.01 5.93 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 126.587 1.955 . . . . 0.0 113.656 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 38.5 mtt180 -94.81 158.89 34.44 Favored Pre-proline 0 N--CA 1.474 0.761 0 C-N-CA 124.634 1.174 . . . . 0.0 111.214 174.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -70.3 136.83 32.51 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 123.307 2.672 . . . . 0.0 110.56 170.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.726 ' SG ' ' HB2' ' A' ' 32' ' ' ALA . 56.6 m -67.03 -8.58 31.25 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.46 1.281 . . . . 0.0 114.46 177.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 76.4 p -61.15 -28.37 69.07 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.351 1.061 . . . . 0.0 111.89 172.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 75.6 m 50.36 35.95 11.96 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.014 1.326 . . . . 0.0 113.104 -176.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -56.14 -33.28 65.02 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.362 1.465 . . . . 0.0 112.501 -176.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -60.26 -14.55 18.55 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.388 1.475 . . . . 0.0 114.35 177.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 92.7 mt -76.65 -2.97 35.42 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 174.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 3.6 p80 -59.87 145.3 46.18 Favored 'General case' 0 CA--C 1.552 1.026 0 CA-C-N 119.5 1.046 . . . . 0.0 113.41 176.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -118.51 -164.88 13.12 Favored Glycine 0 CA--C 1.539 1.591 0 C-N-CA 126.03 1.776 . . . . 0.0 111.525 165.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.84 -20.65 29.47 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 123.277 2.651 . . . . 0.0 112.937 174.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 29.3 ttm180 -93.59 2.2 56.44 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.26 1.424 . . . . 0.0 113.006 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 28.1 m -83.85 136.76 33.99 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.376 1.47 . . . . 0.0 110.011 177.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -96.89 123.62 40.65 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.021 0.928 . . . . 0.0 109.518 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 14.0 tpt180 -60.4 -30.57 69.69 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.721 0.809 . . . . 0.0 112.76 -176.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 21.4 tpp85 -56.9 -41.32 77.88 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.854 1.261 . . . . 0.0 112.504 173.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -72.73 -43.09 63.4 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 121.348 -0.845 . . . . 0.0 111.962 177.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -57.75 -36.49 72.16 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 121.545 -0.722 . . . . 0.0 112.038 174.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.95 -47.94 64.42 Favored 'General case' 0 C--O 1.225 -0.237 0 C-N-CA 125.197 1.399 . . . . 0.0 111.997 173.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.5 mm100 -58.25 -37.0 74.06 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 118.616 -0.707 . . . . 0.0 111.681 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 95.6 mt -59.54 -42.1 86.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 CA-C-N 119.829 1.195 . . . . 0.0 111.83 171.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.72 -34.98 70.04 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.458 0.703 . . . . 0.0 112.891 176.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -68.22 -32.83 73.31 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.981 0.912 . . . . 0.0 111.687 174.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.401 ' HB1' HG11 ' A' ' 112' ' ' VAL . . . -59.79 -27.91 66.97 Favored 'General case' 0 CA--C 1.547 0.827 0 CA-C-N 119.201 0.91 . . . . 0.0 113.035 178.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 53.7 mt -72.55 -14.7 61.7 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.648 1.579 . . . . 0.0 113.134 177.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 70.0 mt -81.86 -20.41 38.97 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.055 0.942 . . . . 0.0 112.268 174.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -89.44 152.74 22.83 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.139 1.352 . . . . 0.0 113.311 -178.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -95.83 7.9 45.04 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.088 1.355 . . . . 0.0 113.509 176.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -126.62 162.31 26.01 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.091 1.756 . . . . 0.0 112.082 -176.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -64.23 141.68 58.69 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.636 1.175 . . . . 0.0 112.063 -179.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 9.9 tpt180 -152.13 138.21 18.24 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.012 1.325 . . . . 0.0 110.646 -173.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -129.24 148.16 51.15 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 168.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 58.3 t -138.79 135.71 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 126.282 1.833 . . . . 0.0 108.232 -171.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -104.69 130.08 52.79 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.931 0.892 . . . . 0.0 110.98 -176.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.2 tt -152.26 147.36 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 123.999 0.919 . . . . 0.0 112.19 -168.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -81.59 121.08 25.88 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 120.872 -1.143 . . . . 0.0 111.601 171.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 10.1 m-30 -109.19 132.15 54.39 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.656 1.982 . . . . 0.0 111.147 173.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -78.31 162.15 26.71 Favored 'General case' 0 CA--C 1.549 0.906 0 O-C-N 121.89 -0.506 . . . . 0.0 112.084 167.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 23.9 ttp180 -115.39 147.56 40.38 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.766 1.626 . . . . 0.0 110.41 173.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -55.77 -24.92 38.41 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 178.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -64.08 -17.82 63.78 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.578 1.551 . . . . 0.0 113.77 173.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 100.41 4.43 54.98 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 125.849 1.69 . . . . 0.0 113.858 -175.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 86.3 p -92.77 -178.94 5.0 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 118.626 1.213 . . . . 0.0 112.569 176.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 21.8 t -150.02 156.67 42.1 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.681 1.192 . . . . 0.0 111.625 -177.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -161.2 164.63 30.32 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.316 1.846 . . . . 0.0 110.657 178.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.68 126.18 35.9 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 123.667 0.787 . . . . 0.0 112.459 170.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 43.4 t -105.07 135.34 46.59 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.837 2.055 . . . . 0.0 110.844 174.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 38.8 tp -93.42 112.79 24.78 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.786 1.235 . . . . 0.0 107.74 160.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 61.1 t -95.39 119.67 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 173.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -113.65 119.44 37.45 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 125.35 1.46 . . . . 0.0 109.598 174.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.401 HG11 ' HB1' ' A' ' 85' ' ' ALA . 5.8 p -94.44 127.64 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 123.897 0.879 . . . . 0.0 109.506 173.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 96.9 t -115.91 111.03 43.38 Favored Pre-proline 0 CA--C 1.537 0.452 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 178.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -73.61 130.71 15.13 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.684 2.256 . . . . 0.0 110.109 -178.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 58.6 t -100.26 124.93 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 123.942 0.897 . . . . 0.0 109.331 176.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 21.4 mtpt -94.58 150.82 19.85 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.665 0.745 . . . . 0.0 112.389 174.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 54.0 p30 -78.96 -173.43 3.54 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.832 1.253 . . . . 0.0 111.694 174.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -67.64 -15.36 63.61 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 175.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -96.59 -18.31 19.84 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.646 1.178 . . . . 0.0 113.206 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 86.67 43.98 5.94 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 125.966 1.746 . . . . 0.0 113.577 -174.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -118.69 154.27 32.99 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.394 1.477 . . . . 0.0 110.175 161.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 57.3 t -80.27 126.44 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 C-N-CA 123.413 0.685 . . . . 0.0 109.29 178.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.8 -24.63 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 N-CA-C 114.217 1.191 . . . . 0.0 114.217 -178.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 64.0 mtm -133.79 157.44 45.89 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.151 1.381 . . . . 0.0 112.205 172.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -117.56 137.08 52.82 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 125.532 1.533 . . . . 0.0 109.298 169.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 47.4 mt -101.54 121.34 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 164.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 8.2 mp -104.99 133.19 50.2 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 172.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -126.03 132.97 51.87 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.481 1.113 . . . . 0.0 110.114 -174.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 15.1 m-30 -107.46 128.21 54.29 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.02 1.328 . . . . 0.0 110.754 -176.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -124.19 131.88 53.57 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.177 1.391 . . . . 0.0 107.396 169.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 71.4 t -78.49 112.09 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 CA-C-N 119.415 1.007 . . . . 0.0 108.293 173.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.4 p -89.13 -24.5 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.429 1.091 . . . . 0.0 112.631 -174.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 13.4 tpt -161.16 119.24 2.4 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.721 1.209 . . . . 0.0 110.609 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -85.18 115.08 22.76 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.489 0.716 . . . . 0.0 109.767 176.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt . . . . . 0 C--O 1.255 1.348 0 C-N-CA 125.025 1.33 . . . . 0.0 113.733 -175.702 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 91.5 mmm . . . . . 0 N--CA 1.495 1.791 0 CA-C-O 118.607 -0.711 . . . . 0.0 110.829 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -80.18 167.69 19.43 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 123.815 3.01 . . . . 0.0 111.88 177.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.5 p -161.07 132.13 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 125.095 1.358 . . . . 0.0 110.619 173.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 31.0 tpt85 -92.09 102.87 15.41 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.165 0.986 . . . . 0.0 110.091 175.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -83.0 169.99 15.37 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.073 1.349 . . . . 0.0 111.117 174.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 128.58 123.48 2.58 Favored Glycine 0 N--CA 1.472 1.073 0 C-N-CA 125.69 1.614 . . . . 0.0 113.028 175.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 48.2 m80 -149.26 172.93 14.07 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 127.214 2.205 . . . . 0.0 109.97 178.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.5 p -151.44 141.59 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 124.09 0.956 . . . . 0.0 111.531 177.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.24 154.15 92.15 Favored Pre-proline 0 CA--C 1.552 1.034 0 C-N-CA 124.666 1.187 . . . . 0.0 112.453 178.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -65.74 128.42 19.92 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 123.298 2.665 . . . . 0.0 110.601 176.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 23.0 mp0 -80.77 169.95 16.92 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.115 1.366 . . . . 0.0 110.953 176.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -71.61 148.22 46.8 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.187 -0.946 . . . . 0.0 110.865 169.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 40.0 p -122.63 -40.54 2.44 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 125.48 1.512 . . . . 0.0 112.122 -174.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -69.94 -55.57 9.31 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.982 0.913 . . . . 0.0 111.11 173.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 62.7 tp -59.34 -35.24 73.48 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.255 1.022 . . . . 0.0 111.255 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -58.56 -31.84 68.37 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 176.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 90.9 m -77.14 -32.89 56.7 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.13 0.972 . . . . 0.0 110.48 175.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 24.8 mm -68.58 -41.86 83.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 123.062 0.545 . . . . 0.0 110.367 173.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 76.1 mt -57.4 -46.67 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 124.384 1.074 . . . . 0.0 110.506 174.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 78.8 mtt-85 -58.71 -31.72 68.52 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 179.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -71.02 -30.51 66.75 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.08 0.952 . . . . 0.0 112.756 177.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -88.83 -26.13 21.83 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.487 1.115 . . . . 0.0 113.371 173.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -67.0 153.89 42.54 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 122.155 0.978 . . . . 0.0 113.369 178.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -79.81 61.21 4.32 Favored Glycine 0 C--N 1.34 0.764 0 C-N-CA 126.074 1.797 . . . . 0.0 110.695 173.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -62.11 -21.36 64.93 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.165 1.386 . . . . 0.0 112.624 -178.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 7.8 t -83.45 -20.11 34.67 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 175.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.1 mpt_? -90.55 179.61 5.8 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.892 1.277 . . . . 0.0 110.309 170.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -122.84 128.65 50.68 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 121.002 -1.061 . . . . 0.0 111.766 -174.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 26.9 p90 -163.93 163.52 23.55 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.084 1.353 . . . . 0.0 112.96 175.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 14.3 pt -141.06 154.84 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 126.062 1.745 . . . . 0.0 110.19 175.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 15.9 mt -110.14 129.07 65.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 124.814 1.246 . . . . 0.0 108.67 177.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -122.5 142.76 50.24 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 124.897 1.279 . . . . 0.0 111.236 178.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -65.55 126.51 28.56 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.163 0.585 . . . . 0.0 111.435 172.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -80.93 -25.02 37.75 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 28.7 mmm180 -80.12 -36.82 34.76 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.616 1.166 . . . . 0.0 112.938 -173.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 52.9 t -68.98 131.85 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 C-N-CA 125.439 1.495 . . . . 0.0 109.753 173.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -59.63 -44.81 93.34 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.518 1.127 . . . . 0.0 113.309 -170.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 20.2 p30 -74.53 -9.54 58.68 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 113.78 1.029 . . . . 0.0 113.78 177.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 72.1 m 54.79 64.34 1.84 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.89 1.676 . . . . 0.0 112.23 -176.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.88 135.56 57.73 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.66 0.784 . . . . 0.0 111.735 179.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 42.3 t -64.33 118.17 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 168.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 36.0 pt -100.17 -19.77 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 124.718 1.207 . . . . 0.0 112.367 177.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -155.24 146.43 22.73 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.246 1.018 . . . . 0.0 111.547 177.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -130.15 149.64 51.77 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.367 1.067 . . . . 0.0 111.858 178.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -74.13 -164.16 0.23 Allowed 'General case' 0 CA--C 1.554 1.134 0 CA-C-N 118.249 0.477 . . . . 0.0 111.128 169.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -107.26 -21.46 12.94 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.935 1.294 . . . . 0.0 112.713 169.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.8 -40.26 58.35 Favored Glycine 0 C--N 1.342 0.915 0 O-C-N 121.678 -0.639 . . . . 0.0 112.585 -178.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -64.39 -31.41 72.61 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 123.966 0.906 . . . . 0.0 112.365 -178.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 36.1 t -60.63 -53.42 57.72 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.373 1.469 . . . . 0.0 110.939 176.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -70.61 -26.7 63.62 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.531 0.732 . . . . 0.0 112.765 178.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 27.4 tp -61.52 -38.35 87.05 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.324 1.05 . . . . 0.0 112.343 173.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 39.1 m -106.3 -35.93 7.01 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 114.686 1.365 . . . . 0.0 114.686 -171.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.83 10.21 55.46 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 125.68 1.61 . . . . 0.0 114.266 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -89.58 -147.89 0.18 Allowed 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 118.558 1.179 . . . . 0.0 111.728 170.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.9 m -161.59 161.07 29.61 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 126.042 1.737 . . . . 0.0 110.606 176.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -53.67 -43.72 69.09 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 121.561 -0.712 . . . . 0.0 111.582 178.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.11 -30.43 36.54 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 175.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -92.85 -36.81 12.63 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.001 1.32 . . . . 0.0 112.193 178.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 53.8 t -73.12 -21.15 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 125.829 1.651 . . . . 0.0 111.504 177.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 57.0 mmm -65.07 135.07 55.12 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 121.014 -1.054 . . . . 0.0 112.126 179.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.0 tp60 69.87 10.33 7.45 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 126.438 1.895 . . . . 0.0 113.577 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 36.4 mmt180 -83.49 151.24 61.78 Favored Pre-proline 0 N--CA 1.471 0.621 0 C-N-CA 124.261 1.024 . . . . 0.0 110.879 177.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.23 131.71 21.13 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.982 2.454 . . . . 0.0 108.758 167.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 22.3 p -67.54 -9.97 47.49 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -172.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 30.8 p -61.17 -26.35 67.65 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.194 1.398 . . . . 0.0 112.269 170.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 94.3 m 52.16 46.9 25.82 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.147 1.379 . . . . 0.0 112.777 175.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -59.23 -23.46 62.34 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.663 1.185 . . . . 0.0 112.867 -178.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -54.6 -25.65 27.79 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.733 1.613 . . . . 0.0 112.96 172.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 74.1 mt -78.36 -7.41 57.27 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 178.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 7.4 t60 -63.66 141.89 58.6 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.48 1.112 . . . . 0.0 112.258 175.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -148.39 -170.17 16.02 Favored Glycine 0 CA--C 1.537 1.434 0 C-N-CA 127.252 2.358 . . . . 0.0 111.857 176.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -64.11 -21.95 67.69 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 123.221 2.614 . . . . 0.0 113.848 -175.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.85 -6.9 50.79 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 176.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 26.7 m -74.96 142.18 43.96 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-N 119.959 1.254 . . . . 0.0 110.474 -174.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 69.0 mm-40 -100.74 124.96 47.1 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.17 0.988 . . . . 0.0 110.133 -170.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -61.47 -40.22 93.75 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.572 0.749 . . . . 0.0 112.797 -176.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 36.1 mmt180 -66.24 -36.04 81.98 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.454 0.701 . . . . 0.0 112.62 175.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.78 -43.73 68.13 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 119.176 0.898 . . . . 0.0 112.045 177.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -57.89 -32.17 67.46 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.17 0.588 . . . . 0.0 112.044 173.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -72.32 -49.76 31.99 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.637 1.175 . . . . 0.0 111.847 172.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 11.6 mm-40 -59.96 -34.37 73.18 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 118.914 0.779 . . . . 0.0 111.738 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 83.1 mt -61.89 -34.89 64.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 CA-C-N 120.034 1.288 . . . . 0.0 112.749 170.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.26 -41.34 63.76 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 119.648 1.113 . . . . 0.0 112.101 172.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -65.44 -28.75 69.46 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 121.29 -0.881 . . . . 0.0 112.095 175.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.66 -20.99 62.3 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 119.353 0.978 . . . . 0.0 113.116 172.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 32.1 mt -90.03 -11.67 40.82 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.79 1.636 . . . . 0.0 112.93 175.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 82.0 mt -93.1 -17.03 24.28 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.605 1.162 . . . . 0.0 111.891 171.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -87.04 144.32 19.3 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 125.165 1.364 . . . . 0.0 113.331 -176.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -87.2 -8.07 57.27 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.751 1.22 . . . . 0.0 113.738 174.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -119.78 161.14 21.27 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.593 1.957 . . . . 0.0 111.01 -177.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -61.76 141.86 57.63 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.458 1.103 . . . . 0.0 112.401 -175.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 71.3 mmt-85 -137.98 131.65 31.1 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.183 0.993 . . . . 0.0 112.529 174.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 38.8 mtmt -108.95 131.51 54.98 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.756 1.622 . . . . 0.0 110.075 169.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 57.3 t -134.26 134.7 54.97 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 125.032 1.333 . . . . 0.0 108.926 -178.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -100.91 131.9 46.57 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.096 0.959 . . . . 0.0 110.776 178.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 19.7 tt -155.46 145.5 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 124.141 0.976 . . . . 0.0 111.82 -169.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -86.38 118.21 25.67 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.101 -0.999 . . . . 0.0 110.682 173.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 11.4 m-30 -105.19 140.6 38.11 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.714 1.605 . . . . 0.0 111.677 175.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -94.01 149.71 20.99 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.312 1.445 . . . . 0.0 111.078 174.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -108.22 156.2 19.61 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 125.735 1.614 . . . . 0.0 112.422 -175.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -64.03 -23.59 67.39 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 113.302 0.852 . . . . 0.0 113.302 175.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -78.87 -6.24 55.59 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.854 1.262 . . . . 0.0 113.618 177.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 94.21 -2.07 68.06 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 125.453 1.501 . . . . 0.0 114.3 -177.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 50.7 m -83.06 176.08 9.51 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.737 1.215 . . . . 0.0 112.244 175.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 23.3 p -154.14 165.78 35.16 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 120.918 -1.114 . . . . 0.0 112.106 172.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -164.91 167.76 18.3 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.214 1.405 . . . . 0.0 113.287 176.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -82.09 122.21 27.56 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.73 0.812 . . . . 0.0 110.141 169.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 45.5 t -105.09 141.25 36.98 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.659 1.984 . . . . 0.0 109.977 173.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 11.3 tp -96.74 118.19 32.66 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.954 1.302 . . . . 0.0 107.716 162.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 65.4 t -100.83 115.63 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 124.835 1.254 . . . . 0.0 108.316 173.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -111.44 110.57 21.08 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 125.278 1.431 . . . . 0.0 107.305 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 34.7 t -97.15 122.01 48.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 73.2 t -106.53 114.67 61.77 Favored Pre-proline 0 CA--C 1.536 0.417 0 N-CA-C 107.653 -1.239 . . . . 0.0 107.653 -177.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -73.46 120.35 6.45 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 123.078 2.518 . . . . 0.0 109.575 179.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 98.3 t -95.15 118.4 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.299 0.639 . . . . 0.0 109.53 175.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 60.8 mttt -87.62 153.42 21.4 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.692 0.797 . . . . 0.0 112.468 171.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -91.4 -173.57 3.63 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.425 1.09 . . . . 0.0 111.584 175.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -60.66 -21.74 63.12 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.05 1.34 . . . . 0.0 114.37 178.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -91.0 -5.45 55.34 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.072 1.349 . . . . 0.0 113.003 178.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 80.94 22.09 61.99 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 124.327 0.965 . . . . 0.0 114.554 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -108.25 148.86 29.37 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.193 1.397 . . . . 0.0 109.99 172.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.7 p -80.23 126.77 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 123.837 0.855 . . . . 0.0 110.703 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -128.31 -23.82 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -173.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 62.6 mtm -132.01 155.51 47.89 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.467 1.507 . . . . 0.0 111.993 171.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -114.83 135.86 53.73 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 125.251 1.421 . . . . 0.0 109.27 167.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 50.9 mt -98.94 115.99 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 163.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 6.2 mp -96.26 117.8 31.52 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 174.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -110.04 131.72 54.8 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 119.366 -0.349 . . . . 0.0 111.252 -177.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 11.2 m-30 -106.84 139.61 40.98 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.954 1.302 . . . . 0.0 111.129 -177.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -144.42 135.34 25.07 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.189 1.396 . . . . 0.0 109.482 175.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 27.5 t -77.46 114.95 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 176.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.9 p -95.44 -24.94 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -176.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 42.8 tpp -164.7 125.33 2.04 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.075 1.35 . . . . 0.0 110.425 179.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -83.81 125.22 31.73 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.574 0.749 . . . . 0.0 110.341 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.32 0 CA-C-O 115.836 -2.031 . . . . 0.0 114.568 -177.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.3 mpp? . . . . . 0 N--CA 1.495 1.789 0 CA-C-O 118.719 -0.658 . . . . 0.0 110.772 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -74.57 157.45 44.58 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 123.67 2.914 . . . . 0.0 111.578 177.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 95.3 t -86.89 110.9 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 174.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 31.8 mmm180 -76.26 139.36 41.08 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.382 1.073 . . . . 0.0 111.159 177.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 9.5 ptp180 -165.13 157.33 15.53 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.873 1.669 . . . . 0.0 112.38 -178.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -107.03 -173.27 22.62 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 125.686 1.612 . . . . 0.0 112.34 168.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 51.7 m80 -83.45 159.16 21.82 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 123.769 0.828 . . . . 0.0 111.547 170.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.3 p -64.8 141.33 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 O-C-N 121.513 -0.742 . . . . 0.0 111.974 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -126.2 154.3 74.41 Favored Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 126.075 1.75 . . . . 0.0 110.994 177.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -65.0 126.1 15.9 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 123.141 2.56 . . . . 0.0 110.891 -179.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 20.9 mp0 -82.64 170.31 15.28 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.299 1.439 . . . . 0.0 110.938 178.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -72.12 147.88 46.25 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 121.137 -0.977 . . . . 0.0 110.661 169.061 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 38.0 p -120.87 -41.24 2.57 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 125.4 1.48 . . . . 0.0 112.141 -174.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -71.04 -56.05 6.96 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 123.922 0.889 . . . . 0.0 111.136 174.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 65.7 tp -57.84 -34.14 69.39 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.607 1.163 . . . . 0.0 111.49 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -60.64 -25.41 66.29 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 176.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 84.9 m -82.93 -33.0 26.9 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.728 1.211 . . . . 0.0 110.852 172.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 26.7 mm -73.05 -38.22 55.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 123.734 0.814 . . . . 0.0 111.496 178.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 54.9 mt -53.81 -38.56 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 123.857 0.863 . . . . 0.0 111.193 176.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 56.2 mtt180 -61.8 -26.2 67.95 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.488 1.115 . . . . 0.0 112.892 178.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -74.84 -38.56 61.97 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.805 1.242 . . . . 0.0 111.339 174.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -81.18 -21.63 39.53 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.245 1.418 . . . . 0.0 113.714 177.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -62.3 -29.48 70.46 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.806 0.842 . . . . 0.0 112.556 173.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 111.97 92.75 2.09 Favored Glycine 0 C--N 1.341 0.843 0 C-N-CA 125.474 1.511 . . . . 0.0 111.288 171.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 61.43 37.69 16.52 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.335 1.454 . . . . 0.0 112.354 166.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 17.4 t -71.78 -25.2 61.92 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -173.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.8 mpp_? -74.63 156.64 36.51 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 122.225 1.012 . . . . 0.0 111.026 174.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.04 140.09 29.98 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.054 0.942 . . . . 0.0 111.058 -176.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -162.79 156.99 20.92 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.555 1.142 . . . . 0.0 113.279 178.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.4 pt -141.34 150.35 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 126.318 1.847 . . . . 0.0 110.439 176.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 16.9 mt -109.67 134.96 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 125.699 1.6 . . . . 0.0 108.444 177.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -130.82 148.25 52.57 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 125.022 1.329 . . . . 0.0 111.09 177.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 15.4 m-20 -67.06 127.89 34.28 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 170.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.74 -30.55 59.24 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 121.864 -0.522 . . . . 0.0 112.355 172.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 64.8 mtm180 -80.68 44.49 0.73 Allowed 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.878 1.671 . . . . 0.0 112.992 -172.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.8 p -162.05 138.62 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 126.448 1.899 . . . . 0.0 110.0 -179.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -58.17 -40.99 82.88 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.168 0.987 . . . . 0.0 112.971 -172.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 24.1 p30 -77.77 -19.47 55.05 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 96.5 m 51.51 57.82 6.16 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.502 1.121 . . . . 0.0 112.43 -172.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.23 141.23 57.67 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.526 1.13 . . . . 0.0 113.098 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 61.8 t -63.75 124.71 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 124.018 0.927 . . . . 0.0 109.847 173.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 45.3 pt -103.51 -20.23 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 125.034 1.334 . . . . 0.0 112.315 172.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 15.1 t80 -155.62 150.61 26.55 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.057 0.943 . . . . 0.0 112.141 177.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 11.2 p -146.75 154.73 41.74 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 120.953 -1.092 . . . . 0.0 113.002 178.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 31.8 t-20 -74.14 -158.52 0.07 Allowed 'General case' 0 CA--C 1.56 1.339 0 C-N-CA 123.225 0.61 . . . . 0.0 112.167 -178.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -111.75 -18.37 12.75 Favored 'General case' 0 N--CA 1.48 1.04 0 O-C-N 120.249 -1.532 . . . . 0.0 112.966 166.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -75.6 -33.21 52.79 Favored Glycine 0 N--CA 1.47 0.911 0 C-N-CA 124.391 0.996 . . . . 0.0 112.632 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -65.47 -36.26 83.35 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.122 0.969 . . . . 0.0 110.989 -178.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 8.1 t -52.21 -47.19 65.76 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.48 1.512 . . . . 0.0 111.859 170.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -76.74 -21.75 54.79 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -178.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 51.9 tp -66.32 -53.84 31.73 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.95 0.9 . . . . 0.0 111.356 174.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 79.9 m -102.48 -17.43 15.79 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -172.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 87.1 6.38 78.96 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.985 1.279 . . . . 0.0 114.167 176.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -86.29 -153.61 0.2 Allowed 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.969 1.308 . . . . 0.0 111.81 171.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 12.0 t -162.8 170.1 18.82 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 120.562 -1.336 . . . . 0.0 111.521 176.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 44.5 ttm180 -53.36 -45.83 69.33 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.417 1.087 . . . . 0.0 111.257 178.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.0 -26.66 49.59 Favored 'General case' 0 CA--C 1.551 0.993 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 176.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -93.99 -38.34 11.22 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.991 1.316 . . . . 0.0 112.268 179.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 51.2 t -86.2 -11.15 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 125.07 1.348 . . . . 0.0 112.297 -177.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 20.0 mmt -65.28 135.44 55.36 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 120.395 -1.441 . . . . 0.0 111.242 168.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.8 tm0? 70.98 8.16 6.43 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 126.298 1.839 . . . . 0.0 113.198 -177.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 37.7 mmt180 -88.88 152.17 48.28 Favored Pre-proline 0 N--CA 1.472 0.673 0 C-N-CA 124.484 1.113 . . . . 0.0 110.837 175.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -70.1 136.04 31.11 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 123.203 2.602 . . . . 0.0 109.404 171.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 30.8 p -68.07 -3.57 10.7 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 -179.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 52.6 p -61.53 -30.99 70.99 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.575 1.15 . . . . 0.0 111.665 166.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 81.8 m 50.62 38.27 18.51 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.633 1.573 . . . . 0.0 112.77 -177.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -58.2 -30.02 66.13 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.641 1.176 . . . . 0.0 112.418 -176.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -59.56 -14.51 13.48 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.04 1.336 . . . . 0.0 114.121 175.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 99.4 mt -75.38 -4.64 40.58 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.369 1.068 . . . . 0.0 113.721 171.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 13.5 p-80 -63.61 140.53 58.88 Favored 'General case' 0 CA--C 1.548 0.888 0 CA-C-N 120.194 1.361 . . . . 0.0 112.911 175.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -115.18 -164.87 14.54 Favored Glycine 0 CA--C 1.539 1.562 0 C-N-CA 125.988 1.756 . . . . 0.0 111.144 165.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -68.96 -21.72 36.88 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.952 2.435 . . . . 0.0 113.008 175.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 83.4 mtt85 -89.28 -9.56 50.16 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.483 1.113 . . . . 0.0 113.869 -178.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 56.7 m -68.91 136.73 53.05 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.756 1.222 . . . . 0.0 111.272 -173.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 21.5 mp0 -83.7 118.63 24.0 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.808 1.243 . . . . 0.0 109.475 -174.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -63.7 -37.72 88.4 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 121.639 -0.663 . . . . 0.0 112.408 -173.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -64.02 -38.05 89.64 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.414 0.686 . . . . 0.0 112.374 173.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.13 -44.25 69.29 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.308 0.958 . . . . 0.0 111.849 177.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.59 -35.47 65.84 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.145 0.578 . . . . 0.0 112.002 173.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.14 -44.99 64.46 Favored 'General case' 0 C--O 1.224 -0.243 0 C-N-CA 124.303 1.041 . . . . 0.0 112.636 172.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.41 ' HB2' HG21 ' A' ' 94' ' ' VAL . 15.6 mm-40 -59.91 -30.83 69.29 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 117.719 -1.134 . . . . 0.0 112.465 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 69.0 mt -59.43 -48.94 85.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 CA-C-N 120.622 1.555 . . . . 0.0 110.773 169.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.41 -37.24 74.43 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.838 0.855 . . . . 0.0 112.824 -178.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 77.5 mm-40 -70.92 -31.38 67.98 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.168 0.987 . . . . 0.0 111.518 175.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -59.58 -31.74 69.73 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 119.464 1.029 . . . . 0.0 112.636 177.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 56.7 mt -68.17 -15.63 63.66 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.386 1.475 . . . . 0.0 113.12 177.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 61.3 mt -83.39 -15.74 48.65 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.041 0.936 . . . . 0.0 112.446 174.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -93.32 153.18 21.25 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 125.377 1.465 . . . . 0.0 113.115 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -97.21 5.7 49.64 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.025 1.33 . . . . 0.0 113.742 177.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.61 159.72 25.86 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.82 1.648 . . . . 0.0 111.416 -179.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -61.21 141.19 57.68 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.753 1.621 . . . . 0.0 112.239 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.48 121.75 8.39 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.058 0.943 . . . . 0.0 111.514 -168.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 37.8 mtmt -106.3 137.34 44.43 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.852 1.261 . . . . 0.0 112.107 172.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.41 HG21 ' HB2' ' A' ' 81' ' ' GLN . 8.3 p -132.16 135.85 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 127.298 2.239 . . . . 0.0 110.136 171.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -101.99 133.74 46.31 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.399 1.48 . . . . 0.0 110.164 176.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 19.1 tt -159.99 144.71 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 124.202 1.001 . . . . 0.0 111.904 -163.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -82.21 121.64 26.89 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 120.911 -1.118 . . . . 0.0 111.872 173.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 11.2 m-30 -103.01 149.9 24.09 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.155 1.782 . . . . 0.0 111.412 172.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -106.28 136.12 46.56 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.299 1.84 . . . . 0.0 111.344 175.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 46.4 ttp180 -99.89 148.98 23.87 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 126.138 1.775 . . . . 0.0 111.3 -176.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -59.13 -22.14 60.4 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 177.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -73.58 -6.63 47.83 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.311 1.444 . . . . 0.0 113.732 174.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 95.95 -1.67 63.4 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 125.955 1.74 . . . . 0.0 113.86 -176.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -80.16 169.47 17.76 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.373 1.469 . . . . 0.0 112.823 -178.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 28.6 p -147.63 158.04 43.83 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.149 -0.969 . . . . 0.0 112.457 168.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -162.89 156.12 19.66 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.787 1.235 . . . . 0.0 111.531 -174.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -75.66 124.1 26.67 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 123.076 0.55 . . . . 0.0 110.162 168.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 12.8 t -111.61 146.51 37.27 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.708 2.003 . . . . 0.0 109.82 173.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 20.0 tp -96.33 124.95 40.51 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 125.514 1.526 . . . . 0.0 108.106 163.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 47.1 t -105.77 121.35 57.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 169.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -114.96 116.06 27.88 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.59 1.556 . . . . 0.0 109.101 173.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.1 p -89.77 125.84 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-O 121.066 0.46 . . . . 0.0 109.897 169.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 88.8 t -109.39 108.54 60.08 Favored Pre-proline 0 CA--C 1.536 0.414 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 174.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.85 126.46 10.71 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.666 2.244 . . . . 0.0 109.462 177.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 52.3 t -96.64 123.26 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 177.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 20.4 mtpt -94.03 149.88 20.84 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.554 0.692 . . . . 0.0 112.269 174.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 54.7 p30 -79.29 -173.64 3.76 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.65 1.18 . . . . 0.0 111.682 174.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -67.27 -15.55 63.76 Favored 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 114.614 1.338 . . . . 0.0 114.614 175.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -96.65 -18.1 19.93 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.812 1.245 . . . . 0.0 113.206 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 85.96 42.85 6.57 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 125.911 1.719 . . . . 0.0 113.563 -173.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -116.27 154.37 30.27 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.277 1.431 . . . . 0.0 110.145 160.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 49.5 t -80.67 125.8 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 178.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.02 -27.03 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -177.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 61.5 mtm -131.42 153.25 49.9 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.784 1.234 . . . . 0.0 112.359 170.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -111.44 137.04 49.76 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 125.303 1.441 . . . . 0.0 109.063 166.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 48.2 mt -104.4 119.09 52.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 163.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -101.23 124.7 47.34 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 173.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -116.14 124.53 50.56 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 124.331 1.053 . . . . 0.0 109.346 -176.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -102.88 143.84 31.96 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.16 1.384 . . . . 0.0 110.571 -178.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.39 128.9 11.4 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.616 0.766 . . . . 0.0 110.361 171.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.4 p -72.69 116.08 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 O-C-N 121.383 -0.823 . . . . 0.0 109.771 175.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.2 p -94.24 -27.6 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 124.767 1.227 . . . . 0.0 112.759 -175.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 25.4 ptp -162.3 147.02 12.39 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.411 1.085 . . . . 0.0 112.618 166.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -89.99 131.49 35.86 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.794 0.838 . . . . 0.0 110.311 178.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.253 1.258 0 N-CA-C 115.492 1.664 . . . . 0.0 115.492 -175.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 pmm? . . . . . 0 N--CA 1.497 1.879 0 CA-C-O 118.778 -0.63 . . . . 0.0 111.511 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -78.7 91.64 1.19 Allowed 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 123.324 2.683 . . . . 0.0 111.064 -177.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 35.3 m -141.13 152.64 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 124.931 1.292 . . . . 0.0 111.778 177.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 76.7 mtp85 -62.7 136.3 57.8 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.796 1.239 . . . . 0.0 111.857 177.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 33.6 ptt-85 -170.37 152.27 3.99 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 126.518 1.927 . . . . 0.0 111.903 -176.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.87 117.22 5.8 Favored Glycine 0 N--CA 1.472 1.096 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 168.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 22.9 t-80 -63.24 -45.56 91.02 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 117.978 0.889 . . . . 0.0 113.11 -170.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.3 p -167.23 141.59 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 125.007 1.323 . . . . 0.0 111.122 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -85.57 145.27 41.62 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 123.751 0.82 . . . . 0.0 110.46 167.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -67.26 158.31 57.59 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.771 2.314 . . . . 0.0 111.656 -179.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -151.22 158.74 44.3 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.717 1.207 . . . . 0.0 111.753 -173.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -80.82 59.7 3.8 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.994 1.718 . . . . 0.0 113.853 -171.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 42.2 p -49.82 -36.46 26.64 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 127.231 2.212 . . . . 0.0 113.969 -176.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -65.79 -50.01 66.23 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.671 0.788 . . . . 0.0 111.838 176.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 61.9 tp -64.9 -36.05 83.1 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.58 1.152 . . . . 0.0 111.299 176.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -59.96 -30.55 69.17 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.75 0.82 . . . . 0.0 112.638 177.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 44.4 m -71.6 -24.12 61.84 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.803 1.241 . . . . 0.0 111.48 173.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 11.1 mm -83.93 -43.97 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.216 1.007 . . . . 0.0 110.434 173.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 97.5 mt -54.31 -47.35 69.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.669 0.787 . . . . 0.0 110.531 177.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 32.9 ptt180 -69.7 -12.22 61.46 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -178.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -83.19 -34.43 25.95 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.441 1.096 . . . . 0.0 112.045 170.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -78.58 -33.77 47.4 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.257 1.023 . . . . 0.0 112.321 173.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -72.32 141.39 48.83 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.428 0.691 . . . . 0.0 111.94 173.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -99.54 -6.72 54.73 Favored Glycine 0 N--CA 1.476 1.317 0 C-N-CA 124.728 1.156 . . . . 0.0 114.114 172.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -89.77 63.28 6.06 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.174 1.39 . . . . 0.0 110.641 -172.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.6 t -77.02 40.98 0.27 Allowed 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 125.27 1.428 . . . . 0.0 112.858 178.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 12.0 mpt_? -91.62 -163.85 1.1 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 128.596 2.759 . . . . 0.0 110.363 177.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.0 mptt -86.2 132.65 33.96 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.102 1.361 . . . . 0.0 110.099 -178.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -163.14 164.24 25.38 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.258 1.023 . . . . 0.0 113.689 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 30.3 pt -144.37 154.53 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 126.736 2.014 . . . . 0.0 110.508 177.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 14.8 mt -120.0 130.71 73.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 125.907 1.683 . . . . 0.0 109.394 -178.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -130.49 145.26 51.82 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 124.485 1.114 . . . . 0.0 111.437 176.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -70.58 125.53 27.07 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 122.043 -0.41 . . . . 0.0 111.159 176.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.58 -29.82 66.35 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -177.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 56.3 mtm180 -80.03 36.66 0.35 Allowed 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.64 1.576 . . . . 0.0 112.86 -172.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 60.5 t -145.62 135.51 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 126.839 2.056 . . . . 0.0 108.87 -169.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -59.13 -45.08 91.87 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.14 0.976 . . . . 0.0 112.726 -174.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -82.79 -12.72 57.26 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 90.9 m 48.65 62.96 2.3 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.375 1.47 . . . . 0.0 111.283 -167.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.81 136.26 55.18 Favored 'General case' 0 CA--C 1.547 0.843 0 O-C-N 121.514 -0.741 . . . . 0.0 111.869 -177.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.2 t -64.23 126.43 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 122.996 0.518 . . . . 0.0 109.873 176.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.1 pt -104.35 -23.16 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.586 1.154 . . . . 0.0 112.49 174.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -147.41 140.65 25.25 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.534 0.733 . . . . 0.0 111.349 178.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.516 ' HB3' ' CE1' ' A' ' 48' ' ' PHE . 2.0 m -131.59 147.62 52.54 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.097 0.959 . . . . 0.0 111.558 -177.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -78.33 -173.24 3.19 Favored 'General case' 0 CA--C 1.554 1.118 0 CA-C-N 119.255 0.934 . . . . 0.0 111.752 172.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -98.71 -22.72 15.75 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.027 1.331 . . . . 0.0 112.353 171.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -73.37 -39.53 50.9 Favored Glycine 0 C--N 1.342 0.873 0 O-C-N 121.815 -0.553 . . . . 0.0 112.455 -177.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.516 ' CE1' ' HB3' ' A' ' 44' ' ' CYS . 0.4 OUTLIER -66.07 -32.32 73.72 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.256 0.623 . . . . 0.0 111.854 -179.345 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 91.2 m -51.29 -55.31 18.93 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.252 1.421 . . . . 0.0 111.587 174.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -71.75 -22.33 61.62 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.876 0.871 . . . . 0.0 113.032 -179.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.16 -52.68 62.87 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.11 1.364 . . . . 0.0 110.873 178.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 76.8 m -98.68 -21.2 16.55 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.51 2.23 58.84 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 125.035 1.302 . . . . 0.0 114.355 179.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -85.81 -152.43 0.16 Allowed 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 124.607 1.163 . . . . 0.0 112.102 171.072 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 80.8 p -157.11 168.87 26.17 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 120.478 -1.389 . . . . 0.0 111.928 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -52.07 -51.65 56.24 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 119.1 -0.476 . . . . 0.0 110.48 168.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.28 -32.45 56.29 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 119.39 0.996 . . . . 0.0 113.52 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -86.4 -39.42 16.4 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.009 0.924 . . . . 0.0 113.295 177.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 79.5 t -80.46 -12.75 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 124.674 1.189 . . . . 0.0 111.639 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 66.1 mmm -66.27 137.1 56.71 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 120.522 -1.361 . . . . 0.0 111.261 173.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 76.43 4.71 3.6 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 127.064 2.145 . . . . 0.0 113.531 -176.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 42.7 mtt180 -92.42 156.21 41.7 Favored Pre-proline 0 N--CA 1.476 0.851 0 C-N-CA 124.257 1.023 . . . . 0.0 112.412 -179.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -67.57 134.91 34.4 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.697 2.931 . . . . 0.0 110.585 170.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 5.1 t -66.97 -18.6 65.46 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -173.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 39.7 p -56.2 -30.05 61.76 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.304 1.442 . . . . 0.0 112.458 172.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 79.1 m 54.05 36.94 25.85 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.25 1.42 . . . . 0.0 112.357 -176.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -57.1 -30.64 64.53 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.85 1.26 . . . . 0.0 112.462 -176.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -58.8 -15.31 11.72 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.912 1.285 . . . . 0.0 114.193 175.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.2 mt -75.21 -6.2 48.46 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.579 1.152 . . . . 0.0 113.694 172.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -65.83 147.81 52.78 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 119.988 1.267 . . . . 0.0 112.492 173.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -125.97 -155.31 8.93 Favored Glycine 0 CA--C 1.537 1.447 0 C-N-CA 125.7 1.619 . . . . 0.0 111.071 165.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.25 -26.91 17.12 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 123.116 2.544 . . . . 0.0 113.712 179.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 53.7 ttm-85 -87.4 -15.35 38.04 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 119.327 0.967 . . . . 0.0 113.1 -177.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 19.8 m -65.07 134.66 54.3 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.311 1.444 . . . . 0.0 110.926 -176.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.438 ' HG3' ' CB ' ' A' ' 78' ' ' ALA . 5.9 pt20 -87.31 125.61 34.34 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -176.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 18.5 tpp85 -60.36 -35.24 75.22 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.206 1.003 . . . . 0.0 112.447 -178.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 24.6 tpp180 -60.23 -46.44 89.76 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.368 1.067 . . . . 0.0 111.715 174.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.438 ' CB ' ' HG3' ' A' ' 75' ' ' GLN . . . -69.46 -42.6 74.68 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 121.043 -1.036 . . . . 0.0 111.981 176.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.13 -35.03 64.25 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 173.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -74.67 -44.84 48.25 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.331 1.452 . . . . 0.0 112.999 173.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -59.16 -34.69 72.39 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 118.868 0.758 . . . . 0.0 111.538 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 86.6 mt -62.19 -37.44 78.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 CA-C-N 119.969 1.259 . . . . 0.0 112.198 172.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.8 -39.88 69.58 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 119.1 0.863 . . . . 0.0 112.143 174.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -64.88 -32.43 74.13 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.598 0.759 . . . . 0.0 111.867 175.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.47 -23.15 65.68 Favored 'General case' 0 CA--C 1.548 0.88 0 O-C-N 121.367 -0.833 . . . . 0.0 112.903 176.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 27.9 mt -85.94 -14.29 45.15 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.112 1.365 . . . . 0.0 113.258 174.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 80.8 mt -88.92 -17.59 29.24 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.139 0.976 . . . . 0.0 111.822 171.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -83.85 152.0 28.17 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 125.3 1.428 . . . . 0.0 112.696 175.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -99.51 11.69 38.46 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.905 1.282 . . . . 0.0 113.857 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -137.71 163.67 30.73 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.963 1.705 . . . . 0.0 111.834 -175.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.97 137.87 57.98 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.282 1.033 . . . . 0.0 111.767 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.69 124.97 10.85 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.297 1.039 . . . . 0.0 111.239 -175.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 43.3 mtmt -100.85 140.78 34.66 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.206 1.402 . . . . 0.0 112.271 171.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 46.2 t -136.44 136.56 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 126.094 1.758 . . . . 0.0 108.526 175.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -102.86 128.78 49.5 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.983 0.913 . . . . 0.0 110.647 178.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.2 tt -151.81 149.28 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.21 1.004 . . . . 0.0 112.207 -168.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -84.29 116.74 23.15 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 120.899 -1.125 . . . . 0.0 111.496 173.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 9.7 m-30 -103.08 140.9 36.71 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.419 1.488 . . . . 0.0 111.055 174.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -105.1 133.12 50.41 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.454 1.502 . . . . 0.0 111.813 178.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 73.9 mtp85 -77.37 163.16 26.67 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.667 1.587 . . . . 0.0 112.267 175.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -65.21 -23.65 67.14 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.722 1.209 . . . . 0.0 113.336 173.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -77.72 -7.7 56.9 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.841 1.257 . . . . 0.0 113.598 174.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 94.11 -1.83 68.05 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 125.425 1.488 . . . . 0.0 114.574 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 48.7 m -80.09 167.77 19.99 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 118.335 1.067 . . . . 0.0 111.756 175.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 20.5 p -148.35 170.33 18.19 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 120.886 -1.134 . . . . 0.0 113.399 176.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -170.21 166.52 8.86 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 126.258 1.823 . . . . 0.0 111.255 -178.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -79.35 123.0 27.07 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.16 0.505 . . . . 0.0 111.103 170.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 6.0 m -106.84 136.46 46.63 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.051 1.74 . . . . 0.0 110.1 168.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 19.0 tp -86.47 123.18 31.4 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 125.033 1.333 . . . . 0.0 107.602 162.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 91.6 t -103.61 117.94 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 169.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -112.16 107.11 15.89 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 126.462 1.905 . . . . 0.0 108.54 177.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 69.7 t -80.67 125.65 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 172.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 45.0 t -109.06 110.62 60.72 Favored Pre-proline 0 C--N 1.328 -0.359 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 169.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.41 132.79 16.68 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.559 2.172 . . . . 0.0 109.546 176.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 73.1 t -99.91 120.75 49.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 172.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 68.9 mttt -92.94 154.99 17.85 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.651 0.78 . . . . 0.0 112.698 171.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -93.66 -173.64 3.23 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.105 0.962 . . . . 0.0 111.641 174.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -61.04 -22.01 64.16 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.015 1.326 . . . . 0.0 114.152 178.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -90.3 -5.4 56.32 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.783 1.233 . . . . 0.0 113.043 178.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 79.32 20.62 69.06 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 124.455 1.026 . . . . 0.0 114.388 -178.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -99.63 146.21 26.72 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.94 1.296 . . . . 0.0 109.621 173.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 61.5 t -76.79 125.34 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 177.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 3.0 pt -121.28 -21.79 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 C-N-CA 124.905 1.282 . . . . 0.0 113.981 -172.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 44.7 mtm -145.52 151.35 38.01 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.72 1.608 . . . . 0.0 110.478 177.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -114.33 129.61 56.65 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 124.595 1.158 . . . . 0.0 109.084 169.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 33.5 mt -99.09 117.45 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 165.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -94.91 117.4 30.07 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 174.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -104.32 127.09 51.91 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 123.259 0.349 . . . . 0.0 111.476 176.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 13.7 m-30 -102.93 134.65 46.0 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.372 1.469 . . . . 0.0 111.146 -179.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -141.83 112.33 7.1 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.71 1.204 . . . . 0.0 109.092 176.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.7 p -64.46 112.7 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 O-C-N 121.186 -0.946 . . . . 0.0 109.399 173.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.0 p -98.83 -26.61 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.511 1.524 . . . . 0.0 112.954 -167.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 24.3 ptp -161.14 154.26 21.3 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.879 1.272 . . . . 0.0 111.241 166.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -77.12 156.48 31.63 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 122.126 0.965 . . . . 0.0 111.713 175.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.455 ' HA ' ' HE3' ' A' ' 135' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.288 0 C-N-CA 125.743 1.617 . . . . 0.0 112.822 161.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.496 1.869 0 CA-C-O 118.874 -0.584 . . . . 0.0 110.992 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -73.67 173.57 13.69 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 123.829 3.019 . . . . 0.0 111.748 173.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 8.5 p -152.39 128.33 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 123.751 0.82 . . . . 0.0 111.252 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 7.3 ppt_? -85.96 -23.29 26.97 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 114.252 1.204 . . . . 0.0 114.252 -175.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 81.8 mtp180 -74.37 142.83 45.04 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.633 1.173 . . . . 0.0 111.595 -178.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -164.9 159.8 32.93 Favored Glycine 0 N--CA 1.47 0.96 0 C-N-CA 124.753 1.168 . . . . 0.0 113.5 178.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 65.4 t60 -160.03 147.99 16.81 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.627 1.571 . . . . 0.0 110.6 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.9 p -165.14 146.09 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 125.557 1.543 . . . . 0.0 110.157 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.25 147.37 98.63 Favored Pre-proline 0 CA--C 1.553 1.082 0 C-N-CA 123.405 0.682 . . . . 0.0 111.646 174.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -67.12 128.88 19.37 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.025 2.484 . . . . 0.0 110.58 -178.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 27.2 mp0 -81.45 155.75 25.7 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.286 1.034 . . . . 0.0 111.742 -176.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -79.77 47.75 0.88 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.292 1.437 . . . . 0.0 113.509 179.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 46.6 p -50.15 -35.76 27.36 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 127.882 2.473 . . . . 0.0 114.398 -171.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -64.49 -50.73 66.3 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.517 0.727 . . . . 0.0 111.491 176.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 60.8 tp -65.59 -37.97 88.16 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.56 1.144 . . . . 0.0 111.312 175.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -61.34 -29.03 69.64 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.153 0.981 . . . . 0.0 112.409 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 29.3 m -71.25 -25.65 62.56 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.823 1.249 . . . . 0.0 111.455 173.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.8 mm -82.38 -43.14 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.932 0.893 . . . . 0.0 110.252 173.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 97.0 mt -56.22 -44.25 78.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 123.628 0.771 . . . . 0.0 110.804 177.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 49.9 ptt85 -70.73 -19.64 62.72 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -78.47 -36.88 44.64 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.036 0.934 . . . . 0.0 111.766 169.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -79.53 -37.32 36.83 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.731 1.212 . . . . 0.0 112.525 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.44 ' HG3' ' H ' ' A' ' 25' ' ' GLN . 10.7 pt-20 -87.11 158.23 19.22 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -171.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -94.72 13.74 66.62 Favored Glycine 0 N--CA 1.477 1.408 0 C-N-CA 125.554 1.549 . . . . 0.0 114.637 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.44 ' H ' ' HG3' ' A' ' 23' ' ' GLU . 56.8 mm-40 -83.49 55.02 3.03 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.447 1.499 . . . . 0.0 111.441 -175.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.1 m -70.69 -3.69 19.82 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.041 1.336 . . . . 0.0 114.189 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -79.59 170.12 17.02 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.226 1.411 . . . . 0.0 111.705 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.5 mptt -90.99 137.22 32.53 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.388 1.075 . . . . 0.0 111.133 -174.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -165.16 162.59 20.15 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.01 1.324 . . . . 0.0 113.329 175.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 14.7 pt -142.18 152.4 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 126.295 1.838 . . . . 0.0 110.662 174.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 11.8 mt -108.61 130.46 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 125.973 1.709 . . . . 0.0 108.977 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -129.0 142.27 50.97 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 124.98 1.312 . . . . 0.0 110.975 177.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -70.36 125.7 27.54 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.75 -0.593 . . . . 0.0 111.087 177.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.39 -31.86 64.13 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.545 0.738 . . . . 0.0 112.355 -178.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 27.7 mmm180 -80.46 37.29 0.39 Allowed 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.922 1.689 . . . . 0.0 112.682 -174.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 98.4 t -143.93 134.78 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 126.911 2.084 . . . . 0.0 108.719 -172.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -56.13 -35.11 66.74 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 115.324 1.602 . . . . 0.0 115.324 -170.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -105.77 -2.33 23.32 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.287 1.435 . . . . 0.0 113.091 -178.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 89.6 m 50.43 68.78 0.71 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 126.074 1.75 . . . . 0.0 112.303 -174.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.22 137.94 57.33 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.04 0.936 . . . . 0.0 112.111 -178.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 37.1 t -65.21 123.75 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 123.587 0.755 . . . . 0.0 109.354 174.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 44.8 pt -103.92 -19.59 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 125.125 1.37 . . . . 0.0 112.52 176.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -156.42 145.64 20.53 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.233 1.013 . . . . 0.0 111.658 178.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 4.7 m -125.7 158.53 34.59 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.359 1.064 . . . . 0.0 112.341 176.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -74.87 -152.37 0.03 OUTLIER 'General case' 0 CA--C 1.559 1.306 0 CA-C-N 118.524 0.602 . . . . 0.0 111.167 166.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -115.05 -21.55 9.97 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.325 1.45 . . . . 0.0 113.215 165.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -74.85 -35.21 51.14 Favored Glycine 0 N--CA 1.471 1.012 0 C-N-CA 124.12 0.867 . . . . 0.0 112.813 -178.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -58.03 -37.31 74.12 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 124.837 1.255 . . . . 0.0 111.861 177.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 38.4 t -58.91 -52.0 67.61 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.405 1.482 . . . . 0.0 111.499 174.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -70.68 -25.97 63.22 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -179.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 38.6 tp -62.87 -40.54 97.83 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.376 1.07 . . . . 0.0 111.973 172.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 50.2 m -106.73 -32.08 8.14 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 115.054 1.502 . . . . 0.0 115.054 -168.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.61 9.51 66.46 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 125.932 1.729 . . . . 0.0 114.437 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -86.17 -144.85 0.11 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 124.609 1.164 . . . . 0.0 111.591 170.17 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 13.3 t -163.6 167.06 21.75 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.986 1.314 . . . . 0.0 111.065 169.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -54.65 -44.24 73.07 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.582 0.753 . . . . 0.0 110.801 176.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.23 -28.03 50.33 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 176.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -91.18 -39.18 12.26 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.982 1.313 . . . . 0.0 111.83 177.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 99.5 t -80.27 -17.6 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 125.671 1.588 . . . . 0.0 112.295 -177.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 80.9 mtp -61.55 133.13 55.32 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 120.85 -1.156 . . . . 0.0 111.309 170.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 23.7 tp60 74.05 3.67 4.45 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 127.08 2.152 . . . . 0.0 113.731 -178.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 33.2 mmt180 -84.55 151.46 58.82 Favored Pre-proline 0 N--CA 1.473 0.686 0 O-C-N 121.016 -1.052 . . . . 0.0 110.934 178.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.83 132.98 24.34 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.526 2.151 . . . . 0.0 109.598 169.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 32.0 p -66.76 -7.55 22.02 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 -176.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 41.3 p -59.7 -27.1 66.15 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.353 1.461 . . . . 0.0 112.536 168.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 67.5 m 57.23 40.56 27.88 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.022 1.329 . . . . 0.0 112.707 178.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -56.51 -29.77 62.22 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.361 1.464 . . . . 0.0 113.006 -175.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 29.2 p90 -62.26 -16.8 55.99 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.806 1.242 . . . . 0.0 114.107 175.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 87.8 mt -79.08 -10.42 59.82 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 174.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.412 ' CD2' HG21 ' A' ' 74' ' ' THR . 47.2 m170 -69.44 118.78 12.74 Favored 'General case' 0 CA--C 1.546 0.827 0 CA-C-N 119.597 1.09 . . . . 0.0 111.402 -177.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -100.98 -163.14 27.75 Favored Glycine 0 CA--C 1.539 1.556 0 C-N-CA 126.166 1.841 . . . . 0.0 112.129 173.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -70.58 -28.41 21.34 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 123.153 2.569 . . . . 0.0 113.149 -179.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 30.4 tpt180 -84.61 -17.35 38.98 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.412 HG21 ' CD2' ' A' ' 70' ' ' HIS . 50.6 m -60.43 132.55 54.25 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.95 1.3 . . . . 0.0 111.876 -170.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 22.9 mp0 -85.26 111.59 19.99 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.546 1.138 . . . . 0.0 110.404 -171.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 -58.24 -33.86 69.81 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.59 0.756 . . . . 0.0 112.463 177.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 21.5 tpp180 -62.03 -39.91 93.93 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.591 1.157 . . . . 0.0 112.244 175.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -77.01 -41.46 42.64 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.526 1.13 . . . . 0.0 112.31 176.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -53.15 -33.36 52.12 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 118.842 0.747 . . . . 0.0 112.797 175.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.01 -41.3 82.4 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 124.969 1.308 . . . . 0.0 112.712 172.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 80.3 mm-40 -64.38 -32.6 74.28 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 118.507 -0.758 . . . . 0.0 111.48 178.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 45.9 mt -59.33 -41.35 83.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 CA-C-N 119.56 1.073 . . . . 0.0 110.586 170.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.16 -35.08 68.93 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 176.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 71.6 mm-40 -64.66 -35.58 81.49 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.439 -0.788 . . . . 0.0 111.446 172.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.15 -21.35 63.69 Favored 'General case' 0 CA--C 1.549 0.922 0 O-C-N 121.383 -0.823 . . . . 0.0 113.189 178.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 57.6 mt -87.9 -11.14 48.55 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 125.925 1.69 . . . . 0.0 114.009 178.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.7 pp -103.94 -2.73 25.7 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 170.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -90.3 144.22 17.38 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 125.039 1.305 . . . . 0.0 112.564 175.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.9 -2.12 58.12 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.7 1.2 . . . . 0.0 113.931 176.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -124.09 159.27 30.34 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.035 1.734 . . . . 0.0 110.739 -174.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 46.4 mp0 -57.28 135.88 56.49 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.522 1.129 . . . . 0.0 111.708 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.58 121.23 11.83 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.229 1.011 . . . . 0.0 110.322 -173.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt -105.05 142.81 34.17 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.358 1.463 . . . . 0.0 111.7 178.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 61.8 t -138.29 131.74 41.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 125.858 1.663 . . . . 0.0 108.91 -177.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -103.88 129.76 51.41 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.682 0.793 . . . . 0.0 110.811 177.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.3 tt -159.78 142.75 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 123.553 0.741 . . . . 0.0 112.149 -166.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -86.38 121.73 29.35 Favored 'General case' 0 N--CA 1.465 0.303 0 O-C-N 121.405 -0.809 . . . . 0.0 110.83 174.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -109.63 154.89 22.16 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.63 1.172 . . . . 0.0 111.844 172.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -113.79 130.85 56.4 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.796 1.638 . . . . 0.0 110.52 175.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 14.8 mmt180 -106.42 166.17 10.73 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.438 1.495 . . . . 0.0 112.811 -168.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -61.14 -26.41 67.66 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.153 0.981 . . . . 0.0 113.59 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -69.77 -9.66 55.39 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.162 1.385 . . . . 0.0 113.813 178.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 87.67 0.85 83.66 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 124.999 1.285 . . . . 0.0 113.241 -171.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 18.4 m -85.95 154.15 21.68 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.159 1.383 . . . . 0.0 111.855 179.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 31.1 p -133.04 153.8 51.14 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.778 0.831 . . . . 0.0 111.513 166.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 19.3 p90 -167.82 157.6 10.18 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 125.053 1.341 . . . . 0.0 112.814 -177.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -75.81 119.49 19.88 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.514 1.126 . . . . 0.0 110.514 176.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 26.8 t -103.74 144.86 30.91 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 125.607 1.563 . . . . 0.0 110.462 172.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 8.7 tp -98.4 112.95 24.79 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 162.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 46.6 t -92.64 115.56 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 124.794 1.238 . . . . 0.0 107.812 171.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -112.98 109.53 19.0 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 124.758 1.223 . . . . 0.0 107.777 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.426 HG22 HD13 ' A' ' 127' ' ' LEU . 79.4 t -82.36 128.95 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 172.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 55.2 t -111.37 112.38 54.62 Favored Pre-proline 0 CA--C 1.536 0.41 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 171.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -74.36 129.24 12.75 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 123.246 2.631 . . . . 0.0 109.88 178.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 80.2 t -102.13 118.66 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 123.9 0.88 . . . . 0.0 108.887 176.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 60.7 mttt -87.84 152.71 21.89 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.583 0.753 . . . . 0.0 112.397 172.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -91.17 -173.76 3.74 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.25 1.02 . . . . 0.0 111.519 175.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -60.31 -21.8 62.44 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.999 1.319 . . . . 0.0 114.394 178.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -90.84 -5.51 55.49 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.14 1.376 . . . . 0.0 113.023 178.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 80.58 22.2 62.65 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 124.403 1.001 . . . . 0.0 114.522 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -107.92 148.6 29.41 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.18 1.392 . . . . 0.0 109.904 172.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.1 p -80.15 126.27 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 123.654 0.782 . . . . 0.0 110.704 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.7 -23.28 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -174.074 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 55.4 mtm -130.25 150.9 51.29 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.028 1.331 . . . . 0.0 112.038 169.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -110.51 134.46 52.35 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 125.41 1.484 . . . . 0.0 109.189 167.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 72.6 mt -98.1 116.98 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 163.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.426 HD13 HG22 ' A' ' 112' ' ' VAL . 1.4 mm? -89.56 118.52 29.25 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 105.685 -1.968 . . . . 0.0 105.685 169.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -103.91 143.45 32.83 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 119.219 -0.42 . . . . 0.0 110.763 173.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -119.6 135.37 54.83 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.594 1.158 . . . . 0.0 110.434 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -138.41 150.49 46.57 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 125.541 1.536 . . . . 0.0 108.29 173.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.2 t -94.23 112.72 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.7 p -91.88 -25.75 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -177.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 32.0 ttm -165.44 124.93 1.75 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.589 1.156 . . . . 0.0 110.813 -175.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -84.33 128.11 34.38 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.584 -0.697 . . . . 0.0 110.481 175.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.457 ' HA ' ' HE2' ' A' ' 135' ' ' LYS . 7.8 mmpt? . . . . . 0 C--O 1.252 1.231 0 CA-C-O 117.644 -1.17 . . . . 0.0 113.11 174.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 N--CA 1.495 1.82 0 CA-C-O 118.748 -0.644 . . . . 0.0 110.823 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -72.76 159.48 48.38 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 123.717 2.945 . . . . 0.0 111.867 177.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 40.2 t -138.18 134.95 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 124.923 1.289 . . . . 0.0 109.462 179.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.73 36.33 1.54 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.502 1.521 . . . . 0.0 113.419 -175.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 -118.51 155.0 31.6 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 126.354 1.862 . . . . 0.0 111.115 178.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -87.96 98.02 2.36 Favored Glycine 0 N--CA 1.473 1.104 0 C-N-CA 124.731 1.158 . . . . 0.0 112.464 -176.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 32.6 p80 -167.07 167.43 14.51 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 126.52 1.928 . . . . 0.0 110.839 175.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 86.9 t -73.67 142.23 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 123.39 0.676 . . . . 0.0 109.785 171.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -154.66 159.88 31.45 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 126.405 1.882 . . . . 0.0 109.947 178.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -67.91 106.21 1.28 Allowed 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.779 2.319 . . . . 0.0 109.787 174.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -80.13 166.91 21.01 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.689 1.196 . . . . 0.0 111.608 178.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -68.85 147.22 52.04 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 121.611 -0.68 . . . . 0.0 111.309 172.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 40.5 p -116.24 -38.89 3.49 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.772 1.629 . . . . 0.0 112.818 -174.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -79.94 -47.29 15.25 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.979 0.912 . . . . 0.0 112.076 177.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 69.3 tp -61.02 -35.15 76.11 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.522 0.729 . . . . 0.0 110.968 177.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -55.18 -28.8 55.55 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 176.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 36.5 m -70.69 -27.61 64.14 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.623 1.169 . . . . 0.0 111.484 174.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 15.4 mm -79.44 -34.77 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 124.265 1.026 . . . . 0.0 109.801 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.9 mp -53.88 -40.22 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 123.265 0.626 . . . . 0.0 110.735 170.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 24.2 mmm-85 -63.46 -29.75 70.98 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 119.058 0.845 . . . . 0.0 112.627 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -73.91 -39.01 64.15 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.353 1.061 . . . . 0.0 111.438 174.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -76.71 -21.88 54.69 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.67 1.188 . . . . 0.0 113.189 178.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -62.18 -15.41 46.15 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 168.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -76.07 43.42 1.72 Allowed Glycine 0 CA--C 1.532 1.113 0 C-N-CA 126.531 2.015 . . . . 0.0 112.969 174.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.4 tp-100 78.89 13.98 1.22 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 127.484 2.313 . . . . 0.0 113.196 171.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 8.6 m -80.99 -5.72 57.91 Favored 'General case' 0 N--CA 1.476 0.868 0 O-C-N 120.384 -1.447 . . . . 0.0 113.758 -173.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 9.3 mmt180 -81.2 171.44 14.87 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.519 1.128 . . . . 0.0 113.148 -175.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -107.66 133.37 52.19 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.861 1.264 . . . . 0.0 110.671 177.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -161.48 158.72 27.0 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 124.333 1.053 . . . . 0.0 112.908 177.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.5 pt -140.46 149.19 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 125.58 1.552 . . . . 0.0 110.767 176.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.1 mp -109.45 127.63 66.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 C-N-CA 125.914 1.685 . . . . 0.0 108.86 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -126.23 140.22 52.72 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 124.827 1.251 . . . . 0.0 111.23 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -71.43 121.79 19.23 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 122.729 0.412 . . . . 0.0 110.818 177.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.94 -28.64 61.61 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.335 0.654 . . . . 0.0 112.461 -178.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 -77.9 37.83 0.25 Allowed 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 126.084 1.753 . . . . 0.0 112.675 -178.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 98.0 t -145.19 136.55 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 127.042 2.137 . . . . 0.0 108.572 -172.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -54.84 -34.42 62.84 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 115.554 1.687 . . . . 0.0 115.554 -170.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -107.49 -0.15 22.37 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.241 1.416 . . . . 0.0 113.136 -178.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 99.4 m 53.83 71.67 0.49 Allowed 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.988 1.715 . . . . 0.0 111.984 -171.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.85 131.07 44.53 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.017 0.927 . . . . 0.0 112.168 -176.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 41.3 t -64.47 123.29 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 123.86 0.864 . . . . 0.0 109.254 172.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 38.3 pt -104.95 -19.04 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 124.869 1.268 . . . . 0.0 112.362 178.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -158.91 141.28 14.01 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.67 1.188 . . . . 0.0 111.145 -178.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 4.0 m -122.63 166.41 14.9 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 121.224 -0.922 . . . . 0.0 112.397 172.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -74.74 -151.64 0.03 OUTLIER 'General case' 0 CA--C 1.557 1.237 0 C-N-CA 122.51 0.324 . . . . 0.0 111.613 169.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -113.56 -22.5 10.27 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 120.472 -1.392 . . . . 0.0 113.2 163.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -74.44 -33.88 55.41 Favored Glycine 0 N--CA 1.47 0.941 0 O-C-N 121.355 -0.841 . . . . 0.0 112.876 -177.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -57.35 -37.84 73.21 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.673 1.189 . . . . 0.0 111.624 176.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 10.2 t -60.85 -53.05 62.11 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.354 1.462 . . . . 0.0 111.61 175.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -71.01 -25.21 62.58 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -178.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 31.8 tp -62.02 -45.23 94.52 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.609 1.164 . . . . 0.0 111.648 170.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 64.2 m -104.65 -32.55 8.86 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 -166.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.05 4.54 63.03 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 126.017 1.77 . . . . 0.0 114.541 -179.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -83.79 -156.22 0.21 Allowed 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 124.814 1.246 . . . . 0.0 112.185 170.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 9.5 t -152.17 168.77 24.26 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 120.286 -1.509 . . . . 0.0 111.135 170.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.1 ttp180 -58.63 -45.5 89.1 Favored 'General case' 0 C--O 1.22 -0.472 0 O-C-N 121.535 -0.728 . . . . 0.0 111.812 -173.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.44 -25.72 37.97 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 175.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -88.56 -39.14 14.35 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.746 1.218 . . . . 0.0 111.645 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 84.4 t -85.67 -24.48 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 125.053 1.341 . . . . 0.0 112.376 -177.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 86.6 mtp -63.44 139.11 58.74 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 120.979 -1.076 . . . . 0.0 110.819 171.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 13.7 tm0? 75.65 -4.1 2.44 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 126.789 2.036 . . . . 0.0 113.784 -177.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 36.9 mmt180 -79.32 157.33 75.49 Favored Pre-proline 0 N--CA 1.473 0.687 0 C-N-CA 124.657 1.183 . . . . 0.0 111.088 173.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -67.22 136.23 39.76 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.398 2.065 . . . . 0.0 109.999 166.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 26.7 p -68.01 -2.2 7.22 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 -179.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 57.1 p -65.32 -29.42 70.16 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.578 1.551 . . . . 0.0 112.231 169.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 74.2 m 58.32 42.76 21.07 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.585 1.554 . . . . 0.0 112.517 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -57.73 -27.01 62.6 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.858 1.263 . . . . 0.0 113.209 -176.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -61.71 -16.21 47.14 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.546 1.138 . . . . 0.0 113.927 174.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 79.9 mt -83.73 -11.45 57.13 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.365 1.066 . . . . 0.0 113.78 172.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 40.0 m170 -73.11 115.45 12.45 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 119.823 1.192 . . . . 0.0 110.65 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -101.66 -162.63 27.03 Favored Glycine 0 CA--C 1.539 1.576 0 C-N-CA 126.157 1.836 . . . . 0.0 112.464 177.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -70.07 -25.79 26.8 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 123.133 2.555 . . . . 0.0 113.132 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.2 tpm_? -82.75 -17.51 44.01 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.883 0.873 . . . . 0.0 113.195 179.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 40.9 m -65.96 138.95 58.17 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.991 1.316 . . . . 0.0 112.384 -168.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 22.3 mp0 -84.48 117.99 24.02 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.338 1.455 . . . . 0.0 110.545 -172.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -60.25 -33.76 72.76 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -177.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 36.6 mmt180 -63.4 -53.27 55.0 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.397 0.679 . . . . 0.0 111.202 172.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.8 -36.89 84.78 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 120.491 -1.381 . . . . 0.0 113.09 -178.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -54.69 -35.49 63.66 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.848 0.859 . . . . 0.0 112.378 171.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -76.81 -45.7 27.67 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 124.555 1.142 . . . . 0.0 112.527 173.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -58.46 -36.94 74.47 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 118.809 0.732 . . . . 0.0 111.15 -176.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 89.3 mt -61.18 -40.17 84.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 CA-C-N 119.825 1.193 . . . . 0.0 111.845 173.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.43 -37.11 68.68 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.526 0.731 . . . . 0.0 112.65 176.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 54.8 mm-40 -67.82 -33.26 74.44 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.987 0.915 . . . . 0.0 111.469 174.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -57.98 -26.02 61.8 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 121.19 -0.944 . . . . 0.0 113.105 178.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 55.3 mt -78.58 -18.13 55.07 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.737 1.615 . . . . 0.0 113.545 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.1 pp -83.38 -20.69 33.75 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 119.473 1.033 . . . . 0.0 112.1 173.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -81.38 154.87 35.27 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 125.075 1.322 . . . . 0.0 112.85 176.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -95.5 1.31 53.9 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.882 1.273 . . . . 0.0 114.214 -178.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -126.91 161.12 29.04 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.179 1.792 . . . . 0.0 111.725 -169.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -62.49 141.67 58.3 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.072 1.349 . . . . 0.0 112.304 -177.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 -152.19 125.54 8.76 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.818 0.847 . . . . 0.0 112.86 -171.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 44.3 mtmt -101.24 139.02 37.49 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.204 1.402 . . . . 0.0 111.592 171.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 67.7 t -134.16 143.66 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 126.082 1.753 . . . . 0.0 108.166 170.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -114.48 136.18 53.29 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.461 1.104 . . . . 0.0 110.9 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.1 tt -161.57 146.45 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 123.561 0.744 . . . . 0.0 112.659 -163.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -84.49 122.35 28.86 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 121.02 -1.05 . . . . 0.0 111.047 172.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 14.7 m-30 -108.42 147.01 32.23 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.232 1.413 . . . . 0.0 112.091 173.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -109.18 132.45 54.11 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.138 1.775 . . . . 0.0 110.627 177.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -107.08 160.23 15.71 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.718 1.607 . . . . 0.0 112.116 -166.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -64.28 -22.93 67.12 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -177.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -76.23 -7.25 54.46 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 124.633 1.173 . . . . 0.0 113.387 175.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 94.97 0.11 64.03 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 125.725 1.631 . . . . 0.0 114.28 -178.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 59.2 m -88.63 162.16 16.49 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.575 1.15 . . . . 0.0 112.421 179.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 26.5 p -138.27 155.64 48.42 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 121.147 -0.971 . . . . 0.0 112.031 168.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -166.04 157.07 13.33 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.982 1.313 . . . . 0.0 112.796 -176.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -75.49 123.04 24.77 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.803 0.811 . . . . 0.0 110.754 177.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 9.0 t -109.93 138.55 46.15 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.312 1.845 . . . . 0.0 109.681 174.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.545 HD13 ' N ' ' A' ' 110' ' ' VAL . 1.2 tm? -83.19 140.46 32.56 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 156.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.545 ' N ' HD13 ' A' ' 109' ' ' LEU . 13.8 t -124.01 112.36 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 125.336 1.454 . . . . 0.0 108.625 169.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -103.36 121.87 43.66 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.978 1.311 . . . . 0.0 109.994 172.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.1 p -91.48 124.38 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 166.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 81.6 t -109.02 111.79 60.35 Favored Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 175.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.31 130.34 13.94 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.875 2.383 . . . . 0.0 109.95 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 63.7 t -101.72 124.25 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 124.096 0.959 . . . . 0.0 108.604 173.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 35.1 mttp -98.09 153.75 18.21 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 175.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -93.11 -174.58 3.6 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.166 0.986 . . . . 0.0 111.294 176.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -59.82 -21.73 61.28 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.039 1.335 . . . . 0.0 114.421 178.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -91.4 -6.04 53.48 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.115 1.366 . . . . 0.0 113.181 179.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 78.62 25.63 60.38 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 124.239 0.923 . . . . 0.0 114.142 -178.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -108.53 152.22 25.03 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.198 1.399 . . . . 0.0 109.899 172.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 10.6 t -80.56 125.77 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 123.306 0.642 . . . . 0.0 109.318 -179.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.8 -24.83 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -176.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 56.6 mtm -130.76 152.91 49.6 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.558 1.143 . . . . 0.0 112.374 167.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -113.26 134.3 54.67 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 125.721 1.608 . . . . 0.0 109.172 168.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 46.1 mt -101.76 117.9 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 165.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -100.16 128.38 46.25 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 106.895 -1.521 . . . . 0.0 106.895 173.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -123.3 130.04 52.18 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.43 1.092 . . . . 0.0 110.313 -172.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -106.38 137.7 43.89 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.889 1.276 . . . . 0.0 111.08 -174.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -142.76 133.09 24.76 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.846 1.258 . . . . 0.0 109.463 177.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 59.4 t -80.27 115.29 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 5.2 p -97.94 -28.85 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -176.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 25.4 ptp -164.13 148.87 10.15 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.367 1.067 . . . . 0.0 113.337 167.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -90.91 130.3 36.86 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.036 0.934 . . . . 0.0 110.741 178.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.255 1.344 0 CA-C-O 115.806 -2.045 . . . . 0.0 115.587 -176.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.2 mtt . . . . . 0 N--CA 1.496 1.856 0 CA-C-O 116.428 -1.749 . . . . 0.0 112.23 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -70.19 151.91 66.82 Favored 'Trans proline' 0 C--N 1.357 1.017 0 C-N-CA 122.432 2.088 . . . . 0.0 111.568 177.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 57.2 t -93.07 127.59 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 123.942 0.897 . . . . 0.0 109.774 -178.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 31.2 mmm180 -89.65 54.38 2.86 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.347 1.459 . . . . 0.0 111.7 -179.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 75.7 ttt-85 -64.21 140.56 58.88 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.459 1.503 . . . . 0.0 111.85 -177.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 145.47 163.72 10.34 Favored Glycine 0 N--CA 1.474 1.173 0 C-N-CA 125.509 1.528 . . . . 0.0 113.647 179.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 60.3 m80 -141.54 170.67 15.28 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 125.917 1.687 . . . . 0.0 111.147 -178.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.5 p -59.6 139.74 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 123.778 0.831 . . . . 0.0 112.23 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.62 153.13 95.53 Favored Pre-proline 0 CA--C 1.552 1.035 0 C-N-CA 124.063 0.945 . . . . 0.0 112.005 174.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -66.69 151.64 82.23 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.91 2.407 . . . . 0.0 111.245 176.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 72.8 mm-40 -66.45 160.27 25.29 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.839 0.856 . . . . 0.0 112.503 177.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -82.72 46.52 1.09 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.27 1.428 . . . . 0.0 113.351 -173.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 57.4 p -51.13 -33.68 27.62 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 127.419 2.287 . . . . 0.0 113.572 -174.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -64.76 -53.96 38.88 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.989 0.915 . . . . 0.0 111.783 173.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 58.8 tp -60.7 -35.96 77.6 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.612 1.165 . . . . 0.0 111.175 176.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -62.31 -26.03 68.19 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 177.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 99.2 m -75.55 -28.13 58.9 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.554 1.141 . . . . 0.0 111.245 171.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 16.1 mm -77.68 -41.76 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 O-C-N 121.417 -0.802 . . . . 0.0 110.702 174.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 90.1 mt -56.19 -48.47 79.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 123.994 0.917 . . . . 0.0 110.564 177.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 16.2 ptp180 -67.08 -23.96 65.91 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -75.94 -33.46 59.82 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 119.523 1.056 . . . . 0.0 112.615 170.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -76.45 -32.01 58.17 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.533 1.133 . . . . 0.0 111.908 175.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -63.45 129.94 42.32 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 118.602 0.637 . . . . 0.0 111.322 172.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.73 8.59 84.55 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 124.457 1.027 . . . . 0.0 115.222 177.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 25.8 tp60 -83.82 52.95 2.41 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.564 1.545 . . . . 0.0 111.952 -171.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 67.8 m -89.04 0.75 56.42 Favored 'General case' 0 N--CA 1.48 1.038 0 O-C-N 120.938 -1.101 . . . . 0.0 113.434 -179.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 6.0 mmt-85 -79.8 177.62 8.77 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.015 1.326 . . . . 0.0 113.075 -176.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.2 mptt -94.08 133.98 36.99 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.947 1.299 . . . . 0.0 110.412 178.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -163.27 161.88 24.97 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.482 1.113 . . . . 0.0 112.805 177.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.2 pt -139.74 158.61 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 126.06 1.744 . . . . 0.0 110.521 173.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 28.3 mt -118.54 132.97 66.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 125.601 1.56 . . . . 0.0 108.868 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -131.33 143.26 50.38 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.349 1.059 . . . . 0.0 111.585 176.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -72.15 123.76 23.58 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.246 0.618 . . . . 0.0 111.489 179.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -79.03 -21.16 47.31 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -178.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 63.7 mtp85 -75.97 28.28 0.11 Allowed 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 126.185 1.794 . . . . 0.0 113.367 -173.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.4 t -151.09 137.64 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 127.114 2.165 . . . . 0.0 108.426 -166.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -63.35 -39.93 95.88 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -175.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 24.9 p30 -81.68 -15.21 55.2 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 114.377 1.251 . . . . 0.0 114.377 179.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 86.2 m 51.56 56.57 7.68 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.439 1.496 . . . . 0.0 113.351 -176.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.87 138.47 55.69 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 12.7 t -60.41 125.07 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 170.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 42.4 pt -104.93 -18.59 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 124.871 1.268 . . . . 0.0 112.619 174.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -156.16 144.99 20.31 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.091 0.956 . . . . 0.0 111.855 177.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 8.1 m -123.94 154.66 39.43 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.294 1.038 . . . . 0.0 110.588 171.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -73.15 -149.16 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.288 0 CA-C-N 118.958 0.799 . . . . 0.0 111.885 172.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -115.66 -22.67 9.08 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 120.248 -1.533 . . . . 0.0 112.885 164.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -74.5 -33.84 55.32 Favored Glycine 0 C--N 1.343 0.962 0 C-N-CA 124.231 0.919 . . . . 0.0 112.791 -178.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -56.94 -38.17 72.54 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.319 1.048 . . . . 0.0 111.292 176.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 51.2 t -59.01 -51.56 69.55 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.108 1.363 . . . . 0.0 111.659 178.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -67.56 -20.28 65.38 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.925 0.89 . . . . 0.0 113.093 178.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.06 -35.56 81.53 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.622 1.169 . . . . 0.0 112.4 176.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 45.4 m -123.09 -24.1 4.79 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 115.578 1.696 . . . . 0.0 115.578 -176.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 87.9 15.46 61.19 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-N 119.77 1.168 . . . . 0.0 114.075 -177.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -85.59 -144.63 0.1 Allowed 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.699 1.199 . . . . 0.0 111.338 170.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 77.8 p -158.22 165.94 33.61 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 124.771 1.228 . . . . 0.0 111.765 174.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 44.8 ttm180 -54.83 -47.3 74.29 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 118.889 -0.577 . . . . 0.0 110.606 171.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.65 -32.58 52.04 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 119.611 1.096 . . . . 0.0 113.932 177.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -89.08 -34.53 16.73 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.942 0.897 . . . . 0.0 113.258 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 99.5 t -84.43 -14.39 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.278 1.031 . . . . 0.0 112.035 178.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 79.5 mmm -76.95 147.38 36.96 Favored 'General case' 0 N--CA 1.474 0.725 0 O-C-N 120.841 -1.162 . . . . 0.0 111.977 175.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 31.8 tp60 69.19 4.42 4.57 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 126.451 1.9 . . . . 0.0 113.433 -175.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 32.3 mmt180 -77.96 153.96 80.3 Favored Pre-proline 0 N--CA 1.47 0.561 0 C-N-CA 124.843 1.257 . . . . 0.0 109.875 174.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -73.55 11.62 1.02 Allowed 'Trans proline' 0 CA--C 1.546 1.118 0 C-N-CA 124.106 3.204 . . . . 0.0 115.205 176.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.478 ' SG ' HD13 ' A' ' 127' ' ' LEU . 7.8 t 77.84 -23.8 0.24 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 126.585 1.954 . . . . 0.0 114.453 163.152 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 37.7 p -58.05 -20.6 40.38 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 126.6 1.96 . . . . 0.0 113.376 172.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 90.6 m 60.53 28.45 18.13 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.388 1.475 . . . . 0.0 112.824 178.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -58.87 -27.72 65.45 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.635 1.174 . . . . 0.0 112.515 -177.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -59.81 -13.86 12.31 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 174.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 92.2 mt -84.02 -3.54 58.09 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.802 1.241 . . . . 0.0 113.891 172.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 9.4 p-80 -66.1 145.6 55.63 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 120.169 1.35 . . . . 0.0 113.415 178.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -128.83 -161.55 10.68 Favored Glycine 0 CA--C 1.538 1.506 0 C-N-CA 126.557 2.027 . . . . 0.0 111.225 166.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.26 -21.34 35.94 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.937 2.425 . . . . 0.0 113.194 177.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 21.6 tpt180 -89.86 -8.75 51.24 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.272 1.029 . . . . 0.0 113.491 -178.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 24.3 m -72.39 141.83 48.72 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.917 1.287 . . . . 0.0 110.579 -176.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 64.4 mm-40 -91.8 122.77 34.64 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.506 0.722 . . . . 0.0 110.04 -173.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 28.7 mmm180 -58.62 -39.36 80.26 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.803 0.841 . . . . 0.0 112.296 -178.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -64.86 -39.5 93.65 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.318 1.047 . . . . 0.0 112.081 176.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -69.2 -43.07 74.9 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.101 -1.0 . . . . 0.0 112.633 178.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -56.89 -34.92 68.36 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 122.95 0.5 . . . . 0.0 112.04 173.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -72.35 -46.75 54.05 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 124.82 1.248 . . . . 0.0 112.549 173.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -61.1 -34.86 75.61 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 118.563 -0.732 . . . . 0.0 111.565 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 87.4 mt -63.1 -38.87 83.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 CA-C-N 120.104 1.32 . . . . 0.0 111.749 171.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.92 -36.87 78.49 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 119.33 0.968 . . . . 0.0 112.296 173.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -65.84 -31.91 73.13 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 121.347 -0.846 . . . . 0.0 111.773 172.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.69 -20.59 65.83 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 119.203 0.911 . . . . 0.0 112.604 175.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 44.6 mt -88.32 -10.75 48.46 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.927 1.691 . . . . 0.0 113.374 172.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 84.5 mt -96.98 -14.64 21.55 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.529 1.132 . . . . 0.0 112.075 172.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -86.48 150.73 23.7 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 125.389 1.471 . . . . 0.0 113.162 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -100.28 8.94 43.4 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.136 1.374 . . . . 0.0 113.678 178.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -134.21 164.83 26.5 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.428 1.891 . . . . 0.0 111.476 -178.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -61.29 138.16 58.24 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.833 0.853 . . . . 0.0 111.854 -179.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 19.7 tpt180 -145.92 128.68 16.26 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.91 0.884 . . . . 0.0 112.058 -178.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 43.1 mtmt -107.34 139.86 41.16 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.76 1.624 . . . . 0.0 111.424 175.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 45.1 t -138.24 138.69 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 125.52 1.528 . . . . 0.0 109.251 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -102.92 127.76 50.0 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.221 1.008 . . . . 0.0 110.962 177.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 19.5 tt -150.71 146.32 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 124.208 1.003 . . . . 0.0 112.352 -171.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -89.9 119.05 29.94 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 121.055 -1.028 . . . . 0.0 111.578 176.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 20.0 m-30 -115.73 157.12 24.77 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.598 1.959 . . . . 0.0 111.314 175.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -114.05 151.9 31.8 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 178.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.54 158.79 28.45 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.493 1.517 . . . . 0.0 110.395 167.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -61.81 -23.78 66.44 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.235 1.014 . . . . 0.0 113.219 166.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -72.31 -9.02 57.95 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.739 1.616 . . . . 0.0 113.709 170.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 97.94 -6.4 62.17 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 126.127 1.822 . . . . 0.0 114.778 179.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 22.1 m -82.12 130.23 35.03 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 118.952 1.376 . . . . 0.0 112.627 -172.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 25.3 p -104.87 153.65 21.09 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.761 1.224 . . . . 0.0 112.46 -177.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -165.61 163.79 19.24 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 126.088 1.755 . . . . 0.0 112.672 169.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -77.87 124.88 28.54 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.37 1.068 . . . . 0.0 111.119 175.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 42.1 t -104.25 137.31 42.35 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.82 2.048 . . . . 0.0 110.128 170.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 6.8 tp -90.28 118.0 29.45 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 161.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 94.9 t -100.87 114.67 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 125.457 1.503 . . . . 0.0 107.903 173.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -115.45 108.72 16.85 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 125.606 1.562 . . . . 0.0 107.129 -175.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.452 HG22 ' HG ' ' A' ' 127' ' ' LEU . 17.1 t -93.52 127.37 45.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 -179.008 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 69.6 t -111.15 112.1 55.41 Favored Pre-proline 0 CA--C 1.535 0.374 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.88 131.6 15.92 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.64 2.227 . . . . 0.0 109.61 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 60.6 t -92.8 105.42 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 169.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 61.5 mttt -82.16 151.7 26.81 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.268 0.556 . . . . 0.0 111.202 166.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -92.96 -173.42 3.28 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.8 0.84 . . . . 0.0 111.831 174.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -60.14 -21.79 62.04 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.128 1.371 . . . . 0.0 114.693 178.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -93.73 -0.72 55.83 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.695 1.198 . . . . 0.0 113.155 177.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 77.87 20.55 73.27 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 124.301 0.953 . . . . 0.0 114.556 178.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -99.22 142.22 30.98 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.462 1.105 . . . . 0.0 109.12 171.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.7 p -76.55 118.97 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-O 122.089 0.947 . . . . 0.0 109.903 174.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.4 pt -106.91 -19.51 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 125.64 1.576 . . . . 0.0 113.29 -174.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 3.6 mtp -157.36 156.33 32.12 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 126.561 1.944 . . . . 0.0 110.512 -174.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -122.56 133.51 54.56 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 125.086 1.355 . . . . 0.0 109.563 175.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 56.8 mt -102.59 114.81 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 166.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.478 HD13 ' SG ' ' A' ' 64' ' ' CYS . 7.4 mp -98.57 119.77 37.85 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 177.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -110.82 135.81 50.82 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 123.354 0.409 . . . . 0.0 111.47 -178.144 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -111.86 138.37 48.55 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.12 1.368 . . . . 0.0 111.433 -175.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -144.03 136.34 26.68 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.42 1.488 . . . . 0.0 109.908 175.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 42.5 t -76.15 114.58 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 176.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.0 p -98.61 -25.61 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -173.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 44.4 tpp -165.2 128.21 2.23 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.154 0.981 . . . . 0.0 111.725 179.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -84.39 127.9 34.27 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.631 0.772 . . . . 0.0 111.386 -179.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.48 ' HA ' ' HE2' ' A' ' 135' ' ' LYS . 11.1 mmpt? . . . . . 0 C--O 1.254 1.299 0 C-N-CA 124.789 1.236 . . . . 0.0 113.103 174.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.1 ttm . . . . . 0 N--CA 1.496 1.857 0 CA-C-O 118.356 -0.83 . . . . 0.0 110.704 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -83.25 -26.08 2.4 Favored 'Trans proline' 0 C--N 1.357 1.011 0 C-N-CA 123.334 2.689 . . . . 0.0 114.535 -175.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.4 t 68.14 54.37 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 125.449 1.5 . . . . 0.0 110.53 177.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -126.22 49.45 1.99 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 126.198 1.799 . . . . 0.0 110.478 -177.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 38.9 mmt180 -67.02 161.94 23.23 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.784 1.633 . . . . 0.0 112.872 -174.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 106.11 145.05 12.59 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 125.895 1.712 . . . . 0.0 112.737 178.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -80.53 58.04 3.07 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 125.231 1.412 . . . . 0.0 111.761 -176.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 36.9 t 79.9 118.2 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 129.106 2.962 . . . . 0.0 109.577 -171.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.23 153.2 94.34 Favored Pre-proline 0 CA--C 1.55 0.968 0 C-N-CA 124.09 0.956 . . . . 0.0 112.266 -178.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -72.8 -8.62 22.66 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 123.369 2.713 . . . . 0.0 114.13 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 68.15 0.89 2.6 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 127.001 2.12 . . . . 0.0 114.674 171.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 36.82 53.53 1.1 Allowed 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 131.398 3.879 . . . . 0.0 113.271 176.228 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 39.7 p -46.19 -38.09 7.89 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 127.758 2.423 . . . . 0.0 114.086 -169.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -62.14 -49.9 74.01 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.058 0.943 . . . . 0.0 111.954 175.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 58.2 tp -69.64 -39.93 76.83 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.343 1.457 . . . . 0.0 111.593 174.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -60.15 -28.41 67.87 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 176.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 95.1 m -69.03 -29.82 68.05 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.294 1.038 . . . . 0.0 110.739 173.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.8 mm -78.13 -41.92 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 123.683 0.793 . . . . 0.0 110.047 174.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 96.5 mt -56.9 -46.53 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 123.437 0.695 . . . . 0.0 110.661 176.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -70.66 -21.39 62.61 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.2 mtpt -78.57 -34.85 46.62 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.53 1.132 . . . . 0.0 112.606 170.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -78.02 -30.48 49.99 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.901 0.88 . . . . 0.0 111.82 175.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 -70.34 168.82 15.16 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.903 0.881 . . . . 0.0 111.772 165.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -81.74 7.5 62.11 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 124.614 1.102 . . . . 0.0 115.299 -177.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -68.16 -38.33 81.99 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 118.845 1.323 . . . . 0.0 113.04 -169.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 83.8 p -92.01 -2.67 56.59 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 -179.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -83.43 171.11 13.79 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 122.738 1.256 . . . . 0.0 113.213 -171.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.3 mptt -109.4 145.91 35.34 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.948 2.099 . . . . 0.0 110.376 -173.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -167.04 163.41 15.84 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.493 1.117 . . . . 0.0 113.333 178.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 20.2 pt -139.71 155.71 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 126.212 1.805 . . . . 0.0 110.327 172.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 17.2 mt -114.63 133.25 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 126.046 1.738 . . . . 0.0 108.688 -177.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -135.29 144.0 46.55 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.454 1.101 . . . . 0.0 112.171 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 57.8 t-20 -76.09 112.59 12.7 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.266 1.027 . . . . 0.0 112.151 -176.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -71.15 -19.69 62.39 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.293 1.037 . . . . 0.0 113.434 -177.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -75.32 -19.59 59.55 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.559 1.144 . . . . 0.0 113.256 179.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 95.4 t -89.42 136.36 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 125.769 1.627 . . . . 0.0 109.171 177.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -55.86 -41.2 74.01 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.789 1.236 . . . . 0.0 113.023 -175.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -79.42 -11.47 59.91 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.394 1.078 . . . . 0.0 113.717 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 88.4 m 52.8 57.85 5.94 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.355 1.462 . . . . 0.0 112.08 -170.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.39 137.07 57.7 Favored 'General case' 0 CA--C 1.548 0.87 0 O-C-N 121.405 -0.809 . . . . 0.0 112.616 -176.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.9 t -60.8 123.81 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 172.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.2 pt -105.03 -17.95 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 125.153 1.381 . . . . 0.0 112.547 175.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -157.2 145.75 19.61 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.065 0.946 . . . . 0.0 112.204 178.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 4.4 m -124.51 156.41 37.35 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.562 1.145 . . . . 0.0 111.504 172.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -73.79 -150.71 0.03 OUTLIER 'General case' 0 CA--C 1.56 1.349 0 CA-C-N 118.86 0.754 . . . . 0.0 111.397 171.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -116.23 -21.45 9.35 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 120.365 -1.459 . . . . 0.0 112.98 163.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -73.73 -34.01 57.11 Favored Glycine 0 N--CA 1.471 1.033 0 C-N-CA 124.126 0.869 . . . . 0.0 112.691 -178.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -58.69 -38.02 77.35 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.52 1.128 . . . . 0.0 111.652 177.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 33.5 t -55.58 -51.73 66.15 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.626 1.57 . . . . 0.0 111.758 178.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -69.27 -18.17 63.83 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 178.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.507 HD11 HG23 ' A' ' 131' ' ' VAL . 10.6 tp -66.99 -44.06 81.33 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.447 1.099 . . . . 0.0 112.317 178.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 80.3 m -112.68 -21.46 11.23 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 114.513 1.301 . . . . 0.0 114.513 -176.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 87.16 14.08 64.95 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 124.417 1.008 . . . . 0.0 114.2 -178.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -87.81 -154.65 0.27 Allowed 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 124.889 1.276 . . . . 0.0 111.857 172.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 70.1 m -150.61 159.47 44.48 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.951 1.3 . . . . 0.0 110.39 178.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 -50.59 -47.0 58.23 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 121.571 -0.706 . . . . 0.0 111.5 175.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.36 -27.53 36.87 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 177.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -91.71 -33.99 14.82 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.991 1.316 . . . . 0.0 112.368 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 57.4 t -88.21 -16.11 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 124.829 1.252 . . . . 0.0 111.947 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 84.0 mmm -73.62 148.06 43.2 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 120.96 -1.088 . . . . 0.0 111.344 171.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 9.7 tm0? 70.98 4.1 4.93 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 126.076 1.75 . . . . 0.0 113.068 -176.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 32.7 mmt180 -82.04 154.84 70.12 Favored Pre-proline 0 N--CA 1.472 0.63 0 C-N-CA 125.021 1.328 . . . . 0.0 110.375 175.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -75.16 11.8 1.4 Allowed 'Trans proline' 0 CA--C 1.548 1.215 0 C-N-CA 124.268 3.312 . . . . 0.0 115.72 176.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 8.3 t 73.89 -17.02 0.47 Allowed 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 126.348 1.859 . . . . 0.0 114.666 166.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 41.1 p -62.05 -23.48 66.5 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 126.095 1.758 . . . . 0.0 113.146 170.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 98.3 m 57.78 28.7 16.32 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.093 1.357 . . . . 0.0 113.004 -176.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -56.78 -31.91 65.11 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.595 1.158 . . . . 0.0 112.22 178.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -60.87 -12.54 11.37 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.995 1.318 . . . . 0.0 114.314 177.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.2 mt -83.74 -2.4 56.19 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 114.101 1.149 . . . . 0.0 114.101 174.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 18.3 p-80 -59.79 143.05 52.08 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 119.781 1.173 . . . . 0.0 113.617 179.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -123.94 -161.64 11.19 Favored Glycine 0 CA--C 1.539 1.551 0 C-N-CA 126.363 1.935 . . . . 0.0 111.517 169.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.22 -20.4 32.72 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 123.069 2.513 . . . . 0.0 113.184 177.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 -88.13 -12.04 45.21 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.245 1.018 . . . . 0.0 113.592 -179.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 18.6 m -72.38 138.83 47.48 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.994 1.317 . . . . 0.0 110.584 -175.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -102.87 131.11 50.01 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.295 1.038 . . . . 0.0 110.544 -177.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 19.9 tpp85 -60.76 -36.34 78.69 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.809 0.844 . . . . 0.0 112.538 -175.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 85.3 mmt-85 -60.67 -41.99 96.17 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.039 0.935 . . . . 0.0 112.448 175.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.64 -45.5 75.18 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 119.144 0.884 . . . . 0.0 112.112 177.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -57.18 -33.6 67.63 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.106 0.562 . . . . 0.0 112.318 173.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -73.28 -46.24 50.97 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 124.696 1.198 . . . . 0.0 112.293 175.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 12.9 mm-40 -61.42 -33.86 74.42 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 119.091 0.859 . . . . 0.0 111.715 -177.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 76.1 mt -63.96 -35.63 74.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 CA-C-N 120.307 1.412 . . . . 0.0 111.958 171.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.75 -35.56 67.5 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 119.112 0.869 . . . . 0.0 112.498 173.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 51.8 mm-40 -67.89 -33.67 75.16 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.564 0.745 . . . . 0.0 111.581 173.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -58.7 -22.05 56.34 Favored 'General case' 0 CA--C 1.547 0.847 0 O-C-N 121.063 -1.023 . . . . 0.0 113.392 178.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 57.7 mt -82.03 -14.55 55.74 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.751 1.621 . . . . 0.0 113.839 177.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.1 pp -85.65 -18.52 32.99 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 119.606 1.094 . . . . 0.0 112.643 173.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -79.82 167.26 51.27 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 124.919 1.247 . . . . 0.0 113.718 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -110.87 -7.57 14.58 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.011 1.725 . . . . 0.0 112.746 175.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -112.25 164.97 12.6 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 127.704 2.401 . . . . 0.0 111.642 179.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 44.1 mp0 -62.58 143.59 57.08 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.903 1.281 . . . . 0.0 112.141 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 16.0 mmt85 -140.64 130.05 23.88 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.891 1.276 . . . . 0.0 111.267 173.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 39.7 mtmt -104.81 136.04 45.06 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.297 1.439 . . . . 0.0 110.847 168.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 66.7 t -135.95 136.79 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 125.345 1.458 . . . . 0.0 108.742 176.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -101.01 131.82 46.71 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.987 0.915 . . . . 0.0 110.882 178.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.1 tt -154.11 150.05 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 124.612 1.165 . . . . 0.0 111.751 -170.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -89.22 125.85 35.25 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.243 -0.911 . . . . 0.0 111.825 174.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 20.0 m-30 -113.99 146.0 40.75 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.737 2.015 . . . . 0.0 111.115 173.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -86.52 156.36 20.12 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 169.257 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 58.3 ttm-85 -101.22 149.11 24.34 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 126.152 1.781 . . . . 0.0 109.332 166.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -54.37 -28.15 41.22 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 114.441 1.274 . . . . 0.0 114.441 177.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -73.68 -6.98 50.18 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.926 1.69 . . . . 0.0 114.088 176.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 99.17 -1.28 57.49 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 125.763 1.649 . . . . 0.0 114.229 -177.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -73.57 168.98 18.2 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 118.407 1.104 . . . . 0.0 112.215 177.041 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 34.9 t -143.02 151.66 41.06 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.341 1.056 . . . . 0.0 111.36 176.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -157.36 151.85 25.16 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.673 1.189 . . . . 0.0 111.587 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -76.57 123.18 25.69 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.411 0.624 . . . . 0.0 110.466 165.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 21.4 t -104.79 137.68 42.21 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.988 1.715 . . . . 0.0 110.377 170.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.3 tp -92.24 116.37 28.89 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 162.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 22.3 t -100.06 115.39 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 124.829 1.252 . . . . 0.0 108.468 176.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -110.79 110.61 21.31 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.721 1.208 . . . . 0.0 108.273 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 71.3 t -78.39 128.75 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 169.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 56.0 t -112.98 113.01 49.8 Favored Pre-proline 0 CA--C 1.538 0.496 0 N-CA-C 107.591 -1.262 . . . . 0.0 107.591 168.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.32 127.82 10.76 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 123.273 2.648 . . . . 0.0 109.741 178.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 79.3 t -102.02 119.7 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 123.912 0.885 . . . . 0.0 109.45 176.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 61.1 mttt -88.52 153.57 21.04 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.693 0.797 . . . . 0.0 112.635 172.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -92.35 -173.58 3.45 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.475 1.11 . . . . 0.0 111.663 175.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -60.11 -22.12 62.4 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.11 1.364 . . . . 0.0 114.465 178.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -90.66 -5.47 55.77 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.119 1.368 . . . . 0.0 112.991 178.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 80.43 22.35 62.71 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 124.396 0.998 . . . . 0.0 114.456 -179.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -108.16 148.24 30.17 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.193 1.397 . . . . 0.0 109.916 172.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.8 p -78.79 126.19 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 123.703 0.801 . . . . 0.0 110.525 178.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.47 -22.82 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 -174.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 56.0 mtm -130.18 149.91 51.67 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.848 1.259 . . . . 0.0 111.977 169.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -107.52 136.04 47.96 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 124.766 1.226 . . . . 0.0 109.126 164.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 75.9 mt -99.26 118.45 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 162.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -93.68 116.76 29.27 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 170.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -101.53 144.53 30.18 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 119.122 -0.466 . . . . 0.0 110.894 176.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -122.46 133.01 54.61 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.63 1.172 . . . . 0.0 111.151 -176.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -137.7 131.09 30.87 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 125.271 1.428 . . . . 0.0 109.2 176.138 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.507 HG23 HD11 ' A' ' 51' ' ' LEU . 71.3 t -76.86 110.95 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 175.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.2 p -93.9 -24.23 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 123.628 0.771 . . . . 0.0 112.744 -174.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 37.9 tpp -163.53 111.69 1.21 Allowed 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.769 1.228 . . . . 0.0 110.572 178.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -82.28 118.91 23.49 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.388 0.675 . . . . 0.0 109.919 176.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt . . . . . 0 C--O 1.254 1.306 0 C-N-CA 125.201 1.4 . . . . 0.0 113.475 -175.456 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 93.1 mtp . . . . . 0 N--CA 1.497 1.893 0 CA-C-O 116.441 -1.742 . . . . 0.0 112.254 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -71.31 157.58 56.54 Favored 'Trans proline' 0 C--N 1.359 1.095 0 C-N-CA 122.521 2.148 . . . . 0.0 111.933 178.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 90.2 t -86.9 125.19 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.031 0.932 . . . . 0.0 110.146 -179.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 35.4 mmt180 -80.21 138.4 36.83 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.615 1.166 . . . . 0.0 111.086 173.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -106.23 160.66 15.18 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.173 1.389 . . . . 0.0 111.275 177.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -85.37 102.18 2.6 Favored Glycine 0 N--CA 1.471 1.002 0 C-N-CA 124.571 1.081 . . . . 0.0 111.647 177.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -166.55 169.75 13.42 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.634 1.973 . . . . 0.0 111.169 177.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.6 p -155.02 133.68 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 124.461 1.104 . . . . 0.0 111.094 176.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -91.63 152.72 43.64 Favored Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 124.952 1.301 . . . . 0.0 111.866 177.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -66.02 118.21 5.31 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 123.267 2.645 . . . . 0.0 110.312 176.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -134.95 -65.97 0.6 Allowed 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.277 1.431 . . . . 0.0 109.74 -175.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -63.94 130.51 44.39 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.101 0.96 . . . . 0.0 110.954 173.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 32.2 p -117.54 -50.77 2.52 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.433 1.493 . . . . 0.0 112.216 172.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -86.36 -56.98 3.18 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.88 0.872 . . . . 0.0 111.762 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 48.1 tp -57.87 -35.06 70.45 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.226 1.01 . . . . 0.0 111.065 178.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -44.77 -37.41 3.77 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 170.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 99.8 m -77.69 -31.64 52.54 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.39 1.076 . . . . 0.0 110.775 179.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 12.2 mm -75.38 -36.22 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 124.675 1.19 . . . . 0.0 110.661 177.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 94.0 mt -54.83 -41.46 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 123.547 0.739 . . . . 0.0 110.529 174.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 7.0 mmt85 -59.31 -32.91 70.48 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 118.864 0.756 . . . . 0.0 112.869 178.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -77.16 -36.75 54.95 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.888 1.275 . . . . 0.0 111.631 177.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -74.85 -25.9 59.31 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.65 1.18 . . . . 0.0 112.688 175.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -60.58 -19.86 58.83 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 173.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -74.8 -10.3 83.39 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 124.632 1.111 . . . . 0.0 114.506 173.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -95.89 45.78 1.08 Allowed 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.772 1.629 . . . . 0.0 110.55 178.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.1 t -85.6 44.87 1.14 Allowed 'General case' 0 N--CA 1.476 0.854 0 O-C-N 120.567 -1.333 . . . . 0.0 112.273 -171.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 22.8 mmm180 -69.27 163.52 24.84 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.519 1.127 . . . . 0.0 111.239 176.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.6 mptt -92.85 123.24 35.97 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.128 -0.982 . . . . 0.0 110.935 -170.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -159.72 163.88 34.36 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.183 0.993 . . . . 0.0 113.096 177.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 32.6 pt -140.97 156.22 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 126.5 1.92 . . . . 0.0 110.006 173.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 10.7 mt -118.27 132.75 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 125.416 1.486 . . . . 0.0 109.006 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -130.87 148.54 52.65 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.44 1.096 . . . . 0.0 111.775 177.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 52.7 t-20 -71.22 125.3 26.57 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.863 0.865 . . . . 0.0 111.045 178.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.06 -26.78 59.65 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 121.463 -0.773 . . . . 0.0 112.824 175.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 77.4 mtp180 -76.41 23.59 0.15 Allowed 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 126.137 1.775 . . . . 0.0 114.462 -170.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.4 m -149.93 148.5 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 126.748 2.019 . . . . 0.0 110.563 -171.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -63.72 -41.01 98.15 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.414 1.086 . . . . 0.0 113.26 -169.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -83.55 -12.67 55.86 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -175.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 90.4 m 49.21 64.3 1.79 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.353 1.461 . . . . 0.0 111.489 -167.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.14 136.18 54.7 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.59 0.756 . . . . 0.0 112.027 -177.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 17.5 t -63.52 123.69 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 C-N-CA 122.869 0.467 . . . . 0.0 109.842 175.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.0 pt -103.67 -21.68 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 125.291 1.436 . . . . 0.0 112.551 175.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -151.07 144.55 24.91 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.187 0.995 . . . . 0.0 111.217 178.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.457 ' HB3' ' CE1' ' A' ' 48' ' ' PHE . 0.3 OUTLIER -135.46 140.65 45.02 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.411 1.084 . . . . 0.0 111.136 -177.685 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -78.96 -175.35 4.48 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 119.97 1.259 . . . . 0.0 112.403 176.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -90.95 -27.2 18.86 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 120.455 -1.403 . . . . 0.0 111.955 172.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -70.93 -41.64 61.49 Favored Glycine 0 C--N 1.343 0.95 0 O-C-N 121.869 -0.52 . . . . 0.0 112.248 -174.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.457 ' CE1' ' HB3' ' A' ' 44' ' ' CYS . 0.4 OUTLIER -69.39 -28.56 66.27 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.185 0.594 . . . . 0.0 112.332 -179.307 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 93.2 m -53.89 -51.76 62.65 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.18 0.992 . . . . 0.0 111.32 177.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -70.99 -19.72 62.5 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.111 0.964 . . . . 0.0 113.582 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 15.2 tp -62.81 -46.43 87.98 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.989 1.316 . . . . 0.0 111.788 -179.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 44.1 t -95.68 -33.52 12.29 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.167 0.987 . . . . 0.0 113.035 171.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.38 7.57 51.52 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 124.753 1.168 . . . . 0.0 114.091 -173.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -84.89 -158.3 0.35 Allowed 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 118.775 1.287 . . . . 0.0 112.36 168.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 10.5 t -155.83 170.24 22.55 Favored 'General case' 0 C--O 1.24 0.581 0 O-C-N 120.772 -1.205 . . . . 0.0 111.643 176.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 -47.46 -47.76 27.04 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.091 1.356 . . . . 0.0 111.44 176.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.05 -26.82 64.92 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -89.5 -36.07 15.6 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.192 0.997 . . . . 0.0 112.487 174.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 80.8 t -84.46 -17.12 10.32 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 C-N-CA 124.962 1.305 . . . . 0.0 111.914 -176.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 44.6 mtm -67.59 140.58 56.92 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 120.524 -1.36 . . . . 0.0 110.453 173.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 12.4 mt-30 67.77 9.64 7.24 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.566 1.546 . . . . 0.0 114.061 -178.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -83.86 155.11 64.82 Favored Pre-proline 0 N--CA 1.472 0.654 0 C-N-CA 124.611 1.165 . . . . 0.0 110.428 170.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.27 133.99 25.87 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.614 2.209 . . . . 0.0 109.029 166.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 3.9 t -65.6 -15.26 62.56 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -171.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 40.8 p -57.67 -28.26 63.61 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.586 1.554 . . . . 0.0 112.581 169.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 86.2 m 56.65 41.6 28.16 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.303 1.441 . . . . 0.0 112.099 -178.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -57.84 -27.45 63.21 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.687 1.195 . . . . 0.0 113.232 -175.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -62.47 -15.6 50.71 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 174.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 80.4 mt -79.47 -13.68 59.41 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 173.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 31.0 m170 -73.25 118.93 16.79 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 119.211 0.914 . . . . 0.0 110.911 -179.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -99.65 -164.32 29.26 Favored Glycine 0 CA--C 1.539 1.534 0 C-N-CA 125.841 1.686 . . . . 0.0 112.574 177.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -70.07 -25.15 27.46 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 123.096 2.531 . . . . 0.0 113.019 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 40.2 ttt180 -84.39 -14.84 48.32 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.898 0.879 . . . . 0.0 112.974 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 31.7 m -69.28 143.99 53.71 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.083 1.353 . . . . 0.0 112.074 -171.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 19.9 mp0 -91.19 118.08 30.16 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.308 1.443 . . . . 0.0 110.257 -168.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 57.6 mmm-85 -58.92 -36.46 74.76 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 121.414 -0.804 . . . . 0.0 113.011 -178.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 25.1 tpp180 -61.58 -45.27 94.82 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.212 1.005 . . . . 0.0 111.528 175.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -72.08 -40.46 68.25 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.104 -0.998 . . . . 0.0 112.724 179.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.42 -34.9 64.83 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.504 0.721 . . . . 0.0 112.017 173.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -73.38 -48.2 35.96 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 124.572 1.149 . . . . 0.0 112.291 172.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -58.62 -35.29 72.25 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 118.536 -0.745 . . . . 0.0 111.998 -178.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 80.7 mt -63.49 -35.63 73.23 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 CA-C-N 120.191 1.36 . . . . 0.0 112.293 172.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.13 -36.63 66.72 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 118.888 0.767 . . . . 0.0 112.339 173.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 48.3 mm-40 -68.91 -32.93 72.91 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.491 0.717 . . . . 0.0 111.74 175.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -58.61 -21.08 52.49 Favored 'General case' 0 CA--C 1.548 0.88 0 O-C-N 121.168 -0.957 . . . . 0.0 113.358 177.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 57.6 mt -83.74 -15.3 49.1 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.669 1.588 . . . . 0.0 113.89 177.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -85.69 -20.87 28.73 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 119.611 1.096 . . . . 0.0 112.183 173.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -82.36 149.75 27.89 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 125.042 1.306 . . . . 0.0 113.444 -178.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.66 -2.22 57.85 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.013 1.325 . . . . 0.0 114.008 178.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -126.27 162.53 25.25 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 126.177 1.791 . . . . 0.0 111.386 -173.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -59.75 136.03 57.87 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.559 1.144 . . . . 0.0 111.931 -178.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.2 129.99 22.96 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.674 1.19 . . . . 0.0 110.311 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 30.9 mtmt -109.26 140.57 42.74 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.565 1.546 . . . . 0.0 111.715 176.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 41.4 t -139.51 136.35 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 126.173 1.789 . . . . 0.0 108.849 178.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -104.31 135.41 45.82 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.262 1.025 . . . . 0.0 110.594 176.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.0 tt -161.11 150.57 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 123.623 0.769 . . . . 0.0 112.554 -165.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -86.72 123.36 31.8 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 121.402 -0.811 . . . . 0.0 112.165 173.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 12.0 m-30 -114.04 140.21 48.64 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 127.157 2.183 . . . . 0.0 111.6 175.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -77.7 162.61 26.86 Favored 'General case' 0 CA--C 1.55 0.942 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 172.193 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 13.2 ptt180 -122.64 155.66 35.92 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.758 1.223 . . . . 0.0 112.723 166.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -52.87 -28.21 22.02 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 126.354 1.861 . . . . 0.0 114.453 -176.068 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -68.06 -12.87 61.62 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.178 1.391 . . . . 0.0 113.683 177.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 94.79 22.95 22.22 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 125.007 1.289 . . . . 0.0 113.569 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 7.9 t -120.36 -173.1 2.5 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.595 1.158 . . . . 0.0 111.576 177.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 16.8 t -144.91 154.33 42.49 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.007 1.323 . . . . 0.0 112.514 -169.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -150.55 148.71 29.0 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.765 1.626 . . . . 0.0 110.97 177.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -74.72 134.26 41.92 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.712 0.768 . . . . 0.0 109.827 166.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 35.1 t -129.55 145.62 51.45 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.827 2.051 . . . . 0.0 110.235 -177.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 14.8 tp -93.9 127.31 39.6 Favored 'General case' 0 N--CA 1.463 0.175 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 161.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 68.7 t -101.87 127.23 55.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 161.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -122.3 121.77 37.51 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 119.289 0.95 . . . . 0.0 109.568 165.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 57.0 t -84.74 133.0 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 175.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 49.8 t -113.67 110.71 49.43 Favored Pre-proline 0 N--CA 1.467 0.411 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 170.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.85 129.99 12.06 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.903 2.402 . . . . 0.0 109.645 178.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 74.3 t -103.46 125.04 58.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.074 0.949 . . . . 0.0 109.587 178.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 66.7 mttt -94.11 153.98 17.84 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 172.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -93.49 -173.89 3.33 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.55 1.14 . . . . 0.0 111.506 176.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -60.27 -22.05 62.65 Favored 'General case' 0 CA--C 1.548 0.865 0 C-N-CA 125.038 1.335 . . . . 0.0 114.406 178.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -90.81 -5.52 55.51 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.144 1.377 . . . . 0.0 112.981 178.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 79.9 22.44 63.75 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 124.476 1.036 . . . . 0.0 114.458 -179.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -107.26 150.06 27.08 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.065 1.346 . . . . 0.0 110.001 173.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 86.8 t -78.25 125.95 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 123.551 0.74 . . . . 0.0 109.353 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.53 -23.27 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 -176.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 56.1 mtm -131.49 151.6 51.43 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.621 1.168 . . . . 0.0 112.155 170.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -110.63 135.25 51.55 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 124.985 1.314 . . . . 0.0 109.108 166.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 64.4 mt -102.19 119.15 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 165.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -95.31 118.09 31.45 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 172.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -107.58 131.92 53.84 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 123.338 0.399 . . . . 0.0 110.475 177.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 13.3 m-30 -108.76 147.94 31.26 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 125.724 1.609 . . . . 0.0 111.585 -177.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -148.63 141.9 25.12 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 125.3 1.44 . . . . 0.0 109.168 176.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 45.3 t -76.6 122.54 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 175.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.7 t -89.94 -39.74 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 125.025 1.33 . . . . 0.0 111.089 175.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 24.7 ttm -171.53 126.43 0.63 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.39 1.076 . . . . 0.0 110.957 -175.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -78.17 125.89 30.01 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 121.303 -0.873 . . . . 0.0 110.016 169.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt . . . . . 0 C--O 1.254 1.336 0 C-N-CA 125.038 1.335 . . . . 0.0 113.58 179.225 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.1 ttp . . . . . 0 N--CA 1.494 1.728 0 CA-C-O 118.429 -0.796 . . . . 0.0 110.709 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -76.63 155.03 35.38 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 123.53 2.82 . . . . 0.0 111.343 175.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.6 p -165.06 143.67 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.905 1.282 . . . . 0.0 110.971 -179.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 37.9 mmt180 -112.98 127.28 56.18 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.164 1.386 . . . . 0.0 110.396 174.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 84.4 mtp180 -84.92 165.78 17.37 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.127 1.371 . . . . 0.0 112.28 -178.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 102.41 -9.65 56.0 Favored Glycine 0 N--CA 1.477 1.424 0 C-N-CA 125.763 1.649 . . . . 0.0 115.085 176.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 59.4 m80 -142.69 156.93 45.1 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.793 1.637 . . . . 0.0 110.846 175.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.8 p -163.75 149.36 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 125.267 1.427 . . . . 0.0 110.696 -178.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.83 151.72 84.37 Favored Pre-proline 0 CA--C 1.552 1.05 0 C-N-CA 124.088 0.955 . . . . 0.0 112.248 174.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -67.38 114.78 3.38 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 123.134 2.556 . . . . 0.0 110.586 -179.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -76.67 -34.67 58.22 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.648 0.779 . . . . 0.0 112.933 -177.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -117.4 64.98 0.73 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 127.351 2.26 . . . . 0.0 110.151 -177.47 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 41.2 p -49.5 -32.24 11.81 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 127.327 2.251 . . . . 0.0 114.136 -177.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -69.81 -50.62 41.2 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.033 0.933 . . . . 0.0 111.911 175.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 58.9 tp -61.84 -35.75 79.19 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.903 1.281 . . . . 0.0 111.154 176.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -56.69 -31.45 64.47 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.125 0.97 . . . . 0.0 112.671 177.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.2 m -72.13 -31.98 66.51 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.376 0.67 . . . . 0.0 111.175 174.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 16.1 mm -73.04 -41.8 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.889 0.876 . . . . 0.0 110.366 176.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 97.1 mt -54.47 -48.15 69.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.0 0.92 . . . . 0.0 110.019 174.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 81.6 mtt-85 -59.68 -27.18 66.19 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -78.18 -24.39 47.23 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.593 1.157 . . . . 0.0 113.112 177.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -90.31 -29.34 18.18 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.252 1.021 . . . . 0.0 112.75 170.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -70.32 177.04 3.54 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.688 1.195 . . . . 0.0 112.755 172.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.96 14.09 82.53 Favored Glycine 0 N--CA 1.471 1.026 0 C-N-CA 124.367 0.984 . . . . 0.0 113.399 176.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 63.19 17.52 10.26 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 127.437 2.295 . . . . 0.0 112.261 -173.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 48.8 m -81.59 41.46 0.63 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 126.56 1.944 . . . . 0.0 112.559 -176.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -67.41 166.63 14.18 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 122.554 1.169 . . . . 0.0 111.3 174.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -104.46 142.09 35.21 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.285 1.434 . . . . 0.0 111.09 -163.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -166.03 162.24 17.81 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.366 1.066 . . . . 0.0 113.751 -178.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 31.4 pt -147.13 156.11 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 127.406 2.282 . . . . 0.0 110.081 -178.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.9 mp -122.03 131.61 72.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 125.126 1.371 . . . . 0.0 109.505 176.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -125.21 147.79 48.92 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 124.959 1.304 . . . . 0.0 111.499 176.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -77.88 130.0 36.07 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.105 0.478 . . . . 0.0 111.454 175.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.37 -21.01 62.92 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.632 1.173 . . . . 0.0 113.902 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 82.3 mtm180 -89.63 -4.56 57.75 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 114.622 1.342 . . . . 0.0 114.622 -167.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 32.4 m -108.99 150.49 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 125.114 1.366 . . . . 0.0 111.7 -173.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -50.21 -55.02 16.96 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 126.163 1.785 . . . . 0.0 114.03 -167.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -105.51 30.74 5.46 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.956 1.703 . . . . 0.0 111.689 -177.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 70.8 m 39.25 54.3 2.23 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 126.24 1.816 . . . . 0.0 113.299 170.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.8 141.04 56.63 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.773 0.829 . . . . 0.0 111.759 -168.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.5 t -65.18 121.51 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 174.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.1 pt -100.51 -15.61 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 125.171 1.389 . . . . 0.0 112.648 177.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -156.24 141.85 17.76 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.616 1.167 . . . . 0.0 111.198 176.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.534 ' HB3' ' CE1' ' A' ' 48' ' ' PHE . 3.3 m -129.66 156.56 44.04 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.971 0.909 . . . . 0.0 111.311 -178.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -78.71 -166.13 0.83 Allowed 'General case' 0 CA--C 1.558 1.272 0 CA-C-N 118.922 0.783 . . . . 0.0 111.274 164.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -111.54 -19.57 12.49 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 125.565 1.546 . . . . 0.0 112.77 168.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.19 -38.98 94.34 Favored Glycine 0 N--CA 1.472 1.047 0 C-N-CA 124.604 1.097 . . . . 0.0 111.942 176.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.534 ' CE1' ' HB3' ' A' ' 44' ' ' CYS . 0.6 OUTLIER -69.42 -30.87 68.91 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.73 0.812 . . . . 0.0 111.444 -176.454 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 83.4 m -49.63 -54.62 17.37 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.2 1.4 . . . . 0.0 111.905 174.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -72.74 -19.91 61.3 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -178.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 16.5 tp -65.01 -49.2 71.12 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.48 1.112 . . . . 0.0 111.461 179.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 79.0 m -107.8 -15.94 14.44 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 -177.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.39 -0.29 59.87 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 125.453 1.502 . . . . 0.0 114.428 172.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -84.39 -154.95 0.18 Allowed 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 124.757 1.223 . . . . 0.0 112.314 171.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.0 t -159.11 168.49 26.49 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 120.604 -1.31 . . . . 0.0 111.652 173.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 36.5 ttm180 -49.56 -49.49 46.12 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.247 1.419 . . . . 0.0 111.044 176.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.82 -27.87 53.47 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -87.98 -49.26 7.18 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.447 1.099 . . . . 0.0 110.651 175.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 69.2 t -72.16 -19.25 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 124.363 1.065 . . . . 0.0 112.13 -172.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 5.4 mmt -64.21 -2.13 1.96 Allowed 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 5.8 tm0? -132.87 14.95 4.32 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.667 1.187 . . . . 0.0 112.341 173.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 37.4 mmt180 -98.48 155.43 36.82 Favored Pre-proline 0 C--O 1.24 0.588 0 C-N-CA 125.459 1.504 . . . . 0.0 111.395 178.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.17 142.07 37.22 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.206 2.604 . . . . 0.0 110.192 172.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 3.2 t -66.15 -11.02 46.62 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 -177.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 40.0 p -68.79 -25.66 64.81 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.344 1.458 . . . . 0.0 112.223 171.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 83.6 m 51.41 42.89 29.65 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.464 1.506 . . . . 0.0 113.013 -177.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -56.42 -31.74 64.2 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.455 1.502 . . . . 0.0 112.978 -175.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -64.85 -15.57 62.02 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.493 1.117 . . . . 0.0 113.932 177.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 87.1 mt -80.69 -11.12 59.68 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.212 1.005 . . . . 0.0 113.019 172.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -76.8 119.48 20.62 Favored 'General case' 0 CA--C 1.546 0.789 0 O-C-N 121.063 -1.023 . . . . 0.0 110.492 -178.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -97.8 -167.26 32.05 Favored Glycine 0 CA--C 1.539 1.546 0 C-N-CA 125.684 1.612 . . . . 0.0 112.366 175.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -68.21 -25.59 36.81 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 123.045 2.497 . . . . 0.0 112.96 177.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -87.61 -5.34 58.78 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.076 0.951 . . . . 0.0 112.847 178.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 63.4 m -70.33 133.44 46.95 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 120.986 -1.071 . . . . 0.0 109.942 179.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 49.8 mm-40 -80.99 123.16 28.11 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -171.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -64.65 -32.8 74.63 Favored 'General case' 0 N--CA 1.476 0.839 0 O-C-N 121.721 -0.612 . . . . 0.0 112.529 -172.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 23.5 tpp180 -61.57 -48.33 81.44 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.298 1.039 . . . . 0.0 111.429 170.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.36 -39.59 81.76 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 121.199 -0.938 . . . . 0.0 112.949 -177.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -54.82 -37.31 65.98 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.234 0.614 . . . . 0.0 112.541 171.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -72.6 -41.39 65.67 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.116 0.967 . . . . 0.0 112.821 173.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.461 ' HB2' HG21 ' A' ' 94' ' ' VAL . 47.9 mt-30 -56.25 -34.4 66.36 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 118.024 -0.989 . . . . 0.0 112.096 179.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 74.9 mt -61.79 -50.24 81.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 CA-C-N 120.197 1.362 . . . . 0.0 110.667 173.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.15 -37.0 83.03 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.825 0.85 . . . . 0.0 112.647 -178.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 79.4 mm-40 -72.71 -31.5 65.05 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.318 1.047 . . . . 0.0 111.776 175.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.54 -29.96 70.95 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 119.592 1.087 . . . . 0.0 112.512 179.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 64.6 mt -65.81 -16.58 63.94 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.914 1.286 . . . . 0.0 113.001 175.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 60.3 mt -80.62 -14.23 58.36 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 121.266 -0.896 . . . . 0.0 112.52 173.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -89.85 145.81 18.46 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 125.159 1.361 . . . . 0.0 113.23 -178.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.17 -2.8 58.11 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.974 1.31 . . . . 0.0 113.942 176.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -125.45 163.9 21.63 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.475 1.91 . . . . 0.0 110.984 -177.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -62.13 146.58 50.12 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.411 1.084 . . . . 0.0 112.907 -175.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.56 127.17 10.86 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.597 1.159 . . . . 0.0 110.514 -170.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.4 mttt -112.46 142.07 45.44 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.997 0.919 . . . . 0.0 112.463 172.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.461 HG21 ' HB2' ' A' ' 81' ' ' GLN . 7.6 p -134.13 133.39 55.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 126.255 1.822 . . . . 0.0 111.275 171.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -93.51 129.56 39.67 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.712 1.605 . . . . 0.0 110.023 172.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.7 tt -158.13 147.77 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.497 1.119 . . . . 0.0 111.339 -166.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -84.64 127.79 34.26 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 120.723 -1.236 . . . . 0.0 111.6 174.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 9.7 m-30 -107.69 140.14 41.19 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.686 1.594 . . . . 0.0 110.134 171.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -108.14 124.16 49.82 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.989 1.715 . . . . 0.0 110.651 175.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 2.5 ptp180 -92.23 159.9 15.41 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.821 1.249 . . . . 0.0 113.755 -177.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -58.81 -22.46 58.6 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 125.272 1.429 . . . . 0.0 114.322 179.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -70.61 -12.34 61.5 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.501 1.12 . . . . 0.0 113.349 176.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 95.35 27.15 11.03 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 124.53 1.062 . . . . 0.0 113.693 178.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 69.0 m -132.8 169.07 17.25 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.735 1.214 . . . . 0.0 111.414 -177.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 22.8 p -139.82 169.9 16.86 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 179.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -164.82 154.62 13.52 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 126.308 1.843 . . . . 0.0 110.348 -176.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -76.81 121.4 23.3 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.952 0.882 . . . . 0.0 110.124 168.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 49.5 t -104.7 140.44 38.06 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 127.755 2.422 . . . . 0.0 109.92 174.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 14.2 tp -93.0 119.0 31.8 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 160.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 44.2 t -103.45 117.19 48.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 124.476 1.11 . . . . 0.0 108.452 172.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -105.33 120.85 42.61 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.375 1.47 . . . . 0.0 108.314 174.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.2 p -93.64 131.09 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 119.483 1.038 . . . . 0.0 109.365 164.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 99.5 t -119.43 103.85 46.26 Favored Pre-proline 0 CA--C 1.537 0.46 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 176.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -75.78 139.76 22.66 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.906 2.404 . . . . 0.0 110.574 -175.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 96.3 t -112.37 125.33 69.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.353 1.061 . . . . 0.0 109.76 -178.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 67.2 mttt -93.55 154.54 17.82 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.036 0.934 . . . . 0.0 113.26 171.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -93.09 -174.21 3.49 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.497 1.119 . . . . 0.0 111.521 176.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -61.67 -20.69 63.71 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.013 1.325 . . . . 0.0 114.548 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -95.39 0.02 53.04 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.856 1.263 . . . . 0.0 113.162 177.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 79.31 22.55 64.9 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 124.155 0.883 . . . . 0.0 114.788 176.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -107.24 150.41 26.68 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.134 1.374 . . . . 0.0 109.987 172.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 59.1 t -79.1 124.97 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 123.565 0.746 . . . . 0.0 109.284 -179.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -127.01 -22.41 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 -176.101 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 53.8 mtm -133.46 154.51 50.74 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.905 1.282 . . . . 0.0 112.552 172.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -119.18 132.94 56.02 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 125.581 1.552 . . . . 0.0 109.556 170.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 41.6 mt -100.66 117.39 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 167.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -102.98 135.42 44.69 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 173.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -130.48 127.44 39.2 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.321 1.049 . . . . 0.0 110.129 -171.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -108.02 139.39 42.73 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.817 1.647 . . . . 0.0 111.647 -173.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -147.72 135.03 20.61 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.129 1.372 . . . . 0.0 109.728 175.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 49.9 t -73.39 117.71 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 CA-C-N 119.365 0.984 . . . . 0.0 108.611 174.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.9 p -95.51 -24.62 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 123.597 0.759 . . . . 0.0 112.666 178.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 14.5 tpt -165.8 134.98 3.26 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.358 1.463 . . . . 0.0 110.411 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -92.28 130.4 37.98 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.482 -0.761 . . . . 0.0 110.979 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt . . . . . 0 C--O 1.253 1.272 0 C-N-CA 125.332 1.453 . . . . 0.0 113.941 178.394 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.4 ttm . . . . . 0 N--CA 1.494 1.751 0 CA-C-O 118.431 -0.795 . . . . 0.0 110.689 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -75.92 141.21 23.83 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 123.254 2.636 . . . . 0.0 110.85 175.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 19.4 m -139.34 38.88 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 124.832 1.253 . . . . 0.0 111.454 -177.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 12.3 ptp85 -65.77 -19.21 65.81 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 115.205 1.558 . . . . 0.0 115.205 -171.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 76.5 mtp85 -128.03 133.25 49.09 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.922 1.689 . . . . 0.0 110.378 174.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -89.93 -54.38 2.19 Favored Glycine 0 N--CA 1.475 1.262 0 C-N-CA 124.783 1.183 . . . . 0.0 112.726 -176.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 66.1 t60 69.22 -33.66 0.25 Allowed 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 128.319 2.647 . . . . 0.0 115.765 170.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.8 p -55.29 -42.97 69.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 126.098 1.759 . . . . 0.0 114.58 -173.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 164.57 157.98 0.07 OUTLIER Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 129.446 3.099 . . . . 0.0 108.392 -165.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -80.53 128.87 7.14 Favored 'Trans proline' 0 CA--C 1.538 0.725 0 C-N-CA 122.444 2.096 . . . . 0.0 111.632 178.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 14.3 mp0 -83.99 -31.89 25.26 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.98 0.912 . . . . 0.0 112.735 173.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -135.0 32.66 3.18 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.902 1.281 . . . . 0.0 113.755 -162.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.8 t -45.83 -35.52 4.51 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 128.186 2.594 . . . . 0.0 114.628 -172.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -65.01 -50.81 64.83 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.197 0.599 . . . . 0.0 111.567 176.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 54.5 tp -64.33 -35.98 82.62 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.201 1.4 . . . . 0.0 111.022 172.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.5 -28.6 67.19 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.677 1.191 . . . . 0.0 112.688 178.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 94.4 m -74.29 -33.34 63.2 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.47 1.108 . . . . 0.0 110.869 173.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.2 mm -73.6 -36.22 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 124.351 1.06 . . . . 0.0 111.108 176.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 96.5 mt -57.04 -42.59 79.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 123.488 0.715 . . . . 0.0 110.818 176.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 89.3 mtt-85 -61.54 -22.05 64.81 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 176.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -76.07 -35.96 59.2 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 120.885 -1.134 . . . . 0.0 112.131 177.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -96.99 -11.85 24.04 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 114.559 1.318 . . . . 0.0 114.559 176.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -64.1 162.33 14.48 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 119.537 1.062 . . . . 0.0 111.91 162.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -80.14 -7.11 88.82 Favored Glycine 0 N--CA 1.473 1.129 0 C-N-CA 124.8 1.191 . . . . 0.0 114.812 -174.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 64.07 30.02 14.02 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.826 1.651 . . . . 0.0 113.195 169.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.2 m -72.42 -9.88 59.08 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.498 1.119 . . . . 0.0 113.941 178.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.3 mpt_? -75.41 166.67 23.24 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.661 1.185 . . . . 0.0 111.243 176.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -87.29 139.92 30.07 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.235 1.014 . . . . 0.0 110.667 -177.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -164.43 163.24 22.3 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 124.588 1.155 . . . . 0.0 112.889 177.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 20.5 pt -139.57 155.35 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 125.852 1.661 . . . . 0.0 110.576 173.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 16.0 mt -113.2 129.55 68.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 125.687 1.595 . . . . 0.0 108.479 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -127.07 144.87 50.92 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 124.53 1.132 . . . . 0.0 111.249 176.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 42.8 t-20 -68.16 127.61 33.54 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.344 0.657 . . . . 0.0 111.146 178.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -83.04 -20.21 35.42 Favored 'General case' 0 CA--C 1.546 0.812 0 O-C-N 121.364 -0.835 . . . . 0.0 113.085 176.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 75.2 mtp180 -77.73 41.01 0.32 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 126.345 1.858 . . . . 0.0 112.759 -175.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.5 p -170.37 138.24 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 126.895 2.078 . . . . 0.0 109.985 -168.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -61.07 -44.67 97.03 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.043 0.937 . . . . 0.0 112.286 -176.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -72.55 -23.18 60.95 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -176.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 89.3 m 57.87 58.95 3.37 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.755 1.222 . . . . 0.0 112.411 -175.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.0 135.83 56.8 Favored 'General case' 0 CA--C 1.551 0.998 0 O-C-N 121.203 -0.936 . . . . 0.0 112.528 -177.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 11.5 t -62.52 123.65 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 C-N-CA 123.473 0.709 . . . . 0.0 109.502 174.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.6 pt -104.61 -19.93 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 125.181 1.392 . . . . 0.0 112.354 176.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 21.3 t80 -153.98 146.17 23.78 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.864 0.866 . . . . 0.0 111.866 177.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 6.9 m -125.35 155.42 40.32 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.185 0.994 . . . . 0.0 111.161 171.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -71.34 -152.35 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.285 0 CA-C-N 118.362 0.528 . . . . 0.0 111.487 170.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -117.11 -17.52 10.26 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 120.229 -1.544 . . . . 0.0 113.205 164.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -76.3 -33.55 48.54 Favored Glycine 0 N--CA 1.471 1.007 0 O-C-N 121.324 -0.86 . . . . 0.0 112.852 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -58.13 -38.44 76.53 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.6 1.16 . . . . 0.0 111.599 177.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 9.9 t -53.0 -51.16 62.54 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.362 1.465 . . . . 0.0 111.825 173.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -74.02 -22.86 59.41 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -178.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 49.5 tp -65.16 -50.0 67.67 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.292 1.037 . . . . 0.0 111.815 176.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 80.6 m -105.86 -20.47 13.43 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 -174.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.77 6.01 70.56 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 124.585 1.088 . . . . 0.0 114.032 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -88.61 -175.72 5.03 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.578 1.151 . . . . 0.0 112.295 171.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 66.5 m -135.41 161.25 35.97 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.104 0.962 . . . . 0.0 111.104 -179.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 46.7 ttm180 -53.37 -42.49 66.95 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 121.497 -0.752 . . . . 0.0 111.842 178.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.04 -28.1 49.61 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 175.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -92.96 -35.2 13.42 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.818 1.247 . . . . 0.0 112.324 178.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 99.3 t -83.64 -12.52 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 124.509 1.123 . . . . 0.0 112.181 178.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 21.3 mmt -68.57 141.86 55.35 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 120.798 -1.189 . . . . 0.0 112.278 172.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 68.74 7.3 6.04 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 126.011 1.724 . . . . 0.0 113.609 -178.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -78.13 152.77 79.56 Favored Pre-proline 0 N--CA 1.472 0.667 0 CA-C-O 117.921 -1.038 . . . . 0.0 109.904 175.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -74.37 13.02 0.95 Allowed 'Trans proline' 0 CA--C 1.549 1.229 0 C-N-CA 124.319 3.346 . . . . 0.0 115.356 176.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 7.5 t 75.14 -27.6 0.19 Allowed 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 126.86 2.064 . . . . 0.0 113.922 167.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 38.8 p -58.92 -19.3 41.2 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 127.162 2.185 . . . . 0.0 113.92 173.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . 0.277 28.5 p 42.81 40.29 2.04 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 127.308 2.243 . . . . 0.0 114.31 178.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -57.59 -32.91 67.65 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.026 0.931 . . . . 0.0 111.765 -177.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -57.04 -15.75 5.79 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.155 1.382 . . . . 0.0 114.253 177.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 89.9 mt -75.18 -2.29 27.17 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 171.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 31.4 p-80 -60.55 133.22 55.89 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 119.826 1.194 . . . . 0.0 112.946 174.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -107.39 -161.95 21.55 Favored Glycine 0 CA--C 1.54 1.651 0 C-N-CA 126.229 1.871 . . . . 0.0 111.468 168.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.05 -26.02 18.75 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 123.083 2.522 . . . . 0.0 113.153 178.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 29.8 ttm180 -94.38 -8.09 39.74 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.547 1.139 . . . . 0.0 113.715 -176.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 25.8 m -64.6 139.41 58.76 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.254 1.421 . . . . 0.0 110.555 179.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -102.43 123.03 45.46 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.174 0.989 . . . . 0.0 109.735 179.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 42.5 mmt180 -61.58 -26.91 68.27 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 24.6 tpp180 -56.21 -46.0 79.65 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.472 1.109 . . . . 0.0 111.797 171.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.36 -45.57 65.82 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.449 1.1 . . . . 0.0 111.954 175.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.52 -33.34 63.68 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 121.62 -0.675 . . . . 0.0 112.709 177.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.59 -41.85 71.78 Favored 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 125.1 1.36 . . . . 0.0 112.502 173.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 24.5 mm-40 -60.81 -33.48 73.08 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 118.328 -0.844 . . . . 0.0 111.347 179.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 46.1 mt -59.36 -43.66 90.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 CA-C-N 120.042 1.292 . . . . 0.0 111.026 171.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.2 -35.8 74.16 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.327 0.651 . . . . 0.0 112.71 177.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 78.4 mm-40 -69.27 -32.52 71.76 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 121.604 -0.685 . . . . 0.0 111.861 174.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.71 -23.21 67.04 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.936 0.894 . . . . 0.0 112.771 178.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 61.1 mt -77.26 -15.04 59.63 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.677 1.591 . . . . 0.0 113.45 174.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 64.2 mt -89.97 -14.67 33.56 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.124 0.969 . . . . 0.0 112.426 179.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -92.64 148.48 19.11 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 125.164 1.364 . . . . 0.0 113.15 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.84 -1.57 58.02 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.721 1.208 . . . . 0.0 113.83 175.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -115.33 161.32 18.66 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.711 2.004 . . . . 0.0 111.208 176.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.79 154.34 39.37 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 178.15 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 29.9 tpt180 -155.07 129.14 8.82 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.635 1.174 . . . . 0.0 111.148 -175.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 39.5 mtmt -102.68 137.63 40.65 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.598 1.559 . . . . 0.0 111.622 174.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 64.4 t -132.97 134.94 57.7 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 C-N-CA 126.414 1.885 . . . . 0.0 108.025 177.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -106.0 130.61 53.9 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.765 0.826 . . . . 0.0 110.381 177.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.0 tt -156.98 147.2 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 124.022 0.929 . . . . 0.0 112.217 -166.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -85.73 126.66 34.15 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.027 -1.046 . . . . 0.0 111.858 174.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 18.3 m-30 -111.92 147.8 35.07 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.528 1.931 . . . . 0.0 111.116 172.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -101.25 150.14 23.29 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.8 0.84 . . . . 0.0 112.538 166.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 40.9 mtm180 -89.59 159.03 17.38 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.956 1.302 . . . . 0.0 112.283 169.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 5.9 mptp? -59.19 -27.16 65.44 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.02 0.928 . . . . 0.0 112.639 166.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -69.93 -11.46 60.89 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 126.255 1.822 . . . . 0.0 114.067 173.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 90.39 -0.67 78.22 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 125.472 1.51 . . . . 0.0 114.471 -176.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -76.74 154.63 33.9 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.533 1.133 . . . . 0.0 111.451 176.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 95.5 m -126.99 156.96 40.78 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 119.382 0.992 . . . . 0.0 112.176 174.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -161.42 154.68 21.25 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.851 1.26 . . . . 0.0 111.998 177.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -77.72 122.78 25.83 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.627 0.771 . . . . 0.0 110.392 165.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 8.2 t -107.55 140.95 39.75 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 126.083 1.753 . . . . 0.0 110.224 173.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.3 tt -92.16 121.59 33.84 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 125.158 1.383 . . . . 0.0 107.491 162.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 48.0 t -101.0 111.37 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 125.068 1.347 . . . . 0.0 108.484 169.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -107.75 107.78 18.71 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.612 1.565 . . . . 0.0 108.997 174.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.407 HG22 ' HG ' ' A' ' 127' ' ' LEU . 50.4 t -78.43 126.91 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 170.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 75.6 t -114.36 116.3 44.19 Favored Pre-proline 0 CA--C 1.538 0.51 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 170.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.69 127.0 9.9 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 123.238 2.625 . . . . 0.0 109.736 179.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 63.0 t -97.18 118.64 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 123.736 0.815 . . . . 0.0 109.279 174.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 60.4 mttt -88.48 153.51 21.1 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.675 0.79 . . . . 0.0 112.587 171.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -93.02 -173.52 3.3 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.518 1.127 . . . . 0.0 111.747 175.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -60.7 -21.36 62.8 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 125.206 1.402 . . . . 0.0 114.705 178.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -93.93 -0.82 55.43 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.854 1.262 . . . . 0.0 113.22 177.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 79.11 22.05 66.46 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 124.222 0.915 . . . . 0.0 114.537 177.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -107.29 147.89 29.69 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 125.119 1.368 . . . . 0.0 109.923 172.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.6 p -77.82 126.38 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 123.405 0.682 . . . . 0.0 110.273 178.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.58 -22.45 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 -175.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 57.7 mtm -131.99 150.96 52.01 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.779 1.231 . . . . 0.0 112.068 168.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -107.92 133.7 51.89 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 125.06 1.344 . . . . 0.0 109.215 165.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 69.2 mt -97.15 119.0 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 163.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.407 ' HG ' HG22 ' A' ' 112' ' ' VAL . 8.6 mp -96.47 119.09 34.32 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 169.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -102.81 124.88 49.16 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 123.547 0.529 . . . . 0.0 110.984 177.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -100.9 126.88 47.55 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.232 1.413 . . . . 0.0 109.998 179.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -141.53 103.94 4.48 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.38 1.072 . . . . 0.0 108.246 -172.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.2 p -61.51 116.9 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 O-C-N 120.981 -1.074 . . . . 0.0 110.473 178.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.9 p -96.76 -27.54 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.817 1.247 . . . . 0.0 113.102 -174.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 24.7 ptp -161.41 147.17 14.02 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.24 1.016 . . . . 0.0 112.64 166.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -88.93 134.31 34.0 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.705 0.802 . . . . 0.0 110.845 177.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt . . . . . 0 C--O 1.253 1.246 0 C-N-CA 125.36 1.464 . . . . 0.0 112.473 177.114 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.8 mmt . . . . . 0 N--CA 1.495 1.78 0 CA-C-O 118.837 -0.602 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -75.35 162.15 36.67 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 123.713 2.942 . . . . 0.0 111.796 176.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 19.7 m -142.1 152.53 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 125.407 1.483 . . . . 0.0 110.707 175.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -161.67 143.69 11.6 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.464 1.106 . . . . 0.0 111.603 -176.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 7.2 ppt_? -159.76 157.57 29.61 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.97 1.708 . . . . 0.0 112.018 175.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -122.38 -144.94 6.88 Favored Glycine 0 N--CA 1.474 1.196 0 C-N-CA 125.987 1.756 . . . . 0.0 112.24 174.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 11.7 p-80 -83.95 151.29 25.14 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 124.049 0.94 . . . . 0.0 111.081 165.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.8 p -76.72 -37.5 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 O-C-N 121.279 -0.888 . . . . 0.0 113.384 -173.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 62.98 152.67 0.11 Allowed Pre-proline 0 CA--C 1.557 1.232 0 C-N-CA 127.234 2.213 . . . . 0.0 112.932 -169.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -68.88 120.4 7.31 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 122.556 2.171 . . . . 0.0 111.281 -177.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 80.5 mm-40 -109.39 -31.96 7.34 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.219 1.008 . . . . 0.0 112.681 179.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -140.92 41.99 1.82 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.795 1.638 . . . . 0.0 112.277 -168.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.8 t -55.95 -23.29 31.18 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 126.634 1.974 . . . . 0.0 114.815 -170.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -75.28 -45.09 42.07 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.252 -0.905 . . . . 0.0 112.018 172.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 52.9 tp -63.18 -35.94 81.96 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.764 1.226 . . . . 0.0 111.16 171.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -52.1 -33.31 39.01 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.548 1.539 . . . . 0.0 112.583 175.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 21.4 m -72.65 -21.56 61.07 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.546 1.538 . . . . 0.0 112.02 176.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.6 mm -82.22 -39.56 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 124.168 0.987 . . . . 0.0 109.953 177.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.9 mp -55.21 -38.95 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 123.422 0.689 . . . . 0.0 111.367 177.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 50.0 ptt85 -73.45 -16.86 61.3 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -178.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -85.69 -36.77 20.04 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.121 1.368 . . . . 0.0 111.297 171.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -70.74 -28.83 65.0 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.485 1.114 . . . . 0.0 112.029 174.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -76.43 168.34 20.24 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 167.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 122.6 -21.86 7.49 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 127.128 2.299 . . . . 0.0 112.554 -176.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 26.3 mp0 -92.5 -19.98 21.43 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.513 1.125 . . . . 0.0 112.256 173.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.9 m 79.66 16.19 0.86 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 126.984 2.113 . . . . 0.0 113.395 168.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.1 173.26 10.34 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 122.557 1.17 . . . . 0.0 111.477 172.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.7 mptt -97.74 139.09 34.14 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.512 1.525 . . . . 0.0 110.351 -179.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -162.15 160.93 27.8 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 124.072 0.949 . . . . 0.0 113.127 173.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 12.8 pt -139.72 153.22 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 125.996 1.718 . . . . 0.0 109.937 175.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.2 mp -116.5 133.31 63.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 C-N-CA 125.337 1.455 . . . . 0.0 109.146 -179.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -132.54 142.81 49.35 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 124.825 1.25 . . . . 0.0 111.815 -176.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -65.56 121.69 15.51 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.518 1.127 . . . . 0.0 111.944 177.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -78.82 -19.87 51.03 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 178.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 26.0 mmm180 -73.31 -40.65 64.34 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.468 1.107 . . . . 0.0 112.527 -175.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 32.6 m -73.55 147.78 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 124.013 0.925 . . . . 0.0 111.892 175.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -62.22 -42.02 98.92 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.574 1.149 . . . . 0.0 113.225 -172.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -77.32 -11.32 59.82 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 113.785 1.032 . . . . 0.0 113.785 -176.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 81.6 m 51.03 60.31 3.97 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.451 1.5 . . . . 0.0 111.776 -170.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.06 137.51 55.07 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.749 0.82 . . . . 0.0 112.023 -176.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 41.4 t -63.71 123.79 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 123.723 0.809 . . . . 0.0 109.263 174.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.6 pt -103.83 -19.74 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.727 1.211 . . . . 0.0 112.298 175.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -154.08 143.72 21.66 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.34 1.056 . . . . 0.0 111.506 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 4.2 m -125.62 157.63 36.73 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.816 1.246 . . . . 0.0 111.594 174.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -73.79 -149.95 0.02 OUTLIER 'General case' 0 CA--C 1.56 1.364 0 CA-C-N 118.622 0.646 . . . . 0.0 111.399 169.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -116.72 -18.69 10.2 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 120.425 -1.422 . . . . 0.0 113.266 163.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -76.0 -34.98 45.83 Favored Glycine 0 N--CA 1.471 0.99 0 O-C-N 121.276 -0.89 . . . . 0.0 112.684 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -55.29 -39.12 69.5 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.857 1.263 . . . . 0.0 111.605 177.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 2.8 t -54.6 -56.76 15.65 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.69 1.596 . . . . 0.0 112.09 176.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -71.31 -20.54 62.18 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -179.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.8 -53.51 56.96 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.64 1.176 . . . . 0.0 110.947 175.129 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 75.9 m -104.94 -31.97 8.99 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 -174.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 109.72 0.12 30.55 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 127.207 2.337 . . . . 0.0 115.945 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -79.58 -160.75 0.28 Allowed 'General case' 0 CA--C 1.554 1.102 0 CA-C-N 118.786 1.293 . . . . 0.0 112.466 177.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 69.8 m -145.01 160.91 40.62 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.055 1.342 . . . . 0.0 110.582 174.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -53.03 -44.11 67.09 Favored 'General case' 0 N--CA 1.478 0.956 0 O-C-N 121.355 -0.841 . . . . 0.0 111.668 177.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.69 -25.95 42.45 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 176.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -91.69 -39.46 11.82 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.024 1.33 . . . . 0.0 112.176 177.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 87.4 t -80.81 -15.84 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 124.502 1.121 . . . . 0.0 112.277 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 68.2 mmm -65.72 137.87 57.58 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 120.843 -1.16 . . . . 0.0 111.34 172.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 29.7 tp60 72.92 6.14 5.29 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 126.508 1.923 . . . . 0.0 113.633 -177.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 34.6 mmt180 -86.88 153.1 54.61 Favored Pre-proline 0 N--CA 1.473 0.699 0 C-N-CA 124.548 1.139 . . . . 0.0 110.84 176.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -71.52 136.01 27.56 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.109 2.539 . . . . 0.0 110.092 171.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 19.0 p -68.69 -7.67 35.53 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -176.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 41.2 p -62.3 -23.97 67.04 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.065 1.346 . . . . 0.0 112.124 168.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 84.0 m 57.69 36.5 26.69 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.617 1.567 . . . . 0.0 113.009 178.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -56.16 -29.44 60.81 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.766 1.226 . . . . 0.0 112.24 177.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -60.62 -13.68 15.84 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.852 1.261 . . . . 0.0 114.357 175.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.3 mt -90.35 -0.65 57.73 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.112 1.365 . . . . 0.0 113.853 174.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -70.96 161.52 30.95 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 -178.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -160.85 -164.62 16.08 Favored Glycine 0 CA--C 1.538 1.52 0 C-N-CA 126.857 2.17 . . . . 0.0 111.052 166.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -63.54 -20.47 69.6 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 123.083 2.522 . . . . 0.0 114.523 -176.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 27.1 mmt85 -88.66 -8.54 54.43 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 119.298 0.954 . . . . 0.0 113.306 175.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 28.7 m -73.7 132.4 42.65 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 119.464 1.029 . . . . 0.0 109.502 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 -87.07 122.16 30.52 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.366 0.666 . . . . 0.0 109.761 -169.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 31.9 mmm180 -58.86 -39.17 80.53 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.771 0.828 . . . . 0.0 112.608 -175.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 17.6 ttm180 -67.99 -35.79 78.93 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.649 0.779 . . . . 0.0 112.31 176.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -71.6 -43.07 66.87 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.061 -1.024 . . . . 0.0 112.217 179.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -56.15 -33.38 65.16 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.161 0.584 . . . . 0.0 111.83 171.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -72.37 -47.65 47.78 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 124.703 1.201 . . . . 0.0 112.259 172.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 13.6 mm-40 -62.28 -34.25 76.2 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 118.404 -0.808 . . . . 0.0 111.775 -179.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 90.7 mt -62.61 -40.06 86.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 CA-C-N 120.198 1.363 . . . . 0.0 111.557 171.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.86 -37.08 81.39 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 119.296 0.953 . . . . 0.0 112.361 174.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 -67.65 -32.18 72.69 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 121.591 -0.693 . . . . 0.0 112.04 173.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.43 -21.97 66.61 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 119.239 0.927 . . . . 0.0 112.761 176.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 41.1 mt -83.38 -14.87 51.82 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.282 1.433 . . . . 0.0 113.134 172.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 74.8 mt -89.9 -16.89 29.07 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.003 0.921 . . . . 0.0 112.01 171.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -83.31 145.52 23.16 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 125.159 1.361 . . . . 0.0 112.5 176.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.81 -4.63 56.49 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -179.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -125.57 160.92 28.37 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.452 1.901 . . . . 0.0 110.652 -178.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -65.11 147.17 53.95 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -176.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.48 123.84 5.91 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.627 1.171 . . . . 0.0 111.147 -164.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 44.1 mtmt -97.65 141.84 30.19 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.2 1.4 . . . . 0.0 112.735 176.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 56.8 t -139.2 138.63 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 126.356 1.863 . . . . 0.0 108.738 174.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -102.15 129.93 48.65 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.163 0.985 . . . . 0.0 110.713 177.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.8 tt -153.22 148.2 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 124.614 1.166 . . . . 0.0 111.847 -168.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -87.78 119.06 27.74 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 120.969 -1.082 . . . . 0.0 111.472 176.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 13.7 m-30 -106.46 140.25 39.66 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.991 1.716 . . . . 0.0 110.9 174.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -92.69 142.3 27.52 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.022 0.929 . . . . 0.0 112.805 176.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 43.0 ttm-85 -80.2 156.57 26.86 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.629 1.972 . . . . 0.0 110.404 174.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 25.6 mmmt -58.02 -26.53 62.55 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 176.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -78.58 -5.98 54.3 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.635 1.574 . . . . 0.0 113.984 177.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 92.14 1.46 69.71 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 125.039 1.304 . . . . 0.0 114.455 -176.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 8.6 t -77.45 178.44 7.19 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 118.319 1.059 . . . . 0.0 111.763 171.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 39.4 t -151.42 154.77 37.27 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.78 1.232 . . . . 0.0 112.376 -170.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -158.81 154.4 26.08 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.232 1.813 . . . . 0.0 110.882 179.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -81.22 124.78 29.58 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 121.815 0.817 . . . . 0.0 110.403 170.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 36.6 t -111.59 140.8 45.91 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.638 1.975 . . . . 0.0 110.801 177.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 18.8 tp -93.15 115.72 28.35 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.996 1.318 . . . . 0.0 108.163 165.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 81.4 t -99.37 118.22 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 171.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -109.69 109.42 20.14 Favored 'General case' 0 C--O 1.225 -0.198 0 C-N-CA 125.689 1.596 . . . . 0.0 108.411 172.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 71.5 t -78.66 130.43 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 169.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 78.1 t -117.22 111.33 40.4 Favored Pre-proline 0 N--CA 1.466 0.361 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 167.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.83 133.79 18.99 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.751 2.301 . . . . 0.0 109.884 179.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 41.1 t -91.74 119.62 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 173.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 66.0 mttt -92.96 151.9 19.65 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.649 0.738 . . . . 0.0 112.365 167.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -92.2 -173.87 3.57 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.959 0.904 . . . . 0.0 111.7 175.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -60.81 -21.3 62.99 Favored 'General case' 0 CA--C 1.548 0.865 0 C-N-CA 125.083 1.353 . . . . 0.0 114.553 178.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -93.99 -0.42 55.54 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.396 1.078 . . . . 0.0 113.105 177.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 77.48 19.87 75.56 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 124.173 0.892 . . . . 0.0 114.465 179.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -98.73 146.81 25.51 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.796 1.238 . . . . 0.0 109.393 172.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 84.1 t -77.2 127.97 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 177.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 3.3 pt -123.39 -23.15 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 -171.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 72.2 mtm -150.58 157.42 42.97 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.855 1.662 . . . . 0.0 110.487 178.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -115.24 132.22 56.68 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 124.683 1.193 . . . . 0.0 109.98 173.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 46.7 mt -97.18 114.84 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 105.647 -1.983 . . . . 0.0 105.647 164.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -92.98 117.91 30.58 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 171.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -107.53 129.76 54.94 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 119.478 -0.296 . . . . 0.0 111.02 178.216 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -109.39 143.18 39.31 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.111 1.364 . . . . 0.0 111.928 -176.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -145.36 145.34 31.15 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 126.007 1.723 . . . . 0.0 108.553 172.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 60.7 t -84.49 117.02 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 174.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.0 p -93.17 -25.97 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -179.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 44.6 tpp -165.28 123.68 1.65 Allowed 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.799 1.24 . . . . 0.0 110.75 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -84.36 123.51 30.27 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 121.562 -0.711 . . . . 0.0 109.819 174.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.255 1.357 0 CA-C-O 115.744 -2.074 . . . . 0.0 115.463 -170.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.4 mtt . . . . . 0 N--CA 1.497 1.882 0 CA-C-O 118.771 -0.633 . . . . 0.0 110.944 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -72.39 160.97 45.62 Favored 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 123.723 2.949 . . . . 0.0 112.149 179.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 67.9 t -83.55 125.33 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 123.883 0.873 . . . . 0.0 109.712 178.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 43.4 ttt-85 -66.63 113.52 4.86 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.272 1.029 . . . . 0.0 111.088 179.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 9.8 ttm-85 48.72 28.99 2.03 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 127.458 2.303 . . . . 0.0 116.787 176.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.86 117.4 5.8 Favored Glycine 0 N--CA 1.472 1.076 0 C-N-CA 124.988 1.28 . . . . 0.0 111.196 178.074 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 7.6 p-80 -167.98 165.93 13.44 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.856 1.662 . . . . 0.0 111.708 -178.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 42.0 t -139.05 141.65 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 125.909 1.684 . . . . 0.0 108.637 174.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.59 150.69 55.44 Favored Pre-proline 0 CA--C 1.551 0.99 0 C-N-CA 124.263 1.025 . . . . 0.0 112.354 176.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -64.46 116.36 3.72 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.857 2.371 . . . . 0.0 110.636 -176.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 72.5 mm-40 -75.39 -35.38 61.08 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.468 0.707 . . . . 0.0 110.974 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -86.49 58.5 5.1 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.625 1.97 . . . . 0.0 111.749 177.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 43.2 p -50.92 -33.35 23.95 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 126.869 2.067 . . . . 0.0 113.749 -178.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -67.87 -47.72 68.11 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.94 0.896 . . . . 0.0 112.116 175.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 39.4 tp -63.15 -36.53 83.92 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.88 1.272 . . . . 0.0 111.072 175.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -59.93 -29.61 68.5 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.667 0.787 . . . . 0.0 112.815 179.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 73.8 m -72.74 -21.43 61.03 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.227 1.411 . . . . 0.0 111.935 173.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.7 mm -87.42 -42.71 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.087 1.355 . . . . 0.0 110.819 173.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 93.5 mt -53.68 -45.25 60.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 124.036 0.934 . . . . 0.0 110.598 178.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -66.09 -24.6 66.73 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 -179.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -79.06 -33.41 44.64 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.602 1.161 . . . . 0.0 111.949 175.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -73.56 -34.17 65.02 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.144 0.978 . . . . 0.0 111.496 170.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.45 178.39 5.3 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 114.395 1.257 . . . . 0.0 114.395 178.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 102.79 12.09 33.25 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 126.596 2.046 . . . . 0.0 112.039 -160.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -133.64 -24.3 1.77 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.636 1.174 . . . . 0.0 113.177 -171.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 75.29 16.57 2.69 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 126.114 1.766 . . . . 0.0 114.38 168.074 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? -73.0 166.42 23.11 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 120.771 -1.206 . . . . 0.0 111.883 174.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.5 mptt -89.96 134.83 34.0 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.351 1.46 . . . . 0.0 110.393 -177.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -159.4 161.7 35.65 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 124.289 1.036 . . . . 0.0 113.17 178.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 20.7 pt -140.02 161.46 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 126.671 1.988 . . . . 0.0 109.733 173.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.9 mp -126.26 133.88 67.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 C-N-CA 124.813 1.245 . . . . 0.0 109.545 177.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -130.85 144.71 51.65 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.673 1.189 . . . . 0.0 111.477 178.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -72.78 125.06 26.63 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 122.844 0.458 . . . . 0.0 111.436 178.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.22 -32.6 70.55 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.341 1.056 . . . . 0.0 112.412 -177.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 25.0 mmm180 -80.11 36.52 0.35 Allowed 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 126.082 1.753 . . . . 0.0 112.796 -173.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 70.3 t -144.07 133.38 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 126.719 2.008 . . . . 0.0 108.977 -171.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -56.61 -35.92 68.83 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 -172.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -103.05 -3.86 25.38 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.544 1.538 . . . . 0.0 113.05 -178.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 5.9 t 52.14 71.37 0.47 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 126.372 1.869 . . . . 0.0 111.664 -174.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.74 133.82 50.94 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 121.254 -0.904 . . . . 0.0 111.658 -176.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 15.6 t -62.62 120.66 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 CA-C-N 118.705 0.684 . . . . 0.0 109.159 171.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 42.9 pt -102.08 -21.68 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 124.766 1.227 . . . . 0.0 112.26 176.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -152.18 144.42 23.95 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.363 1.065 . . . . 0.0 111.575 178.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.468 ' HB3' ' CE1' ' A' ' 48' ' ' PHE . 0.6 OUTLIER -135.04 149.14 50.08 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.491 1.116 . . . . 0.0 111.53 -178.942 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -76.57 -168.96 1.1 Allowed 'General case' 0 CA--C 1.555 1.164 0 CA-C-N 119.226 0.921 . . . . 0.0 111.367 169.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -103.84 -21.63 13.63 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.248 1.419 . . . . 0.0 112.553 169.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.23 -36.18 60.09 Favored Glycine 0 C--N 1.343 0.917 0 O-C-N 121.578 -0.701 . . . . 0.0 112.551 -178.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.468 ' CE1' ' HB3' ' A' ' 44' ' ' CYS . 0.6 OUTLIER -67.68 -30.45 69.98 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 122.98 0.512 . . . . 0.0 111.869 179.53 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 77.6 m -53.53 -52.29 60.14 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.712 1.205 . . . . 0.0 111.757 174.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -71.38 -19.06 62.32 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.966 0.906 . . . . 0.0 113.211 -179.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.428 HD11 HG23 ' A' ' 131' ' ' VAL . 10.3 tp -64.21 -52.83 56.96 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.809 1.244 . . . . 0.0 111.313 179.259 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 71.0 m -101.87 -19.09 15.43 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 95.12 2.11 62.5 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 125.813 1.673 . . . . 0.0 114.344 177.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -83.95 -175.27 5.72 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.778 1.231 . . . . 0.0 113.224 170.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.443 ' H ' ' CG ' ' A' ' 58' ' ' GLU . 69.1 m -137.34 160.13 39.95 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 121.317 -0.865 . . . . 0.0 111.663 -179.076 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 36.1 ttm180 -46.28 -42.25 14.26 Favored 'General case' 0 N--CA 1.48 1.035 0 O-C-N 121.421 -0.799 . . . . 0.0 112.029 171.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.73 -32.84 63.72 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.899 1.28 . . . . 0.0 113.652 178.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.443 ' CG ' ' H ' ' A' ' 55' ' ' SER . 14.2 pt-20 -99.6 -23.65 14.99 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 177.05 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 85.3 t -85.26 -20.49 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 C-N-CA 124.83 1.252 . . . . 0.0 112.659 176.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 53.3 mmm -63.2 138.12 58.44 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 120.403 -1.436 . . . . 0.0 110.843 175.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 67.97 10.06 7.56 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.429 1.492 . . . . 0.0 114.094 179.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 -85.33 156.43 59.68 Favored Pre-proline 0 N--CA 1.472 0.668 0 C-N-CA 124.716 1.206 . . . . 0.0 111.059 174.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -67.27 127.17 16.17 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.495 2.13 . . . . 0.0 109.415 167.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.402 ' SG ' HD13 ' A' ' 127' ' ' LEU . 9.1 t -69.69 -8.88 51.62 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -172.321 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 37.5 p -59.83 -28.1 67.19 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.893 1.277 . . . . 0.0 112.163 169.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 80.9 m 52.35 36.24 19.32 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.208 1.403 . . . . 0.0 112.726 -177.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -57.67 -30.1 65.18 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.624 1.17 . . . . 0.0 112.327 -177.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -59.03 -14.26 9.05 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.186 1.395 . . . . 0.0 114.211 175.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 89.5 mt -78.73 -4.14 47.72 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 173.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 15.9 p-80 -60.71 150.57 31.83 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-N 120.123 1.328 . . . . 0.0 114.268 178.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -142.84 -162.76 9.42 Favored Glycine 0 CA--C 1.54 1.605 0 C-N-CA 126.64 2.067 . . . . 0.0 112.42 173.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -71.04 -8.83 24.45 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 123.623 2.882 . . . . 0.0 114.122 -178.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 84.8 mmt-85 -107.27 8.04 29.64 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.045 1.338 . . . . 0.0 113.531 175.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 22.2 m -89.95 133.24 34.9 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.89 1.276 . . . . 0.0 109.803 178.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -102.45 137.52 40.58 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.295 1.038 . . . . 0.0 109.871 -179.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 27.8 mmt85 -58.84 -37.88 77.45 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.987 0.915 . . . . 0.0 112.199 -177.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 31.6 tpt180 -59.73 -43.99 93.94 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.486 1.115 . . . . 0.0 112.258 176.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.49 -45.9 74.5 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 121.42 -0.8 . . . . 0.0 112.147 178.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -57.28 -35.66 70.06 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 121.645 -0.659 . . . . 0.0 112.522 174.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -72.15 -44.85 62.47 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 125.186 1.394 . . . . 0.0 112.377 175.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.3 mm100 -60.85 -34.98 75.42 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.946 0.899 . . . . 0.0 111.227 -179.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 93.0 mt -60.63 -41.57 88.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 CA-C-N 119.702 1.137 . . . . 0.0 111.841 169.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.78 -32.22 70.59 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 119.562 1.074 . . . . 0.0 112.805 174.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 73.9 mm-40 -64.19 -37.35 87.14 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 121.475 -0.765 . . . . 0.0 111.232 171.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.96 -23.13 65.1 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 113.229 0.826 . . . . 0.0 113.229 177.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 70.3 mt -87.53 -14.09 41.24 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.433 1.493 . . . . 0.0 114.059 178.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.1 pp -100.84 -8.14 22.89 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 168.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -86.26 146.09 20.85 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 125.18 1.371 . . . . 0.0 112.344 175.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -93.42 1.32 56.9 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.57 1.148 . . . . 0.0 113.601 176.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.14 159.92 23.08 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.071 1.748 . . . . 0.0 111.604 -178.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -62.23 135.24 57.39 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.281 1.432 . . . . 0.0 111.937 178.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -138.82 127.9 23.95 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.506 1.122 . . . . 0.0 112.44 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 37.1 mtmt -101.18 132.26 46.75 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.496 1.518 . . . . 0.0 110.465 167.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 46.8 t -133.38 134.5 57.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 125.597 1.559 . . . . 0.0 108.231 177.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -103.85 132.03 50.49 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.761 0.824 . . . . 0.0 110.666 179.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.3 tt -154.79 150.15 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 124.288 1.035 . . . . 0.0 111.729 -168.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -86.98 127.43 35.09 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 120.998 -1.064 . . . . 0.0 111.747 172.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 17.6 m-30 -114.05 138.92 49.74 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.612 1.965 . . . . 0.0 110.719 171.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -85.5 156.31 20.84 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.382 0.673 . . . . 0.0 112.13 167.156 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -115.02 157.61 23.23 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.061 1.344 . . . . 0.0 113.246 172.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -48.84 -33.59 10.87 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 127.141 2.176 . . . . 0.0 114.637 -178.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -70.57 -10.48 59.39 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.259 1.423 . . . . 0.0 113.895 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 97.09 13.05 47.28 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 125.29 1.424 . . . . 0.0 114.264 178.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 22.9 m -107.51 -177.49 3.36 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.696 1.198 . . . . 0.0 111.242 177.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 25.1 p -148.33 171.14 16.48 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 120.878 -1.138 . . . . 0.0 113.291 176.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 18.2 p90 -160.76 159.98 30.75 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.764 1.626 . . . . 0.0 111.468 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -80.44 123.2 27.85 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 123.528 0.731 . . . . 0.0 110.328 167.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 19.0 t -106.93 134.63 49.79 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.212 1.805 . . . . 0.0 110.356 172.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.0 tt -88.13 118.48 27.74 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 161.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 59.7 t -99.78 110.55 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 124.881 1.272 . . . . 0.0 108.217 169.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -102.89 111.47 23.81 Favored 'General case' 0 C--O 1.227 -0.081 0 C-N-CA 125.426 1.49 . . . . 0.0 108.055 172.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.449 HG22 ' HG ' ' A' ' 127' ' ' LEU . 28.0 t -95.17 124.1 47.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.048 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 74.7 t -110.34 115.38 54.38 Favored Pre-proline 0 CA--C 1.537 0.466 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 -178.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -73.96 124.18 8.95 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.947 2.431 . . . . 0.0 109.904 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 88.3 t -98.48 117.12 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 123.328 0.651 . . . . 0.0 109.724 173.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 61.5 mttt -87.39 154.33 20.75 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.883 0.873 . . . . 0.0 112.581 172.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -92.57 -173.53 3.39 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.386 1.075 . . . . 0.0 111.629 175.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -60.18 -22.25 62.69 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.039 1.336 . . . . 0.0 114.416 178.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -90.68 -5.39 55.86 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.058 1.343 . . . . 0.0 113.026 178.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 80.5 22.56 62.12 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 124.425 1.012 . . . . 0.0 114.48 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -108.33 148.38 30.14 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.281 1.432 . . . . 0.0 109.88 172.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.0 p -79.51 125.67 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 123.56 0.744 . . . . 0.0 110.615 179.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.23 -22.86 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 -174.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 56.8 mtm -132.19 154.83 49.17 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.288 1.435 . . . . 0.0 111.857 170.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -117.14 133.52 55.9 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 124.957 1.303 . . . . 0.0 109.27 168.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 55.4 mt -96.59 118.98 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 105.647 -1.982 . . . . 0.0 105.647 166.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.449 ' HG ' HG22 ' A' ' 112' ' ' VAL . 6.9 mp -103.88 117.32 34.06 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 177.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -107.71 126.62 52.83 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 123.417 0.448 . . . . 0.0 110.842 -176.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 16.5 m-30 -102.67 134.07 46.65 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.094 1.358 . . . . 0.0 110.49 -177.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -138.08 127.61 24.92 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 124.885 1.274 . . . . 0.0 109.369 176.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.428 HG23 HD11 ' A' ' 51' ' ' LEU . 71.5 t -74.43 110.75 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 175.248 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.3 p -93.99 -23.58 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 123.711 0.804 . . . . 0.0 112.705 -173.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 14.3 tpt -164.4 129.4 2.74 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.113 1.365 . . . . 0.0 110.461 179.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -89.22 124.33 34.27 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.551 0.74 . . . . 0.0 110.339 178.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 6.7 mmpt? . . . . . 0 C--O 1.253 1.273 0 CA-C-O 117.67 -1.157 . . . . 0.0 112.911 178.648 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.5 ttm . . . . . 0 N--CA 1.495 1.8 0 CA-C-O 118.467 -0.777 . . . . 0.0 110.545 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -75.94 155.29 38.61 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 123.547 2.831 . . . . 0.0 111.889 179.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 58.3 t -141.07 134.69 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 125.252 1.421 . . . . 0.0 109.196 176.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 39.6 ptt180 -163.92 166.02 22.12 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.549 1.54 . . . . 0.0 112.575 -177.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 66.16 26.25 10.6 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 126.418 1.887 . . . . 0.0 113.823 169.073 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -140.45 167.9 25.36 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 125.729 1.633 . . . . 0.0 113.632 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 7.0 p-80 -80.39 172.22 14.05 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 124.916 1.287 . . . . 0.0 112.443 173.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.5 p -57.19 129.06 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 124.159 0.983 . . . . 0.0 112.658 -176.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -88.07 152.08 50.18 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 124.815 1.246 . . . . 0.0 111.971 178.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -63.75 134.55 44.33 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.948 2.432 . . . . 0.0 110.061 174.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -73.37 -66.49 0.68 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.905 0.86 . . . . 0.0 110.612 -177.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 52.1 p-10 -147.18 168.19 22.28 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 126.986 2.114 . . . . 0.0 111.026 -171.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 39.0 p -140.49 -51.76 0.48 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.927 1.691 . . . . 0.0 112.41 -170.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -80.0 -48.01 14.02 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.658 0.783 . . . . 0.0 111.642 177.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 61.8 tp -61.67 -33.39 73.9 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.457 1.103 . . . . 0.0 111.314 177.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -55.22 -32.61 62.41 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.405 1.082 . . . . 0.0 113.271 174.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 27.8 m -76.56 -24.73 53.58 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.437 1.495 . . . . 0.0 111.369 176.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 17.0 mm -81.91 -42.32 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 124.059 0.944 . . . . 0.0 110.522 175.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 81.9 mt -54.34 -48.29 68.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 123.862 0.865 . . . . 0.0 110.61 177.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 36.7 ptt180 -65.85 -19.8 66.01 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 -178.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 24.6 mtpp -77.28 -33.1 55.9 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.52 1.055 . . . . 0.0 112.447 172.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -92.97 -12.07 31.68 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.145 1.378 . . . . 0.0 114.293 178.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -59.47 165.08 3.02 Favored 'General case' 0 CA--C 1.552 1.056 0 CA-C-O 122.353 1.073 . . . . 0.0 112.943 165.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -96.67 42.72 2.16 Favored Glycine 0 N--CA 1.468 0.83 0 C-N-CA 125.878 1.704 . . . . 0.0 114.668 -164.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 25.7 mp0 -74.18 62.22 0.91 Allowed 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.151 1.38 . . . . 0.0 111.292 174.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.7 t 95.4 -2.18 0.07 Allowed 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 128.936 2.894 . . . . 0.0 113.828 165.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -82.45 165.53 20.13 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 122.107 0.956 . . . . 0.0 111.645 178.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.3 mptt -98.88 138.61 35.76 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.32 1.448 . . . . 0.0 111.071 -171.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -162.93 161.93 25.96 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.229 1.012 . . . . 0.0 113.57 179.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 18.0 pt -140.88 157.52 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 126.529 1.931 . . . . 0.0 110.37 174.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 13.5 mt -119.27 134.51 62.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 125.897 1.679 . . . . 0.0 109.062 -178.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -135.86 151.27 49.86 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.205 1.402 . . . . 0.0 112.148 -178.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 34.7 p30 -80.3 111.55 16.78 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.133 0.973 . . . . 0.0 113.335 -174.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.8 -25.0 66.25 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 120.594 -1.316 . . . . 0.0 113.815 -173.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 52.3 mtm180 -84.2 -3.17 57.99 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 -173.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.4 t -109.49 137.16 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 125.434 1.494 . . . . 0.0 108.789 178.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -55.63 -41.58 73.73 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.447 1.099 . . . . 0.0 113.292 -172.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.3 p30 -78.03 -14.82 59.37 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 178.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 96.3 m 49.59 61.92 2.91 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.372 1.469 . . . . 0.0 112.492 -174.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.68 136.13 57.97 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.693 0.797 . . . . 0.0 112.448 179.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 43.7 t -60.8 119.4 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 169.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 45.4 pt -100.8 -17.55 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 125.534 1.533 . . . . 0.0 112.315 176.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -157.93 146.83 19.35 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.336 1.055 . . . . 0.0 112.099 178.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.528 ' HB3' ' CE1' ' A' ' 48' ' ' PHE . 1.9 m -131.24 153.8 49.13 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.462 1.105 . . . . 0.0 111.947 177.114 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -76.84 -166.9 0.75 Allowed 'General case' 0 CA--C 1.556 1.201 0 CA-C-N 118.939 0.79 . . . . 0.0 111.673 169.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -105.61 -19.16 13.86 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.496 1.518 . . . . 0.0 112.759 169.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -75.35 -35.99 46.18 Favored Glycine 0 C--N 1.343 0.968 0 O-C-N 121.488 -0.758 . . . . 0.0 112.549 -179.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.528 ' CE1' ' HB3' ' A' ' 44' ' ' CYS . 0.6 OUTLIER -65.4 -34.38 78.16 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.586 0.754 . . . . 0.0 111.59 179.72 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 57.2 m -51.42 -52.24 47.83 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.192 1.397 . . . . 0.0 111.799 172.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -71.85 -20.14 61.86 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -179.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.52 -54.06 42.13 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.51 1.124 . . . . 0.0 110.618 177.015 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 41.9 t -92.83 -32.64 14.56 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.53 1.84 55.47 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.447 1.499 . . . . 0.0 114.185 -175.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -81.69 -165.99 1.1 Allowed 'General case' 0 CA--C 1.555 1.151 0 CA-C-N 118.706 1.253 . . . . 0.0 113.055 171.097 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 32.8 m -142.39 160.02 41.09 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.894 1.278 . . . . 0.0 111.424 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -47.99 -49.16 31.71 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.018 0.927 . . . . 0.0 111.967 178.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.34 -25.9 37.58 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 179.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -89.62 -35.52 15.81 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.856 1.262 . . . . 0.0 112.124 178.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 18.9 t -93.67 -11.03 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.372 1.069 . . . . 0.0 112.659 -176.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 75.4 mmm -68.46 142.72 55.25 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 120.586 -1.321 . . . . 0.0 111.302 170.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 71.14 5.17 5.37 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 126.268 1.827 . . . . 0.0 113.77 -177.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -76.63 155.26 83.5 Favored Pre-proline 0 N--CA 1.475 0.817 0 C-N-CA 124.483 1.113 . . . . 0.0 110.317 173.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -74.58 12.23 1.16 Allowed 'Trans proline' 0 CA--C 1.549 1.234 0 C-N-CA 124.016 3.144 . . . . 0.0 116.273 179.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 5.8 t 75.24 -23.46 0.24 Allowed 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 126.6 1.96 . . . . 0.0 114.154 169.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 39.3 p -64.05 -21.73 66.64 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 127.561 2.344 . . . . 0.0 113.442 173.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 89.0 m 59.55 36.53 22.85 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.85 1.26 . . . . 0.0 113.168 -178.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -52.14 -36.39 51.27 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.797 1.639 . . . . 0.0 112.434 177.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -66.9 -11.39 55.96 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.715 1.206 . . . . 0.0 114.041 179.009 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 33.7 mt -93.75 -3.15 52.69 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.976 1.31 . . . . 0.0 113.649 171.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.417 ' CG ' HG21 ' A' ' 74' ' ' THR . 0.3 OUTLIER -77.95 118.82 20.62 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 121.092 -1.005 . . . . 0.0 110.318 -178.384 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -107.97 -162.95 21.19 Favored Glycine 0 CA--C 1.538 1.529 0 C-N-CA 126.189 1.852 . . . . 0.0 112.605 178.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -69.12 -22.43 35.04 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 123.339 2.693 . . . . 0.0 113.162 179.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 85.5 mtt85 -84.89 -12.2 53.97 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.16 0.984 . . . . 0.0 113.297 177.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.417 HG21 ' CG ' ' A' ' 70' ' ' HIS . 18.4 m -76.93 151.73 35.61 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.645 1.178 . . . . 0.0 111.244 -173.594 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.8 109.25 18.99 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.027 1.331 . . . . 0.0 109.144 -170.115 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 36.5 mmt180 -64.46 -24.24 67.55 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 121.449 -0.782 . . . . 0.0 112.996 179.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 20.5 tpp180 -58.71 -40.16 82.9 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.344 1.058 . . . . 0.0 112.327 168.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -77.8 -42.05 35.18 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.493 1.517 . . . . 0.0 112.161 175.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -54.18 -37.1 64.12 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 121.559 -0.713 . . . . 0.0 112.167 174.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.95 -47.81 76.32 Favored 'General case' 0 C--O 1.227 -0.113 0 C-N-CA 125.213 1.405 . . . . 0.0 111.291 175.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 22.3 mm-40 -61.51 -38.27 86.76 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 118.136 -0.935 . . . . 0.0 111.039 178.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 96.8 mt -63.16 -45.63 98.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 CA-C-N 120.439 1.472 . . . . 0.0 111.629 172.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.31 -39.48 92.51 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 118.898 0.772 . . . . 0.0 112.779 178.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -76.2 -25.75 55.46 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 124.049 0.94 . . . . 0.0 112.233 176.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -58.74 -29.92 67.09 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 120.172 1.351 . . . . 0.0 112.368 175.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 51.6 mt -67.51 -13.34 61.96 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.998 1.719 . . . . 0.0 113.442 175.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 66.9 mt -87.87 -13.62 41.57 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.307 1.043 . . . . 0.0 112.443 174.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -90.8 146.53 18.48 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 125.102 1.334 . . . . 0.0 113.542 -175.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -86.8 -7.74 57.97 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.899 1.279 . . . . 0.0 113.737 173.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -118.32 162.4 18.35 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.491 1.916 . . . . 0.0 111.428 -175.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -64.6 143.14 58.13 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.613 1.165 . . . . 0.0 112.912 -175.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 27.6 mmt180 -139.52 132.42 29.31 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.101 1.36 . . . . 0.0 111.546 176.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 38.3 mtmt -110.72 131.22 55.23 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.413 1.485 . . . . 0.0 109.854 167.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 64.3 t -132.44 137.08 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 125.126 1.371 . . . . 0.0 108.51 177.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -102.2 131.12 48.93 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.139 0.975 . . . . 0.0 110.762 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.3 tt -156.57 147.58 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.005 0.922 . . . . 0.0 112.033 -169.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -88.97 124.39 34.2 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 120.921 -1.112 . . . . 0.0 111.843 178.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 15.2 m-30 -113.02 134.3 54.58 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.702 1.601 . . . . 0.0 111.678 177.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -73.2 146.08 45.8 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.135 1.374 . . . . 0.0 112.308 169.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 32.4 ptt-85 -117.96 150.69 38.82 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.781 1.632 . . . . 0.0 112.609 173.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -61.83 -13.81 27.6 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.974 1.71 . . . . 0.0 114.373 -179.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -67.33 -12.9 61.35 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.548 1.139 . . . . 0.0 112.797 169.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 100.21 30.1 6.46 Favored Glycine 0 C--N 1.341 0.859 0 C-N-CA 124.914 1.245 . . . . 0.0 113.328 174.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 16.5 t -153.4 -168.33 2.97 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 118.303 1.051 . . . . 0.0 111.991 -174.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 27.0 t -146.64 161.13 41.2 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.203 1.401 . . . . 0.0 111.924 -166.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -165.16 163.35 20.36 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.202 1.801 . . . . 0.0 112.301 173.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -79.53 124.74 28.77 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 123.484 0.714 . . . . 0.0 110.783 176.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 34.0 t -107.2 136.85 46.33 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.254 1.822 . . . . 0.0 109.528 170.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 14.2 tp -88.08 123.28 32.6 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 161.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 60.5 t -108.75 116.91 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 125.336 1.454 . . . . 0.0 108.763 177.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -113.13 112.88 24.57 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.348 1.059 . . . . 0.0 108.991 -178.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.3 p -88.74 120.36 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 121.276 0.56 . . . . 0.0 109.706 172.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 90.5 t -104.25 111.76 65.26 Favored Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 125.341 1.456 . . . . 0.0 107.432 175.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.5 122.76 7.65 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 123.093 2.528 . . . . 0.0 109.418 177.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 60.2 t -94.59 117.8 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 174.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 20.3 mtpt -88.68 149.17 23.64 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.469 0.652 . . . . 0.0 111.175 172.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 51.2 p30 -77.77 -173.39 3.02 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.065 1.346 . . . . 0.0 111.997 175.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -66.24 -15.74 63.43 Favored 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 114.749 1.388 . . . . 0.0 114.749 175.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -97.25 -17.14 20.0 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.567 1.147 . . . . 0.0 113.271 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 86.36 40.48 7.36 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 125.846 1.689 . . . . 0.0 113.636 -174.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -115.06 151.31 34.48 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.267 1.427 . . . . 0.0 109.879 159.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.6 p -83.5 126.58 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 CA-C-N 119.055 0.843 . . . . 0.0 110.532 179.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.69 -27.04 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 -173.43 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 61.2 mtm -129.86 150.72 51.03 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.875 1.27 . . . . 0.0 112.117 171.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -110.75 133.22 53.52 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 125.458 1.503 . . . . 0.0 109.104 167.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 32.9 mt -102.8 119.94 51.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 165.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -100.35 119.62 38.71 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 175.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -107.31 127.8 53.88 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.437 1.095 . . . . 0.0 109.505 -177.438 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 16.1 m-30 -104.37 133.65 48.91 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.084 1.354 . . . . 0.0 110.571 -178.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -142.34 118.68 10.85 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 123.899 0.88 . . . . 0.0 109.758 173.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.0 p -68.27 115.01 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 O-C-N 121.437 -0.79 . . . . 0.0 109.525 176.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.3 p -99.57 -26.61 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 125.283 1.433 . . . . 0.0 113.315 -169.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 24.9 ptp -161.43 148.01 14.43 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.173 0.989 . . . . 0.0 112.898 168.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -90.46 130.04 36.57 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.019 0.927 . . . . 0.0 110.732 -179.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 7.0 mmpt? . . . . . 0 C--O 1.254 1.29 0 C-N-CA 124.355 1.062 . . . . 0.0 112.723 175.046 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.3 mtp . . . . . 0 N--CA 1.496 1.866 0 CA-C-O 118.42 -0.8 . . . . 0.0 110.679 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -78.48 155.43 28.2 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 123.507 2.804 . . . . 0.0 111.512 176.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 62.9 t -91.8 86.57 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 170.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 20.9 tpp180 -64.32 -43.57 94.26 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.469 1.108 . . . . 0.0 112.948 -169.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -122.65 147.27 46.64 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.122 1.769 . . . . 0.0 109.692 170.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -81.11 164.47 46.15 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.477 1.037 . . . . 0.0 111.68 171.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 59.4 m-70 -81.55 161.01 23.73 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 124.283 1.033 . . . . 0.0 112.013 176.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -137.44 -67.87 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 C-N-CA 123.685 0.794 . . . . 0.0 111.523 -174.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 40.75 55.91 7.76 Favored Pre-proline 0 CA--C 1.562 1.409 0 N-CA-C 117.597 2.443 . . . . 0.0 117.597 -174.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -85.21 36.86 0.56 Allowed 'Trans proline' 0 CA--C 1.544 0.991 1 C-N-CA 126.731 4.954 . . . . 0.0 111.348 176.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 -83.97 -159.77 0.4 Allowed 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.716 0.807 . . . . 0.0 109.663 -178.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -73.88 140.98 46.06 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 120.113 -1.617 . . . . 0.0 109.919 167.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 37.1 p -120.98 -45.56 2.37 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.4 1.48 . . . . 0.0 111.719 -172.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -71.54 -46.77 58.62 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.498 0.719 . . . . 0.0 111.221 176.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 64.5 tp -63.15 -36.09 82.46 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.081 0.953 . . . . 0.0 111.138 176.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -59.85 -29.26 68.16 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 174.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 66.3 m -77.04 -19.88 56.6 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.014 1.325 . . . . 0.0 111.505 175.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 22.5 mm -84.33 -43.64 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 125.258 1.423 . . . . 0.0 111.351 170.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 71.6 mt -58.38 -35.54 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 O-C-N 121.424 -0.798 . . . . 0.0 111.022 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -72.47 -7.95 52.53 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 179.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 17.6 mtmt -84.32 -42.08 16.14 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.215 1.406 . . . . 0.0 110.731 171.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -79.72 -40.18 29.49 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.045 1.338 . . . . 0.0 113.054 179.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -81.5 -28.2 34.15 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 118.972 0.806 . . . . 0.0 112.231 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 99.98 97.88 2.21 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 126.436 1.969 . . . . 0.0 112.337 169.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -61.58 -13.76 24.47 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.228 1.411 . . . . 0.0 114.294 178.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.2 m -68.22 -23.74 64.84 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.191 0.996 . . . . 0.0 113.15 170.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -78.35 150.51 33.2 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.193 0.997 . . . . 0.0 109.872 170.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.78 134.61 34.89 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 120.753 -1.217 . . . . 0.0 111.394 178.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -157.89 153.64 26.63 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.311 1.044 . . . . 0.0 112.928 178.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 15.2 pt -140.62 150.14 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 125.871 1.668 . . . . 0.0 109.758 175.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.7 mp -114.27 132.29 63.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 125.364 1.466 . . . . 0.0 108.983 -178.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -132.72 147.42 52.32 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 124.9 1.28 . . . . 0.0 111.849 -176.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 24.2 p30 -73.71 119.25 17.67 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.566 0.746 . . . . 0.0 112.217 -178.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.81 -29.13 61.99 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 120.705 -1.247 . . . . 0.0 112.191 -178.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 29.6 mmm180 -74.61 27.48 0.08 Allowed 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 126.486 1.914 . . . . 0.0 114.039 -176.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 84.9 t -147.33 136.61 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 126.942 2.097 . . . . 0.0 108.805 -171.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -56.93 -43.17 81.18 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.596 1.159 . . . . 0.0 113.019 -173.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -80.2 -14.97 58.02 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -177.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 96.5 m 49.85 68.34 0.76 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.614 1.566 . . . . 0.0 111.487 -168.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.26 136.23 44.56 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.562 0.745 . . . . 0.0 111.516 -174.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 39.8 t -63.74 122.48 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 174.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.6 pt -102.99 -19.66 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 124.987 1.315 . . . . 0.0 112.312 175.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -155.3 144.73 21.13 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.886 0.874 . . . . 0.0 112.54 178.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.44 ' HB3' ' CE1' ' A' ' 48' ' ' PHE . 1.8 m -130.63 152.95 49.44 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.767 1.227 . . . . 0.0 112.656 -179.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -75.22 -166.8 0.54 Allowed 'General case' 0 CA--C 1.557 1.216 0 C-N-CA 122.905 0.482 . . . . 0.0 112.074 170.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -102.9 -23.07 13.76 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.296 1.438 . . . . 0.0 112.705 168.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.85 -34.0 59.58 Favored Glycine 0 N--CA 1.47 0.917 0 C-N-CA 124.892 1.234 . . . . 0.0 112.754 -177.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.44 ' CE1' ' HB3' ' A' ' 44' ' ' CYS . 0.6 OUTLIER -71.4 -32.87 68.93 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 123.904 0.882 . . . . 0.0 111.268 -176.98 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 6.2 t -53.74 -49.26 68.54 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.637 1.175 . . . . 0.0 111.658 171.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -75.56 -21.19 58.1 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -179.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 47.6 tp -63.6 -48.59 76.73 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 121.488 -0.757 . . . . 0.0 111.198 172.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 17.8 t -103.76 -30.63 10.28 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 -172.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.25 6.79 58.67 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 124.307 0.955 . . . . 0.0 114.568 -176.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -88.42 -155.54 0.33 Allowed 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 118.698 1.249 . . . . 0.0 111.655 169.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 12.2 t -162.06 169.12 21.54 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 120.564 -1.335 . . . . 0.0 111.006 175.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -53.51 -44.74 69.32 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.12 0.968 . . . . 0.0 111.394 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.85 -28.49 56.66 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 119.811 1.187 . . . . 0.0 114.025 177.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -92.01 -38.12 12.42 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.854 1.262 . . . . 0.0 112.018 177.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 79.1 t -79.38 -19.07 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 126.057 1.743 . . . . 0.0 111.508 -177.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.39 131.56 50.67 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 120.895 -1.128 . . . . 0.0 110.788 172.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 8.0 tm0? 75.49 5.76 4.05 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 126.229 1.812 . . . . 0.0 113.561 179.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 34.7 mmt180 -85.71 153.01 57.83 Favored Pre-proline 0 N--CA 1.473 0.696 0 C-N-CA 124.536 1.134 . . . . 0.0 111.352 176.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -69.98 134.92 28.66 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 123.133 2.555 . . . . 0.0 109.978 171.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 20.6 p -67.52 -11.57 58.31 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 114.848 1.425 . . . . 0.0 114.848 -174.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 46.9 p -58.44 -30.53 66.98 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.379 1.472 . . . . 0.0 112.114 172.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 91.7 m 51.82 35.21 14.89 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.041 1.336 . . . . 0.0 112.604 -173.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -58.4 -29.72 66.27 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.427 1.091 . . . . 0.0 112.331 -179.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -60.91 -10.36 5.57 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.371 1.468 . . . . 0.0 114.307 175.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 58.0 mt -84.8 2.01 44.18 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.937 1.295 . . . . 0.0 113.952 173.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 13.8 p-80 -66.29 154.5 39.79 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 114.724 1.379 . . . . 0.0 114.724 177.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -151.9 -163.94 11.88 Favored Glycine 0 CA--C 1.54 1.609 0 C-N-CA 127.359 2.409 . . . . 0.0 111.231 167.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.95 -23.08 62.12 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 123.01 2.473 . . . . 0.0 114.916 -173.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 40.1 mmt180 -89.75 -4.28 57.75 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 119.509 1.049 . . . . 0.0 113.644 174.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 31.5 m -73.3 134.18 44.11 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 119.534 1.061 . . . . 0.0 109.532 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 81.2 mm-40 -91.03 117.53 29.66 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -174.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 7.9 tmm_? -59.6 -37.07 77.57 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 121.535 -0.728 . . . . 0.0 112.013 -176.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 25.7 tpt180 -61.22 -40.22 93.2 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.184 0.994 . . . . 0.0 112.087 173.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -71.68 -41.45 68.66 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 120.755 -1.216 . . . . 0.0 112.706 177.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -56.16 -35.03 66.71 Favored 'General case' 0 CA--C 1.546 0.815 0 O-C-N 121.644 -0.66 . . . . 0.0 111.846 172.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.1 -47.76 56.27 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.8 1.24 . . . . 0.0 112.571 172.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -57.71 -37.27 73.23 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 118.764 0.711 . . . . 0.0 111.402 178.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 85.5 mt -62.46 -38.83 82.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 CA-C-N 120.098 1.317 . . . . 0.0 112.068 173.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.71 -38.07 76.8 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 119.326 0.966 . . . . 0.0 112.169 174.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 94.4 mm-40 -66.86 -31.8 72.65 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.55 0.74 . . . . 0.0 111.916 174.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.48 -23.52 66.97 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.997 0.919 . . . . 0.0 112.718 177.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 41.6 mt -82.81 -15.06 53.11 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.255 1.422 . . . . 0.0 113.257 173.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 73.7 mt -90.19 -16.2 29.94 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.236 1.015 . . . . 0.0 112.002 173.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -85.33 148.35 22.96 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 125.238 1.399 . . . . 0.0 112.754 176.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -96.69 4.34 51.91 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 114.279 1.215 . . . . 0.0 114.279 -179.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.32 160.9 30.75 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.349 1.86 . . . . 0.0 110.324 177.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -64.53 145.89 55.44 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -178.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 12.5 tpt180 -148.22 129.57 14.77 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.114 1.366 . . . . 0.0 110.94 -172.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 39.7 mtmt -104.55 138.42 40.94 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.514 1.525 . . . . 0.0 111.274 178.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 45.0 t -139.23 134.67 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 125.163 1.385 . . . . 0.0 109.292 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -101.43 128.41 47.64 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.835 0.854 . . . . 0.0 111.082 178.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.5 tt -153.95 147.2 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 124.924 1.29 . . . . 0.0 111.694 -167.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -84.84 123.88 30.96 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 120.716 -1.24 . . . . 0.0 111.462 173.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 10.2 m-30 -105.64 145.32 31.18 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.807 1.643 . . . . 0.0 110.695 172.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -110.61 131.24 55.22 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.232 1.413 . . . . 0.0 111.716 175.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 59.4 mtt180 -71.21 165.5 23.49 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.922 1.689 . . . . 0.0 112.54 174.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -66.47 -23.02 66.2 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.088 0.955 . . . . 0.0 112.753 170.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -73.36 -11.71 60.58 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.626 1.571 . . . . 0.0 113.814 172.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 90.27 -3.95 82.44 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 125.267 1.413 . . . . 0.0 114.352 -175.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 30.4 m -77.25 164.51 25.52 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 118.213 1.007 . . . . 0.0 111.644 175.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 30.6 p -145.91 166.07 27.09 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 120.9 -1.125 . . . . 0.0 114.007 -178.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -165.44 160.49 18.0 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.154 1.781 . . . . 0.0 110.918 -178.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -79.72 121.69 25.64 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.746 0.818 . . . . 0.0 110.453 169.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 44.5 t -105.64 138.48 41.77 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 127.463 2.305 . . . . 0.0 109.687 174.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 15.4 tp -96.65 112.88 24.45 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 164.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 95.7 t -94.51 114.36 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 124.994 1.318 . . . . 0.0 108.564 174.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -106.23 107.59 18.67 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.991 1.316 . . . . 0.0 107.835 175.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 61.3 t -77.78 130.1 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 166.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 88.6 t -119.55 112.49 35.53 Favored Pre-proline 0 CA--C 1.537 0.462 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 167.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -74.59 134.59 18.75 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.738 2.292 . . . . 0.0 109.91 -179.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 45.5 t -92.81 119.4 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 171.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 66.1 mttt -93.01 151.95 19.59 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 121.648 0.737 . . . . 0.0 112.294 168.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -91.61 -173.78 3.66 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.887 0.875 . . . . 0.0 111.66 174.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -60.26 -22.11 62.68 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.986 1.315 . . . . 0.0 114.347 178.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -90.44 -5.6 55.9 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.747 1.219 . . . . 0.0 113.055 178.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 79.15 20.14 70.59 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 124.371 0.986 . . . . 0.0 114.262 -178.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -98.99 146.49 25.97 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.788 1.235 . . . . 0.0 109.46 172.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 96.5 t -76.09 128.49 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 176.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 3.3 pt -122.91 -24.87 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 113.863 1.061 . . . . 0.0 113.863 -172.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 71.4 mtm -147.82 155.09 41.29 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.492 1.517 . . . . 0.0 110.473 177.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -112.26 132.65 54.82 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.453 1.101 . . . . 0.0 109.774 171.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 56.6 mt -97.57 115.93 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 163.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -95.19 125.78 40.07 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 171.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -114.42 123.6 49.86 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 118.65 -0.691 . . . . 0.0 111.713 179.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 17.9 m-30 -108.9 97.6 7.21 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.409 1.484 . . . . 0.0 113.435 -170.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -109.26 112.9 25.31 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 120.231 -1.543 . . . . 0.0 109.743 -177.159 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.3 p -62.86 108.09 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 O-C-N 121.236 -0.915 . . . . 0.0 110.105 173.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.3 p -85.59 -23.77 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 125.199 1.4 . . . . 0.0 112.749 -176.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 32.5 ttm -163.43 124.89 2.41 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.71 1.204 . . . . 0.0 110.686 -175.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -81.12 127.02 32.18 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.216 0.606 . . . . 0.0 109.943 172.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 6.4 mmpt? . . . . . 0 C--O 1.253 1.284 0 C-N-CA 124.701 1.201 . . . . 0.0 112.81 177.232 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.8 mtp . . . . . 0 N--CA 1.496 1.848 0 CA-C-O 116.543 -1.694 . . . . 0.0 112.424 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.61 138.65 32.6 Favored 'Trans proline' 0 C--N 1.359 1.114 0 C-N-CA 122.324 2.016 . . . . 0.0 111.994 -176.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 96.8 t -145.42 129.67 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 125.617 1.567 . . . . 0.0 108.584 175.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 74.6 mtp85 -103.01 125.63 49.85 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.449 1.099 . . . . 0.0 110.432 175.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 51.5 ptt85 -169.13 167.44 10.46 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 126.895 2.078 . . . . 0.0 111.725 -174.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 131.47 -108.87 0.83 Allowed Glycine 0 N--CA 1.473 1.137 0 C-N-CA 125.489 1.519 . . . . 0.0 111.158 -174.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 33.8 p80 -139.83 164.42 30.03 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.925 1.29 . . . . 0.0 111.945 177.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.0 p -69.99 147.06 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 123.83 0.852 . . . . 0.0 111.431 176.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.16 153.28 95.67 Favored Pre-proline 0 CA--C 1.554 1.11 0 C-N-CA 124.216 1.006 . . . . 0.0 112.059 172.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -67.54 152.33 78.55 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 123.15 2.567 . . . . 0.0 111.697 178.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 23.5 mp0 -71.06 160.28 33.18 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.837 1.255 . . . . 0.0 112.333 -177.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -83.01 47.39 1.22 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.374 1.47 . . . . 0.0 113.181 -175.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 62.3 p -52.74 -30.52 33.07 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 127.543 2.337 . . . . 0.0 114.117 -173.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -68.97 -52.01 33.58 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.839 0.856 . . . . 0.0 111.715 173.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 57.3 tp -61.61 -35.61 78.35 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.83 1.252 . . . . 0.0 111.155 176.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -57.84 -31.16 66.37 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.829 0.851 . . . . 0.0 113.049 176.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 94.7 m -72.91 -29.64 63.29 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.199 1.0 . . . . 0.0 110.929 174.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 12.3 mm -77.07 -41.88 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 O-C-N 121.606 -0.684 . . . . 0.0 110.163 175.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 92.0 mt -55.36 -49.63 71.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 124.07 0.948 . . . . 0.0 110.435 175.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 11.4 ptm180 -71.85 -19.23 62.0 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -176.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -75.49 -39.92 57.91 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.046 0.939 . . . . 0.0 112.443 168.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -82.29 -27.66 32.2 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.516 1.126 . . . . 0.0 113.199 -179.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -64.73 146.62 54.52 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.933 0.893 . . . . 0.0 111.855 174.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -80.37 52.15 4.29 Favored Glycine 0 N--CA 1.467 0.757 0 C-N-CA 125.433 1.492 . . . . 0.0 113.231 -174.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -76.96 -27.57 54.85 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.087 0.555 . . . . 0.0 112.13 170.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 47.0 m -106.4 -34.97 7.26 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -175.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -113.59 149.42 34.54 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.342 1.457 . . . . 0.0 110.216 178.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.52 149.13 30.07 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.537 1.135 . . . . 0.0 112.328 -173.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -165.46 165.52 19.09 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.764 1.226 . . . . 0.0 114.232 -178.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 15.2 pt -144.0 153.1 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 126.978 2.111 . . . . 0.0 109.708 171.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.9 mp -119.57 128.1 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 124.858 1.263 . . . . 0.0 108.795 176.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -120.63 144.56 48.08 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 124.87 1.268 . . . . 0.0 111.413 175.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -68.72 129.51 40.14 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.298 0.639 . . . . 0.0 110.818 172.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -78.44 -26.13 46.13 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 175.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 29.8 mmm180 -76.87 29.06 0.13 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 126.312 1.845 . . . . 0.0 113.894 -174.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.0 m -148.45 148.83 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 126.811 2.044 . . . . 0.0 110.099 -176.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -63.57 -38.13 89.95 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.202 1.001 . . . . 0.0 113.61 -168.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 -89.33 -9.25 51.17 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -174.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 97.6 m 50.65 57.71 6.32 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.603 1.161 . . . . 0.0 111.301 -167.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.26 136.92 52.62 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.028 0.931 . . . . 0.0 112.039 -176.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 46.3 t -63.48 123.03 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.809 0.844 . . . . 0.0 109.723 175.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 38.8 pt -103.18 -19.39 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 125.369 1.468 . . . . 0.0 112.361 175.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -151.91 139.91 20.11 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.537 1.135 . . . . 0.0 110.915 178.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.418 ' HB3' ' CE1' ' A' ' 48' ' ' PHE . 8.2 m -120.9 157.78 29.11 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.713 0.805 . . . . 0.0 111.818 177.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -69.93 -173.15 0.6 Allowed 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 122.707 0.403 . . . . 0.0 111.324 160.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -116.98 -13.34 10.62 Favored 'General case' 0 N--CA 1.481 1.076 0 O-C-N 120.715 -1.241 . . . . 0.0 112.643 167.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -68.31 -41.07 86.86 Favored Glycine 0 N--CA 1.469 0.837 0 C-N-CA 127.492 2.472 . . . . 0.0 112.951 168.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.418 ' CE1' ' HB3' ' A' ' 44' ' ' CYS . 0.4 OUTLIER -65.09 -32.27 73.89 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 123.873 0.869 . . . . 0.0 111.709 -175.729 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 35.3 t -56.3 -50.61 70.92 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.455 1.902 . . . . 0.0 111.374 170.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -74.39 -25.35 59.43 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 178.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 38.2 tp -62.56 -47.59 83.18 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.955 0.902 . . . . 0.0 111.249 170.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 69.0 m -99.76 -32.9 10.8 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 -168.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 93.39 6.77 62.5 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 125.865 1.697 . . . . 0.0 114.089 -178.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -86.69 -144.93 0.12 Allowed 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.642 1.177 . . . . 0.0 111.397 170.377 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 78.2 p -158.36 165.25 35.19 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.901 1.281 . . . . 0.0 112.302 170.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 45.9 ttm105 -52.39 -46.78 66.4 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.242 0.617 . . . . 0.0 111.278 169.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.04 -30.79 60.32 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 119.467 1.031 . . . . 0.0 113.772 177.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -90.05 -38.53 13.52 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.811 0.844 . . . . 0.0 112.927 178.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 41.0 t -82.21 -11.7 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 124.059 0.943 . . . . 0.0 112.302 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 66.1 mmm -67.07 135.08 53.1 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 120.614 -1.304 . . . . 0.0 110.687 171.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 8.8 tm0? 75.2 4.97 4.22 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 126.614 1.966 . . . . 0.0 113.38 -176.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -88.65 155.14 50.84 Favored Pre-proline 0 N--CA 1.476 0.827 0 C-N-CA 124.657 1.183 . . . . 0.0 111.285 175.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -68.42 139.83 46.39 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 123.271 2.647 . . . . 0.0 110.609 170.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 32.1 p -68.41 -2.96 9.67 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 -178.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 40.6 p -63.47 -31.5 72.68 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.154 1.382 . . . . 0.0 112.236 172.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 81.4 m 51.07 34.86 11.65 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.755 1.222 . . . . 0.0 112.862 -173.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -57.98 -31.17 66.65 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.834 1.253 . . . . 0.0 112.58 -175.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -58.11 -15.6 10.1 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.484 1.514 . . . . 0.0 114.311 176.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 87.9 mt -74.51 -7.65 53.73 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 173.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 17.6 p-80 -60.99 140.19 57.87 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 120.197 1.362 . . . . 0.0 113.259 178.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -124.73 -163.57 11.69 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 126.546 2.022 . . . . 0.0 111.786 171.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -69.91 -21.15 33.17 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 123.15 2.567 . . . . 0.0 113.333 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.15 3.0 55.89 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.501 1.12 . . . . 0.0 113.355 178.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 17.3 m -85.76 137.17 32.98 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.092 1.357 . . . . 0.0 109.946 178.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -102.82 131.58 49.6 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.234 1.014 . . . . 0.0 109.997 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 22.4 tpp85 -58.1 -35.17 71.05 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.019 0.927 . . . . 0.0 112.618 -177.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -57.09 -42.02 79.94 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.645 1.178 . . . . 0.0 112.463 177.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -73.12 -43.9 61.02 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.437 -0.789 . . . . 0.0 112.202 177.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.07 -36.15 72.4 Favored 'General case' 0 CA--C 1.545 0.758 0 O-C-N 121.405 -0.809 . . . . 0.0 111.99 174.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.36 -48.02 65.91 Favored 'General case' 0 C--O 1.224 -0.24 0 C-N-CA 125.543 1.537 . . . . 0.0 111.927 173.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -57.43 -39.52 76.4 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 118.286 -0.864 . . . . 0.0 111.215 178.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 97.4 mt -59.92 -45.87 94.61 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 CA-C-N 120.256 1.389 . . . . 0.0 112.003 172.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.9 -36.85 80.92 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 118.827 0.74 . . . . 0.0 112.862 179.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 96.4 mm-40 -69.7 -32.81 71.62 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.707 1.203 . . . . 0.0 111.593 175.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.42 ' HB1' HG11 ' A' ' 112' ' ' VAL . . . -59.74 -29.99 68.53 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 119.09 0.859 . . . . 0.0 112.786 179.275 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 56.1 mt -70.86 -15.93 62.67 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.342 1.457 . . . . 0.0 113.215 177.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 60.5 mt -86.25 -13.04 47.97 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.105 0.962 . . . . 0.0 112.351 174.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -91.6 151.79 21.12 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 125.41 1.481 . . . . 0.0 113.078 178.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -93.39 0.07 56.72 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.91 1.284 . . . . 0.0 113.906 177.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -123.16 160.25 26.89 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.946 1.698 . . . . 0.0 111.208 -173.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -60.06 144.79 48.67 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.106 0.963 . . . . 0.0 112.567 -178.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 13.6 tpt180 -150.36 130.71 13.74 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.199 0.999 . . . . 0.0 111.597 -178.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 38.6 mtmt -110.44 132.27 54.32 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.226 1.41 . . . . 0.0 110.412 173.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 42.6 t -130.24 133.23 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 124.989 1.316 . . . . 0.0 108.466 177.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -102.41 134.92 44.94 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.099 0.96 . . . . 0.0 110.482 -179.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.0 tt -159.32 146.22 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.551 0.741 . . . . 0.0 112.08 -166.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -88.38 122.81 32.3 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 121.516 -0.74 . . . . 0.0 110.466 172.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -110.45 148.34 32.25 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.676 1.191 . . . . 0.0 112.092 173.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -107.63 134.38 50.71 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.995 1.718 . . . . 0.0 110.616 177.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -108.6 156.72 19.21 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.822 1.649 . . . . 0.0 111.394 -166.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -64.59 -20.89 66.52 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 -176.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -76.14 -7.26 54.38 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.525 1.13 . . . . 0.0 113.561 175.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 97.06 0.57 59.96 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 125.581 1.562 . . . . 0.0 114.362 -179.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 25.5 m -90.37 164.04 14.47 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.759 1.223 . . . . 0.0 112.383 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 28.3 p -140.23 158.72 43.59 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 121.103 -0.998 . . . . 0.0 111.734 167.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -167.86 160.1 12.08 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.081 1.352 . . . . 0.0 113.019 -178.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -77.81 121.57 24.26 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 124.186 0.994 . . . . 0.0 110.827 176.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 10.6 t -106.24 141.26 37.88 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.056 1.742 . . . . 0.0 109.566 172.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -86.9 133.42 33.61 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 156.343 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.4 t -117.57 117.18 54.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 124.527 1.131 . . . . 0.0 108.446 171.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -113.52 114.01 25.92 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.288 1.035 . . . . 0.0 108.74 -176.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.42 HG11 ' HB1' ' A' ' 85' ' ' ALA . 2.4 p -86.0 126.94 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 169.159 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 97.6 t -114.59 106.43 52.31 Favored Pre-proline 0 CA--C 1.537 0.447 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 173.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -74.77 132.56 15.88 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.027 2.485 . . . . 0.0 109.819 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 99.1 t -97.14 110.62 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 172.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 63.4 mttt -82.89 152.81 25.4 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.356 0.598 . . . . 0.0 111.556 167.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -92.68 -173.88 3.48 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.922 0.889 . . . . 0.0 111.829 172.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -60.3 -22.06 62.71 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.158 1.383 . . . . 0.0 114.379 178.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -89.7 -5.61 56.87 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.873 1.269 . . . . 0.0 112.993 177.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 78.65 21.53 68.89 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 124.588 1.089 . . . . 0.0 114.27 -178.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -100.3 143.33 30.62 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.678 1.191 . . . . 0.0 109.216 171.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.7 p -76.69 125.22 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-O 121.806 0.812 . . . . 0.0 110.175 174.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 3.9 pt -116.49 -22.66 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 125.378 1.471 . . . . 0.0 113.543 -171.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 55.4 mtm -145.93 150.2 35.63 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.595 1.558 . . . . 0.0 110.799 175.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -114.43 124.54 52.19 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 125.197 1.399 . . . . 0.0 109.504 172.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 47.3 mt -98.39 114.68 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 169.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -102.17 125.22 48.81 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 175.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -117.74 130.21 56.18 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.142 0.977 . . . . 0.0 110.389 -173.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -106.65 135.42 48.2 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.017 1.327 . . . . 0.0 110.554 -177.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -145.17 136.28 24.86 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.757 1.223 . . . . 0.0 109.27 175.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 43.5 t -74.32 117.63 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 177.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.3 p -96.17 -27.53 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -179.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 47.2 tpp -167.45 141.67 3.68 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.064 1.346 . . . . 0.0 110.723 -178.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -88.91 140.12 29.76 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 121.229 -0.919 . . . . 0.0 111.117 177.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.265 0 CA-C-O 117.468 -1.254 . . . . 0.0 112.951 169.599 . . . . . . . . 1 1 . 1 stop_ save_